Research Report 2016

Research Report 2016 Medical

Cover, middle picture: Platelets and fungal hyphae, inverted image; © Hermann/Speth Contents

Foreword ����������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������5

Medical Theoretical Research Units

Biocenter Medical Biochemistry ������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������8 Neurobiochemistry ��������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������12 Clinical Biochemistry ������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������14 Biological Chemistry ������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������16 Cell Biology ��������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������18 Genomics and RNomics ������������������������������������������������������������������������������������������������������������������������������������������������������������������������������22 Molecular Biology ����������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������24 Experimental ­Pathophysiology and ������������������������������������������������������������������������������������������������������������������������������������������28 Molecular Pathophysiology ��������������������������������������������������������������������������������������������������������������������������������������������������������������������������30 Developmental Immunology ������������������������������������������������������������������������������������������������������������������������������������������������������������������������32 Bioinformatics ����������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������34

Department of Physiology and Medical Physics Physiology ����������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������36 Biomedical Physics ��������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������40

Department of Medical Genetics, Molecular and Clinical Pharmacology Cell Genetics ������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������42 Genetic Epidemiology ����������������������������������������������������������������������������������������������������������������������������������������������������������������������������������44 Human Genetics ��������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������48 Biochemical Pharmacology ��������������������������������������������������������������������������������������������������������������������������������������������������������������������������52 Molecular and ­Cellular Pharmacology ����������������������������������������������������������������������������������������������������������������������������������������������������������54

Department of Anatomy, Histology and Embryology Clinical and ­Functional ­Anatomy ������������������������������������������������������������������������������������������������������������������������������������������������������������������56 Neuroanatomy ����������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������58 Histology and Embryology ����������������������������������������������������������������������������������������������������������������������������������������������������������������������������60

Department of Hygiene, and Social Medicine Hygiene and Medical­ ­Microbiology ��������������������������������������������������������������������������������������������������������������������������������������������������������������62 Virology ��������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������66

Institute of Pharmacology ������������������������������������������������������������������������������������������������������������������������������������������������������������������������68

Department of Medical Statistics, Informatics and Health Economics Medical ­Statistics and Informatics ��������������������������������������������������������������������������������������������������������������������������������������������������������������72

Department of Pathology General Pathology ����������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������76

Institute of Legal Medicine ����������������������������������������������������������������������������������������������������������������������������������������������������������������������78

Clinical Research Units

Center of Operative Medicine Visceral, Transplant and Thoracic Surgery ��������������������������������������������������������������������������������������������������������������������������������������������������82 Cardiac Surgery ��������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������88 Vascular Surgery ������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������90 Plastic, Reconstructive­ and Aesthetic Surgery ��������������������������������������������������������������������������������������������������������������������������������������������92 Trauma Surgery ��������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������94 Urology ��������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������96 Orthopedic Surgery ��������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������98 Anaesthesiology and Critical Care Medicine ������������������������������������������������������������������������������������������������������������������������������������������� 102 General and Surgical Critical Care Medicine ��������������������������������������������������������������������������������������������������������������������������������������������106

2 Research Report 2016 Medical University of Innsbruck Center of Internal Medicine Internal Medicine I ������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������110 Internal Medicine II ������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������114 Internal Medicine III ����������������������������������������������������������������������������������������������������������������������������������������������������������������������������������118 Internal Medicine IV ��������������������������������������������������������������������������������������������������������������������������������������������������������������������������������� 122 Internal Medicine V ������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������126 Joint Institution for Emergency Medicine­ and Critical Care Medicine ����������������������������������������������������������������������������������������������������� 130

Center of Psychiatry and Pychotherapy Psychiatry I ������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������� 134 Psychiatry II ����������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������� 138 Medical Psychology ����������������������������������������������������������������������������������������������������������������������������������������������������������������������������������� 140 Child and Adolescent Psychiatry ��������������������������������������������������������������������������������������������������������������������������������������������������������������� 142

Center of and Neurosurgery Neurology ��������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������� 144 Neurosurgery ��������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������� 148

Center of Obstetrics and Gynecology Obstetrics and Gynecology ����������������������������������������������������������������������������������������������������������������������������������������������������������������������� 152 Gynecological ­Endocrinology and ­Reproductive Medicine ������������������������������������������������������������������������������������������������������������������������156

Center of Otorhinolaryngology and Hearing, Speech and Voice Disorders Otorhinolaryngology ������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������160 Hearing, Speech ­and ­Voice Disorders ��������������������������������������������������������������������������������������������������������������������������������������������������������164

Center of Diagnostic Radiology Diagnostic and Interventional Radiology ����������������������������������������������������������������������������������������������������������������������������������������������������166 Neuroradiology ����������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������� 170

Center of Dentistry and CMF-Surgery Prosthodontics, Restorative Dentistry and Periodontology ��������������������������������������������������������������������������������������������������������������������� 174 Orthodontics ����������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������176 Cranio-Maxillo-­Facial and Oral ­Surgery ����������������������������������������������������������������������������������������������������������������������������������������������������� 178

Center of Pediatrics Pediatrics I ������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������� 182 Pediatrics II ��������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������186

Department of Nuclear Medicine ��������������������������������������������������������������������������������������������������������������������������������������������������������� 188

Department of Therapeutic Radiology and ������������������������������������������������������������������������������������������������������������������������192

Department of Dermatology and Venereology ������������������������������������������������������������������������������������������������������������������������������������194 Department of Ophthalmology and Optometry ����������������������������������������������������������������������������������������������������������������������������������198

Women’s Health Center ������������������������������������������������������������������������������������������������������������������������������������������������������������������������� 202

Institute for Neuroscience ��������������������������������������������������������������������������������������������������������������������������������������������������������������������� 204

FWF–funded ­Programmes

Molecular Cell Biology­ and Oncology – DK MCBO ����������������������������������������������������������������������������������������������������������������������������������� 208 Host Response in Opportunistic­ Infections – DK HOROS ������������������������������������������������������������������������������������������������������������������������� 210 Signal Processing in Neurons – DK SPIN ��������������������������������������������������������������������������������������������������������������������������������������������������� 212 SFB-F44–Cell Signaling in Chronic CNS Disorders ����������������������������������������������������������������������������������������������������������������������������������� 214

Core Facilities ������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������� 218

Research Report 2016 Medical University of Innsbruck 3 4 Research Report 2016 Medical University of Innsbruck Foreword

Dear readers,

It is with great pleasure we present our research ac- The current research report was created as part of tivities from 2015–2016 to you, collected together a project from the Knowledge Transfer Centre West in the Medical University of Innsbruck’s (MUI) sec- (WTZ West). This project, which brings together the ond research report. western Austrian Universities and associates, is fi- nanced by the Federal Ministry of Science, Research MUI has made a deep commitment to fostering re- and Economy (BMWFW). The objectives of the WTZ search innovation and excellence with the aim of are, among others, to professionalise knowledge creating knowledge that can advance health. This and technology transfer by simplifying the search commitment is lived up to in collaboration with the for university-based cooperation partners. One of Tirol Kliniken (formerly Tiroler Landeskrankenan- the results of the project is the publishing of two stalten). MUI continues to build on its established research reports and a competence map. main research areas of genetics, epigenetics and genomics, as well as infectiology, immunology and The following pages present the profiles and results organ/tissue replacement, neurosciences and on- for each of MUI’s clinical departments and institutes cology. and underline the discoveries and advances that have come about thanks to the enormous effort of Scientific research at the MUI is very successful our scientists. both nationally and internationally in the highly com- petitive field of research funding. MUI gains approx- I would like to thank all of the scientists for their imately € 40 million of external research funding contribution and their continuing efforts in the name each year. The following externally-funded research of our University as well as all of the people involved programmes and projects are currently established in putting this report together. at the MUI: three FWF-funded doctoral programmes (HOROS, SPIN, MCBO), one special research pro- gramme (SFB-F44 “Cell Signaling in chronic CNS Enjoy reading our second research report! disorders”), 26 EU projects, the K Centre Oncotyrol, the K Project VASCage and five Christian Doppler Univ.-Prof.in Dr.in Christine Bandtlow labs. Vice Rector for Research and International Relations

Research Report 2016 Medical University of Innsbruck 5 6 Research Report 2016 Medical University of Innsbruck Medical Theoretical Research Units

Research Report 2016 Medical University of Innsbruck 7 Biocenter Medical Biochemistry

area of biochemical toxicity focuses on cel- undergo another complete cell cycle lular responses to chemical exposures and We investigate molecular mechanisms that related immunometabolic consequences. link diverse signalling networks to the cen- tral cell cycle control machinery. At the core Research of this machinery is a conserved family of protein kinases, called cyclin-dependent Cell Cycle and Proliferation kinases (CDKs). CDKs become activated by Ludger Hengst binding of a positive regulatory subunit, the Precisely coordinated cell division and cyclin. Sequential activation and inactiva- ­differentiation processes are essential for tion of specific CDK complexes is required growth, development and integrity of multi­ for cell cycle progression. p21 (CDK-inter- cellular organisms. Before cells commit to acting protein, Cip1), p27 (Kinase inhibito- divide, they are exposed to a flood of diverse ry protein, Kip1) and p57 (Kip2) constitute and sometimes conflicting signals aimed one out of two families of CDK inhibitors to regulate cell growth, differentiation, cell (CKI) that bind to CDKs and control CDK proliferation or cell fate. Multiple external kinase activity. Their expression, localisa- as well as internal signals can impinge on tion and modifications play a central role the central cell cycle control machinery in in regulating CDK kinase activity especially Head of Division: order to promote or block cell proliferation. during G1-phase and the decision between Univ.-Prof. Dr. Ludger Hengst All signals need to be properly processed proliferation and cell cycle exit. In addition and integrated to maintain body and organ to their canonical function in CDK kinase Contact: homeostasis. Incorrect signal interpreta- regulation, these inhibitors can also exert Biocenter, Innrain 80–82 tion, processing or integration can lead to CDK independent functions. For example, 6020 Innsbruck hypo- or hyperproliferative disorders, in- the CDK inhibitor p27 can regulate cell mo- cluding diseases like cancer or anaemia. tility and cell migration, linking this tumour [email protected] The decision to continue proliferation or to suppressor protein not only to hyperprolif- Phone: +43 512 9003 70110 exit from the cell cycle into quiescence is eration but also to cancer metastasis. Fax: +43 512 9003 73130 usually made during a specific window of the Among others, we identified the CDK inhibi- www.i-med.ac.at/imcbc/medclinchem- eukaryotic cell division cycle. The cell cycle tor protein p27Kip1. Its activity, localisation folder/medclinchem.html can be subdivided into four phases. DNA or stability can be regulated by diverse mito- replication during S-phase is separated by gen signalling pathways. We investigate how gap phases G1 and G2 from the segregation these pathways control Cip/Kip family pro- Research Branch (ÖSTAT Classifications of the duplicated DNA and other ­cellular tein expression, localisation, modification, components in M-phase (­mitosis and cy- activity or function and study their phys- 104002, 106002, 106037, tokinesis). Cells can decide to withdraw iological roles in normal cells and cancer 106052, 301114 from proliferation or to commit to ­another cells. p27 regulates cell cycle progression round of cell division until they ­progress over the restriction point. Abundant p27 Keywords over the restriction point, a specific­ point binds and inactivates CDKs and can prevent in G1 phase (Fig. 1). Progression over the cell proliferation. The CDK inhibitor protein Cell cycle, cell proliferation, signal trans­ restriction point renders the cell cycle mi- becomes unstable upon cyclin / CDK2 acti- duction, ribosom, phospho-dynamics togen-independent and cells committed to vation, as cells traverse the restriction point

Research Focus

• Cell Cycle & Proliferation (Ludger Hengst) • Signal Transduction & Proliferation (­Wolfgang Doppler) • Phospho-Dynamics (Peter Gruber) • Ribosomal Proteins (Wolfgang Piendl) • Eco- & Nutritional Biochemistry (F. Überall) • Biomedical (Johanne Gostner)

General Facts

Research in the Division of Medical Bio- chemistry is focused on signalling pathways regulating cell proliferation, apoptosis and differentiation in mammalian tissues with special reference to malignant cells. In ad- Fig. 1: Overview of the mammalian cell cycle. Cent-ral CDK/cyclin complexes are indicated dition, RNA-protein interactions are inves- next to the cell cycle position when they are active and the Cip/Kip CDK inhibitors are tigated with a focus on protein translation shown next to CDK/Cyclin complexes, which they bind. The green arrow indicates that p21 and ribosome function. Research in the and p27 are not only inhibitors but also acti-vators of cyclin D / CDKs.

8 Research Report 2016 Medical University of Innsbruck Medical Biochemistry

Fig. 2: A feedback loop controls CDK2 activation at the restriction Fig. 3: Oncogenic tyrosine kinases like JAK2, Src or BCR-Abl can point. Active CDK2 triggers the degradation of its own inhibitor p27, phosphorylate p27. This leads to the activation of bound CDK2. The promoting the switch-like activation of CDK2 kinase at the restric- activated CDK2 can phosphorylate the bound inhibitor p27, leading tion point. to its degradation and strong CDK activation. and progress towards S-phase. A positive Src, BCR-Abl or JAK2, which induce p27 ty- cellular machinery -regulating proliferation feedback loop couples p27 ubiquitin de- rosine phosphorylation. We identified novel and apoptosis. pendent degradation to CDK activation (Fig. mechanisms that control the localisation of In cancer, STAT1 has been shown to fulfil 2). The molecular mechanism that can initi- p27. Recently, we elucidated the molecular opposite roles in either promoting or im- ate this feedback loop in presence of abun- mechanisms that induce p27 stabilisation peding tumour development, depending on dant CDK inhibitors and thus inactivates in the presence of statins. This involves the the stage of tumour development and the CDKs has long remained a puzzle. selective degradation of the ubiquitin ligase particular type of tumour: As a mediator of We observed that oncogenic tyrosine ki- subunit Skp2 and results from inhibition of the interferon-dependent anti-tumour im- nases including BCR-Abl, Src or JAK2 protein geranyl geranylation. mune response, STAT1 prevents or restricts can activate p27-bound CDKs by directly We also identified novel p27 mRNA binding the development of spontaneously-formed phosphorylating the inhibitor. This tyrosine proteins that regulate the IRES- and Cap-de- tumours. However, particularly at later phosphorylation ejects an inhibitory helix pendent translation of p27 and investigated stages of tumour development, where the of p27 from the catalytic cleft of the CDK the role of p27 in apoptosis. anti-tumour immune response is blunted by and permits the p27-bound CDK complex the tumour and immune cells are frequently to bind ATP and to phosphorylate sub- Current Research Projects: subverted to facilitate the growth and sur- strates. Among these substrates is p27 it- • Function and regulation of CDK-inhibitory vival of the tumour, STAT1 can contribute to self. Phosphorylation of p27 by the bound proteins. tumour-promoting effects. CDK generates a phosphodegron which can • Role of translational control for the deci- initiate the ubiquitin proteasomal degrada- sion between cell proliferation and with- Ongoing Research: tion of the CDK inhibitor (Fig. 3). Using this drawal from the cell cycle. We are investigating the role of STAT1 in mechanism that can be abused by diverse • Regulation of cytokine receptor signalling. the infiltration, differentiation and biologi- oncogenic tyrosine kinases mitogen signals • Ubiquitin E3 ligase regulation in response cal function of tumour-infiltrating immune can inactivate and destabilise the inhibi- to stress. cells. Our focus is on HER2-positive breast tor p27 and thereby promote CDK activa- cancer. We are particularly interested in tion and cell cycle progression. Additional STAT1 in Cancer changes to the composition and function of mechanisms include translational control or Wolfgang Doppler tumour infiltrating immune cells upon treat- involve regulation by the ubiquitin proteas- Strengthening a productive anti-tumour im- ment by chemotherapeutic agents, which ome system. mune response as well as suppressing tu- act on the tumour epithelium but also influ- mour-promoting activities of immune cells ence the anti-tumour immune response. Ongoing Research: represent important therapeutic options in Regulation of cell cycle progression through cancer treatment. For the rational design Major Achievements: G1 phase by tyrosine kinases, translational of appropriate strategies to achieve these We could demonstrate anti-tumor as well control in and of the cell cycle; temporal and goals, a more refined knowledge of the as tumor promoting properties of STAT1 in spatial regulation of Cdk-inhibitory proteins mechanisms regulating the recruitment, dif- spontaneously growing mammary tumors­ . during cell cycle progression and in apopto- ferentiation, expansion and function of tu- They are promoted by two different sub- sis, regulation of ubiquitin ligase activity in mour-infiltrating immune cells is mandatory. sets of immune cells, namely CD8+ T G1, molecular mechanism of statin-induced In this context, we investigate the role of a cells and tumor associated macrophages­ cell cycle arrest, cell cycle control by eryth- key mediator of the action of interferons (TAMs). CD8+ T cells contribute to the anti-­ ropoietin and its receptor EpoR. Mouse on cells of the innate and acquired immune neoplastic activity of chemotherapeutic­ knock-in models of tumour development system, the signal transducer and activator agents, i.e. doxorubicin and lapatinib, and of transcription 1 (STAT1). It acts as a tran- this is critically dependent on STAT1. By Major Achievements: scription factor to induce the expression of this means, STAT1 serves in the anti-tumor We discovered a novel mechanism that trig- genes required for antigen processing, mat- response. STAT1 was also shown to be re- gers p27 degradation, CDK activation and uration and recruitment of immune effector quired for the regeneration of the B-cell cell cycle progression and identified differ- cells, and of genes required for the antiviral compartment after doxorubicin induced ent oncogenic tyrosine kinases including defence. STAT1 also co-operates with the bone-marrow toxicity by promoting the

Research Report 2016 Medical University of Innsbruck 9 Biocenter

­development of early B-cell precursors in for both toxicological and pharmaceutic the bone marrow. It is thereby important research. A major goal is the identification for the recovery of the B-cell lineage after of exposure biomarkers, whereby the tryp- treatment with this anti-cancer drug. On the tophan breakdown pathway via indoleamine ­other hand, STAT1 is positively ­influencing 2,3-dioxygenase is a potent target, in par- the infiltration of mammary tumors with ticular for the assessment of immunomod- TAMs by transcriptionally inducing the ex- ulatory effects. pression of the macrophage growth factor CSF1. We could show that intense local pro- Major Achievements: liferation of fully differentiated macrophages An exposure platform for volatile com- rather then low-pace recruitment of blood- pounds was developed.Specific response borne precursors drives the accumulation patterns could be identified for low-dose of TAMs, which themselves are promoting exposures. tumor growth. The tumor promoting effect of STAT1 via influencing differentiation and Future Goals: infiltration of TAMs was supported by the • Development of 3D lung models results of a retrospective study. There we • Investigating metabolic and transcription- Fig. 5: Ribosomal protein L1 from the ar- could show an association of STAT1 mRNA al changes induced by different types of chaeon Sulf-olobus acidocaldarius in com- levels with macrophage infiltration and bad VOC. plex with 23S rRNA prognosis in breast cancer. Ribosomal Proteins could demonstrate that domain I alone is Current Research Projects: Wolfgang Piendl ­sufficient for specific RNA binding, where- We are exploring the mechanisms by which Interaction of Ribosomal Proteins with as domain­ II stabilizes the L1-23S rRNA STAT1 contributes to the chemotherapy-­ rRNA and mRNA ­complex. induced anti-tumor immune response. In We are investigating ribosomal protein L1 particular, we are investigating the role of from different (hyper)thermophilic archaea Major Achievements: the STAT1 target genes CXCL9, CXCL10 and bacteria. They exhibit a 10 to 100 Solution of the structure of the L1 protu- and CXCL11 in the recruitment and fold higher affinity to their specific­binding berance in the ribosome (with the Russian ­differentiation of CD8+ T cells. sites on rRNA and mRNA compared to collaborator); see Fig. 5. that of their mesophilic counterparts. This Construction of a truncated mutant of ribo- Biochemical toxicology ­stronger protein-RNA interaction might somal protein L1 and elucidation of its role Johanna Gostner substantially contribute to the thermal tol- in RNA binding In recent years, special attention has been erance of ribosomes in thermophilic organ- Control of ribosomal protein synthesis in paid to volatile organic compounds (VOC) isms. Our investigations are focusing on the mesophilic and thermophilic archaea as exposures were associated with adverse ­identification and characterization of those As bacteria and eukarya, archaea have effects such as respiratory tract irritation structural features of RNA-binding proteins to coordinate the synthesis of about 60 and sensitisation leading to the develop- that modulate the affinity for their specific ribosomal proteins with each other and ment of allergies and asthma. RNA ­binding site. In this context we deter- with three rRNAs. Research is focusing on To investigate cellular reactions that are ini- mined the crystal structures of L1-rRNA and the MvaL1 operon (encoding ­ribosomal tiated by low-dose of volatile compounds in L1-mRNA complexes at high resolution (in ­proteins L1, L10 and L12) and on the MvaL3 vitro, we developed an exposure platform collaboration with our Russian partners) operon (encoding 5 ribosomal ­proteins) for airborne treatments of cell models. In Function of Ribosomal Protein L1 from ­mesophilic and thermo­philic Methano­ a functional genomics approach, we could L1 is a two-domain protein with N and C coccus species. As in bacteria, regulation of show that even in very low concentrations, ­termini located in domain I. In close collab- the operons takes place at the level of trans- dose-specific response patterns can be oration with a Russian group we ­succeeded lation. The regulator ­protein MvaL1, and identified. Thus, this new approach can in constructing a truncation ­mutant of MvaL4, respectively, binds ­preferentially to contribute to unravelling the mechanisms L1 ­representing domain I by ­deletion of its binding site on the 23S rRNA, and, when of VOC bioactivity, which is of relevance the central part of L1 (= ­domain II). We in excess, binds with lower affinity to its regulatory binding site on its mRNA (in the case of MvaL1 a structural mimic of the 23S rRNA binding site) and thus inhibits trans­ lation of all cistrons of the operon.

Future Goals: • define the translational step at which ­archaeal L1 inhibits its own synthesis • study the mechanism of MvaL4-­mediated autoregulation of its operon in Archaea

Fig. 4: We developed a novel incubator platform to expose cell cultures to volatile organic Eco– and Nutrional Biochemistry & compounds. With this equipment we investigate responses of cell cultures to VOC treatme Nutrigenomics Florian Überall

10 Research Report 2016 Medical University of Innsbruck Medical Biochemistry

• VocOnCell: Design, realization and validation of a novel • Risk/benefit assessment of the impact of tems. In this regard, Phase I detoxification, incubator system to expose cell cultures to volatile compounds, natural products on cells through the use regulated via cytochrome P450 isoenzymes F. Überall, FFG 834169, bridge project. 475,000€. • TRENDS IN NUTRITION: Implementation of novel food of cellular model systems is investigated in depth, as well as Phase II, processing technologies for healthy nutrition, F. Überall, FFG • Identification of gene expressionorchestrated by the Keap1/Nrf2 signalling 840590 headquarter project of PHILIPS . 679,300€ ­signatures and genome wide pathway and pathway. We strive to translate the findings network analysis of our research into applications of use for Collaborations • Cellular detox systems: society and in this context we have taken • Joyce M Slingerland, University of Miami, USA • R. W. Kriwacki, St. Jude Hosp. of Sick Children, Memphis, USA Phase I: Cytochrome­ P450 isoenzymes part in the development of new kitchen ap- • Hartmut Halfter, Universität Münster, Germany (Johannes Hochleitner); pliances for healthier cooking as part of a • Pierre Roger, Bruxelles, Belgium • Stephen J. Elledge, Harvard, Boston, USA Phase II: Keap1/Nrf2 ­signalling (Martina fruitful cooperation with PHILIPS Austria • Joan Conaway, Stowers Institute Kansas City, USA Naschberger) and a detailed understand- GmbH. This project was initiated in 2013. • Drorit Neumann, Tel Aviv University, Israel • Terrance Lappin, Queens University Belfast, UK ing of cellular redox regulated pathways Within this framework, the advancements • Elizabeth M Jaffee, Johns Hopkins, Baltimore, USA • Development of new kitchen appliances thus obtained have been extrapolated into • Johannes Kirchmair, University of Hamburg, Germany • Gennady Lapa, Gause Institute of New Antibiotics, Moscow for healthier cooking (cooperation with the development of a small-scale biosensor • Johann Hofmann (senior advisor) PHILIPS Austria GmbH) and of a small- in accordance with CTR. • Prof. Dr. M. Garber, Institute of Protein Research, Russian ­Academy of Sciences, Pushchino, Moscow Region, Russia scale bio-sensor (cooperation with CTR) • Ulrich-Merzenich G., “Omics”-technologies in phytomedicine, (all + Maria Lerchbaumer) Selected Publications Universitätsklinikum Bonn, Germany • Moscat J., Protein kinase C signaling, Genome Research Risk-benefit assessment of natural products Caspases uncouple p27Kip1 from cell cycle regulated Institute Cincinnati, USA – i.e. volatile organic compounds and phyto- degradation and abolish its ability to stimulate cell • Tonissen K., Eskitis Inst. for Drug Discovery, Griffith Univ., AUS migration and invasion • Schwarzentruber P., Pyrosequencing & microbiome, Microstech, chemicals – is an integral part of biomedi- Podmirsek, S.R., Jäkel, H., Ranches, G.D., Kullmann, M.K., Sohm, Olten, CH cine and potential therapies. Therefore, we B., Villunger A., Lindner H. and Hengst, L. have developed suitable and reliable cellular ONCOGENE: 2016; 35: S. 4580-4590 models to achieve a profound understand- Cellular reactions to long-term volatile organic compound (VOC) exposures ing, in particular of redox-regulated path- Gostner, Johanna M., Zeisler, Johannes, Alam, Mohammad ways. The identification of gene expression Tauqeer, Gruber, Peter, Fuchs, Dietmar, Becker, Kathrin, Neubert, Kerstin, Kleinhappl, Markus, Martini, Stefan, Ueberall, Florian, signatures and genome-wide pathway and SCIENTIFIC REPORTS: 2016; 6: S. 37842 network analysis is at the core of our analy- Tryptophan Metabolism in Allergic Disorders ses. Thereby, our specific focus tackles the Gostner, Johanna M., Becker, Katrin, Kofler, Heinz, Strasser, cell’s own detoxification systems. In this Barbara, Fuchs, Dietmar, INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY: case, phase I detoxification, regulated via 2016; 169: S. 203-215 cytochrome P450 isoenzymes is investigat- The BH3-only protein BIM contributes to late-stage ed in depth (Johannes -Hochleitner), as well involution in the mouse mammary gland as phase II, orchestrated by the Keap1/Nrf2 Schuler, F., Baumgartner, F., Klepsch, V., Chamson, M., Mueller- Holzner, E., Watson, C. J., Oh, S., Hennighausen, L., Tymoszuk, P., signalling pathway (Martina Naschberger). Doppler, W., Villunger, A., Striving for translation of our research into CELL DEATH AND DIFFERENTIATION: 2016; 23: S. 41-51 applications for society, the development Novel antibodies directed against the human erythropoietin of new kitchen appliances for healthier receptor: creating a basis for clinical implementation Maxwell, Perry, Melendez-Rodriguez, Florinda, Matchett, Kyle B., cooking, a fruitful cooperation with PHILIPS Aragones, Julian, Ben-Califa, Nathalie, Jaekel, Heidelinde, Hengst, Austria GmbH, was initiated in 2013 (Maria Ludger, Lindner, Herbert, Bernardini, Andre, Brockmeier, Ulf, Fandrey, Joachim, Grunert, Fritz, Oster, Howard S., Mittelman, Lerchbaumer). Within this framework, the Moshe, El-Tanani, Mohamed, Thiersch, Markus, Gasser, Edith M. advancements have been extrapolated into Schneider, Gassmann, Max, Dangoor, David, Cuthbert, Robert J., Irvine, Alexandra, Jordan, Anne, Lappin, Terence, Thompson, John, small-scale bio-sensor in cooperation with Neumann, Drorit, CTR.analyses. Thereby, our specific focus BRITISH JOURNAL OF HAEMATOLOGY: 2015; 168: S. 429-442 tackles the cell’s own detoxification sys- Bisphenol A suppresses Th1-type immune response in human peripheral blood mononuclear cells in vitro Gostner, Johanna M., Raggl, Emanuel, Becker, Kathrin, Ueberall, Florian, Schennach, Harald, Pease, James E., Fuchs, Dietmar, IMMUNOLOGY LETTERS: 2015; 168: S. 285-292

Complement-Opsonized HIV-1 Overcomes Restriction in Dendritic Cells Posch, Wilfried, Steger, Marion, Knackmuss, Ulla, Blatzer, Michael, Baldauf, Hanna-Mari, Doppler, Wolfgang, White, Tommy E., Hoertnagl, Paul, Diaz-Griffero, Felipe, Lass-Floerl, Cornelia, Hackl, Hubert, Moris, Arnaud, Keppler, Oliver T., Wilflingseder, Doris, PLOS PATHOGENS: 2015; 11: S. e1005005

Selected Fundings

• Funktion der p27 Tyrosin Phosp horylierung durch BCR-Abl, Fig. 6: shows green tea polyphenol (-) Epigal- JAK2 und FLT3 in der Tumorentstehung – FWF Einzelprojekt locatechin-3-gallate in the active site cavity P 24031. L. Hengst. 342,412.00€ • DK MCBO Teilprojekt. Molecular Mecanism of the statin-­ of the human drug metabolizing enzyme Cy- induced cell cycle arrest. L. Hengst. FWF. 118,135€ tochrome P450 2D6. The genetic algorithm • Protein Kinase C Epsilon-induced phosphoproteome P. Gruber. FWF Einzelprojekt P 25491. 267,177.75€ GOLD was used for docking the flexible • Volatile Öle. Herta Firmberg Programm. Johanna Gostner. FWF. non-generic (-) EGCG in the binding site of T 703. 223,500€ CYP2D6.

Research Report 2016 Medical University of Innsbruck 11 Biocenter Neurobiochemistry

training, education and expertise in light (STimulated Emission Depletion) principle microscopy to all scientists on campus. to perform imaging beyond the diffraction limit. Under optimal conditions a resolution Two laser scanning confocal microscopes of 50 nm laterally (xy) and 130 nm axially (z) (Leica SP5, Zeiss, LSM510 Meta), a multi- can be achieved. In addition, STORM tech- functional microscope (Till, iMIC) for live nology has been implemented on the iMIC. cell imaging, which is equipped for TIRF, spinning disk, and FRAP and two wide-field Software support is offered from basic user microscopes are offered. In addition, an in- training to complex calculations. We cur- tegrated stereology microscope/software rently support Fiji, CellProfiler and MATLAB. system for neuron tracing (Neurolucida) A server-based deconvolution software is offered together with the Institute of package (Huygens Professional) enabling Pharmacology. State-of-the-art super-reso- the improvement of the resolution of light lution microscopy is available in collabora- microscopic images. Challenging interac- tion with the Leopold-Franzens-University tive 3D image analyses are done using Im- Innsbruck.A gSTED was installed, which is aris. Microscopy-related teaching is offered based on a Leica SP8 inverted confocal mi- in several PhD programmes and prior to in- croscope outfitted with a very flexible white dependent usage of any microscope all us- Head of Division: light laser source and additional depletion ers receive an instrument-specific training. Univ.-Prof.in Dr.in Christine Bandtlow laser lines. This allows using the STED

Contact: Biocenter, Innrain 80–82 6020 Innsbruck

[email protected] Phone: +43 512 9003 70281 Fax: +43 512 9003 73110 www.i-med.ac.at/neurobiochemistry

Research Branch (ÖSTAT Classification)

106002, 106023, 301114, 301402, 106010

Keywords

Neuroscience, structural plasticity, soma- tosensory neurons, axonal path finding, chondroitin sulphate proteoglycans, neuro- protection

Research Focus

Ongoing studies are aimed at understand- ing the mechanisms of how the CNS re- generation inhibitors such as MAG, Nogo and its receptors, NgRs regulate axon guidance and collateral branching during development. Another focus is to elucidate the role of the Protein kinase N in brain development and post stroke recovery.

Research

Biooptics Core Facility Martin Offterdinger The Division of Neurobiochemistry hosts the Biooptics facility, and provides univer- sity-wide access to advanced equipment, Fig. 1: Signalling by Nogo receptors

12 Research Report 2016 Medical University of Innsbruck Neurobiochemistry

Research

Modulation of Structural Plasticity by Nogo and Nogo Receptors Christine Bandtlow Our group has a long standing interest in understanding the molecular mechanisms regulating axonal growth and sprouting in the mammalian nervous system in the intact and diseased brain (i.e. brain injury, epilepsy or multiple sclerosis). We pursue a variety of mouse genetic approaches combined with surgical, histological, biochemistry-based, and behavioural studies to investigate the function of axon growth inhibitors, such as MAG and Nogo, and their cognate receptors, the GPI-anchored cell-surface receptors of the Nogo Receptor family (NgR1-NgR3) and their interacting binding partners. Ac- Fig. 3: Even a short blockade of oxygen flow in the brain results in a rapid decline of cellular cumulating evidence suggests that these ATP and a subsequent loss of neuronal function and viability. Tissue in the ischemic core is components restrict axonal regeneration beyond therapeutic rescue, however the penumbral tissue is affected by ischemia but still and compensatory sprouting following inju- viable and therefore key for target interventions. ry not only in the CNS, but also in the PNS. Previous studies by us and others support Purine Mediated Neuroprotection Selected Publications also the idea that in the intact CNS, NgR1/2 Gabriele Baier-Bitterlich A novel role for the histone acetyltransferase Hat1 in the signalling acts as a ´brake´ to restrict struc- Ischemia reperfusion severely hampers CENP-A/CID assembly pathway in Drosophila melanogaster Boltengagen, Mark, Huang, Anming, Boltengagen, Anastasiya, tural synaptic plasticity by modulating spine tissue survival in affected brain areas. Ris- Trixl, Lukas, Lindner, Herbert, Kremser, Leopold, Offterdinger, morphology and dynamics. Interestingly, we ing interest in post-stroke brain plasticity Martin, Lusser, Alexandra, also identified NgR2, which is abundantly ex- has powered investigations of therapeu- NUCLEIC ACIDS RESEARCH: 2016; 44: S. 2145-2159 pressed by sensory neurons of the peripher- tic approaches that promote endogenous Schwann Cell Expressed Nogo-B Modulates Axonal Branching of Adult Sensory Neurons Through the Nogo-B al nervous system (PNS), as a suppressor of neurorepair. The main research focus of Receptor NgBR terminal branching of nociceptive nonpep- the lab, over the last decade, has been the Eckharter, Christoph, Junker, Nina, Winter, Lilli, Fischer, Irmgard, Fogli, Barbara, Kistner, Steffen, Pfaller, Kristian, Zheng, Binhai, tidergic afferents during skin innervation. analysis of adenosine receptor-mediated Wiche, Gerhard, Klimaschewski, Lars, Schweigreiter, Ruediger, Loss of NgR2 leads to increased innerva- cellular signalling. Based on our recent ex- FRONTIERS IN CELLULAR NEUROSCIENCE: 2015; 9: S. 454 tion of somatosensory endings in the epi- perimental work, we have discovered a can- Enhanced Axon Outgrowth and Improved Long-Distance dermis, associated with a hypersensitivity didate role of Protein kinase N in the reg- Axon Regeneration in Sprouty2 Deficient Mice Marvaldi, Letizia, Thongrong, Sitthisak, Kozlowska, Anna, Irschick, to mechanical pain and cold sensation. We ulation of neuroprotective processes. Our Regina, Pritz, Christian O., Baeumer, Bastian, Ronchi, Giulia, currently delineate the structural and mo- current research objective is to define the Geuna, Stefano, Hausott, Barbara, Klimaschewski, Lars, lecular mechanisms that lead to enhanced neuron-specific function of PKN1 in brain DEVELOPMENTAL NEUROBIOLOGY: 2015; 75: S. 217-231 mechanosensitivity in NgR2-null mice. development and post-stroke recovery. Selected Funding

• FWF, W1206: Doctoral College ´Signal processing in neurons´ • FWF, P2600_B24: „Analyse der Rolle der PRK1 in der Neuroprotektion”

Core Facilities

Biooptics/Light microscopy

Fig. 2: Confocal imaging of low-threshold Fig. 4: Immunostaining of white matter (red; mechanoreceptors (LTMRs) forming lanceo- NF200) and Purkinje cells (green; Calbin- late complexes at a hair follicle in hairy skin din). stained with Tuj1 (green) and NFH (red).

Research Report 2016 Medical University of Innsbruck 13 Biocenter Clinical Biochemistry

Research Branch (ÖSTAT Classification) Research

104002, 106002, 106037, The Potential of CE-MS for the Analysis 106052, 301114 of PTMs Given the pivotal role of post-translational Keywords modifications (PTMs) in the regulation of a cellular environment, there is a constant Protein microanalysis facility, protein anal- push towards developing new, highly sen- ysis, PTM identification, mass spectrome- sitive and sophisticated PTM identification try, phospho-proteomics, proteome-wide methods. A relatively new approach known quantification, capillary electrophoresis, as CE-MS, capillary electrophoresis- elec- HPLC, method development, epigenetics trospray ionization mass spectrometry, is an elegant method that combines electro- Research Focus phoresis with mass spectrometry; our re- search group has successfully implemented • Multidimensional LC/CE-MS-based meth- this method to posttranslational modified od development peptides and proteins. Citrullination, also • PTM identification of various nuclear and known as deimination, is an arginine-di- Vice Head of Division (interim): extracellular proteins rected PTM with the potential to alter the ao. Univ.-Prof. Dr. Herbert Lindner • Identification of histone-modification pat- structure, function, and antigenicity of terns at the nucleosomal level proteins; nonetheless, the identification of Contact: • Method development for top-down and citrullinated peptides remains an analyti- Biocenter, Innrain 80–82 middle-down proteomics using ETD- and cal challenge. The conversion of arginine 6020 Innsbruck HCD- fragmentation to the non-standard amino acid citrulline is • Development of absolute quantification catalysed by a family of calcium-dependent [email protected] methods for targeted proteins enzymes, also known as peptidylarginine Phone: +43 512 9003 70310 • Investigation of in-vivo O-Glycosylation deiminases (PAD); five PAD isoforms can Fax: +43 512 9003 70300 of the low abundance marker NT-proBNP be distinguished, each presenting different www.i-med.ac.at/imcbc/­ in blood plasma with affinity proteomic tissue-specific expression patterns. At a clinbiochemfolder/clinbiochem.html methods and mass spectrometry from pa- physiological pH, arginine expresses a pos- tients suffering of severe heart failure itive charge due to the guanidinium group, • CE method development for characteriza- whereas citrulline is neutral. Citrullination tion of viral gene therapy generates “altered-self” epitopes that may present antigenic properties thus prompting General Facts autoimmune responses against previously benign proteins. Altered calcium homeosta- The main focus of our lab was set on the sis accompanied by protein citrullination is development of high-resolution meth- associated with several neurodegenerative ods for the separation and identification disorders, including Alzheimer’s disease, of post-translationally modified proteins, rheumatoid arthritis, and multiple sclerosis. which are needed to determine their bio- Our current project focuses on the identi- logical significance. With this in mind we fication and quantification of post-transla- introduced a set of separation methods tional modifications with the help of CE-MS. into our lab based on capillary electropho- resis (CE), reversed-phase chromatography, Investigation of in-vivo O-Glycosyla- hydrophilic interaction liquid chromatogra- tion of the Low Abundance Biomarker phy (HILIC) and mass spectrometry (MS). NT-proBNP by Means of Affinity Pro- As a result of continuously improving and teomics Methods and Mass Spectrom- further developing our program we are etry in the Blood Plasma from Patients now able to offer a wide range of analyti- Suffering of Severe Cardiac Failure Head of Division (interim): cal services intended to support other sci- The aim of this project is to develop analyt- Univ.-Prof. Dr. Ludger Hengst entists involved in research at the Medical ical methods for the investigation of b-type University of Innsbruck (for more informa- natriuretic peptides, which are common- Contact: tion go to “Protein Micro-Analysis Facility”). ly used as a biomarker in the detection Biocenter, Innrain 80–82 Our main areas of applied science include, of severe heart failure. An increase in the 6020 Innsbruck but are not limited to: LC/CE-ESI-MS, HPLC ‘stretch stimulus’ in ventricles causes cardi- (e.g. RPC, HILIC, IEC, GPC), capillary elec- omyocytes to synthesize and secrete proB- [email protected] trophoresis, phospho-proteomics, chro- NP, a precursor peptide that is subsequently Phone: +43 512 9003 70110 matin immune-precipitation, co-immuno- cleaved into the biologically active BNP Fax: +43 512 9003 70300 precipitation, affinity proteomics methods, (brain natriuretic peptide) and into the inac- and proteome-wide quantification (e.g., tive N-terminal form, NT-proBNP. They prove SILAC, iTRAQ, TMT, Dimethyl labeling). to be challenging analytes due to their low

14 Research Report 2016 Medical University of Innsbruck Clinical Biochemistry © Analytical Chemistry: 2011: 83 (19):7297–305

Fig. 1: The design of a sheathless interface for coupling capillary electrophoresis to mass spectrometry (Faserl et al. 2011: Anal. Chem. 83(19): 7297–305).

abundancy in a complex matrix such as the determination of aluminium by means A novel role for the histone acetyltransferase Hat1 in the CENP-A/CID assembly pathway in Drosophila melanogaster blood, as well as due to their high levels of of GF-AAS.) Utilizing this method we test- Boltengagen, Mark, Huang, Anming, Boltengagen, Anastasiya, variability and inconsistency, a result of di- ed the hypothesis that women with breast Trixl, Lukas, Lindner, Herbert, Kremser, Leopold, Offterdinger, Martin, Lusser, Alexandra, verse enzymatic processes and degradation cancer present higher concentrations of NUCLEIC ACIDS RESEARCH: 2016; 44: S. 2145-2159 mechanisms. Furthermore, proBNP is O-gly- aluminium in breasts, blood, and urine com- cJun N-terminal kinase (JNK) phosphorylation of serine 36 is cosylated to various extents at different pared to healthy control patients. Because critical for p66Shc activation sites, which is why this project especially fo- the upper outer quadrant of the breast ex- Khalid, Sana, Drasche, Astrid, Thurner, Marco, Hermann, Martin, Ashraf, Muhammad Imtiaz, Fresser, Friedrich, Baier, Gottfried, cuses on the analysis of naturally occurring hibited a disproportionately high incidence Kremser, Leopold, Lindner, Herbert, Troppmair, Jakob, forms of this polypeptide and its posttrans- of breast cysts and breast cancer, we in- SCIENTIFIC REPORTS: 2016; 6: S. 20930 lational modifications. Characterization, as vestigated whether a regional distribution Selected Funding well as, a relative and an absolute quantifi- of aluminium throughout the breast could • Coupling capillary electrophoresis to mass spectrome- cation of the specific forms present in dif- be detected in women with breast cancer. try for protein and proteome analysis. Industrial Project ferent concentrations, is critical to under- with AB SCIEX /Beckman Coulter; U.S.A.; Herbert Lindner • Investigation of in-vivo O-Glycosylation of the low abun- standing pathobiological mechanisms and dance marker NT-proBNP by Affinity Proteomics Meth- could also be relevant in the diagnosis of ods and Mass Spectrometry in blood plasma from pa- tients with severe heart failure.Industrial Project with cardiac failure and other related diseases. Roche Diagnostics GmbH Penzberg, BRD; Herbert Lindner

AAS - Measurement of Aluminium in Collaborations Breast Tissue Biopsies, Blood, and Urine National: • Reinhard Dallinger, Institute of , LFU, Innsbruck, Austria Another point of interest that has our atten- • Peter Ladurner, Institute of Zoology, LFU, Innsbruck, Austria tion is the ascertainment of elemental anal- • Nicolas Singewald, Institute of Pharmacy, LFU, Innsbruck, Austria ysis using graphite furnace atomic absorp- International: tion spectrometry (GF-AAS). In collaboration • J. Ausio, University of Victoria, Victoria, Canada • M. Freitas, Ohio State University Medical Center, Columbus, with the Department of Medical Statistics USA and the Department of Obstetrics and Gy- Fig. 2: Electrospray formation of the CE-MS • N. Guzman, Princeton Biochemicals Inc., New Jersey, USA • Pedro Suau, Universitat Autonoma de Barcelona, Spain naecology we began an investigation of the system • David Chen, Department of Chemistry, University of British association between breast cancer and the Columbia, Vancouver Canada use of aluminium bearing antiperspirants in Selected Publications Core Facilities a hospital based case control study. The de- Identification of novel post-translational modifications in The facility is an establishment within the Division of Clinical Bio- tection of aluminium in human tissue is not linker histones from chicken erythrocytes chemistry and is dedicated to providing scientists with equipment, a trivial undertaking; it is indispensable that Sarg, Bettina, Lopez, Rita, Lindner, Herbert, Ponte, Inma, Suau, expertise, and custom services for the detection, characteriza- Pedro, Roque, Alicia, tion and quantification of proteins and peptides on a recharge all measures be taken to avoid any potential JOURNAL OF PROTEOMICS: 2015; 113: S. 162-177 basis. This facility possesses and operates several state of the contamination of the tissue. We combined art instrumentation, such as: a Q Exactive HF, a hybrid FT mass Linker histone partial phosphorylation: effects on second- spectrometer LTQ Orbitrap XL ETD, an LTQ VELOS mass spec- microwave digestion with graphite furnace ary structure and chromatin condensation trometer (from Thermo Fisher Scientific), a Procise 492 protein atomic absorption spectrometry (GF-AAS) Lopez, Rita, Sarg, Bettina, Lindner, Herbert, Bartolome, Salvador, sequencer (Applied Biosystems), nano-LC gradient systems Ulti- Ponte, Inma, Suau, Pedro, Roque, Alicia, Mate 3000 (Dionex), various capillary electrophoresis and HPLC to yield an accurate, high in precision, repro- NUCLEIC ACIDS RESEARCH: 2015; 43: S. 4463-4476 systems, and, last but not least, a solar M6 dual Zeeman spec- ducible method for measuring aluminium in trometer (Thermo Fisher Scientific) for trace element analysis. Quantitative Proteomics Using Ultra low Flow Capillary breast tissue biopsies, blood, and urine. (Mi- Electrophoresis-Mass Spectrometry Faserl, Klaus, Kremser, Leopold, Mueller, Martin, Teis, David, Lind- crowave digestion generates clear homog- ner, Herbert H., enous digests that are perfectly suited for ANALYTICAL CHEMISTRY: 2015; 87: S. 4633-4640

Research Report 2016 Medical University of Innsbruck 15 Biocenter Biological Chemistry

and riboflavin, but in contrast to these, are the functional spectrum of neurofibromin formed in the mammalian body. in as much detail as possible. Our research Lastly, attention is directed towards the activities currently include determining ethical, cultural, and social issues concerning the structure of full length neurofibromin innovative technologies in biomedicine. (FWF-grant: P28975) as well as defining its interacting partners (Dunzendorfer- General Facts Matt et al., 2016, PNAS 113, 7497-7502) (collaborations Frank Mc Cormick, UCSF, The unit consists of 5 principal investigators Lukas A. Huber, Innsbruck). In addition we who study the impact biomolecular systems are currently exploring the mechanisms of have on human health and disease. Our the neurofibromin-mediated repression of research areas include pteridine and lipid MHCII-protein-expression (collaboration metabolism, as well as intracellular signal with Andreas von Deimling, Heidelberg). transduction and its regulation, particularly In addition we investigate the interactions in the context of (small) guanine nucleotide between components of cellular complexes binding (G) proteins. important for lysosomal function. In addition we strive to understand We continued to expand our platform of novel biotechnologies in the context of biophysical instruments by implementing Head of Division: biomedicine, how they are created, and a multi angle light scattering (MALS) Univ.-Prof. Dr. Klaus Scheffzek how they serve the emerging market; system, which is capable of accurately simultaneously we seek to explore their determining molecular weight and levels Contact: ethical, social, and cultural dimensions. of microheterogeneity of multicomponent Biocenter, Innrain 80–82 Based on research and education in this complexes. 6020 Innsbruck particular field the inter-institutional and interdisciplinary network bioethics Neuropsychoimmunology [email protected] ethucation (http://www.i-med.ac.at/ Dietmar Fuchs Phone: +43 512 9003 70330 ethucation/index.html.en) was established Mood changes and depression are common Fax: +43 512 9003 73110 in 2007 which is the Austrian unit of in patients suffering from inflammatory www.i-med.ac.at/imcbc/ the UNESCO Chair in Bioethics’ (Haifa) disorders such as viral infections, auto- molecularcellbiologyfolder/molcellbiol.html International Network (http://www. immune syndromes, malignant tumour unesco-chair-bioethics.org/). diseases, and adiposity. Although the The spectrum of our implemented methods pathogenesis of these symptoms remains Research Branch (ÖSTAT Classification) includes biochemical techniques such unclear several of our recent studies as FPLC/HPLC for preparative protein have shown a correlation between 106041, 301904, 301303, purification and their analysis, eukaryotic neuropsychiatric deviations in patients and 301902, 302040 cell cultures, various biophysical as well as elevated concentrations of neopterin and bioanalytical methods, and biomolecular increased tryptophan breakdown (Kyn/Trp) Keywords x-ray crystallography. in blood samples. These findings shed light We consider teaching a major responsibility on the relevance and importance of these Structural biology, biomolecular in the education of young scientists and observations in neuropsychoimmunology. crystallography, signal transduction/regu- contribute to respective activities for Higher blood phenylalanine levels and lation, biochemistry, molecular biology, students of the Medical as well as of the higher phenylalanine to tyrosine ratios have clinical chemistry, protein purification, high Leopold- Franzens University Innsbruck. been observed in these patients as well as pressure liquid chromatography, bioethics, in healthy elderly patients. The combination immunobiology Research of the Kyn/Trp-ratio with the Phe/Tyr-ratio can be especially useful in deciding whether Research Focus Structural Biology: Structure and Interactions of the Neurofibromatosis This unit studies the structural biology of Type1 Protein, Mechanisms of G disease proteins, currently focusing on Protein Complexes neurofibromatosis type 1, an inheritable Klaus Scheffzek disease that has a relatively high incidence, We aim at understanding the disease but is poorly understood in regards to mechanisms of neurofibromatosis type-1 its pathogenic mechanisms. In addition (NF1), a genetic disease with a relatively we investigate complexes important for high incidence. NF1 patients have an endosomal functions. increased tumour risk, present a variety Furthermore, this unit´s research is directed of developmental defects, and frequently towards understanding the biochemistry suffer of learning disabilities. The tumour Fig. 1: The previously enigmatic extra domain and clinical immunology of the pteridine suppressor gene NF1 encodes the giant (Nex/Cex) of a major Ras specific signal and tryptophan-metabolism; pteridines are protein neurofibromin (320 kDa) and is not regulatory module (NF1-GRDmin) serves structurally related to the vitamins folic acid functional in NF1 patients due to genetic as a binding platform for its membrane alterations. Our long term goal is to define recruitment factor Spred1.

16 Research Report 2016 Medical University of Innsbruck Biological Chemistry

from philosophy, social and political sciences, law, economics and health management. Main topics of research are new technologies in the context of assisted reproductive technologies, third party cross-border reproductive care and its international regulation, unintended traumatisation of patients in the context of medicalised reproduction, and prevailing deterministic views in the dynamic field of genetics/genomics, PhD projects deal with the ethics of reprogenetics in developing countries and with the definition of “race” in pharmacogenomics. © Proceedings of the National Academy of Sciences USA, 2015 Academy © Proceedings of the National Fig. 2: Metabolic scheme of the impact of alkylglycerol monooxygenase knockdown on ether lipid metabolism

Selected Publications serotonergic or noradrenergic/adrenergic/ phenylalanine. Tetrahydrobiopterin is The neurofibromin recruitment factor Spred1 binds to the dopaminergic treatments are more likely currently used to treat phenylketonuria, GAP related domain without affecting Ras inactivation Dunzendorfer-Matt, Theresia, Mercado, Ellen L., Maly, Karl, Mc- to be useful in the individual patient. More a rare inherited disease in humans that Cormick, Frank, Scheffzek, Klaus, recently the effect of nutrition and life style affects the phenylalanine hydroxylase. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF habits (e.g. physical exercise and sports), on Alkylglycerol monooxygenase is an espe­cially THE UNITED STATES OF AMERICA: 2016; 113: S. 7497-7502 these abovementioned immunobiochemical labile integral membrane protein. In 2010, Mood, food, and cognition: role of tryptophan and serotonin Strasser, Barbara, Gostner, Johanna M., Fuchs, Dietmar, pathways, has presented itself as a focal forty-six years after it was first described, CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC point of our research. we managed to assign a sequence to this CARE: 2016; 19: S. 55-61

Several clinical and in vitro studies utilizing enzyme; this enabled us to manipulate Effects of Exhaustive Aerobic Exercise on Tryptophan-Ky- the model of freshly isolated peripheral its expression in cultured macrophage- nurenine Metabolism in Trained Athletes Strasser, Barbara, Geiger, Daniela, Schauer, Markus, Gatterer, blood mononuclear cells (PBMC) have like cells. We were able to show that the Hannes, Burtscher, Martin, Fuchs, Dietmar, been performed, and more than 50 papers knockdown of alkylglycerol monooxygenase PLOS ONE: 2016; 11: S. e0153617 have been published in 2015 and 2016 in had a pro-found impact on the lipidome Tetrahydrobiopterin and alkylglycerol monooxygenase sub- a worldwide collaboration with different of these cells (Figure 2). In addition, stantially alter the murine macrophage lipidome research groups. The reference given manipulation of tetrahydrobiopterin Watschinger, Katrin, Keller, Markus A., McNeill, Eileen, Alam, Mo- hammad T., Lai, Steven, Sailer, Sabrina, Rauch, Veronika, Patel, below refers to a review article, in which biosynthesis led to corresponding changes Jyoti, Hermetter, Albin, Golderer, Georg, Geley, Stephan, Wer- the general concept of this work can be in the lipidome. For the first time these ner-Felmayer, Gabriele, Plumb, Robert S., Astarita, Giuseppe, Ral- ser, Markus, Channon, Keith M., Werner, Ernst R., deduced and detailed references can be findings were able to constitute a functional PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF extracted (Strasser B, Gostner JM, Fuchs connection of tetrahydrobiopterin biosyn- THE UNITED STATES OF AMERICA: 2015; 112: S. 2431-2436 D. Mood, food, and cognition: role of thesis to lipid metabolism in an intact cell. tryptophan and serotonin. Curr Opin Clin In collaboration with research groups Selected Funding Nutr Metab Care 2016;19:55-61). located in San Diego (USA), Oxford (UK), • Structure of the neurofibromatosis type 1 protein, Austrian and Bergen (Norway), we investigated the Science Fund (FWF), Klaus Scheffzek • Alkylglycerol monooxygenase in Dictyostelium discoideum, Alkylglycerol Monooxygenase: A Novel role of alkylglycerol monooxygenase in Austrian Science Fund (FWF), Ernst R. Werner Ether-Lipid Cleaving Enzyme Caenorhabditis elegans, a worm that is • Closing the crucial genetic gap in plasmalogen biosynthesis. Austrian Science Fund (FWF), Ernst R. Werner Katrin Watschinger, Gabriele Werner- widely used as a model organism. We found Felmayer, Georg Golderer and Ernst R. that impairment of tetrahydrobiopterin Collaborations Werner synthesis in these animals led to a • Luciel Capuron, University of Bordeaux, France Built on almost forty years of pteridine weakening of their cuticle. This is a result of • Keith Channon, Jonathan Hodgkin, University of Oxford, United Kingdom research in this institute, the focus of our impairing the alkylglycerol monooxygenase, • Pidder Jansen-Dürr, Leopold Franzens University, Innsbruck, research is directed towards ether lipid and not of other tetrahydrobiopterin- Austria • Frank McCormick, University of California San Francisco metabolism. The degradation of ether lipids dependent reactions. Interestingly (UCSF), San Francisco, USA requires alkylglycerol monooxygenase, a enough, alkylglycerol monooxygenase • Andreas von Deimling, University Heidelberg, Heidelberg, Ger- many tetrahydrobiopterin dependent enzyme. was functionally associated with the • Magnus Gisslen, Lars Hagberg, Östra University Hospital, Go- Tetrahydrobiopterin, a cofactor, is struc- susceptibility of these animals to bacterial thenburg, Sweden • Harald Mangge, Eva Reininghaus, Medizinische Universität turally related to the vitamins folic acid infections. Graz, Austria and riboflavin, but is synthesized in both • Teo T Postolache, University of Baltimore, MD, USA the animal and human body. It is needed Bioethics • Richard W Price, Institut of Neurology, San Francisco General Hospital, UCSF, USA in five specific hydroxylation reactions; Gabriele Werner-Felmayer • Markus Ralser, University of Cambridge, United Kingdom including the conversion of phenylalanine Current work focuses on epistemology, • Thomas Rausch, UniversityHeidelberg, Heidelberg Germany • Barbara Prainsack, Kings College London; UK to tyrosine by phenylalanine hydroxylase. culture and ethical dimensions • Silke Schicktanz University Medicine Goettingen; Germany This conversion is the key step in the in biomedicine. It is inspired by • International Network of the UNESCO Chair in Bioethics, Haifa, degradation of the essential amino acid interdisciplinary dialogue with colleagues Israel

Research Report 2016 Medical University of Innsbruck 17 Biocenter Cell Biology

Research Branch (ÖSTAT Classification) The LAMTOR Complex –The Crossroad between Signal Transduction and 106013, 106023, 106037, Endosomal Biogenesis 106041, 301904 Over the last two decades we have shown that the LAMTOR complex (late endoso- Research Focus/Keywords mal/lysosomal adaptor, MAPK and MTOR activator) is recruited to the membrane • Signal Transduction and Proteomics of late endocytic compartments, where it • Cell Differentiation can actively influence MAPK, mTORC sig- • Membrane Traffic and Signalling nalling, and endosomal trafficking. On the organismal level, the LAMTOR is involved General Facts in numerous biological processes includ- ing immunity, early embryogenesis, tissue Our division studies molecular mechanisms homeostasis, cellular proliferation, and mi- that determine cellular function and organi- gration (Wunderlich et al., J Cell Biol 2001; zation. To address these fundamental ques- Teis et al. Dev Cell 2002; Kurzbauer et al., tions we use a combination of genetic mod- PNAS 2004; Teis et al., JCB 2006; Bohn et el systems (yeast, mouse and human cells), al., Nature Med 2007; Sancak et al., Cell Head of Division: microscopy, and quantitative proteomics. 2010; Bar-Peled et al., Cell 2012; Taka- Univ.-Prof. Dr. Lukas A. Huber We provide an international and dynamic re- hashi et al., Biochemical and biophysical search environment for Master and PhD stu- research 2012.; Schiefermeier et al., JCB Contact: dents and Postdocs. We are embedded in the 2014; Scheffleret al., Nature comm. 2014) Biocenter, Innrain 80–82 international PhD program MCBO (Molecu- To dissect how LAMTOR functions we have 6020 Innsbruck lar Cell Biology and Oncology), coordinate performed an interaction screen using TAP- several EU projects and have numerous na- MS (Tandem Affinity Purification, coupled [email protected] tional and international collaborations with to Mass Spectrometry). The LAMTOR core Phone: +43 512 9003 70170 academic partners and biotech companies. interactome includes LAMTOR1-5 proteins- Fax: +43 512 9003 73100 the RAG GTPases (that mediate the trans- www.i-med.ac.at/cellbio Research location of mTORC1 to endosomes/lyso- somes), the regulatory-associated protein Three research groups are current- of mTOR Raptor, subunits of the vacuolar ly active at the Division of Cell Biology: H+-ATPase, and a lysosomal solute carrier (SLC38A9). We could show that SLC38A9 The Huber Lab: is an integral component of the amino ac- Signal Transduction and Proteomics id-sensing machinery that controls the acti- This lab focusses on the role of scaffold pro- vation of mTORC1 (Rebsamen et al., Nature, teins that are in spatial and temporal control 2015, Figure 1). We are currently analyzing of signal transduction. In addition, our group novel LAMTOR interactions partner and how addresses the interaction between signal- they are linked to signalling and endosomal ling and intracellular trafficking, both in the biogenesis. endocytic as well as the secretory pathways.

Fig. 1: Core interactome of the LAMTOR complex.

18 Research Report 2016 Medical University of Innsbruck Cell Biology

Microvillus Inclusion Disease - Intracel- lular Trafficking and Epithelial Polarity Microvillus inclusion disease (MVID) is an autosomal recessive enteropathy and fre- quently causes lethal diarrhea in the first few weeks of life. Hallmark characteristics of MVID are a lack of microvilli on the surface of villous enterocytes, the presence of intra- cellular microvillus inclusions, and cytoplas- Fig. 3: Muscle satellite cells grown under differentiation conditions. Immunofluorescence mic accumulation of periodic acid-Schiff microscopy images depict (from left to right): TIS7 wild type differentiated myoblasts, not (PAS)-positive vesicles in enterocytes. fusing TIS7 knockout mouse-derived myoblasts and same cells following the TIS7 over-ex- pression. Together with our local collaborators (Pedi- atrics I and the Division of Histology and Em- t-SNARE protein pivotal for polarized api- (CF). Lung disease is the major cause of bryology), we were the first to identify muta- cal exocytosis and secretion in epithelial morbidity and mortality in cystic fibrosis, tions in the unconventional type Vb myosin cells. Using cellular models for epithelial/ an autosomal recessive disease caused by motor protein (MYO5b), in a cohort of nine enterocyte polarity and genome-editing mutations in CFTR. In CF chronic infections MVID patients (Mueller et al., Nature Genet- technologies we identify intracellular net- and dysregulated neutrophilic inflamma- ics 2008). In a follow-up study 15 novel non- works, that ensure correct polarized in- tion lead to a progressive destruction of sense and missense mutations in MYO5B tracellular traffic and thereby maintain the airways. In contrast to macrophages could be identified in 11 independent MVID proper epithelial polarity, are researched. neutrophils of TIS7-deficient mice showed patients (Ruemmele et al., Human Mutation decreased neutrophil effector functionality. 2010). Further investigations focused on the The Vietor Lab: In vivo TIS7 deficiency caused delayed bac- role of Myosin Vb and its relationship to Rab Cell Differentiation terial clearance from the airways, but also Small GTPases in establishing correct epi- The interplay between cell proliferation exhibited fewer symptoms of inflammation thelial polarity (Thoeni et al., Traffic 2014) and differentiation controls development and lung disease. In humans, TIS7 polymor- (Vogel et al., Journal of Cell Biology 2015). and regeneration and therefore repre- phisms are predominately associated with sents a possible therapeutic target. Based variations in neutrophil effector function; Recently, we identified new mutations in on our studies, we predict that the tran- this data indicates that TIS7 modulates the the STX3 gene in patients that tested neg- scriptional co-regulator TPA-inducible se- pathogenesis of cystic fibrosis lung disease ative for mutations in MYO5B; the STX3 quence 7 (TIS7) is an important regulator by regulating neutrophil effector function. gene was identified as the cause of a var- of cellular regeneration events. TIS7 is These findings were published in Nature iant of MVID. (Wiegerinck et al., Gastro- differentially expressed in several differ- in collaboration with the Cincinnati Col- enterology 2014). Syntaxin 3 is an apical ent polarized cell types and its expression lege of Medicine (Gu et al., Nature 2009). can be induced by growth factors and TPA. In our recent paper we identified the pro- We have shown that TIS7 interacts with the tein ICln as the specific, novel protein down- SIN3 complex and regulates transcription stream of TIS7 controlling the process of my- in an HDAC-dependent manner (Vietor et ogenesis. We have shown that the complex al., EMBO J 2002). In the promoter region TIS7 / ICln epigenetically regulates expres- of TIS7-regulated downstream target genes sion of the muscle regulatory gene myoD we have identified a common regulatory in a protein methyl transferase activity-de- motif C/EBPalpha-Sp1 transcription fac- pendent manner. Thereby we have identified tor "module" (Wick et al., J Mol Biol 2004). Furthermore, TIS7 has the ability to inhibit the Wnt signalling in an HDAC-dependent manner. TIS7 expression increases during the process of tissue regeneration following a challenge like muscle injury or intestinal resection. Our previous studies have shown that in TIS7 deficient mice the expression of myogenic regulatory proteins is dereg- ulated and the differentiation and fusion potential of muscle satellite cells is im- paired (Vadivelu et al., Mol Cell Biol 2004).

Fig. 2: Cover page of the Journal of Cell Bi- Using TIS7 knockout mice generated in ology (Vogel et al., Journal of Cell Biology our lab, the research group of our collab- 2015). displaying the MVID-CaCo2 model orators surrounding Prof. Chris Karp at the Fig. 4: Fused TIS7 wt skeletal muscle cells cell line. Disturbed microvilli formation and Cincinnati College of Medicine, USA iden- grown under differentiation conditions in prominent subapical secretory granules are tified TIS7 to be the main modifier of the culture. Raster electron scanning micro- visible.pression. severity of lung disease in cystic fibrosis graph.

Research Report 2016 Medical University of Innsbruck 19 Biocenter

cellular processes, including: membrane scission at the end of cytokinesis, release of budding HIV from host cells, micro-ves- icle formation at the plasma membrane, plasma membrane repair, quality control of nuclear pore complex assembly, and nuclear envelope reformation and sealing.

Cell growth and survival requires the selec- tive degradation of cellular components; Defects in cellular degradation systems corrupt cellular homoeostasis, results in cellular protein aggregation which in re- turn causes of a wide variety of diseases ranging from cancer to neurodegenera- tion. How different cellular degradation systems work together is not understood. Fig. 5: Lack of fat vacuoles in the jejunum of TIS7 SKMc15 double knockout mice (right). Oil red oil staining; magnification 40x. The Teis Lab focuses on the molecular mechanisms that are required for the selec- tive degradation of integral membrane pro- teins. A key step in this process occurs on endosomes, where the endosomal complex- es required for transport (ESCRTs) bind to and sort ubiquitinated membrane proteins via the multivesicular body (MVB) pathway into the lumen of lysosomes for degrada- tion (Figure 7). This process requires re- verse membrane to bud intraluminal MVB vesicles (ILVs) away from the cytoplasm and into the lumen of MVBs (Figure 8A). We showed that the assembly of the ESCRT-III complex and the coordinated binding of Fig. 6: TIS7 SKMc15 double knockout mice are significantly leaner. 6 months old male mice; the AAA-ATPase Vps4 is essential for this n= 6; Chow diet; (left). TIS7 SKMc15 double knockout mice gain significantly less weight process (Adell et al. JCB 2014). Topologi- upon feeding with high fat diet. 11 weeks male mice; n= 11; 3 weeks high fat diet; (right). cally similar ESCRT dependent membrane budding reactions are required in distinct a novel mechanism in which TIS7-specifi- turn causes of a wide variety of diseases cellular processes, including: membrane caly controls skeletal muscle differentia- ranging from cancer to neurodegenera- scission at the end of cytokinesis, release of tion. In particular, in this novel pathway ICln tion. How different cellular degradation budding HIV from host cells, micro-vesicle regulates MyoD expression via its interac- systems work together is not understood. formation at the plasma membrane, plasma tion with the methyl transferase PRMT5 membrane repair, quality control of nuclear (Lammirato et al., BMC Biology 2016). The Teis Lab focuses on the molecular pore complex assembly, and nuclear enve- SKMc15 is a protein which is highly homol- mechanisms that are required for the lope reformation and sealing. How the ES- ogous to TIS7. Our laboratory generated selective degradation of integral mem- CRT machinery catalyses these membrane SKMc15 single as well as TIS7 SKMc15 dou- brane proteins. A key step in this process remodeling reactions remains unclear. ble knockout mice, to study their role during occurs on endosomes, where the endo- embryonic development and in adult mice. somal complexes required for transport Thus one key question in our lab is to TIS7 SKMc15 double knockout mice are sig- (ESCRTs) bind to and sort ubiquitinated understand how the ESCRT machin- nificantly smaller and leaner. Surprisingly, membrane proteins via the multivesicu- ery sculpts membranes (Figure 8B). they never grown fat and are fully resistant lar body (MVB) pathway into the lumen Furthermore, we would like to understand against weight gain upon feeding with the of lysosomes for degradation (Figure 7). how the ESCRT dependent degradation of high fat-diet. We are currently characteriz- This process requires reverse membrane membrane proteins interacts with auto- ing the underlying molecular mechanism. to bud intraluminal MVB vesicles (ILVs) phagy and proteasomal degradation path- away from the cytoplasm and into the lu- ways and how their coordinate function con- Teis Lab: men of MVBs (Figure 8A). We showed tributes to cell growth and survival, given Membrane Traffic and Signalling. that the assembly of the ESCRT-III com- the key role of ESCRTs during developmen- Cell growth and survival requires the selec- plex and the coordinated binding of the tal and disease. To address these questions tive degradation of cellular components; AAA-ATPase Vps4 is essential for this yeast was determined as the best suited Defects in cellular degradation systems process (Adell et al. JCB 2014). Topologi- model system, because it combines genetics corrupt cellular homoeostasis, results in cally similar ESCRT dependent membrane with quantitative proteomics, biochemical cellular protein aggregation which in re- budding reactions are required in distinct methods, and different imaging approach-

20 Research Report 2016 Medical University of Innsbruck Cell Biology

Fig. 7: Schematic Representation of the MVB Pathway..

Fig. 8: (A) 3D-Modeling of cryo-fixed cells. Fig. 9: (A) Fluorescence microscopy of liv- MVBs (yellow), Intralumenal MVB vesicles ing yeast, vacuole (red), GFP-CPS (green). (ILVs) (red), vacuole (blue). (B) Model of ES- (B) Graphical representation of quantitave CRT-III and Vps4 during ILV neck constric- proteomics. tion. es (Figure 9A, B). Our results suggest that the MVB pathway and autophagy function together to ensure cell survival during nu- trient limitation (Mueller et al. eLife 2015). Selected Publications

The coordinated action of the MVB pathway and autophagy Asymmetric arginine dimethylation of RelA provides a re- ensures cell survival during starvation pressive mark to modulate TNF alpha/NF-kappa B response Mueller, Martin, Schmidt, Oliver, Angelova, Mihaela, Faserl, Klaus, Reintjes, Anja, Fuchs, Julian E., Kremser, Leopold, Lindner, Herbert Weys, Sabine, Kremser, Leopold, Pfaffenwimmer, Thaddaeus, Da- H., Liedl, Klaus R., Huber, Lukas A., Valovka, Taras, lik, Thomas, Kraft, Claudine, Trajanoski, Zlatko, Lindner, Herbert, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF Teis, David, THE UNITED STATES OF AMERICA: 2016; 113: S. 4326-4331 ELIFE: 2015; 4: S. e07736 Cargo-selective apical exocytosis in epithelial cells is con- SLC38A9 is a component of the lysosomal amino acid sens- ducted by Myo5B, Slp4a, Vamp7, and Syntaxin 3 ing machinery that controls mTORC1 Vogel, Georg F., Klee, Katharina M. C., Janecke, Andreas R., Muel- Rebsamen, Manuele, Pochini, Lorena, Stasyk, Taras, de Araujo, ler, Thomas, Hess, Michael W., Huber, Lukas A., Mariana E. G., Galluccio, Michele, Kandasamy, Richard K., Snijder, JOURNAL OF CELL BIOLOGY: 2015; 211: S. 587-604 Berend, Fauster, Astrid, Rudashevskaya, Elena L., Bruckner, Ma- nuela, Scorzoni, Stefania, Filipek, Przemyslaw A., Huber, Kilian V. M., Bigenzahn, Johannes W., Heinz, Leonhard X., Kraft, Claudine, Selected Funding Bennett, Keiryn L., Indiveri, Cesare, Huber, Lukas A., Superti-Fur- • FWF: FWF P 30263 (DT); FWF P 29583 (DT), Special research ga, Giulio, program SFB021 (LAH, DT), PhD Program MCBO (LAH, NATURE: 2015; 519: S. 477-+ DT), START-Prize (DT), P18531-B12 (TV), P22350-B12 (IV), P26682-B21 (LAH) Lysosomal signaling in control of degradation pathways • EU: FP7 Optatio (LAH), HFSP Career Development Award (DT) Huber, Lukas A., Teis, David, CURRENT OPINION IN CELL BIOLOGY: 2016; 39: S. 8-14

Research Report 2016 Medical University of Innsbruck 21 Biocenter Genomics and RNomics

scriptome, invoIved in the differentiation of their differential expression in human pa- mouse embryonic stem (ES) cells into neu- tients as well as animal disease models. ral cells, by generating specialized ribonu- Indeed, by these approaches sever- cleo-protein particle (RNP)-derived cDNA li- al miRNAs have been implicated in braries. By high-throughput sequencing and the etiology of neurological diseases. transcriptional profiling we identified sev- In addition to miRNAs, however, there is eral novel miRNAs to be involved in ES cell a large number of short ncRNA species differentiation, as well as seven small nucle- (sized about 18 – 200 nt), which are either olar RNAs. Based on these findings, we have poorly characterized or which belong to generated a custom micrarray chip, covering other known classes of ncRNAs (i.e. sn- novel ncRNAs from ES cell differentiation. RNAs, snoRNAs, or piRNAs) for which no Another research interest is the regu- high-throughput tools have been available lation of ribosomal translation by natu- to perform expression profiling. Thus in ral and non-natural modifications intro- this project, which is part of the SFB F44 duced into functionally important regions “Cell signaling in chronic CNS disorders”, of the ribosome as well as incorporated we developed an unbiased and compre- into the coding sequences of the mRNA hensive microarray platform to profile the to investigate decoding and termination. expression of thousands of these novel Head of Division: ncRNA species from mouse brain tissues. Univ.-Prof. Dr. Alexander Hüttenhofer Research To date, we have applied this customized microarray, designated as neuro-ncRNA Contact: Role of ncRNAs in Neurodevelopmental chip, to selected mouse models for LTCC Biocenter, Innrain 80–82 Disorders activity and CNS disorders e.g. Alzheimer’s 6020 Innsbruck Alexander Hüttenhofer disease, Multiple-system atrophy. Thereby Small non-protein-coding RNAs (ncRNAs) we discovered more than 100 novel ncRNA [email protected] play important roles in the regulation of candidates whose expression was found to Phone: +43 512 9003 70250 gene expression and have been implicat- be de-regulated in comparison to wild type Fax: +43 512 9003 73100 ed in a number of diseases of the central controls. In the Alzheimer mouse model, we www.rnomics.at nervous system (CNS). Thereby, a well-char- identified two snoRNAs, whose expression acterized class of small ncRNAs is repre- was deregulated prior to amyloid plaque for- sented by miRNAs, for which numerous mation. Interestingly, presence of snoRNAs Research Branch (ÖSTAT Classification) commercial tools (e.g. qPCR panels, micro could be detected in cerebral spine fluid arrays) have been developed to screen samples in humans, thus potentially serving 106002, 106014, 106023

Keywords

Non-coding RNAs; RNPs, RNA sequencing (RNAseq), ribosome, translation, termination

Research Focus

In cells from all organisms two different types of RNA molecules are found: messen- ger RNAs (mRNAs), and so-called “non-pro- tein-coding RNAs” (ncRNAs). Many known ncRNAs, such as microRNAs, are involved in the regulation of gene expression. Our group works on the identification of regu- latory non-coding RNAs in various model organisms. In particular, we are interested in the identification of ncRNAs regulating neuronal development and in the identifi- cation of ncRNAs involved in CNS diseases.

General Facts

Our group works on the identification of reg- ulatory non-coding RNAs (ncRNAs) in various Fig. 1: Two classes of RNA species are transcribed from genomes of all organisms: messen- model organisms for which we have coined ger RNAs (mRNAs) and non-coding RNAs (ncRNAs); ncRNAs are not translated into proteins the term “Experimental RNomics". We have and many of them are able to regulate gene expression by regulating transcription or trans- characterized the entire small ncRNA tran- lation of mRNAs and thus act a genetic switches.

22 Research Report 2016 Medical University of Innsbruck Genomics and RNomics

5-methylcytosine (m5C) and pseudouridine (Ψ) in this class of RNA was only identified recently. The influence of any of these mod- ifications on ribosomal translation is largely unknown and has been mainly a matter of speculation. Employing a cell free transla- tion system, we systematically investigate the effects of single modified mRNA res- idues on translation fidelity and efficiency.

Modified mRNA Nucleotides as Tool to Investigate Translation Processes Fig. 2: Non-natural modifications can be site-specifically incorporated into the 16S rRNA, to Matthias Erlacher determine their impact on decoding. Whereas mRNA modifications are a poten- tial tool to regulate translation processes, as early diagnostic makers for Alzheimer’s tion. This aim will be achieved by identifying we aim to employ a broad spectrum of disease. In addition, we could show the altered expression patterns of ncRNAs/ RNA base modifications to get a deeper applicability of our customized microar- miRs in painful vs. non-painful diabetic neu- insight into mechanistic details of the de- ray to human post-mortem brain tissue of ropathies (dPNP), in complex regional pain coding process during protein synthesis. Alzheimer’s disease patients and healthy syndrome (CRPS) after trauma vs. patients Besides, we establish various tools to also individuals. We identified 51 differentially after trauma without CRPS and in addition in address translation initiation and termina- expressed ncRNAs by expression profiling painful and non-painful nerve lesions (NL). tion employing RNA derivatives. The aim of post mortem human brain samples of An initial quality check showed that ncRNAs is to reveal molecular details of transla- Alzheimer’s disease patients with healthy can robustly be measured from white blood tion processes at a so far unmet detail. controls and could also show that 60% of the cells and from serum. A first analysis in white ncRNAs which are present on our custom- blood cells and serum of n=10 patients with Selected Publications ized microarray exhibit expression signals painful and non-painful dPNP revealed that Changes in the miRNA-mRNA Regulatory Network Precede above background in human tissue. In ad- ncRNA profiles can almost perfectly dif- Motor Symptoms in a Mouse Model of Multiple System At- rophy: Clinical Implications dition, we focused on the biochemical char- ferentiate between these two subgroups. Schafferer, Simon, Khurana, Rimpi, Refolo, Violetta, Venezia, acterization of the novel ncRNA candidates Serena, Sturm, Edith, Piatti, Paolo, Hechenberger, Clara, Hackl, Hubert, Kessler, Roman, Willi, Michaela, Gstir, Ronald, Krogsdam, by in situ hybridization to define cellular as Modified mRNA Nucleotides Regulate Anne, Lusser, Alexandra, Poewe, Werner, Wenning, Gregor K., well as subcellular localizations of ncRNAs. Translation Processes Huettenhofer, Alexander, Stefanova, Nadia, Matthias Erlacher PLOS ONE: 2016; 11: S. e0150705 Idendification of ncRNA Patterns as Bi- RNA modifications can be found in every or- Nucleotide modifications within bacterial messenger RNAs regulate their translation and are able to rewire the genetic omarkers for Pain and Inter-Individual ganism in all three domains of life. Although code Variations more than 100 different types were identi- Hoernes, Thomas Philipp, Clementi, Nina, Faserl, Klaus, Glasner, Heidelinde, Breuker, Kathrin, Lindner, Herbert, Huettenhofer, Alexander Hüttenhofer fied, mRNAs were thought to be only rarely ­Alexander, Erlacher, Matthias David, This project is part of the EU Project “ncR- modified. Whereas N6-methyladenosine NUCLEIC ACIDS RESEARCH: 2016; 44: S. 852-862 NAPain” and aims to the identification of (m6A) was described already 4 decades ago mRNA modifications: Dynamic regulators of gene expres- pain predisposing ncRNA patterns as bio- and shown to be the most abundant modifi- sion? Hoernes, Thomas Philipp, Huettenhofer, Alexander, Erlacher, markers for pain and inter-individual varia- cation in eukaryotic mRNAs, the presence of ­Matthias David, RNA BIOLOGY: 2016; 13: S. 760-765 Impact of the Chromatin Remodeling Factor CHD1 on Gut Microbiome Composition of Drosophila melanogaster Sebald, Johanna, Willi, Michaela, Schoberleitner, Ines, Krogs- dam, Anne, Orth-Hoeller, Dorothea, Trajanoski, Zlatko, Lusser, ­Alexandra, PLOS ONE: 2016; 11: S. e0153476 Expression of the vault RNA protects cells from undergoing apoptosis Amort, Melanie, Nachbauer, Birgit, Tuzlak, Selma, Kieser, Arnd, Schepers, Aloys, Villunger, Andreas, Polacek, Norbert, NATURE COMMUNICATIONS: 2015; 6: S. 7030 Selected Funding SFB 044; 7th framework EU: SysKid; 7th framework EU: ncRNA- Pain; FWF P 28494-BBL Collaborations • Joerg Vogel, MPI Berlin Germany • Ralph Bock, MPI Potsdam, Germany • Jürgen Brosius, University of Münster, Germany • Norbert Polacek, University of Bern, Sitzerland • Eric Westhof, Université de Strasbourg, France • Simpson Joseph, University of California, USA Core Facilities Fig. 3: Modifications (triangles) within coding sequences of mRNAs can regulate protein syn- • Genome Seq Core thesis. • Affymetrix core facility

Research Report 2016 Medical University of Innsbruck 23 Biocenter Molecular Biology

Research Branch (ÖSTAT Classification) secretory proteins and components, such as antimicrobial proteins and iron-chelat- 106023, 106022, 106024, ing siderophores, of which both have po- 301114, 303020 tential in antifungal therapy and diagnosis. The Redl group investigates the mechanism Keywords of action of lipocalins, which are secretory scavenger proteins. Thus, lipocalins are im- Chromatin and epigenetics, histone mod- portant components of the innate immune ifying enzymes, ATP-dependent chromatin system, yet they might also be involved in remodeling, RNA cytosine methylation, fil- allergic reactions. The Lusser group con- amentous fungi, iron metabolism, fungal ducts studies of fundamental gene regula- infection, antifungal drugs, bioactive fungal tory mechanisms involving the remodeling products, siderophores, lipocalins, antimi- of chromatin structure as well as posttran- crobial proteins, innate immunity and allergy scriptional modification of RNAs. Finally, the Loidl group investigates histone modifying Research Focus enzymes, in particular the role of acetyl- ation of regulatory non-histone proteins. Physiology, Gene Regulation and Together, the researchers make use of a wide Head of Division: Secondary Metabolism in Filamentous array of experimental model systems includ- Univ.-Prof. Dr. Peter Loidl Fungi ing filamentous fungi (Aspergillus, Penicilli- • Iron metabolism in filamentous fungi: links um, Acremonium, Neurospora), the fruit fly Contact: to human disease Drosophila melanogaster, and mammalian Biocenter, Innrain 80–82 • Functions of histone modifying enzymes models such as embryonic stem cells and 6020 Innsbruck in gene regulation, fungal physiology and somatic cell lines as well as knock-out mice. as targets for novel antifungal substances Continuous third party funding (e.g. FWF) [email protected] • Structure and mechanism of action and of all research groups, the participation Phone: +43 512 9003 70201 applicability of antimicrobial peptides/ of members of the division in several in- Fax: +43 512 9003 73100 proteins secreted by filamentous fungi tra- and extramural network activities www.i-med.ac.at/molbio such as the FWF-funded PhD programs Lipocalins and their Involvement in In- “HOROS” and “MCBO”, the Infect-ERA nate Immunity and Allergy network “AspMetNet” and the D-A-CH net- work on iron sensing in filamentous fungi Epigenetics and Epitranscriptomics or the attraction of postdoctoral fellows • Biological roles of ATP-dependent chroma- funded by external fellowships attests tin remodeling enzymes to the high standard of research quality. • RNA methylation and its impact on RNA Staff of the Division of Molecular Biology metabolism also contribute substantially to the curric- • Posttranslational acetylation of regulatory ular teaching activities at the MUI. Notably, non-histone proteins the division chair, Peter Loidl, is Vice Rector for Academic Affairs at the university. He General Facts also took a leading role in the establishment of the two new study directions in Molecular The Division of Molecular Biology is home Medicine (Bachelor and Master studies) and to six independent research groups, whose he is the coordinator of the Molecular Med- scientific interests range from the investiga- icine Bachelor program. Gerald Brosch is tion of diverse aspects of filamentous fungi coordinator and Alexandra Lusser is deputy physiology and metabolism, to the study of coordinator of the PhD Program “Regulation secretory lipocalins, to research into the na- of Gene Expression”, and Bernhard Redl is ture and significance of chromatin remod- coordinator of the Molecular Medicine Mas- eling and epitranscriptomic mechanisms. ter program. Beyond that, all group lead- ers teach lectures, seminars and practical A common long-term goal of all groups is courses in the curricula of human medicine, to explore the relationship of the diverse dental medicine, molecular medicine (bach- processes mentioned above with diagnos- elor and master) and of the PhD curriculum. tics and treatment of human disease. In this regard, the groups of Hubertus Haas, Research Gerald Brosch/Stefan Graessle, and Flor- entine Marx-Ladurner strive to elucidate Physiology, Gene Regulation and Sec- pathogenicity determinants and potential ondary Metabolism in Filamentous Fungi drug targets of filamentous fungi. Moreover, Gerald Brosch, Stefan Graessle, Hubertus they examine the regulatory mechanisms Haas, Florentine Marx-Ladurner of secondary metabolites (e.g. penicillin), Fungi affect the life of mankind in positive

24 Research Report 2016 Medical University of Innsbruck Molecular Biology

and negative ways. On the one hand, fun- borne fungal pathogen of humans. It causes gi are major players in saprobic decompo- allergic and invasive diseases depending on sition, they mutually interact with plants the immune status of the patient. Unsatis- (mycorrhiza), serve as food source (mush- fying diagnostic and therapeutic possibil- rooms) or in food production (e.g., bread, ities are reflected in a high mortality rate. cheese, alcohol), and produce widely used A. fumigatus and its low-pathogenic relative primary (e.g. citric acid) and secondary me- Aspergillus nidulans produce extracellular tabolites (e.g. penicillin). On the other hand, siderophores (triacetylfusarinine C) for iron some fungi are pathogens of plants (e.g. acquisition and intracellular siderophores Fusarium spp.) and animals (e.g. Aspergil- (ferricrocin) for storage and distribution of lus fumigatus), or spoil food by contami- iron. Siderophore biosynthesis is regulated nation or toxin production (e.g. aflatoxin). by two transcription factors, SreA and HapX. Fig. 2: Production of penicillin (PN) in differ- Therefore, fungi impact ecology, biotech- Siderophores are central components of ent Aspergillus HDAC-mutants. A bacterial nology, medicine, agriculture and food in- the fungal metabolism as they affect ger- growth inhibition assay plate with Kocuria dustry. The best-studied fungal organism mination, sexual and asexual reproduction, rhizophila as indicator organism was used is Saccharomyces cerevisiae. In several oxidative stress resistance and virulence. to quantify PN in the medium of wild type aspects, however, the physiology of this Lack of siderophore biosynthesis renders A. (wt), ΔhdaA, ΔhosA, and two double mutant unicellular organism is not comparable to fumigatus apathogenic. Consequently, the strains after 24h, 48h, and 60h of growth. that of the more complex filamentous fun- siderophore system represents a novel at- The relative sizes of bacterial growth inhibi- gi (e.g. iron metabolism, light regulation, tractive target for improvement of antifungal tion zones correspond to relative accumula- secondary metabolism). Three research therapy and diagnosis of fungal infections. tion of PN in the culture medium of the fun- groups in the Division of Molecular Biol- gus. Whereas the class 2 HDAC HdaA has a ogy address different aspects of filamen- Additional research topics include iron repressing effect, the class 1 enzyme HosA tous fungal physiology ranging from iron sensing, heme metabolism, noncoding seems to be crucial for the production of PN metabolism and its significance for patho- RNAs, secondary metabolism (e.g. ceph- in Aspergillus nidulans. genesis (Haas), to chromatin-linked mecha- alosporin biosynthesis by Acremonium nisms of gene expression control (Brosch/ chrysogenum), identification of poten- methylation of DNA on distinct cytidines, Graessle) and the nature and mechanisms tial drug targets, diagnosis of fungal in- covalent posttranslational modifications of of action of antimicrobial proteins produced fections and improvement of molecu- histones have profound structural and func- lar tools for the manipulation of fungi. tional consequences for the transcription program of a cell. The main research focus Major Achievements: of this lab lies on elucidating the functional Identification and characterization of impact of histone acetylation and histone/ fungal iron-regulatory and iron-sens- protein arginine methylation on fungal phys- ing mechanisms. Characterization of iology. In particular we are interested in fungal iron uptake and storage, par- studying to what extent histone modifying ticularly the siderophore system. activities are involved in fungal pathogenic- ity as well as to investigate their role in reg- Regulatory and structural links of iron ulating secondary metabolite production. homeostatic mechanims and other met- abolic pathways, e.g. pH regulation, er- To this end, the group has generated As- gosterol biosynthesis, hypoxia . pergillus strains with individual or pairwise Fig. 1: Cover Figure of Natural Product Re- deletion of all protein arginine methyltrans- ports 31(10). “Fungal siderophore metabo- First-time in vivo PET-imaging of fungal infec- ferase (PRMT) genes and of the class I his- lism with a focus on Aspergillus fumigatus”. tions using 68Gallium-labelled siderophores tone deacetylases (HDACs) RpdA and HosA. Haas H. 2014. Using these tools together with specifically Future Goals: engineered transgenes, their impact on vi- by filamentous fungi (Marx-Ladurner). Detailed characterization of the iron and ability and metabolism of the fungus was heme homeostasis-maintaining mecha- studied. Moreover, proteomic and tran- Iron Metabolism in Filamentous Fungi: nisms of filamentous fungi (in particular of As- scriptomic analyses were performed to (i) Links to Human Disease pergilli) and applied medical and biotechno- characterize novel substrates and (ii) to Hubertus Haas logical exploitation of the gained knowledge. investigate the contribution of HDACs and Our central research goal is to character- PRMTs to the regulation of secondary me- ize fungal metabolism and to exploit this Functions of Histone Modifying En- tabolism as well as to stress response genes. knowledge for both improvement of an- zymes in Gene Regulation and Fungal tifungal therapy and diagnosis of fungal Physiology Major Achievements: infections as well as improvement of the Gerald Brosch and Stefan Graessle Identification of a novel PRMT (RmtD) infil- biotechnological potential of fungi. The In addition to distinct regulatory sequences amentous fungi, which differs from other present research focuses on iron/sidero- in gene promoters, the readout of genetic in- PRMTs in that it does not accept canonical phore metabolism of Aspergilli. Aspergillus formation in eukaryotes is significantly con- substrates (histones, RNPs) but instead fumigatus is a typical saprobic filamentous trolled at the chromatin level. In addition to methylates three as yet unknown proteins. ascomycete but also the most common air- ATP-dependent chromatin remodeling and Identification and functional characteriza-

Research Report 2016 Medical University of Innsbruck 25 Biocenter

tion of two fungal-specific protein domains with antimicrobial activity from Penicillium ing. In addition, we study novel functions of in the HDAC RpdA, which are essential for chrysogenum, Aspergillus nidulans and lipocalins in innate immmunity and allergy. the viability of Aspergillus and thus might Aspergillus fumigatus. Antimicrobial pro- Major Achievements: serve as targets for future antifungal therapy. teins are promising candidates for the de- Isolation of two novel lipocalin re- Identification of the HDAC HosA as a ma- velopment of novel therapies applicable in ceptor candidates by membrane pro- jor regulator of medically important sec- medicine as well as in agriculture and in the tein cross-linking and phage-display ondary metabolites of filamentous fungi. food industry to prevent and treat microbi- al infections. Therefore, the detailed char- Future Goals: Future Goals: acterization of these proteins is of crucial • Confirmation of the two receptor Isolation and identification of nov- importance and a prerequisite for the devel- candidates as lipocalin receptors by el targets of Aspergillus PRMTs. Eluci- opment of new therapeutic approaches and biochemical methods (Isothermal ti- dation of the biological role of RmtD. their successful application in the future. tration calorimetry, Biacore analysis), Development of antifungal strategies tar- and by biological assays (cellular up- geting the fungal-specific domains of RpdA. Major Achievements: Identification of (novel) HDAC-regu- Understanding the structure-func- lated secondary metabolites (SM) of tion relation of antimicrobial pro- Aspergilli and elucidation of the con- teins and first steps towards their bi- trol-mechanisms of the corresponding otechnological/medical application. SM gene clusters via HosA and HDACs. Future Goals: Structure, Mechanism of Action and Identification of molecular targets for the Applicability of Antimicrobial Peptides/ development of new therapeutic drugs. Proteins Secreted by Filamentous Fungi Rational design of antimicrobial proteins Florentine Marx-Ladurner and peptides with improved efficiency and Filamentous fungi secrete a wide range of specificity. Characterization of additional different proteins into the external medium, cellular functions of antifungal proteins Fig. 4: Types of molecular recognition prop- which are used for diverse functions, such apart from their antimicrobial activity. erties of lipocalins. (1) lipophilic ligands as nutrient assimilation, quorum sensing, illustrated as cargo. (2) soluble macro- host invasion and colonization, etc. Apart Lipocalins and their Involvement in In- molecule ligands such as proteins. (3) a from some secreted enzymes, which have nate Immunity and Allergy lipocalin-specific membrane receptor is re- been developed for a variety of commer- Bernhard Redl sponsible for cellular uptake of the lipoca- cial uses (mainly for the fermentation in- We investigate structural and functional lin-ligand complex. dustry), only few extracellular proteins are features of human lipocalins. The protein well characterized with respect to their superfamily of lipocalins consists of small, function, such as pathogenicity or cell sig- mainly secretory proteins defined on the take studies, knock-down experiments) nalling factors. Our main scientific interest basis of conserved amino acid sequence is to identify, isolate and further charac- motifs and their common structure. Func- Epigenetics and Epitranscriptomics terize the molecular, structural and func- tionally, they are important extracellular Chromatin Remodeling and RNA Modi- tional level of novel extracellular proteins carriers of lipophilic compounds in verte- fications brates, invertebrates, plants and bacteria. Alexandra Lusser There is increasing evidence that this group Eukaryotic DNA is assembled into a nucleo- of proteins is involved in a variety of physi- protein complex termed chromatin whose ological processes including retinoid, fatty basic repeating unit is the nucleosome. The acid and pheromone signalling, immuno- way in which DNA is organized in chroma- modulation, inflammation, detoxification, tin allows for highly efficient compaction modulation of growth and metabolism, tis- of the genetic material and provides addi- sue development, apoptosis, and even be- tional levels of control to the regulation of havioral processes. Whereas the structural nuclear processes, such as transcription, basis of lipocalin-ligand binding is now well replication, repair and recombination. understood, there is a major lack of knowl- We are interested to learn how the es- edge regarding the mechanisms by which tablishment and maintenance of eukary- lipocalins exert their biological effects. This otic chromatin affects those processes. is mainly due to the fact that only limited data are available on lipocalin receptors and We approach this question by studying the lipocalin-receptor interactions, although molecular mechanisms and biological con- it is well accepted that many, if not all, of text of chromatin assembly and remodeling Fig. 3: Live-cell imaging of Neurospora cras- these proteins are able to bind to specific processes. Major research questions in sa conidia exposed to BODIPY-labelled anti- cell receptors. Our main research focus is my lab are: (i) The biochemical analysis of fungal protein PAF (green, vacuoles) and co- on identification of cellular lipocalin recep- chromatin assembly processes using in vit- stained with propidium iodide (red, nucleic tors, characterization of molecular mecha- ro assays and single molecule techniques in acids) and calcofluor-white (blue, fungal cell nisms of receptor-ligand interaction and on collaboration with the lab of C. Dekker (TU wall). biological processes beyond receptor bind- Delft), (ii) the study of biological functions

26 Research Report 2016 Medical University of Innsbruck Molecular Biology

Selected Publications An Iron-Mimicking, Trojan Horse-Entering Fungi-Has the Time Come for Molecular Imaging of Fungal Infections? Haas, Hubertus, Petrik, Milos, Decristoforo, Clemens, PLOS PATHOGENS: 2015; 11: S. UNSP e1004568 "Invisible" Conformers of an Antifungal Disulfide Protein Re- vealed by Constrained Cold and Heat Unfolding, CEST-NMR Experiments, and Molecular Dynamics Calculations Fizil, Adam, Gaspari, Zoltan, Barna, Terezia, Marx, Florentine, ­Batta, Gyula, CHEMISTRY-A EUROPEAN JOURNAL: 2015; 21: S. 5136-5144 Insight into the antifungal mechanism of Neosartorya fis- cheri antifungal protein Viragh, Mate, Marton, Annamaria, Vizler, Csaba, Toth, Liliana, ­Vagvoelgyi, Csaba, Marx, Florentine, Galgoczy, Laszlo, PROTEIN & CELL: 2015; 6: S. 518-528 Embryonic stem cell differentiation requires full length Chd1 Piatti, Paolo, Lim, Chin Yan, Nat, Roxana, Villunger, Andreas, Geley, Stephan, Shue, Yan Ting, Soratroi, Claudia, Moser, Markus, Lusser, Alexandra, SCIENTIFIC REPORTS: 2015; 5: S. 8007 Nucleosome Assembly Dynamics Involve Spontaneous Fluc- tuations in the Handedness of Tetrasomes Vlijm, Rifka, Lee, Mina, Lipfert, Jan, Lusser, Alexandra, Dekker, Cees, Dekker, Nynke H., CELL REPORTS: 2015; 10: S. 216-225 Fig. 5: Working model for the loading mechanism of newly synthesized centromeric histone A Penicillium chrysogenum-based expression system for the production of small, cysteine-rich antifungal proteins variant CENP-A into chromatin in Drosophila. Similar to what is known for canonical his- for structural and functional analyses tone loading (upper part), nascent CENP-A is complexed in the cytoplasm with its dimeri- Sonderegger, Christoph, Galgoczy, Laszlo, Garrigues, Sandra, Fizil, Adam, Borics, Attila, Manzanares, Paloma, Hegedues, Nikoletta, zation partner H4 and the histone acetyltransferase HAT1. HAT1 escorts CENP-A/H4 into Huber, Anna, Marcos, Jose F., Batta, Gyula, Marx, Florentine, the nucleus, where the histones are presumably handed over to other chaperone complexes MICROBIAL CELL FACTORIES: 2016; 15: S. 192 before incorporation into chromatin at the centromere. C I, II, III, IV – different chaperone A novel role for the histone acetyltransferase Hat1 in the complexes (see also Boltengagen et al., Nucl. Acids Res. 2016). CENP-A/CID assembly pathway in Drosophila melanogaster Boltengagen, Mark, Huang, Anming, Boltengagen, Anastasiya, Trixl, Lukas, Lindner, Herbert, Kremser, Leopold, Offterdinger, Martin, Lusser, Alexandra, NUCLEIC ACIDS RESEARCH: 2016; 44: S. 2145-2159 of the ATP-dependent chromatin remodeling which all can cause structural and func- Ergothioneine Biosynthesis and Functionality in the Oppor- factor CHD1 in Drosophila and in mouse, tional rearrangements in chromatin and tunistic Fungal Pathogen, Aspergillus fumigatus (iii) the study of centromeric chromatin as- therefore represent essential elements Sheridan, Kevin J., Lechner, Beatrix Elisabeth, O'Keeffe, Grainne, Keller, Markus A., Werner, Ernst R., Lindner, Herbert, Jones, Gary sembly in Drosophila and (iv) the analysis of of the complex epigenetic histone code. W., Haas, Hubertus, Doyle, Sean, 5-methylcytosine distribution and function During the last years it became more SCIENTIFIC REPORTS: 2016; 6: S. 35306 in mammalian mRNA (“epitranscriptomics”). and more clear that a huge number of Histidine biosynthesis plays a crucial role in metal homeo- non-histone proteins are substrates stasis and virulence of Aspergillus fumigatus Dietl, Anna-Maria, Amich, Jorge, Leal, Sixto, Beckmann, Nicola, Major Achievements: for enzymes that were initially iden- Binder, Ulrike, Beilhack, Andreas, Pearlman, Eric, Haas, Hubertus, Characterization of CHD1 as a factor re- tified as histone-modifying enzymes: VIRULENCE: 2016; 7: S. 465-476 quired for embryonic stem cell differenti- this holds true, in particular, for histone A Class 1 Histone Deacetylase with Potential as an Anti- fungal Target ation. Demonstration of CHD-type chro- acetyltransferases (HATs) and HDACs. Bauer, Ingo, Varadarajan, Divyavaradhi, Pidroni, Angelo, Gross, matin remodelling factor regulation during Silke, Vergeiner, Stefan, Faber, Birgit, Hermann, Martin, Tribus, Martin, Brosch, Gerald, Graessle, Stefan, contextual fear extinction learning and in The focus of our research is the analysis of MBIO: 2016; 7: S. e00831-16 a mouse model for trait anxiety. Involve- functional consequences of acetylation of ment of CHD1 in Drosophila gut microbi- non-histone proteins, such as the nucleolar Selected Funding ome homeostasis. Elucidation of the role transcription factors UBF and PAF53 and • Study of centromeric chromatin assembly pathways in Dro- sophila melanogaster, MCBO-PhD Program, FWF (2015), of histone acetyltransferase 1 in CENP-A the cell cycle regulatory protein Rb2/p130. ­Alexandra Lusser assembly into chromatin in flies. Demon- • “The gamma-core motif of antifungal proteins from Ascomyce- tes”, Austrian Science Fund FWF I 3132-B21 (2016), Florentine stration of spontaneous DNA handed- Major Achievements: Marx-Ladurner ness fluctuations in H3/H4 tetrasomes. Identification of UBF and PAF53 as well as of Rb2/p130 as substrates for post- Collaborations Elaine Bignell, Imperial College, London, UK; Axel Brakhage, F. Future Goals: translational acetylation. Demonstration Schiller University Jena, Germany; Robert Cramer, Geisel School of Medicine at Dartmouth, USA; Michael J. Hynes, Univ. of Mel- Study the roles of CHD1 in Drosophila metab- of cell-cycle dependence of Rb2/p130 bourne, Australia; Jean-Paul Latgé, Institut Pasteur, Paris, France; olism.Study the prevalence and physiological acetylation and characterization of the Antonio DiPietro, Univ. Cordoba, Spain; William Nierman, George significance of RNA cytosine modifications. cross talk between Rb2/p130 acetylation Washington Univ., Rockville, USA; Gillian Turgeon, Cornell Univ., Ithaca, USA; Cees Dekker, Nynke Dekker, Technical University and cell cycle-dependent phosphorylation. Delft, Netherlands; Chin-Yan Lim, A*-STAR, Singapore; Dmitry Fyodorov, Albert Einstein College of Medicine, Bronx, USA; Gyula Posttranslational Acetylation of Regula- Batta, University of Debrecen, Hungary; László Galgóczi, Univer- tory Non-Histone Proteins Future Goals: sity of Szeged, Hungary; Nick D. Read, University of Manchester, Peter Loidl Study of the effects of mutations of acetylat- UK; José F. Marcos, IATA, Valencia, Spain; Nancy Keller, University of Wisconsin, Madison, USA; Manfred Jung, Albert-Ludwigs-Uni- Histones are prominent substrates of post- able lysines in Rb2/p130 on cell cycle pro- versität Freiburg, Germany; Antonello Mai, Università degli Studi translational modifications, like acetylation, gression. di Roma "La Sapienza“, Italy; Gianluca Sbardella, Università di Salerno, Fisciano, Italy; Arne Skerra, TU Munich, Freising, Ger- methylation, phosphorylation and others many; Ben J. Glasgow, University of California, Los Angeles, USA.

Research Report 2016 Medical University of Innsbruck 27 Biocenter Experimental ­Pathophysiology and Immunology

“Experimental Pathology” in Prague, moved Atherosclerosis", supported by solid data in 1887 to Innsbruck to become the first from in vitro and animal experiments as professor here. Hermann Pfeiffer was chief well as from cross-sectional and prospec- from 1919–1921, Gustav Bayer followed tive longitudinal studies in human cohorts. him in 1922 and led the institute until In essence, this concept states that clas- 1938 when the NS regime forced him, sical atherosclerosis risk factors first act an intellectual Jew, to end his life. After as endothelial stressors inducing the ex- WW2, Theodor von der Wense rebuilt the pression of a stress protein (heat shock institute, and acted as Ordinarius until protein 60 – Hsp60), which then acts as a 1973. He died in 1977 (http://de.wikipe- “danger signal” and thus serves as a tar- dia.org/wiki/Theodor_von_der_Wense). get for preexisting innate and adaptive an- Kurt Loewit, a descendant of the above ti-Hsp60 immunity. Our present research mentioned Moritz Loewit, took over as inter- is focused on a) the elucidation of the mi- im chief until 1975, when Georg Wick was gratory pathways of HSP60-reacive T-cells nominated. Wick – an immunologist with into the arterial intima and b) the contin- long-term training in USA in the laboratory uation and extension of our EU FR7-fund- of Witebsky, the founder of the concept of ed project TOLERAGE that resulted in the autoimmunity – extended the institute to a development of an Hsp60-based, orally Head of Division (interim): large unit of sometimes 50 collaborators tolerizing vaccine against atherosclero- Univ.-Prof. Dr. Lukas A. Huber working in different fields, i.e. besides sis. Recently, atherogenic HSP60-pep- immunology also in endocrinology and tides were identified in the murine and Contact: molecular biology. A large armamentar- human sytems that may be optimal can- Biocenter, Innrain 80–82 ium of research as well as diagnostic didates for such an orally applied vaccine. 6020 Innsbruck methods was implemented. Later, the institute was renamed as Institute of The Immunology of Fibrosis [email protected] PATHOPHYSIOLOGY (reflecting its teach- Georg Wick Phone: +43 512 9003 70171 ing subject more properly), and finally di- Fibrosis is an important consequence of Fax: +43 512 9003 73960 vided into 3 smaller units (Divisions), i.e. various pathological conditions ranging http://biocenter.i-med.ac.at/epihome from tissue damage, over inflammation, • Experimental Pathophysiology & Immu- reactions against foreign body implants nology (Georg Wick, later interimistically to “spontaneous” fibrotic diseases, al- Research Branch (ÖSTAT Classification) Lukas A. Huber) ways being associated with inflammato- • Molecular Pathophysiology (Reinhard ry immunologic processes. An impaired 301105, 301108, 301109, Kofler) function of regulatory T cells (Treg) within 301902, 302072 • Developmental Immunology (Andreas fibrotic tissues has been recently shown Villunger) by us. This year, a scientific cooperation Keywords aimed at elucidating the development All three joined the Biocenter, where they of peri-silicone mammary implant fibro- Autoimmunity, atherosclerosis, systemic act independently with respect to their sis was started with groups from the MIT. sclerosis, fibrosis, molecular endocrinol- research interests, yet are still combined ogy, teaching Pathophysiology to Med- in their teaching duties in what is called Systemic Sclerosis ical and Molecular Medicine students BEREICH PATHOPHYSIOLOGIE. Siegfried Roswitha Sgonc Schwarz, a member of the Division of Ex- The group is interested primarily in the Research Focus perimental Pathophysiology and Immu- pathogenesis and therapy of systemic nology, has coordinated the teaching of sclerosis (SSc), which is studied in human • The Immunology of Atherosclerosis: Heat Pathophysiology, has written several text- patients as well as in the spontaneous avi- shock protein 60, “danger signal” “at- books, and has contributed substantially an model UCD-200/206, the only animal tracting” preexisting innate and adaptive to the curricular teaching activities at the model that manifests the whole clinical, anti-Hsp60 immunological reactions. MUI till his retirement in 2015. For his histopathological and serological spec- • The Immunology of Fibrosis: Devel- continuous commitment to the academic trum of human SSc. Thus, only the com- opment of peri-silicone mamma- education of Medical students at the Sur- parative study of UCD-200/206 chickens ry implant fibrosis. Impaired func- anaree University of Technology (SUT) in and human SSc made it possible to iden- tion of regulatory T-Cells (Treg). Thailand he received the Honorary Doctor- tify microvascular endothelial cells as the • Pathogenesis and therapy of systemic scle- ate Degree in Medicine of the SUT in 2016. primary target of the autoimmune attack. rosis: Microvascular damage and repair After many years studying pathomecha- mechanisms. Development of skin fibrosis. Research nisms and genetic factors underlying the disease, we are now focusing on the devel- General Facts The Immunology of Atherosclerosis opment of novel therapeutic approaches. Georg Wick There is an unmet need for an effective The former institute of EXPERIMENTAL This project of the last two decades re- pro-angiogenic therapy of ischemic lesions PATHOLOGY was initiated in the late 19th sulted in the formulation of a new “Auto- in patients with SSc. Vascular alterations century. Moritz Loewit, from the Institute of immune Concept for the Development of in both, human and avian SSc, predomi-

28 Research Report 2016 Medical University of Innsbruck Experimental ­Pathophysiology and Immunology

is capable of translating a supra-physiolog- ical dose into a physiological tiny dose and of sustaining this dose long enough to per- mit vessels to mature into stable vessels.

Major Achievement: Effective therapy of ischemic skin le- sions in an animal model of SSc.

Prizes: Publication Prize from the Austri- an Society of Rheumatology and Re- habilitation (ÖGR Publikationspreis)

Future Goal: To study the influence of VEGF121-fibrin ther- apy on the development of fibrosis in SSc.

Selected Publications Efficient therapy of ischaemic lesions with VEGF121-fibrin in an animal model of systemic sclerosis Allipour Birgani, Shadab, Mailänder, Marion, Wasle, Ines, Dietrich, Hermann, Gruber, Johann, Distler, Oliver, Sgonc, Roswitha, ANNALS OF THE RHEUMATIC DISEASES: 2016; 75: S. 1399-1406

© R . Sgonc Searching for a good model for systemic sclerosis: the molecu- Fig. 1: Model for the development and pathophysiology of systemic sclerosis. lar profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis Cipriani, Paola, Di Benedetto, Paola, Dietrich, Hermann, Ruscitti, nantly affect the microvasculature. Initial- of the lesions treated with VEGF121-fibrin Piero, Liakouli, Vasiliki, Carubbi, Francesco, Pantano, Ilenia, Be- ly, endothelial cell apoptosis is induced by showed clinical improvement, whereas rardicurti, Onorina, Sgonc, Roswitha, Giacomelli, Roberto, ARCHIVES OF MEDICAL SCIENCE: 2016; 12: S. 828-843 anti-endothelial cell antibody dependent 71•0% of fibrin treated controls, and 93•1% cellular cytotoxicity (ADCC) via the Fas/ of untreated lesions deteriorated. This was Characterisation of the inflammatory response in Dupuytren's disease Fas ligand pathway. Intimal proliferation, accompanied by significantly increased Mayerl, Christina, Del Frari, Barbara, Parson, Walther, Boeck, occlusion of blood vessels, and capillary growth of stable microvessels, up-regula- Guenther, Piza-Katzer, Hildegunde, Wick, Georg, Wolfram, Dolores, JOURNAL OF PLASTIC SURGERY AND HAND SURGERY: 2016; 50: rarefaction lead to decreased blood flow, tion of the pro-angiogenic VEGF receptor-2 S. 171-179 a state of chronic ischemia, and to clini- (VEGFR-2) and its regulator TAL-1, and in- Mycobacterial heat shock protein 65 (mbHSP65)-induced athero- cal manifestations such as fingertip ulcers crease of endogenous endothelial VEGF ex- sclerosis: Preventive oral tolerization and definition of atheropro- and comb lesions. Tissue hypoxia normally pression. Long term studies showed lasting tective and atherogenic mbHSP65 peptides induces angiogenesis, but in SSc vascular effects on improvement and prevention of Grundtman, Cecilia, Jakic, Bojana, Buszko, Maja, Onestingel, Elisabeth, Almanzar, Giovanni, Demetz, Egon, Dietrich, Hermann, repair and angiogenesis seem to be strong- ischemic lesions supporting the notion that Cappellano, Giuseppe, Wick, Georg, ly disturbed. One of the key molecules in cell-demanded release of fibrin-bound VEGF ATHEROSCLEROSIS: 2015; 242: S. 303-310 the induction of angiogenesis is vascular Selected Funding endothelial growth factor (VEGF). In SSc • Effects of VEGF121 modified fibrin on ischemic lesions chronic and uncontrolled over-expression in systemic sclerosis: a new therapeutic approach. FWF: of VEGF results in chaotic vessels, and in- P23230-B13, Roswitha Gruber-Sgonc • Das vaskulär assoziierte lymphoide Gewebe (VALT) bei Ath- tractable fingertip ulcers. Vice versa, VEGF erosklerose. ÖNB Nr. 15953, Georg Wick is a potent mediator of angiogenesis if its • Thymoglobulin Oral, SANOFI Aventis Group, Georg Wick availability is temporally and spatially con- trolled. We have addressed this therapeutic Collaborations • Oliver Distler, Center of Exp. Rheumatology, University Hospi- dilemma in SSc by a novel approach using a tal Zurich, Switzerland

VEGF121 variant that covalently binds to fi- © R . Sgonc • Roberto Giacomelli, University of Aquila, School of Medicine, brin, and gets released on demand by cellu- Italy • Susanne Kerje, Department of Medical Sciences, Uppsala Uni- lar enzymatic activity, only as long as need- Fig. 2: Effects of topical VEGF121-fibrin versity, Sweden ed. With this approach we mimic nature, therapy on ischemic comb lesions. Sev- • Andrew Newby, Bristol Heart Institute, Bristol, UK where longer VEGF isoforms are bound to en days after treatment angiogenesis was extracellular matrix components until lib- significantly increased in VEGF121-fibrin erated in a tightly controlled manner by lo- treated lesions compared to fibrin treated cal enzymatic activity of cells invading the and untreated controls, resulting in clear matrix. Using UCD-206 chickens, we could clinical improvement. Immunofluorescence show that cell-demanded release of locally double stainings on frozen comb sections of applied fibrin-bound VEGF121 leads to the endothelial cells with anti-von Willebrand formation of morphologically normal blood factor (vWF, red) and mural cells with an- vessels, and clinical improvement of early ti-alpha smooth muscle actin (αSMA, green) and late ischemic lesions. Over all, 79•3% antibodies.

Research Report 2016 Medical University of Innsbruck 29 Biocenter Molecular Pathophysiology

• Defining the role of the BCL-2 rheostat in initiation of differentiation and ciliogenesis. glucocorticoid-induced apoptosis in child­ Ciliogenesis requires exit from the cell divi­ hood acute lymphoblastic leukaemia cells sion cycle, because the basal body, which anchors the cilium at the plasma mem­ General Facts brane is derived from the centrosome, which during cell division is otherwise The Division of Molecular Pathophysiology also required for the formation of a bipo­ has a longstanding interest in the molecular lar mitotic spindle. Alterations in the cell mechanisms that control cellular prolifer­ division cycle can therefore interfere with ation and cell death in pathophysiological ciliogenesis. Depending on the molecular conditions such as cancer with the ultimate structure of the cilium, these antenna-like goal of applying this knowledge to improve structures can either be motile or non-mo­ diagnosis and therapy of human diseases. tile. Non-Motile, or primary, cilia are found on many cell types and are important sig­ We use interdisciplinary approaches and nalling domains. Abnormal structure or collaborate on the national and inter­ function of cilia result in a wide variety of national level to better understand the conditions that are summarised as ciliopa­ mechanisms of chromosome congression thies and more than 100 genes have been Vice Head of Division (interim): and segregation during mitosis as well as identified so far that contribute to these ao. Univ.-Prof. Dr. Stephan Geley the role of the mitotic ubiquitin ligase AP­ diseases. During our work on ciliogenesis, C/C in order to uncover mechanisms that we have identified a potential novel player, Contact: might contribute to aneuploidy, a com­ a poorly characterised RNA-binding pro­ Biocenter, Innrain 80–82 mon hallmark of human malignancies. tein, whose depletion impaired ciliogenesis. 6020 Innsbruck The onset of anaphase and the activation Beyond mitosis, we focus on ciliogenesis of the APC/C during mitosis is regulated [email protected] and non-cell cycle related functions of cyc­ by the spindle assembly checkpoint (SAC). Phone: +43 512 9003 70365 lin-dependent kinases. We try to dissect how Non- or wrongly attached kinetochores Fax: +43 512 9003 73100 the cell cycle control systems govern the generate an inhibitory signal, the mitotic http://biocenter.i-med.ac.at/ formation of primary as well as motile cilia checkpoint complex MCC, that binds to molecular-pathophysiology both during the development of vertebrate and inactivates CDC20 to keep the APC/C model organisms as well as in cell lines. inactive until correct bipolar attachment Head of Division (interim): to the mitotic spindle is achieved, which ao. Univ.-Prof. Dr. Arno Helmberg The research of our division is supported by results in termination of checkpoint sig­ grants from the FWF (Austrian Science Fund) nalling and subsequent APC/C activation, [email protected] as well as the Tyrolean Cancer Aid Society. which results in APC/C-dependent securin Phone: +43 512 9003 70366 cleavage and separase activation, which Research leads to the resolution of cohesin-mediated sister chromatid cohesion, which are then Cell Cycle Control pulled apart to the two poles of the mitot­ Stephan Geley ic spindle. Termination of SAC signalling is Research Branch (ÖSTAT Classification) Cyclin-dependent kinases (CDKs) are pro­ responsive to microtubule binding and in­ line-directed serine threonine kinases that ter- as well as intrakinetochore tension. For 301109, 301108, 301105, 301101, consist of a catalytic and a regulatory sub­ checkpoint silencing, kinetochores employ 301203, 301306, 301904, 304003 unit, the cyclin. CDKs comprise a family of a mechanic means to physically remove 20 different cyclin-CDK pairs that are best checkpoint signalling proteins from the ki­ Keywords known for their role in cell cycle regulation netochore in a dynein-dependent manner. and transcription. The cell cycle regulators Dynein is a large multi-subunit microtu­ Mitosis, cell cycle, CDK, APC/C, pro­ CDKs are negatively regulated by the mitot­ bule minus-end directed motor protein that liferation, differentiation, development, ic ubiquitin ligase APC/C, which targets the plays multiple roles in mitosis. Dynein is ciliogenesis, cell death, cancer mitotic cyclins for proteasome-dependent required for the dissolution of the nuclear degradation. APC/C activity during mito­ envelope, chromosome congression to the Research Focus sis required CDK activity and the WD40 metaphase plate as well as the onset of an­ repeat protein CDC20, which are required aphase. After nuclear envelope breakdown, • Function of the APC/C activator Fzr1/ for the onset of anaphase and exit from dynein and its activatory complex dynactin, CDH1 during development, in tis­ mitosis. In the ensuing G1-phase CDC20 is are recruited to kinetochores by the Spin­ sue homeostasis and in ciliogenesis substituted for by CDH1/FZR1 to keep the dly-RZZ complex. This complex binds to • Molecular analysis of the kinetochore APC/C active until the onset of DNA rep­ kinetochores only during prometaphase by Spindly-RZZ complex in human cells lication. The switch from high CDK activity binding to the kinetochore protein ZWINT-1. • Identification of substrates of CDK16 during mitosis to low CDK activity during Spindly is the most peripheral component and functional analysis in human cells G1 phase is required to allow the resetting of this complex and makes direct contacts • Molecular characterisation of RBM26, of the cell division cycle, for replication li­ to dynactin and possibly other dynein sub­ a potential novel ciliopathy gene censing, for exit from the cell division cycle, units. The binding of Spindly to the RZZ

30 Research Report 2016 Medical University of Innsbruck Molecular Pathophysiology

ment of FZR1 zebrafish morphants, several modifications during SAC silencing. Define developmental pathways were found to be the conse-quences of FZR1 depletion in dampened, which resulted in developmen- tissue homeostasis. Functional character- tal delay and embryonic death. The pleio- isation of CDK16 substrates. Structural tropic phenotype of Fzr1 depletion might be analysis of the CDK16-CyclinY-14-3-3 pro- due to impaired ciliogenesis, due to a failure tein complex. Characterisation and func- to downregulate Aurora and CDK kinases, tional analysis of the RBM26 interactome. which promotes ciliary resorption and in- terferes with differentiation. In contrast to these effects during G1-phase, we could not detect effects during exit from mitosis upon Fzr1 depletion, e.g. in nuclear enve- Selected Publications lope reformation and timing of cytokinesis. Conditional RNAi Using the Lentiviral GLTR System Pfeiffenberger, Elisabeth, Sigl, Reinhard, Geley, Stephan, METHODS IN MOLECULAR BIOLOGY: 2016; 1448: S. 121-138 Functional Analysis of CDK16: CDK16 is mainly expressed in neurons and Beclin 1 is dispensable for chromosome congression and proper outer kinetochore assembly the testes and is activated by cyclin Y and Fava, Luca L., Rainer, Johannes, Haschka, Manuel D., Geley, Stephan, Villunger, Andreas, Fig. 1: RBM26 mutations show kidney cys- cyclin Y-like 1. By using crosslinking mass EMBO REPORTS: 2015; 16: S. 1233-1236 ts and heart edema and smaller eyes (1A). spectrometry we defined the relative ori- entation of the CDK subunit and its bind- The NOXA-MCL1-BIM axis defines lifespan on extended RBM26 is required for retinal differentiati- mitotic arrest on (1B wildtype, 1C RBM26 mutant). ing partner and defined a novel role for Haschka, Manuel D., Soratroi, Claudia, Kirschnek, Susanne, Ha- ecker, Georg, Hilbe, Richard, Geley, Stephan, Villunger, Andreas, 14-3-3 proteins in complex assembly and Fava, Luca L., complex requires its farnesylation and CDK activity. We generated an analogue NATURE COMMUNICATIONS: 2015; 6: S. 6891 blocking thereby prevents the recruitment sensitive variant of CDK16 and used this of dynein to kinetochores during mitosis, enzyme to identify potential protein sub- Selected Funding which results in chromosome congression strates. Human cancer cell lines lacking MCBO Graduate Program (W1101-P06) failures and SAC-mediated arrest in mitosis. CDK16 or cyclin exhibited reduced WNT Collaborations signalling, suggesting an important role Our work focuses on: of this kinase in tumour cell proliferation. • Barisic M, Danish Cancer Center, Copenhagen, Denmark • Ben-Aroya, Bar Ilan University, Ramat Gan, Isreal • Understanding the molecular role of Spin- • DiCunto F, University of Turin, Turin, Italy dly farnesylation Characterisation of RBM26: • Kaldis P, IMCB, A-Star, Singapur • Maiato H, IBMC, Porto, Portugal • Understanding the role of the APC/C in RBM26 is a poorly characterised gene har- • Sakamoto K, Nestlé Institute of Health Sciences SA, Lausanne, G1 phase in ciliogenesis and develop- bouring two RNA binding and one PWI do- Switzerland • Vervoorts J, RWTH Aachen University, Aachen, Germany ment main. The Dro-sophila homolog swm is an • Understanding the role of poorly-charac- essential gene involved in cell cycle regu- terised members of the CDK family lation and/or hedgehog signalling. We de- • Defining the role of RBM26 in ciliogenesis fined the expression of human RBM26 and studied its subcellular localization pattern. Results: By targeting RBM26 in several human cell lines using the CRISPR-Cas9 system, we Farnesylation of Spindly: ruled out an essential function of RBM26 By using mass spectrometry we found that in cell lines, but could define an essential only a fraction of Spindly is farnesylated function in ciliogenesis. Consistent with a and non-farnesylated Spindly can be de- role in ciliogenesis, a zebrafish RBM26 mu- tected outside of mitosis. The selective tant showed a ciliopathy phenotype (Fig.1). timing of farnesylation of Spindly is due to the sequestration of Spindly from farnes- Major Achievements: yltransferase due to different subcellu- lar localization, as shown by the analysis • Characterisation of Spindly farnesyla- of a Spindly mutant harbouring a muta- tion tion in the nuclear localisation sequence. • Identification of FZR1 function in cilio- In addition, the C-terminus of Spindly is genesis also not processed upon farnesylation as • Identification of CDK16 targets and it is in canonical farnesylated proteins, function in cancer cells which might explain the absence of de- • Characterisation of the CDK16-Cyclin tectable membrane binding by Spindly. Y-14-3-3 protein complex • Identification of RBM26 as a novel cili- APC/C Function in Ciliogenesis and De- opathy gene velopment: We have generated conditional Fzr1 knock- Future Goals: out mice and found that FZR1 is essential for develop-ment. When analysing the develop- Define the role of post-translational Spindly

Research Report 2016 Medical University of Innsbruck 31 Biocenter Developmental Immunology

can either promote or prevent apoptosis. Survival-promoting BCL2 family members, i.e. BCL2, BCLX, BCLW, MCL1 and A1/BFL1 share four Bcl-2 homology domains (BH1- BH4) with each other. All these proteins are critical for cell survival, since loss of any of them causes premature cell death of certain cell types. Consistently, overexpression of BCL2 pro-survival molecules is associated Fig. 1: Proposed interrelation of BCL2 family pro- with prolonged cell survival and resistance teins in apoptosis triggered on extended mitotic to cytotoxic drugs in a number of model sys- arrest. tems, but more importantly, also in tumour patients. The pro-apoptotic BCL2 family mem- the functions of this multi-protein complex. bers can be divided into two classes: the BAX- Ongoing projects like proteins, i.e. BAX, BAK, BOK that contain • MCBO-Doctoral College four BH-domains (multi-domain pro-apoptotic • BH3-only proteins in the regulation of ­mitotic Bcl-2 proteins) and the BH3-only proteins. and post-mitotic cell death The latter include BIM, BID, PUMA, NOXA, • Regulation of BCL2 protein stability during Head of Division: BMF, BAD, HRK and BIK that are unrelated in mitosis Univ.-Prof. Dr. Andreas Villunger their sequence to each other or other BCL2 • The PIDDosome in sterile inflammation, tu- family members (except for the BH3-domain). mour suppression and regeneration Contact: We study the role of pro-survival BCL2 family • Identification of Caspase-2 substrates Biocenter, Innrain 80–82 proteins and BH3-only proteins using geneti- 6020 Innsbruck cally modified model systems in tumourigen- Non-coding RNAs in Normal esis, lymphocyte development and function. Haematopoiesis & Disease [email protected] Sebastian Herzog Phone: +43 512 9003 70380 Caspase-2, cell cycle control and the In the last decade, our understanding of Fax: +43 512 9003 73960 DNA-damage response the human genome and its regulation has www.apoptosis.at Cells that have been exposed to DNA-damag- dramatically changed. Initially considered ing agents aim to repair the inflicted damage. to be “junk”, it is now clear that the non- However, when this attempt fails, cells usual- protein coding region, which comprises Research Branch (ÖSTAT Classification) ly activate an apoptotic program or senesce about 98% of the ~3·109 DNA bases, is to avoid the spread of cells with defective extensively transcribed and gives rise to 301105, 301108, 301902, 301904 genomes. DNA-damage can also arise in re- numerous non-coding RNAs. The function sponse to mitotic errors or multipolar cell divi- of these non-coding RNAs, however, is often Keywords sions. How mitotic errors trigger cell death or unclear. prolonged arrest remains unclear. Apoptosis, tumour biology, non-coding The p53-induced protein with a death domain MicroRNAs in Haematopoiesis and RNAs in haematopoiesis, glucocorticoids, (PIDD)1 has been identified as a gene acti- transformation immunology, lymphocyte development vated in response to p53 upon DNA damage. MicroRNAs (miRNAs) are small, non-coding Together with the adapter molecule RAIDD, RNAs that mediate post-transcriptional si- General Facts PIDD1 has been implicated in the activation lencing of a predicted 60% of protein-coding of Caspase-2, an endopeptidase implicated genes in mammals. Since their discovery, they The laboratory's work focuses on the develop- in apoptosis and cell cycle control in a mul- have emerged as central mediators of many, ing immune system with an emphasis on cell ti-protein complex dubbed the PIDDosome. if not all biological processes. In our work, death signalling and its cross talk to the cell PIDD1 has recently also been implicated in we aim to decipher how miRNAs regulate cycle machinery during transformation as well DNA damage-induced NF-kB activation and complex transcriptional networks, focusing as steroid hormones and miRNA function in cytokine release, promoting the transcription on lymphocyte development as a well-estab- the establishment of self-tolerance. of inflammatory genes by forming a complex lished model system. In particular, we want to with the kinase RIPK1 and Nemo. Caspase-2 elucidate the role of individual miRNAs under Research and the PIDDosome have been implicated physiological conditions as well as upon ab- in multiple cellular responses including the errant expression, mimicking an oncogenic Leukocyte Development, Cell Death & one triggered by deprivation of metabolites, situation. To this end, we combine gain- and Transformation heat shock or DNA damage and senescence. loss-of-function approaches, both in vitro as Andreas Villunger Our work has recently helped to define the well as in vivo, with biochemical and molecu- BH3-only proteins in cell death and disease role of the PIDDosome as an upstream ac- lar techniques. Whether a cell continues to live in response tivator of the tumour suppressor, p53, in Molecular regulation of microRNA function to diverse forms of stress or undergoes response to incomplete cell division (Fig.2). MiRNA research has traditionally focused on apoptosis along the intrinsic cell death sig- We are currently investigating the role of these the downstream events, i.e. the identification nalling pathway is largely determined by proteins in tumour suppression and organ re- of target genes that are actively repressed by the complex interplay between individual generation and aim to identify Caspase 2-spe- the microRNA and thus establish a defined members of the BCL2 protein family that cific substrates to gain further insight into phenotype. In contrast, the upstream reg-

32 Research Report 2016 Medical University of Innsbruck Developmental Immunology

and identity of humoral immune cells and how moter. This allows convenient detection and they impact on antibody production in both purification of Treg cells by flow cytometry health and disease. Specifically, our investiga- and the possibility to isolate nearly 100% pure tions aim to: Treg cells. Identifying functionally relevant microRNA- Glucocorticoids and T cell development mRNA interactions Selection processes in the thymus ensure Using genetic model systems, we want to that mature peripheral T cells fulfil two es- understand individual miRNA-mRNA interac- sential prerequisites: activation by foreign tions from the mechanistic and physiologic peptides bound to (host) MHC molecules, but viewpoint. We hope to gain general insights tolerance to self-derived peptides presented into miRNA-mRNA interaction dynamics. in the same context. To that end, thymocytes Together with colleagues from the Mel- that express T cell receptors (TCRs) with high amed-group (Technion, Israel) we could show avidity for self-antigen:MHC and therefore are that a c-Myc/miR-17-92/Pten auto-stimu- potentially autoreactive, undergo apoptosis latory axis regulates positive and negative (negative selection). In contrast, thymocytes selection of immature B cells. Currently, we expressing TCR with moderate avidity for focus on exploring the regulation of apoptotic self-antigen:MHC are rescued and differen- Fig. 2: Proposed model of PIDDosome-mediated cell effector molecules by the miR-17-92 miRNAs tiate into mature T cells that migrate to the cycle arrest in response to supernumerary centro- and the relevance of these interactions for a periphery (positive selection). Glucocorticoid somes. functional humoral immune response. hormones (GC) have been suggested to in- fluence these processes, e.g. induce apop- ulatory networks that feed into miRNA ac- Understanding the Role of DNA Demethyl­ tosis in developing T cells, and the thymus tivity have been largely neglected. With few ation in B Cell Development and Function itself reportedly produces GC. In addition, exceptions, it is not known which signalling We are exploring how the recently identified GC resistance of thymocytes against GC-in- cascades feed into the transcription of cer- epigenetic regulators of DNA demethylation, duced apoptosis is associated with autoim- tain miRNAs. Moreover, we only have a limited the Tet enzymes, secure proper B cell differen- mune diseases. We focus therefore on the understanding about the processes that spe- tiation and effector functions. In a fruitful col- following questions: i) what is the molecular cifically regulate miRNA biogenesis and lack laboration with the Bergman-group (Hebrew background of thymocyte resistance to GC-in- insight into how miRNA decay/turnover is University, Israel), we investigated the impact duced apoptosis in animal models of autoim- specifically regulated. To shed light onto these of the Tet enzymes in B cell development. We mune diseases, and ii) what factors determine different regulatory aspects, we have recent- found that nearly all lineage-specific demeth- sensitivity to GC-induced apoptosis in imma- ly established a genome-wide CRISPR/Cas9 ylation during B cell development is mediated ture vs. mature thymocytes. To address these loss-of-function screening platform. With the by these proteins. Tet enzymes contribute to questions, we use mice that specifically lack help of fluorescent sensors for miRNA activity, establishing a functional mature B cell com- the GC receptor (GR) either in conventional T we are currently using this platform to unrav- partment mainly by preventing demethylation cells or in Treg cells. elling the processes that determine and con- of enhancers regulating genes that are criti- trol the function of several clinically relevant cally involved in the control of B cell differen- Selected Publications A c-Myc/miR17-92/Pten Axis Controls PI3K-Mediated Positive and miRNAs. tiation. Negative Selection in B Cell Development and Reconstitutes CD19 Deficiency Benhamou D, Labi V, Novak R, Dai I, Shafir-Alon S, Weiss A, Gaujoux R, Arnold R, Shen-Orr SS, Rajewsky K, Melamed D., Molecular Immunology Regulation of Immunity by Glucocorticoid CELL REPORTS. 2016; 16: S 419-31. Verena Labi Hormones The NOXA-MCL1-BIM axis defines lifespan on extended mitotic arrest Haschka, Manuel D., Soratroi, Claudia, Kirschnek, Susanne, Haecker, Georg, Protective immunity against pathogens de- Jan Wiegers Hilbe, Richard, Geley, Stephan, Villunger, Andreas, Fava, Luca L., NATURE COMMUNICATIONS: 2015; 6: S. 6891 pends on the proper differentiation and matu- Impact of life span on regulatory T cell matura- Conditional knockdown of BCL2A1 reveals rate-limiting roles in BCR- dependent B-cell survival ration of antigen-specific, non-autoreactive B tion and function Sochalska, M., Ottina, E., Tuzlak, S., Herzog, S., Herold, M., Villunger, A., CELL and T lymphocytes from hematopoietic stem Regulatory T cells (Treg) expressing the tran- DEATH AND DIFFERENTIATION: 2016; 23: S. 628-639 MAP3K11 is a tumor suppressor targeted by the oncomiR cells. Upon recognition of foreign antigens scription factor Foxp3 play an essential role in miR-125b in early B cells Knackmuss, U., Lindner, S. E., Aneichyk, T., Kotkamp, B., Knust, Z., Villunger, A., Herzog, S., by the B cell receptor, B cells are recruited keeping immune homoeostasis and prevent- CELL DEATH AND DIFFERENTIATION: 2016; 23: S. 242-252 into germinal centres (GC) in lymphatic tis- ing autoimmunity. A spontaneous loss of func- Selected Funding sues where they undergo iterative rounds of tion-mutation in foxp3 in ‘scurfy’ mice leads to • Cell death control on extended mitotic arrest, FWF, Andreas Villunger • New insights into Bcl2 family: from biophysics to function, FWF, Andreas proliferation, somatic mutation and selection fulminant lymphoproliferation and multi-organ Villunger to differentiate into plasma cells producing autoimmunity. For a better and more efficient • The role of the PIDDosom in tumor suppression, FWF, Andreas Villunger • Die Rolle des PIDDosoms in der Tumorentstehung, Villunger A., FWF high-affinity antibodies and memory B cells. therapy of autoimmune diseases, a more pro- • Identifikation von PIDDosom-Aktivatoren für die Krebstherapie, FWF, Andreas Villunger Impairment of B cell development or the GC found knowledge is essential for factors that • Glucocorticoids and regulatory T cells, FWF, Jan Wiegers reaction underlies vaccine failure, improper affect (i) Treg maturation and number in the Collaborations pathogen clearance, immunodeficiency, au- thymus and (ii) Treg homoeostasis under ei- • Georg Häcker, Freiburg, DE toimmunity and cancer. Transcription factors ther normal conditions or during the course • Andreas Strasser, WEHI, Melbourne, AUS • Pascal Schneider, Lausanne, CH and signalling molecules guiding these pro- of an immune response. (iii) It is currently • Alexander Egle, PMU, Salzburg, AT • Veronika Sexl, Vienna, AT cesses are increasingly understood, however also unclear how life span influences the ca- • Jörg Hackermüller at Helmholtz Center for Environmental Research (UFZ), Leipzig, DE much less is known about how the expression pacity of Treg to suppress immunity. To study • Falus A., Dept. of Genetics, Cell- and Immunobiology (earlier Dept. of Biology) at Semmelweis University, Budapest, HU of these proteins is regulated. Thus, our aim is maturation and function of Treg cells, we use • Reul J. M., Laboratories of Integrative Neuroscience and Endocrinology to understand the regulatory mechanisms of foxp3GFP knock-in mice that coexpress GFP (LINE), University of Bristol, UK • Boyd R. L., Department of Immunology, Monash University, Clayton, Victoria, gene expression that secure proper cell fate under control of the endogenous foxp3 pro- Australia

Research Report 2016 Medical University of Innsbruck 33 Biocenter Bioinformatics

Head of Division: Univ.-Prof. DI Dr. Zlatko Trajanoski

Contact: Biocenter, Innrain 80–82 6020 Innsbruck

[email protected] Fig. 1: Genome Biology; Molecular phenotypes and immunophenotypes of colorectal cancers Phone: +43 512 9003 71401 Fax: +43 512 9003 73100 Research Branch (ÖSTAT Classification) human diseases we explore data of diverse http://icbi.at functional genomics using computational 102004, 106005, 106014, methods. We aim to identify and prioritize 301902, 301904 candidate genes by analyzing high-dimen- sional data sets, and further characterize Keywords their pathways, thus contributing to the understanding of the pathophysiology of Bioinformatics, computational biology, diseases. genomics 2. Cancer Immunology : Our aim is to de- Research Focus code the interactions between tumor and immune cells using a combined computa- The Division of Bioinformatics has broad tional-experimental approach. Specifically, expertise in bioinformatics and computa- we are interested how the immune system tional biology. The research includes the shapes the mutational spectrum of the tu- development of methods for integrative mor during progression. analyses of heterogeneous data sets and reconstruction of biomolecular networks. Bioinformatics Services A unique feature is the bidirectional flow of information between the experimentalists We provide services regarding bio-informat- and the theoreticians. In particular the lab ics for researchers at the Biocenter and at asks biological questions using computa- the Medical University of Innsbruck, and tional methods and then tests the resultant also for external collaborators. We maintain hypotheses using experimental techniques. a high-performance computational infra- The major focus of our research activities is structure and a number of software tools, directed towards cancer immunology. continuously adapting them to state-of-the- art software technology (see http://icbi. General Facts at). The software development is directed towards specialized databases, analytical The research activities at the Division of Bi- pipelines, and web-services. We additionally oinformatics are directed towards two ma- advise scientists on designing experiments jor thrusts: and support analyses of high-dimensional data sets including NGS (next-generation 1. Computational Genomics: In context of sequencing) data and imaging data.

34 Research Report 2016 Medical University of Innsbruck Bioinformatics

this goal, we extensively explore the data available publicly on the immunogenicity of cancer mutanomes, and carry out experi- mental studies using organoids and mouse models. Additionally, we create mathemat- ical models at various scales and perform simulations that will help us to identify im- mune signals controlling tumor heterogen- ity, clonal evolution and tumor progression. These models and simulations can then be verified experimentally.

Selected Publications Pan-cancer immunogenomic analyses reveal genotype-im- munophenotype relationships and predictors of response to checkpoint blockade Charoentong P*, Finotello F*, Angelova M*, Mayer C, Efremova M, Rieder D, Hackl H, Trajanoski Z. CELL REPORTS: 2017; 18: S. 248-262

Fig. 3: Nature Review Genetics Computational genomics tools for dissecting tumor-im- mune cell interactions An infrastructure for cancer immunotherapy and precision oncology requires state-of-the-art Hackl H*, Charoentong P*, Finotello F*, Trajanoski Z. molecular tools and dedicated IT-Infrastructure NATURE REVIEWS GENETICS 2016; 17: S. 441-458 Characterization of the immunophenotypes and the antige- management and the sophisticated com- nomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy Research putational analysis of experimental data. In Angelova M*, Charoentong P*, Hackl H*, Fischer M, Snajder R, Krogsdam AM, Waldner MJ, BIndea G, Mlecnik B, Galon J, Tra- order to get meaningful biological results, janoski Z Computational genomics each step of the analysis workflow needs to GENOME BIOLOGY: 2015; 16: S. 64 Recent advances in genome sequencing be carefully considered, and specific tools technologies rapidly change the research need to be used for certain experimental Selected Funding • DK MCBO, FWF, Zlatko Trajanoski and routine work of biologists and hu- setups. Furthermore, the challenge of the • APERIM, EU Horizon2020, Zlatko Trajanoski (coordinator) man geneticists. Due to the fast decline ‘next-generation biology/genetics’ will be of costs, NGS is now affordable even for to narrow down the list of candidate var- smaller-sized, pure research laboratories. iants and to interpret remaining variants. Whole-genome and whole-exome sequenc- The major focus of our research is to narrow ing have proven to be valuable methods down genome search space by integrating for discovering the genetic causes of rare and analyzing disparate data sources, in- Mendelian disorders and of complex dis- cluding various omics- and clinical-data. We eases. The current bottleneck is not the se- aim to identify causative genes, prioritize quencing of DNA itself but structured data candidates for experimental studies, and characterize pathways contributing to the pathophysiology of diseases.

Cancer Immunology Most advanced solid tumors remain incura- ble and are resistant to chemotherapeutics and targeted therapies. A series of recent studies reported unexpected intra-tumor heterogeneity which may contribute to this failure. Focusing on the mutational spec- trum of various cancers, only little is known so far about the immunogenicity of these mutations and their characteristic immune responses. Identification of non-synony- mous mutations, processed and present- ed in an immunologically relevant way, will highlight the mechanisms driving tumor progression and provide a rich source for novel immunotherapeutic targets. Thus, it Fig. 2: Cell Reports is of high importance to decode the cross- Immunophenogramm proposed to identify talk between tumor and immune system patients responding to immunotherapy with during tumor development. Our long-term checkpoint blockers goal is to investigate tumor-immune cell interactions in solid tumors. To achieve

Research Report 2016 Medical University of Innsbruck 35 Department of Physiology and Medical Physics Physiology

from ongoing projects developing human up, in the generation of mental disorders iPSCs (induced pluripotent stem cells) into and are further explored in the ceRNAPSych humanised model systems and microRNAs Project funded by the FFG. as novel biomarkers and druggable targets for chronic neuropathic pain disorders. 2. Bioactive lipids and their role in nervous system function and pathophysiology General Facts Understanding the role of bioactive lipid mediators within the central nervous system The major task of the Division of Physiology has recently gained increasing attention, as is the study and teaching of human phys- it has been connected to major diseases iology. Physiology aims to understand how such as multiple sclerosis and Alzheimer's organisms survive and function. This chal- disease. Even though much data about the lenging subject deals with physical and functions of S1P and LPA receptors has chemical factors responsible for the origin, been collected for other organ systems, we the development, the progression and even still lack a complete understanding of their the termination of life. The study of physi- specific roles, in particular within neurons ology includes (i) the understanding of the and the brain. Currently, there is ongoing activity of a given cell and its interaction FWF-funded research on the role of S1P in Head of Division: with the cellular environment, (ii) the neuron excitation, regenerative processes Univ.-Prof.in Dr.in Michaela Kress complex interaction of different cell and synaptic signalling. Furthermore, types in tissues and organs and (iii) the the pathogenesis of neuron dysfunction Contact: interactions of these organ systems which in hereditary lipid storage disorders is Schöpfstr. 41 are critical for the maintenance of whole investigated. 6020 Innsbruck body homeostasis and life. Understanding the healthy function of organisms and their Function of Calcium Channels in [email protected] parts, leads to better understanding of Muscle and Brain Phone: +43 512 9003 70801 processes that occur in diseased states. B.E. Flucher, G.J. Obermair Fax: +43 512 9003 73800 Eight research groups are involved in Voltage-gated calcium channels are www.i-med.ac.at/dpmp/physiologie/ cutting edge research on nociception, key regulators of cellular functions in calcium signalling, cell membranes and electrically excitable cells. They control renal and alveolar epithelial physiology. the communication between nerve and Research Branch (ÖSTAT Classification) We employ a wide range of models and muscle cells, muscle contraction, and techniques including cell culture, imaging, are importantly involved in regulating 301109, 301110, 301114, gene and protein expression, calcium muscle growth and differentiation during 301402, 301406 microfluorimetry, high resolution live development and in response to exercise. microscopy and electrophysiology. These In nerve cells they regulate a variety Keywords eight research groups are partners in local, of vitally important functions including national and international consortia and are neurotransmitter release, gene regulation, Neurophysiology, renal physiology, muscle funded by the European Commission, the and neuronal plasticity. The importance of physiology, lung physiology, cell volume reg- FWF, the FFG and private foundations. voltage-gated calcium channels is reflected ulation, non-coding RNA, toxicology, elec- by a range of disorders related to aberrant trophysiology, cell biology, nociception Research calcium channel functions such as the muscle diseases myotonic dystrophy Research Focus On the Trail of nervous System and malignant hyperthermia as well as Disorders Scientific research at the Division of M. Kress, M. Langeslag Physiology focuses on basic and preclinical translational experimental work in the areas 1. Non-coding RNAs of neurophysiology and the physiology Non-coding RiboNucleic Acids (ncRNAs), of muscle and epithelial organs. Current their expression and their function are research projects include the science assessed in the nervous system, and in of normal biomolecular functions of particular in the development of chronic humans in good health, their organs, and postoperative pain in an FWF funded the cells of which they are composed of. project. M. Kress coordinates the European Understanding healthy body functions lays research consortium ncRNAPain with local the ground to explore the pathogenesis of partners A. Hüttenhofer, Z. Trajanoski common diseases like renal dysfunction or (both Biocenter), F. Kronenberg (Div. Gen. chronic pain, amongst a plethora of others. Epidemiology) and 10 international partners; Fig. 1: Structure-function analysis of two Our research is based on cellular models, the aim of this consortium is to decode the functionally distinct splice variants of the organs and systems, and employs an role of these biological molecules in the skeletal muscle calcium channel revealed integrated interdisciplinary approach. Particular pain system. ncRNAs perform multiple, the molecular mechanism regulating the innovation potential is expected to arise vitally important roles in our genetic make- voltage-sensitivity of channel activation.

36 Research Report 2016 Medical University of Innsbruck Physiology

neurological diseases including migraine, waste products, renal cells, particularly the epilepsy, autism, ataxia, chronic pain, mood proximal tubule, will internally process the disorders, and Parkinson’s and Alzheimer’s majority of drugs and chemicals, and thus disease. Our research teams use state-of- often have higher concentrations of these the-art molecular genetics, molecular and compounds than any other cell in the body. cell biology, electrophysiology, histology, Compounds that injure renal epithelial and high-resolution microscopy approaches cells can initiate and/or accelerate CKD to study calcium channel functions in (chronic kidney disease). The StemBANCC muscle and nerve cells: (Stem cells for biological assays of novel drugs and predictive toxicology) is an 1. Calcium channels in the neuro-muscular IMI-funded project with the main aim to system produce iPSC from large patient cohorts In the past years we elucidated the mole- and differentiate these into target cells. cular identity and specific functions of se- We focus on the differentiation of patient veral hitherto unnoticed channel isoforms. derived iPSC into renal lineages with the Structure-function studies revealed the mo- aim to use these cells and this technology lecular mechanism underlying the unique in drug safety assessment regimes. Robust biophysical properties of the skeletal mu- and reproducible differentiation protocols scle calcium channel. Analysis of a genetic have been elaborated for proximal tubule mouse model identified the importance of like cells and podocyte like cells. In the the newly identified calcium channel splice next phase these cells will be challenged variant for muscle fiber type specification with pharmaceuticals including those and its involvement in muscle disease. On- known to have renal liabilities. In 2016 going experiments examine its role in the the Horizon 2020 EUToxRisk project; “EU- formation of the neuromuscular junction ToxRisk, "An Integrated European ‘Flagship’ during embryonic development. An unex- Program Driving Mechanism-based Toxicity pected observation of a diabetic phenotype Testing and Risk Assessment for the in a mouse mutant lacking a specific com- 21st Century" was launched, where the © Gerald Obermair ponent of calcium channels revealed the Jennings laboratory is a partner involved importance of the auxiliary α2δ-1 subunit in Fig. 2: Fluorescence microscopy of cultured in investigating molecular mechanisms the blood-glucose regulation by pancreatic neurons (upper panel) allowed for the first of chemical induced nephrotoxicity. The β-cells. time super-resolution imaging (lower panel) project aims to create human based in vitro of calcium channels (red) within dendritic testing platforms for kidney, liver, lung and 2. Calcium channels in the brain spines (green) opposite synaptic terminals brain; with the aim to improve regulatory Neuronal functions in the brain are critically (blue). decision making using non-animal methods. regulated by the connections between ner- ve cells, the synapses. Calcium channels adult kidney harbours resident stem cells. 2. Sex differences in the kidney control and fine-tune pre- and postsynaptic Thus, the kidney unlike the liver is not a The research focus of the Lechner group is functions and consequently a pathological- highly rejuvenative organ, which is most the study of sex differences in the kidney. ly altered regulation can directly contribute likely an evolutionary compromise allowing Sex differences between men and women to brain diseases. In our research we could the anatomical complexity required for affect most, if not all, organ systems in recently identify how a specific subtype of high function and the maintenance of the the body, but there is a significant gap in neuronal calcium channels regulates the very narrow margins required for whole knowledge of female physiology aside from stability and therefore the function of post- body homeostasis. Indeed, the kidney is organ functions involved in reproduction. synaptic structures, a finding relevant for an extremely accomplished organ and can Regarding the kidneys, while international synaptic destabilization observed in Parkin- carry out 100 % of its duties with only a registries show that fewer women than son’s disease. Beyond their role in regula- fraction of the nephrons we are born with. men develop kidney failure, the underlying ting the entry of calcium into nerve cells, However, we continually lose nephrons causes are unknown. To investigate, the subunits of calcium channels are also in- through-out life and will, all things being research team has examined whether hor- volved in the formation and maintenance of equal, eventually breach the renal functional mone changes due to the female menstru- synaptic connections. Thus, in our ongoing reserve and enter end-stage renal disease. al cycle might affect kidney cells. For this research we investigate how the so-called Thus, anything that contributes to chronic purpose, urinary samples from healthy α2δ subunits regulate the formation of dis- renal failure has the potential to seriously women of reproductive age were collected tinct and specialized synaptic connections curtail life quality and life-span. Aging daily and analyzed for menstrual cycle–as- populations and associated risk factors such sociated changes of different proteins. Kidney Function and Mechanisms of as diabetes and heart disease, have pushed Specifically, 2 enzymes — fructose-1,6-bis- Kidney Diseases chronic kidney disease (CKD) incidence to phosphatase and glutathione-S-transfera- G. Gstraunthaler, J. Lechner, P. Jennings unprecedented levels (currently at 10 % of se-alpha — were measured­ that are found in Each kidney consists of approximately 1 the European population). proximal tubular cells, the most populous million nephrons at birth. De novo nephro- cell type in the kidney. When proximal tu- genesis does not occur after birth and there 1. Renal toxicity bular cells are damaged, these enzymes is no strong evidence suggesting that the Due to the role of the kidney in eliminating are released into the urine, making them

Research Report 2016 Medical University of Innsbruck 37 Department of Physiology and Medical Physics

vels, as brought about by the natural mens- explanation for the stimulatory effect of trual cycle, might be involved in periodic Mucosolvan on surfactant release: This tissue re-modeling not only in reproductive drug acts by depletion of acidic Ca2+ stores organs, but to a certain extent in the kid- in AT II cells via a simple, and probably neys as well. Understanding the mechanis- widespread pharmacodynamic principle – a ms that might be responsible for women’s drastic breakdown of vesicular H+ gradients lower susceptibility to kidney failure may with an ensuing discharge of Ca2+ ions. help design better kidney-related therapies Since its introduction by an early work of T. for women and men. Haller, this topic gained a strong upsurge in the last few years, in particular in the field of © J Am Soc Nephrol Respiratory Cell Physiology neurodegenerative disorders. Currently, the Fig. 3: Fructose-1,6-bisphosphatase peaks T. Haller team is also active in establishing improved correlate to the menstrual cycle: Quantitative as well as qualitative cell culture systems and in exploiting label- Estrogen urinary metabolite (Estrone- perturbations in the pulmonary surfactant free optical methods to resolve surfactant 3-glucuronide) concentrations over the system of different etiologies, including biogenesis and its nanostructure in live menstrual cycle of healthy ovulating women a ­disruption of type II cell homeostasis, cells. are shown as median (solid line), 25th and are increasingly considered as underlying 75th percentile (dashed lines). Ovulation causes of a spectrum of idiopathic Insulin Secretion and Cell Volume day is displayed as day 0. The hatched area respiratory and interstitial lung diseases, Regulation represents the two time windows, in which some of which are associated with a J. Fürst urinary excretion of a proximal tubular significant morbidity and mortality. The Diabetes mellitus occurs throughout the marker protein, namely urinary Fructose- research of the group of T. Haller focuses on world but is more common (especially 1,6-bisphosphatase, peaks with respect the regulation and mechanisms of surfactant type 2) in more developed countries. Its to the remaining cycle. Both phases are secretion by type II pneumocytes, the prevalence is increasing rapidly and an characterized by a preceding drop of the significance and the biophysical properties estimated 750 million people will have estrogen level. (from Seppi et al J Am Soc of surfactant at the respiratory air-liquid diabetes by 2030. Although genetic Nephrol 2016: https://www.asn-online.org/ interface, and on alveolar epithelial cell background and environmental (i.e. dietary) about/press/releases/ASN_PR_20160422_ physiology in general. In 2016 the group factors have been associated with diabetes JASNLechner886Final.pdf) could resolve an old enigma concerning the pathogenesis, the underlying physiological absolutely essential role of the surfactant mechanisms need to be explored in more important clinical markers for kidney in- protein B (SP-B) whose experimental detail. Our main interest is studying the jury. The investigators detected transient inactivation leads, within hours, to lethal physiology of pancreatic beta cells in vitro, increases of ­fructose-1,6-bisphosphatase respiratory failure. We showed that SP-B with a focus on the role of cell volume and glutathione-S-transferase-alpha­ cor- is acting as a catalytic ‘zipper’ to open the regulatory mechanisms as well as reactive relating with specific phases of the female compact surfactant complexes immediately oxygen species and antioxidants in insulin reproductive hormone cycle, namely ovula- upon their first contact with the respiratory secretion and beta cell survival. tion and menses. This result suggests that air-liquid interface. Inhibition of this process cyclical changes of female hormones might blocks the formation of an active surface affect kidney cell health, potentially provi- coat which normally counteracts the strong ding women with an increased resistance recoil tendency of alveoli, in particular after against kidney damage. It is conceivable end-expiration. In other projects, dedicated that recurring changes of sex hormone le- to pharmacological topics, we found an

© Biochim. Biophys. Acta 1863 (2016): 2124-2134

Fig. 4: ABCa3 (red) and SP-B (green) distribution in an alveolar type II cell (left). Immunogold SEM demonstrating SP-B (yellow) on the surface of exocytosed surfactant (center). Model for SP-B dependent adsorption of surfactant complexes at an air-liquid interface (right)

38 Research Report 2016 Medical University of Innsbruck Physiology

Selected Publications Selected Funding Ablation of Sphingosine 1-Phosphate Receptor Subtype 3 • ceRNAPsych, FFG, M. Kress Impairs Hippocampal Neuron Excitability In vitro and Spa- • NIPPS, FWF, M. Kress tial Working Memory In vivo • SPIN, Doctoral College FWF, M. Kress Weth-Malsch, Daniela, Langeslag, Michiel, Beroukas, Dimitra, • EU-ToxRisk, "An Integrated European ‘Flagship’ Program Driving Zangrandi, Mechanism-based Toxicity Testing and Risk Assessment for the Luca, Kastenberger, Iris, Quarta, Serena, Malsch, Philipp, 21st Century", Horizon 2020, Jennings Kalpachidou, Theodora, Schwarzer, Christoph, Proia, Richard L., • StemBANCC "Stem cells for Biological Assays of Novel drugs Haberberger, and predictive toxiCology " EU 7th Framework and EFPIA. Jen- Rainer V., Kress, Michaela, nings and Gstraunthaler FRONTIERS IN CELLULAR NEUROSCIENCE: 2016; 10: S. 258 • SFB F4415-B23, Importance of Cav1.3 intra-and extracellular modulators for synapse stability in normal and diseased striatal Development and characterization of a pseudo multiple re- MSNs, FWF, (G. Obermair and B. Flucher) action monitoring method for the quantification of human • FWF, P27031: The role of calcium channels in acetylcholine uromodulin in urine receptor pre-patterning during neuromuscular junction de- Hammond, Thomas G., Moes, Suzette, Youhanna, Sonia, Jennings, velopment (Flucher) Paul, Devuyst, Olivier, Odermatt, Alex, Jeno, Paul., • FWF, W1101: Doctoral College in “Molecular Cell Biology and BIOANALYSIS: 2016; 8: S. 1279-1296 Oncology” 4th funding period; Speaker: B. Flucher (Flucher) • FWF Herta Firnberg Project: Molecular mechanisms of the Inter-laboratory study of human in vitro toxicogenom- STAC3-CaV1.1 interaction in skeletal muscle EC coupling. ics-based tests as alternative methods for evaluating chem- T855, (M. Campiglio, co-applicant B.E. Flucher) ical carcinogenicity: a bioinformatics perspective Herwig, R., Gmuender, H., Corvi, R., Bloch, K. M., Brandenburg, A., Castell, J., Ceelen, L., Chesne, C., Doktorova, T. Y., Jennen, D., Jen- nings, P., Limonciel, A., Lock, E. A., McMorrow, T., Phrakonkham, Collaborations P., Radford, R., Slattery, C., Stierum, R., Vilardell, M., Wittenberger, • Josef Penninger, IMBA, Vienna, Austria T., Yildirimman, R., Ryan, M., Rogiers, V., Kleinjans, J., • Hermona Soreq, Hebrew University Jerusalem, Israel ARCHIVES OF TOXICOLOGY: 2016; 90: S. 2215-2229 • Rohini Kuner, University Heidelberg, Germany • Claudia Sommer, University Würzburg, Germany A small key unlocks a heavy door: The essential function • Paul Heppenstall, EMBL Monterotondo, Italy of the small hydrophobic proteins SP-B and SP-C to trigger • Marzia Malcangio, Kings College London, UK adsorption of pulmonary surfactant lamellar bodies • Marc Landry, University Bordeaux, France Hobi, Nina, Giolai, Michael, Olmeda, Barbara, Miklavc, Pika, • Amy Lee, University of Iowa, Iowa City, USA Felder, Edward, Walther, Paul, Dietl, Paul, Frick, Manfred, Perez- • Jörg Striessnig, University of Innsbruck, Austria Gil, Jesus, Haller, Thomas, • Jutta Engel, Saarland University, Homburg, Germany BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RE- • Jing Hu, University of Tübingen, Germany SEARCH: 2016; 1863: S. 2124-2134 • Martin Heine, Leibniz Institute for Neurobiology, Magdeburg, Germany Restricting calcium currents is required for correct fiber • Petronel Tuluc, University of Innsbruck, Austria type specification in skeletal muscle • Valentina Di Biase, Medical , Graz, Austria Sultana, Nasreen, Dienes, Beatrix, Benedetti, Ariane, Tuluc, • Veit Flockerzi, Saarland University, Homburg, Germany Petronel, Szentesi, Peter, Sztretye, Monika, Rainer, Johannes, • Laszlo Csernoch, University of Debrecen, Hungary Hess, Michael W., Schwarzer, Christoph, Obermair, Gerald J., Cser- • Vladimir Yarow-Yarovoy, University of California Davis, Davis noch, Laszlo, Flucher, Bernhard E., CA, USA DEVELOPMENT: 2016; 143: S. 1547-1559 • Frederic Bois, University of Compiègne / INERIS, France • Wolfgang Dekant, University of Würzburg, Germany Splice variants of the Ca(V)1.3 L-type calcium channel regu- • Bob van de Water, Leiden University, The Netherlands late dendritic spine morphology • Martin Leonard, Public Health England, UK Stanika, Ruslan, Campiglio, Marta, Pinggera, Alexandra, Lee, Amy, • Norman P. Curthoys, Colorado State University, Ft. Collins, CO, Striessnig, Joerg, Flucher, Bernhard E., Obermair, Gerald J., USA SCIENTIFIC REPORTS: 2016; 6: S. 34528 • Zam Cader, University of Oxford, UK • Paul Dietl, University Ulm, Germany Two distinct voltage-sensing domains control voltage sensi- • Jesus Perez-Gil, Complutense University, Madrid, Spain tivity and kinetics of current activation in Ca(V)1.1 calcium • Markus Ritter, Paracelsus Medical University, Salzburg, Austria channels Tuluc, Petronel, Benedetti, Bruno, de Bagneaux, Pierre Coste, Grabner, Manfred, Flucher, Bernhard E., JOURNAL OF GENERAL PHYSIOLOGY: 2016; 147: S. 437-449

Quercetin Stimulates Insulin Secretion and Reduces the Vi- ability of Rat INS-1 Beta-Cells Kittl, Michael, Beyreis, Marlena, Tumurkhuu, Munkhtuya, Fuerst, Johannes, Helm, Katharina, Pitschmann, Anna, Gaisberger, Martin, Glasl, Sabine, Ritter, Markus, Jakab, Martin, CELLULAR PHYSIOLOGY AND BIOCHEMISTRY: 2016; 39: S. 278- 293

Sex Differences in Renal Proximal Tubular Cell Homeostasis Seppi, Thomas, Prajczer, Sinikka, Doerler, Maria-Magdalena, Eiter, Oliver, Hekl, Daniel, Nevinny-Stickel, Meinhard, Skvortsova, Iraida, Gstraunthaler, Gerhard, Lukas, Peter, Lechner, Judith, JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY: 2016; 27: S. 3051-3062

Research Report 2016 Medical University of Innsbruck 39 Department of Physiology and Medical Physics Biomedical Physics

laser light. Optical Manipulation conference series in Highlights: trapping of the largest swim- Obergurgl. ming micro-organisms ever trapped "all-op- M Ritsch-Marte was recently elected full tically"; combined acoustic and optical trap- member of the Austrian Academy of Scienc- ping of even larger specimens. es. Alexander Jesacher is also affiliated to Solar UV Radiation: optimisation of spec- the University of Erlangen via his Young Re- troradiometric instruments and develop- searcher Award (SAOT Award). ment of analysis techniques for solar radia- tion spectra and aerosol optical depth. Research Highlights: the Austrian UV measurement network (UV-Index). Biomedical Optics

General Facts RESCH-Microscopy We have developed a scanning microscopy The Division of Biomedical Physics pursues method for the acquisition of volumetric application-oriented basic research pro- sample information from planar scans. The jects devoted to the development of novel method, which we termed RESCH (= “refo- optical methods and technologies in med- cusing after scanning using helical phase Head of Division: icine or cell biology. Currently there exist engineering”), can be considered a variant o. Univ.-Prof. in Dr.in two Research Groups: the Biomedical Op- of Image Scanning Microscopy where the Monika Ritsch-Marte tics Group and the UV-Radiation Group. The imaging point-spread-function (PSF) has research has largely been funded external- been changed such that 3D information Contact: ly, e.g. by FWF, ERC (Advanced Investigator can be efficiently collected, e.g. by bring- Müllerstraße 44 Grant catchIT, Ritsch-Marte, 2010-2015), ing the detection PSF of a scanning micro- 6020 Innsbruck and EU networks. scope into a helical shape. Suitable data The Biomedical Optics Group has a high post-processing allows for the reconstruc- [email protected] visibility in the international Biophotonics tion of volumetric data from a single planar Phone: +43 512 9003 70870 community, in particular for contributions scan. Fig.1(a) shows a RESCH-microscopy Fax: +43 512 9003 73870 to Holographic Optical Tweezers and to example of a fluorescently stained microtu- www.i-med.ac.at/dpmp/bmp Synthetic Holographic Microscopy using bule-network in fixed COS-7 cells. The en- wavefront shaping with so-called Spatial tire data was collected in a single 2D-scan Light Modulators, miniaturized liquid crystal (NA 1.25, wavelength: excitation/emission Research Branch (ÖSTAT Classification) displays with individually addressable mi- = 640/670 nm). By setting specific “virtu- crometer-sized pixels. al pinholes” that select the raw-data points 206003, 103037, 302044, The UV-Radiation group is interested in var- to be integrated, one can retrieve individ- 103021, 103040 ious aspects of solar UV radiation. They op- ual sections of the 3D sample from differ- timise spectroradiometric instruments and ent axial positions around the focal plane. Keywords develop analysis techniques to measure solar radiation spectra and aerosol optical High Resolution Confocal Raman Microscopy Biophotonics, optical trapping, acoustic depth, as well as operating the Austrian UV We have constructed one of the highest-re- trapping, nonlinear microscopy, Raman mi- monitoring network. solving confocal Raman systems, boosting croscopy (coherent and spontaneous), digi- the spatial resolution of confocal Raman mi- tal holographic microscopy, phase contrast, Recent Special Recognitions and Awards: croscopy by a factor of about 1.25. This im- spatial light modulators, UV measurements, The Division of Biomedical Physics has provement was achieved by implementing a solar UV radiation hosted several international conferences in specifically designed fiber-based light col- the last few years, including the Trends in lection system with multiple line-readout on Research Focus

Programmable Microscopy: wavefront shaping with Spatial Light Modulators inside an optical microscope, to emulate and cus- tomize “classic” microscopy techniques or to create new techniques. Highlights: spiral phase contrast, mul- ti-plane imaging, single-shot quantitative differential interference contrast, lensless imaging through a scattering medium, pro- grammable confocal microscopy. Acoustically-assisted Optical Trapping: Fig. 1: Super-resolution techniques developed in Innsbruck: a) RESCH microscopy allows one to recon- contact-free handling of microscopic parti- struct 3D information from specially recorded 2D scan by post-processing based on “virtual pinholes”. cles (micro-organisms, micro-beads, living b) Improved resolution in Raman microscopy by exploiting the pixel-reassignment technique (also cells, cell organelles, or DNA-strands) with known as “Image Scanning Microscopy”).

40 Research Report 2016 Medical University of Innsbruck Biomedical Physics

Hybrid Optical and Acoustic Trapping for high quality UV measurements, the re- While optical trapping in a single, focused search group is responsible for the quality laser beam offers very precise manipula- control and publication of the Austrian UV tion of small particles such as single cells, monitoring network within a long term re- it lacks the ability to handle many (thou- search grant of the Austrian Governmental sands) particles or large specimens (>10 Department for Environment. At the mo- µm). In contrast, acoustic trapping in stand- ment, the results of 16 stations in Austria ing ultrasound waves is well suited for par- and nearby Bavaria and Switzerland are allel handling of many/large particles, but published in near real time (www.uv-index. without the ability of single particle control. at), together with a regional map, showing Thus we have developed a hybrid device the distribution of the level of UV exposure that combines the strengths of acoustic modulated by the actual cloud cover, de- and optical trapping, as well as facilitating rived from actual pictures of the Meteosat Top: Prototype device for 3D acoustic trap- high-resolution optical imaging. A major satellite (cf. Fig.3). The data are presented ping for hybrid optical and acoustic trap- challenge was to gain a proper understand- in units of the ‘uv-index’, which is an inter- ping supporting high resolution imaging. ing of how the acoustic resonances within nationally agreed quantity for harmful UV Bottom: Demonstration of acoustic trapping the device are affected by the close contact exposure, taking into account the sensitiv- of yeast cells with dynamic control of the between the device and the microscope ity of the human skin for UV radiation. An trapping strength in all directions: With immersion lens, requiring careful character- example of these maps is shown in Fig.3, confinement only along the vertical direc- ization of the acoustic properties by means where also the measurement sites are tion, the cells are levitated within a plane (a) of force measurements by optically trapped marked. It gives the maximum UV-index on without surface contact. Additional acoustic test particles. Even 3D acoustic trapping 20.05.2016, clearly influenced by cloudi- fields acting along the horizontal axis force with good optical access is becoming feasi- ness and topography. the cells into stripes (b, c), or 3D clusters (d). ble, to shape and probe large (up to several The capability for absolute UV measure- the spectrometer CCD together with a data 100 µm) cell clusters in a contact-less man- ments is also applied to characterize arti- post-processing method known as “pix- ner (cf. Fig.2). ficial UV sources as e.g. used in sun beds el-reassignment”. Fig.1 (b) demonstrates in solaria. In cooperation with international this, showing a cluster of polystyrene mi- UV Radiation agencies (e.g. Commission Internationale cro-beads, imaged in the spectral band from The main aim of the research group is the de l’Eclairage CIE) these data are inter- 3045 to 3112 wavenumbers with a com- measurement of solar radiation in the spec- preted in terms of harmful and potentially mercial confocal Raman microscope (left), tral range from the UV to the near IR, to in- healthy effects. Also measurements in con- and our resolution-improved Raman micro- vestigate various aspects relevant for humans nection with workplace security and protec- scope (right). The images show the cumula- and the biosphere. Specific research topics tion were carried out. tive energy detected in the respective band. include UV radiation, aerosols and trace gas- es in the atmospheric column (air quality) and Color-dependent Point Spread Function the study of complex radiative transfer sce- Engineering narios in the land-atmosphere system. Based on our earlier work on multi-colour The research group maintains two meas- Selected Publications diffractive optics, we could demonstrate urement sites, one in Innsbruck (at the roof Acoustic force spectroscopy Sitters, Gerrit, Kamsma, Douwe, Thalhammer, Gregor, Ritsch-Marte, Monika, wavelength-sensitive pupil phase engi- of the University of Innsbruck) and one at Peterman, Erwin JG, Wuite, Gijs JL, neering in microscopy. We showed that a mountain site above the city (Hafelekar). NATURE METHODS: 2015; 12: S. 47-50 the Stokes shift of common fluorophores Routine measurements of aerosol optical Three-dimensional information from two-dimensional scans: a scanning microscope with postacquisition refocusing capability is sufficient to provide largely independent depth (with a sun photometer), cloudiness Jesacher, Alexander, Ritsch-Marte, Monika, Piestun, Rafael, OPTICA: 2015; 2: S. 210-213 phase modulation for the excitation laser (sky camera) and erythemal UV radiation Cortical contractility triggers a stochastic switch to fast amoeboid and the emitted fluorescence using a single (Biometer) are performed to compile cli- migration in 3D environments Ruprecht, V., Wieser S., A. Callan-Jones, M. Smutny, H. Morita, K. Sako, V. diffractive optical element. This enables a matological time series for a representa- Barone, M. Ritsch-Marte, M. Sixt, R. Voituriez, C.Ph. Heisenberg, new, more versatile sort of pupil phase en- tive location in an alpine valley. Other more CELL: 2015; 160; S. 673-685 gineering. specific research questions are targeted in Quality assessment of solar UV irradiance measured with array spectroradiometers dedicated field campaigns. Detailed model Egli L., J. Gröbner, G. Hülsen, L. Bachmann, M. Blumthaler, J. Dubard, M. Khazova, R. Kift, K. Hoogendijk, A. Serrano, A. Smedley, J. Vilaplana simulations of the measurements are per- ATMOSPHERICAL MEASUREMENT TECHNIQUES: 2016; 9: S. 1553-1567

formed with a full 3D state-of-the-art radia- Acoustic force mapping in a hybrid acoustic-optical micromanipulation tive transfer model. device supporting high resolution optical imaging Thalhammer, Gregor, McDougall, Craig, MacDonald, Michael P., Ritsch-Marte, In the laboratory, we develop and character- Monika LAB ON A CHIP: 2016; 16: S. 523-1532 ize diode array spectroradiometer systems, to adopt them for solar measurements, Selected Funding

with emphasis on stray light, absolute ra- Extension of the Christian Doppler Laboratory for Microscopic an Spectroscopic Material Characterisation (MS-MACH), Christian Doppler diometric calibration and stability. Specific Forschungsgesellschaft, (Coordinator Assoc.Prof. D. Stifter, Johannes Kepler algorithms are developed and optimized Universität Linz), Ritsch-Marte Monika, 2010 –2017 Fig. 3: The Div. for Biomedical Physics operates to exploit the information content of solar Collaborations • Padgett, Miles, University of Glasgow, UK the Austrian UV measurement network gener- spectra with respect to atmospheric com- • Piestun, Rafael, University of Colorado, Boulder, USA ating the on-line UV-Index for Austria, which is position. • Wuite, Gijs, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands • Nevas, Physikalisch-Technische Bundesanstalt, Berlin, Germany updated every few minutes. Based on the long-established competence • Gröbner, World Radiation Center, Davos, Switzerland

Research Report 2016 Medical University of Innsbruck 41 Department of Medical Genetics, Molecular and Clinical Pharmacology Cell Genetics

by a complex activation process involving based approach. differentiation of the resting cell into a proliferating lymphoblast that actively Research secretes immune-regulatory cytokines or displays targeted cytotoxicity, ultimately Cell Genetics Team: leading to recruitment of innate immune Gottfried Baier, Natascha Kleiter, Thomas cell types and the initiation of an effective Gruber, Nikolaus Thuille, Kerstin Bellaire- immune response. Siegmund, Victoria Klepsch, Karin Albrecht- In order to understand the physiology Schgör, Sebastian Peer, William Olson, Nina and pathophysiology of T lymphocytes, it Posch, Michaela Kind et al. is necessary to decode the biochemical Because of its biological complexity, processes that integrate the signals received cancer is still poorly understood. Chronic from antigens, cytokines, and integrins inflammation has been shown, both as well as inhibitory receptors. Our work experimentally and epidemiologically, to aims to explore and identify gene products predispose to and also to be an inseparable of distinct members of the AGC family of aspect of clinically prevalent cancer protein serine/threonine kinases and their entities. Therefore, understanding the effector substrates that act as key players in breakdown of both tumour and immune Head of Division: mediating proper T cell-mediated immunity cell functions in cancer progression is Univ.-Prof. Dr. Gottfried Baier and in fine-tuning the immune response of utmost importance to better fight this outcome. The underlying goal of the work frequently incurable disease. My team was Contact: is to understand the selective functions the first to reveal the lymphocyte-intrinsic Peter Mayr Straße 1a of these proteins in signal transduction PKC/NR2F6/CBLB axis as an essential 6020 Innsbruck pathways in lymphocytes and to use this signalling node at the crossroads between information to develop strategies for inflammation and cancer. It is our mission to [email protected] manipulating the immune response, either identify molecular signatures that influence Phone: +43 512 9003 70514 in order to promote immunosuppression in the risk of developing inflammation- Fax: +43 512 9003 73518 the context of autoimmune diseases, graft associated tumours, employing established www.baierlab.com rejection and inflammatory responses or for research tools and state-of-the-art genetic, augmentation as a cancer immunotherapy- biochemical, proteomic and transcriptomic

Research Branch (ÖSTAT Classification:

106002, 301109, 301905, 301301

Keywords

T lymphocyte signalling, T cell effector dif- ferentiation and function, intracellular im- mune checkpoints, autoimmunity, cancer immunity, innovative immunological therapy concepts.

Research Focus

Our team has expertise in signal transduc- tion, mouse genetics, the differentiation of effector/memory T cells and the abili- ty of these cells to alter adaptive immune responses. In particular, we have gained experience in investigating molecular sig- nalling processes through the use of hy- pothesis-driven mechanistic studies and by utilising unbiased mass spectrometry based screens and next generation sequencing to characterise novel protein-protein and pro- tein-DNA interactomes and transcriptomes.

General Facts Fig. 1: The major research topic of the group relates to the biochemical, molecular and func- The function of mature T cells is to tional analysis of the signal transducing protein kinase network within the haematopoietic recognize and respond to foreign antigens system.

42 Research Report 2016 Medical University of Innsbruck Cell Genetics

Fig. 2: Our research aims to elucidate the underlying inter- and intracellular mechanisms that shape the T cell compartment (in yellow) to recognize and reject a tumour cell (in blue). as well as large scale in vitro and in vivo Selected Publications Selected Fundings CRISPR/Cas9 perturbation screening- Proof of Principle for a T Lymphocyte Intrinsic Function of • T cell-intrinsic role of PKCalpha in canonical TGFbetaR signalling Coronin 1A. based functional genomic technologies. (G. Baier),FWF P25044 450k€,2013-2016 Siegmund K, Klepsch V, Hermann-Kleiter N, Baier G. • CBLB inhibitory signalling pathways in cancer (G. Baier) FFG Defining this as yet poorly elucidated Siegmund, Kerstin, Klepsch, Victoria, Hermann-Kleiter, Natascha, BRIDGE, 842388, CBL-AIM, 400k€, 2014-2016 effector pathway with its profoundly Baier, Gottfried, • Christian Doppler Laboratory for immune therapy‐mediated JOURNAL OF BIOLOGICAL CHEMISTRY: 2016; 291: S. 22086- cancer rejection via NR2F6 blockade (G. Baier), CDL I-CARE, relevant role would enable development 22092 630k€, 2016-2018 of preventive and immune-therapeutic • PhD program in „Molecular Cell Biology and Oncology” (2 PIs: Inhibition of CBLB protects from lethal Candida albicans sepsis G. Baier and N. Kleiter), FWF DK-MCBO, 300k€, 2014-2019 strategies against cancer and potentially W Wirnsberger, Gerald, Zwolanek, Florian, Asaoka, Tomoko, • PKCtheta/Coronin 1A axis in CD4+ T cell subpopulations (K. Kozieradzki, Ivona, Tortola, Luigi, Wimmer, Reiner A., Kavirayani, also against other immune pathologies. Bellaire-Siegmund) FWF-Lise Meitner Program M1636, Anoop, Fresser, Friedrich, Baier, Gottfried, Langdon, Wallace Y., 160k€, 2014-2017 Our three-pronged approach to achieve Ikeda, Fumiyo, Kuchler, Karl, Penninger, Josef M., • Analysis of the TGFbeta/CBLB pathway in autoimmunity and NATURE MEDICINE: 2016; 22: S. 915-+ this goal is to: (i) delineate biological and tumour immunity (T. Gruber), FWF P26892, 320k€, 2014-2017 clinical properties of the immunological • NR2F6 governs immune defense against microbial pathogens cJun N-terminal kinase (JNK) phosphorylation of serine 36 is (N. Kleiter), FWF P28694, 320k€, 2016-2019 PKC/NR2F6/CBLB network, (ii) develop critical for p66Shc activation. Khalid, Sana, Drasche, Astrid, Thurner, Marco, Hermann, Martin, a cutting-edge CRISPR-mediated gene Ashraf, Muhammad Imtiaz, Fresser, Friedrich, Baier, Gottfried, knockout generation strategy rendering Kremser, Leopold, Lindner, Herbert, Troppmair, Jakob, adoptively transferred T cells capable of SCIENTIFIC REPORTS: 2016; 6: S. 20930 rejecting tumours and their metastases The Nuclear Orphan Receptor NR2F6 Is a Central Checkpoint for Cancer Immune Surveillance. at distal organs and (iii) exploit human Hermann-Kleiter, Natascha, Klepsch, Victoria, Wallner, Stephanie, combinatorial T cell therapy concepts for Siegmund, Kerstin, Klepsch, Sebastian, Tuzlak, Selma, Villunger, Andreas, Kaminski, Sandra, Pfeifhofer-Obermair, Christa, Gruber, prevention of immune-related adverse Thomas, Wolf, Dominik, Baier, Gottfried, events as well as of tumour recurrence by CELL REPORTS: 2015; 12: S. 2072- reducing opportunities for the tumour to Novel protein kinase C theta: coronin 1A complex in T develop resistance in the clinic. Insight into lymphocytes. Siegmund, Kerstin, Thuille, Nikolaus, Posch, Nina, Fresser, the functions of the NR2F6/CBLB axis and Friedrich, Baier, Gottfried, involved mechanisms is a prerequisite for CELL COMMUNICATION AND SIGNALING: 2015; 13: S. 22 understanding how the microenvironment at the tumour site either supports tumour Collaborations • Jürgen Wagner and Gerhard Zencke; Novartis Pharma, Basel, growth and spread or prevents tumour Switzerland; initiation and progression, the latter by • Michael Leitges, Biotechnology Centre of Oslo, University of Oslo, Norway; host-protective cancer immunity. • Noah Isakov, Ben Gurion University of the Negev, Israel; • Wallace Langdon, University of Western Australia, Perth, AUS; • Arthur Kaser, Department of Gastroenterology, Cambridge, UK

Research Report 2016 Medical University of Innsbruck 43 Department of Medical Genetics, Molecular and Clinical Pharmacology Genetic Epidemiology

serves as a bridge between basic and clini- pants investigated almost 10 million single cal research. We have three different pillars nucleotide polymorphisms (SNPs): we iden- that develop their strength by an interleaved tified 48 SNPs in theLPA gene region, which collaboration. 1) A protein chemistry and were all associated with Lp(a) concentra- cell culture laboratory performs a variety tions independently from each other as well of structure-functional and epidemiologic as independently from the apo(a) isoforms. studies regarding various phenotypes re- A SNP-score with Lp(a)-increasing alleles lated to lipoprotein metabolism and other showed an increase of median Lp(a) values metabolic phenotypes. 2) A molecular-ge- from 2.1 mg/dL to 91.1 mg/dL from the netic lab performs sequencing and genotyp- minimum to the maximum number of alleles ing for various projects, with a strong focus (Figure 1). The SNP with the highest effect on mitochondrial DNA as well as on target- on Lp(a) concentrations is also associated ed evaluation of certain candidate genes. 3) with an 80% higher risk for coronary artery The computational & statistical genetics lab disease for each copy of the minor allele. In focusses on statistics, epidemiology, com- addition, we found the APOE2-determining puter science and bioinformatics and repre- allele of rs7412 in the APOE gene to be sig- sents an important cross-link between the nificantly associated with Lp(a) concentra- various research groups. During the last few tions. Each APOE2 allele decreased Lp(a) by Head of Division: years a pronounced entanglement of these 3.34 mg/dL corresponding to ≈15% of the Univ.-Prof. Dr. Florian Kronenberg three "units" to a strongly collaborating population´s mean values. alliance became more and more evident. Contact: There is almost no major project in which 2. A Large Mutation Screening Project Schöpfstraße 41 not at least two main groups are involved. Searching for Mutations in the KIV-2: we 6020 Innsbruck Besides these three pillars our institute hypothesized that the KIV-2 might contain harbours the "Sequencing & Genotyping unknown variants, which affect Lp(a) con- [email protected] Core Facility" offering Sanger-sequencing, centrations. To elucidate this question we Phone: +43 512 9003 70560 large scale genotyping services, and man- developed in a first step novel sequencing Fax: +43 512 9003 73561 agement of large epidemiological studies. technologies and bioinformatic approach- http://www3.i-med.ac.at/genepi New technologies such as Nanopore se- es to sequence 123 samples with differ- quencing or digital droplet PCR recently ent Lp(a) phenotypes. In a second step we became a major focus of this facility. The confirmed the most promising finding in an Research Branch (ÖSTAT Classification): output and success of our institute is based additional 2,892 participants from the gen- on a constant dialogue between the vari- eral population. This revealed a novel vari- 102004,102010, 301301, ous disciplines in a problem-oriented and ant present in 22% of the population, which 301302, 303007 critical elucidation of research questions. strongly reduces Lp(a) concentrations by 21 mg/dL and markedly reduces the increased Keywords Research cardiovascular risk of individuals with the low molecular weight apo(a) phenotypes Genetic epidemiology, lipoprotein metabo­ ­ Lipoprotein(a) (Figure 2). Knowledge about the carrier sta- lism, complex phenotypes, genome-wide Claudia Lamina, Stefan Coassin, association studies, mitochondrial DNA, Florian Kronenberg computational genetics, cloud ­computing, High concentrations of lipoprotein(a) [Lp(a)] structural biology, risk factors, cardio­ are a risk factor for cardiovascular disease. vascular disease, biomarkers These high concentrations are mostly ge- netically influenced by the so-called low Research Focus molecular weight apo(a) isoforms that double the risk for cardiovascular disease. We aim to identify determinants of health These isoforms are determined by a large and disease related to genetic variability, and highly complex genetic region (“KIV-2 environmental components and biochem- repeat”) in the LPA gene which is still poorly ical parameters and to study their physio- characterized. Despite this strong genetic logical or pathophysiological functions. Our regulation, Lp(a) concentrations of individu- phenotypes of interest are complex in na- als with the same isoform combination can Fig. 1: Boxplot of Lp(a) concentration for ture due to their interplay and are related vary 200-fold. This suggests that Lp(a) lev- groups of a SNP-score (sum of Lp(a)-increas- to atherosclerosis, diabetes mellitus, meta- els are modified by additional genetic vari- ing alleles), derived from the 48 independ- bolic syndrome, cancer, and associated in- ants which have to be identified. We recent- ent SNPs in the broad LPA gene region. An termediate phenotypes such as lipoprotein ly completed two major research projects underlying barplot shows the distribution metabolism and inflammation. to identify such variants: of the score in KORA F3 and KORA F4. The blue line indicates the predicted values of General Facts 1. A Large Genome-Wide Association Lp(a) for mid-interval values of the SNP- Study Meta-analysis of Lp(a) Concentra- score, based on a linear regression from the Our Institute with about 18-20 members tions involving more than 13,781 partici- SNP-score on Lp(a).

44 Research Report 2016 Medical University of Innsbruck Genetic Epidemiology

©Bernhard Rupp Fig. 2: Effects of 4925G>A variant on median Lp(a) concentrations: Carriers of this Fig. 3: Structural model of afamin newly discovered genetic variant located within the KIV-2 copy number variation show markedly reduced Lp(a) concentrations especially in isoforms which are re- this cell-culture model we will investigate garded as low molecular weight apo(a) isoforms (Western Blot (WB) isoforms ≤23 the regulation of afamin expression in a K-IV repeats). series of in-vitro experiments as well as the influence of afamin on the secreted lipopro- tus therefore improves patient classification apoA-IV concentrations was very limited. tein/lipid pattern. Second, we have initiated and contributes to the understanding of the Therefore, we initiated a genome-wide me- an ambitious project centered on a struc- extremely large variability of Lp(a) levels ob- ta-analysis comprising the data of seven ture-guided approach to understand the served in low molecular weight apo(a) iso- studies including about 16000 participants. function and properties of afamin. Despite form carriers. In collaboration with the Divi- Two independent SNPs located in or next to its disease-association and similarity to al- sion of Cell Biology (Mariana Eca Guimaraes the APOA4 gene and one SNP in the KLKB1 bumin indicating a significant potential of Araujo PhD, Univ. Prof. Dr. Lukas A. Huber) gene were identified. It was possible to in- acting as a general lipophilic drug transport- and the Division of Genomics and RNomics itiate the next step of analysis with these er, other than homology models (Figure 3) (Univ. Prof. Dr. Alexander Hüttenhofer), we three identified SNPs and other already nothing is known about the molecular struc- finally observed that this variant decreases published results from genome-wide stud- ture and its relation to known and unknown splicing efficiencyin-vitro and is associated ies: a Mendelian randomization study to functions of afamin. Analysis of the molecu- with a reduced amount of protein originat- evaluate the causal direction of the relation lar structure of afamin and of its complexes ing from the mutant allele. between apoA-IV and kidney function. Sur- with small molecule ligands is an effective prisingly, we could show that the estimated means to reveal the origin of its functional Apolipoprotein A-IV glomerular filtration rate (eGFR) as a meas- diversity, allowing critical evaluation of its Claudia Lamina, Barbara Kollerits, ure of kidney function influences apoA-IV transport properties and whether and how Stefan Coassin, Florian Kronenberg and not the other way round. it might have any potential as a possible Apolipoprotein A-IV (apoA-IV) is a glyco- therapeutic target. Any results from these protein, which has anti-atherogenic prop- Afamin studies will therefore be completely new erties. We showed already earlier that Barbara Kollerits, Claudia Lamina, Florian and of significant ground-breaking interest apoA-IV is increased in the early stages of Kronenberg, Bernhard Rupp, Hans Dieplinger as a milestone result in the structural biolo- chronic kidney disease and that it predicts Our research focused primarily on the epi- gy and blood plasma transport/lipoprotein progression of chronic kidney disease. We demiology and the biochemical and struc- research community. Several expression could recently generalize this association of ture-functional characterization of afamin, systems for afamin have been developed so apoA-IV with kidney function to the general a previously described vitamin E binding far, allowing the optimal strategy for crys- population: in a combined analysis of two protein expressed primarily in the liver and tallizing afamin. The structure of one of the population-based studies (about 6000 par- circulating in the bloodstream. We previous- available monoclonal antibodies against ticipants) we could show that high apoA-IV ly showed a strong association of afamin afamin (N14) has already been determined concentrations are associated with reduced plasma concentrations with all parameters and described. Possible complexes of this kidney function independently of classi- of the metabolic syndrome. Our most re- and other antibodies will also be attempted cal risk factors for chronic kidney disease. cent analysis revealed a strong association and their structure determined. Therefore, apoA-IV can be used as an early of elevated afamin concentrations and the marker to indicate renal impairment even in prevalence and incidence of type 2 diabe- Mitochondrial DNA the general population. One very important tes mellitus in a meta-analysis totalling Hansi Weissensteiner, Liane Fendt, Florian question follows these results: is apoA-IV >20,000 human subjects from 8 popula- Kronenberg, Lukas Forer, Sebastian Schönherr only a marker for kidney disease or does it tion-based cohorts. Furthermore, we found Our projects on mitochondrial DNA (mt- causally influence kidney function or vice afamin to be strongly predictive for the de- DNA) currently focus on three topics: versa? This question cannot be answered velopment of hepatic steatosis (commonly 1. Bioinformatic tools for mtDNA se- by observational epidemiological studies associated with the metabolic syndrome) in quence analysis and genotyping to unrav- alone. Since apoA-IV is partly genetical- 1500 participants of the population-based el the path of our female ancestors to the ly regulated, a statistical method known Young Finn Study during a 10-year follow-up. detection of disease: mitochondria possess as Mendelian Randomization can serve as In order to unravel mechanistic insights their own DNA which is inherited by wom- a valuable tool to answer the question of into the (patho)physiological functions of en only. This allows classification of mtDNA causality. To be able to use this method, afamin, we essentially chose two method- profiles into haplogroups that are important one has to know genetic variants which in- ological approaches: first, a human hepatic in evolutionary, forensic and medical ge- fluence apo-IV on the one hand and kidney cell line (HepG2), established very recent- netics. We developed an automatic classi- function on the other hand. Until recent- ly, and permanently expressing afamin via fication in 2011, HaploGrep, which is used ly the knowledge on genetic regulation of the TALEN genome editing technology. With by many groups worldwide; recently we

Research Report 2016 Medical University of Innsbruck 45 Department of Medical Genetics, Molecular and Clinical Pharmacology

presented a markedly extended version, or apoptosis is induced. We have contribut- can be uploaded (VCF or 23andMe format) HaploGrep 2. A further powerful tool is the ed several papers over the last 8 years to receiving phased and imputed genomes in mtDNA-Server which is designed to identify this research area showing associations of return (Figure 4). This service has been de- low-level variants in mtDNA Next-Genera- relative telomere length with cardiovascu- veloped in cooperation with the University tion-Sequencing projects. Both tools were lar disease or cancer. In the most recent of Michigan and the Eurac Research Centre published in the Web server Issue 2016 of clinical study we found a pronounced asso- (led by Christian Fuchsberger and Goncalo "Nucleic Acids Research", are freely avail- ciation between shorter relative telomere Abecasis). It is one of the currently largest able and led to many cooperations world- length and prevalent cardiovascular disease available genetic services that imputed >10 wide. in almost 5000 patients from the German million genomes and is used by >2,000 2. Cancer Research Sequencing Projects: Chronic Kidney Disease (GCKD) Study. In active users. The underlying approach and Mitochondria, playing a vital role for ener- a methodological study we were able to methods have been published in three Na- gy production, are thought to be involved in demonstrate that the DNA extraction meth- ture Genetic papers with several collabora- the initiation of cancer formation. By taking od has a pronounced influence on the meas- tors: The main paper describes the Michigan advantage of Next-Generation Sequencing urement of relative telomere length. If this Imputation Server architecture itself and (NGS) and the previously described mtD- observation is not adequately considered in improvements to the imputation machin- NA-Server, we analyze low-level mutations epidemiological studies, the probability of ery. The second contribution introduces the (heteroplasmies) in the mitochondrial DNA spurious or lost associations is quite high. new HRC reference panel (Haplotype Refer- in cancer/benign tissue pairs. We could ence Consortium) of 64,976 haplotypes at show the reliability of NGS to detect somat- Large international Meta-analysis 39,235,157 SNPs constructed using whole ic mtDNA mutations in oral squamous cell Projects genome sequence data from 20 studies of carcinoma. We currently try to shed light Claudia Lamina, Barbara Kollerits, predominantly European ancestry. The third on mutational and tissue specific differenc- Florian Kronenberg paper illustrates the new phasing algorithm es in tumor and benign prostate samples, Epidemiological and genetic-epidemiologi- "Eagle2" that attains high accuracy across with a range of different methods such as cal studies often are possible only if many a broad range of cohort sizes by efficiently NGS, High-Resolution Respirometry (HRR) groups worldwide contribute their data for leveraging information from large external and RNA-Sequencing. The cancer research a meta-analysis. Each single study alone reference panels (such as the Haplotype projects are in collaboration with the De- would not have the statistical power to find Reference Consortium, HRC). All three partments of Cranio-, Maxillofacial and Oral an association between a certain biomark- contributions have been integrated into the Surgery, Urology, Pathology, the Division er or a genetic variant with an outcome Michigan Imputation Server of Bioinformatics, the Institute of Analyti- of interest (e.g. cardiovascular disease or Registry for Familial cal Chemistry and Radiochemistry of the diabetes). We therefore organize or con- Hypercholesterolemia (FH) University Innsbruck and Oroboros Instru- tribute data from our cohorts to many con- Hans Dieplinger ments. sortia which in the end often include data Since 2015, Hans Dieplinger has been in 3. mtDNA Copy Number Determination: from millions of investigated individuals in charge of a project aiming at establishing the mitochondrial content in a cell reflects their analysis. In the past we have headed an Austrian-wide registry for individuals af- the energy demand of a particular cell and meta-analyses on adiponectin and apolipo- fected with familial hypercholesterolemia changes might cause diseases with an ox- protein A-IV concentrations, ankle-brachi- (FH). This initiative is a central activity of idative phenotype. For these reasons the al-index or peripheral arterial disease. We the Austrian Atherosclerosis Society (AAS) measurement of copy number variation currently perform analyses on concentra- and is organised in close collaboration with recently became a hot topic, the stand- tions of Lp(a), apolipoprotein A-IV and afa- related scientific disciplines and societies ardization of the measurement, however, min, and are leading an analysis of chronic is a nightmare. We therefore have set up kidney disease and its influence on the de- a duplex quantitative PCR based assay for velopment of peripheral arterial disease in determination of mitochondrial DNA copy more than 800,000 prospectively followed number relative to nuclear DNA. A plasmid individuals. containing both targets is used for normal- ization and drastically reduces the intra-as- Providing Large Genetic Services at no say variability. Costs Lukas Forer, Sebastian Schönherr, Telomere Length Hansi Weissensteiner, Florian Kronenberg Barbara Kollerits, Claudia Lamina, Florian The computational lab of the Genetic Epide- Kronenberg miology focuses on methods and tools de- Forer © Sebastian Schönherr and Lukas Telomeres are non-coding, repetitive DNA velopment in the area of genetic research. sequences at the end of linear chromo- Several cloud-based genetic services have Fig.4: Principle of the Michigan Imputation somes, reaching a length of 5-15kb. Their been developed and provided to research- Server: first incomplete DNA sequences de- principle task is to sustain chromosomal in- ers at no costs: mtDNA-Server provides a rived from genotyping of e.g. 500,000 SNPs tegrity by capping and protecting DNA. With free service for the analysis of human mi- are uploaded to the server. Second by com- aging, linear DNA shortens progressively tochondrial DNA data, currently focusing paring with the complete reference DNA with each cell division due to the inability on reliable identification of heteroplasmy of more than 32,000 samples the unknown of DNA polymerase to completely replicate (>= 1%) and contamination. The Michigan DNA stretches are statistically imputed to to the very end. When telomere length has Imputation Server provides a free genotype receive a DNA sequence as complete as pos- become critically short cellular senescence imputation service where GWAS genotypes sible.

46 Research Report 2016 Medical University of Innsbruck Genetic Epidemiology

(cardiology, internal medicine, pediatrics, striking advantage of this technology is the reads (achieving up to >100,000 bp). This human genetics, epidemiology, laboratory enormous read lengths which are potential- allows the resolution of complex gene re- medicine) and the Austrian patient organi- ly achievable, the very small size of the sys- gions. Our Division has been selected to sation FHchol Austria. tem (virtually a large USB stick) and a pol- participate in the early testing phase of this FH is a frequent metabolic disorder cor- ymerase-free, single molecule sequencing technology in 2015 and is currently working relating with a high risk of premature car- approach able to detect even base modifi- on applications of Nanopore sequencing to diovascular disease. With an estimated cations. While common next-generation-se- repetitive genes (e.g. LPA or MUC genes) prevalence of 1:250, we can expect about quencing technologies have read lengths of and the establishment of single molecule 30,000 affected individuals in Austria. How- about 100-300 bp, Nanopore sequencing haplotyping in large copy number variants. ever, more than 90% of them are not yet di- technically allows 100-1000-fold longer agnosed and adequately treated. Mutations in three genes [LDL receptor (LDLR), apoli- poprotein B (APOB) and proprotein conver- tase subtilisin/kexin type 9 (PCSK9)] are the major causes of FH. The inheritance is autosomal-dominant. Elevated LDL-C con- centrations in individuals with heterozygous FH may cause premature cardiovascular events. Thanks to effective cholesterol-low- ering therapies including apheresis as well as novel medication that prove to have even better results, FH can be managed effec- tively. The registry is currently under development and the first patients and their families will be registered soon

Nanopore Sequencing („MinION“) Stefan Coassin, Hansi Weissensteiner, Sebastian Schönherr Nanopore sequencing is the most recent Fig 6: Team of Genetic Epidemiology sequencing technology (Figure 5). The most Selected Publications Association between apolipoprotein A-IV concentrations and chronic Multinational Assessment of Accuracy of Equations for Predicting Risk kidney disease in two large population-based cohorts: results from the of Kidney Failure: A Meta-analysis KORA studies Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, Chodick G, Collins Stangl S*, Kollerits B*, Lamina C, Meisinger C, Huth C, Stöckl A, Dähnhardt D, AJ, Djurdjev O, Elley CR, Evans M, Garg AX, Hallan SI, Inker LA, Ito S, Jee SH, Böger CA, Krämer BK, Peters A, Kronenberg F Kovesdy CP, Kronenberg F, Heerspink HJ, Marks A, Nadkarni GN, Navaneethan JOURNAL OF INTERNAL MEDICINE: 2015;278: S.410-423 SD, Nelson RG, Titze S, Sarnak MJ, Stengel B, Woodward M, Iseki K A genome-wide association meta-analysis on apolipoprotein A-IV JAMA: 2016; 315:164-174 concentrations Lamina C*, Friedel S*, Coassin S, Rueedi R, Yousri NA, Seppälä I, Gieger C, Selected Funding Schönherr S, Forer L, Erhart G, Kollerits B, Marques-Vidal P, Ried J, Waeber G, • "Structure-function investigations of human afamin", FWF, Bernhard Rupp Bergmann S, Dähnhardt D, Stöckl A, Kiechl S, Raitakari OT, Kähönen M, Willeit • Extension of the "German Chronic Kidney Disease Study"; German BMBF J, Kedenko L, Paulweber B, Peters A, Meitinger T, Strauch K, Lehtimäki T, Hunt and KfH Stiftung; Florian Kronenberg SC, Vollenweider P, Kronenberg F • "Center of Common Disease Genetics", NIH Subaward agreement with the HUMAN MOLECULAR GENETICS: 2016; 25: S. 3635-3646 University of Michigan (Goncalo Abecasis); Florian Kronenberg (together The N14 anti-afamin antibody Fab: a rare VL1 CDR glycosylation, with Christian Fuchsberger, Lukas Forer and Sebastian Schönherr) crystallographic re-sequencing, molecular plasticity and conservative versus enthusiastic modelling Collaborations Naschberger A, Fürnrohr BG, Lenac Rovis T, Malic S, Scheffzek K, Dieplinger • Gonçalo Abecasis, Center of Statistical Genetics, University of Michigan, H, Rupp B Ann Arbor, USA ACTA CRYSTALLOGRAPHICA SECTION D: 2016; 72: S. 1267-1280 • Enis Afgan, Ruđer Bošković Institute Zagreb, Croatia & Johns Hopkins © Oxford Nanopore Technologies HaploGrep 2: Mitochondrial Haplogroup Classification in the Era of High University, Baltimore, USA Throughput Sequencing • Steven C. Hunt, Cardiovascular Genetics Division, University of Utah, Salt Fig 5: Principle of Nanopore sequencing (top Weissensteiner H, Pacher D, Kloss-Brandstaetter A, Forer L, Specht G, Bandelt Lake City, USA panel), the USB-stick sized MinION System HJ, Kronenberg F, Salas A, Schönherr S • Institute of Epidemiology, Helmholtz Zentrum München, Neuherberg, NUCLEIC ACIDS RESEARCH: 2016; 44: W58-W63 Germany • Günther Specht, Department of Database and Information Systems; mtDNA-Server: next-generation sequencing data analysis of human (bottom panel, left) and the read length Institute of Computer Science, University of Innsbruck, Innsbruck, Austria mitochondrial DNA in the cloud • Matthew Bowler, Synchrotron Diffraction, EMBL Grenoble, France achieved during an experiment of Nanopo- Weissensteiner H, Forer L, Fuchsberger C, Schöpf B, Kloss-Brandstaetter A, • Kai-Uwe Eckardt, Department of Nephrology and Hypertension, University of Specht G, Kronenberg F, Schönherr S Erlangen-Nürnberg, Erlangen, Germany re sequencing a more than 10,000 bp large NUCLEIC ACIDS RESEARCH: 2016; 44: W64-W69 • Nicole Probst-Hensch, Swiss Tropical and Public Health Institute, Basel, Next-generation genotype imputation service and methods plasmid (bottom panel, right). Nanopore se- Switzerland Das S*, Forer L*, Schonherr S*, Sidore C, Locke AE, Kwong A, Vrieze SI, • Anna Köttgen, Division of Genetic Epidemiology, University of Freiburg, Chew EY, Levy S, McGue M, Schlessinger D, Stambolian D, Loh PR, Iacono quencing is based on the measurement of Freiburg, Germany WG, Swaroop A, Scott LJ, Cucca F, Kronenberg F, Boehnke M, Abecasis GR*, • Arif B. Ekici, Institute of Human Genetics, University of Erlangen-Nürnberg, Fuchsberger C* the electric potential changes while a DNA Erlangen, Germany NATURE GENETICS: 2016; 48: S. 1284-1287 strand is translocated through a protein Reference-based phasing using the Haplotype Reference Consortium Corefacilities pore and allows read lengths far beyond 10 panel Sequencing & Genotyping Core Facility Loh PR, Danecek P, Palamara PF, Fuchsberger C, Reshef A, Finucane K, The Sequencing & Genotyping Core Facility owns state-of-the-art equipment kb (limited in principle only by the length Schoenherr S, Forer L, McCarthy S, Abecasis GR, Durbin R, Price L for Sanger sequencing, high throughput genotyping and qPCR and fragment NATURE GENETICS: 2016; 48: S. 1443-1448 analysis: of the DNA preparation). The possibility to Influence of DNA extraction methods on relative telomere length • Sequenom MassARRAY4 MALDI-TOF System: multiplex genotyping and measurements and its impact on epidemiological studies methylation analysis trivialize sequencing of products beyond 10 Raschenberger J*, Lamina C*, Haun M, Kollerits B, Coassin S, Boes E, Kedenko • QuantStudio 6 Flex System: large scale genotyping and qPCR L, Köttgen A, Kronenberg F • 3130xl System: Sanger sequencing and fragment analysis kb in size opens new opportunities in ge- SCIENTIFIC REPORTS: 2016; 6: S. 25398 • Fragment Analyzer: automated, high-throughput capable fragment analysis nome mapping, resolution of copy numbers, Association of relative telomere length with cardiovascular disease in a for NGS library quality assessment large chronic kidney disease cohort: the GCKD study • 8 and 96 channel TECAN pipetting robots for large pipetting jobs and difficult genome regions and sequencing Raschenberger J*, Kollerits B*, Titze S, Köttgen A, Bärthlein B, Ekici AB, Forer L, automated sample normalization Schönherr S, Weissensteiner H, Haun M, Wanner C, Eckardt KU, Kronenberg F • On cooperative basis: Nanopore Sequencing using the ONT MinION system novel (pathogenic) microorganisms. ATHEROSCLEROSIS: 2015; 242:S. 529-534

Research Report 2016 Medical University of Innsbruck 47 Department of Medical Genetics, Molecular and Clinical Pharmacology Human Genetics

Research Branch (ÖSTAT Classification) sequencing for a large number of individ- ual genes, massively parallel (“next gener- 301301, 301304, 301307, ation”) sequencing - both panel and clinical 302064, 304002 exome -, multiplex-ligation-dependent probe amplification (MLPA), methylation and im- Keywords printing analyses, fragment length typing and Southern Blot for microsatellite repeat Human genetics, molecular genetics, analyses, and others. Due to the close link cytogenetics, mitochondrial genetics, with the large basic research unit, interest- transcript analysis, tumour disposition ing observations or unclarified cases may syndromes, genetic skin diseases, be directly transferred into further investi- metabolic medicine, cancer genetics gations on a research basis. The diagnostic laboratories are equipped for a wide range Research Focus of relevant cell biology techniques, in par- ticular DNA and RNA analyses and the func- • Genetic causes of rare diseases, including: tional analysis of genetic alterations. Spe- ––Inherited connective tissue disease cial research foci are on the metabolism ––Inherited metabolic diseases of cardiolipins and other membrane lipids Head of Division: ––Genetic disease of the teeth and of organelles and cells, as well as connec- Univ.-Prof. DDr. Johannes Zschocke periodontal tissue tive tissue diseases and the intracellular ––Developmental disorders, intellectual processing of extracellular matrix proteins. Contact: disability and dysmorphic syndromes The division is dedicated to interdisciplinary Peter Mayr Straße 1/1 • Genetic causes of tumours and tumour collaboration and is happy to carry out both 6020 Innsbruck dispositions, including: diagnostic tests and research investigations ––Inherited cancer disposition syndromes for a large number of hospital centres in [email protected] ––Breast and ovarian cancer Innsbruck and elsewhere. Phone: +43 512 9003 70501 ––Hamartomatous tumours Fax: +43 512 9003 73510 ––Cytogenetics of haematological Research www.humgen.at malignancies • Membrane lipid metabolism of organelles Periodontal Ehlers-Danlos and cells Syndrome and other Inherited • Transcription and transcript processing Connective Tissue Diseases of nuclear genes, in particular splice Johannes Zschocke, Albert Amberger mechanisms Ehlers-Danlos Syndromes (EDS) denote a • New methods of genetic laboratory group of inherited connective tissue disor- diagnosis, mutation databases, molecular ders characterized by joint hypermobility, genetic quality control skin hyperelasticity and fragility of various tissues. It is mostly caused by deficiencies General Facts of different collagens or other causes of dis- turbed processing or assembly of extracel- The primary aim of the Division of Human lular matrix proteins. The 2017 Inter­national Genetics is clarifying the genetic deter- Classification of the Ehlers–Danlos syn- minants of health and disease in humans, dromes, recently published with important with special focus on rare diseases that are contributions from Innsbruck, distinguishes inherited as monogenic traits, and on ge- 13 subtypes based on the clinical features netic variants that have a major impact on and involving various different pathomech- human biology and substantial disease rele­ anisms. The molecular basis of several EDS vance. This aim is achieved by combining subtypes has been elucidated in Innsbruck. comprehensive patient services and exper- Recently, clinicians and scientists from tise in clinical genetics, molecular genetics ­Human Genetics, Dentistry and Virology and cytogenetics with basic research. The at the MUI, in collaboration with Swedish, institute includes the Centre for Medical French, American, and UK colleagues, iden- Genetics Innsbruck which provides med- tified that the previously disputed periodon- ical genetic services for Western Austria tal form of Ehlers-Danlos syndrome (pEDS) with extensive outpatient clinics and inpa- is a specific condition caused by heterozy- tient consultation in Innsbruck and several gous missense mutations in C1R or C1S. regional hospitals. The diagnostic labora- The defining clinical feature of pEDS is tories cover all relevant methods for DNA, rapidly progressive periodontitis and tooth RNA, and chromosome analysis including loss at a young age; additional symptoms classical cytogenetics, fluorescence-in-situ include lack of attached gingiva, pretibial hybridization (FISH), DNA-Array (molecular ­hyperpigmentation, skin and vascular fragil- karyotyping), tumour cytogenetics, Sanger ity, easy bruising, and variable musculoskel-

48 Research Report 2016 Medical University of Innsbruck Human Genetics © American Journal of Human Genetics, 2016 © American Journal of Human Genetics,

Fig. 1: C1r and C1s Structure A) Modular structure of C1r and C1s and main binding sites to assemble C1. The CUB domain (for complement C1r/C1s, uEGF, BMP1) is a structural motif of approximately 110 residues found almost exclusively in extracellular and plasma membrane-associated proteins. The EGF-like domain is an evolutionary conserved protein domain, which derives its name from the epidermal growth factor where it was first described. It comprises about 40 amino acid residues with six cysteines that form characteristic intra-domain disulfide bonds (1-3, 2-4, and 5-6). CCP (Complement Control Proteins) domains are also termed Sushi domains or Short Consensus Repeats and contain about 60 amino acid residues, each with 4 conserved cysteines that form intradomain disulfide bonds (1-3 and 2-4). These domains are involved in interaction between subunits of proteins and between proteins. The Serine Protease (SP) domains are mostly catalytic domains evolutionary related to the trypsin-chymotrypsin enzymes. The same color code is used for the domains throughout the figure. B) C1q (yellow) is a hexamer of heterotrimers that contains in its cone the main protease interfacial domains that are crucial for C1r/C1s tetramer assembly. Each heterotrimer (A, B, C chains) contains a protease binding site in its collagen stem and a C-terminal globular recognition domain. This incomplete C1 model includes two copies each of C1r and C1s interaction domains (violet, red) and two copies of C1r catalytic domains (blue). C) Schematic view of the main protease conformational changes during C1 assembly, with strong bending between the interaction and catalytic domains. The central C1r/C1r interface (C/C, blue) involves C1r CCP1 and SP head to tail interactions. D and E) Mapping the C1r and C1s variants on 3D structure models. The wild-type residues affected by variants that cause pEDS are shown in colored spheres. The homologous modules are about the same size in the two proteases, which are shown at a different scale. (reprinted from Kapferer-Seebacher et al., American Journal of Human Genetics 2016;99:1005-14) etal symptoms. CUB1-EGF-CUB2-CCP1(Sushi)-CCP2(Sush- function of these genes and from loss of the i)-SP(serine protease) (Figure pEDS-1). They C1 esterase inhibitor. The findings open a novel connection be- associate as a tetramer that binds to a bou- We have now embarked on an international tween the inflammatory classical com- quet-like structure made of six C1q subunits collaborative research project jointly fund- plement pathway and connective tissue to form the C1 complex. Each C1q subunit ed by Austria and France to elucidate the homeostasis. C1R and C1S code for com- is a heterotrimer of A, B, and C chains which pathomechanism of pEDS. The study will ponents of the complement complex C1 forms a collagen-like stem (Figure pEDS-2). involve the systematic characterization of which upon activation triggers the classi- Upon binding of C1q to appropriate targets the clinical presentation and disease com- cal complement cascade to destroy invad- such as antigen–antibody complexes, C1r plications in all available individuals with ing microorganisms and initiate defense is auto-activated by cleavage and can then heterozygous C1R or C1S gain-of-function mechanisms. Complete loss of C1r or C1s cleave C1s to form the active C1esterase. mutations. Intracellular locali-zation, modi- caused by homozygous C1R or C1S null mu- This enzyme can now cleave C4 and C2 fication and activation of complement 1 as tations causes a lupus-erythematosus-like to form the classical pathway C3 conver- well as of collagen and other ECM proteins syndrome with increased susceptibility to tase. pEDS results from specific classes of will be investigated as the exact processes infections and increased risk of developing hetero­zygous mutations in C1R and C1S. are not fully understood and may be directly autoimmune diseases. C1r and C1s have an The mechanism of pathogenesis of these or indirectly disturbed by pEDS mutations. identical domain structure characterized by mutations differs from homozygous loss of It is to be expected that the project will not

Research Report 2016 Medical University of Innsbruck 49 Department of Medical Genetics, Molecular and Clinical Pharmacology

of our current work is to investigate the interdependency of mitochondrial phos- pholipid homeostasis in membranes with mitochondrial functioning and its impact of leucine catabolism, in order to elucidate the principal pathological principles of respec- tive 3MGAurias. Important steps towards successfully answering this research ques- tion are a) the assembly of a comprehen- sive patient fibroblast cell line collection for 3MGAurias, b) the generation of stable CRISPR/Cas9 knockout lines for the two 3MGAurias: MEGDEL Syndrome (SERAC1) and Barth Syndrome (TAZ), and c) estab- lishing the methodological LC-MS/MS plat- form for mitochondrial lipidomics as well as further assays for assessing mitochondrial functions. Lipidomics platform: Our recently devel- oped LC-MS/MS platform allows us to elu- Fig.2: Mitochondrial leucine catabolism is affected by 3-methylglutaconic aciduria related cidate, in combination with mathematical genetic mutations: Leucine catabolic enzymes are shown in blue colour. All depicted proteins modelling techniques, the composition of are localized to mitochondria, except for the cytosolic BCAT1. Evidence of membrane the mitochondrial cardiolipin composition association (M) or soluble forms (S) is shown in red letters. in very great detail (see Fig. 2). Recorded MS1 data is utilized for quantification of up to ~120 different CL species as well as doz- only shed light on the specific pathogenesis pear to be functionally connected to mi- ens of monolyso-CL and oxidized CL spe- of pEDS but will also help to delineate the tochondrial membranes and phospholipid cies. At the same time MS/MS fragment disease-causing mechanisms in other EDS homeostasis therein, especially regarding a data allows us to compute detailed struc- subtypes and connective tissue pathologies. mitochondria exclusive class of phospholip- tural information, acyl chain distributions ids, the cardiolipins (CL) . and lipid molecule symmetry information Membrane Lipid Metabolism Research questions and strategy: Key aim for each of the quantified CL species; data of Organelles and Cells Markus Keller, Johannes Zschocke Problem: A major unsolved problem con- nected with human metabolic diseases is that many clinically relevant metabolic pa- rameters are used for differential diagnosis; however, the underlying pathobiochemical mechanisms for their appearances are frequently elusive. Thus, there is a lack of comprehensive knowledge with respect to structure and regulation of respective meta­ bolic pathways and/or the function of the genes involved. Background: This is especially the case for 3-methylglutaconic acidurias (3MGAuria), a group of human inherited diseases characterized by the accumulation of 3-methylglutaconic acid (3MGA) in patient plasma and urine. Only in primary 3MGAuria can this accumulation be explained easily via defects in the AUH gene, resulting in the blockage of mitochondrial leucine degradation and the cell´s inability to detoxify the 3MGA precursor 3-Methylglutaconyl- Fig. 3: LC-MS/MS analytical platform for the quantification of cardiolipin profiles. A) 2D CoA (see Fig 2). representation of the LC-MS elution pattern of more than 120 different cardiolipin species However, for a series of other 3MGAuria in the mass range of 1300-1500 m/z. B) Full MS1 spectrum at RT=9 min shows different CL causing genes there is no pathological ra- classes eluting at the same time, with different m/z. C) Details for example peak m/z 1428, tionale explaining this phenotype (e.g. TAZ, 8.8 min (CL70:4): i) Natural isotope pattern ii) Double peak caused by subspecies. D) Iden- OPA3, TMEM70, CLOB, DNAJC19, SERAC1). tified phospholipid species: PA: Phosphatidic acid, PC: Phosphatidylcholine, PE: Phosphati- Still, it is noticeable that those genes ap- dylethanolamine, and PS: Phosphatidylserine (measured with a modified HPLC gradient)

50 Research Report 2016 Medical University of Innsbruck Human Genetics

which is therefore ideally suited to study polyposis syndromes. It has only recently Selected Publications genetic perturbations of mitochondrial been recognized as a distinct childhood High prevalence of BRCA1 stop mutation c.4183C>T in the phospholipid homeostasis. Additionally this cancer susceptibility syndrome. As such Tyrolean population: implications for genetic testing. method has already been extended to cover there is still a lack of knowledge on the Pölsler L, Fiegl H, Wimmer K, Oberaigner W, Amberger A, Traunfellner P, Morscher RJ, Weber I, Fauth C, Wernstedt A, other important phospholipid lipid classes natu­ral history of this syndrome. Sperner-Unterweger B, Oberguggenberger A, Hubalek M, Marth (Fig. 3D). Major achievements: Making the molecu- C, Zschocke J. EUROPEAN JOURNAL OF HUMAN GENETICS: 2016; 24: S. 258- lar diagnosis in a number of patients the lab 262 substantially contributed to delineation of Cancer Genetics PMS2 inactivation by a complex rearrangement involving Katharina Wimmer the syndrome with regard to tumour spec- an HERV retroelement and the inverted 100-kb duplicon on This research is strongly associated with trum and non-neoplastic features. This led 7p22.1. Vogt J, Wernstedt A, Ripperger T, Pabst B, Zschocke J, Kratz C, the clinical diagnostic lab of the division to the development of clinical diagnostic Wimmer K. which offers molecular analyses for the criteria proposed by a European consortium EURPEAN JOURNAL OF HUMAN GENETICS: 2016; 24: S. 1598- 1604 whole spectrum of cancer susceptibility under the leadership of our lab. syndromes. Future goals: To uncover pathogenetic Periodontal Ehlers-Danlos Syndrome Is Caused by Mutations in C1R and C1S, which Encode Subcomponents C1r and C1s A major aim of the cancer genetics research mechanisms, in particular secondary so- of Complement. lab is the development and improvement of matic mutations, underlying the develop- Kapferer-Seebacher I, Pepin M, Werner R, Aitman TJ, Nordgren A, Stoiber H, Thielens N, Gaboriaud C, Amberger A, Schossig diagnostic tools for the identification and ment of neoplastic and non-neoplastic A, Gruber R, Giunta C, Bamshad M, Björck E, Chen C, Chitayat classification of mutations. In collaboration features in CMMRD patients, as well as to D, Dorschner M, Schmitt-Egenolf M, Hale CJ, Hanna D, Hennies HC, Heiss-Kisielewsky I, Lindstrand A, Lundberg P, Mitchell AL, with a bioinformatics team at the Johannes evaluate clinical data on CMMRD patients in Nickerson DA, Reinstein E, Rohrbach M, Romani N, Schmuth M, Kepler University, Linz, the lab has devel- close collaboration with the European con- Silver R, Taylan F, Vandersteen A, Vandrovcova J, Weerakkody R, Yang M, Pope FM; Molecular Basis of Periodontal oped and evaluated a novel bioinformatics sortium, both with the ultimate goal to im- EDS Consortium., Byers PH, Zschocke J. tool that is now used in the clinical diagnos- prove the management of CMMRD patients. AMERICAN JOURNAL OF HUMAN GENETICS: 2016; 99: S. 1005- 1014 tic lab for detection of copy number varia- tions in targeted massively-parallel (next 17-Hydroxysteroid dehydrogenase type 10 predicts survival of patients with colorectal cancer and affects mitochondrial generation) sequencing panel data. Further- DNA content. more, the lab has long-standing experience Amberger A, Deutschmann AJ, Traunfellner P, Moser P, Feichtinger RG, Kofler B, Zschocke J. with RNA-based assays that substantially CANCER LETTERS: 2016; 374: S. 149-155 increase mutation detection rates in tumour Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase suppressor genes by effectively uncovering deficiency: urinary organic acid profiles and expanded splice alterations caused by mutations that spectrum of mutations. Pitt JJ, Peters H, Boneh A, Yaplito-Lee J, Wieser S, Hinderhofer K, either fully escape the detection of gDNA Johnson D, Zschocke J. based assays or cannot be readily be clas- JOURNAL OF INHERITED METABOLIC DISEASE: 2015; 38: S. 459- 466 sified as deleterious from the analysis of gDNA only. The evaluation of these ‘atypical’ Collaborations splice mutations e.g. in the NF1 gene also • Messiaen, Ludwine, University of Alabama at Birmingham, provides novel insights into the basic mech- Birmingham, AL, USA • Kratz, Christian, Department of Pediatric Hematology & anisms of splice site definition and inactiva- Oncology, Hannover Medical School, Hannover, Germany tion. RNA-based assays also proved pivotal • Povysil, Gundula, Institute of Bioinformatics, Johannes Kepler University, Linz, Austria in circumventing diagnostic obstacles that are caused by the presence of pseudogenes e.g. of the mismatch repair gene PMS2. Future goals: Transfer of experience and knowledge gained with RNA-based mutation analysis in the Sanger sequencing era into the massive parallel sequencing era. This will involve the evaluation of ‘atypical’ splice mutations with the aim to deduce commonly applicable rules for the selection of unclassified variants (i.e. variants of unknown pathogenicity) likely to affect mRNA splicing for further mRNA analyses. A second aim of this research lab is the ­genetic and clinical characterization of a rare autosomal recessive cancer suscep- tibility syndrome caused by biallelic mu- tations in one of the four DNA mismatch repair (MMR) genes MLH1, MSH2, MSH6, and PMS2. This condition is denoted ­“Constitutional mismatch repair deficiency” (CMMRD) and shows clinical overlap with other cancer susceptibility syndromes, no- tably neurofibromatosis­ type 1 (NF1) and

Research Report 2016 Medical University of Innsbruck 51 Department of Medical Genetics, Molecular and Clinical Pharmacology Biochemical Pharmacology

Research Branch (ÖSTAT Classification) ogy. In October 2009, Hans-Günther Knaus was appointed interim director. 301206, 301902, 106002, The Division of Biochemical Phar- 106023, 106006 macology is substructured into two largely independent research groups, Keywords headed by Sandra Santos-Sierra and Manfred Grabner. A detailed descrip- Pharmacology, immunology, biochemistry, tion of the research topics is given below. molecular biology, biophysics Grabner Lab Research Focus The basic mechanism of skeletal mus- cle contraction is driven by release of • Grabner´s lab focusses on structur- Ca2+ from SR (sarcoplasmic reticulum) al and functional studies of multiple stores. Two distinct Ca2+ channels inter- components of the skeletal muscle ex- act with each other in this complex pro- citation-contraction (EC) coupling ma- cess called excitation-contraction (EC) chinery, using zebrafish and mouse as coupling. These are the voltage-gated model organisms. Another focus of this L-type Ca2+ channel or dihydropyridine re- Vice Head of Division (interim): lab is the role of Ca2+-activated Cl- chan- ceptor (DHPR) of the surface membrane ao. Univ.-Prof. Dr. Manfred Grabner nels in skeletal muscle EC coupling. and the intracellular Ca2+ release channel or ryanodine receptor (RyR1) of the SR. Contact: • Sandra Santos-Sierra: Pharmacological Our main research aim is to elucidate the Peter Mayr Straße 1 modulation of the innate immune re- structure-function relationship of this fas- 6020 Innsbruck sponse. Our research interests focus on cinating bidirectional Ca2+ channel cross- understanding the human innate immune talk in skeletal muscle. We succeeded in [email protected] response in inflammatory diseases, in fine-mapping the domains of the DHPRα 1S Phone: +43 512 9003 70407 particular the activity of phagocytes and and β1α subunits that are crucial for this Fax: +43 512 9003 73440 the signaling processes involved. Based protein-protein signal transduction. Besides www.i-med.ac.at/ibp on this knowledge we intend to develop structure-functional domain mapping, our novel substances that may be specifi- research is devoted to investigate the role of Head of Division (interim): cally applied to modulate the immune Ca2+ through skeletal muscle DHPR, which Univ.-Prof. Dr. Hans-Günther Knaus activity (stimulation or down-regulation). is not (directly) involved in EC coupling.

[email protected] General Facts Sandra Santos-Sierra Phone: +43 512 9003 70440 The innate immune system plays a crucial Until his retirement in 2009, Hart- role not only in fighting infections, but also mut Glossmann was director of the in numerous diseases and pathological con- Division of Biochemical Pharmacol- ditions, including cancer. Toll-like receptors

© Cell Calcium

Fig. 1: Due to the lack of evolutionary pressure (in species with Ca2+-independent excita- 2+ tion-contraction coupling) skeletal muscle DHPRα1S Ca conductivity gradually reduced as evolution progressed. Interestingly, the DHPR of the early ray-finned fish sterlet (Acipens- er ruthenus) is phylogenetically positioned above the mammalian rabbit DHPRα1S which 2+ retained robust Ca conductivity, but below the euteleost zebrafish DHPRα1S which com- 2+ pletely lost Ca conductivity. Remarkably, our results revealed that sterlet DHPRα1S still retained the Ca2+ conductivity but influx is significantly reduced compared to rabbit. The 2+ cardiac DHPRα1C of all 3 species has an identical high Ca conductivity.

52 Research Report 2016 Medical University of Innsbruck Biochemical Pharmacology

their potential to bind TLR2 in HEK293 cells overexpressing the receptor and bearing an NFκB-dependent reporter construct.

Two groups of compounds were selected and their mechanism of action is under char- acterization: First, TLR2-antagonists which bind the TLR2/1 and TLR2/6 heterodimers at the lipopeptide ligand (Pam3CSK4) bind- ing site, as indicated by molecular modeling (Fig. 2A); Second, TLR2-agonists whose binding mode is structurally not defined yet, as these compounds have synergistic activ- ity with other TLR2 ligands (Fig. 2B). The ac- tivity of the different compounds in mouse and human immune cells has been tested and proof of their in vivo activity is under way.

In order to modulate TLR activity, small molecules show better properties than natural TLR2 ligands (e.g. their synthesis is cheaper and they can be purified to clinical grade). Consequently, the novel TLR2-an- © ChemMedChem, Murgueitio et al (A), 2014, S. Santos-Sierra (B) tagonists may be applied in pathologies Fig. 2: A. Small-molecules TLR2 antagonists. The inhibitory concentration lies in the low where TLR2 over-activation leads to an micromolar range and it was determined as the inhibition in TNFα production by human increased inflammatory response. On the monocytes after TLR2 stimulation. B. Small-molecules TLR2 agonists. The compounds syn- other hand, TLR2-agonists may be used ergize with known TLR2 ligands (as shown in luciferase experiments) pointing to a possible as adjuvants in those settings in which allosteric binding site in the receptor. the immune system does not respond.

(TLRs) are major components of this sys- DHPR voltage-sensing and flow activation Selected Publications tem. They recognize pathogens via ligation (Tuluc et al., 2016). Finally we could show Two distinct voltage-sensing domains control voltage 2+ of pathogen-associated molecular patterns that DHPR Ca influx into mammalian sensitivity and kinetics of current activation in Ca(V)1.1 calcium channels (PAMPS), likewise they bind some host de- skeletal muscles – which has been under Tuluc, Petronel, Benedetti, Bruno, de Bagneaux, Pierre Coste, rived ligands resulting from tissue damage investigation for more than half a centu- Grabner, Manfred, Flucher, Bernhard E., (DAMPS). Thus, the central role of TLRs in ry – is (very surprisingly) an evolutionary JOURNAL OF GENERAL PHYSIOLOGY: 2016; 147: S. 437-449 various inflammatory processes and in sep- remnant (Dayal et al., 2017, in revision) Selected Funding sis is well recognized. For this reason, the • 2014-recent: Austrian Science Fund (FWF) P27392-B21; discovery of substances with modulatory Future Goals: Structure – Functional Link in the DHPR ß1a Subunit for Tetrad activity on TLR signalling may have impor- In our present FWF grant (P27392-B21) Formation and Skeletal Muscle Motility. • 2005-recent: Graduate Program Molecular Cell Biology and tant implications in therapy of a broad spec- we explore molecular regions of the Oncology (MCBO) at the Medical University Innsbruck funded trum of pathologies linked to inflammation. essential DHPR β1a subunit respon- as W1101-B12 by Austrian Science Fund (FWF); (B. Flucher, sible for DHPR tetrad formation. Speaker). Research Collaborations Our research also focuses on the role of • Prof. Clara Franzini-Armstrong: Department of Cell and 2+ Grabner Lab Ca -activated Cl- channels in the skeletal Developmental Biology, Univ. of Pennsylvania , Philadelphia, muscles of zebrafish, which are activated U.S.A • Prof. Dr. Francesco Zorzato; Department of Life Sciences and Recent Major Achievements: during EC coupling (MCBO, W1101-B12, Biotechnologies, University of Ferrara, Italy In a recent study we investigated the phy- funded by FWF). In euteleost fish (which • Dr. Werner Melzer: Department of Molecular Physiology and Biophysics, Universität ULM, Deutschland logenetic disappearance of DHPR Ca2+ have the highest evolved skeletal muscles) influx in skeletal muscle. We found that the Ca2+-activated Cl- channel plays a role towards the development of ray-finned fish- in shaping the muscle action potential. es – which are phylogenetically advanced compared to mammals – the DHPR Ca2+ Santos-Sierra Lab conductance “fades out”, while the final Toll-like receptor 2 (TLR2) recognizes bac- “turn off” needed the 3rd round of genome terial di- and tri-acylated lipopeptides and duplication (Ts3R), on the basis of eutel- also some host endogenous ligands such as eost fishes (Schrötter/Dayal & Grabner, HMGB1 or hyaluronan. We have identified 2017). In cooperation with the lab of Prof. several compounds, synthetic small-mol- Flucher (Department of Physiology) we ecules, which are bona fide TLR2 ligands. described two distinct voltage-sensing The novel compounds were retrieved from DHPR domains which are responsible for a combined in silico/in vitro screening for

Research Report 2016 Medical University of Innsbruck 53 Department of Medical Genetics, Molecular and Clinical Pharmacology Molecular and ­Cellular Pharmacology

Research Branch (ÖSTAT Classification) ground level of the Pharmacology/ Ge- netics building in Peter-Mayr Strasse 1 in 301406, 301206 approx. 110m2 of lab- and office space. The majority of equipment and facilities Keywords is shared with other Pharmacology units (Division for Biochemical Pharmacology Ion channels, protein biochemistry, anti- or the Institute of Pharmacology). Our unit bodies, proteomics, immunoprecipitation employs a total of 5 people: The division head, a part-time administrator, 2 research Research Focus assistants (1 out of the 2 researchers is on maternity leave since almost 2 years) Our research unit focuses on certain key and an animal care keeper. Both research aspects of voltage- and ligand-gated ion assistants and the division head are MDs channels. We are interested in the subunit and also have clinical duties especially re- composition of several ion channel fam- lated to the institutional ethics committee. ilies as well as their cellular and subcellu- lar distribution. In addition, our research Research aims to identify the respective ion chan- Head of Division: nel nanodomains via immunoprecipitation Our lab is primarily interested in investi- Univ.-Prof. Dr. Hans-Günther Knaus experiments as well as via high-sensitivity gating the composition, microenvironment sequencing by mass spectrometry. We also and distribution of various ion channels, Contact: investigate the distribution and subunit in particular several classes of potassium Peter Mayr Straße 1 composition of ion channels (mostly volt- and TRPV channels. All these channels 6020 Innsbruck age-gated and calcium-activated potas- appear to associate with other molecular sium channels) in human brain regions. components in complexes, so-called 'mi- [email protected] crodomains'. We aim to establish the com- Phone: +43 512 9003 70440 General Facts position of these ion channel complexes by Fax: +43 512 9003 73440 use of various detergent solubilisation pro- www.i-med.ac.at/molpharm Our research unit is quite small in terms tocols, immunoprecipitation experiments of associated personnel, resources and and sequencing of isolated ion channel associated lab space. We reside on the complexes through mass spectrometry. . © Brain Struct . Funct Fig. 1: Comparison of SK2-LI obtained with antibodies directed against the C-terminal and the N-terminal region of the SK2 peptide. Adjacent sections of SK2-LI detected with AN- TI-CSK2 and Anti-.NSK2. In hippocampus, SK2-LI was detected in molecular layer and in strata oriens and radiatum of CA1 (a, b). In granule cell layer, SK2-LI could be detected mainly in the plasma membrane (c, d).

54 Research Report 2016 Medical University of Innsbruck Molecular and ­Cellular Pharmacology © J Comp . Neurol

Fig. 2: Overview of Slick and Slack channel mRNA and protein labelling in mouse brain (Bregma –0.5 mm). A,B: Representative autoradio- graphs of Slick and Slack channel in situ hybridization. C,D: Corresponding areas of Slick and Slack channel immunolabelling. A–D: Particu- larly strong in situ hybridization and immunohistochemical signals for Slick and Slack channel expression were detected in the subfornical organ. D: Slack channel immunostaining was also evident in the lateral globus pallidus. Scale bar 5 1,000 lm.

Distribution of Various Potassium Distribution of Slick and Slack Major Achievements: Channels in Human Brain. Potassium Channels in Mouse Brain. Complete panels of sequence-directed an- Hans-Günther Knaus Hans-Günther Knaus tibodies against a large number of different We investigated the distribution and expres- We have established the distribution and ion channel families were characterized. By sion of SK2 channels (small conductance subcellular localization of Slick and Slack use of these antibodies, the microdomain calcium activated potassium channels) in channels in the mouse brain through in environments of some of these ion chan- human brain by Western blot analysis and situ hybridization and immunohistochemis- nels were established. immunohistochemistry. Immunoblot ana­ try. Both channels were widely distributed lysis of human brain indicated expression and exhibited distinct distribution patterns. Future Goal: of four distinct SK2 channel isoforms: the However, in some brain regions, their ex- To characterize some of these novel interac- standard, the long and two short isoforms. pression overlapped. Intense Slick channel tion partners in terms of their precise func- Immunohistochemistry in paraffin-em- immunoreactivity was observed in process- tion in the respective ion channel complex. bedded post-mortem brain sections was es, varicosities, and neuronal cell bodies performed in the hippocampal formation, of the olfactory bulb, granular zones of Selected Publications amygdala and neocortex. In hippocam- cortical regions, hippocampus, amygdala, Differential Distribution of the Sodium-Activated Potassium Channels Slick and Slack in Mouse Brain pus, SK2-like immunoreactivity could be lateral septal nuclei, certain hypothalamic Rizzi, Sandra, Knaus, Hans-Guenther, Schwarzer, Christoph, detected in strata oriens and radiatum of and midbrain nuclei, and several regions of JOURNAL OF COMPARATIVE NEUROLOGY: 2016; 524: S. 2093- area CA1-CA2 and in the molecular layer. the brainstem. The Slack channel showed 2116 In the amygdala, SK2-like immunoreactiv- primarily a diffuse immunostaining pattern, Small-Conductance Ca2+-Activated Potassium Type 2 Channels Regulate the Formation of Contextual Fear ity was highest in the basolateral nuclei, and labelling of cell somata and processes Memory Murthy, Saravana R. K., Sherrin, Tessi, Jansen, Chad, Nijholt, while in neocortex, staining was mainly was observed only occasionally. The highest Ingrid, Robles, Michael, Dolga, Amalia M., Andreotti, Nicolas, found enriched in layer V. Activation of Slack channel expression was detected in Sabatier, Jean-Marc, Knaus, Hans-Guenther, Penner, Reinhold, Todorovic, Cedomir, Blank, Thomas, SK2 channels is thought to regulate neu- the olfactory bulb, lateral septal nuclei, ba- PLOS ONE: 2015; 10: S. e0127264 ronal excitability in brain by contributing sal ganglia, and distinct areas of the mid- to the medium after hyperpolarization. brain, brainstem, and cerebellar cortex. In Small-conductance calcium-activated potassium type 2 channels (SK2, KCa2.2) in human brain How­ever, SK2 channels are blocked by addition, comparing our data obtained from Willis M, Trieb M, Leitner I, Wietzorrek G, Marksteiner J, Knaus H-G BRAIN STRUCTURE AND FUNCTION: 2016; 10.1007/s00429- apamin with a sensitivity that suggests mouse brain with a previously published 016-1258-1 heteromeric channels. These expression study on rat brain revealed some differ- data of SK2 human isoform b in brain could ences in the expression and distribution of Collaborations Peter Ruth, Pharmacology, Tuebingen, Germany explain the variability of electrophysiologi- Slick and Slack channels in these species. Bernd Fakler, Physiology II, Freiburg, Germany cal findings observed with SK2 channels.

Research Report 2016 Medical University of Innsbruck 55 Department of Anatomy, Histology and Embryology Clinical and Functional­ ­Anatomy

tice, but the whole Division's activity is fo- sue, where we could resolve some mecha- cused on the welfare and health of people. nisms of the negative adipogenetic effect The Division therefore sees its main role of weight loss, the proliferation and adi- in the development, exchange and imple- pogenic differentiation of adipose derived mentation of clinical and clinically applied stem cells. Further research was conduct- anatomy used in research and teaching as a ed to predict drug sensitivity using 3D cell basic science with indirect and direct bene- culture models, and to study the interaction fits for patients. between cancer cells and immune cells. Ad- The Division of Clinical and Functional Anat- ditionally, peculiarities of the innervation of omy is staffed by eleven scientific and ten the extraocular muscles, and of the ultras- administrative members. tructural and developmental features of the The Division operates laboratory facilities tessellated endoskeleton of sharks and rays for histology and immunohistology, an ul- were addressed. trasound laboratory, and an extensive body donation program, both for educational and Developmental Anatomy of the Inner scientific purposes. Ear The Division contributes much to the pre- In continuation with previous research, re- clinical training of future medical practition- cent papers addressed the neurosensory Head of Division: ers. The broad spectrum of learning activ- differentiation providing first-hand insights Univ.-Prof. Dr. Erich Brenner, MME ities includes lectures as well as practical into the fetal development of the vestib- exercises. Therefore, also some scientific ular end organs as well as their pattern of Contact: efforts deal with medical education and the innervation, with the aim of contributing Müllerstraße 59 body donation program. Further education- towards our understanding of balanced de- 6020 Innsbruck al activities include regular courses for the velopment. Studies on the innervation pat- continuing medical education of different tern in the developing ear demonstrated the [email protected] medical disciplines. Among them, there are presence of nerve fibres in the prosensory Phone: +43 512 9003 71121 workshops and surgical courses organized domain at gestational week (W) 8, followed Fax: +43 512 9003 73112 in cooperation with the corresponding clin- by afferent synaptogenesis at W 11, thus www.anatomie-innsbruck.at ics of the Medical University of Innsbruck providing insights into the early assem- and also with international organizations bly of the neural circuit and organization and societies. in humans. Investigations of the pre- and Research Branch post-somatic segments of the human type Research I spiral ganglion neurons let us assume that 301102, 301104, 301106, the non-myelinated Schwann cells protect 301107, 301111 Clinical and Functional Anatomy these spiral ganglion neurons from further Research in this field was characterised by degeneration following dendrite loss. This Keywords intense collaborations with local, national may give further explanation as to why spi- and international clinicians of all kinds (e.g. ral ganglion neurons can persist as electri- Clinical Anatomy, Functional Anatomy, Ul- Traumatology, Visceral Surgery, Plastic and cally excitable monopolar cells even after trasonography, Medical Education, Inner Ear Reconstructive Surgery, Radiology, etc.) long-time deafness. ranging from transanal minimal-invasive Research Focus surgery (the TAMIS project), towards new Ultrasound techniques for bone augmentation. Re- Previously existing collaborations resulted • Clinical and Functional Anatomy in col- search in the field of shock-wave therapy in several seminal papers addressing the op- laboration with clinical departments (e.g. resulted in a pioneering paper showing that timal analgetic block for total knee arthro- Traumatology, Visceral Surgery, Plastic and this therapy could lead to a causal treat- plasty (TKA), a new technique for pudendal Reconstructive Surgery, Radiology, etc.) ment for ischemic spinal cord injury, and • Developmental Anatomy of the Inner Ear showed that the alteration of inflammatory • Ultrasound guided blockages of plexus response resulted in reduced calcification and peripheral nerves in aortic xenografts. A focus that is more • Ultralow-dose computed tomography anatomical was given to the anterolateral • Neuromonitoring and -modulation ligament of the knee, the femoral torsion, • Anatomical (medical) education the insertion footprint of the teres major muscle, the vastus lateralis muscle, and General Facts some biomechanical tests, and also to the description of two extremely seldom ana- Mors Auxilium Vitae – Death aids life. This tomical variations: a common trunk of the saying, mounted on a door of the depart- coronary arteries, and a cross-doubled pa- ment, aptly characterizes the basic concep- tellar ligament. ©Erich Brenner tual design and objectives of our group. This Fig. 1: Core competencies of the division, means that anatomy is not considered a dis- Basic research internal view. orange: research activities, cipline decoupled from daily medical prac- Basic research dealt with the adipose tis- blue: methods and resources

56 Research Report 2016 Medical University of Innsbruck Clinical and ­Functional Anatomy

blockade of the popliteal plexus by an ob- turator nerve block or local anesthetic infil- tration of the posterior genicular capsule or local infiltration of the interspace between the popliteal artery and the capsule of the posterior knee is required.

Ultralow-dose computed tomography New protocols were developed in order to reduce the radiation burden for several are- as such as the jaw, and the face.

Neuromonitoring and –modulation There is a growing interest in this topic, which we addressed by publications on the implantation techniques for pudendal neu-

© Developmental Neurobiology © Developmental romodulation, but also for the intraopera- Fig. 2: Radial sections of the developing cochlea tive neuromonitoring of the non-recurrent at W8, W11, W12 and in adults. (A) MBP-LI laryngeal nerve. (myelin basic protein-like immunoreactivity) in adults within the Rosenthal's canal and Anatomical (medical) education in the osseous SG (spiral ganglion) (inset 2). International collaborations resulted in an No expression until the end of W12 (inset 1). innovative review on assessment in anat- (B) Glutamate immunostaining by means of omy presenting a wide range of possible postembedding techniques on semithin sections assessment forms, and investigated the – within the OC (organ of Corti) and the SG (inset regrettably low – attitudes of medical stu- 1) compared to adult (inset 2). (C) PRPH –LI dents towards the clinical importance of (peripherin like immunoreactivity) at W11 by Embryology.

means of pre-embedding techniques. (D) At W8, © J Am Heart Assoc SY (Synaptophysin) immunoreactive fibers are Selected Publications recognized within the GER (Greater Epithelial Development of the innervation of the human inner ear Pechriggl, E. J., Bitsche, M., Glueckert, R., Rask-Andersen, H., Blumer, M. J., Ridge) and in the adjacent mesenchyme. Note Fig. 3: Shock wave therapy improves functional Schrott-Fischer, A., Fritsch, H., that an excess of these fibers go first into the outcome and survival. A, In the socalled cylinder DEVELOPMENTAL NEUROBIOLOGY: 2015; 75: S. 683-702 Shock Wave Treatment Protects From Neuronal Degeneration via a acellular matrix of the future tectorial membrane test, it was counted how often a mouse stood up on Toll-Like Receptor 3 Dependent Mechanism: Implications of a First-Ever (inset). (E, F) Semithin sections of SGs and organs its hind limbs during 30 seconds as an indicator Causal Treatment for Ischemic Spinal Cord Injury Lobenwein, D., Tepeköylü, C., Kozaryn, R., Pechriggl, E. J., Bitsche, M., Graber, of Corti (insets) at the beginning of W11 (E) and of functionality of the lower body. *P<0.05. M., Fritsch, H., Semsroth, S., Stefanova, N., Paulus, P., Czerny, M., Grimm, M., Holfeld, J., the end of W12 (F). (G) Overview of the future OC B, The locomotor test counted the number of JOURNAL OF THE AMERICAN HEART ASSOCIATION: 2015; 4: Article e002440 on TEM (Transmission Electron Microscope) level fields that a mouse crossed per 30 seconds and Neurosensory Differentiation and Innervation Patterning in the Human Fetal Vestibular End Organs between the Gestational Weeks 8–12 illustrating the precursors of the IHCs (inner hair was another parameter for mobility, agility, and Johnson Chacko, Lejo, Pechriggl, Elisabeth J., Fritsch, Helga, Rask-Andersen, cells) and OHCs (outer hair cells). (H) Overview speed. *P<0.05. C, The beam-walking time was Helge, Blumer, Michael J. F., Schrott-Fischer, Anneliese, Glueckert, Rudolf, FRONTIERS IN NEUROANATOMY: 2016; 10: Article 111 of the future organ on TEM level illustrating the an indicator for speed and coordination. D, The Ultrasound-Guided Pudendal Nerve Block at the Entrance of the precursors of the IHCs and OHCs. At the end of number of slips during a beam walk was the main Pudendal (Alcock) Canal: Description of Anatomy and Clinical Technique Bendtsen, T. F., Parras, T., Moriggl, B., Chan, V., Lundby, L., Buntzen, S., W12, stereocilia of the inner hair (arrow) and parameter for the measurement of coordination. Dalgaard, K., Brandsborg, B., Børglum, J., pillar cells (inset) are already detectable. Scale Mice still showing paraparesis or even mild REGIONAL ANESTHESIA AND PAIN MEDICINCE: 2016; 41: S. 140-145 bar: 100 µm (inset A1), 50 µm (A, E, F; inset A2), paraplegia slipped off the beam more often. E, The nonrecurrent laryngeal nerve: A clinical anatomic mapping with regard to intraoperative neuromonitoring 20 µm (B, C, D, G; insets B2, E), 10 µm (H; insets The grip test measured the time that a mouse was Konschake, M., Zwierzina, M. E., Pechriggl, E. J., Moriggl, B., Brenner, E., Hörmann, R., Prommegger, R., B2, D, F), 2 µm (inset H). able to hold itself in an inverted position and gave SURGERY: 2016; 160: S. 161-168 clear information about strength and functionality nerve block, which is based on easily recog- of the hind limbs. *P<0.05. F, The Kaplan–Meier Collaborations • Abd Ellah M., Department of Diagnostic Radiology, South Egypt Cancer nizable sonoanatomical patterns and prob- curve showed that more than two-thirds of the Institute, Assiut University, Egypt • Aigner F., Pratschke J., Biebl M, Department for General, Visceral and ably implies no risk of sacral plexus block- untreated control animals did not survive the first Transplantation Surgery, Charité Universitätsmedizin, Berlin, Germany ade, a L5 dorsal ramus block; this block can 24 hours. This is due to severe visceral ischemia. • Al-Ekrish A., Al-Shawaf R, Al-Sadhan R., Department of Oral Medicine and Diagnostic Sciences, College of Dentistry, King Saud University, Riyadh, also be used for sonoelastography. Periph- A much higher percentage of the shock wave– Saudi Arabia • Atturo F., Department of Neurology, Mental Health and Sensory Organs, eral nerve block for total knee arthroplasty treated animals survived the study end point of Otorhinolaryngologic Unit, Medicine and Psychology, Sapienza, Rome, Italy • Bauer S., Foditsch E., Janetschek G., Sievert K.-D., Zimmermann R., is ideally motor-sparing while providing ef- 7 days. CTR indicates control; min, minutes; sec, Department of Urology and Andrology, Paracelsus Private Medical University, Salzburg, Austria fective postoperative analgesia. A femoral seconds; SWT, shock wave therapy. • Blumer R., Maurer-Gesek, B., Streicher J., Center of Anatomy and Cell triangle block guided by internal anatomical Biology, Medical , Vienna, Austria • Børglum J., Department of Anesthesia, Zealand University Hospital & structures visible with ultrasonography or the extraarticular retinaculum of the medial Roskilde Hospital, University of Copenhagen,Copenhagen, Denmark • Brichova H., First Faculty of Medicine, Institute of Histology and Embryology, midway between the anterior superior iliac part of the knee. However, it does not alle- Charles University Prague, Prague, Czech Republic • Brodmann M., Clinical Division for Angiology, University Clinics for Internal spine and the base of the patella provides viate pain deriving from the popliteal nerve Medicine, Medical University of Graz, Austria • Butler A., Dahwan S., Hoang J., Cory M., Zeng K., Butler P., Larry L. Hillblom effective analgesia after medial parapatel- branches innervating the intra-articular Islet Research Center, David Geffen School of Medicine, University of lar arthrotomy through the integument and excision component of TKA. Supplemental California, Los Angeles, US

Research Report 2016 Medical University of Innsbruck 57 Department of Anatomy, Histology and Embryology Neuroanatomy

nerve regeneration and glial proliferation by are all involved in neuronal plasticity. On mainly applying cellular methods combined the other hand, FGFs bind unrelated recep- with high-resolution imaging. tors, e.g. the Nogo receptor (NgR1), which is involved in axon outgrowth inhibition. Research Our PhD students investigate whether this crosstalk may be relevant for the regener- Our group (Drs Hausott, Valovka, Csanaky, ation of lesioned sensory neurons (coop- Klimaschewski; PhD students Fogli, Park, eration with Neurobiochemistry). Several Gilbert, Jamsuwan) focuses on the morpho- mechanisms have evolved to regulate FGF logical consequences of fibroblast growth signalling. These range from internalization factor (FGF) dependent signalling mecha- and degradation of the receptor to modu- nisms in the nervous system. A variety of lation of receptor kinase activity by phos- cell lines, primary neurons, animal models phatases and regulation of accessibility and advanced imaging techniques are used of downstream signalling pathways (Fig. 1). to study the signalling pathways activated Sprouty proteins act as intracellular nega- by FGF receptors in neurons and glial cells, tive regulators of receptor tyrosine kinases respectively. including FGFRs and the nerve growth fac- tor receptor (TrkA). Members of our Division Head of Division: Several FGFs and FGFRs play important contributed to the elucidation of Sprouty2 Univ.-Prof. Dr. Lars Klimaschewski roles in brain development and adult brain function in the lesioned peripheral nervous plasticity following various types of insult system by providing evidence that this sig- Contact: to the peripheral or to the central nervous nalling regulator acts as inhibitor of axonal Müllerstraße 59 system. Some FGFs mediate tissue repair regeneration in vitro and in vivo. Our data 6020 Innsbruck and regeneration, often by reactivating de- corroborate the functional significance of velopmental signalling pathways. FGFRs the ERK pathway (extracellular signal-reg- [email protected] transduce the effects of other membrane ulated kinases) for axon elongation and Phone: +43 512 9003 71160 receptors such as NCAM (Neural cell adhe- support a role for Sprouty2 as a potential Fax: +43 512 9003 73112 sion molecule), L1, and N-cadherin which novel target for pharmacological inhibition www.neuroanatomy.at

axotomy-induced growth factors activating receptor tyrosine kinases (RTKs)

Research Branch (Östat Classification) Surface RTK  axon branching

RTK endocytosis  axon elongation 301405, 301402, 301403, 301407 lipids synthesized axonally

trans -Golgi derived vesicle Keywords RTK recycling (Rabs 6, 8, 10, 13, 33a)  axon elongation

kinesin motors Cellular neuroscience, FGF receptor signal- early endosome + ling and trafficking, fluorescence imaging (EEA1 + Rabs 5, 21) microtubules RTK degradation  + dynein motors reduced axon growth Research Focus

Overall interests of our Division are: late endosome/lysosome • Axotomy-induced neuronal plasticity recycling endosome (LAMP1 + Rab 7) (Arf6 + Rabs 4, 11, 35) • Fibroblast growth factor (FGF) receptor ? signalling in the nervous system The Aims of our research are: • Interference with FGF receptor transport/ cell body axolemma growth cone signalling © European Journal of Neuroscience • to promote neuronal survival and axonal Fig. 1: Membrane supply and RTK shuttling in growing axons. Lipids travel through regenerating axons regeneration in the form of trans-Golgi derived or locally synthesised endosomal membranes. Kinesin-dependent • to control glial proliferation and migration vesicle transport along microtubules followed by regulated vesicle exocytosis, endocytosis and recy- cling results in membrane addition to axons and to growth cones. EEA1 (Early Endosome Antigen 1), General Facts LAMP1 (Lysosomal associated membrane protein 1), Arf6 (ADP-ribosylation factor 6) and other small GTPases of the Rab family (RAS related in brain) identify the different vesicle populations. Rab5 labels The Division of Neuroanatomy at the Med- early endosomes which carry plasma membrane receptors following their activation and internalisa- ical University of Innsbruck offers lectures tion. Whereas surface receptor tyrosine kinases mainly induce axonal branching, internalised recep- and seminars in functional as well as com- tors signal from endosomes and preferentially stimulate axon elongation which is further increased by parative Neuroanatomy for MD and PhD receptor recycling. Interference with lysosomal receptor degradation stimulates axonal growth in gen- students. We study fundamental neurobio- eral. It is unclear whether lysosomal vesicles participate in membrane addition during their retrograde logical phenomena such as axon outgrowth, transport along the axon. Taken from EUROPEAN JOURNAL OF NEUROSCIENCE, 2016, 43, 309-317.

58 Research Report 2016 Medical University of Innsbruck Neuroanatomy

methylation is currently investigated by group member Dr Valovka (Fig 3). Protein methylation involves an addition of methyl groups by S-adenosyl-methionine (SAM) de- pendent methyltransferases and is known to have a major effect on the functions of a protein. We are particularly interested in the protein arginine methyltransferase 1.

Selected Publications

Enhanced axon outgrowth and improved long-distance axon regeneration in Sprouty2 deficient mice Marvaldi L, Thongrong S, Kozłowska A, Irschick R, Frei A, Pritz CO, Bäumer B, Ronchi G, Geuna S, Hausott B, Klimaschewski L. DEVELOPMENTAL NEUROBIOLOGY, 2015, 75, 217-231

Schwann cell expressed Nogo-B modulates axonal branching of adult sensory neurons through the Nogo-B receptor NgBR Eckharter C, Junker N, Winter L, Fischer I, Fogli B, Kistner S, Pfaller K, Zheng B, Wiche G, Klimaschewski L, Schweigreiter R. FRONTIERS IN CELLULAR NEUROSCIENCE, 2015, 9, 454

Sprouty2 and -4 hypomorphism promotes neuronal survival and astrocytosis in a mouse model of kainic acid induced neuronal damage Thongrong S, Hausott B, Marvaldi L, Agostinho AS, Zangrandi L, Burtscher J, Fogli B, Schwarzer C, Klimaschewski L. HIPPOCAMPUS, 2016, 26, 658–667

siRNA mediated down-regulation of Sprouty2/4 diminishes ischemic brain injury Klimaschewski L, Pinar Sueiro B, Martinez Millan L. NEUROSCIENCE LETTERS, 2016, 612, 48-51

Membrane turnover and receptor trafficking in regenerating axons (Review) Hausott B, Klimaschewski L. EUROPEAN JOURNAL OF NEUROSCIENCE, 2016, © Hippocampus 2016 © Hippocampus 43, 309-317 Fig. 2: Glial fibrillary acidic protein (GFAP) staining 3 weeks after unilateral injection of saline or KA (kainic acid) into the dorsal hippocampus. As compared to saline injection (A-D), prominent KA in- Selected Funding duced reactive astrocytosis is detected in the ipsilateral and contralateral hippocampus of both geno- • Morphological consequences of fibroblast growth factor (FGF) dependent types (E-H). Spry2/4+/- mice reveal higher GFAP intensity in the ipsilateral and contralateral molec- signaling mechanisms (2 students within PhD program ‚Signal Processing in Neurons’), FWF (W1206-B05), Dr L. Klimaschewski ular layers as compared with WT (wild-type) mice. Higher magnification of the cortex (I-N) and the • Receptor tyrosine kinase trafficking in neurons and glioma cells in response to Sprouty2 regulation, FWF (P 28909-BBL), Dr B. Hausott molecular layer (Mol, O-T) are shown to reveal single astrocytes and their processes (arrowheads). • Regulation of PRMT1 by multiple phosphorylations/Regulation der PRMT1 Quantifications of GFAP average staining intensity in the cortex (U) and of the molecular layer (V) cor- durch Proteinphosphorylierung, FWF (P24251-B20), Dr T. Valovka relate with increased numbers of reactive astrocytes (W). Mean ± SEM (n = 4), one-way ANOVA, bar = Collaborations 500 µm (A-H) or 100 µm (I-T). Taken from HIPPOCAMPUS, 2016, 26, 658–667. • Ludwig Boltzmann Institute for Traumatology, Vienna • University of the Basque Country, Spain, Department of Neurosciences • Universitat Autonoma de Barcelona, Spain, Department of Physiology to accelerate long-distance regeneration in ways. The tools developed will be used for • University of Torino, Italy, Department of Clinical and Biological Sciences lesioned peripheral nerves. Members of our several in vivo projects investigating the • The Norwegian Radium Hospital, Norway, Department of Biochemistry, Institute for Cancer Research group also elucidated neuroprotective ef- therapeutic potential of Sprouty2 regu- • Hannover Medical School, Germany, Center for Anatomy • University Cologne, Germany, Institute for Anatomy fects of combined Sprouty2/4 reduction in lation in neurons or astrocytes following • University Berlin (Charite), Germany, Center for Anatomy • Yeditepe University Istanbul, Turkey, Department of Genetics and a mouse model of human epilepsy-induced experimental brain injuries as well as in Bioengineering neurodegeneration (cooperation with Neu- animal models of human glioblastoma. • University of Zagreb School of Medicine, Croatia, Laboratory for Regenerative Neuroscience ropharmacology) suggesting that enhanced Finally, the possible significance of Sprouty2 ERK signalling by interference with Sprouty proteins may prevent neuronal degener- ation in several brain disorders, possibly by stimulating astroglial proliferation (Fig. A B 2). Besides inhibiting the RAS/RAF/ERK pathway, Sprouty2 appears to interfere with other signalling pathways (PI3K/AKT, PLCγ) and with FGFR1 trafficking. Bene- fiting from the expertise of the Geley lab (PhD program Molecular Cell Biology and Oncology), our PhD student Park developed tools to modulate Sprouty2 levels by gener- ating Spry2W253 and Spry2Y55 mutations via site directed mutagenesis. Moreover, we analyze cell proliferation, FGF depend- ent signalling and receptor trafficking in Fig.3: A) Chemistry of arginine methylation. Methylation of arginines in proteins is cat- primary cells and in various neuronal and alysed by the family of protein arginine methyltransferases PRMTs (indicated in blue). glioma cell lines applying FACS analysis, B) 3D structure of the major type I protein arginine methyltransferase 1 explaining the molecular de- live-cell high-resolution receptor imaging tails of SAM binding. Amino acid residues mediating recruitment of SAH (S-adenosyl-L-homocysteine) and fluorescent reporters of signalling path- (orange) into the cofactor binding pocket are shown in red, green and blue.

Research Report 2016 Medical University of Innsbruck 59 Department of Anatomy, Histology and Embryology Histology and Embryology

Research Branch (ÖSTAT Classification) focuses research on ultrastructural aspects of intracellular membrane trafficking and 106049, 106052, 301107, signaling, performed in close collaboration 301114, 301304 with local and international research groups. The Endothelial Biology Group focuses on Keywords early diagnostics of colorectal cancer by use of fluorescent targeted nanoparticles. Cellular electron microscopy, organelle ultrastructure, membrane trafficking,Research ­endosomal/lysosomal pathways, auto- phagy, targeted nanoparticles, colon ­cancer, Cellular Electron Microscopy molecular imaging, early diagnosis Michael W. Hess High-resolution microscopy with emphasis Research Focus on ultrastructural analyses of subcellular architecture in the context of intact tissues High-resolution microscopy with emphasis and cells from model organisms and pa- on ultrastructural analyses of subcellular tient samples. Our cell biological research architecture in the context of intact tissues concentrates on ultrastructural aspects of Head of Division (interim): and cells from model organisms and pa- intracellular membrane trafficking and sig- Univ.-Prof. Dr. Lars Klimaschewski tient samples. Both groups in the Unit fo- nalling (e.g., Refs. (Vogel GF, et al. 2015)) cus on imaging, the group of Prof. Hess on in various organisms, performed in collab- Contact: high-resolution microscopy and the group oration with the groups of L. A. Huber and Müllerstraße 59 of Prof. Debbage on molecular imaging us- D. Teis (Division of Cell Biology), as well as 6020 Innsbruck ing fluorescent nanoparticles. T. Müller, A. Janecke, G.F. Vogel (Department of Paediatrics I). Our methods of choice for [email protected] General Facts investigating (genome-edited) human and Phone: +43 512 9003 71160 animal cell models, biopsy samples from pa- Fax: +43 512 9003 73112 The Division of Histology and Embryology at tients and eukaryotic model organisms such www.i-med.ac.at/ahe/ the Medical University of Innsbruck provides as mice, yeast, flatworms and the freshwa- histologie-embryologie lecture series and practical courses in ter polyp Hydra are advanced cryo-based Histology for undergraduate students in immuno-electron microscopy and electron Human Medicine and Molecular Medicine. tomographic 3D-reconstruction. Membrane In addition, we offer special lectures and trafficking is studied with special emphasis courses on submicroscopic morphology, on the biogenesis and maturation of endo- and on advanced cellular electron cytic compartments (Vogel GF, et al. 2015), microscopy for MD and PhD students. cargo biosynthesis and recycling, as well as The Cellular Electron Microscopy group autophagy. Among others we are also inter- ested in the relationships between cargo biosynthesis and trafficking, cytoskeletal architecture and maintenance of cellular polarity. All these processes are severely disturbed in Microvillus Inclusion Disease (MVID), a rare, fatal congenital intestinal disease that affects infants soon after birth; the clinical appearance presents severe watery, non-inflammatory diarrhoea, nutri- ent malabsorption and metabolic acidosis. In general, MVID patients depend on total parenteral nutrition. Small bowel transplan- tation is the only curative therapy, but many patients die within the first few years of life (Vogel GF, et al. 2016). In the previous years our multidisciplinary cell biological-clini- cal team provided mechanistic insight into the pathophysiology of MVID (Vogel GF, et al. 2015). We demonstrated mutations in the motor protein Myosin5b or the apical Fig. 1: Immuno-electron microscopic detection of fluorescently-tagged FGFR1 (fibroblast membrane protein Syntaxin3, disrupting growth factor receptor1) transiently expressed in U373 human glioblastoma cells. Immu- selective apical cargo trafficking and exo- nogold-particles (arrows) localize to endo/lysosomal compartments and the plasma mem- cytosis in epithelial absorptive cells of the brane (unpublished data by M.W. Hess in collaboration with L. Klimaschewski and K. Czanaky small intestinum, leading to mislocalisation (Division of Neuroanatomy)). of pivotal brush border ion transporters rel-

60 Research Report 2016 Medical University of Innsbruck Histology and Embryology

(SAM) dependent methyltransferases and is known to have a major effect on the functions of a protein. We are particularly interested in the protein arginine methyltransferase 1.

Selected Publications

Hess Group:

Ultrastructural Morphometry Points to a New Role for LAM- TOR2 in Regulating the Endo/Lysosomal System Vogel, Georg F., Ebner, Hannes L., de Araujo, Mariana E., Schmie- dinger, Thomas, Eiter, Oliver, Pircher, Haymo, Gutleben, Karin, Witting, Barbara, Teis, David, Huber, Lukas A., Hess, Michael W, TRAFFIC: 2015; 16: S. 617-634

Cargo-selective apical exocytosis in epithelial cells is con- ducted by Myo5B, Slp4a, Vamp7, and Syntaxin 3 Vogel, Georg F., Klee, Katharina M., Janecke, Andreas R., Muller, Thomas, Hess, Michael W., Huber, Lukas A, JOURNAL OF CELL BIOLOGY: 2015; 211: S. 587-604. Fig. 2: 3D-modelling of the immuno-electron microscopic localization patterns of fluores- Towards understanding microvillus inclusion disease cently-tagged Rab11 stably expressed in human CaCo2 colon carcinoma cells. Immuno- Vogel, Georg F., Hess, Michael W., Pfaller, Kristian, Huber, Lukas A., Janecke, Andreas R., Muller, Thomas, gold-particles (yellow) localize preferentially to vesiculo-tubular recycling endosomes (red) MOLECULAR AND CELLULAR PEDIATRICS: 2016; 1: S.3 in the subapical cytoplasm (unpublished data by M.W. Hess and G.F. Vogel (formerly: Divi- sion of Histology and Embryology)). An inducible mouse model for microvillus inclusion disea- se reveals a role for myosin Vb in apical and basolateral trafficking Schneeberger, Kerstin, Vogel Georg F., Teunissen Hans, van Om- evant for physiological enterocyte function. kinds of nanoparticles: SINTEF (Foundation men Domenique D., Begthel, Harry, El Bouazzaoui, Layla, van Vugt, These data, obtained from our genome-edit- for industrial and technical research) in Anke H.M., Beekman, Jeffrey M., Klumperman, Judith, Muller, Thomas, Janecke, Andreas, Gerner, Patrick, Huber, Lukas A., Hess, ed cell models, have recently been further Norway; led by Dr. Ruth Schmid developing Michael W., Clevers, Hans, van Es, Johan H., Nieuwenhuis, Ed- complemented by thorough analyses of an PACA nanoparticles, the University of ward, e.S., Middendorp, Sabine, PROCEEDING OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA: inducible Myosin5b knock-out mouse mod- Porto in Portugal led by Prof. Manuel 2015; 40:S. 12408-12413. el (Schneeberger­ K., et al. 2015), ­generated Coelho developing gold nanoparticles by our long-term collaborators from and the Medical University of Innsbruck, Debbage Group: UMC-Utrecht (S. Middendorp,­ H. Clevers). led by Prof. Paul Debbage (coordinator) Targeted drugs and nanomedicine: present and future. Thurner GC, Chabicovsky M, Abdelmoez A, Debbage P (2015) Another major focus of our electron micros- developing protein nanoparticles. The FRONTIERS IN MEDICINAL CHEMISTRY, 2015;9: S 182 – 233; copy group is methodological research for consortium includes one clinical partner: Colorectal diagnostics: the NanoEFEct project. the development of new preparation and the Gastroenterology Clinic at the Friedrich- Debbage P, Schmid R, Coelho MAN, Waldner M, Moritz B imaging techniques for precise 3-dimen- Alexander University ­Erlangen-Nürnberg, HÄMATOLOGIE & ONKOLOGIE:2015; 5: S.122 – 124 sional localisation of macromolecules in the led by Prof. Maximilian Waldner, and one Screening and identification of molecular targets for cancer context of natively cryo-immobilised tissues management partner: CESAR­ in Vienna therapy Abdelmoez A, Coraça-Huber DC, Thurner GC, Deb- and cells, as shown, for example in Fig. 1 (Central European Society for Anticancer bage P, Lukas P, Skvortsov S, Skvortsova I (2016) and 2. Research) not only providing management CANCER LETTERS; doi: 10.1016/j.canlet.2016.03.002 but also interfacing with regulatory Endothelial Biology Group authorities, led by Dr. Berta Moritz and Dr. Collaborations

Paul Debbage, Gudrun Thurner Max Rössler. The NanoEFEct consortium • Sabine Middendorp (Department of Paediatric Gastroenterolo- Pivoting towards epithelial biology, Prof. created a series of candidate nanomaterials gy, Wilhelmina Children’s Hospital, University Medical Centre (UMC) Utrecht, 3584 EA, Utrecht, The Netherlands) Paul Debbage and Dr. Gudrun Thurner for use in diagnosis of colorectal carcinoma; • Ernest Cutz (Division of Pathology, Department of Paediatric ­develop nanoparticles for molecular imag- Figure 1 shows the type of imaging achieved Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada) ing to achieve early diagnose of cancerous by our Innsbruck team. During 2016 this • James R. Goldenring (Section of Surgical Sciences, Epithelial lesions in the human body. Our main focus work of our group won the CAST technology Biology Center, and Department of Cell & Developmental Bio- logy, Vanderbilt University School of Medicine, Nashville, TN, at the moment is on colorectal carcinoma award (https://www.i-med.ac.at/mypoint/ USA) cancer lesions, but other tumorous lesions news/704443.html) and was evaluated • Dr. Maria Vicent (CIPF, Valencia, Spain); • Prof. Axel Walch (Helmholtz Institute, Munich, Germany); are in our broader field of research, includ- positively in a competitive evaluation by • Contipro a.s., an industrial firm in Dolní Dobrouč, Czech Re- ing therapy of such lesions. the European Nanomedicine Translation public. • The ETP (European Technology Platforms) and particularly We coordinate the European EraNet Advisory Board (http://www.enatrans.eu/ Prof. Patrick Boisseau and Prof. Mike Eaton. research project NanoEFEct (2014 to public/services/translation-advisory-board/ • Clinic for Gastro-Enterology (Prof. Herbert Tilg; Prof. Hubert Schwaighofer) 2017) (https://www.cesar.or.at/main. translation-advisory-board , Nanomed TAB). • Clinic for Radiology (Prof. Werner Jaschke) asp?kat1=96&kat2=699&kat3=540; • Clinic for Radiotherapy and Radiooncology (Prof. Peter Lukas) • Clinic for Obstetrics and Gynaecology (Dr. Elisabeth Sölder) www.i-med.ac.at/mypoint/thema/697136.html), In successor projects we plan to optimise • Clinical Biochemistry, Biozentrum (Prof. Heribert Talasz) an international consortium consisting our successful strategy and move forward to • Department of Pharmaceutical Chemistry (Prof. Barbara Ma- tuszczak) of five partners, three scientific partners translational activities in collaboration with • Department of Pharmaceutical Technology (Prof. Andreas concerned with the development of different the Tyrol Clinics. by S-adenosyl-methionine Bernkop-Schnürch)

Research Report 2016 Medical University of Innsbruck 61 Department of Hygiene, Microbiology and Social Medicine Hygiene and ­Medical Microbiology­

Branch of Research (Östat Classification) orrhagic E. coli and prevention of nosoco- mial infections. 303026, 303002, 303015, • HMM seeks to prevent illness and death 303013, 303020 from targeted infectious disease threats through research and the translation of Keywords scientific information into real-world, practical applications, policies, and solu- Infectious diseases, hygiene, immunity, fun- tions (Figure 1). gal pathogens, antifungal resistance, EHEC, HIV, dendritic cells, platelets, complement, General Facts N-chlorotaurine, nosocomial infections, public health Infectious diseases are turning into one of the most frequent causes of death in the Research Focus world; presently we face bacteria and fun- gi to develop resistances to antibiotics and Understanding Infections: antimycotics and the fact that an increas- From Pathogenesis to Diagnosis ing number of emerging pathogens spread • The tasks of the Division of Hygiene and worldwide. Understanding of biological prin- Head of Division: Medical Microbiology (HMM) comprise re- ciples underlying the mechanisms by which Univ.-Prof.in Dr.in Cornelia Lass-Flörl search, teaching, laboratory diagnosis of infectious agents adapt, and undermine the infectious diseases, environmental, hospi- defence mechanisms of a host is critical for Contact: tal and technical hygiene as well as public fighting diseases. HMM conducts basic and Schöpfstraße 41 health. translational research on molecular mech- 6020 Innsbruck • Scientific activities cover fungal patho- anisms of pathogenesis of bacterial, viral, genicity, antifungal resistance, virulence or fungal infections and strategies for their [email protected] factors, molecular mechanisms of host prophylaxis and therapy. HMM's mission is Phone: +43 512 9003 70703 pathogen-interaction including the com- to coordinate and strategically align transla- Fax: +43 512 9003 73700 plement system, basic immunological re- tional infection research with the aim of de- www.i-med.ac.at/hygiene search (interactions of dendritic cells/T- veloping new diagnostic, preventative and cells), antimicrobial agents (antimycotics therapeutic methods for treating infectious and endogenous antiseptics), enterohem- diseases. To achieve this, HMM has formed

Fig. 1: Translation of in vitro to in vivo – overview of research questions targeted at HMM.

62 Research Report 2016 Medical University of Innsbruck Hygiene and ­Medical Microbiology

Research

Emerging Infections with a Focus on Enterohemorrhagic Escherichia Coli (EHEC)-Induced Hemolytic Uremic Syn- drome (HUS) Experiences of the last decade clearly demonstrate the vulnerability of modern society to emerging pathogens. Outbreaks and epidemics affect virtually all aspects of our lives, threatening health. A prompt health-care response is critical to prevent a rapid spread of infection and requires knowledge of the pathogen, pathogen reser- voirs, and risk-factors as well as broad-spec- trum drugs. Researchers (WG Orth-Höller & WG Würzner) investigate the interaction of EHEC virulence factors with the com- plement cascade and evaluate whether a transient complement blockade opens new therapeutic strategies. HMM will pursue immune modulation strategies focusing on the role of complement, and will provide genetic factors potentially responsible for Fig. 2: Identifying underlying networks contributing to infectious diseases. disease development (Figure 3). thematic translational units of scientists, e.g. the advent of medical progress, the each dedicated to one specific pathogen or successful application of immunosuppres- infectious disease. HMM is one of the larg- sion in transplanted patients, and the use est microbiology diagnostic laboratories in of immunomodulatory agents for treating Austria, with an average sample through- various diseases from cancer to rheumatoid put of 250,000 specimens per year. HMM arthritis. is associated to with all major hospitals in Tyrol, placing it in a key position in the di- Reducing the incidence relies on rapid agnostic laboratory landscape in Austria. and specific diagnosis, effective antifungal The research part of the division consists drugs, novel immunotherapeutic strategies, of 7 Associate-Professors, 1 Assistant-Pro- and adherence to infection control and ste- fessor, 5 Post-Docs, several PhD-, Master- rility practices. and Bachelor students and 7 technical as- sistants. The diagnostic unit consists of 9 CD-Fungus deals with the following three medical doctors, 3 Post-Docs, and 26 tech- main research questions: How to best find, nical assistants. treat and prevent mucormycosis?

The mission of HMM is to bridge the gap be- Tacking these key questions needs Fig. 3: Invasive fungal lung infection display- tween basic and translational research into 1. recognising mucormycosis as such ing hyphae (mucor species) and yeast cells. microbial pathogenesis (Figure 2). 2. identification of the source and type of infection Exploiting Immune Response to Infec- Christian-Doppler-Laboratory for Inva- 3. identification of the pathogen tion sive Fungal Infection 4. understanding the underlying patho- The human immune system is constantly In 2015 a “Christian-Doppler (CD)-Labo- mechanisms active in combating diseases. Research- ratory for Invasive Fungal Infections” was 5. initiation of early targeted treatment, and ers have developed novel methods for as- set up. Within the estimated 2 million fun- 6. providing a clean and safe hospital sessing the immune response in molecular gal species on earth, about 600 cause dis- ­environment. detail focusing on HIV-1 and opportunistic eases in humans; the most important are fungal pathogens. During the acute and Candida, Aspergillus, Mucorales and Cryp- CD-Fungus attempts to unravel scientific chronic phases of infection, dendritic cells tococcus. Fungal infections are increasing questions raised by implementing 3 mod- (DC), macrophages and platelets are of and are associated with excessive morbid- ules which will ultimately advance our un- major interest. Various aspects of opsoni- ity and mortality (Fig. 3). Over 300 million derstanding of fungal pathology, improve zation (complement, antibody) as well as people are acutely or chronically infected, diagnosis and treatment of mucormycosis the impact of cellular complement are con- leading to death, long term illness, and re- and enhance patients’ outcome and safety sidered in all in vitro experimental set-ups duced work capacity. The reasons this prob- in terms of prevention of nosocomial and to mimic the in vivo situation. Furthermore lem has emerged are likely multifactorial, hospital-associated infections. 3D cell-cultures of lung and lymphoid tis-

Research Report 2016 Medical University of Innsbruck 63 Department of Hygiene, Microbiology and Social Medicine

new resistance mechanisms (WG Lackner- Lass-Flörl). Another main focus is to iden- tify the underlying mode of amphotericin B resistance in Aspergillus terreus. In this context we evaluate mitochondria as crucial modulators of polyene resistance (WG Wil- flingseder-Blatzer-Lass-Flörl). The mission of HMM is to bridge the translational gap between basic research and the develop- ment of novel antifungal drugs. HMM will support epidemiologic, translational and clinical studies to improve the management of fungal diseases.

N-Chlorotaurine: Assessing of New Anti- septic Solutions and Antimicrobial Sur- faces Fig. 4: Involvement of the complement system in the pathogenesis of EHEC-associated HUS N-chlorotaurine, a long-lived oxidant pro- duced by activated human leucocytes, has sues are developed in a perfusion system in vitro and in vivo models are under inves- been synthesized as sodium salt in our di- to study host-pathogen interactions in an tigation (WG Binder-Lass-Flörl, WG Wilfling- vision and is under clinical investigation immunological setting close to reality (WG seder, WG Speth). HMM will pursue immune for local treatment of infections of multiple Wilflingseder). These studies focus on the modulation and new treatment strategies to body regions, including sensitive ones (Fig- impact of viral opsonisation patterns on provide promising options for the develop- ure 5). Inhalation is one of the most promis- signalling pathways within DCs, on DC mat- ment of novel and more effective antifun- ing recent topics. Basic research assesses uration, and on DC antigen presentation to gal therapies. This topic is also dealt with its microbicidal activity against biofilms and CD4+ and CD8+ T cells (WG Wilflingseder in the FWF-funded doctoral programme of investigates the activity against emerging & WG Posch; Figure 4). excellence, HOROS, for HOst Response in pathogens (WG Nagl). While antibiotics are Opportunistic infectionS and the Christian frequently considered the first line of con- Another goal is to evaluate the interaction of Doppler laboratory for invasive fungal infec- tainment for nosocomial infections, there is platelets and fungal pathogens; such inter- tions. increasing effort being devoted to prevent play might result in mutual platelet activa- infections. Researchers at the division are tion or inhibition, hence resulting in additive Therapy-Resistant Fungal Infections screening surface materials that prevent antifungal defence or excessive inflamma- A disturbing and rapid increase of infec- bacteria, viral and fungal contamination and tion and thrombosis (WG Speth-Rambach). tions caused by antimycotic-resistant fun- persistence on medical surfaces (WG Mayr- Another project aims at elucidating fungal gal pathogens is a big public health concern Lass-Flörl). proteins which allow pathogens to escape which medicine is facing today. Most severe from complement interactions, subse- and fatal cases result from healthcare-as- Laboratory Diagnostics, Hospital and quently protecting the fungus from the sociated fungal infections, which are in- Technical Hygiene destructive action of an activated immune creasingly caused by Candida, Aspergillus The division HMM fulfils its tasks in detec- system (WG Würzner). This groundbreaking and Mucorales. Hence, a major focus is to tion and identification of pathogens causing research is forming the basis for the devel- investigate azole and echinocandin-resist- infections. This covers bacteriology, para- opment of novel treatment strategies and ance in yeasts and molds and to discover sitology, mycobacteriology and mycology. eventually of vaccines. The diagnostic laboratories are certified according to ISO 9001:2009. Special parts Fungal Infections of the Immunocom- are controlled by external audits in accord- promised Patient ance to §67 Austrian Medicines Law and Our aging population and the growing prev- FDA, Division of Manufacturing and Product alence of chronic diseases force modern Quality. Within the sector of hospital and medicine to use aggressive cancer thera- technical hygiene (accredited according to pies and organ or bone marrow transplanta- ISO/IEC 17025 and ISO/IEC 17020) guide- tion, which result in or require immunosup- lines for prevention of infectious diseases pression. In immunocompromised patients, are developed and controlled correspond- fungal pathogens, usually efficiently con- ing to the statutory prescription for techni- trolled by the immune system, can cause cal facilities (e.g. disinfection machines). life-threatening diseases that may be dif- ficult to treat with currently available an- Public Health ti-mycotics. While the degree of immune Vaccine hesitancy is a growing complex and alteration is a major contributor to fungal context specific problem in many European disease in immunocompromised patients, countries and the elimination goal of rubella knowledge of other factors related to treat- Fig. 5: Three-dimensional image of dendritic and measles is at stake. Understanding the ment failure is limited. Hence, various new cells infected with HIV-1 magnitude of the problem and identifying

64 Research Report 2016 Medical University of Innsbruck Hygiene and ­Medical Microbiology

H2O Taurin H O - 2 2 e O2 + HOCl N-Chlortaurin NADPH2 Cl- Chlorierte AS/Peptide Dichloramine H+ MPO 2 O H O Monochloramin NADPH- 2 2 2 + Bakterium H EPO Monobromamin Oxidase- Dibromamine Bromierte AS/Peptide Komplex Br- Superoxid- HOBr N-Bromtaurin H2O Dismutase Taurin H2O

NADP++2 H+

Fig. 6: Synthesis of N-chlorotaurine by human granulocytes. the root causes of the determinants of hes- itancy are essential to tailor immunization strategies. Researchers investigate deter- minants of vaccine hesitancy and effective- ness of tailored communication strategies to address concerns and finally increase vaccine uptake.

Selected Publications Collaborations

• Jacques Meis and colleagues, Canisius Wilhelmina Hospital Geographically predominant genotypes of Aspergillus Complement-opsonized HIV-1 overcomes restriction in den- and Radboud University Medical Centre, Nijmegen, The Neth- terreus species complex in Austria: a microsatellite typing dritic cells erlands study Posch W, Steger M, Knackmuss U, Blatzer M, Baldauf HM, Dop- • Sybren de Hoog, Fungal Biodiversity Centre, Utrecht, The Lackner M, Coassin S, Haun M, Binder U, Kronenberg F, Haas H, pler W, White TE, Hörtnagl P, Diaz-Griffero F, Lass-Flörl C, Hackl H, Netherlands Jank M, Maurer E, Meis JF, Hagen F, Lass-Flörl C. Moris A, Keppler OT, Wilflingseder .D • Maiken C. Arendrup, Staten Serum Institut, Copenhagen, Den- CLIN MICROBIOL INFECT: 2016;22:270-276. PLoS PATHOG: 2015;11:e1005005. mark • Axel Brackhage and colleagues, Hans Knöll Institut, Jena, Ger- N-Chlorotaurine exhibits fungicidal activity against therapy- many refractory Scedosporium species and Lomentospora Selected Funding • Ricardo Araujo and colleagues, Institute of Molecular Patholo- prolificans FWF W1253-B24: HOROS Doctoral Programme of Excellence gy and Immunology of the University of Porto, Portugal Lackner M, Binder U, Reindl M, Gönül B, Fankhauser H, Mair C, “Wirtsabwehr bei opportunistischen Infektionen”. 2014 - 2018 • Kevin Kavanagh, National University Ireland, Maynooth, Ireland Nagl M. • Mike Birch, f2G Manchester, UK ANTIMICROB AGENTS CHEMOTHER: 2015;59:6454-6462. FWF KLI459: Tolerability of inhaled N-chlorotaurine in humans – a • Helge Karch and colleagues, University Münster, Münster, phase I clinical study. 2015 – 2016 Germany Identification of Aspergillus fumigatus surface components • Simon Satchell, University of Bristol, Bristol, United Kingdom that mediate interaction of conidia and hyphae with human FWF P24598-B13: HIV infection and transmission close to reality. • Asier Saez-Cirion, Unité de Régulation des Infections Rétrovi- platelets 2012 – 2016 FWF W011010-21: DC-iphering complement- and rales, Institut Pasteur, France Rambach G, Blum G, Latgé JP, Fontaine T, Heinekamp T, Hagleitner Fc-receptor-mediated HIV-1 incorporation in and effects on DC • Arnaud Moris, INSERM UMRS945, Infection et Immunité, M, Jeckström H, Weigel G, Würtinger P, Pfaller K, Krappmann S, function in search for novel therapeutical targets. 2015 – 2019 UPMC, France Löffler J, Lass-Flörl C, Speth .C FWF P25389-B13: Deciphering the role of Th17 paradigm for viral • Teunis Geijtenbeek, Center of Infection and Immunity, Aca- J INFECT DIS: 2015;212:1140-1149. infections. 2013 – 2016 FWF P26117-B20: Relevance of platelets demic Medical Center, Netherlands and complement for the pathogenesis of invasive fungal infec- • Felipe Diaz-Griffero, Department of Microbiology and Immu- Microbial contamination of glaucoma eyedrops used by pa- tions 2014 – 2016 nology, Albert Einstein College of Medicine, NY 10461, US tients compared with ocular medications used in the hos- • Frank Ebel, Max-von-Pettenkofer-Institut, München, pital CD-Labor für Invasive Pilzinfektionen. 2015 – 2022 Deutschland Teuchner B, Wagner J, Bechrakis NE, Orth-Höller D, Nagl M. • Admar Verschoor, TU München, München, Deutschland MEDICINE (Baltimore): 2015; 94:e583. FP7-PEOPLE-2013-ITN: ITN (Marie Sklodowska-Curie actions). • Jean-Paul Latgé, Institut Pasteur, Paris, Frankreich From omics to patient improving diagnostics of pathogenic • Sven Krappmann, Universitätsklinikum Essen, Deutschland Prospective multicenter PCR-based Aspergillus DNA screen- yeasts. 2015 – 2019 • Jürgen Löffler, Universitätsklinikum Würzburg, Deutschland ing in high-risk patients with and without primary antifungal FWF KLI005610: NOBICS – Novel Biomarker in Invasive Candidia- • Donald C. Sheppard, McGill University Montreal, Canada mould prophylaxis sis/Candida.2016-2019 Springer J, Lackner M, Nachbaur D, Girschikofsky M, Risslegger B, Mutschlechner W, Fritz J, Heinz WJ, Einsele H, Ullmann AJ, Löffler J, Lass-Flörl C. CLIN MICROBIOL INFECT: 2016;22:80-86.

Research Report 2016 Medical University of Innsbruck 65 Department of Hygiene, Microbiology and Social Medicine Virology

and Heribert Stoiber, the deputy director. In retroviruses enhances the infection of DCs addition, there are three junior group lead- and influences DC-mediated induction of ers: Dr. Guido Wollmann, oncolytic viruses, virus-specific CD8 T cell (Fig. 1) as well as and Dr. Janine Kimpel, vector vaccines, as- regulatory T cell (Treg) responses. In friend sociated with D.v.Laer, as well as Dr. Zoltan virus (murine retrovirus) infection of mice, Banki, complement and dendritic cell vac- Treg mediate the shift of a primarily CD8 cines, associated with H. Stoiber. driven virus control to a cytotoxic CD4 cell Clinical routine: Around 30% of the employ- response. Similarly, Tregs play a pathogenic ees work in the serologic and virologic diag- role in other chronic infections with virus- nostics group, which services the university es including HIV and HCV. Interestingly, we hospital Innsbruck (LKI), the regional hospi- found that the FV-driven Treg induction and tals and medical practices. expansion is complement dependent. In an Collaborations: The division has developed FWF-funded project, we now aim to eluci- an oncolytic viral cancer vaccine as well as date the mechanisms involved. complement enhanced therapeutic antibod- ies. To drive these two developments into Combined Dendritic Cell Vaccine with clinical application, two companies were Oncolytic VSV-GP Virotherapy founded, ViraTherapeutics GmbH (founder Dorothee von Laer, Zoltan Banki Head of Division: D.v.Laer) and Lysovac (founder H. Stoiber), Oncolytic viruses (OV) represent a prom- Univ.-Prof.in Dr.in respectively. ViraTherapeutics has recently ising cancer therapy option by specifically Dorothee Holm-von Laer secured an investment from Boehringer In- replicating in and killing cancer cells while gelheim that will cover the development up leaving healthy cells undamaged. The on- Contact: to early clinical phase II trials. colytic virus, VSV-GP, has been successfully Peter Mayr Straße 4b The division collaborates with several inter- tested in several xenograft and syngeneic 6020 Innsbruck national groups and in addition with groups mouse tumour models. Since oncolytic ac- and clinics in Innsbruck: Haematology and tivity of VSV-GP releases antigens from can- [email protected] Oncology (Gastl), Urology (Culig, Horn- cer cells they induce an anti-cancer immune Phone: +43 512 9003 71701 inger), Gynaecology (Fiegl, Mart), Dermatol- response which was found to be enhanced Fax: +43 512 9003 73701 ogy (Romani) a.o. by a DC-based cancer vaccine (Koske et al, http://www3.i-med.ac.at/virologie Core facility: The division established and in prep). Studies of the mechanism are re- is now coordinating (Dr. Janine Kimpel) vealing a complex interplay of the antiviral the BSL2 and BSL3 animal facility of the and antitumoral immune response. Research Branch (ÖSTAT Classifications) ­Medical University Innsbruck, including an in vivo imaging system (IVIS- PerkinElmer). VSV-GP-Based Viral Vector Vaccines 303034, 301906, 301902, 302091 Dr. Janine Kimpel Research Live-attenuated vaccines have proven to Keywords be highly protective and cost-effective. For Complement, Dendritic Cells and T Cell diseases, for which safe live-attenuated vac- Virology, virologic diagnostics, innate im- Responses in Retroviral Infections cines cannot be generated, e.g. HIV, Malar- munity, virotherapy, cancer immunotherapy, Zoltan Banki and Heribert Stoiber ia, HCV and cancer, viral vector vaccines are vaccines As professional antigen presenting cells, a promising alternative. We have previously dendritic cells (DC) have a key function in described the first viral vector vaccine, VSV- Research Focus the initiation of specific T-cell responses GP, that does not induce neutralizing anti- upon infections with viruses including ret- bodies to the viral vector in mouse models The focus of the division of Virology is to roviruses. Complement opsonization of (Tober et al., 2014). VSV-GP is the vesicular develop novel biopharmaceuticals and vac- cines. This research spans from elucidating the modes of action of novel therapeutics to the clinical translation and development in the spin-off biotech companies of the di- vision. Specific foci are: • Virus-based oncolytic cancer vaccine strategies and their mode of action. • Viral vector-based vaccines primarily against HIV. • Complement-enhanced vaccines and ther- apeutic antibodies.

General Facts Fig. 1: Dendritic cells (DCs) treated with complement-opsonized retrovirus Friend murine Structure: The Division of Virology has two leukemia virus (C-F-MuLV) are more effective in stimulating T cells than DCs treated with professors: Dorothee von Laer, the director, F-MuLV alone.

66 Research Report 2016 Medical University of Innsbruck Virology

Fig. 2: Oncolytic effect of VSV-GP is enhanced by combination treatment with ruxolitinib in an orthotopic xenograft model. A2780 tumors stably expressing luciferase were established in nude mice by i.p. injection, and treated 4 days later with VSV-GP, ruxolitinib or a combination thereof. At indicated time points mice were analyzed for luciferase signal using bioluminescence imaging. stomatitis virus pseudotyped with the glyco- cells can directly lyse cancer tissue but, therapeutic efficacy of the VSV-GP treat- protein GP of an arenavirus (LCMV). We are importantly, they can also act in concert ment in IFN competent tumours (Fig. 2, currently working on the development of with the immune system to induce an an- Dold et al., 2016). Combinations with other VSV-GP based vaccines against infectious titumor immune response. Our group has immune therapeutics are currently being in- diseases such as HIV and RSV. We showed generated a particularly effective and safe vestigated. In addition, mechanistic studies that the viral envelope proteins from HIV oncolytic virus, VSV-GP. A number of stud- on the positive and negative effects of viral or RSV are produced at high amounts in in- ies have confirmed successful treatment infection of tumor tissue on the anticancer fected cells. Additionally, viral envelope pro- of various cancer types in mouse models. immune responses are being studied. In teins are efficiently incorporated into the However, efficacy is mitigated in interferon parallel, clinical grade virus production and membrane of newly formed VSV-GP parti- (IFN) responsive relative to IFN resistant toxicology tests are under way to prepare cles. Here, the HIV envelope forms trimers, tumors. Accordingly, blockade of the inter- for first in man studies. presenting crucial epitopes for the induc- feron response by ruxolitinib enhanced the tion of HIV broadly neutralizing antibodies, e.g. MPER, CD4 binding side, V1V2 loop Selected Publications Selected Funding of gp120. After immunization of mice high Application of interferon modulators to overcome partial • European HIV Vaccine Alliance, EU-Project, Univ.Prof. Dr. titers of antibodies are induced. Currently, resistance of human ovarian cancers to VSV-GP oncolytic Dorothee von Laer viral therapy • VSV system as HIV vaccine, FFG-Bridge, Univ.Prof. Dr. Dorothee we are investigating different heterologous Dold C, Rodriguez Urbiola C, Wollmann G, Egerer L, Muik A, von Laer and homologous prime boost regimes. Ad- Bellmann L, Fiegl H, Marth C, Kimpel J, von Laer D. • Regulatorische T- Zellen, FWF, Univ. Prof. Dr. Heribert Stoiber MOLecular THERapy- ONCOLYTICS: 2016; 3: 16021. ditionally, we are interested in understand- Pre-vaccine era cervical human papillomavirus infection Collaborations ing the competition or potential mutual among screening population of women in west Austria enhancement of the immune responses to Borena W, Grünberger M, Widschwendter A, Kraxner KH, Marth E, • L. Kenner, LBI-CR, AKH, VETMED, Vienna, Austria Mayr P, Meier J, Ruth N, Guerrero AT, Marth C, Holm-von Laer D. • M. Bette, Department of Anatomy, Philipps University Marburg, the vaccine antigen and the VSV-GP vector BMC PUBLIC HEALTH: 2016;16: 889. Germany • J. Schmitz, B. Haynes; Harvard Medical School, Boston, USA vaccine, with the aim to further improve the Low prevalence of HPV detection and genotyping in- • A. van den Pol; Yale University, New Haven, USA efficacy of the VSV-GP vaccine vector. non-muscle invasive bladder cancer using single-step PCR • A. Oxenius; ETH Zürich, Zürich, Switzerland followed by reverse line blot • HP Kiem; Fred Hutchinson Cancer Research Center, Seattle, Pichler, R., Borena, W., Schäfer, G., Manzl, C., Culig, Z., List, S., USA VSV-GP-Based Oncolytic Cancer Neururer, S., Von Laer, D., Heidegger, I., Klocker, H., Horninger, • J. Bell; CICR - Centre for Innovative Cancer Research, Ottawa, W., Steiner, H., Brunner, A. USA Vaccines WOLRD JOURNAL OF UROLOGY: 2015; 33: S.2145-51 • H. Miletic; University of Bergen, Bergen, Norway Dr. Guido Wollmann • F. Kreppel; University Ulm, Ulm, Germany Complement Component C5 Recruits Neutrophils in the • L. Lehmann; Ludwigs-Maximilian-Univeristy, Munich, Germany The field of cancer therapy has been expe- Absence of C3 during Respiratory Infection with Modified riencing a paradigm shift in recent years Vaccinia Virus Ankara Philip J. R. Price, Zoltán Bánki, Angelika Scheideler, Heribert Devices and Services due to the impact of immune therapy on Stoiber, Admar Verschoor, Gerd Sutter and Michael H. Lehmann BSL-2 and BSL-3 mouse facility, In vivo imaging system (IVIS- Journal of IMMUNOLogy: 2015; 194: S.1164-1168 long-term remission rates. Oncolytic virus- PerkinElmer) es (OV) that selectively replicate in cancer

Research Report 2016 Medical University of Innsbruck 67 Institute of Pharmacology Pharmacology

Research Branch (ÖSTAT Classification) a variety of cutting-edge experimental ap- proaches to address fundamental research 301206, 301406, 301210, questions related to the identification of 301401, 301403 novel molecular targets and the develop- ment of new therapeutic concepts for neu- Keywords ropsychiatric disorders. The Department provides training in phar- Neuropeptides, metabotropic glutamate macology to both medical under­graduate receptors, opioid receptors, neuropeptide ­ ­Y and graduate students. An additional task of receptors, fear learning, anxiety disorders, the Institute is to contribute within national epileptogenesis and international societies to the promo- tion of Pharmacology. This is done through Research Focus the board functions (R. Fischer-Colbrie, Secretary) in the Austrian Pharmacological • Characterization of the neural networks ­Society (APHAR) and the organization of the underlying physiological and pathological Annual Meeting of the APHAR every 3 years fear/anxiety and identification of novel in Innsbruck. treatment strategies Furthermore, the Department of Pharma­ Head of Institute: • Etiology and novel treatment of temporal cology provides independent drug and Univ.-Prof. Dr. Francesco Ferraguti lobe epilepsy therapeutic information to doctors through the “Pharmainformation” bulletin and con­ Contact: General Facts tributes to a variety of public bodies (e.g. Peter Mayr Straße 1a Ethic Committee of the Medical University 6020 Innsbruck The Department of Pharmacology, estab- of Innsbruck) involved in the evaluation of lished in 1886, is a centre of excellence in drug safety and development. [email protected] Neuro- and Psycho-pharmacology, and uses Phone: +43 512 9003 71204 Fax: +43 512 9003 73200 www.i-med.ac.at/pharmakologie

Fig. 1 Synapse made between a thalamic axon terminal and a spine of an intercalated neuron visualized by freeze-fracture replica immunolabelling. The image shows a cross-fractured axon terminal shown in light blue and small portions of its P-face labeled with 15 nm gold particles detecting Channelrhodopsin 2-YFP (ChR2). Within the terminal, the membrane of numerous synaptic vesicles can be observed (sv). The terminal forms an asymmetric synapse with a spine. The postsynaptic membrane specialization (PSD) on the E-face shows a characteristic cluster of intramembrane particles and is labeled with 5 nm gold particles revealing glutamate AMPA-Rs.

68 Research Report 2016 Medical University of Innsbruck Pharmacology

Neuropeptides in Fear and Anxiety Ramon Tasan The laboratory investigates the role of neuro­peptides in modulating emotional be- haviours that are related to fear and hunger. A further aim is to unravel the underlying synaptic correlates of these emotional re- sponses. Avoiding danger and finding food are two intimately associated, life-sustain- ing behaviors that are organized in survival circuits and strongly modulated by emo- tions. Maladaptation within such survival circuits can induce dysregulated, pathologi- cal behavior, resulting in the development of feeding- or anxiety-disorders. Interestingly, neuropeptides are essential modulators of Fig. 2: Recorded and filled neurons of the intercalated cell masses of the amygdala both, energy homeostasis and anxiety-relat- ed behaviors. For instance, PP-fold peptides, Research particular, we seek to determine whether including neuropeptide Y (NPY), peptide YY ­dopamine-depletion of the amygdala elicits (PYY) and pancreatic polypeptide (PP) are Neural Circuits underlying Emotional pathological anxiety in mice. released during states of hunger or acute Behaviour danger. While the anxiolytic and fear-reduc- Francesco Ferraguti Major Achievements: Identification of novel ing properties of these neuropeptides are The laboratory is primarily interested in cell types of the intercalated cell masses increasingly evident, a potential interaction ­understanding the neural mechanisms me- of the amygdala and their participation of feeding and fear has not been elucidated diating emotional information processing in amygdala neural circuits processing so far. and the roles that classical neurotrans- sensory stimuli. Neuropeptides are highly enriched in the mitters have (e.g. glutamate and GABA Future Goals: Identification of the neural amygdala and hippocampus, two brain re- receptors) on the acquisition, storage and substrates of social behaviour as well as of gions that are fundamentally involved in ­retriev­al of emotional memories in the the mechanisms of disturbed emotion pro­ controlling emotional behaviors. There, they amygdala. cessing and social interaction. are considered to act as essential media- Although a large body of in vivo work has tors significantly shaping synaptic function- suggested that the encoding and retention of memories for events that signal threat involve specific neuronal activity patterns with characteristic temporal dynamics, the underlying neural networks and their plasticity remain in large part to be eluci- dated. A first step in understanding these networks is the characterization of the main cell types of the amygdala and the identifi- cation of their participation in intrinsic and extrinsic circuitries of this region. Our work in recent years involved primar- ily the anatomical, pharmacological and physio­logical characterization of different GABAergic cell types of the basolateral complex and of the intercalated cell mass- es of the rodent amygdala. Currently, tak- ing advantage of recent developments in ­molecular genetics, viral trans-synaptic tracing and novel ultrastructural techniques (e.g. SDS-digested freeze-fracture replica immunogold labelling), we investigate long- range connections between amygdala GAB- Aergic neurons and cortical or subcortical­ brain structures as well as structural syn- aptic plasticity of amygdala inhibitory net- works. Moreover, we examine the pharmacologi- cal and anatomical bases of anxiety disor- Fig. 3: Axonal projections (shown in blue) of a large intercalated neuron (shown in red) of the ders in models of Parkinson`s disease. In amygdala located in the intermediate capsule

Research Report 2016 Medical University of Innsbruck 69 Institute of Pharmacology

Fig. 4: EEG depth electrode recording from the ipsilateral hippocampus of an epileptic mouse before and after KOR agonist treatment ing. Through a multidisciplinary approach, epileptogenesis than wild-type animals. Neuronal Circuitries of the Subiculum in which involved immunohistochemistry, Application of a KOR agonist during epilep- Epileptogenesis neuronal tract tracing, ex vivo slice electro- togenesis reduces neurodenegeration and Meinrad Drexel, Günther Sperk physiology with pharmaco- and optogenetic neurochemical alterations. On the other The group currently investigates the role approaches in different transgenic mouse hand, activation of KOR is known to induce of GABAergic interneurons of the subicu- lines, we have demonstrated that several dysphoria in humans. Applying 4 channel lum in the generation of epileptic seizures. neuropeptides of the gut-brain axis are fun- in vivo EEG combined with behavioral test- ­Epileptic seizures are generated by abnor- damentally involved in the modulation of ing we investigate G-protein biased KOR mal excessive or synchronous neuronal ac- fear and fear extinction behaviour, an effect agonists and AAV based overexpression of tivity. Malfunctioning of microcircuits of the that highly depends on the homeostatic sit- ­dynorphin in the kainic acid model of tem- hippocampus, thalamus or cortex may be uation of the individual, emphasizing a mu- poral lobe epilepsy. causative. Neurophysiological information tual interaction of survival circuits for fear formed in the hippocampus is processed and hunger. Major Achievements: Proof of principle that and transmitted to multiple brain areas. G-protein biased KOR agonists and AAV Recently we obtained evidence that mal- Major Achievements: Identification of based overexpression of dynorphin can sup- functioning of the subiculum, the main out- neuro­peptides of the gut-brain axis that are press seizures without inducing aversion. put area of the hippocampus, is crucially also fundamentally involved in the modula- Future Goals: Development of novel phar- involved in the generation of epileptic sei- tion of fear and fear extinction behavior. macological and gene-therapeutical thera- zures in animal models of temporal lobe Future Goals: Characterization of peripher- pies for drug-resistant epilepsy patients. ­epilepsy. In particular GABA/somatostatin al modulators of hunger and satiety which and GABA/parvalbumin neurons target- could also affect fear learning, closing the ing the dendritic trees and the somata of loop of the gut-brain axis in controlling emo- tionally driven behaviors.

Opioid Systems in Epilepsy and Emotional Control Christoph Schwarzer The laboratory investigates the role of the endogenous dynorphin/kappa opioid re- ceptor (KOR) system in epilepsy and epilep- togenesis. Moreover, by gaining insight into the functional neuroanatomy of the dynor- phin/KOR in emotional control, a further aim is to minimize potential side-effects of KOR agonist treatment. Epilepsy is one of the most frequent neuro­ logical diseases, which presently cannot be cured. A high number of patients are refrac- tory to pharmacological treatment, render- ing surgical removal of parts of the brain the ultimate solution. Moreover, epilepsy shows high comorbidity with anxiety and depres- sion. In recent years, we provided evidence that the activation of KOR plays an important role in epileptogenesis. Thus, dynorphin deficient mice display faster progression and more neurodegeneration in models of Fig. 5: Microcircuits of the subiculum

70 Research Report 2016 Medical University of Innsbruck Pharmacology

­pyramidal neurons, respectively, as well as Selected Publications afferent glutamate/calretinin neurons orig- Sensory Inputs to Intercalated Cells Provide Fear-Learning inating in the n. reuniens thalami may be Modulated Inhibition to the Basolateral Amygdala Asede, Douglas, Bosch, Daniel, Luethi, Andreas, Ferraguti, impaired in their function. Francesco, Ehrlich, Ingrid, We use transgenic mice that allow cell NEURON: 2015; 86: S. 541-554 specific overexpression of tetanus toxin Regulating anxiety with extrasynaptic inhibition introduced by stereotactic injections of a Botta, Paolo, Demmou, Lynda, Kasugai, Yu, Markovic, Milica, Xu, Chun, Fadok, Jonathan P., Lu, Tingjia, Poe, Michael M., Xu, Li, respective viral vector into the subiculum Cook, James M., Rudolph, Uwe, Sah, Pankaj, Ferraguti, Francesco, or n. reuniens thalami. Tetanus toxin is then Luethi, Andreas, ­selectively expressed in GABA/somato- NATURE NEUROSCIENCE: 2015; 18: S. 1493-+ stain, GABA/parvalbumin or glutamate/ Hippocampal Theta Input to the Amygdala Shapes Feedforward Inhibition to Gate Heterosynaptic Plasticity calretinin neurons at the site of injection Bazelot, Michael, Bocchio, Marco, Kasugai, Yu, Fischer, David, and impairs neurotransmitter release from Dodson, Paul D., Ferraguti, Francesco, Capogna, Marco, these neurons. We are then monitoring EEG NEURON: 2015; 87: S. 1290-1303 activity in these mice for one month and The G-protein biased partial K opioid receptor agonist 6'- probe development of epilepsy. So far we GNTI blocks hippocampal paroxysmal discharges without inducing aversion demonstrated that selective silencing of Zangrandi, Luca, Burtscher, Johannes, MacKay, James P., Colmers, William F., Schwarzer, Christoph, GABA/parvalbumin neurons in the subicu- BRITISH JOURNAL OF PHARMACOLOGY: 2016; 173: S. 1756- lum leads to spontaneous limbic seizures 1767 and highlighted the crucial role of these Pancreatic polypeptide and its central Y-4 receptors neurons in the manifestation of temporal are essential for cued fear extinction and permanent suppression of fear lobe epilepsy. Verma, D., Hoermer, B., Bellmann-Sickert, K., Thieme, V., Beck- Sickinger, A. G., Herzog, H., Sperk, G., Tasan, R. O., BRITISH JOURNAL OF PHARMACOLOGY: 2016; 173: S. 1925- Major Achievements: Identification that se- 1938 lective silencing of GABA/parvalbumin in- terneurons in the subiculum leads to spon- Selected Funding taneous limbic seizures. • Signal processing in neurons (SPIN). Austrian Science Fund Future Goals: Investigate the role of CCK- (FWF) Doctoral college Program no. W12060, F. Ferraguti & C. Schwarzer and calretinin-containing interneurons of • Cell signaling in chronic CNS disorders. Austrian Science the subiculum in the generation of epileptic Fund (FWF) Sonderforschungsbereich Program no. F44-17, F. Ferraguti seizures. • Plasticity of amygdala intercalated cell microcircuits in fear learning. Austrian Science Fund (FWF) grant no. I2215, F. Ferraguti • Functional significance of the metabotropic glutamate receptor 1 (mGlu1) splice variants. Austrian Science Fund (FWF) grant no. I2220, F. Ferraguti

Collaborations

• Prof. Aiba A., the University of Tokyo, Tokyo, Japan • Prof. Becker A., Dept. Neuropathology, University of Bonn, Bonn, Germany • Prof. Beck-Sickinger A., University of Leipzig, Leipzig, Germany • Dr. Bonaventure P., Johnson & Johnson Pharmaceutical Research & Development, USA • Prof. Capogna M., Aarhus University, Copenhagen, Denmark • Dr. Ehrlich I., University of Tübingen, Tübingen, Germany • Prof. Heilbronn R., Dept. Virology, Campus Benjamin Franklin, Charité – Medical School, Berlin, Germany • Prof. Herzog H., Garvan Institute of Medical Research, Australia • Prof. Lüthi A., Friedrich Miescher Institute, Basel, Switzerland • Prof. Pape H.C., Westfälische Wilhelms-Universität, Münster, Germany

Research Report 2016 Medical University of Innsbruck 71 Department of Medical Statistics, Informatics and Health Economics Medical ­Statistics and Informatics

Research Branch (Östat Classification) searchers in all aspects of statistical study planning, protocol writing, applications for 305907, 305905, 305904, ethical review, data management, statistical 303026, 303025 analysis and publication. We provide exper- tise regarding the usage of statistical (R, Keywords SAS, Stata, SPSS, etc.) and data manage- ment software (REDCap). Lalit Kaltenbach Medical statistics, biostatistics, statistical has developed an e-CRF system for the in- methods, epidemiology, medical informat- ternational, multicentre LEVOREP trial. ics, medical documentation, clinical trials, Other multi-centre trials with major partic- registries, Risk Prediction, Prevention ipation of our division are the EU-funded Gannet53 randomized controlled trial, as Research Focus well as other studies such as the BADDHY, PLATA, VITRIS, AFREEZE, ForaC and FIinTIC Cardiovascular and Cancer Epidemiology trials. Marina Popovscaia and Hanno Ulmer are trial statisticians of the international, In cardiovascular and cancer epidemiology, multicenter phase I and phase II Gannet53 we investigate metabolic and lifestyle fac- ovarian cancer treatment studies. Head of Division (interim): tors as potential risk factors for disease in- The division with Lalit Kaltenbach as re- ao. Univ.-Prof. Dr. Hanno Ulmer cidence and mortality with a special focus sponsible IT manager runs five Austria-wide on sex/gender related differences. registries: The HIR registry, the PCI registry, Contact: the IIK registry, the Ablation registry, and Schöpfstraße 41/1 Statistical and Epidemiological Methods the Parkinson registry. The Austrian socie- 6020 Innsbruck ties of Cardiology and Neurology are part- The focus of the division lies in the devel- ners in these projects. [email protected] opment and application of statistical and The statistical consulting and the partici- Phone: +43 512 9003 70900 epidemiological methods for modelling bi- pation in these projects are fundamental Fax: +43 512 9003 73922 omedical associations in the framework of for the strong publication record of the www.i-med.ac.at/msig/ causal inference. division. In relation to the number of em- ployees, the division has a top rank within Medical Informatics and Documentation MUI in recent years regarding total number of publications. In 2015 to 2016, a total Medical informatics, which is a multidis- of 86 original research papers have been ciplinary research field, targets the use of published by researchers of the division information technology in order to improve (mostly co-authorships). In order to support health care. researchers submitting their PhD and habil- itation theses, Joachim Masser developed Biobanking and BioMolecular the SCORE program. It enables the adminis- Resources Research Infrastructure tration of the personal publication record of (BBMRI.MUI) MUI researchers, including impact factors, citations and journal rankings. BBMRI.MUI aims to establish a state-of-the- Michael Edlinger (treasurer) and Hanno Ul- art biobanking infrastructure at the Medi- mer (founding president) have established cal University of Innsbruck and to increase the Austrian Society of Epidemiology. The close cooperation between, and harmoni- society has gained 80 members during zation of, local, national and international the first two years and has been scientif- biobanks. ically lively with a wide range of activities including symposia with Hirsch-index>100 General Facts researchers Rick Grobbee, Jaako Tuomileh- to and Evout Steyerberg. For further details The Division of Medical Statistics and In- see http://www.oegepi.at/ formatics provides a major contribution to the teaching of medical students. Besides Research offering obligatory lectures in semesters 1, 5 and 8, we focus on teaching diploma and Cancer Epidemiology PhD students. Students who are working on Hanno Ulmer their diploma and PhD theses are advised In cancer epidemiology, we investigate met- on the use of appropriate statistical meth- abolic and lifestyle factors as potential risk ods. factors for cancer incidence and mortality. Additionally, we provide statistical consulta- Metabolic syndrome is a cluster of factors tions to all researchers of MUI with a focus characterized by obesity, hypertension, on clinical studies. We support clinical re- dyslipidemia and high blood glucose. The

72 Research Report 2016 Medical University of Innsbruck Medical ­Statistics and Informatics

Fig. 1. Path diagram of the relation between sex (exposure), cardiovascular risk factors (mediators), and death from CHD (outcome) in presence of measured (age and year of examination) and unmeasured confounding. CHD = coronary heart disease. prevalence of metabolic syndrome is rising Cardiovascular Epidemiology and Risk Statistical and Epidemiological Methods worldwide. Individuals with metabolic syn- factors Hanno Ulmer drome have a higher risk of cardiovascular Hanno Ulmer Whereas, over the years, the division had a diseases and diabetes, but less is known Using data from the population-based strong research record in classification and about the association with cancer. Vorarlberg health examination database regression methods we are now setting a We participated in the Me-Can project, con- (VHM&PP), we have been investigating the new focus in the field of causal inference, taining a large database with health exami- role of metabolic risk factors such as obe- developing and applying mediation analy- nation data from about 570,000 individuals sity, blood pressure, blood lipids, blood sug- sis techniques for epidemiologic research from Sweden, Norway and Austria. Meas- ar, gamma-glutamyltransferase or uric acid problems. By taking into account potential urements such as height, weight, blood in cardiovascular disease since 2003. The outcomes, so called counterfactuals, these pressure, blood glucose, triglycerides and 2015/2016 publications, in this long tradi- techniques try to uncover the underlying total cholesterol were recorded between tion, focus on causal relationships between mechanisms and clarify why and how an 1972 and 2004. Individuals in the database sex/gender, risk factors and coronary heart exposure brings about the outcome of in- have been followed until their death, em- disease as well as overweight/obesity, risk terest. Josef Fritz is currently applying such igration or the end of follow-up, according factors and coronary heart disease. Josef methods to investigate the contribution of to the principles of epidemiological cohort Fritz applied state-of-the-art statistical me- cardiovascular risk factors to the gender studies. To obtain cause of death and can- diation analysis techniques in order to ana- gap in mortality from coronary heart dis- cer incidence information, the database lyze these relationships from a completely ease. was linked to cancer registries in each new perspective. In one of the papers, a country. The division is a key partner in the clear causal explanation is given for the Medical Informatics and Documentation Me-Can project. substantial age-dependent differences re- Georg Göbel More recently, we have set up a case-con- garding mortality from coronary heart dis- In the division of Medical Statistics and In- trol study to investigate the association of ease between men and women. formatics, we have a strong focus on the aluminium exposure and breast cancer. Together with researchers from the Division use of semantic web technology in order to Caroline Linhart is working on this study in of Cardiology at MUI, Michael Edlinger is in- integrate data repositories and to support cooperation with MUI scientists from the volved in a large clinical cohort study (CAR- medical documentation. Formal, semanti- Divisions of Gynaecology, Plastic Surgery DIIGAN) working on a prediction score for cally enriched knowledge representation and Biochemistry at MUI. patients undergoing coronary angiography. by means of ontologies provides a powerful

Research Report 2016 Medical University of Innsbruck 73 Department of Medical Statistics, Informatics and Health Economics

solution to facilitate semantic interoperabil- The research focus of Philipp Hofer is on in order to implement a university-wide ity and knowledge sharing within the scope the usage of IT-based semantic techniques state-of-the-art biobanking infrastructure of e-health, medical documentation, or bi- and (bio-) medical ontologies for biobank at the Medical University of Innsbruck. The obanking. An ontology represents classes data representation. Ontologies are ma- project is implemented in strong coopera- of entities of the real world and focuses on chine-readable and provide a unified, se- tion with local hospital management Tirol the definition of concepts and relations be- mantic description of sample collections Kliniken. Reference processes based on the tween them. They offer a good solution for and related data, allowing data integration CEN Technical Specification for Molecular addressing the challenge of machine-reada- across heterogeneous biobank catalogues in vitro diagnostic examinations are cur- ble concepts in order to support health care and information systems. For this, he pro- rently under development within an inter-in- providers and researchers with their daily posed an IT-based, semi-automated con- stitutional working group.They aim to spec- work. cept recommendation within a regional ify pre-examination processes for several Sabrina Neururer focuses on ontologized biobank catalog to support and encourage different material types such as snap-frozen versions of classification systems for health biobank custodians to use ontology con- or FFPE tissue, venous whole blood, serum, care, especially the formalization of the cepts and coding standards rather than free plasma, and urine. Austrian procedure catalogue (Österreichis- text for describing their sample collections Currently, several independent decentral- cher Leistungskatalog) for health procedure . ized collections of human biomaterials are coding. For this, a four-step approach, con- Biobanking and BioMolecular located at different MUI divisions. Based on sisting of a comparative analysis, a defini- Resources Research Infrastructure the approval of the local ethics committee, tion analysis, a typological analysis, and the (BBMRI.at) most of these separate sample collections ontology implementation was developed. Georg Göbel are linked to pseudonymized, detailed clin- It provides a novel framework to semanti- BBMRI.at, an Austrian project, aims to de- ical data. The project aims at integrating cally enrich procedure classifications. This velop a cutting-edge biobanking infrastruc- archived biospecimens with clinical and approach pubslished bei Neururer et al. [5] ture for Austria in order to increase coop- molecular data in a collaborative environ- is currently re-used and extended in order eration and harmonization among biobanks ment that emphasizes scientific insights, to serve further research purposes, such as and towards industry. Since 2014, the local while ensuring security and compliance. An the semantical enrichment of any free-text research team has worked on establishing upcoming issue will be the digitalization of information. Project proposals focusing on common guidelines for the collection of hu- FFPE slides. In addition a comprehensive bi- this refinement are currently under review. man biosamples and on data management obank management system will be launched

Fig. 2: Direct versus indirect effects of sex on CHD mortality by age group. The direct effect of sex and the indirect ones mediated through the risk factors are displayed as proportions of the estimated age-specific HRs on a logarithmic scale. Values below 0 indicate proportions mediated in favour of men. CHD = coronary heart disease; HR = hazard ratio.

74 Research Report 2016 Medical University of Innsbruck Medical ­Statistics and Informatics

in order to support researchers with collec- tion and sample and quality management tasks. The software will enable users to integrate patient materials, clinical, speci- men, genetic and molecular assay data, in order to deliver a holistic, unified view, and facilitates data exploration and hypotheses driven research without extra programming or IT support. Multi-level user access con- trol ensures that all collaborators can work effectively while ensuring compliance with patient consent and maintaining regulatory guidelines.

Selected Publications

Mediation analysis of the relationship between sex, cardiovascular risk factors and mortality from coronary heart disease: Findings from the population-based VHM&PP cohort Fritz, Josef, Edlinger, Michael, Kelleher, Cecily, Strohmaier, Susan- ne, Nagel, Gabriele, Concin, Hans, Ruttmann, Elfriede, Hochleit- ner, Margarethe, Ulmer, Hanno, ATHEROSCLEROSIS: 2015; 243: S. 86-92

A strong interaction between age and overweight/obesity on the risk of coronary heart disease in the context of metabolic mediation. Fritz J, Strohmaier S, Nagel G, Concin H, Ulmer H, EPIDEMIOLOGY: 2016; 27(3): S. 13-4

Metabolic risk score and cancer risk: pooled analysis of seven cohorts Stocks, Tanja, Bjorge, Tone, Ulmer, Hanno, Manjer, Jonas, Haggs- trom, Christel, Nagel, Gabriele, Engeland, Anders, Johansen, Dorthe, Hallmans, Goran, Selmer, Randi, Concin, Hans, Tretli, Stei- nar, Jonsson, Hakan, Stattin, Par, INTERNATIONAL JOURNAL OF EPIDEMIOLOGY: 2015; 44: S. 1353-1387

Semi-automated evaluation of biomedical ontologies for the biobanking domain based on competency questions Hofer, Philipp; Neururer, Sabrina; Hauffe, Helga; Insam, Thomas; Zeilner, Anette; Göbel, Georg, STUDIES IN HEALTH TECHNOLOGY AND INFORMATICS: 2015; 212; S. 65-72 Collaborations • Odd Aalen, University of Oslo, Oslo, Norway • Tone BjØrge, Bergen University, Bergen, Norway • Larry Brant, National Institute on Aging, Baltimore MD, USA • Hans Concin, Arbeitskreis für Vorsorge- und Sozialmedizin, Bre- genz, Austria • John Danesh, University of Cambridge, Cambridge, UK • Rick Grobbee, University Medical Centre Utrecht, Utrecht, the Netherlands • Leo Held, University of Zurich, Zurich, Switzerland • Cecily Kelleher, University College Dublin, Dublin, Ireland • Yuan Lu, Harvard University, Cambridge MA, USA • Anna Lukanova, German Cancer Research Centre, Heidelberg, Germany • Jonas Manjer, Lund University, Malmö, Sweden • Gabriele Nagel, University of Ulm, Ulm, Germany, • Petra Peeters, Imperial College, London, UK • Ruth Pfeiffer, National Cancer Institute, Bethesda MD, USA • Pär Stattin, Umeå University, Umeå, Sweden • Ewout Steyerberg, Erasmus MC University Medical Centre Rot- terdam, Rotterdam, the Netherlands • Reinhild Strauss, Medical University of Vienna, Vienna, Austria • Jaakko Tuomilehto, University of Helsinki, Helsinki, Finland • Christopher Wild, International Agency on Research of Cancer, Lyon, France • Kurt Zatloukal, Medizinische Universität Graz, Austria

Research Report 2016 Medical University of Innsbruck 75 Department of Pathology General Pathology

biobank consisting of formalin-fixed paraf- nosis, support diagnosis and assistance in fin-embedded material (FFPE) is located at treatment allocation as well as identifica- our division thus making us an important tion of potential therapeutic targets using connecting link between basic science and molecular pathological methods. Current clinical research. This translational research projects deal with the early detection of is reflected by a close cooperation with cli- lung cancer and the role of molecular pa- nicians and researchers in the fields of on- thology for therapy in lung cancer patients. cology, surgery, radiology, nuclear medicine, head & neck as well as cranio-maxillofacial The research groups for uropathology, hae- surgery, dermatology and other depart- matopathology and cranial-maxillofacial ments. surgery represent a particular field of inter- est at our division and are therefore high- Research lighted separately.

Oncology 1) Uropathology Main topics are the diagnosis of rare tumour The main topic in the field of uropathology entities, tumour biology and mechanisms is prostate cancer focusing on tumour biol- of treatment resistance, evaluation of bio- ogy, mechanisms of treatment resistance, Head of Division (interim): markers to predict individual risk and prog- evaluation of biomarkers for diagnosis, risk ao. Univ.-Prof.in Dr.in Bettina Zelger

Contact: Müllerstraße 44 6020 Innsbruck

[email protected] Phone: +43 512 9003 71301 Fax: +43 512 9003 73301 www.i-med.ac.at/pathologie

Research Branch (ÖSTAT Classification)

301301, 301108, 301103, 302013

Keywords

Oncology, uropathology, haematopathology, gastrointestinal pathology, oropharyngeal pathology, pathology of infections, immunology, transplantation, biobanking, morphomics, digital pathology

Research Focus

• Oncology • Infectiology, immunology and transplantation • Biobanking, morphomics, digital pathology

General Facts Fig. 1: Schematic illustration of a model of hyperspectral images and the morphological The Division of General Pathology focusses integrity after IR imaging measurements of mucormycosis in a human tissue section. A on diagnostic clinical pathology and was- single acquisition of an unstained sample records thousands of images across numerous responsible for the routine pathological wavelengths, resulting in an image stack forming a three-dimensional (3D) image data cube. diagnosis of biopsies and surgical speci- The challenges to analyze IR imaging data are that: (a) the obtained image data cube may be mens obtained from most of the Clinical viewed as spatially located spectra, with the processing tools of classical spectroscopy being Departments of the Medical University of applied to single spectra; (b) the data may be viewed as images, with image-processing tools Innsbruck with an emphasis on oncology, being used to extract higher-quality spatial information. Thus, the combination of IR imaging, especially of the lymphatic tissue, the uro- signal and image processing, and histomorphological investigations makes IR imaging a genital tract and oropharyngeal tumors. A multidisciplinary method.

76 Research Report 2016 Medical University of Innsbruck General Pathology

lecular signatures allowing the stratification Selected Publications of patients who are susceptible to curative Vasculitic wheel - an algorithmic approach to cutaneous treatment of oral squamous cell carcinoma. vasculitides Ratzinger, Gudrun, Zelger, Bettina Gudrun, Carlson, J. Andrew, Patient samples that have been and are Burgdorf, Walter, Zelger, Bernhard, still being collected at the Department for JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN ­Cranio-Maxillo-Facial and Oral Surgery and GESELLSCHAFT: 2015; 13: S. 1092-1117 at the Department of Pathology (biobank) Pulmonary mucinous adenocarcinomas: architectural will be systematically collected, dissected, patterns in correlation with genetic changes, prognosis and survival and prepared to be accessible for this study. Geles, Abidin, Gruber-Moesenbacher, Ulrike, Quehenberger, Franz, Manzl, Claudia, Al Effah, Mohamed, Grygar, Elisabeth, Juettner-Smolle, Freyja, Popper, Helmut H., Infectiology, Immunology and VIRCHOWS ARCHIV: 2015; 467: S. 675-686

Transplantation Low Beclin-1 expression predicts improved overall survival Fig. 2: Lymph node infiltration by an aggres- The main topics include morphology and in patients treated with immunomodulatory drugs for sive B-cell-lymphoma (H&E; 40x) harbour- immune phenotype of the inflammatory multiple myeloma and identifies autophagy inhibition as a promising potentially druggable new therapeutic target: an ing a C-MYC rearrangement (see inset: the infiltrate of composite allograft transplan- analysis from The Austrian Myeloma Registry (AMR) Willenbacher, Wolfgang, Thangavadivel, Shanmugapriya, Greil, fusion signal represents an intact C-MYC, tations and limb transplantation in animal Richard, Willenbacher, Ella, Weger, Roman, Manzl, Claudia, the single orange and green signal indicates experiments in close cooperation with the Joehrer, Karin, Brunner, Andrea, a rearrangement – dual color break apart Department of Surgery, Medical University LEUKEMIA & LYMPHOMA: 2016; 57: S. 2330-2341 probe for C-MYC) of Innsbruck. Tumor-infiltrating immune cell subpopulations influence Further fields of attention are the immu- the oncologic outcome after intravesical bacillus calmette- guerin therapy in bladder cancer prognosis and therapy allocation as well as nology and new therapeutic approaches Pichler, Renate, Fritz, Josef, Zavadil, Claudia, Schaefer, Georg, Culig, Zoran, Brunner, Andrea, potential therapeutic targets. Furthermore in chronic inflammatory bowel disease in ONCOTARGET: 2016; 7: S. 39916-39930 the function of the androgen receptor and close cooperation with the Department of the role of stem cells, cytokines and inflam- Endocrinology, Gastroenterology and Meta­ Distinct galactofuranose antigens in the cell wall and culture supernatants as a means to differentiate Fusarium mation in tumour progression and treat- bolic Diseases and the morphology of cu- from Aspergillus species Wiedemann, Annegret, Kakoschke, Tamara Katharina, Speth, ment resistance are evaluated in close co- taneous vasculitis in cooperation with the Cornelia, Rambach, Guenter, Ensinger, Christian, Jensen, Henrik operation with the Department of Urology. Department of Dermatology and Venerolo- Elvang, Ebel, Frank, INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY: 2016; Another field of interest is bladder cancer, gy. Another ongoing project deals with the 306: S. 381-390 currently concentrating on tumour immu- evaluation of new methods of detection of nology and especially the role of the PD1/ mycoses from blood and tissue using PCR Selected Funding

PDL1 axis in advanced and metastasized based methods and molecular imaging • The pattern of immune cell infiltration in DLBCL, NOS: Detecting bladder cancer. Further projects concen- techniques (mid-infrared microscopic) in co- differences between molecular lymphoma subtypes as a target for rational treatment allocation; Firma Celgene; Assoz. Prof. trate on biomarkers for risk, prognosis and operation with the Department of ­Hygiene, PD Dr. Andrea Brunner-Véber (Pathology)/Dr. Ella Willenbacher resistance to BCG-therapy as well as the Microbiology and Social Medicine as well as (Hematology) • Novel biomarkers in predicting response to intravesical Bacillus prevalence of HPV infection in superficial the Institute of Forensic Medicine. Calmette-Guèrin (BCG) therapy in high-risk, non-muscle invasive bladder cancer. bladder cancer (NMIBC); Medizinischer Forschungsfonds Tirol (MFF); Dr. Renate Pichler (Urology)/Assoz. Prof. PD Dr. Andrea Biobanking, Morphomics, Digital Brunner-Véber (Pathology) 2) Haematopathology Pathology • HRSM - Kooperationsausschreibung 2016 Teilbereich Forschung EK; Bundesministerium für Wissenschaft und The main field of interest is the patholo- Our department operates on a large bio- Forschung; Ao. Univ. Prof. Dr. Bettina Zelger/Assoz. Prof. PD gy of malignant lymphomas, focusing on bank of FFPE-specimens. In addition froz­ Dr. Georg Göbel/Dr. Georg Schäfer/MMag. Dr. Johannes Pallua autophagy and the immune microenvi- en tissue (FT) from urological cancers PhD ronment including the PD1/PDL1 axis in (prostate, bladder, kidney) as well as other Collaborations ­B-cell-neoplasias (multiple myeloma, folli- cancer types (breast, colon) are stored for • Prof. Dr. Martina Prelog, Department of Pediatrics, University of cular lymphoma) as well as the morphology, research purposes. DNA-Extraction of FFPE Würzburg, Würzburg, Germany immune phenotype and molecular patholo- and FT is offered as are further molecular • Kooperation mit den Medizinischen Universitäten Wien und Graz, sowie der Veterinärmedizinischen Universität Wien im gy (MYD88 and CXCR4 mutations) of lym- pathological analyses. Equipment also in- Rahmen des Hochschulrauminfrastrukturantrages (HRSM) phoplasmacytic/plasmacytoid lymphomas. cludes a scanning unit for slide evaluation. 2016 A current project deals with aggressive To further strengthen our morphomics B-cell-lymphomas including immune mi- unit we participated in the “HRSM-applica- croenvironment, potential prognostic bio- tion 2016” in close cooperation with the markers, such as C-MYC translocations and ­Medical Universities of Vienna and Graz therapeutic targets such as PD1 and PDL1. and the University of Veterinary Medicine In addition, a wide number of clinical stud- ­Vienna, which was positively evaluated. ies are provided with tumour samples from our biobank of FFPE specimens.

3) Cranio-Maxillofacial Pathology This project aims at the application and in- tegration of clinical, molecular pathological, molecular imaging (MALDI-IMS, FTIR imag- ing and µCT), bioinformatics and protein identification technologies to identify mo-

Research Report 2016 Medical University of Innsbruck 77 Institute of Legal Medicine Legal Medicine

identification of the 2004 South Asian Tsu- come this major limitation by developing nami victims (Sri Lanka), the missing chil- prototype tools for predicting appearance, dren of the Russian Tsar family Romanov, age, and ancestry from DNA traces. This al- the 1973 victims of the regime in Chile, lows the construction of composite sketch- the 2014 missing students from Ayotzina- es of unknown trace donors directly from pa, Mexico, and diverse international crime their traces left behind at crime scenes. cases. The GMI harbours the mitochondrial (mt) Core Facility Metabolomics DNA database EMPOP (http://empop.online/) Herbert Oberacher that over the years has become the primer The mission of the Core Facility Metabolo- reference for forensic mtDNA databasing mics is to serve as an enabling resource for and quality control of mtDNA data. The research and development programs at the GMI also hosts the autosomal STR data- Medical University of Innsbruck. We aim to base STRidER that provides freely-availa- provide expertise and state-of-the-art tech- ble, quality-controlled STR allele frequen- nologies for the qualitative and quantitative cies to the scientific community (http:// analysis of small bioorganic molecules. strider.online/). Furthermore, the GMI has Common targets are drugs, pharmaceuti- demonstrated experience in assay design cals, endogenous compounds, and metab- Head of Institute: and development for the NGS analysis by olites thereof included in all kinds of biolog- o. Univ.-Prof. Dr. Richard Scheithauer first publishing mitochondrial DNA NGS ap- ical samples (e.g. biofluids, cells, tissues). plications on the PGM (Parson et al. 2013) Contact: and first PCR multiplex assays for mitoge- Systematic Toxicological Analysis (STA) Müllerstraße 44 nome NGS of degraded forensic samples Herbert Oberacher 6020 Innsbruck (Parson et al. 2015) as well as development STA is defined as the application of an ade- and application of large SNP multiplexes quate analytical strategy for the detection [email protected] for human identification (Mayr-Eduardoffet and identification of as many as possible po- Phone: +43 512 9003 70600 al. 2015) and ancestry informative analysis tentially toxic compounds and their metab- Fax: +43 512 9003 73600 (Mayr-Eduardoff et al. 2016). The GMI is the olites in biological samples. It is an integral www.gmi.eu host of the Core Facility Metabolomics. part of the medicolegal examination of drug consume and poisoning. To maximize the Research forensically relevant information obtained Research Branch (ÖSTAT Classification) from casework samples, we are developing Paradigm Change? Moving Forensic new and advanced workflows for STA. 301206, 301902, 106006, Genetics to Highly Sensitive and More 301110, 106041 Discriminatory Analysis by Next Gener- Drug Checking ation Sequencing (NGS) Herbert Oberacher Keywords Walther Parson Drug checking is a harm reduction service The institute plays an international key role that helps users avoid ingesting unknown Forensic genetics, genetic identification, in addressing relevant issues in Forensic and potentially dangerous substances and next generation sequencing, cell line iden- Human Identification using Next Generation adulterants found in street drugs. Further- tification, forensic DNA phenotyping, disas- Sequencing techniques. more, drug checking services assist in ter victim identification, forensic toxicology, identifying trends in illicit drug markets. We drug screening, therapeutic monitoring, Increasing the Discrimination Power of support the local drug checking initiative metabolomics Forensic Mitochondrial DNA Analysis by run by “Drogenarbeit Z6”, and the Ministry Mitogenome Sequencing of Health with our expertise in drug analy- Research Focus Walther Parson sis. Furthermore, to facilitate and acceler- The institute is leading international re- ate the compound identification process, The Institute of Legal Medicine (GMI) at the search to maximize the forensically rele- we are developing new and advanced tools Medical University of Innsbruck harbours vant information content from mitochondri- such as mass spectral libraries. the Austrian Central DNA Laboratory that al DNA sequencing from unknown samples was established in 1997. It represents Aus- (crime scenes and human identification) Wastewater Analysis tria in the European DNA Profiling Group using Next generation Sequencing technol- Herbert Oberacher (EDNAP), the Network of Forensic Science ogies. Wastewater analysis is a rapidly developing Institutes (ENFSI), and the Interpol Moni- scientific discipline with the potential for toring Expert Group (MEG). The GMI has a Forensic DNA Phenotyping: Providing monitoring real-time data on geographical strong focus on technology-based projects Evidentiary Leads by Predicting Exter- and temporal trends in illicit drug use. It involving electrophoresis, real-time PCR, nally Visible Characteristics and Bio-Ge- involves sampling a source of wastewater, mass spectrometry, and massive parallel ographical Origin by DNA Analysis such as a sewage influent to a wastewater sequencing (MPS) strategies. The GMI is re- Walther Parson treatment plant. Monitoring the effluent of peatedly consigned to handle international Unknown perpetrators of crime cannot be wastewater treatment plants is of impor- casework requests, some of which received identified with the current forensic use of tance in environmental research. Compre- international media attention, such as the DNA without a reference samples. We over- hensive analysis provides information on

78 Research Report 2016 Medical University of Innsbruck Legal Medicine

Pospiech, Ewelina, Karlowska-Pik, Joanna, Marcinska, Magdalena, Abidi, Sarah, Andersen, Jeppe Dyrberg, van den Berge, Margreet, Carracedo, Angel, Eduardoff, Mayra, Freire-Aradas, Ana, Morling, Niels, Sijen, Titia, Skowron, Malgorzata, Soechtig, Jens, Syndercombe-Court, Denise, Weiler, Natalie, Schneider, Peter M., Ballard, David, Borsting, Claus, Parson, Walther, Phillips, Chris, Branicki, Wojciech, EUROFORGEN-NoE Consortium, FORENSIC SCIENCE INTERNATIONAL-GENETICS: 2015; 19: S. 280-288

Forensic ancestry analysis with two capillary electrophoresis ancestry informative marker (AIM) panels: Results of a collaborative EDNAP exercise Santos, C., Fondevila, M., Ballard, D., Banemann, R., Bento, A. M., Borsting, C., Branicki, W., Brisighelli, F., Burrington, M., Capal, T., Chaitanya, L., Daniel, R., Decroyer, V., England, R., Gettings, K. B., Gross, T. E., Haas, C., Harteveld, J., Hoff-Olsen, P., Hoffmann, A., Kayser, M., Kohler, P., Linacre, A., Mayr-Eduardoff, M., McGovern, C., Morling, N., O'Donnell, G., Parson, W., Pascali, V. L., Porto, M. J., Roseth, A., Schneider, P. M., Sijen, T., Stenzl, V., Court, D. Syndercombe, Templeton, J. E., Turanska, M., Vallone, P. M., van Oorschot, R. A. H., Zatkalikova, L., Carracedo, A., Phillips, C., EUROFORGEN-NoE Consortium, FORENSIC SCIENCE INTERNATIONAL-GENETICS: 2015; 19: S. 56-67

Fig. 1: Eric Pokorak (Unit Chief, Mitochondrial DNA Unit, FBI) & Douglas Hares (Custodian Current status of non-targeted liquid chromatography- of the US National DNA Database, FBI) visit the Institute of Legal Medicine (Prof. Richard tandem mass spectrometry in forensic toxicology Oberacher, Herbert, Arnhard, Kathrin, Scheithauer, Prof. Walther Parson) for collaboration on mtDNA interpretation. TRAC-TRENDS IN ANALYTICAL CHEMISTRY: 2016; 84: S. 94-105.

Compound identification in forensic toxicological analysis the fate of potential surface and ground Just, Rebecca S., Scheible, Melissa K., Fast, Spence A., Sturk- with untargeted LC-MS-based techniques water pollutants. To maximize the informa- Andreaggi, Kimberly, Roeck, Alexander W., Bush, Jocelyn M., Oberacher, Herbert, Arnhard, Kathrin, Higginbotham, Jennifer L., Peck, Michelle A., Ring, Joseph D., BIOANALYSIS: 2015; 7: S. 2825-2840 tion obtained from water samples, we are Huber, Gabriela E., Xavier, Catarina, Strobl, Christina, Lyons, developing new and advanced workflows for Elizabeth A., Diegoli, Toni M., Bodner, Martin, Fendt, Liane, Analytical Validation of a Portable Mass Spectrometer Kralj, Petra, Nagl, Simone, Niederwieser, Daniela, Zimmermann, Featuring Interchangeable, Ambient Ionization Sources for the qualitative and quantitative analysis of Bettina, Parson, Walther, Irwin, Jodi A., High Throughput Forensic Evidence Screening drugs and their transformation products in FORENSIC SCIENCE INTERNATIONAL-GENETICS: 2015; 14: S. Lawton, Zachary E., Traub, Angelica, Fatigante, William L., 141-155 Mancias, Jose, O'Leary, Adam E., Hall, Seth E., Wieland, Jamie R., wastewater. Oberacher, Herbert, Gizzi, Michael C., Mulligan, Christopher C., Evidence for frequent and tissue-specific sequence JOURNAL OF THE AMERICAN SOCIETY FOR MASS heteroplasmy in human mitochondrial DNA SPECTROMETRY: 2016; Epub ahead of print: S. Selected Publications Naue, Jana, Horer, Steffen, Sanger, Timo, Strobl, Christina, Hatzer- Grubwieser, Petra, Parson, Walther, Lutz-Bonengel, Sabine, Combining a portable, tandem mass spectrometer with Recommendations of the DNA Commission of the MITOCHONDRION: 2015; 20: S. 82-94 automated library searching - an important step towards International Society for Forensic Genetics (ISFG) on quality streamlined, on-site identification of forensic evidence control of autosomal Short Tandem Repeat allele frequency Massively parallel sequencing of complete mitochondrial O'Leary, Adam E., Oberacher, Herbert, Hall, Seth E., Mulligan, databasing (STRidER) genomes from hair shaft samples Christopher C., Parson, Walther, Huber, Gabriela, Moreno, Lilliana, Madel, Maria- Bodner, Martin, Bastisch, Ingo, Butler, John M., Fimmers, Rolf, Gill, ANALYTICAL METHODS: 2015; 7: S. 3331-3339 Peter, Gusmao, Leonor, Morling, Niels, Phillips, Christopher, Prinz, Bernadette, Brandhagen, Michael D., Nagl, Simone, Xavier, Mechthild, Schneider, Peter M., Parson, Walther, Catarina, Eduardoff, Mayra, Callaghan, Thomas C., Irwin, Jodi A., Successful adaption of a forensic toxicological screening FORENSIC SCIENCE INTERNATIONAL-GENETICS: 2016; 24: S. FORENSIC SCIENCE INTERNATIONAL-GENETICS: 2015; 15: S. workflow employing nontargeted liquid chromatography- 97-102 8-15 tandem mass spectrometry to water analysis Steger, Julia, Arnhard, Kathrin, Haslacher, Sandra, Geiger, Hairy matters: MtDNA quantity and sequence variation Massively parallel sequencing of forensic STRs: Klemens, Singer, Klaus, Schlapp, Michael, Pitterl, Florian, along and among human head hairs Considerations of the DNA commission of the International Oberacher, Herbert, Desmyter, Stijn, Bodner, Martin, Huber, Gabriela, Dognaux, Society for Forensic Genetics (ISFG) on minimal ELECTROPHORESIS: 2016; 37: S. 1085-1094 nomenclature requirements Sophie, Berger, Cordula, Noel, Fabrice, Parson, Walther, Parson, Walther, Ballard, David, Budowle, Bruce, Butler, John M., FORENSIC SCIENCE INTERNATIONAL-GENETICS: 2016; 25: S. 1-9 Gettings, Katherine B., Gill, Peter, Gusmao, Leonor, Hares, Douglas Selected Funding R., Irwin, Jodi A., King, Jonathan L., de Knijff, Peter, Morling, Niels, Ancient mtDNA sequences from the First Australians Prinz, Mechthild, Schneider, Peter M., Van Neste, Christophe, revisited European project: Willuweit, Sascha, Phillips, Christopher, Heupink, Tim H., Subramanian, Sankar, Wright, Joanne L., DNASEQEX - DNA-STR Massive Sequencing & International FORENSIC SCIENCE INTERNATIONAL-GENETICS: 2016; 22: S. Endicott, Phillip, Westaway, Michael Carrington, Huynen, Leon, Information Exchange, funded by the European Commission, 54-63 Parson, Walther, Millar, Craig D., Willerslev, Eske, Lambert, David Coordinator: National Institute of Toxicology and Forensic M., Sciences - Madrid (. A. Alonso), GA No. HOME/2014/ISFP/ D5S2500 is an ambiguously characterized STR: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF AG/LAWX/ 4000007135, 2016-2018. MUI is coordinating Identification and description of forensic microsatellites in THE UNITED STATES OF AMERICA: 2016; 113: S. 6892-6897 technological platforms the genomics age Phillips, C., Parson, W., Amigo, J., King, J. L., Coble, M. D., Steffen, Inter-laboratory evaluation of SNP-based forensic Collaborations C. R., Vallone, P. M., Gettings, K. B., Butler, J. M., Budowle, B., identification by massively parallel sequencing using the FORENSIC SCIENCE INTERNATIONAL-GENETICS: 2016; 23: S. Ion PGM (TM) • Institute of Mathematics, University Innsbruck, Innsbruck, 19-24 Eduardoff, M., Santos, C., de la Puente, M., Gross, T. E., Fondevila, Austria M., Strobl, C., Sobrino, B., Ballard, D., Schneider, P. M., Carracedo, • Institut Geschichtswissenschaften / Europäische Ethnologie, Helena, the hidden beauty: Resolving the most common A., Lareu, M. V., Parson, W., Phillips, C., University Innsbruck, Innsbruck, Austria FORENSIC SCIENCE INTERNATIONAL-GENETICS: 2015; 17: S. West Eurasian mtDNA control region haplotype by • Zentralinstitut für Bluttransfusion und Immunologische 110-121 massively parallel sequencing an Italian population sample Abteilung, Tirol Kliniken, Innsbruck, Austria Bodner, Martin, Iuvaro, Alessandra, Strobl, Christina, Nagl, • Armed Forces DNA Identification Laboratory, Rockville, USA Evaluation of DNA Variants Associated with Androgenetic Simone, Huber, Gabriela, Pelotti, Susi, Pettener, Davide, Luiselli, • Bundeskriminalamt Wiesbaden, Wiesbaden, Germany Donata, Parson, Walther, Alopecia and Their Potential to Predict Male Pattern Baldness • Institut für Veterinärpathologie, University Giessen, Giessen, FORENSIC SCIENCE INTERNATIONAL-GENETICS: 2015; 15: S. Germany 21-26 Marcinska, Magdalena, Pospiech, Ewelina, Abidi, Sarah, Andersen, Jeppe Dyrberg, van den Berge, Margreet, Carracedo, Angel, • Department of Internal Medicine, Innsbruck Medical University, Innsbruck, Austria Mitochondrial DNA heteroplasmy in the emerging field of Eduardoff, Mayra, Marczakiewicz-Lustig, Anna, Morling, Niels, • Department of Gynecology and Obstetrics, Innsbruck Medical massively parallel sequencing Sijen, Titia, Skowron, Malgorzata, Soechtig, Jens, Syndercombe- Just, Rebecca S., Irwin, Jodi A., Parson, Walther, Court, Denise, Weiler, Natalie, Schneider, Peter M., Ballard, University, Innsbruck, Austria FORENSIC SCIENCE INTERNATIONAL-GENETICS: 2015; 18: S. David, Borsting, Claus, Parson, Walther, Phillips, Chris, Branicki, • Department of Neurology, Innsbruck Medical University, 131-139 Wojciech, EUROFORGEN-NOE Consortium, Innsbruck, Austria PLOS ONE: 2015; 10: S. e0127852 Full mtGenome reference data: Development and Core Facilities characterization of 588 forensic-quality haplotypes Evaluation of the predictive capacity of DNA variants representing three US populations associated with straight hair in Europeans • Metabolomics

Research Report 2016 Medical University of Innsbruck 79 80 Research Report 2016 Medical University of Innsbruck Clinical Research Units

Research Report 2016 Medical University of Innsbruck 81 Center of Operative Medicine Visceral, Transplant and Thoracic Surgery

Research Branch (ÖSTAT Classification) Sepsis Treatment of abdominal sepsis with open 301306, 301902, 301904, abdomen treatment and negative pressure. 302056, 302083 Daniel Swarovski Research Laboratory Keywords Research within the DSL complements state of the art clinical work with basic and trans- Metastatic surgery, ischemia-reperfusion lational scientific projects in the areas of injury, sepsis, transplantation biology, transplantation biology, molecular oncolo- molecular oncology, intracellular signalling, gy and wound healing/tissue regeneration. mitochondria, reactive oxygen species Common to all of them is the involvement (ROS), translational research of intracellular signalling pathways, reactive oxygen species (ROS) and the mitochondria Research Focus in the development of these pathological conditions but also as possible targets for Oncology – Metastatic Disease therapeutic intervention. • Clinical studies on surgical oncology including both retrospective single centre General Facts Director: studies and prospective international Univ.-Prof. Dr. Dietmar studies, according to the affected organs The Department of Visceral, Transplant and Öfner-Velano, MAS, MSc, F.A.C.S. • Clinical and experimental studies on Thoracic Surgery maintains not only an in- peritoneal carcinomatosis and metastatic ternationally-established high volume trans- Contact: disease plant program with transplantation of all Anichstraße 35 solid organs (kidney, liver, pancreas, small 6020 Innsbruck Ischemia-Reperfusion Injury in Organ bowel, cluster and, in cooperation with the Transplantation Department of Cardiac Surgery, heart and [email protected] One main focus of our research is to gain a lung), as well as vascularised compo­site Phone: +43 512 504 22600 better understanding of the pathophysiologi­ ­allografts, but also covers as a Central Hos- Fax: +43 512 504 22602 cal mechanisms underlying ischemia-reper- pital with tertiary patient care the entire www.chirurgie-innsbruck.at fusion (I/R) injury. I/R injury represents a field of general, visceral and thoracic sur- threat to which all transplanted organs are gery in adults and children. Translational subjected in the process of transplantation research takes place at the Department of and which is known to crucially influence ­Visceral, Transplant, and Thoracic ­Surgery graft and patient long-term survival. Identi- with its associated Daniel Swarovski fication of the mechanisms involved would ­Research Labora­tory. Work is proceeding not only help to better understand this pro- along three main axes, which cover the cess but also to identify new treatment tar- fields of main interest in transplantation, gets. surgical oncology and infectiology, name- ly ischemia-reperfusion injury, sepsis and

Head of Daniel Swarovski Research Laboratory: Univ.-Prof. Dr. Jakob Troppmair

Contact: Innrain 66/6th floor 6020 Innsbruck

[email protected] Phone: +43 512 504 27819 Fax: +43 512 504 24625 www.i-med.ac.at/tx-research Fig. 1: Gastric cancer with peritoneal carcinomatosis

82 Research Report 2016 Medical University of Innsbruck Visceral, Transplant and Thoracic Surgery

metastatic disease. In parallel to patient care with an extended quality assurance program and risk management, the Daniel Swarovski Research Laboratory (DSL) rep- resents a high-end research unit which cre- ates a perfect symbiosis between clinicians and basic scientists. In a “bed to bench and back” ­approach: complex treatment regimens and clinical trials can be further enhanced by molecular in-depth analysis. Furthermore, the research line is supple- mented by the development of proof of con- cept trials employing a large variety of mi- cro-surgically most-challenging organ and limb transplantation models in small as well as large animals. Together with Prof. Jakob Troppmair as head of the DSL research lab- oratory, senior staff surgeons and/or senior surgical residents investigate infectious, oncological and transplantation-related Fig. 2: Mucinous neoplasia of the peritoneum (Pseudomyxoma peritonei) topics in cell culture, small animal models and specimens from clinical trials in collab- (e.g. international multicentre study on sur- mary affected organs: oration with regional and international re- gical morbidity in lung cancer patients with search colleagues. Within a project, group VATS-lobectomy). ABCSG Study 16/SALSA: Prospective, leaders usually mentor diploma students, randomised, open-label, multi-centre, who get the unique opportunity to develop The clinical research includes diagnostic phase-II-study evaluating the effect of a not only basic science but also (micro)sur- tools (e.g. the diagnostic value of ultrasound secondary adjuvant endocrine therapy gical skills. in thyroid cancer) as well as new treatment with anastrozole­ for 2 years vs. 5 years in options (e.g. hyperthermic intraperitoneal patients with hormone-receptor-positive Research chemotherapy in patients with peritoneal breast cancer after 5 years prior adjuvant carcinomatosis). Of course, experimental endocrine therapy. (Research Group Breast Resarch Focus Oncology – Metastatic projects also play a very important role in Cancer) Disease oncological research at the Department Leader: Ass.-Prof. Priv.-Doz. Dr. Alexander of Visceral, Transplant and Thoracic Sur- Study on volatile organic compounds in non- Perathoner, Ass.-Prof. Priv.-Doz. Dr. Florian gery: scientists in our own laboratories or small cell lung cancer tumour tissue, aiming Augustin, Dr. Pamela Kogler in cooperating laboratories work on various to define tumour markers for monitoring of Oncological science is one of the most projects, including studies on transcription therapy and for early detection of recurrent important and dynamic areas of surgi- factors (e.g. STAT-1 in gastric cancer and disease. (Research Group Lung Cancer) cal science. The Department of Visceral, colorectal cancer), adhesion molecules Transplant and Thoracic Surgery is able to (e.g. CD44v6 in patients with non-small cell LM-02 Trial: A perioperative, single-arm, mul- offer complete surgical management of lung cancer), cytokines (e.g. in ­peritoneal ticentre, phase-II academical trial to investi- the whole spectrum of surgical malignan- carcinomatosis) and numerous other pro- gate the efficacy and safety ofpanitumumab ­ in cies from very frequent tumours such as teins (e.g. lipocalin 2 in colon cancer pa- combination with irinotecan/5-fluorouracil/­ colon cancer to very rare tumours such tients). leucovorin (FOLFIRI) in patients with previ- as peritoneal­ malignancies. Therefore, on- ously untreated, RAS-wild-type, potentially cological research at the Department of Given that the treatment of patients with resectable colorectal cancer liver metasta- Visceral, Transplant and Thoracic Surgery metastatic disease has changed significant- ses. (Research Group Colorectal Cancer) is also characterised by a broad field of ly in the last years due to the development variegated research topics according to of multimodal therapies, the Department of ASAMET Trial: A randomised, phase II, dou- the different affected organs (e.g. thyroid Visceral, Transplant and Thoracic Surgery ble-blind, placebo-controlled, multicentre, cancer, gastric cancer, lung cancer). Surgi- intends to establish this topic as a new fo- 2x2 factorial design biomarker tertiary cal science is typically dominated by clini- cus in surgical oncological science. The aim prevention trial of low dose aspirin and cal research: all patients with a malignant of the Metastasis Research Group in the fu- ­metformin in stage I-III colorectal cancer disease are registered in databases (e.g. ture will be to combine clinical and experi­ patients. (Research Group Colorectal Can- Austrian HIPEC Registry) to allow periodic mental scientific projects in order to im- cer) retrospective and prospective analyses. The prove understanding of metastatic disease Single centre prospective analysis of can- ongoing surveillance of oncological patients and treatment of patients with metastases. cer-associated cytokines in serum and also enables the Department to participate The following list of different exemplary ­peritoneal fluid of patients undergoing cy- in important national (e.g. ABCSG 16/ clinical and experimental studies displays toreductive surgery (CRS) and hyperther- SALSA Study and ABCSG 26/SOLE Study the broad spectrum of oncological research mic intraperitoneal chemotherapy (HIPEC) on extended endocrine therapy in breast at the Department of Visceral, Transplant for peritoneal surface malignancies as a po- cancer patients) and international studies and Thoracic Surgery according to the pri- tential tool for perioperative therapy moni-

Research Report 2016 Medical University of Innsbruck 83 Center of Operative Medicine

solutions for their effect on preventing I/R injury on individual tissues of a vascular- ised composite isograft. In summary, limit- ing cold ischemia time below 6 hours was observed to be the most significant factor to reduce tissue damage in VCA. Our data indicate that preservation solutions in gen- eral seem to have little impact to avoid tis- sue damage in a vascularised composite ­allograft. Interestingly, histomorphologic signs of regeneration were also observed in skeletal muscle, the tissue being affect- ed most of all in a vascularised composite graft. These observations give rise that ischemic tissue (muscle) damage in VCA might be reversible to a certain extent. However, novel strategies to attenuate IR injury in VCA are urgently needed.

In this context, the analysis of the im- munomodulatory properties of tetra­ hydrobiopterin, a naturally occurring potent antioxidative agent structurally related to Fig. 3: Real-time live confocal imaging of the cortical region of a glomerulus of a kidney. Fol- the vitamin’s folate and riboflavin is en- lowing left renal ischemia and reperfusion fine needle biopsies of murine kidneys were tak- tertained in a dedicated research track. en and incubated with the live stains Syto 16 (green), propidium iodide (PI; red) and wheat In addition to its antioxidative properties, germ agglutinin (WGA, blue), thereby staining all the nuclei, the nuclei of the dead cells and tetra­hydrobiopterin is also known as an the tissue morphology. Images were acquired with a 40x water immersion objective. One essential co-factor for a set of 8 different representative example is shown consisting of a z-stack of 25 planes with a spacing of 1 μm. enzymes, including the three nitric oxide synthase (NOS) isoforms (neuronal, en- dothelial, and inducible). We could show in toring. (Research Group Peritoneal Carcino- transplantation. The assessment of tissue a pancreas transplantation model in mice matosis) damage is performed by morphological that treating the donor with exogenous analysis including life confocal fluorescence tetrahydro­biopterin could effectively pre- Research Focus Ischemia-Reperfusion microscopy, histopathology and immuno- vent lethal I/R injury in the transplanted Injury histochemistry, electron microscopy, and recipient [1,2]. Leader: ao. Univ.-Prof. Dr. Stefan Schneeberger, biomolecular methods including western Assoz.-Prof. Priv.-Doz. Dr. Manuel Maglione, blots, enzyme activity assays, RTqPCR, pro- In a clinically more relevant model, the Ass.-Prof. Dr. Rupert Oberhuber teomics and gene chip analysis. same treatment regimen was also able to Solid organ transplantation has become the prevent lethal I/R injury in a brain death routine therapy for end-stage organ failure While the phenotype of I/R injury has mouse model. Recently, we could demon- and advancements in surgery, preservation been quite well established in solid organ strate in an aortic transplantation model techniques, immunosuppressive and an- transplantation, no such detailed analysis the crucial role of severe I/R injury in in- ti-infection therapy have helped to reach a is available for transplantation of vascular- ducing transplant vasculopathy and the 90% graft survival rate in liver, kidney and ised composite tissue allografts such as the role of tetrahydrobiopterin in preventing it. pancreas transplantation. hand or the face. While this field is relatively The two constitutive nitric oxide synthase new, in the past 15 years vascularised com- isoforms (endothelial and neuronal) were Currently, not only organ shortage and late posite tissue allotransplantation (VCA) has identified as the target for tetrahydrobiop- allograft loss but also the complex and con- become a rapidly advancing field with more terin treatment in the prevention of both suming logistics represent remaining major than 100 hand/forearm transplantations I/R injury and the subsequent transplant hurdles to further enhancing the success and 20 face transplantations carried out vasculopathy. Based on the observation that of solid organ transplantation. Limiting is- in transplant centres all over the world. We tetrahydrobiopterin prevents acute rejec- chemia/reperfusion (I/R) injury may help to have recently established the first in-depth tion in a heart transplantation model inde- increase the organ pool, limit short and long analysis of the tissue damage induced by pendently of nitric oxide synthase activity, term graft damage and ease the burden of I/R injury in rodent models. Employing the focus of future studies will also be on the emergency of the transplant procedure. electron microscopy, confocal microscopy a possible immunomodulatory role of other Hence the focus of both clinical and experi- and molecular analysis of tissue-infiltrating tetra­hydrobiopterin-dependent enzymes. mental research efforts at our institution is inflammatory cells and markers for tissue Current projects in this field focus on (1) to gain a better understanding and to find damage, we have identified the injury to in- ­simvastatin, which is hypothesised to pre- a way to prevent and ameliorate I/R injury. dividual tissues as well as the architecture vent I/R injury and transplant ­vasculopathy Clinical trials and in vitro studies are ac- of the graft. Furthermore, we have tested by a tetrahydrobiopterin-mediated process, companied by rodent models for organ established as well as novel preservation and on the immunomodulatory role of the

84 Research Report 2016 Medical University of Innsbruck Visceral, Transplant and Thoracic Surgery

tetrahydrobiopterin-dependent enzyme mor necrosis factor-α, interleukin [IL]-1β, of this concept is to enhance recovery and tryptophan hydroxylase (TPH-1). IL-6, IL-10, IFNgamma, IL-4, IL-2, Rantes allow bowel reconstruction in a second-look (CCL5), Mip1a (CCL3), IP10 (CXCL-10), operation. 1. Cardini B, Watschinger K, Hermann TGFbeta, MCP1(CCL2)) is performed em- M, Obrist P, Oberhuber R, Brandacher ploying real-time polymerase chain reac- At present we are performing a prospective G, et al. Crucial Role for Neuronal Nitric tion (PCR). All nuclei are stained with Syto randomised study on the surgical treatment Oxide Synthase in Early Microcirculatory 16. To discriminate between live and dead of patients with colonic perforation and Derangement and Recipient Survival cells propidium iodide (PI) staining. In order peritonitis, treating with a damage control following Murine Pancreas Transplantation. to visualise tissue morphology wheat germ strategy and application of abdominal vac- PLoS One. 2014;9(11):e112570. doi: agglutin (WGA) in will be added as a third uum therapy. 10.1371/journal.pone.0112570. PubMed stain. Cytokine expression and confocal mi- PMID: 25389974; PubMed Central PMCID: croscopy readouts may eventually help to In collaboration with the World society of PMCPMC4229216. the true quality and suitability of organs for emergency surgery (WSES) indication and transplantation. strategies for open abdomen treatment 2. Prevention of lethal murine pancreas with negative pressure in abdominal sep- ischemia reperfusion injury is specific Our aim is to establish a rapid assessment sis and a strategy for optimal antimicrobial for tetrahydrobiopterin. Maglione M, tool of donor liver quality and investigate its therapy were elaborated and published: Cardini B, Oberhuber R, Watschinger predictive value for the clinical use. Based • Antimicrobials: a global alliance for opti- K, Jenny M, Gostner J, et al. Transpl on our experimental data we propose a mising their rational use in intra-abdom- Int. 2012;25(10):1084-95. doi: prospective clinical trial combining live inal infections (AGORA). Sartelli M et al. 10.1111/j.1432-2277.2012.01530.x. confocal real-time analysis, cytokine ex- World J Emerg Surg. (2016) PubMed PMID: 22805419. pression profiling, as a new clinical tool for • The role of the open abdomen procedure the ­assessment of graft quality in deceased in managing severe abdominal sepsis: 3. Treatment with tetrahydrobiopterin donor liver transplantation. WSES position paper. Sartelli M et al. overcomes brain death-associated injury in World J Emerg Surg. (2015) a murine model of pancreas transplantation In summary, significant progress in the im- As ERAS concepts have changed in favour Oberhuber R, Ritschl P, Fabritius C, Nguyen mediate diagnosis of organ quality and I/R of preoperative bowel preparation and AV, Hermann M, Obrist P, Werner ER, injury has been achieved and is currently oral antibiotics, a new focus will be ad- Maglione M, Flörchinger B, Ebner S, Resch implemented in clinical trials. Since the dressed on the feasibility and side effects T, Pratschke J, Kotsch K. technological innovation of machine per- of bowel preparation and preoperative oral Am J Transplant. 2015 Nov;15(11):2865- fusion is being introduced at our centre, antibiotics, e.g. selection of resistant bac- 76. doi: 10.1111/ajt.13364 further and significant advancements can teria, change in the microbial flora, the be expected. This development, combined ­microbiome and postoperative intestinal 4. Oberhuber R, Riede G, Cardini B, with the prospect to develop a meaningful function. Bernhard D, Messner B, Watschinger K, prophylaxis and treatment of I/R injury may et al. Impaired Endothelial Nitric Oxide result in significant amelioration of organ Daniel Swarovski Research Laboratory Synthase Homodimer Formation Triggers damage in the process of transplantation Development of Transplant Vasculopathy - but also allow for significant prolongation of The Daniel Swarovski Research Laboratory Insights from a Murine Aortic Transplantation organ preservation, thereby lifting the bur- (DSL) associated with the Department of Model. Oberhuber R, Riede G, Cardini den of high-urgency surgical procedures. Visceral, Transplant and Thoracic Surgery B, Bernhard D, Messner B, Watschinger (VTT, Director: Univ.Prof. Dr. med. Dietmar K, et al. Sci Rep. 2016;6:37917. Epub Research Focus Sepsis Öfner-Velano) was established to add to 2016/11/24. doi: 10.1038/srep37917. Leader: Priv.-Doz. Dr. Reinhold Kafka-Ritsch the challenging and successful solid organ PubMed PMID: 27883078; PubMed Central The research on abdominal sepsis is inte- transplantation program initiated by Prof. PMCID: PMCPMC5121662. grated into the clinical routine of the depart- Raimund Margreiter, an equally ambitious ment; the main focus is on the development research focus. Both basic researchers and 5. Brandacher G, Maglione M, Schneeberger of new strategies for the treatment of ab- clinical research groups carry out scientific S, Obrist P, Thoeni G, Wrulich OA, et al. dominal sepsis. The ongoing prospective projects at the DSL, which provides a broad Tetrahydrobiopterin compounds prolong randomised study is administered by our range of methodological platforms in the ar- allograft survival independently of their study coordination office. eas of molecular and cellular biology, imag- effect on nitric oxide synthase activity. Abdominal sepsis with generalised perito- ing, immune phenotyping and small animal Transplantation. 2006;81(4):583-9. nitis is a life-threatening condition requiring surgery. PubMed PMID: 4. immediate surgical intervention. Despite Apart from the group of Jakob Troppmair, intervention, a high percentage of these the DSL harbours groups headed by clinical In order to address the suitable of organs patients develop severe septic shock with fellows, in particular a.o. Univ. Prof. Dr. Ste- for transplantation from older donors and multi-organ dysfunction. At the time of fan Schneeberger and Assoz. Prof. PD Dr. extended criteria donors (ECD) assessment emergency laparotomy, patient recovery is Manuel Maglione, who carry out research of kidney and liver graft cell viability and uncertain and stabilisation of the patient in projects in the area of IRI and composite inflammation during organ preservation is the intensive care unit is recommended. We tissue allotransplantation (CTA) in close col- to have prognostic value in addition and have developed a damage control concept laboration with the other members of the beyond the established clinical parameters. using abdominal vacuum therapy to treat lab. Moreover, the group of a.o. Univ. Prof. Expression of cytokines, e.g. (CXCL-1, tu- patients’ abdominal sepsis. The primary aim Dr. Erich Gnaiger focuses on the develop-

Research Report 2016 Medical University of Innsbruck 85 Center of Operative Medicine

suppressor genes have been identified and catalytically active compounds have been targeted by small molecular weight com- pounds. Success has been varying and de- velopment of resistance continues to be a problem. Alternative target are currently sought in the metabolic alterations, which allow tumour cells to adapt to increasing and changing needs. Driving forces behind the metabolic switch are changes in the tumour microenvironment, oncogenic sig- nalling pathways and mutations affecting in- trinsic compounds of metabolic pathways. Less researched are changes in the produc- tion of ROS, which usually appears to be in- creased in tumours, while there may also be exemptions, e.g. melanoma. Conceptually, the current understanding is that despite the high ROS phenotype of tumours, they still are exquisitely sensitive to a further in- Fig. 3: Scheme of pathways regulating p66Shc activation based on our recent findings. Our crease of ROS, which is triggered by many data also suggest that phosphorylation of S36 by JNK1/2 primes p66Shc for subsequent drugs used in cancer treatment, for exam- phosphorylation by PKCβ ple. Also, lowering ROS levels in tumours may negatively affect tumour survival. Our ongoing research aims at understanding ment and implementation of methods for idoreductase p66Shc. p66Shc ablation has how oncogenic signalling pathways regulate the high-resolution respirometry and is an been shown to prevent many disease con- ROS levels in tumours and how this knowl- important collaboration partner in many na- ditions linked to oxidative stress, including edge may be exploited to design therapeu- tional and international research projects. IRI, while not negatively affecting normal tic approaches for the modulation of intra- development or postnatal life. p66Shc is cellular ROS levels to induce tumour cell Preventing ischemia-reperfusion injury normally located in the cytoplasm and acti- death. The focus is on mechanisms, which (IRI) vation is thought to require phosphorylation we also study in the setting of IRI. In par- Cessation of blood flow during the trans- on serine 36 by PKCß, which is essential ticular, p66Shc is overexpressed in many plantation of solid organs (ischemia) and for mitochondrial import and oxidation of tumors and has been shown to be neces- subsequent reperfusion are potent triggers cytochrome c resulting in the production sary for the drug-induced killing of prostate for the impairment of organ function. Para- of H2O2. Our initial experiments suggested cancer cells. doxically it is the burst in the production of that phosphorylation regulation of p66Shc reactive oxygen species (ROS) during early activation is far more complex and that Regulation of Tumour Growth by reperfusion, which triggers inflammatory PKCß is not the kinase involved in S36 Protein-Protein interactions processes and the activation of the innate phosphorylation. A particular focus was on Cell signalling pathways comprise of addi- immune system and thus is most critical for mitogen-activated protein kinases (MAPKs). tional proteins as well as the core signalling the development of IRI. Clinically, antioxi- This group of kinases gets activated dur- molecules, which are essential for proper dants have proven inefficient in the preven- ing early reperfusion and we have already signal propagation and signal delivery. In tion or treatment of IRI. To this end, we have shown previously that signalling through the search for alternative approaches to begun to study means to control excessive RAF-MEK-ERK prevented excessive ROS overcome treatment resistance to kinase ROS production during early reperfusion. production, mitochondrial Ca2+ overload inhibitors, targeting the interaction of sig- We initially identified signalling pathways and cell death. A pro-oxidant function we nalling proteins with their scaffold proteins, activated at the earliest time points during could demonstrate for signalling through for example, may provide novel therapeutic reperfusion and then addressed their con- p38-MK2. Since no inhibitors of p66Shc are approaches. In our work we are targeting tribution to the development of IRI with a currently available, we reasoned that under- the interaction of RAF kinases with the pro- particular focus on ROS production, using standing the complex regulation of p66Shc teins RKIP and BAG-1. RKIP may negatively in vitro and in vivo (organ clamping, organ activation will provide targets for therapeut­ interfere with the signal propagation from transplantation in rodents) approaches. ic interference with the development of RAF kinases to their downstream target Another important question relates to the ­oxidative damage. MEK1/2. Not surprisingly therefore RKIP is source of ROS. frequently lost in tumours. In a longstand- Preventing malignant Transformation ing collaboration with Assoz.-Prof. Priv.-Doz. In the past, mitochondrial and non-mito- by oncogenic BRAF Dr. Armin Zebisch and Univ. Prof. Dr. Heinz chondrial sources (in particular NADPH-de- Recent decades have seen a rapid develop- Sill from the Medical University of Graz, we pendent oxidases, NOX) have been im- ment in the understanding of the genetic al- have begun to analyse the contribution of plicated, mainly through genetic studies, terations contributing to tumour formation RKIP to malignant transformation and have in the development of IRI. To this end, we and of the pathways and processes regulat- recently addressed the role of miRNAs in have begun to focus our research on the ox- ed by them. Many oncogenes and tumour the regulation of RKIP expression. We have

86 Research Report 2016 Medical University of Innsbruck Visceral, Transplant and Thoracic Surgery

previously identified BAG-1 as the binding Selected Publications Collaborations • Peter J. Friend, Rutger Ploegh, University of Oxford, Nuffield partner of RAF kinases, which may be in- Impaired Endothelial Nitric Oxide Synthase Homodimer Department of Surgical Sciences, Oxford, UK volved in cell survival. Formation Triggers Development of Transplant Vasculopathy • Keith M., Channon University of Oxford, Division of - Insights from a Murine Aortic Transplantation Model Cardiovascular Medicine, Radcliffe Department of Medicine, Oberhuber, Rupert, Riede, Gregor, Cardini, Benno, Bernhard, Wellcome Trust Centre for Human Genetics, Oxford, UK David, Messner, Barbara, Watschinger, Katrin, Steger, Christina, • Darius Mirza, University Hospitals Birmingham, Liver and Recent Major Achievements Brandacher, Gerald, Pratschke, Johann, Golderer, Georg, Werner, Hepato-Pancreato-Biliary (HPB) Unit, Birmingham, UK Ernst R., Maglione, Manuel, Identification of signalling pathways • Gerald Brandacher, Andrew WP Lee, Johns Hopkins Medical SCIENTIFIC REPORTS: 2016; 6: S. 37917 ­regulating p66Shc activation: In our work, University, Department of Plastic Surgery, Baltimore, USA • University of Pittsburgh Medical Center (UPMC), Division of we identified key phosphorylation steps and cJun N-terminal kinase (JNK) phosphorylation of serine 36 is Plastic and Reconstructive Surgery, Department of Surgery, critical for p66Shc activation Pittsburgh, USA kinases involved in the activation of p66Shc Khalid, Sana, Drasche, Astrid, Thurner, Marco, Hermann, Martin, • Hans Schlitt, Universitätsklinikum Regensburg, Klinik und Ashraf, Muhammad Imtiaz, Fresser, Friedrich, Baier, Gottfried, providing the basis for future therapeutic Poliklinik für Chirurgie, Regensburg, GER Kremser, Leopold, Lindner, Herbert, Troppmair, Jakob, • Kurt Werner Schmid, Universitätsklinikum Essen, Institut für testing in animal models. PKCβ had already SCIENTIFIC REPORTS: 2016; 6: S. 20930 Pathologie, Essen, GER been implicated in the phosphorylation of • Emmanuel Morelon, Hospices Civils de Lyon, Hospital Edouard serine 36 on p66Shc, which is necessary Treatment With Tetrahydrobiopterin Overcomes Brain Herriot - Transplantation, néphrologie et immunologie, Lyon, FR Death-Associated Injury in a Murine Model of Pancreas • Emmanouil S. Papadakis, Graham Packham, Ramsey Cutress, for mitochondrial import and pro-oxidant Transplantation Cancer Research UK Centre, Cancer Sciences Division, Oberhuber, R., Ritschl, P., Fabritius, C., Nguyen, A. -V., Hermann, University of Southampton Faculty of Medicine, Southampton function. Re-evaluation of these findings M., Obrist, P., Werner, E. R., Maglione, M., Floerchinger, B., Ebner, General Hospital, Southampton, United Kingdom S., Resch, T., Pratschke, J., Kotsch, K., could confirm the requirement for PKCβ but • Andrew Cato, Karlsruhe Institute of Technology, Institute of AMERICAN JOURNAL OF TRANSPLANTATION: 2015; 15: S. 2865- Photon and Synchrotron Radiation, Eggenstein-Leopoldshafen, not for the phosphorylation of S36. In our 2876 Germany work, we identified the kinases responsible • Armin Zebisch, Heinz Sill, Division of Hematology, Medical for S36 phosphorylation and mapped the CD11c(+) Dendritic Cells Accelerate the Rejection of Older University of Graz, Graz, Austria Cardiac Transplants via Interleukin-17A • Stefan Wiese, Faculty for Biology and Biotechnology, Group Oberhuber, Rupert, Heinbokel, Timm, Biefer, Hector Rodriguez sites targeted by PKCβ. Use of these sites for Molecular Cell Biology, Ruhr University Bochum, Bochum, Cetina, Boenisch, Olaf, Hock, Karin, Bronson, Roderick T., Wilhelm, Germany for the regulation of p66Shc activation was Markus J., Iwakura, Yoichiro, Edtinger, Karoline, Uehara, Hirofumi, • Eduard Stefan, Institute of Biochemistry and Center for Quante, Markus, Voskuil, Floris, Krenzien, Felix, Slegtenhorst, confirmed by genetic means and MS. Molecular Biosciences, University of Innsbruck, Innsbruck, Bendix, Abdi, Reza, Pratschke, Johann, Elkhal, Abdallah, Tullius, Austria Stefan G., Regulation of oncogenic RAF signaling CIRCULATION: 2015; 132: S. 122-131 : RKIP has been by interacting proteins Receptor for hyaluronic acid-mediated motility (RHAMM, positioned between RAF and MEK and CD168) expression is prognostically important in both nodal negative and nodal positive large cell lung cancer RKIP loss, which is frequently observed in Augustin, Florian, Fiegl, Michael, Schmid, Thomas, Pomme, tumours and may contribute to the hyper-­ Geoffrey, Sterlacci, William, Tzankov, Alexandar, activation of ERK1/2. The reasons for RKIP JOURNAL OF CLINICAL PATHOLOGY: 2015; 68: S. 368-373 loss are largely unknown. In recent collabo­ The role of lipocalin-2 in liver regeneration Kienzl-Wagner, Katrin, Moschen, Alexander R., Geiger, Sabine, rative work, we have identified miR-23a as Bichler, Alexandra, Aigner, Felix, Brandacher, Gerald, Pratschke, a negative regulator of RKIP expression in Johann, Tilg, Herbert, AML and have provided data that suggest LIVER INTERNATIONAL: 2015; 35: S. 1195-1202 the importance of this observation beyond Novel Insights into the PKC-dependent Regulation of the Oxidoreductase p66Shc this tumour entity. Haller, Martina, Khalid, Sana, Kremser, Leopold, Fresser, Friedrich, Furlan, Tobias, Hermann, Martin, Guenther, Julia, Drasche, Astrid, Leitges, Michael, Giorgio, Marco, Baier, Gottfried, Lindner, Herbert, Troppmair, Jakob, JOURNAL OF BIOLOGICAL CHEMISTRY: 2016; 291: S. 23557- 23568

Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP Hatzl, Stefan, Geiger, Olivia, Kuepper, Maja Kim, Caraffini, Veronica, Seime, Till, Furlan, Tobias, Nussbaumer, Erika, Wieser, Rotraud, Pichler, Martin, Scheideler, Marcel, Nowek, Katarzyna, Jongen-Lavrencic, Mojca, Quehenberger, Franz, Woelfler, Albert, Troppmair, Jakob, Sill, Heinz, Zebisch, Armin, CANCER RESEARCH: 2016; 76: S. 3644-3654

A combination of trastuzumab and BAG-1 inhibition synergistically targets HER2 positive breast cancer cells Papadakis, Emmanouil, Robson, Natalia, Yeomans, Alison, Bailey, Sarah, Laversin, Stephanie, Beers, Stephen, Sayan, A., Ashton- Key, Margaret, Schwaiger, Stefan, Stuppner, Hermann, Troppmair, Jakob, Packham, Graham, Cutress, Ramsey, ONCOTARGET: 2016; 7: S. 18851-18864 Selected Funding • DK Molecular Cell Biology and Oncology (MCBO), FWF W1101

Research Report 2016 Medical University of Innsbruck 87 Center of Operative Medicine Cardiac Surgery

focus on surgical outcome, quality control, energy shockwaves modulate inflamma- and development of modern cardiosurgical tion and thereby create the environment strategies combined with patient well-being for regeneration. In ischemic myocardium and advanced training of surgeons and sur- this mainly means neovascularization (new gical staff. blood vessel formation). Both, angiogene- sis (sprouting of existing vessels) as well as The research strategy of the University vasculogenesis (de novo vessel formation Clinic for Cardiac Surgery is split into two by recruitment of endothelial progenitor main concepts and generally covers central cells) can be found. aspects of cardiovascular surgery, medi- cine, and biology. With application-oriented During the last years we developed shock- projects we seek i) to improve myocardial wave therapy for application directly to the protection and regeneration after infarc- myocardium and have been able to show tion, ii) to understand the pathophysiology promising results by means of functional of heart valve disease, and iii) to develop heart improvement. Our current research new tests allowing for the early diagnosis aims to fully elucidate the working mecha- of and screening for thoracic aortic aneu- nism in order to support broad clinical use rysms in blood samples. Several of these of shockwave therapy for patients suffering Director: studies are done in cooperation with com- from myocardial infarction. Univ.-Prof. Dr. Michael Grimm panies. With basic science projects we seek to define fundamental molecular and Innate Immunity Toll-like receptors (TLR) Contact: cellular pathophysiological processes lead- represent a highly conserved part of the Anichstraße 35 ing to cardiovascular diseases, allowing for innate immune system. They have been 6020 Innsbruck a later application in diagnosis, prevention described to play numerous roles in physio- and treatment of patients. Techniques cover logical and pathological mechanisms. TLR3 [email protected] areas of analytical chemistry, molecular and and TLR4 closely interact with each other as Phone: +43 512 504 22501 cellular biology, primary human cell culture, they share a common signalling pathway via Fax: +43 512 504 22502 tissue and organ culture studies, as well as TRIF (TIR-domain-containing adapter-induc- www.i-med.ac.at/carelab patient-based studies. ing interferon-β). Our aim is to elucidate the role of these two receptors in the heart. Toll- Research like receptor 3 binds double-stranded RNA Research Branch (ÖSTAT Classifications) or nucleic acids in general, being thereby Myocardial Regeneration by Shockwave responsible to recognize viral infections. 304007, 302048, 302083, Therapy TLR4 usually detects lipopolysaccharides 302018, 302026 The main aim of our research in this field from Gram-negative bacteria. Recently, we is to regenerate infarcted myocardium, re- found that TLR3 signalling induces regener- Keywords spectively the hibernating myocardium. We ation to myocardium as well as acting pro- use LAD ligation models–chronic, acute and tective in spinal cord ischemia. In parallel to Myocardial infarction, heart valve disease, ischemia/reperfusion–in different species. this effect, TLR4 gets down-regulated. angiogenesis, shockwave therapy, gene Besides regeneration we work on the induc- therapy tion of angiogenesis as well as vasculogen- Discovering the Pathophysiology of esis. Heart Valve Calcification Research Focus Calcific aortic valve is the most prevalent In addition to our in-vivo models we use sev- heart valve pathology in the developed The aim of the cardiosurgical research eral in-vitro assays, such as the transwell laboratory is to perform highest quality ex- migration assay and as an ex-vivo model the perimental research with a clear focus on aortic ring assay. translational aspects. Our projects shall broaden the knowledge in pathophysiology Shockwaves are sound-pressure waves that of the heart in order to develop new treat- occur in nature whenever there is a sudden ment strategies. Such new treatments are release of energy, e.g. as thunder when investigated in the experimental setting in lightning. In medicine they are used for animal models and cell cultures - not for more than 30 years in lithotripsy to disinte- publication only, but with the clear intention grate kidney stones. to establish newly developed techniques in the clinical setting for the benefit of our car- More recently they were found to have diosurgical patients regenerative effects at low energy levels. Therefore shockwaves are already routine- General Facts ly used in orthopaedics and traumatology Fig 1: Angiogenesis – vessel sprouting with- for tendon pathologies, bon non-unions or in the heart muscle in an ischemic boarder The University Clinic of cardiac surgery wound healing disturbances. Without harm- zone induced by direct cardiac shockwave acts as a modern cardiosurgical unit with ing cells or causing any other damage, low therapy in a mouse LAD ligation model.

88 Research Report 2016 Medical University of Innsbruck Cardiac Surgery

Thereby, we analyze the role of biomechan- include smoking, hypertension and athero- ics in the development of aortic valve dis- sclerosis. Despite this knowledge, it is very ease. Biomechanical strain and stress were difficult to predict which patients are more shown to play a major role in the develop- likely to develop an aortic aneurysm, as for- ment of calcific aortic valve disease, as the merly given risk factors are very common disease starts where the mechanical strain within a population. is highest. Patients who show increased strain upon the aortic valve due to bicuspid Therefore, we investigate possible patho- valves or hypertension have a significantly mechanisms behind aortic aneurysms and higher risk for the development of calcific dissections in order to develop superior aortic valve disease. diagnostic tools and treatment options to further improve patient care. For this type However, it remains unknown how the of research we mainly use animal models mechanical stimulus is translated into a from different mouse knock-out strains and pro-calcific response. In addition, our lab collect samples from our cardiosurgical pa- works aims to elucidate the interaction tients in order to investigate tissue and cel- between innate immunity and calcific aor- lular aspects of the pathology. Fig. 2: Echocardiography with the Visualson- tic valve disease. It is becoming more and ics Vevo 1100 (corefacility) of mouse aortic more evident that the innate immune sys- Selected Publications valves (upper pictures) and 3D modeling of tem and its pattern recognition receptors aortic valve leaflets from microCT pictures. play a major role in the pathogenesis of Toll-like receptor 3 signalling mediates angiogenic response upon shock wave treatment of ischaemic muscle. various cardiovascular pathologies. Howev- Holfeld J, Tepeköylü C, Reissig C, Lobenwein D, Scheller B, Kirchmair E, Kozaryn R, Albrecht-Schgoer K, Krapf C, Zins K, world and is concomitant with devastating er, its role in the development and progres- Urbschat A, Zacharowski K, Grimm M, Kirchmair R, Paulus P. consequences. A progressive stenosis of sion of calcific aortic valve disease remains CARDIOVASCULAR RESEARCH: 2016 Feb 1;109(2):331-43. doi: the aortic orifice impedes regular blood largely unknown. 10.1093/cvr/cvv272. flow during systole causing increased work- Shock Wave Treatment Protects From Neuronal load for the left ventricle. Progression of Degeneration via a Toll-Like Receptor 3 Dependent Discovering the Pathophysiology of Aor- Mechanism: Implications of a First-Ever Causal Treatment the disease can result in heart failure. The tic Aneurysm Formation for Ischemic Spinal Cord Injury. Lobenwein D, Tepeköylü C, Kozaryn R, Pechriggl EJ, Bitsche M, pathology starts as aortic valve sclerosis, Aortic diseases include a plethora of pathol- Graber M, Fritsch H, Semsroth S, Stefanova N, Paulus P, Czerny a state in which the leaflets are thickened ogies that can affect people across all age M, Grimm M, Holfeld J. JOURNAL OF THE AMERICAN HEART ASSOCIATION: 2015 Oct without significant stenosis. groups. This is ranging from genetic disor- 27;4(10):e002440. doi: 10.1161/JAHA.115.002440. ders (e.g. Marfan Syndrome, congenital ab- This stage precedes aortic valve stenosis, normalities) which are more commonly seen Alteration of inflammatory response by shock wave therapy leads to reduced calcification of decellularized aortic where measurable obstruction of the out- in younger individuals, to aortic aneurysms xenografts in mice. Tepeköylü C, Lobenwein D, Blunder S, Kozaryn R, Dietl M, Ritschl P, flow tract and significant gradients above and aortic dissections, which usually affect Pechriggl EJ, Blumer MJ, Bitsche M, Schistek R, Kotsch K, Fritsch are observed. Described risk factors for aged patients. Depending on the severity of H, Grimm M, Holfeld J. EUROPEAN JOURNAL OF CARDIOTHORACIC SURGERY: 2015 calcific aortic valve disease include older the disease, most of the patients suffering Mar;47(3):e80-90. doi: 10.1093/ejcts/ezu428. age, male sex, hypertension, smoking, hy- from this aortic pathology will need surgical percholesterolemia and diabetes. repair. Moreover, aortic pathologies such as Core Facilities aortic dissection or traumatic aortic injury On a cellular level it has been shown that often are acute life-threatening conditions Corefacility for small animal echocardiography – Visualsonics valvular interstitial cells, the predominant that need immediate surgical repair. Very Vevo 1100 cell type in heart valves, can switch to an little is known about the mechanisms that osteoblastic phenotype upon triggers like lead to the development of aortic aneu- inflammation, oxidative stress, renin-angio- rysms or dissections. Known risk factors tensin signalling and cause progressive cal- cification. In a healthy valve, this cell type is responsible for maintain the homeostasis of the valve. However, it is poorly understood which factors contribute to the phenotype switch of valvular interstitial cells. Better knowledge of the calcification process could reveal new targets for the detection of early stage valve disease and for thera- peutic intervention. Our group aims to iden- tify novel pathomechanisms of calcific aor- tic valve disease. We therefore established numerous in vitro models using cells isolat- ed from human aortic valves obtained from cardiosurgical patients to mimic calcifica- tion. In addition, we have established vari- Fig. 3: The pathomechanism of aortic aneurysm formation is one of the main focus of the ous murine in vivo models of valve disease. cardiosurgical research laboratory

Research Report 2016 Medical University of Innsbruck 89 Center of Operative Medicine Vascular Surgery

Research Branch (ÖSTAT Classification) Therefore a mouse model was established to investigate the protective effect of 302018, 302052, 302063, tetrahydrobiopterin. 302070, 302077 A positive family history for atherosclerotic Keywords diseases delineates a relevant risk for indi- viduals to also suffer from cardiovascular Peripheral arterial disease, cerebrovascular complications. This risk is especially high disease, aortic aneurysm, aortic dissection, if cardiovascular complications among rel- vascular trauma, venous disease, arterial atives occurred in young ages. We are plan- and venous thrombosis, atherosclerosis ning to participate in the EVA (Early Vascular Aging) study (in cooperation with Prof. Dr. U. Research Focus Kiechl-Kohlendorfer and PD. M. Knoflach).

• Treatment of patients with asymptomatic Research stenosis of the internal carotid artery (comparing the treatment techniques Bone Marrow Derived Stem Cell carotid artery stenting vs. carotid PD Dr. Rantner Director: endarterectomy in the ACST-2) Patients with critical limb ischemia frequent- Univ.-Prof. Dr. Gustav Fraedrich • Treatment and follow up of patients with ly lack the opportunity for manual revascu- acute and chronic Type B-Dissection larisation using surgical bypass or endovas- Contact: • Bone marrow derived stem cells in the cular methods to improve limb perfusion. Anichstraße 35 treatment of patients with critical limb This might be due to repetitive surgical and 6020 Innsbruck ischemia endovascular treatments which failed over • Risk factor assessment in patients with time or due to the absence of viable blood [email protected] peripheral arterial disease and investiga- vessels in the calf. This is especially true for Phone: +43 512 504 22587 tion of cardiovascular complication rates patients with additional diabetes mellitus. Fax: +43 512 504 22559 in a long term follow up A relevant number of those patients suffer http://gefaesschirurgie.tirol-kliniken.at • Vascular trauma including early and long- from major amputation. The intra-arterial term outcome, functional analysis and application of bone marrow derived stem quality of life (focusing on upper extremity cells (specially treated as Rexmyelocel-T) is injury) supposed to improve the blood flow to pre- • Neuroprotection in spinal cord ischemia viously ischaemic tissue by angiogenesis. (in a mouse model) To follow this research question we partici- • Screening of families with members with pate in a multicentre trial. Study kick off will premature coronary artery disease, pre- be in June this year. mature cerebrovascular disease

General Facts

This summary of scientific work at the Department of Vascular Surgery shall be seen as supplement and extension of the scientific report from the years 2013/2014.

In addition to the previously elaborated scientific aims of our research unit we meanwhile stepped into the topic of stem cells in the treatment of patients with critical limb ischaemia.

One of our major research interests still lies in the treatment of patients with stenosis of the internal carotid artery (ICA). The two competing treatment techniques (carotid endarterectomy and carotid artery stenting) are still being compared to one another to find the ideal treatment technique for each individual patient.

Neuroprotection in spinal cord ischaemia Fig. 1: Sonography and intraoperative view is a relevant topic in vascular surgery. of a symptomatic carotid stenosis

90 Research Report 2016 Medical University of Innsbruck Vascular Surgery

Carotid Artery Disease Assessment of a Positive Family outcome during the long term. This is par- PD Dr. Rantner History for Cardiovascular and ticularly important in the upper limb. Our We already put a lot of effort into the ques- Cerebrovascular Disease research group analysed factors associat- tion of the optimal timing of treatment in PD Dr. Rantner ed with poor functional outcome, and used patients with symptomatic ICA stenosis. First degree relatives of patients with pre- standardised questionnaires to report on Results from the CSTC (Carotid Stenosis mature coronary artery disease (CAD) car- long-term quality of life, limb function and Trialists’ Collaboration) are currently under ry a substantially higher risk for CAD. It is cold intolerance, which is another common revision in “Stroke”. meanwhile well known that a positive family finding in this setting. Additionally we meanwhile participate in history of disease is a relevant risk factor the ACST-2 (Asymptomatic Carotid Surgery for incidence and prevalence of coronary Trial). In this international multicentre tri- heart disease and stroke. This correlation Selected Publications al patients with asymptomatic stenosis of remains significant even after the correc- Long-term Clinical Outcome and Functional Status After the internal carotid artery are randomized tion for measured familial risk factors such Arterial Reconstruction in Upper Extremity Injury Frech, A., Pellegrini, L., Fraedrich, G., Goebel, G., Klocker, J., towards carotid endarterectomy or carotid as cholesterol, hypertension, obesity and EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR artery stenting. With this trial the safety diabetes. The assessment of a detailed SURGERY: 2016; 52: S. 119-123 and efficacy of carotid artery stenting in medical family history questionnaire and Association between age and risk of stroke or death from stroke prevention will be investigated and a quantitative family risk score were pub- carotid endarterectomy and carotid stenting: a meta- compared to carotid endarterectomy. We lished already in 1986. These additional analysis of pooled patient data from four randomised trials Howard, George, Roubin, Gary S., Jansen, Olav, Hendrikse, Jeroen, entered the trial in November 2015 and in- assessment tools helped to improve the Halliday, Alison, Fraedrich, Gustav, Eckstein, Hans-Henning, cluded 21 patients so far. precision of family history as a predictor of Calvet, David, Bulbulia, Richard, Bonati, Leo H., Becquemin, future disease. Jean-Pierre, Algra, Ale, Brown, Martin M., Ringleb, Peter A., Brott, Thomas G., Mas, Jean-Louis, Carotid Stenting Trialists', Neuroprotection in Spinal Cord We plan to participate in the EVA study to LANCET: 2016; 387: S. 1305-1311 Ischemia assess family histories concerning prema- Very Urgent Carotid Endarterectomy Does Not Increase the Dr. Gratl (MUI Start), Dr. Gummerer ture atherosclerotic complications. All first Procedural Risk Neurological complications such as degree relatives of patients with premature Rantner, B., Schmidauer, C., Knoflach, M., Fraedrich, G., paraplegia as a result of spinal cord ischemia coronary artery disease and premature cer- EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY: 2015; 49: S. 129-136 (SCI) during thoracic or thoracoabdominal ebrovascular disease are invited to partici- aortic aneurysm repair are serious pate in vascular examinations (intima media Functional Assessment and Evaluation of Outcome After Endovascular Therapy With Coverage of the Left Subclavian complications. Tetrahydrobiopterin (BH4) thickness, ABI, aortic stiffness,…) to assess Artery in Case of Blunt Thoracic Aortic Injury. is one of five essential cofactors of the the individual cardiovascular risk. This pro- Gombert, Alexander, Kotelis, Drosos, Griepenkerl, Ulrike M., NOS and is crucial in the production of NO. ject is planned to be carried out as a PhD Fraedrich, Gustav, Klocker, Josef, Glodny, Bernhard, Jacobs, Michael J., Greiner, Andreas, Grommes, Jochen, It has been shown to efficiently abrogate project. ANNALS OF VASCULAR SURGERY: 2016; [Epub ahead of print]: S. ischemic reperfusion in transplant surgery. Left ventricular ejection fraction is associated with prevalent We therefore established a mouse model Vascular Trauma and incident cardiovascular disease in patients with to evaluate the effect of BH4 compared to PD Dr. Klocker intermittent claudication - results from the CAVASIC Study Vitamin C and saline injection. First tests to Trauma mechanisms in our institution most Rantner, Barbara, Pohlhammer, Johannes, Stadler, Marietta, Peric, Slobodan, Hammerer-Lercher, Angelika, Klein-Weigel, Peter, identify the optimal BH4 concentrations are frequently include blunt injuries, which is in Fraedrich, Gustav, Kronenberg, Florian, Kollerits, Barbara, finished. Histopathological examinations contrast to other centres with mainly pene- ATHEROSCLEROSIS: 2015; 239: S. 428-435 and immunohistochemical evaluations are trating trauma (e.g. stab- and gunshot inju- Collaborations still missing. ries). In blunt injuries, vascular injuries are • University of Oxford, Oxford, United Kingdom (ACST-2) regularly associated with bone and nerve • Rexgenero Limited, London, United Kingdom injuries, which lead to worse functional • Univ. Prof. Dr. Andreas Greiner, Charité, Berlin, Germany

Fig. 2: The risk of stroke or death after treatment of symptomatic carotid stenoses by endarterectomy (CEA) or stenting (CAS), adopted from Rantner et al (2013).

Research Report 2016 Medical University of Innsbruck 91 Center of Operative Medicine Plastic, ­Reconstructive and Aesthetic Surgery

Research Branch (ÖSTAT Classification) major units of the Department, ie. the units for Breast/Limb/Nerve-Surgery, Congenital 106018, 106039, 302062 Deformities – Reconstructive Surgery and Wound management/healing are support- Keywords ed by the research laboratory unit headed by C.Ploner, PhD. The laboratory staff com- Adipose tissue, adipose derived stem cells, prises one Senior Postdoc, one clinical PhD wound healing, immune cells, transplanta- student, one technical assistance (BMA) tion, implants, congenital deformities, tho- and 3 clinical researchers. racic wall deformities, cytokines Research Research Focus The Impact of Fat Tissue on Wound • Physiology of fat tissue resident mesen- Healing and Tumorigenesis chymal stem cells and adipocytes and Christian Ploner (PI), Evi Morandi (PhD- their impact on wound healing. Student), Susanne Lobenwein (BMA) • Repair of congenital thoracic wall deform- Despite great advances in tissue-engineer- ities and consequences on cardiopulmo- ing of the skin, impaired wound healing still nary function and quality of life. remains one of the most serious problems Director: • Immuno-Biocompatibility of implant sur- in plastic surgery. We are primarily inter- Univ.-Prof. Dr. Gerhard Pierer faces. ested in defining mechanisms of (chronic) wound healing, especially delineating the Contact: General Facts role of the fat tissue in this complex cellu- Anichstraße 35 lar interplay. Disesteemed for many years 6020 Innsbruck VISION as tissue exclusively dedicated to energy The ISO-9001:2008 certified research unit storage, the white adipose tissue (WAT) has [email protected] of the Plastic, Reconstructive and Aesthetic become one of the most studied tissues, as Phone: +43 512 504 22731 Surgery was established in autumn 2011, recent reports uncovered its metabolic and Fax: +43 512 504 22735 enabling dedicated doctoral researches to endocrine functions in-vivo as well as its im- www.pci.or.at follow clinical goals on a sound scientific portance for the development of metabolic basis. Our vision is to apply basic research disorders, control of immune response and techniques to address clinical challenges wound healing. In addition, fat tissue har- and translate these findings into new ther- bors a high number of easily accessible, apeutic approaches. undifferentiated adipose derived stem cells (ADSC) that are presently being tested in AIMS clinical applications, including wound heal- 1. Defining the role of Adipocytes in ing approaches. However, isolated trans- wound healing of chronic wounds plantation of these cells in wound beds only The fat tissue has a great impact on phys- marginally enhanced the healing process, iological and psychological processes in and cells embedded in engineered matrices the human body. We address the question stayed entrapped and impacted on wound how cellular and secretory components healing rather by secretory action than by of the fat tissue influence the healing of proliferation or differentiation. Therefore we chronic wounds and interact with the im- initiated a project focusing on wound matrix mune system. controlled molecular processes affecting the regenerative potential of distinct cuta- 2. Surgical correction of congenital tho- neous (keratinocytes, fibroblasts) and sub- racic wall deformities and its impact cutaneous cell types (adipocytes, ADSC). on physical and physiological health One of the most important matrix compo- We address the question how surgery of nents for dermal wound healing is fibronec- Head of Research Laboratory: chest wall deformities impacts on cardi- tin, a high molecular weight glycoprotein, Christian Ploner, PhD opulmonal and psychological parameters which is recognized by specific cell surface and quality of life. proteins of the integrin family, namely inte- Contact: grin alpha 5 and alpha V. In our most recent Anichstraße 35 3. Immuno-Biocompatibility of implant publication we delineated the function of 6020 Innsbruck surfaces these integrins for ADSC physiology and The aim is to determine whether/how identified intracellular pathways associated [email protected] implant surfaces impact on the activity of with these two integrins. We now aim to ad- Phone: +43 512 504 82648 immune cells. dress these effects in other primary human Fax: +43 512 504 22735 cell types important for the wound healing STRUCTURE process, in order to gain more knowledge Three research groups equivalent to the 3 on the molecular mechanisms activated by

92 Research Report 2016 Medical University of Innsbruck Plastic, Reconstructive and Aesthetic Surgery

there is a consequent change of pulmonary want to investigate whether coating these function and quality of life in patients. In the implants with different extracellular matrix study all patients will undergo preoperative substrates prior to exposure to serum pro- and postoperative evaluation with Comput- teins alters the activity of T-cells or impact ed Tomography CT scan, pulmonary func- on monocyte/macrophage attachment. Im- tion test and cycle ergometry in an upright portantly, we also aim to define molecular and furthermore in a supine position, as mechanisms that are responsible for the well as transthoracic echocardiogram. Ad- different activation of Treg-cells, to gain fun- ditionally, all patients will fill out a pre- and damental scientific knowledge about smart postoperative standardized questionnaire surface coatings of implants. (including quality of life, patient’s satisfac- tion and physical activity) and be examined Selected Publications by a professional psychologist. We hypoth- ITGAV and ITGA5 diversely regulate proliferation and adipo- esize that our results will provide evidence genic differentiation of human adipose derived stem cells Morandi, E. M., Verstappen, R., Zwierzina, M. E., Geley, S., Pierer, that pulmonary function is related to the G., Ploner, C., Fig. 1: Live tissue staining of human white depth of the depression or protrusion and is SCIENTIFIC REPORTS: 2016; 6: S. 28889 adipose tissue imaged by use of confocal probably causal for functional deficits, and Differentiation between Acute Skin Rejection in Allotrans- plantation and T-Cell Mediated Skin Inflammation Based on microscopy [in cooperation with M. Her- might explain why repair of the defect can Gene Expression Analysis mann (Department of Anesthesiology and result in improved pulmonary function, ex- Wolfram, Dolores, Morandi, Evi M., Eberhart, Nadine, Hautz, The- resa, Hackl, Hubert, Zelger, Bettina, Riede, Gregor, Wachter, Tan- Critical Care Medicine, Medical University ercise tolerance and quality of life. ja, Dubrac, Sandrine, Ploner, Christian, Pierer, Gerhard, Schnee- Innsbruck)]. Adipocytes were stained with berger, Stefan, BIOMED RESEARCH INTERNATIONAL: 2015; S. 259160 BODIPY 493 (green), nuclei with Höchst Optimization of Silicone Breast Complications Related to Pectus Carinatum Correction: 33342 (blue), and cell-membranes (glyco- Implants by Surface-Dependent Lessons Learned from 15 Years' Experience. Management proteins) with Wheat Germ Agglutinin Al- Immunoregulation and Literature Review Del Frari, Barbara, Sigl, Stephan, Schwabegger, Anton H., exa-Fluor-647 (red). Dolores Wolfram (PI), Giuseppe Cappellano PLASTIC AND RECONSTRUCTIVE SURGERY: 2016; 138: S. (Senior Postdoc) 317E-329E contact with different extracellular matrix This project aims to improve the immuno- Pectus excavatum repair from a plastic surgeon's perspec- constituents. In a second study we investi- logical biocompatibility of silicone mam- tive Schwabegger, Anton H., gate how tumor cells from distinct origins mary implants (SMIs). We investigate the ANNALS OF CARDIOTHORACIC SURGERY: 2016; 5: S. 501-512

(multiple myeloma, breast cancer, prostate effect of different silicone surfaces used in The versatility of the medial thigh lift for defect coverage in cancer or ovarian cancer) affect proximal the SMI production from different compa- the genito-perineal region Djedovic G, Del Frari B, Matiasek J, Schiltz D, Engelhardt T, Pierer mesenchymal stem cells and adipocytes. nies on T-cell activity, with specific focus on G, Rieger UM We are especially interested in the mech- regulatory T-cells (Tregs). Tregs are known Int Wound J. 2016 Aug 1. doi: 10.1111/iwj.12634. [Epub ahead anisms by which tumor cell secreted cy- key players in the initial stages of peri-SMI of print] tokines affect adipocyte differentiation and fibrosis and act immunosuppressively by Collaborations delipidation at the molecular level. We found controlling the activation of other lympho- Prof. Fiona Watt, Kings College, London, UK that cytokines secreted by tumor cells pro- cytes. Since implants after insertion are Prof. H.C. Hennies,University of Huddersfiel, Huddersfield, UK Prof. W.P.Andrew Lee, Johns Hopkins University, Baltimore, USA mote adipocyte differentiation and alter the exposed to blood, which contains proteins Prof. Gerhard Brandacher, Johns Hopkins University, Baltimore, development and maturation of lipid drop- interacting with the implant-surface, we USA lets within differentiating adipocytes. We are presently screening for those cytokines that are responsible for this effect, intend- ing to identify new molecules/pathways targeting the tumor-adipocyte interaction.

Cardiopulmonary Function after Chest Wall Deformity Surgery Barbara Del Frari (PI), Stephan Sigl (PhD- student), Anton Schwabegger (Senior PI) Pectus excavatum and carinatum are the most common types of congenital anteri- or chest wall deformities. These deformi- ties often present not only as an aesthetic disturbance but are also associated with obstructive pulmonary mechanics and ab- normal cardiac physiology. The frequency of thoracoplasties has increased due to improving experience and to modified sur- gical techniques. The aim of our prospective study is to evaluate the effect of surgical repair on the pectus excavatum and pec- tus carinatum deformity itself and whether Fig. 2: Preoperative 3D VR-CT scan of a 13-year old male with an asymmetrical funnel chest.

Research Report 2016 Medical University of Innsbruck 93 Center of Operative Medicine Trauma Surgery

ratory, a morphology and cell biology labo- Research ratory and the Core facility Micro CT. This setting supports clinical research, as wells Clinical Studies and Documentation Unit as laboratory research on macroscopic, mi- Mariette Fasser, MSc croscopic and cellular level. In recent years the focus of clinical studies in trauma surgery has no longer been lim- Clinical research in Trauma Surgery rep- ited to medical device investigations: due resents a special challenge, because of to growing experience and know-how, an its high throughput of in- and out-patients expansion to interdisciplinary projects and and its wide range of treatment modali- further aims became possible. One example ties. The main research fields are medical is the EU-funded DO-HEALTH study which ­device studies and investigator-initiated tri- is focused on Vitamin D supplementation, als which explore new treatment methods. Omega 3 intake and home exercise as Our study coordinators (“study nurses”) prophylactic measures aiding healthy aging support clinical staff in the organization (study goals: to reduce risk of falls, to im- and administration of clinical trials, ensur- prove cognitive impairment and cardiovas- ing a complete collection and archiving of cular improvement). The involvement of the data and patient follow-ups according to department in this project was a new ap- Director: the “Good Clinical Practice” guidelines and proach and opened doors for similar highly Univ.-Prof. Dr. Michael Blauth legal requirements. The clinical study cen- representative epidemiological­ projects. tre unit was certified in 2011 by the Clinical However, the main research focus contin- Contact: Research Organization “AO Foundation”. ues to be on musculoskeletal topics, with Anichstraße 35 The main collaborators are the Clinical Trial investigations of trauma related research 6020 Innsbruck Center of the Medical University Innsbruck questions e.g. fixation of distalradius ­ frac- and the AO foundation/Trauma. tures, studies on proximal humerus frac- [email protected] tures with focus on osteoporotic bone and Phone: +43 512 504 22821 In the biomechanics laboratory material loss of fracture reduction implant failure Fax: +43 512 504 22824 testing machines are available for in vitro and steps to prevent fixation failure. www.unfallchirurgie-innsbruck.at testing of soft and hard biological tissues, with several custom-made test setups for Biomechanics Laboratory various anatomical regions as well as joint Werner Schmölz, Assoc. Prof., PhD, Research Branch (ÖSTAT Classifications) simulators for the spine, shoulder and hand. Dipl.-Ing (FH) These allow in vitro functional evaluation of Implant anchorage in spinal stabilisation 106049, 211904, 302019, interventional surgical procedures for the procedures in patients having reduced 302085, 305908 stabilisation or reconstruction of joints as bone quality still poses a challenge to the well as of soft and hard tissue. Research pro- surgeons. Therefore, a new test setup was Keywords jects have been carried out in collaboration developed which allows the application with the Dept. of Anatomy and ­Embryology, Clinical studies, biomechanics, fracture Dept. of Neurosurgery, Dept. of Craniofacial fixation, cell biology, osteoporosis, geriatric Surgery and Dept. of ­Orthopaedic Surgery. patients The main focus of the morphological/cell Research Focus biological laboratory lies on basic research into osteoporosis and its underlying Research in the Department of Trauma mechanisms and the resulting stem cell ­Surgery focuses on the evaluation, develop- differentiation defects, as well as on ment and improvement of new and existing research on intervertebral discs. To conduct treatments and therapies for traumatic and these studies a fully equipped tissue degenerative musculoskeletal diseases, not culture unit is at our disposal for adult exclusively, however, with focus on geriatric stem cell differentiation experiments and patients. investigations on intervertebral disc cells. In addition histological, ultrastructural and General Facts biochemical analysis can be carried out. Research projects have been carried out In the clinical routine setting the depart- in collaboration with the Dept. of Anatomy, ment is organised into teams specialised Histology and Embryology, Dept. of in anatomical regions. The clinical patient Therapeutic Radiology and Oncology, Dept. Fig. 2: In vitro test set-up used to apply based research, as well as the applied and of Plastic-, Reconstructive- and Aesthetic physio­logical loading to pedicle screws and basic research of all the clinical teams at Surgery, as well as with several groups of provoke screw loosening. Red arrows show the department, is supported by an infra- the CCB. the load application and the pivot axis to structure consisting of a clinical study and ­allow a tilting motion of the screw in the documentation unit, a biomechanics labo- vertebral body.

94 Research Report 2016 Medical University of Innsbruck Trauma Surgery

of physiologic pedicle screw loading and The behaviour of bovine disc cells, and is capable of reproducing the mechanism changes in disc matrix following in vitro of pedicle screw loosening seen in clinical compression, were tested to compare the practice. Various augmentation techniques findings to data on human intervertebral and materials as well as screw designs to discs (IVD) after burst fracture of the cer- enhance pedicle screw anchorage were in- vical spine. Specimens were studied mac- vestigated. It could be shown that augmen- roscopically, histologically, and ultrastruc- tation significantly improves screw anchor- turally to define healthy cells, balloon cells, age and while for PMMA as augmentation and disc cell death (DCD). There was a posi- material the technique is only of secondary tive correlation between DCD and absorbed importance, for other augmentation mate- energy in all compartments of bovine discs. rials e.g. silicon, the enhancement strongly Both species showed similar patterns of depends on the augmentation technique DCD in the different compartments as well applied. To improve instrumentation for as similarities in cell morphologies and in cervical and lumbar spinal fusion proce- matrix damage. © European Spine Journal dures, experiments were conducted in vitro Fig. 3: 3D reconstruction of a section from a to investigate the primary and secondary „Local Remodelling and Mechano- mesenchymal stem cell, based on an electron stiffness of various supplementary instru- Regulation of Bone Fracture Healing tomogram, showing a single, branched, mentations. Based on the results, recom- in Healthy, Aged, and Osteoporotic threadlike mitochondrion with cristae, mendations on the type of instrumentations Humans“ marked here in yellow, and mitochondrial and their stiffness were given. Univ.-Prof. Dr. Michael Blauth membrane, in red. After surgical treatment of cruciate liga- Currently there is little knowledge of frac- ment injuries, graft elongation and graft ture healing, even though the radius frac- with wrist fractures. This will ultimately al- fixation affect post-surgical joint stability. ture is one of the most human fractures. low better monitoring of the repair process Therefore, currently established and re­ Age-related and osteoporotic changes in to improve clinical diagnosis and prognosis. cently developed new graft preparation bone can interfere with the healing process A broad range of expertise will be provided techniques, as well as femoral and tibial and thus, fractures become a serious prob- in a Swiss-Austrian-German DACH collabo- graft-bone fixation techniques, were in­ lem in our aging society. A high-resolution ration, where ETH Zurich, the Medical Uni- vestigated in experiments in vitro. It could computed tomography (HR-pQCT) helps versity Innsbruck, the Inselspital Bern, and be shown that a graft preparation technique us to assess the bone microstructure in Ulm University combine their strengths. which had recently been developed for less patients. This will elucidate local bone frac- invasive surgery resulted in an increased ture healing and help investigating whether graft elongation after surgical treatment. age and osteoporosis affect the healing process. Besides time-lapse CT images we Morphology and Cell Biology acquire corresponding biomarker meas- Laboratory urements and clinical evaluation in patients Hannes L. Ebner, PhD To optimise future treatment of osteo­ Selected Publications Selected Funding po­­rosis, the potential of aminobisphos- Injectable collagenase Clostridium histolyticum as a DO-HEALTH, EU- 7th framework, http://www.do-health.eu phonates to enhance the development of nonsurgical treatment for Dupuytren's disease Arora, R., Kaiser, P., Kastenberger, T. -J., Schmiedle, G., Erhart, S., bone-forming osteoblasts from progenitor Gabl, M., Collaborations OPERATIVE ORTHOPADIE UND TRAUMATOLOGIE: 2016; 28: S. cells was evaluated. The aminobisphospho- Clinical Investigation Unit: 30-37 nates investigated significantly enhanced • AO Foundation/Trauma What is the optimal salvage procedure for cut-out after osteoblast formation and thus provide Morphology and Cell Biology Laboratory: surgical fixation of trochanteric fractures with the PFNA or • Prof. Dr. med. B. von Rechenberg, University of Zürich, Zürich, ­further insights into their possible mode of TFN? A multicentre study Swisse Brunner, Alexander, Buettler, Markus, Lehmann, Uwe, Frei, Hans action in the treatment of osteoporosis. • Prof. Dr. med. P. Pietschmann, MedUni Wien, Wien, Austria Curd, Kratter, Renato, Di Lazzaro, Marco, Scola, Alexander, • Priv. Doz. Dr. P. J. Richards, University of Zürich, Zürich, Swisse Adipose-derived stromal cells (ASCs) Sermon, An, Attal, Rene, • Priv. Doz. Dr. G. Krumschnabel, Oroboros Labs, Innsbruck, INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE are increasingly being used for ortho­ Austria paedic-based tissue engineering, due to INJURED: 2016; 47: S. 432-438 Biomechanics Laboratory: A Simple Method for Measurement of Femoral Anteversion- their ability readily­ to undergo osteogenic • Prof. Dr. med. Tobias Schulte, University of Münster, Germany Validation and Assessment of Reproducibility • Prof. Ralph Müller, ETH, Zürich, Swisse ­differentiation. We used in vitro and in vivo Brunner, Alexander, Eichinger, Martin, Hengg, Clemens, • Priv-Doz. Dr. med Heiko Koller, Bad Wildungen, Germany Hoermann, Romed, Brenner, Erich, Kralinger, Franz, approaches to evaluate the use of ASCs • Priv. Doz Dr. med Stefan Freude, University of Tübingen, JOURNAL OF ORTHOPAEDIC TRAUMA: 2016; 30: S. E273-E278 as a treatment strategy for age-­related Germany • Dr. med. Richard Bostelmann, University of Düsseldorf, DE The J-Shaped Bone Graft for Anatomic Glenoid osteo­porosis. When differentiated in con­ • Dr. med Claudia Druschel, Charite University medicine, Berlin, Reconstruction A 10-Year Clinical Follow-up and Computed Germany di­tioned culture media harvested from Tomography-Osteoabsorptiometry Study • Dr. Kanna Gnanalingham, Dept of Neurosurgery, Manchester, Deml, Christian, Kaiser, Peter, van Leeuwen, Wouter F., Zitterl, osteo­porotic patient-derived human ASCs, UK Magdalena, Euler, Simon A., Doz, Priv, osteo­porotic patient-derived human bone AMERICAN JOURNAL OF SPORTS MEDICINE: 2016; 44: S. 2778- marrow ­stromal cells showed a significant 2783 Core Facilities improvement in their osteogenic potential. Allograft augmentation in proximal humerus fractures MicroCT These findings support the use of ASCs as Euler, S. A., Kralinger, F. S., Hengg, C., Wambacher, M., Blauth, M., OPERATIVE ORTHOPADIE UND TRAUMATOLOGIE: 2016; 28: S. an ­autologous cell-based approach for the 153-163 treatment of osteoporosis.

Research Report 2016 Medical University of Innsbruck 95 Center of Operative Medicine Urology

Urological Department is directed by Wolf- Establishment of Novel Biomarker in gang Horninger. Predicting response to Bacillus Calmette- The Department covers the entire Guérin (BCG) Therapy in high risk, non- diagnostic and therapeutic range of urology, muscle invasive bladder cancer (NMIBC) running five operating theaters, urological Renate Pichler and neuro-urological outpatient clinics, Bladder Cancer is the second most com- two adult urological wards, and a pediatric mon diagnosed urological cancer. ward. The Division of Experimental Urology While NMIBC can be cured endoscopically is integrated in the Department of Urology. by surgery and intravesical installation ther- A main focus of the Department is the treat- apy, patients with BCG refractory NMIBC ment of urological malignancies. In 1993, have a significant higher probability of the European Prostate Center Innsbruck cancer specific mortality. Current research was founded in order to ensure optimal pa- focuses on the understanding of the exact tient care and clinical research on prostate immune mechanism of BCG induced antitu- cancer and prostatic diseases. In addition mor activity. to the diagnosis and treatment of prostate diseases, a prostate cancer-screening pro- The Androgen Receptor – Key Regulator ject called Tyrol Project was implemented in in Prostate Cancer Director: 1993 to offer early detection and curative Helmut Klocker Univ.-Prof. Dr. Wolfgang Horninger treatment of prostate cancer for affected The androgen receptor (AR), a hormone men. induced transcription factor, is intimately Contact: Reconstructive Urology covers surgical linked to prostate cancer and is the primary Anichstraße 35 repair of the urogenital tract after trauma therapeutic target in this malignancy. For 6020 Innsbruck or for treatment of incontinence, whereas two decades, researchers of the Depart- neuro-urology treats patients with function- ment of Urology have been contributing to [email protected] al disorders of the bladder and the sphinc- worldwide efforts to elucidate the molecu- Phone: +43 512 504 24811 ter. Pediatric Urology offers diagnoses and lar mechanism of AR function and its role in Fax: +43 512 504 24873 treatments for all congenital, as well as ac- progression and therapy resistance. Several www.uro-innsbruck.at quired genitourinary problems, from birth to mechanisms have been identified and were adulthood. the basis for the development of new AR targeting drugs that led to prolonged surviv- Research Branch (ÖSTAT Classification) Research al of patients. Current research is focused on the AR tran- 302086, 301103, 302013, Prostate Cancer Screening scriptome. This includes protein-coding 305904, 603124 Wolfgang Horninger, Jasmin Bectic genes, such as AGR2 (Anterior Gradient 2), a More than 20 years after the introduction cellular chaperone, which is a potential tumor Keywords of prostate specific antigen (PSA) testing in clinical practice, early detection of prostate Prostate cancer, bladder cancer, tumor cancer is still a matter of debate. markers, androgen receptor, cytokines, Some prostate cancer-screening studies, growth factors, uro-onco-immunology mainly conducted in Europe, showed a de- crease in prostate cancer mortality and a Research Focus stage migration towards lower, potentially curable prostate cancer stages at the time • Prostate cancer treatment and therapy re- of diagnosis. sistance mechanisms However, the same studies showed a con- • Androgen receptor signaling and its role in siderable number of overdiagnoses and prostate cancer development, therapy and overtreatments. therapy resistance Our own data (“Prostate Cancer demonstra- • Tumor immunology and immunotherapy tion Project”, “Tyrol Study”) showed that 20 with a focus on dendritic cells, γδ-T-lym- years after initiation of an area-wide early de- phocytes and BCG instillation therapy in tection program, a 64% decrease in prostate NMIBC cancer mortality was achieved. Overdiagnosis • Diagnostics and tumor markers for urolog- was seen in 16-20% of all screened men. ical tumors, in prostate cancer and blad- Therefore, the aim of our Prostate Cancer der cancer Unit is to identify new, better markers for prostate cancer. General Facts Moreover, we try to optimize prostate can- The Innsbruck Department of Urology was cer detection (multiparametric MRI, mpM- founded in 1964 under the direction of RI) and prostate cancer treatment to avoid Hans Marberger. Georg Bartsch was direc- overdiagnosis and reduce the side effects Fig. 1: Posttranslational feedback-regulation tor from 1988 to 2010 and since 2011 the of (over)-treatment. of androgen receptor

96 Research Report 2016 Medical University of Innsbruck Urology

marker, or microRNA genes, such as the host several types of stromal cells. In tumor tis- genes of miR22 and miR29a, two epigenetic sue, the interplay between the epithelium regulators involved in invasion and apoptosis, and the stroma is thought to create an op- respectively. Investigation of posttranslational timal microenvironment for tumor growth regulation of AR protein and activity uncov- and progression driven by “activated” stro- ered a feed-back-loop regulation, which is mal cells. Hence, the use of 3D co-culture potentially targetable by the well-known dia- systems for in vitro cancer research is a betes drug, metformin (Fig.1). highly important issue when studying the molecular changes occurring in the differ- Cytokines and Growth Factors in ent cell types as well as for testing novel Prostate Cancer therapies and drugs. Zoran Culig Recently 3D prostate cancer organoid cul- Researchers are primarily interested in the ture protocols were established. The stud- regulation of cellular events by cytokines in ies have shown that the molecular expres- castration therapy-resistant prostate cancer. sion pattern of cell type specific markers is There is a particular focus on interleukin-6, markedly altered in 3D versus 2D cultures. whose levels are up-regulated in prostate In addition, androgen responsiveness, as malignancy, and on endogenous regulators well as drug responses, are significantly of cytokine signaling. In this context, it is es- changed in 3D epithelial-stromal co-culture pecially interesting that these molecules are organoids, suggesting a strong influence of implicated in the acquisition of resistance to fibroblasts on tumor cell behavior (Fig.3). chemotherapy with docetaxel (Fig.2). In order Future goals will focus on the interplay be- Fig. 4: Mevalonate metabolism to improve therapy in advanced prostate can- tween epithelial cells and fibroblasts using cer, inhibition of growth factors and other on- this 3D cell culture system with the aim of im- Selected Publications cogenes up-regulated during prostate cancer proving responsiveness to current therapies. High incidence of clinically significant concomitant prostate cancer in patients undergoing radical cystectomy for bladder cancer: A 10-year single-center experience. Immunology and Immunotherapy of Heidegger I, Oberaigner W, Horninger W, Pichler R.Urol Oncol. 2016 Dec 10. pii: S1078-1439(16)30370-2. doi: 10.1016/j. Urological Tumors urolonc.2016.11.004. [Epub ahead of print] Martin Thurnher Is Eotaxin-1 a serum and urinary biomarker for prostate The immunology/immunotherapy group cancer detection and recurrence? Heidegger I, Höfer J, Luger M, Pichler R, Klocker H, Horninger W, has a research interest in how the immune Steiner E, Jochberger S, Culig Z. Prostate. 2015 Dec;75(16):1904- system reacts against growing tumors. Spe- 9. cifically, they are interested in the activation Age-Adjusted PSA Levels in Prostate Cancer Prediction: Updated Results of the Tyrol Prostate Cancer Early of yo-T-lymphocytes by intermediates of the Detection Program mevalonate pathway (Fig. 4). Heidegger I, Fritz J, Klocker H, Pichler R, Bektic J, Horninger W.PLoS One. 2015 Jul 28;10(7). Since deregulation of mevalonate metabo- PSA Isoforms' Velocities for Early Diagnosis of Prostate lism can lead to malignant transformation, Cancer.Heidegger I, Klocker H, Pichler R, Horninger W, Bektic J.Anticancer Res. 2015 Jun;35(6):3567-70. yo-T-cells also play an important role in the The ONCOTYROL Prostate Cancer Outcome and Policy Model: immunosurveillance of tumors, such as blad- Effect of Prevalence Assumptions on the Benefit-Harm der cancer. Improved understanding of these Balance of Screening. Mühlberger N, Kurzthaler C, Iskandar R, Krahn MD, Bremner KE, Oberaigner W, Klocker H, Horninger W, interactions will foster the development of Conrads-Frank A, Sroczynski G, Siebert U. Med Decis Making. Fig. 2: SOCS-3 function in prostate cancer. innovative immunotherapies, as well as the 2015 Aug;35(6):758-72. For all publications look at: https://urologielabor-innsbruck.tirol- SOCS-3 is a common negative regulator for an- establishment of prognostic markers and kliniken.at/page.cfm?vpath=publikationen-gesamtuebersicht drogen and IL-6 pathways in prostate cancer. monitoring technologies. Selected Funding progression by androgen ablation therapy are • Austrian Research Fund, FWF • K1 Center Oncotyrol investigated. Combination therapies will be • MUI Start Grant Fund developed in the future in order to establish • Tyrolean Research Fund • Tirolean Cancer Society (Krebshilfe Tirol) personalized therapies. This research work, • Research Fund of the Austrian National Bank performed in several projects, received nu- • Medical Research Fund (MFF) • Astellas Pharma Investigator Driven Grant merous international recognitions for its con- tribution to the current understanding of pros- Collaborations tate cancer development and progression. • Holger Sültmann, DKFZ Heidelberg, D • Mark A. Rubin, Weill Cornell Medical College, New York US • Michal R. Schweiger & Hans Lehrach, MPI for Molecular Models for Prostate Cancer Research Genetics, Berlin, D • William R.G. Watson, Conway Institute of the University College Iris E. Eder-Neuwirt Dublin, IRE In-vitro prostate cancer research is main- • Francesca Demichelis, University of Trento, I • Christian Fuchsberger & Johannes Rainer, EURAC Bolzano, I ly conducted with immortalized cell lines, • Narisu Narisu, NIH Bethesda, US which lose relevant growth characteristics Fig. 3: LNCaP prostate cancer epithelial cells • Glen Kristiansen, University of Bonn, D • Normam, J. Maitland, University of York, UK when grown on a plastic surface. In addi- co-cultured with GFP-labeled cancer associ- • Andrew C.B. Cato, Karlsruhe Institute of Technology, D tion, the human prostate is composed not ated fibroblasts (CAF) at a ratio of 1:1 in 3D • Jan Bouchal, University of Olomouc, , CR only of epithelial cells, but also contains Perfecta 96 well plates • Philip A. Cole, Johns Hopkins University, Baltimore, USA

Research Report 2016 Medical University of Innsbruck 97 Center of Operative Medicine Orthopedic Surgery

Research Branch (ÖSTAT Classification) focuses on biomechanical studies aiming to increase allograft stability in difficult re- 302057, 303020, 301902, vision cases and to improve techniques and 302048, 206001 instruments for bone removal. The area of implant-related infections, coordinated by Keywords Dr. Coraça-Huber, develops studies aimed at the understanding of biofilm building and Orthopaedics, medical microbiology, immu- attachment on biomaterial surfaces. For nology, minimal-invasive surgery, biomedical that, different biofilm models are carried engineering out using the main strains associated with implant-related infections. Prevention and Research Focus treatment, as well as antibiotic and anti- septic susceptibility tests, can be carried Clinical Research out for systemic or local therapy. Also, diag- We perform applied studies mainly in the nostic techniques are being studied aimed fields of spine, arthroplasty, knee, and pae- at the reduction of false negatives in im- diatric orthopaedics, with a special interest plant-associated infections. For that, molec- in infection, implant migration and postop- ular identification of biofilms are in develop- Director: erative car driving ability. ment. Research in the immunological field Univ.-Prof. Dr. Martin Krismer of implant-related infections has also been Experimental Orthopaedics carried out. The aims are detecting immune Contact: Two main research areas are investigated activation parameters as a sign of infection Anichstraße 35 at the Experimental Orthopaedics labora- and monocyte differentiation and activation 6020 Innsbruck tories. The area of biomedical engineering in co-evolution with microbial infection. focuses on biomechanical studies aiming [email protected] to increase allograft stability in difficult re- Research Phone: +43 512 504 22691 vision cases and to improve techniques and Fax: +43 512 504 22701 instruments for bone removal. The area of Biofilm Formation and Antimicrobial www.orthopaedie-innsbruck.at Implant-related infections develops studies Susceptibility Tests on detection, prevention and treatment of Improved understanding of the structure infections related to biofilm attachment. of biofilms and how they function will help to develop treatments to eliminate biofilms General Facts from implant surfaces. In vitro models of biofilms allow the testing of antimicrobial Clinical Research susceptibility and the analysis of biofilm In addition to a new VICON system in clini- architecture and molecular behaviour. In cal use, we perform gait and motion analy- this kind of study, we investigated whether sis in our Biomechanics Lab (Dr. Haid) and biofilms growin vitro on metal discs and outdoor with a Lukotronic system. on microtiter plates. The evaluation of the biofilms formed on different surfaces was Implant migration measurement based assessed by comparing the antibiotic sus- on EBRA was developed and is being de- ceptibility of S. aureus and by examining veloped in cooperation with the Unit of the structure of S. aureus biofilms grown by ­Geometry and CAD at Innsbruck University scanning electron microscopy (SEM). Also, (Prof. Husty). Software and scanning equip- several biomaterials can be tested for bio- ment are available. film growth and efficacy tests for biomateri- als with antimicrobial properties. Brake reaction time for car driving is meas- ured in an experimental setting with high ac- Biofilms-Specific Genes and the Head of Experimental ­Orthopaedics: curacy. Postoperative measurements have Diagnosis of PJIs Univ.-Prof. Dr. Michael Nogler been performed for various operations. A staphylococcal bacterial biofilm is pro- duced in a two-step process: initial bacte- Contact: Experimental Orthopaedics rial attachment to the surface of a foreign Innrain 36 The unit of Experimental Orthopaedics is a body or host tissue followed by a biofilm 6020 Innsbruck research department within the Department formation, consisting of bacterial prolifera­ of Orthopaedic Surgery of the ­Innsbruck tion, intercellular adhesion, and extracel- [email protected] Medical University. The unit is divided into lular slime substance production. The pri- Phone: +43 512 9003 71691 two major research areas. The area of bi- mary attachment to a surface is related to Fax: +43 512 9003 73691 omedical engineering, coordinated by Dr. a cell surface protein exhibiting autolysin/ Putzer, focuses on improving techniques adhesin and fibrinogen-binding activity. This for filling bony defects and bone removal protein autolysin-E (AtlE) is encoded by the in the field of orthopaedics. The research chromosomal atlE gene. Initial adhesion is

98 Research Report 2016 Medical University of Innsbruck Orthopedic Surgery

feasible molecular methods, like polymer- ase chain reaction (PCR). Our objective with this research area is to develop a new PCR method by detecting biofilm markers from the joint aspirates of PJI patients.

Immunology of Biofilm Infection Here we study the interaction of the com- plement system with bacteria in nosocomial joint infections. We will try to create means to improve the complement mediated ly- sis of the bacteria. Thus, results achieved during this study will not only broaden the basic knowledge about complement in nosocomial joint infections but also have clinical implications. Ultimately this induc- tion of CML might make it possible to heal infections in vivo making graft renewal un- necessary. This study not only increases our knowledge about interactions of bac- teria causing nosocomial infection with the innate immune system but can ultimately lead to the development of a novel, indirect Fig. 1: S. epidermidis biofilm detection strategy. This strategy could be transferred into the clinical setting adding mediated not only by the AtlE itself but also dispersed from a mature biofilm regain the to direct bacterio­logic testing and thus via its enzymatic function. The hydrolysis of physiological characteristics of planktonic helping reduce the number of false negative the cell wall peptidoglycan leads to autoly- cells and may disseminate to new locations samples drawn from patients after joint re- sis and thus to the release of extracellular thereby causing acute infection. Although construction surgery. DNA (eDNA), which has been shown to be biofilm-specific genes have been investigat- an important component of staphylococcal ed, none of this knowledge has been used Bone Tissue as Antibiotic Carrier biofilms. The second stage of biofilm for- to develop new PJI diagnostics. These bio- In orthopaedic surgery, bone grafts are used mation demonstrated that cell aggregation film-specific markers can be detected by for reconstructing bone defects caused by and biofilm accumulation were mediated by the products of the chromosomal ica gene locus, which is composed of four genes or- ganised in an operon structure (icaA, icaD, icaB and icaC). The icaADBC operon leads to the production of polysaccharide inter- cellular adhesin (PIA), also known as poly- N-acetyl glucosamine (PNAG). Despite the undeniably important role of the icaADBC operon controlling PIA/PNAG production in staphylococcal biofilms, the existence of a PIA/PNAG-independent biofilm mech- anism is known. Other important genes associated with biofilm formation and the accumulation phase in S. epidermidis are aap, fbe and embp, encoding accumulation adhesion protein (Aap), fibrinogen binding protein (Fbe) and extracellular matrix-bind- ing protein (Embp), respectively. Embp is characterised as a giant 1MDa extracel- lular protein and is sufficient for biofilm formation in icaADBC- and aap-negative S. epidermidis. Potentially, as Embp and PIA can function as intercellular adhesins inde- Fig. 2: Staphylococcal biofilm life cycle (FnBPs – fibronectin binding proteins; CltA – pendently or parallel, Embp in combination ­fibrinogen-binding protein-clumping factor A; Cna – collagen binding protein; Bbp – bone with PIA can be used for development of a sialoprotein-binding protein; PNAG – poly-N-acetylglucosamine; PIA – polysaccharide inter­ polyvalent S.epidermidis vaccine, for ex- cellular adhesion; Bap – biofilm associated protein; Bhp – Bap homologue protein; eDNA ample, and improve diagnostic techniques. – extracellular DNA; icaADBC – genes involved in the synthesis of PIA; bap gene – involved In the final phase of biofilm growth, cells in the synthesis of Bap).

Research Report 2016 Medical University of Innsbruck 99 Center of Operative Medicine

implant associated complications, trau- Selected Publications ma and tumours. While autografts can be Lyophilized allogeneic bone tissue as an antibiotic carrier used, donor site morbidity can be avoided Coraca-Huber, Debora C., Ammann, Christoph G., Nogler, Michael, Fille, Manfred, Frommelt, Lars, Kuehn, Klaus-Dieter, using allografts. Bone grafts can either be Foelsch, Christian, used as large structural bone grafts from CELL AND TISSUE BANKING: 2016; 17: S. 629-642 post-mortem donors or as bone chips from BAG-S53P4 as an additive to bone allografts: A laboratory morselized femoral head donated by living study using an uniaxial compression test David, Putzer, Johannes, Fuchs, Debora, Coraca-Huber, Ammann, patients undergoing total hip arthroplasty. Christoph, Michael, Liebensteiner, Michael, Nogler, Such bone chips are used to fill defects that JOURNAL OF ORTHOPAEDIC RESEARCH: 2015; 33: S. 1875-1879 require biomechanical stability, which can © Journal Surgical Innovation Retracting Soft Tissue in Minimally Invasive Hip Arthroplasty be achieved by compressing the chips into Using a Robotic Arm: A Comparison Between a Semiactive Retractor Holder and Human Assistants in a Cadaver Study the defect site. Fresh frozen bone chips are Fig. 3: Retracting soft tissue in minimally Putzer, David, Klug, Sebastian, Haselbacher, Matthias, Mayr, preferred because they contain the origi- invasive hip arthroplasty using a bionic in- Eckart, Nogler, Michael, nal osteoconductive and osteoinductive sprired concept of a robotic arm. SURGICAL INNOVATION: 2015; 22: S. 500-507 proteins. However, fresh frozen chips can Collaborations add the risk of local contaminations. Sur- control retraction forces and minimise soft • Heraeus Medical GmbH, Wehrheim, Germany gery with bone allografts is complex and tissue damages related to it, the possibility • Incocon GmbH, Attnang-Puchheim, Austria time-consuming; therefore it is prone to a of using a semiactive robotic retractor hold- higher infection rate (2.0–2.5%). Antibiotics er was evaluated in a concept study. Devices & Services delivered from an implanted biomaterial can • Zeiss Fluorescence Microscope Axio Lab.A1 be potentially used to prevent infections, Improvement of Current Orthopaedic • Scanning Electron Microscope JSM-6010 InTouchScope • Ultraschalll-Spezialgerät Bandelin B providing high concentrations of antibiotics Therapies • Plantar Measurment System Novel at the surgical site without local or systemic By developing or evaluating new technolo- • 3D Printer Formlabs • VICON Nexus 2.1.1 gait lab with 2 Amti OR6-7-1000 ground toxicity. In addition, these materials should gies and surgical instruments orthopaedic reaction force measurement plates be osteoconductive and osteoinductive, treatments can be improved. Understand- • Lukotronic motion analysis for outdoor use thus supporting bone healing without fur- ing the effects of radial shock wave thera- • Brake reaction time measurement setting ther surgery. Morselized bone allografts can pies on the human body are currently evalu­ be used as carriers by impregnating them ated in a patient model. Additionally, ideas with antibiotic solutions or by mixing them for the improvement of current orthopaedic with antibiotic powders. procedures or surgical instruments are col- Also, biomechanical compression tests lected. So far, five innovative ideas for new were carried out for different preparation instruments have been awarded with the procedures to study the mechanical effect CAST award. of grain size distribution, water and fat con- tent and the possibility of enhancing osteo- Brake Response Times after Various conductive and osteoinductive properties Surgeries (Different Authors) of allograft by adding bioglass or platelet Brake response times were recorded for rich plasma. different orthopaedics braces (ankle, knee) and therapeutic shoes. Computer-Assisted Bone Removal Procedures An analysis of orthopaedic surgical proce- dures resulted in a limited subset of plan- ning functions for bone removal procedures. One research focus is dedicated to comput- er interaction in the operation room. New measurement technologies can provide more information to smart instruments, which can enhance surgical skill resulting in more precise bone removal procedures.

A simulation study determined the max- imum reachable depth of straight instru- ments inserted into the femoral canal. In this case, constraints for a simulated bone removal procedure in a femoral canal were determined. For the detection of additional constraints, a new technology for the de- tection of the soft tissue envelope during hip arthroplasty was evaluated in a cadaver study. In almost every surgical procedure retraction of soft tissue is necessary. To

100 Research Report 2016 Medical University of Innsbruck Orthopedic Surgery

Research Report 2016 Medical University of Innsbruck 101 Center of Operative Medicine Anaesthesiology and Critical Care Medicine

Research Branch (ÖSTAT Classification) of their regular working hours is dedicat- ed to research activities. The total amount 302004, 302053, 302074, 302058 of so called “research time” for each em- ployee varies between 10% of total working Keywords hours for a first-year resident up to 40% of total working hours for a few attend- Anaesthesiology, critical care medicine, ing physicians who have achieved certain emergency medicine, pain medicine, scientific accomplishments (publications, ­palliative care, breathing gas, coagulation successful grant applications, research awards). This means that the Department Research Focus of Anaesthesiology and Critical Care Med- icine does not employ full time researchers. Anaesthesiology, critical care medicine, emergency medicine, pain medicine, pallia- The Department however, is affiliated tive care, cardiopulmonary resuscitation, air- with the “Institute of breath gas analy- way management, vasodilatory shock, post- sis” (Chair: Prof. Christopher Mayhew). traumatic shock, coagulation, hypothermia, This basic science research group shares regional anaesthesia, transplantation, neu- the basic science laboratory with the De- Director: ro- and obstetrical anaesthesia, muscle re- partment of Anaesthesiology and Critical o. Univ.-Prof. Dr. Karl Lindner laxants, mountain rescue, microcirculation, Care Medicine and employs 8 full time re- prediction models, breathing gas analysis. searchers. There are several joint collab- Contact: orations and projects with this institute. Anichstraße 35 General Facts 6020 Innsbruck Due to the various specialty fields and The department performs about 40.000 topics in anaesthesiology, researchers [email protected] anaesthesia cases per year in 60 operating of our Department cover many differ- Phone: +43 512 504 28503 and diagnostic rooms. Being a university ent research aspects. The following list Fax: +43 512 504 28504 hospital, the department covers all surgical gives an overview of the different re- www.anaesthesie-innsbruck.at disciplines, is responsible for six postoper- search groups and topics of interest: ative care units, three intensive care units (general surgery, trauma and transplanta- Research Group Dr. Peter Mair tion critical care units), two shock rooms, (Main Focus: Mountain Emergency ground emergency service at two different Medicine) locations (Innsbruck and Telfs), a rotor wing • Initiation and start of the „Interna- unit, a pain unit and an anaesthesia out- tional Alpine Trauma Registry“, a patient clinic. Additionally, our physicians prospective multicentre observational have teaching responsibilities (anaesthesia study about preclinical care of severe- classes for medical students), perform spe- ly injured people in the alpine setting. cial skills trainings (first aid classes, ventila- This is a joint project with the Insti- tion management classes, basic life and ad- tute for alpine emergency medicine of vanced life support trainings) and perform the EURAC in Bozen, South Tyrol, Italy. bedside teaching for our medical students • Collaboration and recruitment of patients during their mandatory anaesthesiology ro- for the „International Hypothermia tation. In addition, the Department of Anaes- Registry“. This prospective multicentre thesiology and Critical Care Medicine runs observational study of the University of an experimental laboratory for basic science Geneva, Switzerland, collaborates with research and a large animal operating room. many European centres to provide clini- cal care of severely hypothermic patients Research • Extracorporeal life support during As can be anticipated from the section shock and cardiopulmonary resuscita- above, the Department of Anaesthesiology tion. This is a joint project with the univer- and Critical Care Medicine covers a large sity clinic for cardiac surgery, Innsbruck variety of different activities, including • ”Preclinical and clinical treat- all clinical aspects of anaesthesia proce- ment of avalanche victims”: a ret- dures, postoperative care, intensive care rospective analysis with the Institute medicine, emergency medicine, teaching for alpine emergency medicine of the responsibilities and various research activ- EURAC in Bozen, South Tyrol, Italy. ities. It should be noted that all anaesthe- • Cerebral monitoring during cardio­ siologists involved in research activities (in- pulmonary resuscitation: experimental cluding basic science and clinical research) studies led by Dr. Gabriel Putzer, Clinic are primarily employed as physicians and for Anaesthesiology and Critical Care clinical care providers. Only a limited part Medicine.

102 Research Report 2016 Medical University of Innsbruck Anaesthesiology and Critical Care Medicine

Research Group Dr. Corinna Research Group Dr. Judith Martini Research Group Dr. Axel Kleinsasser Velick-Salchner and Dr. Helmuth Tauber (Main Focus: Coagulation and (Main Focus: High Altitude Medicine and (Main Focus: Coagulopathy in Cardiac and Microcirculation) Postoperative Care) Vascular Surgery) • Shiga toxin and its interaction with • Cardiorespiratory fitness in high altitude. • Stress response in patients undergoing plasmatic coagulation – Is shorten- • Stress response in patients undergoing carotid endarterectomy in regional anaes- ing of clotting time and binding of carotid endarterectomy in regional anaes- thesia versus general anaesthesia: a ran- antithrombin and heparin by Shiga thesia versus general anaesthesia: a ran- domized prospective observational study. toxin 2 a key event in haemolytic domized prospective observational study. • Acquired von Willebrand Syndrome uremic syndrome? Cooperation with (AVWS) in patients with ECMO/ECLS. The Division of Hygiene and Medical Mi- Research Group Dr. Ruth Kröss • Transcranial Doppler analysis in crobiology, Medical University Innsbruck (Main Focus: Paediatric Anaesthesia) patients undergoing carotid en- • The effect of plasma expanding solu- • Study investigator for NECTARINE: NE- darterectomy in regional anaes- tions on clot structure: The view onate-Children sTudy of Anaesthesia thesia versus general anaesthesia: a ran- through the confocal microscope. pRactice IN Europe. Epidemiology of domized prospective observational study. • Contrast media induced acute ef- morbidity and mortality in neonatal an- • Administration of von Wille- fects on chronic kidney injury – A pi- aesthesia: A European prospective multi- brand factor concentrate in bleed- lot study in pigs. Cooperation with the centre observational study led by the Eu- ing patients on ECMO/ECLS. University Clinic for Radiology, Innsbruck roepan Society of Anesthesiology (ESA). • Correlation of fibrinogen levels• IVUS guided transcatheter aortic • Study investigator for APRICOT: Anaes- and chest tube drainage in chil- valve implantation – A feasibility study thesia PRactice In Children Observation- dren undergoing congenital heart in pigs. Cooperation with the Universi- al Trial: European prospective multicen- surgery: A retrospective analysis. ty Clinic of Cardiac Surgery, Innsbruck. tre observational study: Epidemiology of severe critical events, led by the Euro- Research Group Dr. Petra Innerhofer Research Group Dr. Thomas Luger pean Society of Anaesthesiology (ESA). and Dr. Elgar Oswald (Main Focus: Anaesthesia in Geriatric • Assessment of soft tissue and bone (Main Focus: Trauma Induced Coagulopathy) Patients; Emergency Medicine under diameter for intraosseous needles in Reversal of trauma induced coagulopathy extreme Conditions) children and adults. A retrospective sin- (RETIC study). • Ultrasound guided regional anaesthesia gle-centre observational study. In col- in a glucose-6 phosphate dehydroge- laboration with Dr. Peter Paal, Kranken- Research Group Dr. Karl-Heinz nase deficient geriatric trauma patient. haus der Barmherzigen Brüder, Salzburg. Stadlbauer • Pneumothorax and ultrasound guided (Main Focus: Treatment of Haemorrhagic interscalenus block. Research Group Dr. Michael Baubin Shock in Trauma Patients, Anaesthesia in • Tension pneumothorax. A simulation study. (Main Focus: Emergency Medicine, Quality Vascular Surgery) • Emergency medicine under extreme con- Assessment) • The “VITRIS trial”: The role of vasopres- ditions (the MARS Analogue Simulation). • Contribution to the “German cardio- sin as on top-medication during life threat- • Multidisciplinary management of geriat- pulmonary resuscitation registry” ening haemorrhagic shock in trauma. ric fractures. A joint project with the uni- • Development of performance in- • The “PLATA trial”: Peripheral nerve versity clinic of traumatology, Innsbruck. dicators for quality assessment block for prevention of phantom limb • Psychological support during long dis- of emergency medical services. pain after transtibial amputation. tance sailing. Research Group Dr. Wolfgang Lederer (Main Focus: Emergency Medicine; Obstetric Anesthesia) • Assessment of biomarkers in cer- ebrospinal fluid during pregnancy. • Systemic hypotension following intrave- nous administration of non-ionic contrast medium during computed tomography. • Airway management by laryngeal tube during out-of-hospital cardiac arrest • A comparison of Narkotrend, BIS and NIRS during neurointerventional procedures • Breath analysis and evaporation • Vasopressin and leucocyte function • AED instructions for first responders and recommendations for basic life support © Martin Hermann Research Group Dr. Günther Putz Fig. 1: Real Time Live Confocal Imaging showing the plasticity of fibrin networks (Main Focus: Obstetric Anaesthesia) Changes of biomarkers in cerebrospinal fluid during preeclampsia.

Research Report 2016 Medical University of Innsbruck 103 Center of Operative Medicine

Research Group Dr. Stefan Jochberger • Pharmacokinetics of trimethoprim-sul- Selected Publications (Main Focus: Gynaecology and Obstetric fametrole in critically ill patients with Results of rotational thromboelastometry, coagulation Anaesthesia) continuous veno-venous haemofil- activation markers and thrombin generation assays in orthopedic patients during thromboprophylaxis with • Pain management during labour. tration. Collaboration with the Uni- rivaroxaban and enoxaparin: a prospective cohort study Oswald, Elgar, Velik-Salchner, Corinna, Innerhofer, Petra, Tauber, • State of the art obstetric anaesthesia. versity Clinic of Internal Medicine. Helmuth, Auckenthaler, Thomas, Ulmer, Hanno, Streif, Werner, • “Status quo” of obstetric anaesthesia in • Infectious complications af- BLOOD COAGULATION & FIBRINOLYSIS: 2015; 26: S. 136-144 Austria. ter heart transplantation. Thrombolysis and clinical outcome in patients with stroke • Sugammadex and its effects on after implementation of the Tyrol Stroke Pathway: a retrospective observational study contraceptive plasma hormone levels Research Group Dr. Gabriel Putzer and Willeit J, Geley T, Schöch J, Rinner H, Tür A, Kreuzer H, Thiemann N, Knoflach M, Toell T, Pechlaner R, Willeit K, Klingler N, Praxmarer upon reversal of rocuronium bromide. Dr. Patrick Braun S, Baubin M, Beck G, Berek K, Dengg C, Engelhardt K, Erlacher • Do erythrocyte concentrates, fresh frozen (Main Focus: Cardiopulmonary T, Fluckinger T, Grander W, Grossmann J, Kathrein H, Kaiser N, Matosevic B, Matzak H, Mayr M, Perfler R, Poewe W, Rauter A, plasma and platelet concentrates contain Resuscitation) Schoenherr G, Schoenherr HR, Schinnerl A, Spiss H, Thurner T, CCL 11? • Monitoring of brain oxygena- Vergeiner G, Werner P, Wöll E, Willeit P, Kiechl S. tion during hypothermic CPR. LANCET NEUROLOGY: 2015; 1: S 48-56 • Publication study 2016: Publica- Admission blood glucose predicted haemorrhagic shock in Research Group Dr. Janett Kreutziger multiple trauma patients (Main Focus: Emergency Medicine) tion trends in the G20 countries Kreutziger, Janett, Rafetseder, Andreas, Mathis, Simon, Wenzel, Volker, El Attal, Rene, Schmid, Stefan, • The importance of blood glu- • CANAP Study: Cannabinoids as pre- INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE cose levels in the prehospital medication and PONV prophylaxis in pa- INJURED: 2015; 46: S. 15-20 management of trauma patients tients undergoing general anesthesia. Extracorporeal Membrane Oxygenation Induces Short- • A comparison of endotracheal in- • Near infrared spectroscopy (NIRS) Term Loss of High-Molecular-Weight von Willebrand Factor Multimers tubation with videolaryngoscopy in children. Correlation between Tauber, Helmuth, Ott, Helmut, Streif, Werner, Weigel, Guenter, (McGrath®) versus conventional la- NIRS and anesthesia depth in chil- Loacker, Lorin, Fritz, Josef, Heinz, Anneliese, Velik-Salchner, Corinna, ryngoscopy for prehospital intubation dren between 0-3 years of age. ANESTHESIA AND ANALGESIA: 2015; 120: S. 730-736 of emergency patients in air rescue. A • HUP vs. SUP study. Effect of head up posi- multicenter, prospective, randomized tioning versus supine positioning on brain Efficacy of Argatroban in Critically Ill Patients with Heparin Resistance: A Retrospective Analysis trial. Cooperation with H. Trimmel, Hos- oxygenation and metabolism during exper- Treichl, Benjamin, Bachler, Mirjam, Lorenz, Ingo, Friesenecker, Barbara, Oswald, Elgar, Schlimp, Christoph J., Pedross, Florian, pital Wiener Neustadt, Vienna, Austria. imental cardiopulmonary resuscitation. Fries, Dietmar, • Use of the GlideScope Ranger Video La- • Contrast media induced acute effects SEMINARS IN THROMBOSIS AND HEMOSTASIS: 2015; 41: S. ryngoscope for Emergency Intubation in on chronic kidney injury – A pilot study 61-67 the Prehospital Setting: A Randomized in pigs. Cooperation with the Univer- Outcome of avalanche victims with out-of-hospital cardiac arrest Control Trial. Cooperation with H. Trimmel, sity Clinic for Radiology, Innsbruck Moroder, Luca, Mair, Birgit, Brugger, Hermann, Voelckel, Wolfgang, Hospital Wiener Neustadt, Vienna, Austria. • IVUS guided transcatheter aortic valve Mair, Peter, • Crowdfunding for financing hospital infra- implantation – A feasibility study in RESUSCITATION: 2015; 89: S. 114-118 structures – An international comparison. pigs. Cooperation with the University Bronchoalveolar Lavage Fluid (1,3)beta-D-Glucan for the • Comparison of interscalenus block with Clinic of Cardiac Surgery, Innsbruck. Diagnosis of Invasive Fungal Infections in Solid Organ Transplantation: A Prospective Multicenter Study general anesthesia and intravenous anes- • Near infrared spectroscopy (NIRS) in Mutschlechner, Wolfgang, Risslegger, Brigitte, Willinger, Birgit, Hoenigl, Martin, Bucher, Brigitte, Eschertzhuber, Stephan, Lass- thesia for ambulant shoulder repositioning. patients undergoing carotid endarter- Floerl, Cornelia, • Inflammatory parameters in necrotizing ectomy under regional anaesthesia. TRANSPLANTATION: 2015; 99: S. E140-E144 fasciitis. Collaboration with the Depart- • EVITA vs. EVONE. Two different Delayed and intermittent CPR for severe accidental ment of Anesthesia Bern, Switzerland. ventilation concepts and their in- hypothermia Gordon, Les, Paal, Peter, Ellerton, John A., Brugger, Hermann, fluence on atelectasis in pigs. Peek, Giles J., Zafren, Ken, Research Group Dr. Franz Wiedermann • True CPR simulation study. Conven- RESUSCITATION: 2015; 90: S. 46-49 tional CPR versus True CPR during and Dr. Martina Stichlberger Is epinephrine during cardiac arrest associated with worse (Main Focus: Effects of Vasopressin) patient transport in the ambulance. outcomes in resuscitated patients? Effect of vasopressin and catecholamines on the migration of leukocytes • Development of an agonist and antagonist Wiedermann FJ, Stichlberger M, Lederer W. of procalcitonin/vasopressin in a bioassy: Institute of Breath Gas Analysis CRITICAL CARE: 2015; 19: S. 120 migration of human monocytes in re- Dr. Christopher Mayhew Computed advisory systems in daily practice for predicting sponse to procalcitonin and its fragments. • In vitro studies of volatile compo- concentrations and effects of combined anesthetics: a new field in anesthesia? • Effects of Vasopressin on mi- nents of bacteria or different cell lines. Velik-Salchner, C., gration of human leukocytes. • Detection of human volatile compo- MINERVA ANESTESIOLOGICA: 2015; 81: S. 1151-1152 nents of breath or urine after nat- Multicenter evaluation of a lateral-flow device test for Research Group Dr. Stephan ural disasters (e.g. earthquakes) diagnosing invasive pulmonary aspergillosis in ICU patients Eigl, Susanne, Prattes, Juergen, Lackner, Michaela, Willinger, Eschertzhuber • Anaesthesiological monitoring of Birgit, Spiess, Birgit, Reinwald, Mark, Selitsch, Brigitte, Meilinger, (Main Focus: Anaesthesia for Solid Organ breath after surgical procedures. Michael, Neumeister, Peter, Reischies, Frederike, Woelfler, Albert, Raggam, Reinhard B., Flick, Holger, Eschertzhuber, Stephan, Transplantation, Postoperative Care of Krause, Robert, Buchheidt, Dieter, Thornton, Christopher R., Lass- Transplant Patients) Floerl, Cornelia, Hoenigl, Martin, • Concentrations of echinocandins in as- CRITICAL CARE: 2015; 19: S. 178 cites, pleural effusion, bile, wound se- Ultrasound-guided regional anesthesia for carotid cretion and cerebrospinal fluid – a pilot endarterectomy induces early hemodynamic and stress hormone changes study. Collaboration with the University Hoefer, Judith, Pierer, Eve, Rantner, Barbara, Stadlbauer, Karl- Heinz, Fraedrich, Gustav, Fritz, Josef, Kleinsasser, Axel, Velik- Clinic of Internal Medicine and the Divi- Salchner, Corinna, sion of Hygiene and clinical microbiology. JOURNAL OF VASCULAR SURGERY: 2015; 62: S. 57-67

104 Research Report 2016 Medical University of Innsbruck Anaesthesiology and Critical Care Medicine

European Resuscitation Council Guidelines for Resuscitation Pijls, Ruud, Cebula, Grzegorz, Correia, Vitor Gouveia, Cimpoesu, 2015 Section 4. Cardiac arrest in special circumstances Diana, Raffay, Violetta, Trenkler, Stefan, Markota, Andrej, Truhlar, Anatolij, Deakin, Charles D., Soar, Jasmeet, Khalifa, Gamal Stroemsoee, Anneli, Burkart, Roman, Perkins, Gavin D., Bossaert, Eldin Abbas, Alfonzo, Annette, Bierens, Joost J. L. M., Brattebo, Leo L., EuReCa ONE Collaborators, Guttorm, Brugger, Hermann, Dunning, Joel, Hunyadi-Anticevic, RESUSCITATION: 2016; 109: S. 145-146 SIlvija, Koster, Rudolph W., Lockey, David J., Lott, Carsten, Paal, Peter, Perkins, Gavin D., Sandronis, Claudio, Thies, Karl-Christian, Recommended practice for out-of-hospital emergency Zideman, David A., Nolan, Jerry P., Cardiac Arrest Special, anaesthesia in adults: Statement from the Out-of-Hospital RESUSCITATION: 2015; 95: S. 148-201 Emergency Anaesthesia Working Group of the Emergency Medicine Research Group of the German Society of European Resuscitation Council Guidelines for Resuscitation Anaesthesiology and Intensive Care 2015 Section 2. Adult basic life support and automated Hossfeld, Bjoern, Bein, Bertold, Boettiger, Bernd W., Bohn, external defibrillation Andreas, Fischer, Matthias, Graesner, Jan-Thorsten, Hinkelbein, Perkins, Gavin D., Handley, Anthony J., Koster, Rudolph W., Jochen, Kill, Clemens, Lott, Carsten, Popp, Erik, Roessler, Markus, Castren, Maaret, Smyth, Michael A., Olasveengen, Theresa, Schaumberg, Alin, Wenzel, Volker, Bernhard, Michael, Monsieurs, Koenraad G., Raffay, Violetta, Graesner, Jan-Thorsten, EUROPEAN JOURNAL OF ANAESTHESIOLOGY: 2016; 33: S. 881- Wenzel, Volker, Ristagno, Giuseppe, Soar, Jasmeet, Adult Basic 897 Life Support Automated, RESUSCITATION: 2015; 95: S. 81-99 Fibrinogen supplementation ex vivo increases clot firmness comparable to platelet transfusion in thrombocytopenia Intracardiac Doppler Echocardiography for Monitoring Schenk, B., Lindner, A. K., Treichl, B., Bachler, M., Hermann, of Pulmonary Artery Pressures in High-Risk Patients M., Larsen, O. H., Fenger-Eriksen, C., Wally, D., Tauber, H., Velik- Undergoing Transcatheter Aortic Valve Replacement Salchner, C., Fries, D., Mueller, Silvana, Velik-Salchner, Corinna, Edlinger, Michael, BRITISH JOURNAL OF ANAESTHESIA: 2016; 117: S. 576-582 Bonaros, Nikolaos, Heinz, Anneliese, Feuchtner, Gudrun, Bartel, Thomas, Cerebrospinal fluid levels of tau and phospho-tau-181 JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY: proteins during pregnancy 2016; 29: S. 83-91 Lederer, Wolfgang, Dominguez, Cristina Alomar, Popovscaia, Marina, Putz, Gunther, Humpel, Christian, Intracardiac echocardiography for guidance of transcatheter PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF aortic valve implantation under monitored sedation: a WOMENS CARDIOVASCULAR HEALTH: 2016; 6: S. 384-387 solution to a dilemma? Bartel, Thomas, Edris, Ahmad, Velik-Salchner, Corinna, Mueller, Breath analysis for in vivo detection of pathogens related to Silvana, ventilator-associated pneumonia in intensive care patients: EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING: 2016; a prospective pilot study 17: S. 1-8 Filipiak, Wojciech, Beer, Ronny, Sponring, Andreas, Filipiak, Anna, Ager, Clemens, Schiefecker, Alois, Lanthaler, Simon, Helbok, Manual Versus Mechanical Chest Compressions On Raimund, Nagl, Markus, Troppmair, Jakob, Amann, Anton, Surfaces Of Varying Softness With Or Without Backboards: JOURNAL OF BREATH RESEARCH: 2015; 9: S. 016004 A Randomized, Crossover Manikin Study Putzer, Gabriel, Fiala, Anna, Braun, Patrick, Neururer, Sabrina, Exhaled methane concentration profiles during exercise on Biechl, Karin, Keilig, Bernhard, Ploner, Werner, Fop, Ernst, Paal, an ergometer Peter, Szabo, A., Ruzsanyi, V., Unterkofler, K., Mohacsi, A., Tuboly, E., JOURNAL OF EMERGENCY MEDICINE: 2016; 50: S. 594-+ Boros, M., Szabo, G., Hinterhuber, H., Amann, A., JOURNAL OF BREATH RESEARCH: 2015; 9: S. 016009 Neurophysiological effects of needle trauma and intraneural injection in a porcine model: a pilot study Hybrid Volatolomics and Disease Detection Kirchmair, L., Stroehle, M., Loescher, W. N., Kreutziger, J., Voelckel, Broza, Yoav Y., Mochalski, Pawel, Ruzsanyi, Vera, Amann, Anton, W. G., Lirk, P., Haick, Hossam, ACTA ANAESTHESIOLOGICA SCANDINAVICA: 2016; 60: S. 393- ANGEWANDTE CHEMIE-INTERNATIONAL EDITION: 2015; 54: S. 399 11036-11048

Functional Recovery of a Human Neonatal Heart After Diagnosing lactose malabsorption in children: difficulties in Severe Myocardial Infarction interpreting hydrogen breath test results Haubner, Bernhard J., Schneider, Johanna, Schweigmann, Ulrich, Ruzsanyi, Veronika, Heinz-Erian, Peter, Entenmann, Andreas, Schuetz, Thomas, Dichtl, Wolfgang, Velik-Salchner, Corinna, Stein, Karall, Daniela, Mueller, Thomas, Schimkowitsch, Alexander, Joerg-I., Penninger, Josef M., Amann, Anton, Scholl-Buergi, Sabine, CIRCULATION RESEARCH: 2016; 118: S. 216-221 JOURNAL OF BREATH RESEARCH: 2016; 10: S. 016015

Effects of Stomach Inflation on Cardiopulmonary Function and Survival During Hemorrhagic Shock: A Randomized, Devices and Services Controlled, Porcine Study Braun, Patrick, Putzer, Gabriel, Strapazzon, Giacomo, Wimmer, 60 operating/diagnostic rooms, general surgery, post-operative, Angela, Schnell, Hermann, Arnold, Henrik, Neururer, Sabrina, transplantation, and trauma intensive care unit, six postanesthesia Brugger, Hermann, Wenzel, Volker, Paal, Peter, care units, anesthesiology outpatient clinic, medical and nursing SHOCK: 2016; 46: S. 99-105 student education, emergency medical service ground and rotorwing unit, pain service, basic science research laboratory, Use of the GlideScope Ranger Video Laryngoscope for and animal operating room. Emergency Intubation in the Prehospital Setting: A Randomized Control Trial Trimmel, Helmut, Kreutziger, Janett, Fitzka, Robert, Szuets, Stephan, Derdak, Christoph, Koch, Elisabeth, Erwied, Boris, Voelckel, Wolfgang G., CRITICAL CARE MEDICINE: 2016; 44: S. E470-E476

Monitoring of brain oxygenation during hypothermic CPR - A prospective porcine study Putzer, Gabriel, Braun, Patrick, Strapazzon, Giacomo, Toferer, Martha, Mulino, Miriam, Glodny, Bernhard, Falk, Markus, Brugger, Hermann, Paal, Peter, Helbok, Raimund, Mair, Peter, RESUSCITATION: 2016; 104: S. 1-5

EuReCa ONE-27 Nations, ONE Europe, ONE Registry A prospective one month analysis of out-of-hospital cardiac arrest outcomes in 27 countries in Europe Graesner, Jan-Thorsten, Lefering, Rolf, Koster, Rudolph W., Masterson, Siobhan, Boettiger, Bernd W., Herlitz, Johan, Wnent, Jan, Tjelmeland, Ingvild B. M., Ortiz, Fernando Rosell, Maurer, Holger, Baubin, Michael, Mols, Pierre, Hadzibegovic, Irzal, Ioannides, Marios, Skulec, Roman, Wissenberg, Mads, Salo, Ari, Hubert, Herve, Nikolaous, Nikolaos I., Loczi, Gerda, Svavarsdottir, Hildigunnur, Semeraro, Federico, Wright, Peter J., Clarens, Carlo,

Research Report 2016 Medical University of Innsbruck 105 Center of Operative Medicine General and Surgical Critical Care Medicine

Research Branch (ÖSTAT Classification) interdisciplinary team consisting of medical doctors, (molecular) biologists and (medical) 302004, 302031, 302053, students in very close collaboration. This 301103, 106011 way we can translate basic research into medical practice. Our aim is to understand Keywords the basic process of coagulation disorders with the aim of improving patient treatment. Confocal microscopy, thromboelastometry, By combining clinical practice with ex- coagulation, intensive care medicine, fibrin- perimental research, we evaluate novel ogen, trauma, coagulopathy, sepsis, critical treatment options with the long-term goal illness, fluid management of gaining an (inter)national registration for the respective indication or medication. Research Focus Head of the research laboratory with a fo­ cus on acquired coagulation disorders Our research team is dedicated to developing in critically ill patients is Ao. Univ.-Prof. new strategies to improve clinical outcome Dr. Dietmar Fries. In addition to top focussing on coagulation management and level standard-of-care technologies for volume replacement. Our interdisciplinary coagulation testing we were able to Director: team is trying to find optimal treatment mobilize sufficient funds to acquire a o. Univ.-Prof. Dr. Karl Lindner options, alternative methods and strategies spinning-disc confocal microscope for our to target the therapy to the individual needs laboratory. With our confocal specialist, Dr. Contact: of patients in the field of emergency-, Martin Hermann, we offer this special, life- Anichstraße 35 perioperative- and critical care medicine. imaging technique to various departments 6020 Innsbruck Our research involves basic experimental of the Medical University of Innsbruck as as well as clinical research. well as to external partners. Major goals [email protected] regarding confocal imaging are the search Phone: +43 512 504 28503 General Facts for new diagnostic/prognostic methods, as Fax: +43 512 504 28504 well as novel staining possibilities in order https://intensiv.tirol-kliniken.at Our research projects are carried out by an to minimize animal experiments.

© Martin Hermann

Fig. 1: Biopsychronology of a live murine kidney biopsy using Syto 16 (blue), propidium io- dide (red) and wheat germ agglutinin (green) to visualize nuclei of living/dead cells and tis- sue morphology. Image acquisition was performed on a confocal spinning disc microscope. This work was supported by Grants of the OeNB and the Daniel Swarovski Foundation Biopsychronolgy and is currently being translated into clinical practice by Dr. Rupert Oberhuber & coworkers from the VTT/DSL.

106 Research Report 2016 Medical University of Innsbruck General and Surgical Critical Care Medicine

thromboembolism the phenomenon of of the superior rectal arteries was found Heparin resistance is responsible for to be technically feasible, safe and well insufficient antithrombotic prophylaxis tolerated. Nevertheless, certain differences or therapy. In this context, the use of in the style of the various embolization coils direct thrombin inhibitors may be useful. can be found. Clinical experience showed Argatroban is a direct thrombin inhibitor that the thrombogenicity of embolization which binds to thrombin in a rapid and coils equipped with fibers is much higher reversible manner. Therefore, the aim of the than the thrombogenicity of those without planned study is to investigate whether the fibers. Therefore, the aim of the study is administration of Argatroban (Argatra®) is to assess the change in coagulation status able to achieve a prophylactic or therapeutic after treatment with embolization coil fibers © Martin Hermann antithrombotic therapy in a reasonable time (fibers) ex vivo. The primary endpoint is the period in critically ill patients, assumed to difference in ROTEM EXTEM clotting time Fig. 2: Starting with a drop of blood and the have a heparin resistance and being at risk between baseline and ex vivo addition of addition of live stains cellular as well as for thrombosis or thromboembolism. The about 30 fibers. molecular key players may be analyzed in primary endpoint is to achieve the targeted real time without the need of fixation. aPTT of ≥ 45 seconds at 8 hours (6-8h), A retrospective analysis comparing the once the patients have a diagnosed heparin fibrinogen level in survivors and non- Research resistance and heparin dose was increased survivors during sepsis or argatroban administration started. Project leader: M Bachler and C Fibrinogen concentrate in trauma Niederwanger induced coagulopathy (FIinTIC study). Rivaroxaban and PCC: Prothrombin During SIRS or SEPSIS the fibrinogen levels A multicenter, multinational placebo Complex Concentrate in Patients with elevate quite above the norm value range. controlled double blinded study. bleeding complications related to Latest findings have revealed new roles Project leader: D Fries Rivaroxaban (Riva-PCC). of fibrinogen and its cleavage products In the event of marked blood loss fibrinogen Project leader: D Fries and B Schenk in the innate immune system other than reaches critical values as a rule more In life-threatening bleeding events, the non- mediating the immune response and so than any other coagulation factor, or vitamin K antagonist oral anticoagulants enhancing the pro-inflammatory state. platelets. Recent clinical data showed that (NOACs) pose a great challenge for Fibrinogen entraps invading pathogens fibrinogen concentrate can improve clot physicians. The aim of this study is to test for when it forms a fibrin network. During firmness and offers a better safety profile effective reversal of the NOAC rivaroxaban coagulation and the subsequent fibrinolysis than platelet concentrates. Therefore, by use of the non-specific reversing agent a peptide (Bß15-42) cleaved from the the aim of this study is to assess whether PCC (prothrombin complex concentrate). ß-chain acts as an antibiotic and maintains fibrinogen concentrate, administered at Patients with life-threatening bleeding the endothelial barrier function, improving the site of the accident, is able to improve events under rivaroxaban treatment are the endothelial tight junctions by binding coagulation until arrival at the hospital: included and 25 U kg-1 of PCC administered. to the endothelium, and may improve Fibrinogen concentrate or placebo are Blood samples are collected immediately the outcome in septic patients. On the administered as an infusion at the site of before PCC administration and at various other hand, hyperfibrinogenemia is often the accident. Patients are evaluated on time points afterwards. Primary endpoint is associated with an increased risk for blood coagulation parameters, adverse-, the difference in thrombin generation (TG) thromboembolic events and microvascular thrombotic- and bleeding events until seven before and ten minutes after administration fibrin deposition during sepsis. Therefore, days after inclusion. The primary endpoint of PCC. Thrombosis screening is performed the aim of this study is to investigate the is the difference in maximum clot firmness 7 days after PCC administration via duplex role of hyperfibrinogenemia during sepsis. (MCF) of the fibrin clot (FIBTEM) between ultrasound. Septic patients, hospitalized between 2000 V1 (before study drug administration) to 2014 at the University Hospital Innsbruck and V2 (15 minutes after administration Ex vivo investigation of the effects of (Austria) are enrolled retrospectively. The of the study drug) as assessed by ROTEM fibered embolization coils on coagulation peak of the C-reactive protein (day 0) is thromboelastometry (MCFFIBTEM). Project leader: B Schenk and M Freund used as indicator of the most intense period Endovascular embolization is a procedure of a septic event. Data are collected on a Argatroban in critical ill patients with to treat abnormal blood vessels in the daily basis from 3 days before (day -3) heparin resistance (ArgHeR). brain and other parts of the body. It is an until 3 days after (day 3) the peak of the Project leader: D Fries and M Bachler alternative to open surgery. It is mostly C-reactive protein. Primary endpoint is the Despite the great advances made in used to fill aneurysms, but also for blunt difference in the fibrinogen level between anticoagulation therapy in recent years, and penetrating traumatic injuries: These survivors and non-survivors. thrombosis and pulmonary embolism injuries to solid organs and extremity remain preventable complications and vessels are often managed using trans- Real Time Live Confocal Microscopy significantly influence morbidity and catheter arterial embolization. For a wide Project leader: M Hermann mortality, especially in critically ill patients. range of materials and clinical scenarios Our real time live confocal microscopy An inadequate response to Heparin, known embolization is appropriate. Embolic approach relies on a spinning disc confocal as Heparin resistance, has been reported agents such as coils may prove to be the microscope, which has been financed in up to 22% of patients undergoing CPB. safest and most effective form of therapy. entirely by funds acquired from our industrial In the treatment and prophylaxis of venous In several case studies coil embolization partners. Our aim is to open up a window

Research Report 2016 Medical University of Innsbruck 107 Center of Operative Medicine

into the cellular/molecular universe with the goal to study cellular processes and develop new methods as well as tools for both basic science as well as prognostic/ diagnostic methods suitable for clinical practice. These goals can only be achieved by close collaboration with partners within the Medical University of Innsbruck. The most recent example for such an approach is a method named “Biopsychronology” which has been developed together with the Daniel Swarovski Research Laboratory (DSL) and was presented on the cover of Transplant International, in which it was published. Positive international feedback in the form of a research highlight in Nature Reviews Nephrology, an Editor´s Choice in Science Translational Medicine and an invited chapter in Methods Molecular Biology encouraged us to continue this approach (for details see: www.clotwork. at). © Martin Hermann

Fig. 3: Live confocal visualization of a human blood clot showing the fibrin network (green), erythrocytes (red) and nuclei of leucocytes (blue)

Selected Publications Selected Funding

A Class 1 Histone Deacetylase with Potential as an In 2016 we were able to obtain a grand total of € 933,497.03 Antifungal Target through funding. In other words, a part of this money was received Bauer I, Varadarajan D, Pidroni A, Gross S, Vergeiner S, Faber B, in 2016 from previous contracts or stipulated in contracts signed Hermann M, Tribus M, Brosch G, Graessle S. during the current year (for 2016 and following years). Moreover, MBIO: 2016; 7. we are going to finalize contracts over € 300,000 for clinical studies and over € 80,000 for experimental projects in the near Fibrinogen supplementation ex vivo increases clot firmness future. comparable to platelet transfusion in thrombocytopenia Schenk B, Lindner AK, Treichl B, Bachler M, Hermann M, Larsen OH, Fenger-Eriksen C, Wally D, Tauber H, Velik-Salchner C, Fries D. Collaborations BRITISH JOURNAL OF ANAESTHESIA: 2016; 117: S. 576-582. • Univ.-Prof. Dr. Dirk Meyer, Molekulare Genetik und Entwicklungsbiologie, Naturwissenschaftliche Universität, Ex vivo reversal of effects of rivaroxaban evaluated using Innsbruck, Österreich thromboelastometry and thrombin generation assay • Prof. Dr. med. Christian F. Weber, Oberarzt, Klinik für Kidney Research Schenk B, Würtinger P, Streif W, Sturm W, Fries D, Bachler M. Anästhesiologie, Intensivmedizin und Schmerztherapie, BRITISH JOURNAL OF ANAESTHESIA: 2016; 117: S. 583-591. Universitätsklinikum Frankfurt, Theodor-Stern-Kai 7, 60590 Methods in Molecular Biology Frankfurt am Main Biopsychronology: A Method Using Live In search for in vivo methods to visualize clot forming in cut • Tel HashomerMedical University of TelAviv, Israel Tissue Staining to Image Cell Function in vessels and interrupted flow. • US Army, Fort Sam Houton, Texas, USA Solomon C, White NJ, Hochleitner G, Hermann M, Fries D. • Dept. of Bioengineering, Univ. of San Diego, USA the Kidney. BRITISH JOURNAL OF ANAESTHESIA: 2016; 116: S. 554-555. • Dept. for Anesthesia, Aarhus, Denmark • Dept. for Hematology, Kings College London, UK Ashraf MI, Fries D, Streif W, Aigner F, Biopsychronology: A Method Using Live Tissue Staining to • Dept. for Trauma Surgery, Cologne Merheim Medical Center, Hengster P, Troppmair J, Hermann M. Image Cell Function in the Kidney Germany Ashraf MI, Fries D, Streif W, Aigner F, Hengster P, Troppmair J, Methods Mol Biol. 2016;1397:81-90. Hermann M. METHODS IN MOLECULAR BIOLOGY: 2016;1397: S. 81-90.

Efficacy of argatroban in critically ill patients with heparin resistance: a retrospective analysis.T Treichl B, Bachler M, Lorenz I, Friesenecker B, Oswald E, Schlimp CJ, Pedross F, Fries D. SEMINARS IN THROMBOSIS AND HEMOSTASIS: 2015; 41: S. 61-67

Point-of-Care Testing in Critically Ill Patients Fries, Dietmar, Streif, Werner, SEMINARS IN THROMBOSIS AND HEMOSTASIS: 2015; 41: S. 75-83

Fibrinogen concentrate improves clot strength in patients with haematological malignancies requiring platelet transfusion Munk-Andersen, H., Schenk, B., Larsen, O. H., Fries, D., Fenger- Transfusionsassoziierte Pharmakotherapie. Eriksen, C., TRANSFUSION MEDICINE: 2016; 26: S. 291-296 Fibrinogen (FI) Dietmar Fries, Mirjam Bachler, Martin Hermann. Springerverlag.

108 Research Report 2016 Medical University of Innsbruck General and Surgical Critical Care Medicine

Research Report 2016 Medical University of Innsbruck 109 Center of Internal Medicine Internal Medicine I

Research Branch (ÖSTAT Classification) • The role of inflammation and metabolism in development of non-alcoholic fatty liver 301904, 302012, 302014, disease 302016, 302025 • Molecular effects of environmental fac- tors in obesity and insulin resistance and Keywords the interaction of several organs or tis- sues in metabolic disease Gastroenterology, endocrinology, metabo- • Bariatric surgery and metabolic or immu- lism, inflammation, hepatology, nutrition, nological effects on the host non-alcoholic fatty liver disease, inflamma- • Lipoprotein metabolism and atheroscle- tory bowel disease rosis

Research Focus General Facts

The research of our department is focused The Department of Internal Medicine I has on translational research in the fields of its focus in the specific medical areas of gastroenterology, endocrinology, metabo- gastroenterology, endocrinology, metabo- lism and hepatology and is represented by lism and hepatology. Our division has about Director: several research groups. The overall objec- 40 employees and many members are in- Univ.-Prof. Dr. Herbert Tilg tive of our scientific activities is to gain bet- volved both in clinical work and research. ter insights into pathophysiology of preva- Our laboratories are perfectly equipped and Contact: lent diseases such as inflammatory bowel our researchers are able to perform state- Anichstraße 35 disease, non-alcoholic fatty liver disease, of-the art research in the field of cellular 6020 Innsbruck obesity, type 2 diabetes and atherosclero- and molecular work. The common aim of sis. Better knowledge will help to improve our research activities is to increase knowl- [email protected] clinical management of these patients in edge in the respective disease areas and to Phone: +43 512 504 23539 the future. improve patient care. We have established Fax: +43 512 504 23538 The major research topics are: different national and international collabo- http://inneremed1.tirol-kliniken.at • The cause and effects of intestinal in- rations throughout the world. Our research flammation particularly in connection has been funded by the Austrian Research with diseases like Crohn´s disease and Promotion Agency (FFG), Austrian Science ulcerative colitis Fund (FWF), Christian Doppler Forschungs-

Fig. 1: Pathophysiology of NAFLD and the metabolic syndrome. Recent studies revealed a substantial contribution of the microbiota for metabolic diseases. The current model sug- gests that environmental factors (e.g. dietary factors, antibiotic treatment) and host-derived factors (e.g. genetics, metabolic signalling, pregnancy) are closely communicating with the resident microbiota. Vice versa, the presence of a (healthy) commensal microbiota affects metabolic signalling of the host (e.g. FIAF (fasting-induced adipocyte factor), AMPK (AMP-ac- tivated protein kinase)), similar to bacterial digestion of dietary end-products (e.g. short chain fatty acids). It emerges that alterations in microbial structure and function modulate the penetrance of metabolic dysfunction and obesity. The origin of microbial derangements in metabolic diseases remains largely enigmatic but may involve antibiotic treatment early in life, dietary changes and host genetics. Adapted from (Tilg and Adolph, 2015).

110 Research Report 2016 Medical University of Innsbruck Internal Medicine I

Fig. 2: Proposed mechanism ALD and mode of action of IL-8 blockade by the pepducin x1/2pal-i1 therapy. Ethanol-associated cytotoxicity induces hepatic expression of IL-8 which recruits neutrophils to instigate inflammation and mediate hepatic pathology through danger signals. Inhibition of IL-8 with pepducin x1/2pal-i1 may protect against ALD by inhibition of detrimental inflammatory cascades. IL, inter- leukin; MMP, matrix metalloproteinases; MPO, myeloperoxidase; ROS, reactive oxygen species; TNF, tumour necrosis factor. Adapted from Wieser V et al, Gut, 2016. gesellschaft (CDG), European Union (FP7) neutrophilic inflammation (Wieser Vet al., derstand the close interaction between var- for several years now and we have published J Hepatol, 2015). Therapeutically, we have ious organs or tissues in obesity and insulin our research in highly respected interna- established that neutrophilic inflammation resistance. We are especially interested in tional Journals such as Nature Communi- and ALD can be reversed through selective investigating the crosstalk between adipose cations, New England Journal of Medicine, blockade of IL-8 (Figure 2) (Wieser V et al., tissue and the liver. By secreting adipocy- Gut, Cell Host Microbe, Gastroenterology Gut, 2016). As the microbiota is critically tokines and inflammatory cytokines and and many others. involved in regulation of hepatic diseases also by releasing fatty acids, the adipose (Tilg & Adolph, Curr Opin Pediatr, 2015), we tissue critically determines hepatic triglyc- Research are currently studying the impact of specific eride accumulation in states of insulin re- bacterial strains on the susceptibility to de- sistance resulting clinically in non-alcoholic Hepatology veloping ALD. These studies may be inform- fatty liver disease. On the other hand fat The research group has an interest in liver ative to translate basic research findings accumulation in the liver further diminishes diseases and in the closely related metabol- into novel therapeutic approaches. hepatic insulin sensitivity by interfering with ic syndrome and focuses on investigating the insulin signalling pathway (Figure 3). disease mechanisms in non-alcoholic fatty Endocrinology and Metabolism liver disease (NAFLD) and alcoholic liver Insulin Resistance Another focus of our research is to char- disease (ALD), respectively (Figure 1). The Insulin resistance is a hallmark of type 2 di- acterize endocrine alterations in obesity. world health organisation noted a steep rise abetes and is highly prevalent in obesity. In Currently, we are especially interested in of these disease entities for which treat- our research group we are especially inter- defining metabolic effects of growth hor- ment modalities are desperately needed. ested in defining tissue-specific molecular mone in metabolically highly active tissues Thus, in order to establish treatment mo- effects of various diets including ones with in order to better understand the clinical dalities, we investigate how inflammation high fructose, sucrose and/or fat content. significance of low growth hormone action modulates the susceptibility to NAFLD and Furthermore, we aim to characterize cel- in obesity. ALD; inflammation has been implicated lular effects of incretin hormones in more in liver diseases for more than 20 years. detail. In an animal model of diet-induced Bariatric Surgery Recently, we have published work that re- insulin resistance we were able to show Bariatric surgery is an ideal model to study vealed an impact of hepatic type I interfer- that dietary components have tremendous the effects of sustained weight reduction. on signalling in the development of NAFLD effects on whitening of adipocytes and adi- In several papers our groups were able to and the metabolic syndrome (Wieser V pose tissue inflammation. Parts of these re- show that pronounced weight reduction is et al., Gut, 2016). Furthermore, we unrav- sults were presented at the 4th Helmholtz- associated with improvements of inflamma- elled that a siderophore that regulates iron Nature Medicine Diabetes Conference. tion, cardiovascular surrogate markers and homeostasis promotes ALD by regulating Another focus of our work is to better un- important parameters of glucose or lipid ho-

Research Report 2016 Medical University of Innsbruck 111 Center of Internal Medicine

meostasis. In a recent work we found that that HDL-cholesterol is causally involved biome, our commensal bacteria and their tissue expression of heme-oxygenase-1, in pathogenesis of cardiovascular disease. metabolic properties, and how this “organ a key enzyme in heme catabolism which HDL particles are well known for their func- within an organ” affects human physiology has also been linked to the pathogenesis of tion in reverse cholesterol transport (März both in homeostasis and in disease. On the diet-induced insulin resistance and inflam- W, Ritsch A J Am Coll Cardol, 2016). The one hand we are interested in how exoge- mation, significantly decreases with weight focus of our research is to investigate pleio- nous environmental signals such as nutri- loss after bariatric surgery (Ress C et al., tropic functions of HDL particles. Currently, ent factors are integrated via the microbi- Diabet Med, 2017). In other work relative we aim to define determinants of choles- ome into communication pathways with telomere length was found to be increased terol efflux in human endothelial cells and the host. On the other hand we are looking after bariatric surgery in the long term, pre- macrophages and to better characterize for host factors that in turn are capable of sumably due to amelioration of metabolic regulatory mechanisms of key enzymes or shaping gut community compositions. In traits. These findings further emphasize proteins in reverse cholesterol transport in this context we were able to identify a host beneficial pleiotropic effects of significant animal models of atherosclerosis. In a clini- factor called Lipocalin 2 (Lcn2) potently weight loss in obese patients (Laimer M et cal study, we work on determination of HDL shaping intestinal bacterial structures dur- al., Int J Obes, 2016). particle activity in patients at very high car- ing intestinal inflammation. We could show diovascular risk. that Lcn2 deficiency was not associated Atherosclerosis with increased intestinal inflammation in Many epidemiological studies have shown Gastroenterology experimental colitis but that lack of Lcn2 that low HDL-cholesterol levels are asso- Intestinal inflammation constitutes another resulted in the spontaneous development of ciated with high cardiovascular risk. How- central research focus of our Department, intestinal tumors. This has significant trans- ever, in some interventional studies thera- both clinically and experimentally. Re- lational relevance since colitis-associated peutical increases of HDL-cholesterol were cent advances in sequencing technologies cancer represents a redoubtable complica- not associated with reductions of cardio- opened up the possibility to study the ex- tion of human inflammatory bowel diseas- vascular risk, challenging the hypothesis tremely exciting field of the intestinal micro- es. Furthermore, we were able to show that © World Journal of Gastroenterology © World

Fig. 3: Figure 3 shows the close interaction between systemic glucose metabolism and hepatic fatty acid metabolism. In states of insulin resistance high concentrations of circulating free fatty acids and proinflammatory cytokines promote hepatic triglyceride accumulation. Vice versa intermediates of long chain fatty acids inhibit insulin signaling in hepatocytes, further diminishing hepatic insulin sensitivity. DNL, de novo lipogenesis; ACC; Acetyl CoA carboxylase, ER, endoplasmic reticulum, ; DAG, diacylglycerol; IRS, insulin receptor substrate; LXR, ligand-activated transcription factor; SREBP, sterol regulating element binding protein, CPT-1, carnitine palmitoyl transferase 1; LD, lipid droplet; ATGL, adipose triglyceride lipase; CIDEB, cell death inducing DFFA like effector B; ChREBP, Carbohydrate response element; ROS, reactive oxygen species; PNPLA2 patatin-like phospholipase domain-containing protein2. Adapted from Ress & Kaser. World Journal Gastroenterology, 2016

112 Research Report 2016 Medical University of Innsbruck Internal Medicine I

both inflammation and tumor development Selected Publications Selected Funding depended on an altered microbial composi- Reversal of murine alcoholic steatohepatitis by pepducin- • Christian Doppler Research Laboratory for metabolic tion triggered by Lcn2 deficiency. Strikingly, based functional blockade of interleukin-8 receptors crosstalk, Christian Doppler Research Association (CDG), Euro we were able to identify Alistipes spp. as a Wieser V, Adolph TE, Enrich B, Kuliopulos A, Kaser A, Tilg H, 770,000, 2015-2021, Assoz Prof. Priv Doz. Dr. Susanne Kaser Kaneider NC • Epithelial glutathione peroxidase 4 in the control of intestinal culprit species indeed driving both inflam- Gut. 2016 Feb 8. pii: gutjnl-2015-310344. doi: 10.1136/ homeostasis, Austrian Science Fund (FWF), Euro 331,758.00, mation and tumorigenesis. Notably, we gutjnl-2015-310344. 2016-2018, Dr. Timon Adolph, PhD • VASCage – Research Center of Excellence in Vascular Ageing, also found Alistipes in human patients with Lipocalin 2 Protects from Inflammation and Tumorigenesis Austrian Research Promotion Agency (FFG), COMET, Euro spontaneous colorectal cancer. We were Associated with Gut Microbiota Alterations 360,000.00 2014-2018; Univ. Prof. Dr. Herbert Tilg Moschen AR, Gerner RR, Wang J, Klepsch V, Adolph TE, Reider SJ, • HDL function and atherosclerosis: Studies in apolipoprotein able to publish our research in highly re- Hackl H, Pfister A, Schilling J, Moser PL, Kempster SL, Swidsinski E knockout rabbits, Austrian Science Fund (FWF), Euro spected international Journals such as Cell A, Orth Höller D, Weiss G, Baines JF, Kaser A, Tilg H. 231,689.20 Euro, 2015-2018, ao Univ. Prof. Mag. Dr. Andreas Cell Host & MICROBE: 2016; 19: S. 455-69. Ritsch Host & Microbe and Nature communica- • Long-term effects of weight loss on atherosclerosis, Austrian tions. Current studies in our laboratory are Lipocalin 2 drives neutrophilic inflammation in alcoholic Science Fund (FWF), Euro 177,408.00, 2014-2016; ao Univ. liver disease Prof. Dr. Christoph Ebenbichler focusing on additional mechanistic under- Wieser V, Tymoszuk P, Adolph TE, Grander C, Grabherr F, Enrich B, Pfister A, Lichtmanegger L, Gerner R, Drach M, Moser P, Zoller H, pinnings of Lcn2-microbiome interactions Weiss G, Moschen AR, Theurl I, Tilg H. Collaborations and Alistipes-dependent inflammation and JOURNAL OF HEPATOLOGY: 2016; 64: S. 872-80 • Charles A. Dinarello, Denver, Colorado, USA tumorigenesis. Gut microbiome development along the colorectal adenoma- • Georg Schett, Erlangen, Germany carcinoma sequence • Stefan Schreiber, Kiel, Germany Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z, Zhang D, Xia • Arthur Kaser, Cambridge, UK Clinically, we are currently involved in sever- H, Xu X, Jie Z, Su L, Li X, Li X, Li J, Xiao L, Huber-Schönauer U, • Fredrik Bäckhed, Gothenburg, Sweden al Phase 2 and 3 trials such as the SMAD7 Niederseer D, Xu X, Al-Aama JY, Yang H, Wang J, Kristiansen K, • Patrice Cani, Brussels, Belgium Arumugam M, Tilg H, Datz C, Wang J. • Willem de Vos Wageningen, The Netherlands antisense oligonucleotide Mongersen in Nature Communication: 2015; 11: 6528. • Roberto Vettor, Verona, Italy Crohn’s disease, the JAK1 inhibitor Filgotin- • Javier Crespo, Santander, Spain • Winfried März, Freiburg, Germany ib in Crohn’s disease and ulcerative colitis, • Arnold von Eckardstein, Zurich, Switzerland and the LY3074828 a humanized anti-p19 • Zsuzsanne Bosze, Gödöllö, Hungary IgG4 antibody that blocks interleukin 23 in Crohn’s disease. Contribution to these international multicenter trials enables us to offer desperately needed treatment op- tions to our patients and to contribute to the improvement of clinical management of patients with inflammatory bowel diseases in general.

Research Report 2016 Medical University of Innsbruck 113 Center of Internal Medicine Internal Medicine II

Research Branch (ÖSTAT Classification) fields. As there is significant clinical and scientific overlap between these medical 302030, 301902, 302072, 303031 disciplines the combined expertise at our department creates a positive synergy and Keywords gain of knowledge for optimized treatment of patients and in performing clinical and Internal medicine, infectious diseases, laboratory based research. Our department immunology, rheumatology, pneumology, consists of three inpatient wards, and three host-pathogen interaction, metal and lipid outpatients clinics with a focus on infec- metabolism, anemia research, immune me- tious disease/immunology and tropical diated diseases, immune deficiency, tropi- medicine, on rheumatology and on pneu- cal medicine mology, respectively. Apart from routine investigations of internal medicine, we also Research Focus perform laboratory diagnostics of infectious diseases, tropical infections, auto-immune Based on the broad clinical expertise at our disorders and immunodeficiency as well as department the research at our institution functional pulmonary analyses along with covers many different aspects of basic re- bronchoscopy. A study center coordinates search and clinically relevant topics in infec- the clinical studies at our institution. Director: tious diseases, immunology, rheumatology Univ.-Prof. Dr. Günter Weiss and pneumology, both at the level of labo- Several research groups investigate rel- ratory based science and clinical research evant topics in our fields of interest as Contact: including clinical studies with a major aim detailed below, making use of up-to-date Anichstraße 35 to translate the results of our scientific in- laboratory technologies of biochemistry, 6020 Innsbruck vestigations from bench to bedside for the molecular biology, cell biology, immunology, benefit of our patients. microbiology and genetics both in vitro and [email protected] in vivo. Our laboratories are well equipped Phone: +43 512 504 23251 General Facts with modern infrastructure including high Fax: +43 512 504 23317 throughput PCR, a FACS analyzer or an in https://inneremed2.tirol-kliniken.at Apart from all aspects of general internal vivo fluorescence imager. medicine our institution has a focus and core expertise in infectious disease, clini- A major goal of our institution is also devot- cal immunology, rheumatology and pneu- ed to high quality education in clinics and mology, thus being the reference center for science, to provide an excellent environ- Western Austria in some of these medical ment for international competitive research

Fig. 1: Erythroide niche: Erythroblasts (Ter119 FITC-green) and nursing macrophage (CD169 Cy3-red)

114 Research Report 2016 Medical University of Innsbruck Internal Medicine II

in the laboratory and at the bedside, and secreted by many bacterial species and for the maintenance of iron homeostasis be- to inspire medical doctors to combine re- some fungi to supply iron for metabolism cause they take up senescent erythrocytes search with their clinical occupation and to and proliferation. We have seen that Lcn-2 and re-utilize iron. Accordingly, in various critically evaluate the clinical practice and has an additional immune-regulatory prop- pathophysiological conditions, where eryth- the available information. erty: Lcn-2 represses IL-10 thus licensing rocyte life span is compromised and hemol- high-output production of tumor necrosis ysis can occur, macrophages expand their Research factor, interleukin-6 and reactive nitrogen erythrophagocytotic capacity to avoid tis- species. sue damage via the radical promoting activ- Research in Molecular Immunology and ity from erythrocyte-derived heme. Recent- Infectious Diseases Further, we could demonstrate that the cel- ly, we identified an on-demand mechanism In our recent studies, we have character- lular localisation of the intracellular bacteri- that clears erythrocytes and recycles iron ized the roles of three candidate genes in um, Listeria monocytogenes, determines its (Theurl et al. Nature Medicine 2016). We the course of Salmonella Typhimurium in- dependence on iron availability and the or- showed that monocytes that express high fection. All three gene products (i.e. iron chestration of immune effector pathways in- levels of lymphocyte antigen 6 complex, lo- regulatory proteins-1 and -2, lipocalin-2 and cluding the restriction of iron availability. In cus C1 (LY6C1, also known as Ly-6C) ingest heme oxygenase-1) are expressed in mye- summary, the maintenance of macrophage stressed and senescent erythrocytes, accu- loid cells and are involved in macrophage iron homeostasis and innate immune effec- mulate in the liver via coordinated chemot- iron handling and immune response. tor functions are intimately linked. This is actic cues, and differentiate into ferroportin Iron regulatory proteins (IRPs) orchestrate illustrated by the fact that IRPs, Hmox-1 and 1 (FPN1, encoded by SLC40A1)-expressing cellular iron homeostasis by posttranscrip- Lcn-2 fulfil central tasks at the intersection macrophages that can deliver iron to hepat- tional mechanisms. In collaboration with of these pathways. ocytes. Bruno Galy and Matthias W. Hentze (EMBL, Heidelberg), we have seen that mice lacking Anemia Research On the basis of these data we find it inter- both IRP-1 and IRP-2 in the myeloid com- A central research focus of this clinic is esting that macrophage-derived factors partment have increased ferritin expression to study the pathophysiology of anemia of such as S100A8/S100A9 directly affect in macrophages, which translates into high- chronic disease (ACD) and to identify new erythroid differentiation in an inflammato- er serum ferritin levels. While these mice potential new treatment options. ry state. Moreover, erythroid niche mac- have normal erythropoiesis and unimpaired rophages have been shown to have a direct iron recycling from aged red blood cells, In the general Western population, ane- effect on erythroid differentiation in a thal- they are susceptible to infection with the mia of chronic disease (ACD), also termed assemia model in a yet not completely un- iron-dependent bacterium Salmonella Typh- anemia of inflammation (AI), is the most derstood way. imurium. Mechanistically, IRPs restrict the frequent entity in hospitalized patients, oc- ferritin-associated iron pool in macrophag- curring in subjects with diseases involving Erythroid niche macrophages seem to nurse es thus limiting the availability of iron for chronic immune activation (such as pa- the developing erythroid cells with iron and/ intracellular Salmonella. Moreover, IRPs tients with auto-immune diseases, infection or other growth factors. However, the spe- stimulate the production of tumor necro- and cancer, but also in subjects with chron- cific iron source provided by the erythroid sis factor, interleukin-6 and of lipocalin-2 ic kidney disease, congestive heart failure niche macrophages and the whole set of by macrophages, thus contributing to im- or obesity). growth factors provided by these cells are proved bacterial killing. far from being understood. As understand- The underlying causes are multifactorial ing of these mechanisms may have high Heme oxygenase-1 (Hmox-1) catalyzes the and include an impaired biological activity potential for the development of new thera- degradation of heme, a process central to of the red cell hormone erythropoietin but peutic approaches for treatment of ACD we the recycling of iron from aged red blood also anti-proliferative effects of different are currently focusing our research in this cells. Since Hmox-1 is up-regulated in re- cytokines, like TNF-α and interleukin-1, to- area. sponse to Salmonella infection, we investi- wards the proliferation and differentiation gated a putative immune-modulatory role of of erythroid progenitor cells. Most impor- Research in Clinical Immunology and Hmox-1. The results obtained showed that tantly, an immunity driven diversion of cel- Clinical Infectious Diseases the early induction of Hmox-1 during the lular and systemic iron trafficking results in Within the last two years we could gain course of Salmonella infection is detrimen- iron retention within cells of the reticuloen- new insights into the role of immune acti- tal to the innate immune response. Induci- dothelial system and thus in an iron restrict- vation in patients with rheumatoid arthritis, ble knock-down of Hmox-1 in macrophages ed erythropoiesis. Novel treatment strate- COPD, HIV, and patients with solid tumors. resulted in improved bacterial killing attrib- gies are based on our expanding knowledge In patients with rheumatoid arthritis we utable to increased production of tumor ne- on the mechanisms underlying these patho- could demonstrate a relationship between crosis factor and of anti-bacterial reactive logic processes. The iron hormone hepcidin elevated neopterin and osteoprotegerin oxygen species. Therefore, Hmox-1 inhibi- as well as several cytokines are involved in levels before treatment with TNF-inhibi- tion may be an adjunct therapy in the set- macrophage iron retention. Pharmacologic tors. In patients with HIV we found a rela- ting of Salmonella Typhimurium infection. inhibition of hepcidin activity was previously tionship between alterations in tryptophan Lipocalin-2 (Lcn-2) is an innate immune pep- shown by us and others to increase the iron and iron metabolism, furthermore the role tide with pleiotropic effects. For instance, it delivery from macrophages and to reverse of disturbed amino acid metabolism in the stimulates the chemotaxis of neutrophils anemia, a novel therapeutic principle which development of neuro-psychiatric symp- and neutralizes bacterial siderophores. is now being tested in clinical phase I and II toms was discussed in a review. In patients Siderophores are small iron chelators trials. Macrophages also play a critical role with cancer we investigated the relationship

Research Report 2016 Medical University of Innsbruck 115 Center of Internal Medicine

between quality of life, depression and im- resenting the major cohort of patients, and disease-specific clinical database together mune activation. The clinical studies were efforts for improved screening within high with a clinical biobank will further support further focusing on identification of novel risk populations (e.g. patients with connec- translational research. Hyperuricaemia is diagnostic parameters for respiratory in- tive tissue disease). Interestingly, systemic a frequent clinical condition eventually re- fections and investigations toward on the iron deficiency without anemia is frequent sulting in gout. While local urate deposition potential benefit of physiotherapy in the in patients with pulmonary arterial hyper- results in activation of the immune system treatment of pneumonia. tension (PAH) (Figure 2). Whether this is an via the NALP3 inflammasome, hyperuricae- independent comorbidity or is causally re- mia also causes systemic metabolic effects, We could show different profiles of inflam- lated to the initiation or progression of PAH and increased circulating uric acid levels matory parameters and neopterin for the is still unknown. are a known risk factor for coronary heart differential diagnosis between community diseases. In a fruitful collaboration with the acquired pneumonia/CAP, COPD and CAP Our translational research aims to under- clinics of radiology this association is inves- plus COPD and in seasonal influenza. In a stand the physiological control of systemic tigated by the combination of state of the prospective pilot study we found that sets and cellular iron metabolism and its distur- art ultrasound and computer tomography and levels of volatile organic compounds/ bances in PAH. By investigation of clinical (DECT) imaging along with investigations of VOCs allow the discrimination between phenotypes of a cohort of PAH patients and the effects of immune-modulatory drugs on stable and exacerbated COPD (submitted). characterization of associated iron dysho- the course of the disease in vitro and in vivo. In another pilot study we could show that meostasis at serum and monocytes levels, physiotherapy in the treatment of elderly including cytokines, growth factors and An ongoing clinical study currently investi- patients with CAP improved the activities of mitochondrial function signature further gates the prevalence and nature of anemia daily life and duration of hospital stay (sub- insights on iron metabolism will be gained. in systemic rheumatic diseases, its impact mitted). on disease activity, morbidity and mortality Rheumatological Research along with its modification by disease mod- Pneumological Research Our clinical rheumatological research is ifying drugs. Our pneumological research is focused on focused on the evaluation of a new referral rare pulmonary diseases. The orphan lung tools for primary care physicians and spe- We conduct clinical trials in inflammatory diseases comprise many disorders such as cialists to our outpatient unit, diagnostic bowel disease, viral hepatitis, biliary dis- pulmonary arterial hypertension (PAH), lung issues (with specific impact on sonogra- eases, hepatocellular carcinoma or non-al- fibrosis, sarcoidosis and cystic lung diseas- phy), validation of new classification criteria coholic liver disease. To ascertain the high es. All those patients are registered within (e.g. for polymyalgia rheumatica and Be- quality requirements of good clinical prac- a database and a biobank with biological hcet's disease) and outcome of rheumatic tice our department employs two study co- specimen will be established. diseases (e.g. by supporting the interna- ordinators, Mag. Toaba and Mag. Zotter. Ongoing projects concern patients with tional evaluation of the new ASAS-health pulmonary arterial hypertension (PAH) rep- index). Our current work on a structured

Fig. 2: Prevalence of iron deficiency (%) in 84 patients with PAH depending on the ID definition.

116 Research Report 2016 Medical University of Innsbruck Internal Medicine II

Selected Publications Selected Funding

On-demand erythrocyte disposal and iron recycling requires • ERA-INFECT -Epigenetic basis and therapeutic implications of transient macrophages in the liver the cross-regulation of arginase 1 and inducible nitric oxide Theurl I, Hilgendorf I, Nairz M, Tymoszuk P, Haschka D, Asshoff M, synthase in chronic leishmaniasis and salmonellosis-- G. Weiss He S, Gerhardt LMS, Holderried TAW, Seifert M, Sopper S, Fenn • FWF (TAM Eisenmetabolismus in der Progression von AM, Anzai A, Rattik S, McAlpine C, Theurl M, Wieghofer P, Iwamoto Brustkrebs) – I. Theurl Y, Weber GF, Harder NK, Chousterman BG, Arvedson TL, McKee • Nationalbankprojekt (Jubiläumsfondsprojekt Nr. 17271 M, Wang F, Lutz OMD, Rezoagli E, Babitt JL, Berra L, Prinz M, "Klinische und translationale Untersuchung der Eisen Nahrendorf, M, Weiss G, Weissleder R, Lin HY, Swirski FK. Dyshomöostase bei Patienten mit Lungenhochdruck") - J. Löffler NATURE MEDICINE: 2016; 22: S. 945-51.

Iron Regulatory Proteins Mediate Host Resistance to Collaborations Salmonella Infection Nairz M, Ferring-Appel D, Casarrubea D, Sonnweber T, Viatte L, • Christian Bogdan, Mikrobiologisches Institut - Klinische Schroll A, Haschka D, Fang FC, Hentze MW, Weiss G, Galy B. Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum CELL HOST MICROBE: 2015; 18: S. 254-61 Erlangen and Friedrich-Alexander Universität (FAU) Erlangen- The Iron age of host-microbe interactions. Nürnberg, Erlangen, Germany Soares MP, Weiss G. • Thomas Decker, Max Perutz Laboratory, Dr. Bohr-Gasse 9, 1030 EMBO REPORT: 2015; 16: S. 1482-500 Vienna Vienna • Jonathan Jantsch, Institut für Klinische Mikrobiologie und Heme oxygenase 1 controls early innate immune response Hygiene, Universitätsklinikum Regensburg , 93053 Regensburg of macrophages to Salmonella Typhimurium infection • Martina U. Muckenthaler, Bruno Galy and Matthias W. Hentze, Mitterstiller AM, Haschka D, Dichtl S, Nairz M, Demetz E, Talasz H, Molecular Medicine Partnership Unit, European Molecular Soares MP, Einwallner E, Esterbauer H, Fang FC, Geley S, Weiss G. Biology Laboratory and University of Heidelberg, Heidelberg, CELL MICROBIOLOGY: 2016; 10: S. 1374-89 Germany • Ferric C. Fang, Department of Laboratory Medicine, University Macrophage defense mechanisms against intracellular of Washington, Seattle, WA, USA bacteria • Filip Swirski, Center for Systems Biology, Massachusetts Weiss G, Schaible UE General Hospital, Boston MMUNOLOGICAL REVIEWS: 2015; 264: S. 182-203

Lipocalin-2 ensures host defense against Salmonella Typhimurium by controlling macrophage iron homeostasis and immune response Nairz M, Schroll A, Haschka D, Dichtl S, Sonnweber T, Theurl I, Theurl M, Lindner E, Demetz E, Aßhoff M, Bellmann-Weiler R, Müller R, Gerner RR, Moschen AR, Baumgartner N, Moser PL, Talasz H, Tilg H, Fang FC, Weiss G. EUROPEAN JOURNAL OF IMMUNOLOGY: 2015; 45: S. 3073-3086

Patients suffering from axial spondyloarthritis (aSpA) show an age-inappropriate shrinkage of thymic output, shortening ot telomere lengths and an impaired telomerase enzyme as hallmark features of premature immunosenescence Fessler J, Raicht A, Husic R, Ficjan A, Duftner C, Schwinger W, Dejaco C, Schirmer M. Premature senescence of T-cell subsets in axial spondyloarthritis. ANNALS OF THE RHEUMATIC DISEASES: 2016; 75: S. 748-54.

Recommendations informing clinicians about best practices in the care of patients with PMR Dejaco C, Singh YP, Perel P, Hutchings A, Camellino D, Mackie S, Abril A, Bachta A, Balint P, Barraclough K, Bianconi L, Buttgereit F, Carsons S, Ching D, Cid M, Cimmino M, Diamantopoulos A, Docken W, Duftner C, Fashanu B, Gilbert K, Hildreth P, Hollywood J, Jayne D, Lima M, Maharaj A, Mallen C, Martinez-Taboada V, Maz M, Merry S, Miller J, Mori S, Neill L, Nordborg E, Nott J, Padbury H, Pease C, Salvarani C, Schirmer M, Schmidt W, Spiera R, Tronnier D, Wagner A, Whitlock M, Matteson EL, Dasgupta B. 2015 ANNALS OF THE RHEUMATIC DISEASES: 2015; 74: S. 1799-807

Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis Kurz, Katharina, Herold, Manfred, Russe, Elisabeth, Klotz, Werner, Weiss, Guenter, Fuchs, Dietmar, DISEASE MARKERS: 2015; : S. 276969

Research Report 2016 Medical University of Innsbruck 117 Center of Internal Medicine Internal Medicine III

Research Branch (ÖSTAT Classification) (Cardiology), Ass.-Prof. Dr. A. Mayr (Radiology), 302006, 302030, 302032 Dr. H-J. Feistritzer, PhD (Cardiology), Dr. S. J. Reinstadler, PhD (Cardiology), Keywords Dr. M. Reindl, PhD Student (Cardiology), Dr. L. Nieß, PhD Student (Cardiology), Atherosclerosis, angiogenesis, cardiac Currently 9 medical Diploma Students magnetic resonance tomography, cardio- vascular regeneration, aging, bio-marker Summary: The Working Group „Cardiac Magnetic Res- Research Focus onance Tomography (CMR)“ of Prof. Dr. B. Metzler, MSc was founded in 2002 and pub- The focus of our cardiovascular research lished over 50 peer reviewed publications group is based on 3 complementing since then. Their main focus is CMR in pa- ­columns to develop novel therapies for tients with ST-segment elevation myocar- cardiac and vascular regeneration as well dial infarction (STEMI), cardiac metabolic as the implementation of new imaging magnetic resonance spectroscopy and the methods and translational research to the development of novel clinical applications clinic: of phase-contrast CMR and MR-angiogra- Director (interim): phy in patients with aortic stenosis. Univ.-Prof. Dr. Günter Weiss Column 1: Cardiac Regeneration and ­Aging: The aim is to develop novel therapies The working group is based on a close co- Contact: to build new heart tissue and vessels. operation between the University Clinic of Anichstraße 35 Column 2: The major goal is to utilize novel Internal Medicine III, Cardiology and An- 6020 Innsbruck imaging technologies like MSCT or MRT to giology (Head: Prof. Dr. G. Weiss) and the monitor and improve clinical therapies. Department of Radiology (Head: Prof. W. [email protected] Column 3: Monitoring of international Jaschke) at the Medical University of Inns- Phone: +43-512-504-23251 phase 2–3 Clinical studies. bruck. The team of Prof. Metzler consists of Fax: +43-512-504-23317 two associate professors, two fellows with a http://inneremed3.tirol-kliniken.at/ General Facts clinical PhD and two PhD-Students as well as currently 9 diploma students. In the department of Cardiology and Angiology research is structured into In 2015 and 2016 the working group pub- several groups with distinct research lished 17 peer reviewed original research focusses ranging from translational articles and obtained six research grants. research on cardiovascular regeneration, International cooperation with the CMR atherosclerosis and angiogenesis to clinical working groups of Prof. H. Arheden at the research focussing on cardiac magnetic University Lund, Sweden and Prof. Dr. H. resonance tomography. The group of Thiele at the University Lübeck, Germany, Doz. Brenner works on cardiovascular with another seven publications, were initi- regeneration and stem cell therapy. Related ated. Future aims are to establish extended research is conducted by Doz. Zaruba cooperation with centres in Austria to per- and his group who also work on cardiac form multi-centre CMR studies. regeneration and aging. Doz. Zaruba recently received an FWF grant as outlined Cardiovascular Regeneration and Aging below. Prof. Metzler works on cardiac Leader: Ass.-Prof. PD Dr. Marc-Michael imaging by MRI especially related to acute Zaruba coronary syndroms. The group of Prof. Mair Group members: Ass.-Prof. M.M. Zaruba, works on cardiac biomarkers and clinical S.K. Ghadge (PhD), M. Messner (PhD implications. The group of Prof. Kirchmair student) and Dr. Theurl is doing research on vascular biology and angiogenesis. They described Research Topics: novel angiogenic factors, the neuropeptides I. Cell specific role of SDF-1 (Stromal catestatin and secretoneurin. Dr. Theurl cell-derived factor 1) in the recruitment received an FWF grant also outlined below. of progenitor cells after myocardial ischemiav(FWF P28817-B28). Research Ongoing research suggests a fundamen- tal role of the SDF-1/CXCR4 (CXC-Mo- Cardiac Magnetic Resonance Tomography tiv-chemokine receptor 4; SDF-1 receptor) Leader: Univ.-Prof. Dr. Bernhard Metzler, axis in cardiac repair and tissue homeo- MSc, FESC stasis after ischemia. Recently, we could Members: Assoz.-Prof. PD Dr. G. Klug demonstrate that genetic and pharmacolog-

118 Research Report 2016 Medical University of Innsbruck Internal Medicine III © Elsevier

Fig. 1: Feeding with high cholesterol diet (HD) leads to a significant increase of atherosclerotic plaques in the aorta of placebo treated mice as compared to animals on a normal diet (ND). The addition of the DPP4 inhibitor Sitagliptin reduced the development of atherosclerotic plaques and high cholesterol diet whereas the CXCR4 blocker AMD3100 abolished the Sitagliptin-mediate protective effect. ical inhibition of (SDF-1) degradation after homing and myocardial repair. ment of heart failure. myocardial infarction (MI) prevents adverse Future Goals: Cardiovascular Regeneration cardiac remodelling and may even enhance 1.) Lineage tracing of regenerative cell pop- Leader: Priv.Doz. Dr. med. Christoph Brenner cardiac regeneration. Nevertheless, the ulations in the neonatal and adult heart to Cardiovascular diseases are the most fre- precise cellular mechanisms how SDF-1 develop new therapies for severe heart fail- quent cause of death in Europe. None of dependent cell migration is orchestrated re- ure. the presently available options for the treat- main barely understood. In our current FWF ment of atherosclerosis has been shown to funded project we aim to identify important 2.) Elucidating the role of aging-related en- significantly reduce atherosclerosis. This cellular sources for SDF-1 dependent cell zymes in the development and progression vascular disease can lead to ischemic heart recruitment and cardiac repair. of heart failure. disease.

We first aim to investigate the cell specific II. Aging related splicing variants in The aim of our working group is to identify effects of SDF-1 ablation in smooth muscle patients with cardiomyopathy basic cellular mechanisms in cardiovascular cells and pericytes with respect to myocar- Ass.-Prof. M.M. Zaruba, disease that can be transferred to and in- dial CXCR4+ cell recruitment and cardiac S.K. Ghadge (PhD), vestigated in clinical trials. repair utilizing conditional SDF-1 specific M. Messner (PhD student) knockout mouse models. Further studies Defined mutations in the human lamin A We have recently shown that phar­ are designed to elucidate the therapeutic gene or in enzymes processing the impor- macological inhibition of DPP4 (dipeptidyl- potential of HIF (hypoxia-inducible factor) tant nuclear membrane protein LMNA (e.g. peptidase 4) can improve recruitment of -prolylhydroxylase inhibitors (PHI) to induce Zmpste24) are causally involved in prema- regenerative cells from the blood into dis- SDF-1 gene expression and stimulate cardi- ture aging syndromes like progeria. Patients eased cardiovascular tissue in a preclinical ac repair in the ischemic heart. suffering from progeria develop severe car- model. In a next step we were then able diovascular morbidities like stroke, myocar- to translate these promising results into a Ultimately, these approaches might be dial infarction, and severe atherosclerosis phase III clinical trial. very useful to develop novel therapies to leading to early death. augment myocardial repair mechanisms Lab-2-Go puts Device through its Paces. or even reconstitute myocardial mass fol- We are currently using this model to investi- The university has launched a study of lowing cardiac injury. Our preliminary data gate new targets that can inhibit this aging the practical application of a measuring suggest that inhibition of prolyl hydroxylase process. In the current projects we inves- device developed by four European may be a promising target for HIF-1α medi- tigate whether premature aging enzymes, companies that enhances the chances ated SDF-1 activation to increase stem cell such as LMNA, play a role in the develop- of recovery for cardiovascular patients.

Research Report 2016 Medical University of Innsbruck 119 Center of Internal Medicine © R . Kirchmair

Fig. 2: Pellets (P) containing Control buffer, VEGF (vascular endothelial growth factor) or Secretoneurin were implanted into mouse corneas. Vessels are stained by fluorescence labelled lectin. Secretoneurin and VEGF induce growth of blood vessels out of limbus artery (red arrow) towards the pellet.

Leader: Prof. Johannes Mair tended to form the basis for fine-tuning the stimulation of growth factor receptors. In suspected cases of acute myocardial in- device, followed by approval of the Minicare farction (AMI), rapid and reliable diagnosis diagnosis system in Europe and ultimately improves the chances of survival, as well as worldwide. minimising complications later on. Cardiac troponin I is a reliable indicator of heart Therapeutic Angiogenesis by muscle damage. This protein is normally Secretoneurin and Catestatin identified in hospital laboratories, a process Leader: Prof. Rudolf Kirchmair. that takes at least an hour. However, four Team members: companies – Philips, Conworx Technology, Markus Theurl M.D., Daniela Lener, Micro Systems Limited and Scienion AG Ursula Stanzl, Clemens Gutmann – have come up with a handy biophotonic We could recently demonstrate that point-of-care measuring device called Min- the neuropeptides Secretoneurin and icare. The instrument should enable iden- Catestatin induce angiogenesis in models tification of cardiac troponin I in minutes, of limb and cardiac ischemia. These findings allowing doctors to diagnose myocardial were accompanied by positive effects on damage. vascular cells as shown by stimulation of receptors for potent angiogenic cytokines Clinical Evaluation like VEGF (vascular endothelial growth As part of the EU’s Lab-2-Go project, Pro- factor), FGF (fibroblast growth factor) fessor Johannes Mair and his team (Uni- and IGF (insulin-like growth factor). versity Hospital for Internal Medicine III, Secretoneurin gene therapy exerted these Cardiology and Angiology) started a clinical effects not only in healthy animals but also study in mid-January 2015 to investigate in Apo E knock out mice which exhibit a the Minicare’s application in practice and high vascular risk. to improve technical applications in the system A further six European cardiolo- Future studies should evaluate exact gy centres, based in France, Germany, the mechanisms of Secretoneurin mediated Netherlands and the UK, are participating in this multi-centre study. The results are in-

120 Research Report 2016 Medical University of Innsbruck Internal Medicine III

Selected Publications Selected Funding • Ass.-Prof. M.M. Zaruba: FWF P28817-B28: "Smooth muscle Gliptins and their target dipeptidyl peptidase 4: implications specific role of SDF-1 in cell recruitment and cardiac repair af- for the treatment of vascular disease ter MI”. 327.512 Euro. Remm, Friederike, Franz, Wolfgang-Michael, Brenner, Christoph, • Dr. Markus Theurl: FWF P26251 : “Catestatin for treatment of EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACO- myocardial ischemia”. 262.731 Euro. THERAPY: 2016; 2: S. 185-193

Combined therapy with sitagliptin plus granulocyte-colony Collaborations stimulating factor in patients with acute myocardial infarc- tion-Long-term results of the SITAGRAMI trial • Charité Centrum Herz-, Kreislauf- und Gefäßmedizin, Medizi- Gross, Lisa, Theiss, Hans Diogenes, Grabmaier, Ulrich, Adrion, nische Klinik für Kardiologie, Berlin, Deutschland: Dr. Nicolle Christine, Mansmann, Ulrich, Sohn, Hae-Young, Hoffmann, Ellen, Kränkel, Univ.-Prof. Dr. Ulf Landmesserz Steinbeck, Gerhard, Franz, Wolfgang-Michael, Brenner, Christoph, • Medizinische Klinik und Poliklinik I, Klinikum der Universität INTERNATIONAL JOURNAL OF CARDIOLOGY: 2016; 215: S. 441- München – Großhadern, Deutschland: Prof. Dr. Hans Theiss, Dr. 445 med. Sebastian Clauß • Prof. H. Arheden at the University Lund, Sweden Sitagliptin plus granulocyte colony-stimulating factor in • Prof. Dr. H. Thiele at the University Lübeck, Germany patients suffering from acute myocardial infarction: A dou- ble-blind, randomized placebo-controlled trial of efficacy and safety (SITAGRAMI trial) Brenner, Christoph, Adrion, Christine, Grabmaier, Ulrich, Theisen, Daniel, von Ziegler, Franz, Leber, Alexander, Becker, Alexander, Sohn, Hae-Young, Hoffmann, Ellen, Mansmann, Ulrich, Steinbeck, Gerhard, Franz, Wolfgang-Michael, Theiss, Hans Diogenes, INTERNATIONAL JOURNAL OF CARDIOLOGY: 2016; 205: S. 23-30

Pharmacological DPP4 inhibition for the prevention of vas- cular diseases Brenner, C., Franz, W. M., INTERNATIONAL JOURNAL OF CARDIOLOGY: 2016; 202: S. 49-49

DPP-4 inhibition ameliorates atherosclerosis by priming monocytes into M2 macrophages Brenner, C., Franz, W. M., Kuehlenthal, S., Kuschnerus, K., Remma, F., Gross, L., Theiss, H. D., Landmesser, U., Kraenkel, N., INTERNATIONAL JOURNAL OF CARDIOLOGY: 2015; 199: S. 163- 169

Secretoneurin gene therapy improves hind limb and cardi- ac ischaemia in Apo E-/- mice without influencing systemic atherosclerosis Theurl M, Schgoer W, Albrecht-Schgoer K, Lener D, Wolf D, Wolf M, Demetz E, Tymoszuk P, Tancevski I, Fischer-Colbrie R, Franz WM, Marschang P, Kirchmair R. Cardiovascular Research: 2015;105: S. 96-106

Oscillometric analysis compared with cardiac magnetic res- onance for the assessment of aortic pulse wave velocity in patients with myocardial infarction Feistritzer, Hans-Josef, Klug, Gert, Reinstadler, Sebastian J., Rein- dl, Martin, Mayr, Agnes, Schocke, Michael, Metzler, Bernhard, JOURNAL OF HYPERTENSION: 2016; 34: S. 1746-1751

Heart rate and left ventricular adverse remodelling after ST-elevation myocardial infarction Reindl, Martin, Reinstadler, Sebastian Johannes, Feistritzer, Hans-Josef, Tiller, Christina, Mayr, Agnes, Klug, Gert, Metzler, Bernhard, INTERNATIONAL JOURNAL OF CARDIOLOGY: 2016; 219: S. 339- 344

Prognostic value of left ventricular global function index in patients after ST-segment elevation myocardial infarction Reinstadler, Sebastian J., Klug, Gert, Feistritzer, Hans-Josef, Kofler, Markus, Pernter, Bastian, Goebel, Georg, Henninger, Benjamin, Mueller, Silvana, Franz, Wolfgang-Michael, Metzler, Bernhard, EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING: 2016; 17: S. 169-176

Cardiomyocyte-derived CXCL12 is not involved in cardio- genesis but plays a crucial role in myocardial infarction Muehlstedt, Silke, Ghadge, Santhosh K., Duchene, Johan, Qadri, Fatimunnisa, Jaerve, Anne, Vilianovich, Larisa, Popova, Elena, Pohlmann, Andreas, Niendorf, Thoralf, Boye, Philipp, Ozcelik, Ce- mil, Bader, Michael, JOURNAL OF MOLECULAR MEDICINE-JMM: 2016; 94: S. 1005- 1014

Research Report 2016 Medical University of Innsbruck 121 Center of Internal Medicine Internal Medicine IV

Research Branch (ÖSTAT Classification) well as inpatients facilities and a state of the art unit for extra-corporeal therapy (hemo- 302050 as well as peritoneal dialysis, plasmapher- esis, liver support therapy, immune-ad- Keywords sorption) allow us to serve a large clinical population and this background drives our Chronic kidney disease, pathophysiology, translational research efforts. The laborato- systems biology, stratified/personalized ries of the Department maintain a clinical medicine, epidemiology, autoimmune dis- routine as well as a molecular biology (in- ease, hemodialysis, cardiovascular mortal- cluding microarray facility) and cell culture ity, renal transplantation unit. Our clinical trial core unit manages in- vestigator driven projects as well as the par- Research Focus ticipation in large multicentre clinical trials and a large bio-banking effort. In order to better characterize patho-phys- iologically complex phenotypes such as The most recent project is to relocate the chronic kidney disease, we apply modern „Austrian Dialysis and Transplantation Reg- epidemiology and “Omics”-techniques in istry“ to Innsbruck in collaboration with the Director: conjunction with state of the art systems bi- Department of Statistics, Informatics and Univ.-Prof. Dr. Gert Mayer ology approaches to derive prognostic and Health Economy. The common denominator predictive biomarkers to implement innova- of the Department´s research activity is the Contact: tive stratified/personalized treat-ment. This area of personalized/stratified medicine in Anichstraße 35 translational research focus is supported by the various aspects of Nephrology and we 6020 Innsbruck experimental and clinical studies in select- collaborate with multiple academic and in- ed populations and by strong national and dustry partners in national and/or EU fund- [email protected] international collaborations. ed projects. During our recent activities Phone: +43 512 504 25855 we focused primarily on the application of Fax: +43 512 504 25857 General Facts systems-biology techniques within the FP https://nephrologie.tirol-kliniken.at 7 funded project SysKid, to which our De- The Department is the tertiary referral cen- partment was one of the main contributors. tre for patients with acute and chronic renal Last year a successor project (Beat-DKD) diseases (native kidney, renal replacement was funded by the Innovative Medicine Ini- therapy, kidney transplantation) and hyper- tiative. Beat-DKD again is a large consorti- tension for the Western part of Austria and um project with 28 academic and industry Southern Tyrol. Specialised outpatients as partners and next to WP lead functions our

VALIDATION INTEGRATION DISCOVERY TRANSLATION

WP1 BM in observational prospective studies

WP5 Validation PERSONALIZED Integration WP2 Systems medicine MEDICINE Efficacy BM in intervention studies

WP3 Mechanisms & pathways WP6 Qualification Medical products

WP4 Imaging BM

Fig. 1: The work package structure of Beat-DKD.

122 Research Report 2016 Medical University of Innsbruck Internal Medicine IV

Department is involved in various research activities (figure 1).

Research

Basic Research Activities

Cellular and Molecular Nephrology Lead: Herbert Schramek MD, Markus Pirklbauer MD Diabetes mellitus (DM) is a major and grow- ing health problem worldwide. Normalizing hyperglycemia is not only crucial for slow- ing progression of the disease process but also for preventing secondary consequenc- es such as diabetic nephropathy. Sodium glucose cotransporters SGLT2 and SGLT1 in the apical membrane of the proximal tu- bule have been established as the primary mechanisms of glucose reabsorption in the kidney. Inhibitors of SGLT2 have recently been approved for human use in type 2 DM. Although studies in mice have shown that pharmacological SGLT2 inhibition itself in- Fig. 2: The effect of SGLT-2 inhibitors and cytokines on SGLT-2 mRNA expression levels in creases renal SGLT2 protein expression and the proximal tubular cell line RPTEC/TERT1 although expression of SGLT2 mRNA and protein is increased in renal biopsies from human subjects with diabetic nephropathy, capture micro-dissection, renal compart- pharmaceutical industry, and in the Austri- there is very limited data in the literature ment specific differential mRNA and miR- an TOPVAS study, which recruits patients about the regulation of sodium gradient NA expression in human and animal tissue, after renal transplantation and dissects the dependent glucose transporter expression. Doz. Dr. Michael Rudnicki focuses on re- effects of ageing on transcriptional pro- The lab is currently studying the effects of spective combined data analysis. In collab- files in the kidney and calcineurin inhibitor pharmacological inhibitors of sodium glu- oration with the Mario Negri Institute (Ber- toxicity. In order to validate our “in silico” cose cotransporters on gene expression in gamo/Italy) we were able to identify and derived hypotheses on predictive biomark- human proximal tubular cells. Utilizing two characterize a novel miRNA (miR-184) as a ers we are also leading several large scale, SGLT2 inhibitors, namely Empagliflocin and downstream effector of albuminuria, which national and multinational prospective co- Canagliflocin, we investigate their effects drives renal fibrosis in a rat model of diabet- hort studies with (e.g. PROVALID, a study on SGLT2 and GLUT2 expression in the ic nephropathy. Further miRNAs are being in 4.000 patients with type 2 diabetes in 5 presence and in the absence of pro-inflam- studied as serum biomarkers to distinguish European countries; TOPVAS including 240 matory and pro-fibrotic ligands such as IL- diabetic from non-diabetic renal diseases. patients after renal transplantation in Aus- 1β and TGF-β1. Additional study endpoints Recently, in-house generated transcriptom- tria) or without bio-banking (Austria Dialysis are the expression of TSP-1, CTGF, CCL2, ics data were complemented by proteomic, and Transplant Registry). The data collect- CCL5, and IL-6. In a second ongoing exper- metabolomic and genomic profiles in the ed there form the basis for outcomes and imental approach, cDNA microarray anal- large, multinational EU FP-7 funded project health economics research on a European ysis is performed in the two independent SysKid (Systems Biology towards Novel level. proximal tubular cell lines RPTEC/TERT1 Chronic Kidney Disease). In collaboration and HK-2 exposed either to Empagliflocin with EMERGENTEC biodevelopment and the Assoc. Prof. Dr. Hannes Neuwirt, another or Canagliflocin when compared with un- Medical Universities of Vienna and Gronin- team member, is working on biomarkers treated control cells. One of several inter- gen we developed a system biology derived that predict long term graft function and esting preliminary results of these studies molecular model of renal disease in type II the role of the complement system in kid- is shown in figure 2. diabetes and identified molecular process- ney transplant models. A further clinical es associated with progressive renal func- research focus is on ABO incompatible re- Translational Research Activities tion loss. Biomarkers reflecting these path- nal transplantation. Additionally Dr. Neuwirt ways were discovered and validated in large is exploring alternative dialysis modalities, Transcriptional Profiling and Systems patient cohorts. Currently we are working such as electro-osmosis in collaboration Biology Application in Chronic Renal to match the disease specific molecular with Prof. Thomas Bechtold (Research Insti- Disease profiles with drug mode of action molecular tute of Textile Chemistry and Textile Physics Lead: Johannes Leierer PhD, Gert Mayer MD profiles to gain access to targeted therapy. University). Several years ago we established (in col- This approach will be put forward in the IMI laboration with the University of Stanford/ project BEAT-DKD, which started late 2016 Dr. Julia Kerschbaum, MSc, a further mem- California) microarray technology to study and coordinates the efforts of many aca- ber of our team, is working on prediction whole organ and, via application of laser demic centres from around the world and models for adverse events in patients with

Research Report 2016 Medical University of Innsbruck 123 Center of Internal Medicine

tional studies on the safety of the ADH an- tagonist Tolvaptan for treatment of autoso- mal-dominant polycystic kidney diseases.

Living kidney donation is the optimal treat- ment for patients with end-stage renal dis- ease, but data on the risks for the donors are controversially discussed. In a close collaboration with the Department of Vis- ceral, Transplant and Thoracic Surgery we evaluated the long-term clinical course of live kidney donors who donated their kidney in Innsbruck between 1985 and 2015. The risks of chronic kidney and cardiovascular disease have been quantified, and risk fac- tors have been identified, which are now being used for risk stratification of future kidney donors. In addition we currently eval- uate the impact of donor characteristics on the graft function of the recipient.

Regarding the excessive cardiovascular mortality in patients with end stage renal disease, Markus Pirklbauer investigates the possible detrimental effect of positive calcium mass balance during hemodialy- sis. Supported by an educational research

. 2016 grant provided by the Austrian National Bank we recently published first experimen- tal evidence for the existence of a rapidly exchangeable calcium pool counteracting

© J Immunol Res acute deviations of extracellular calcium concentration in hemodialysis patients, and Fig. 3: A current concept of our understanding of FSGS: A circulatory factor, yet to be identi- for the involvement of bone in acute extra- fied, leads to podocyte damage and this again may intiate the onset of nephrotic syndrome. cellular calcium regulation in vivo. Based on Several factors, including soluble urokinase plasminogen activator receptor (suPAR) have the promising results of our acute calcium been discussed, leading to β3-integrin activation and downstream to podocyte changes (foot kinetics studies we are currently establish- process effacement and proteinuria) ing a research-collaboration with the Renal Research Institute New York (Head: Prof. Peter Kotanko). chronic kidney disease. In particular, she analysis of PD patients treated locally and is interested in the prediction of cardiovas- in a multicentre national study, Julia Ker- The kidney is often affected by autoimmune cular events and kidney failure in patients schbaum and Michael Rudnicki identified disorders. Our research aim is delineating with type II diabetes. Furthermore, she is factors associated with risk of peritonitis. pathogenetic steps in nephrotic syndrome working on general epidemiological issues Interestingly oral active vitamin D therapy (figure 3), anti-neutrophil cytoplasm anti- in order to identify factors which might im- was associated with a decreased incidence body (ANCA)-associated vasculitis (figure prove prognosis in our patients and she is and improved survival. In collaboration with 4) and systemic lupus erythematosus (SLE). a main contributor to the “Austrian Dialysis the Department of Nephrology, Ospedali We are currently working on a proteomics and Transplantation” registry transfer. Riuniti di Bergamo/Italy, we examined the approach using a novel method (SWATH- effect of an anti-CD20 antibody in frequent- MS), which may help to identify novel candi- Clinical Research Activities ly relapsing nephrotic diseases in children dates in proteinase 3 (PR3)-positive vasculi- and in adults. tis (supported by Addenbrooke’s Charitable Targeted Therapy in Renal Disease Trust). Moreover, we aim to delineate the Lead: Michael Rudnicki MD (peritoneal Based on data obtained in a prospective connection between autoimmunity and the dialysis, anti CD20, rare diseases such as study and a review we were able to show human microbiome. Staphylococcus aureus ADPKD or Mb. Fabry, live kidney donation), that this approach is a valuable therapeu- may be directly involved in the etiopatho- Markus Pirklbauer MD (cardiovascular tic option. In collaboration with the Depart- genesis of granulomatosis with polyangii- mortality on hemodialysis); ment for Pediatrics we treat and recruited tis (GPA). We are currently working on two Andreas Kronbichler MD (autoimmune patients with rare diseases, in particular projects, one supported by NIHR and one diseases) Fabry´s disease, into a European multicen- by Arthritis Research UK, to check wheth- Peritonitis is the most serious complication tre study on enzyme replacement therapy. er colonization with Staphylococcus aureus in patients on peritoneal dialysis (PD). In an We also participate in national and interna- is secondary to vasculitis or coincides with

124 Research Report 2016 Medical University of Innsbruck Internal Medicine IV

the onset/relapse of the disease. Thus, the Clearly, the future aim will be a combina- Selected Publications future aims are to combine clinical findings tion of these events with a mechanistic ap- Effect of rituximab on malignancy risk in patients with with an experimental setting to increase the proach potentially revealing patients at risk ANCA-associated vasculitis van Daalen EE, Rizzo R, Kronbichler A, Wolterbeek R, Bruijn JA, understanding of these diseases. These ef- to develop such complications. This effort Jayne DR, Bajema IM, Rahmattulla C forts are driven forwards via collaboration is driven via collaborations within the Eu- ANN RHEUM DIS: 2016; doi: 10.1136/annrheumdis-2016-209925 with Dr. David Jayne (Cambridge University ropean Vasculitis Society. In addition, the International Network of Chronic Kidney Disease cohort Hospitals, UK). From a clinical perspective, research group will participate in several studies (iNET-CKD): a global network of chronic kidney disease cohorts we are mainly interested in complications clinical trials and is currently co-investiga- Dienemann T, Fujii N, Orlandi P, Nessel L, Furth SL, Hoy WE, of immunosuppressive treatment, i.e. in- tor in a European trial aiming to investigate Matsuo S, Mayer G, Methven S, Schaefer F, Schaeffner ES, Solá L, Stengel B, Wanner C, Zhang L, Levin A, Eckardt KU, Feldman HI. fectious complications, malignancy and ve- the role of extracorporeal treatment (IAS) in BMC NEPHROL 2016 doi: 10.1186/s12882-016-0335-2 nous thromboembolic events. refractory SLE. Acute calcium kinetics in haemodialysis patients Pirklbauer M, Schupart R, Mayer G EUR J CLIN INVEST 2016;46:976-984

Renal microRNA- and RNA-profiles in progressive chronic kidney disease. Rudnicki M, Perco P, D´haene B, Leierer J, Heinzel A, Mühlberger I, Schweibert N, Sunzenauer J, Regele H, Kronbichler A, Mestdagh P, Vandesompele J, Mayer B, Mayer G. EUR J CLIN INVEST 2016;46:213-26

Selected Funding

• Hämoelektroosmose; Austria Wirtschaftsservice Ges.m.b.H. ; Hannes Neuwirt • Arthitis Research UK Microbiome Pathfinder Award; Andreas Kronbichler

Collaborations

• Bernd Mayer, EMERGENTEC biodevelopment GmbH; Vienna, Austria • Rainer Oberbauer, Division of Nephrology and Dialysis; Medical University Vienna • Harald Mischak, Mosaiques Diagnostics GmbH; Hannover, Germany • Peter Rossing, STENO Diabetes Center; Gentofte, Denmark • Johannes Mann, Universität Erlangen; Erlangen, Germany • Dick de Zeeuw, Hiddo Lambers Heerspink, Academisch Ziekenhuis; Groningen, The Netherlands • Andrzej Wiecek, Slaski Uniwersytet Medyczny Katowicach; Kattowice, Poland • Laszlo Rosivall, Semmelweis University; Budapest, Hungary • Patrick Mark, University of Glasgow; Glasgow, UK • Timothy Meyer, Stanford University School of Medicine; California, USA • David Jayne, Vasculitis and Lupus Clinic, Cambridge University Fig. 4: The "bacterial signature" of patients with vasculitis may help to discriminate active Hospitals; United Kingdom patients from inactive, healthy and diseased controls. • Annette Bruchfeld, Division of Renal Medicine, Karolinska Institutet; Stockholm, Sweden • Daiki Nakagomi, Department of Allergy and Clinical Immunology, Chiba University; Chiba, Japan • Thomas Neumann, Department of Internal Medicine III, Jena University Hospital; Jena, Germany • Jae Il Shin, Department of Pediatric Nephrology, Yonsei University College of Medicine, Severance Children’s Hospital; Seoul, Korea • Piero Ruggenenti, Department of Nephrology, Ospedali Riuniti di Bergamo/Italy • Peter Kotanko, Renal Research Institute, Mt Sinai Medical Center, New York, USA • Mathias Kretzler, Ann Arbour University Michigan, USA

Research Report 2016 Medical University of Innsbruck 125 Center of Internal Medicine Internal Medicine V

Research Branch (ÖSTAT Classification) malignant hematological diseases and solid neoplasms. Interdisciplinary competence 302024, 302055, 302058, centers have been established for hemato- 302013, 302009 logical diagnostics (IHK) and hematopoietic stem cell production (ICCT). In 2016, 30- Keywords 40 clinical studies were active for patient recruitment. Approximately 10% of the Personalized cancer medicine, precision cancer patients are currently entered into oncology, geriatric assessment, molecular ­academic or industry-sponsored clinical profiling, 3D tumor tissue culture, studies. In addition, UKIM5 plays a major biomarker, immuno-oncology role in health care research as coordinat- ing center for several regional and national Research Focus registries (CML, myeloma, MDS, lymphoma, lung cancer, soft tissue sarcoma). Further, The clinical research of The Department since 2012 UKIM5 offers a postgraduate of Internal Medicine 5 (UKIM5) is focused Clinical PhD program for Clinical Cancer on interventional clinical trials (phase I – Research. III), clinical drug development and health Director: care research, including clinical outcome Research Univ.-Prof. Dr. Günther Gastl ­research in “real life”, clinical decision mak- ing and cost-effectiveness analysis of thera­ Tumor Angiogenesis Contact: peutic interventions in hematology and Doz. Dr. Eberhard Gunsilius Anichstraße 35 oncology. UKIM5 is dedicated to promote The tumor angiogenesis group investigates 6020 Innsbruck and further develop the principles of per- predictive biomarkers for antiangiogenic sonalized cancer medicine for curative and therapies and screens natural and synthetic [email protected] pallia­tive cancer medicine based on patient compounds for their anti-angiogenic activi- Phone: +43 512 504 24003 assessment, tumor profiling and continu- ty in-vivo using the chorion allantois mem- Fax: +43 512 504 25615 ous disease monitoring. As core infrastruc- brane (CAM) assay. Novel marine-derived www.haematologie-onkologie.at ture of the Comprehensive Cancer Center compounds were tested for anti-myeloma ­Innsbruck (CCCI), UKIM5 cooperates and antiangiogenic activities in vitro and in with its clinical partners at the University vivo. Multiple myeloma (MM) cell lines NCI- ­Hospital, the OncoNetwork of Western Aus- 929, OPM-2 and U266 and primary human tria/South Tyrol and with clinical research­ MM cells were used for in vitro drug testing. groups and networks at the national and in- In, addition, a culture system of MM cells ternational level. was established in a bone-resembling ma- Translational research is focused on bio- trix, where eGFP-transfected MM cell lines marker research & development using in allowed the determination of tumor growth vitro test systems and tissues and body and apoptosis by a GFP-ELISA and visualiza- fluids collected ex vivo, comprehensive tion of the tumor size by confocal microsco- molecular cancer profiling, drug testing in py in vitro and in vivo (MM xenografts in the vitro and in vivo and development of com- CAM assay). 4 marine compounds (Plitidep- binatorial treatment approaches including sin, Zalypsis, PM00113, and Thiocoraline A) antiangiogenic and immunotherapeutic showed considerable anti-myeloma activ- interventions. Within the CCCI UKIM5 col- ity in vitro and in vivo. Apart from directly laborates in translational and basic cancer affecting myeloma cells, marine-derived research with its clinical partners, preclin- compounds (Plitidepsin-analogs PM01215 ical institutes and research faciltities (eg., and PM02781) also exert antiangiogenic CCB, Austrian Drug Screening Institute), activity on HUVECs at nanomolar concen- ONCOTYROL, the Tyrolean Cancer Research trations. Moreover, some compounds inhib- Institute, UMIT, and research institutions, ited angiogenesis in vivo (CAM assay). Two networks and platforms in Austria, Europe analogs of Plitidepsin were shown to induce and in the US. cell cycle arrest in G1 phase, expression of the cell cycle inhibitor p16INK4A and General Facts senescence-associated beta galactosidase activity. PM01215 and PM02781 induce ox- UKIM5 comprises a 50 bed-hospital includ- idative stress and cause alterations in vas- ing a stem cell transplation unit, an outpa- cular maturation factors Vasohibin-1 and tient clinic, an oncology trial center (OTC), Dickkopf-3. laboratory services, translational research The cytokine FLT3-ligand (FLT3-L) is in- facilities and a FACS sorting core facility. volved in the growth and differentiation of UKIM5 provides state-of-the-art care pri- hematopoietic cells and is involved in the marily for patients with non-malignant and angiogenic processes of MM. FLT3-L was

126 Research Report 2016 Medical University of Innsbruck Internal Medicine V

cused on molecular profiles of MM and genetic changes in MM-associated vascular ­endothelium.

Translational Oncology Prof. Dr. Heinz Zwierzina This group developed a 3D cell culture (“hanging-drop system”) model reflecting the tumor microenvironment (“microtis- sues”). The compound culture model con- sists of 3 different cell types (tri-culture), cancer cells, fibroblasts and endothelial cells. This cell culture model using cell lines can be used for investigating infiltrating im- mune cells in cancer tissue (Fig 1). Recent- ly, in cooperation with the Depts of Surgery and Pathology, primary tumor tissue from cancer patients was cultivated to generate 3D microtissues from lung and GI carcino- mas (Fig. 2). Currently, the effect of au-

© Immunobiology Journal tologous immune cells on matched cancer microtissues is being investigated. Further, Fig. 1: Cell line A549 (A) (B) and A549 + SV80 fibroblasts (C) (D) cultured for 10 days followed this group is establishing a biobank for “liq- by co-incubation with PBMC (for 24 h) with or without IL-2. Anti-E-cadherin (brown) and uid biopsies” from cancer patients undergo- anti-CD45 (red) double staining; Bar 100 µm ing immunotherapeutic interventions. evaluated in bone marrow of MM patients in MM patients. Thus FLT3-L could become Biomarkers for Tumor Immunity & for its prognostic significance. Bone mar- useful as a biomarker for early identification Immune Monitoring row plasma levels of FLT3-L were deter- of RRMM patients. Further, the research PD Dr. Sieghart Sopper mined in patients with monoclonal gam- group focused on differences in responses A major topic of the group is the phenotypic mopathy of undetermined significance to proteasome inhibition (PI) and unfolded and functional characterization of immune (MGUS), patients with newly diagnosed MM protein responses (UPR) between sensitive cells involved in tumor-host interactions (NDMM) and patients with relapsed/refrac- and refractory MM and intrinsically resist- and during treatment of different cancer tory MM (RRMM) by a sandwich ELISA. High ant solid tumor cell lines. Responsiveness entities. This includes assessment of leuko- levels of FLT3-L (threshold FLT3-L >92 pg/ to Bortezomib (BTZ) is based on a complete cyte subpopulations in the blood of hema- ml) in bone marrow of MM patients identify inhibition of the proteasome in MM cells tologic malignancies (CML, MDS) as well as patients with progressive disease and are and intact induction of p53/Noxa-medi- investigations of immune competent cells associated with relapse or refractoriness ated apoptosis. Currently, research is fo- isolated from solid tumor tissue derived

A B

Fig. 2: Microtissue established from NSCLC cancer in a hanging drop (panel A, 40x) and a HE stained section (panel B) of FFPE microtissue.

Research Report 2016 Medical University of Innsbruck 127 Center of Internal Medicine

from lung and ovarian cancer. By combining tablish the relevance of assessment scores Experimental & Clinical Cancer multidimensional flow cytometry with multi- including HRQoL and functional capacities Genomics plex determination of soluble analyte, levels as patient-reported outcomes (PROs). The PD Dr. Gerold Untergasser, of CD62L in peripheral blood were found MDS-Right project has a strong focus on Prof. Dr. Michael Steurer to be predictive for molecular responses of HRQoL in MDS cancer patients with the This group is focused on molecular profiling CML patients to TKI treatment. With a new aim of improving HRQoL by taking into ac- of solid tumors and hematological malig- high-end flow cytometer funded by the FFG count impairments assessed with recently nancies in order to genomically character- this research area will be expanded in the developed questionnaires (QUALMS).The ize malignancies at diagnosis, recurrence near future. ultimate goal is to develop guidelines to and at the refractory stage. Molecular Cancer stem cells provide potential tar- tailor healthcare interventions according to profiling is mainly based on targeted NGS gets for immunotherapeutic interventions. a patient’s individual needs. In 2016, Prof. technology and is supplemented by expres- In a systematic screen of dozens of can- Stauder received the prestigious Paul Cal- sion profiling, immunohistochemistry, flow cer cell lines, we found that expression of abresi Award from the International Society cytometry and ELISA. The primary goal is ABC transporters defines cells with stem of Geriatric Oncology (SIOG) for outstanding the detection of prognostic and/or predic- cell properties. Using differential gene ex- achievements in geriatric oncology (Fig. 3). tive genomic biomarkers and druggable pression analysis, we identified the guano- driver mutations or down-stream signaling sine exchange factor VAV3 as a potential pathways for selecting appropriate targeted stem cell specific target. Expression of a agents or combinatorial therapeutic strate- truncated variant of VAV3 was found to be gies. In solid tumors, the role of EpCAM as associated with refractiveness to platinum a prognostic and predictive biomarkers has based therapy in a cohort of ovarian cancer been studied for more than 10 years. Re- patients. A patent was filed on the use of cently, monoclonal antibodies recognizing VAV3 splice variants as a novel biomarker the extracellular portion and the intracel- for cancer. The next steps include the val- lular signaling part of the EpCAM molecule idation of this marker in other cancer enti- have been developed, allowing investigation ties and investigations of the function of the of the signaling state of this transmembane truncated variant in malignant cells as well cell adhesion molecule. In 2015, a collabo­ as its immunogenic potency. ration with Caris Life Sciences (Phoenix, USA) was started for profiling recurrent Biology of Ageing and Personalised Fig. 3: Prof. Reinhard Stauder, Recipi- or refractory solid tumors and designing Treatment of Elderly Cancer Patients ent of the Paul Calabresi Award from the therapies according to molecular profiles Prof. Dr. Stauder, MSc ­International Society of Geriatric Oncology (ONCO-T-PROFILE program). In addition, This group is focused on integrating a pa- (SIOG) multiple myeloma and B-CLL have been tient’s individual health status (comorbid- selected as malignant disease models in ities, performance and nutritional status) order to investigate the clonal evolution and health-related quality of life (HRQoL of these cancers and to identify potential including mood, mobility, depressions, therapeutic targets during disease progres- functions of daily living) in treatment deci- sion. Recently, molecular profiling has been sions in order to improve clinical outcome complemented by immunoprofiling of solid and ameliorate treatment-related toxicities. and liquid neoplasms (in collaboration with Currently two research projects promote the Tumor Immunology Group) and a clinical these goals: (1) the ERA-NET “Triage-MDS” program (COMBASKET) was set up for com- Translational Implementation of genetic binatorial therapeutic interventions with im- evidence in the management of MDS pro- mune checkpoint blockade as a backbone. ject within the TRANSCAN primary and secondary prevention of cancer call, and the H2020 project MDS-RIGHT (providing the right care to the right patient within the MyeloDysplasticSyndrom at the right time). Both projects are embedded in the EUMDS Registry of the European Leukemia Network (ELN). The TRIAGE-MDS project focuses on next generation sequencing of MDS patient samples in order to improve targeted ther- apy depending on mutation profiles of indi- vidual patients. The interplay of molecular aberrations, assessment status and anemia are analyzed and compared with reference populations to elucidate mechanisms of ageing both in frail and in elderly cancer patients. These analyses form the basis for individualized treatment algorithms and es-

128 Research Report 2016 Medical University of Innsbruck Internal Medicine V

Selected Publications High prevalence of side population in human cancer cell Selected Funding lines. Boesch, M., A.G. Zeimet, H. Fiegl, B. Wolf, J. Huber, H. Klocker, G. Translational Oncology Group Translational Oncology Group Gastl, S. Sopper, and D. Wolf, ONCOSCIENCE: 2016; 3: S. 85-87 • Establishment of a 3D cell culture model to investigate interactions of tumor – stromal co-cultures with Infiltration of lymphocyte subpopulations into On-demand erythrocyte disposal and iron recycling requires cancer microtissues as a tool for the exploration of immunocompetent cells. K1 Center ONCOTYROL & Austrian monocyte-derived transient macrophages in the liver. Agency for Advancement of Research (FFG). Project No III. immunomodulatory agents and biomarkers Theurl I. Hilgendorf, M. Nairz, P. Timoszuk, D, Haschka, M. Asshoff, Koeck S, Zwierzina M, Huber JM, Bitsche M, Lorenz E, Gamerith G, 2.4.PO € 105.000,--. S. He, L. Gehradt, T. Holderried, M. Seifert, S. Sopper, A. Fenn, A. • Biology of Aging & Personalized Treatment of Elderly Dudas J, Kelm JM., Zwierzina H, Amann A Anzai, S, Rattik, C. McAlpine, M. Theurl, P. Wieghofer, Y. Iwamoto, IMMUNOBIOLOGY: 2016; 221: S. 604-617 Cancer Patients MDS-RIGHT; Horizon 2020, Grant agreement G. Weber, N. Harder, B. Chousterman, T. Arvedson, M. Mckee, No 634789, within Personalising health and care program F. Wang, O. Lutz, E. Rezoagli, J. Babitt, L. Berra, M. Prinz, M. Evaluation of assays for drug efficacy in a three-dimensional PHC-2014-634789. € 144 000,-- Nahrendorf, G. Weiss, R. Weissleder, H.Y.Lin, F.K. Swirski. NATURE • TRIAGE-MDS (Translational Implementation of genetic model of the lung MEDICINE: 2016; 22: S. 945-+ Huber J M, Amann A, Koeck S, Lorenz E, Kelm JM., Obexer P, evidence in the management of MDS); Austrian Science Fund I 1576 within the TRANSCAN ERA Net. € 190 000,-- Zwierzina H, Gamerith G Experimental & Clinical Cancer Genomics JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY: 2016; 142: S. 1955-1966 Biomarkers for Tumor Immunity & Immune Monitoring Detection of soluble EpCAM (s(EpCAM) in malignant ascites • Intrazellulärer Routineassay zur Detektion der TKI- predicts poor overall survival in patients treated with The impact of metformin and salinomycin on transforming Wirksamkeit in CML Patienten, ÖNB Projekt No. 14781 catumaxomab. (Prof. Dominik Wolf). € 88.100.-- growth factor -induced epithelial-to-mesenchymal transition Seeber A, Brajcu I, Untergasser G, Nassir M, Fong D, Botta L, Gastl in non-small cell lung cancer cell lines • Identification and targeting of ovarian cancer stem cells, G, Fiegl H, Zeimet A, Sehouli J, Spizzo G. Oncotyrol Project 2.1.8; FFG Koeck S, Amann A, Huber JM., Gamerith G, Hilbe W, Zwierzina H ONCOTARGET: 2015; 6: S. 25017-25023 ONCOLOGY LETTERS: 2016; 11: S. 2946-2952 • Improvement of tumor immune therapy by adoptive cell transfer of cblb-deficient hyperreactive immune cells. Soluble EpCAM levels in ascites correlate with positive Hertha Firnberg Fellowship (Dr. C. Lutz-Nicoladoni,) Project No Treatment of patients with refractory metastatic cancer cytology and neutralize catumaxomab activity in vitro according to molecular profiling on tumor tissue in the T550-B19; € 206.000,- , FWF Seeber A, Martowicz A, Spizzo G, Burattio T, Obrist P, Fong D, Gastl • Patent PCT/EP2015/074797 (GEF Isoforms as cancer stem clinical routine: an interim-analysis of the ONCO-T-PROFILE G, Untergasser G. BMC CANCER: 2015; 15: S. 372 project. cell-specific biomarkers and therapeutic targets in ovarian cancer) Seeber A, Gastl G, Ensinger C, Spizzo G, Willenbacher W, Kocher Predominant expression of truncated EpCAM is associated F, Leitner C, Willenbacher E, Amann A, Steiner N, Eisterer W, Voss with a more aggressive phenotype and predicts poor overall Experimental & Clinical Cancer Genomics A, Russell K, Zwierzina H. survival in colorectal cancer GENES & CANCER. 2016;7: S.301-308 • Genomic profiling of multiple myeloma at diagnosis and Seeber A, Untergasser G, Spizzo G, Terracciano L, Lugli A, Kasal A, disease progression. Oncotyrol (Dr. W. Willenbacher) Project Kocher F, Steiner N, Mazzoleni G, Gastl G, Fong D. INTERNATIONAL No 4.4 PO ; € 322.000,- Biology of Aging & Personalized Treatment of Elderly Cancer JOURNAL OF CANCER: 2016; 139: S. 657-663 Patients BRAF inhibition in hairy cell leukemia with low-dose Collaborations Clinical judgement and geriatric assessment for predicting vemurafenib prognosis and chemotherapy completion in older patients Dietrich S, Picher A, Endris V, Peyrade F, Wendtner CM; Follwos • Competence Center ONCOTYROL Innsbruck, Austria with a hematological malignancy GA, Hüllein J, Jethwa A, Ellert E, Walther T, Liu X, Dyer MJ, Eletr T, • Arbeitsgemeinschaft Tumortherapie (AGMT) Salzburg, Austria Hamaker M. E., Augschoell J., Stauder R., Brummer T, Zeiser R, Hermann M, Herold M, Weichert W, Dearden • Austrian Breast and Colon Cancer Study Group (ABCSG), LEUKEMIA & LYMPHOMA: 2016; 57: S. 2560-2567 C, Haferlach T, Seiffert M, Hallek M, von Kalle C, Ho AD, Gaehler A, Vienna, Austria Andrulis M, Steurer M, Zenz T. • Central European Society for Anticancer Research (CESAR) Time-dependent changes in mortality and transformation BLOOD: 2016; 127: S. 2847-2855 Vienna, Austria risk in MDS • Mian M, MD, Dept Hematology Bolzano, Italy Pfeilstoecker M, Tuechler H, Sanz G, Schanz J, Garcia-Manero Clinical Cancer Research • Piccin A, MD PhD, Interdisciplinary Medical Research Center G, Sole F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian Bolzano, Italy H, Kuendgen A, Malcovati L, Cazzola M, Cermak J, Fonatsch C, Clinical evaluation of a Mucorales-specific real-time PCR • Wolf D, MD, Dept. Hematology & Oncology, Bonn University Le Beau MM, Slovak M L, Levis A, Luebbert M, Maciejewski J, assay in tissue and serum samples. Bonn, Germany Machherndl-Spandl S, Magalhaes SM, Miyazaki Y, Sekeres Springer J, Lackner M, Ensinger C, Risslegger B, Morton CO, • MDS Net, Duesseldorf University Duesseldorf, Germany MA, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Nachbaur D, • Arbeitsgemeinschaft Internistische Onkologie (AIO), Berlin, Loosdrecht AA, Germing U, Haase D, Greenberg PL Lass-Flörl C, Einsele H, Heinz WJ, Loeffler J Germany BLOOD: 2016; 128: S. 902-910 JOURNAL OF MEDICAL MICROBIOLOGY: 2016; 65: S. 1414-1421 • Sehouli J, MD, Frauenklinik, Charite Berlin, Germany • Schweizerische AG für klinische Krebsforschung (SAKK) Bern, Cytopenia levels for aiding establishment of the diagnosis Treatment With α-1-Antitrypsin for Steroid-Refractory Acute Switzerland of myelodysplastic syndromes Intestinal Graft-Versus-Host Disease: A Report of 2 Cases. • Vesalius Research Center, Leuven, Belgium Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Gerner RR, Feistritzer C, Moschen AR, Kircher B, Moser P, Tilg H, • SWG Elderly Task Force in Hematology, Institut Jules Bordet Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Nachbaur D. TRANSPLANTATION: 2016; 100: S. E158-E159 Brussels, Belgium Kuendgen A, Levis A, Malcovati L, Cazzola M, Cermak J, Fonatsch • De Witte T, European MDS Registry of the ELN Nijmegen, C, Le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski Clinical impact of GATA2 mutations in acute myeloid Netherlands J, Magalhaes SM, Miyazaki Y, Pfeilstöcker M, Sekeres M, Sperr leukemia patients harboring • Jansen J, PhD; Radboud University Medical Center, Nijmegen, WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, CEBPA mutations: a study of the AML study group. Netherlands Germing U, Haase D. Theis F, Corbacioglu A, Gaidzik VI, Paschka P, Weber D, Bullinger L, • Ossenkoppele G, MD, University Medical Center Amsterdam, BLOOD: 2016; 128: S. 2096-2097 Heuser M, Ganser A, Thol F, Schlegelberger B, Göhring G, Köhne Netherlands CH, Germing U, Brossart P, Horst HA, Haase D, Götze K, Ringhoffer • Porkka K MD; Clinical Hematology, Helsinki University Helsinki, Marine compounds inhibit growth of multiple myeloma in M, Fiedler W, Nachbaur D, Kindler T, Held G, Lübbert M, Wattad M, Finland vitro and in vivo. Salih HR, Krauter J, Döhner H, Schlenk RF, Döhner K. • CALGB, University of Chicago Chicago, M USA Steiner N, Ribatti D, Willenbacher W, Jöhrer K, Kern J, Marinaccio LEUKEMIA: 2016; 30: S. 2248-2250 • Voss Andreas, MD, Caris Life Sciences Inc., C.O.D.E. Phoenix, C, Aracil M, Garcia-Fernandez LF, Gastl G, Untergasser G, USA Gunsilius E. Prospective multicentre PCR-based Aspergillus DNA • Greenberg P, MD, IWG-MDS (International Working Group – ONCOTARGET: 2015; 6: S. 8200-8209 screening in high-risk patients with and without primary MDS) Stanford, USA antifungal mould prophylaxis. Springer J, Lackner M, Nachbaur • Balducci L, MD, International Society of Geriatric Oncology The Aplidin analogs PM01215 and PM02781 inhiobit D, Girschikofsky M, Risslegger B, Mutschlechner W, Fritz J, Heinz (SIOG), angiogenesis in vitro and in vivo. WJ, Einsele H, Ullmann AJ, Löffler J, Lass-Flörl .C CLINICAL • Lee Moffit Comprehensive Cancer Centre, Tampa, FL, USA Borjan B, Steiner N, Karbon S, Kern J, Francesch A, Hermann M, MICROBIOLOGY AND INFECTION: 2016; 22: S. 80-86 • Klepin H, MD, ASH– Hematology and Aging Special Interest Willenbacher W, Gunsilius E, Untergasser G. Group, BMC CANCER: 2015; 15: S. 738 Rituximab maintenance versus observation alona in patients • Comprehensive Cancer Center of Wake Forest University, Wake with chronic lymphocytic leukemia who respond to first-line Forest, NC, USA Tumor Immunology Biomarkers & Immune Monitoring or second-line rituximab-containing chemoimmunotherapy: • MD Anderson Cancer Center, Houston, TX,USA final results of the AGMT CLL-8a Mabtenance randomized The nuclear orphan receptor NR2F6 is a central checkpoint trial. Core Facilities for cancer immune surveillance. Greil R, Obrtlikova P, Smolej L, Kozak T, Steurer M, Andel J, Hermann-Kleiter N, Klepsch V, Wallner S, Siegmund K, Klepsch S, Burgstaller S, Mikusova E, Gercheva L, Nösslinger T, Papajik FACS Sorting Facility (Leader: PD Dr. Sieghart Sopper) Tuzlak S, Villunger A, Kaminski S, Pfeifhofer-Obermair C, Gruber T, T, Ladicka M, Girschikofsky M, Hrubisko M, Jäger U, Fridrik M, Cell sorting & Multidimensional Flow Cytometry Wolf D, Baier G. CELL REPORTS: 2015; 12: S. 2072-2085 Pechersdorfer M, Kraliokova E, Burcoveanu C, Spasov E, Petzer A, Mihaylov G, Raynov J, Oexle H, Zabernigg A, Flochova E, Palasthy Heterogeneity of Cancer Stem Cells: Rationale for Targeting S, Sthelikova O, Doubek M, Altenhofer P, Pleyer L, Meclhhardt T, the Stem Cell Niche. Klingler A, Mayer J, Egle A. Boesch, M., S. Sopper, A.G. Zeimet, D. Reimer, G. Gastl, B. LANCET HAEMATOLOGY: 2016; 3: S. E317-E329 Ludewig, and D. Wolf, BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER: 2016; 1866: S. 276-289

Research Report 2016 Medical University of Innsbruck 129 Center of Internal Medicine Joint Institution for Emergency ­Medicine and Critical Care Medicine

Research Branch (ÖSTAT Classification) ministratively, the unit is affiliated to the ­Department of Internal­ Medicine I (Director: 302031 Prof. Dr. ­Herbert Tilg).

Keywords The unit is involved in several clinical mul- ticentre trials investigating early diagno- Acute kidney injury, sepsis, cardio pulmonary sis and treatment of acute kidney injury, resuscitation, biomarkers, microvesicles, treatment of severe infections and sepsis copeptin, plasma pharmacokinetics, target- as well as antimicrobial pharmacokinetics. site pharmacokinetics, pharmacodynamics, Complementary in vitro models are used to antimicrobial agents investigate inflammatory mechanisms of re- nal injury. Research Focus The research unit comprises the ­Laboratory • Applied clinical as well as bench-to- of Inflammation Research (U-1-015) host- bedside research covering several aspects ing two research groups: the Intensive of critical illness with special emphasis Care Medicine group (Anna Brandtner, on acute kidney injury (AKI), sepsis, and ­Julia Hasslacher, Viktoria Haller, Sebastian Director: cardiopulmonary resuscitation (CPR) Klein, Georg Lehner, Alexander ­Magnutzki, Univ.-Prof. Dr. Michael Joannidis • Definition and clinical validation of Birgit Zassler) led by Michael Joannidis and biomarkers for diagnosis and prognosis of the Clinical Pharmacokinetics group (Rene Contact: AKI and CPR Welte, Tiziana Gasperetti) led by Romuald Anichstraße 35 • Identification and characterisation of Bellmann. 6020 Innsbruck microvesicles in severe sepsis • Intensive care specific pharmacodynamics Collaboration partners include all University [email protected] and pharmacokinetics Clinics (I-V) of the Department of Internal Phone: +43 512 504 24181 Medicine, the Neurological Intensive Care Fax: +43 512 504 24199 General Facts Unit and the Surgical/Trauma Intensive www.i-med.ac.at/notfallmedizin/ Care Unit as well as the Division of Hygiene The Joint Institution/Division of Medical and Medical Microbiology and the Division Intensive Care and Emergency Medicine of Molecular and Cellular Pharmacology. was established in December 2012. Clini- cally, it was designed as a core facility for Research the ­Department of Internal Medicine, pro- viding a high level of Intensive Care and Intensive Care Medicine Emergency Medicine. It comprises a level Michael Joannidis three intensive care unit and the medical This group is involved in clinical research emergency room including a short stay in critical illness with a major interest in (maximum 24 hours) ward located in the acute kidney injury and cardiopulmonary ­Medizinzentrum Anichstraße (MZA). Ad- ­resuscitation. A second major focus is

© Schock, 2016

Fig. 1: Characterisation of microvesicles in septic shock, by applying high-sensitivity flowcytometry ­ (0.3 µm resolution): Comparison of endothelium- (CD144+, CD62E+) MV, ­platelet- (CD41+) and presumably leukocyte-derived MV (CD31+/CD41-/AnnexinV-) in ­patients with septic shock who survived or did not survive 48h after blood was drawn.

130 Research Report 2016 Medical University of Innsbruck Emergency ­Medicine and Critical Care Medicine

ly complicated by devastating coagulation disturbances leading to disseminated intra- vascular coagulation (DIC). Microvesicles (MV) are capable of mediating pleiotropic inflammatory signals during sepsis and may play a key role in the propagation of thrombin generation via phosphatidylser- ine exposure as well as in the initiation of blood coagulation by specific epitopes such as tissue factor. In a prior project funded by the OeNB Anniversary Fund, we developed a specific high-sensitivity flow cytometry approach which enabled us to measure previously undetectable smaller MV down to 0.3 µm diameter­ . Using this approach we found that increased levels of MV detected in patients with septic shock predominantly originate from circulating cells, indicating excessive leukocyte and platelet activa- tion rather than MV release from damaged ­endothelia. This effect was even more en- hanced in ­lethal septic shock (figure 1).

Secondly, we could demonstrate that MV are not eliminated by CRRT, but that the contact of blood with artificial membranes leads to further release of platelet- and leukocyte-derived MV, indicating a further proinflammatory stimulus by extracorpo­ real treatment. These results triggered a subsequent project funded by the OeNB (anniversary funds project 15708) in which we are investigating the role of MV in ac- tivating the coagulation in sepsis. We suc- cessfully established specific coagulation assays which allowed us to investigate the

© Resuscitation, 2015 © Resuscitation, interactions between MV, the endothelium and the coagulation system in a translation- Fig. 2: Course of a) MR-proANP and b) Copeptin dichotomised between good (CPC 1–2) al approach. The results indicate a crucial and poor outcome (CPC 3–5). CPC – cerebral performance category, *indicates significant role of the endothelium-mediated activation ­difference between outcome groups (good versus poor outcome, Students’ T-test, p < 0.05). of the coagulation system by MVs carrying tissue factor.

­investigation of microvesicles in sepsis. tary approach we are currently investigating Hypoxic Brain Damage after Cardio­ Acute Kidney Injury (AKI) the effect of cell cycle arrest on cellular pulmonary Resuscitation (CPR) AKI in the critically ill is associated with sig- ­recovery from damage as well as reversibil- Cardiac arrest is one of the major causes of nificant mortality and long term morbidity ity of cell cycle arrest after relief from cell death in cardiovascular disease, frequent- including end stage renal disease. This was stress after a defined insultin vitro using an ly associated with long-term neurological clearly demonstrated by the AKI-EPI study, endo-epithelial co-culture system. Finally deficits in case of survival. In 2014 secre- the largest prospective observational study, we participated in the design and execu- toneurin was identified by our research which indicated an incidence of AKI above tion the first prospective placebo controlled group as a very sensitive and robust bio- 50%. We also participated in several other randomised controlled trial testing alkaline marker predicting unfavourable neurolog- multicentre trials investigating biomarkers phosphatase for reducing severity and dura- ical outcome after CPR. In a subsequent for AKI: The SAPPHIRE and OPAL study tion of sepsis associated AKI (STOP-AKI). Its study we analysed the additional biomark- defined and evaluated the cell cycle arrest results will be available in 2017. ers MRproANP and copeptin in the same proteins TIMP-2 and IGFBP-7 as ­early pre- cohort of 150 consecutive patients admit- dictors of AKI with an unprecedented sen- Microvesicles in Severe Sepsis and ted to our ICU after successful CPR (figure sitivity and specificity. This was followed by Septic Shock 2). Though showing acceptable prediction the international multicentre RUBY study Severe sepsis has a worldwide annual inci- of outcome their performance was clearly­ which tested TIMP-2 and IGFBP-7 and other dence of around 3/1000 inhabitants and a inferior to secretoneurin­ with regard to biomarkers with regard to their capability to mortality rate > 50 % when proceeding to being influenced by therapeutic hypother- predict recovery from AKI. In a complemen- septic shock. This syndrome is frequent- mia or haemolysis. A further investigation

Research Report 2016 Medical University of Innsbruck 131 Center of Internal Medicine

Since most infections occur in tissue rath- er than in the blood stream, target-site pharma­cokinetics might be even more relevant for clinical outcome than plasma pharmacokinetics. Biliary Candida infec- tions are a particular therapeutic challenge. Therefore, biliary AMB pharmacokinetics in patients treated with lipid-formulated AMB and biliary AMB pharmacodynamics by in vitro and ex vivo-simulations were inves- tigated. Biliary AMB concentrations were ­lower and displayed a slower rise and de- cline than plasma levels (figure 3). Fungal growth and AMB activity were impaired by bile. Thus, treatment of fungal cholangitis with lipid-formulated AMB is not supported by our data.

Whereas echinocandins are highly active against candidaemia, their efficacy against deep-seated or disseminated Candida ­infections is less clear and data on their © Int J Antimicrob Agents, 2015 © Int J Antimicrob Agents, target-site pharmacokinetics is sparse. Although echinocandins are relatively Fig. 3: Amphotericin B levels in bile and plasma: in bile, total amphotericin B levels have safe, micafungin caused foci of altered been measured (green lines) after standard dose of liposomal amphotericin B at steady hepatocytes (FAH) in rats. Therefore, we state. In plasma, amphotericin B that had been liberated for lipid-encapsulation (LI AMB), have started a project on quantification Lipid-bound amphotericin B (LB AMB), and total amphotericin B (TO AMB) were separately of ­echinocandins in various human body determined. ­fluids and tissues which is supported by the ­Austrian Research Funds FWF (project no. KLI 565-B31). Assessment of echinocandin of the performance of the well-established 2) Investigating specific effects of MV sub- pharmacokinetics and antifungal efficacy biomarker neuron specific enolase (NSE), types on distinct proteolytic processes of in body fluids, as well as detection of FAH combining our patients with those of four the coagulation system in DIC. in human liver, are further objectives. Ten other centres, resulted in the currently larg- 3) Definition of biomarker panels for neuro- ICUs in 5 Austrian centres are participating est cohort of 1053 patients after success- logic outcome prediction after CPR. in this project and will include 138 critical- ful CPR and found a higher threshold of 90 ly patients providing up to ~1,000 blood µg/l for reliable prediction of unfavourable Clinical Pharmacokinetics and body fluids samples. In addition, tissue neurological outcome in patients treated Romuald Bellmann samples will be taken during routine autop- with mild therapeutic hypothermia. The Severe infections are a common reason sies from 30 patients who have died after manuscript will appear in early 2017. for critical illness. Adequate antimicrobial­ echinocandin treatment. chemotherapy is crucial for the clinical Major Achievements: outcome. Sub-therapeutic antimicrobial Major Achievements: Determination of tar- 1) Clinical validation of cell cycle arrest pro- dosage results in poor response and may get site kinetics of lipid-formulated AMB in teins as biomarkers for AKI and renal re- promote the emergence of resistant micro- critically ill patients. covery. organisms. On the other hand, critically ill 2) Establishment of high-sensitivity flow patients are at an enhanced risk of drug tox- Future Goals: Plasma and target-site ­cytometric MV analysis and characteri- icity. Absorption, distribution, metabolism ­pharmacokinetics and pharmacodynam- sation of circulating MV as being mainly and elimination of drugs can be altered by ics of echinocandins and of trimethoprim platelet and leucocyte derived in septic critical illness depending on the state of dis- sulfona­mide combinations. shock; use of extracorporeal systems ease, type of organ failure and the required seems to enhance this effect rather than treatment modality. An increasing number eliminate MV. of patients present with profound immuno- 3) Identification and evaluation of secreto- logical dysfunction, facilitating infections by neurin, MRproANP and copeptin as early opportunistic pathogens such as invasive predictors for severe hypoxic brain dam- fungal infections associated with a mor- age. tality rate exceeding 50%. Optimal choice and dosage of antifungal agents, guided by Future Directions: pharmacokinetic and ­pharmacodynamic 1) Investigating clinical interventions atten- considerations, will improve the clinical out- uating AKI and stimulating renal recovery come. in critically ill patients.

132 Research Report 2016 Medical University of Innsbruck Emergency ­Medicine and Critical Care Medicine

Selected Publications

Characterization of Microvesicles in Septic Shock Using High-Sensitivity Flow Cytometry Lehner, Georg Franz, Harler, Ulrich, Haller, Viktoria Maria, Feistritzer, Clemens, Hasslacher, Julia, Dunzendorfer, Stefan, Bellmann, Romuald, Joannidis, Michael, SHOCK: 2016; 46: S. 373-381

Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI) Peters, Esther, Mehta, Ravindra L., Murray, Patrick T., Hummel, Jurgen, Joannidis, Michael, Kellum, John A., Arend, Jacques, Pickkers, Peter, BMJ OPEN: 2016; 6: S. e012371

Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study Hoste, Eric A. J., Bagshaw, Sean M., Bellomo, Rinaldo, Cely, Cynthia M., Colman, Roos, Cruz, Dinna N., Edipidis, Kyriakos, Forni, Lui G., Gomersall, Charles D., Govil, Deepak, Honore, Patrick M., Joannes-Boyau, Olivier, Joannidis, Michael, Korhonen, Anna-Maija, Lavrentieva, Athina, Mehta, Ravindra L., Palevsky, Paul, Roessler, Eric, Ronco, Claudio, Uchino, Shigehiko, Vazquez, Jorge A., Vidal Andrade, Erick, Webb, Steve, Kellum, John A., INTENSIVE CARE MEDICINE: 2015; 41: S. 1411-1423

Outcome prediction and temperature dependency of MR- proANP and Copeptin in comatose resuscitated patients Broessner, Gregor, Hasslacher, Julia, Beer, Ronny, Lackner, Peter, Lehner, Georg Franz, Harler, Ulrich, Schiefecker, Alois, Helbok, Raimund, Pfausler, Bettina, Hammerer-Lercher, Angelika, Joannidis, Michael, RESUSCITATION: 2015; 89: S. 75-80

Biliary amphotericin B pharmacokinetics and pharmacodynamics in critically ill liver transplant recipients receiving treatment with amphotericin B lipid formulations Welte, Rene, Eschertzhuber, Stephan, Weiler, Stefan, Leitner- Rupprich, Sandra, Aigner, Maria, Lass-Floerl, Cornelia, Stienecke, Eva, Bellmann-Weiler, Rosa, Joannidis, Michael, Bellmann, Romuald, INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS: 2015; 46: S. 325-331 Selected Funding

• Interaction between microvesicles, endothelium and the coagulation system in sepsis and DIC, OeNB Anniversary Fund (project 15708), Michael Joannidis • Target-Site Pharmacokinetics and –Activity of Echinocandins, Austrian Research funds FWF (Project KLI 565-B31), Romuald Bellmann

Collaborations

• Univ. Prof. Dr. Thomas Staudinger, Intensive Care Unit, Internal Medicine I, Medical University Vienna, Vienna, Austria • Professor Stefan Kluge, Department of Intensive Care Medicine, Hamburg Eppendorf, Hamburg, Germany • Prim. Univ.-Prof. Dr. Christian Wiedermann, Department of Internal Medicine, Central Hospital of Bolzano, Bolzano, Italy • John Kellum, MD, FCCM, FACP, University of Pittsburgh School of Medicine, Pittsburg, PA, USA • Ravindra L. Mehta, MD, UCSD Medical Centre, San Diego, CA, USA • Univ.-Prof. Dr. Jaroslav Sterba, Department of Pediatric Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic • Dr. Piotr Smuszkiewicz, Department of Anesthesiology, Intensive Therapy and Pain Treatment, University Hospital Przybyszewskiego, Poznan, Poland • Univ.-Prof. Dr. Markus Müller und Priv. Doz. Dr. Markus Zeitlinger, Universitätsklinik für Klinische Pharmakologie, AKH, Wien

Research Report 2016 Medical University of Innsbruck 133 Center of Psychiatry, Psychotherapy and Psychosomatic Medicine Psychiatry I

Research Branch (ÖSTAT Classification) MCI to dementia. To this end, next to find- ings from well-established neuropsycho- 302038, 302045, 302046, logical tests, anatomical imaging findings 302065, 302066 and both peripheral and central biomarkers are explored. The Departments of Neurora- Keywords diology, the Department of Psychiatry and Psychotherapy A, Hall State Hospital and Bio-psycho-social aspects of diseases, the Laboratory for Experimental ­Alzheimer doctor-patient-relationship, psychotherapy Research are important collaborating part- ners. Next to that, Dr. Defrancesco is a Research Focus board member of the Austrian Alzheimer Society (ÖAG) and her research group takes • Alcoholism part in the national multi-centric cohort • Alzheimer´s disease study PRODEM-Austria. • Drug safety • Patient related outcomes In addition, they participate in local as well • Psychopharmacology as regional projects in the field of demen- • Schizophrenia tia care (Demenz braucht Kompetenz, Tirol Director: • Substance use disorder Kliniken), studies dealing with various physi­ Univ.-Prof. Dr. W. Wolfgang • Suicide disorders cal, cognitive and social activities as pos­ Fleischhacker sible risk or protective factors for dementia General Facts (GERDA, TGF project). Under the leadership Contact: of Imrich Blasko the group participates in Anichstraße 35 Embedded in the clinical services of a phase 2 study to assess the safety and 6020 Innsbruck the center, the research groups in the efficacy of active immunisation against ­Department of Psychiatry I have a long ­phosphorylated tau protein in patients with [email protected] standing tradition of dealing with a host of mild Alzheimer´s disease. Phone: +43 512 504 23669 different topics related to various aspects Fax: +43 512 504 25267 of psychiatry. They are supported by a num- The driving ability of the elderly is a research https://psychiatrie.tirol-kliniken.at/ ber of international collaborators and fund- topic studied in collaboration with Ilsemarie page.cfm?vpath=psychiatrie-i ed by grants from the European Union, the Kurzthaler, who leads the Department’s traf- ­Austrian ­Science Foundation, the European fic safety in psychiatry group. Organisation for Research and Treatment in Cancer (EORTC), the European Group Behavioral and Clinical Psychology for Research in Schizophrenia and the Verena Günther pharmaceutical industry, the latter through Behavioural and Clinical Psychology focus­ both investigator initiated grants as well as ses primarily on cognitive/behavioural as- classical industry sponsored phase II and pects of chronically ill patients (e.g. body phase III trials. In addition, international col- image in patients with an insulin pump, laborators include Keio University in Tokyo, psychological aspects of patients with the University of Bergen in Norway, Icahn an implantable cardioverter defibrillator) School of Medicine at Mount Sinai and and on the conceptualization and evalua- Zucker Hillside Hospital in New York as well tion of stigma-management-programs­ and as local collaborators within the Depart- ­cognitive training programs in psychiatric ment and also other medical disciplines of patients. the Medical University Innsbruck. Health psychology aims to evaluate our Research nico­tine cessation program and focusses on aspects of body image and body modifi- Age Related Psychiatric Disorders cation (eg in blind people). Michaela Defrancesco, Eberhard Deisenhammer, Bernhard Holzner, Consultation/Liaison Service, Quality Imrich Blasko of Life, Outcomes Research This research group has its main base in Bernhard Holzner the Memory Clinic of the Department. In In close collaboration with the Department addition to providing clinical service for the of Psychosomatics, this group investigates catchment area, specific areas of scientific the impact of disease and treatment on the interest include the neuropsychological and subjective health status of chronic somati- anatomical underpinnings of mild cognitive cally ill patients. This is done by the appli- impairment (MCI) and Alzheimer dementia. cation of late breaking statistical (item re- In this context, a strong emphasis is given to sponse theory) and technical methodology possible predictors for the conversion from (web-based questionnaire data collection).

134 Research Report 2016 Medical University of Innsbruck Psychiatry I

The group is developing item banks and a partner in the Human Brain Project, one chotics being one example of these efforts. computer-adaptive questionnaires in ­order of the two flagship research projects fund- to tailor the questions selected by a so- ed by the European Commission, involving Cognition phisticated CAT algorithm to the respective over 100 partner universities in Europe and Both neuro- and social cognition present an- health status of the patient. This leads to some outside Europe. Alois Saria leads the other focus of this research group. More re- maximizing measurement precision and “Education Program” of this project cently, the investigation of social cognition minimizing patients‘ burden. Furthermore, to coordinate education and training of a in symptomatically remitted patients suffer- the study group is also developing patient large number of PhD students in this multi- ing from serious mental illness has received portals for web-based home-monitoring of disciplinary project. much attention. To this end, a number of patients. studies investigating Emotional Intelligence Addiction Research, Preclinical have been conducted in patients suffering Some of this work is done under the aegis Gerald Zernig from schizophrenia or bipolar disorder, their of EORTC and with support from the oncolo- Impaired social interaction is a hallmark unaffected siblings as well as healthy con- gy units in the Departments of Haematology symptom of many psychiatric diseases trol subjects, to identify social cognitive and Gynaecology of the MUI. including substance dependence. Gerald deficits as potential trait markers for these Zernig’s group studies the neural basis of disorders. Experimental Alzheimer Research a reorientation away from cocaine as a pro- Christian Humpel totypical drug of abuse toward dyadic (i.e., Resilience In close collaboration with the clinical one-to-one) social interaction using, e.g., A number of studies investigated resilience researchers, research in the Laboratory gSTED (gated Stimulated Emission Deple- and its biological correlates in patients with of Experimental­ Alzheimer’s disease fo- tion) microscopy of immunofluorescently schizophrenia and bipolar disorder with a fo- cusses on investigating the development labelled neurons, dendritic morphology cus on religion and culture. The primary aim of beta-amyloid­ plaques in Alzheimer’s dis- change analysis, transgenic mouse models of these studies was to investigate trans- ease. In an EU project the effect of protec- (drd1cre, creTVA), and the modulation of cultural differences in resilience across tive and regenerative biomaterials (collagen gene expression by stereotaxic delivery of patients from two different geographical scaffolds) on dopaminergic and cholinergic transcription vectors. Zernig also investi- regions, Austria and Japan that have differ- neurons in organotypic brain slices is being gates power abuse disorder as a non-drug ent religious and cultural backgrounds (i.e. studied. Furthermore, the role of platelets dependence syndrome. Christianity and Buddhism). in the progression of cerebral amyloid angi- opathy is explored. Another research focus Schizophrenia Research Another study investigates the degree and is to find and establish novel biomarkers in Wolfgang Fleischhacker, Alex Hofer quality of resilience as well as its correlates blood to diagnose Alzheimer’s disease. In (e.g. hope, self-esteem, social support) addition to peripheral markers, this lab also Clinical Psychopharmacology across students from local universities. scientifically evaluates routinely acquired Past and ongoing studies focus on antipsy- ­Using 3 T-MRI and fMRI and focusing on CSF samples from patients referred either chotics, ranging from early drug develop- sex differences, we are currently examining from the Memory Clinic or from the inpa- ment in phase II clinical trials all the way potential structural and functional cerebral tient units of the Department. to large-scale international pragmatic ef- differences in subjects with a high degree of fectiveness studies. The underlying theme resilience compared to subjects with a low Experimental Psychiatry Unit is always enhancing treatment options for degree of resilience in close collaboration Alois Saria, Gerald Zernig patients with schizophrenia. The European with the Department of Neurology. The Experimental Psychiatry Unit is one First Episode in Schizophrenia Trial (EU- of the host labs for the international PhD FEST) and the Optimization of Treatment Substance Use Disorder, Clinical program “Signal Processing in Neurons”. and Management of Schizophrenia in Eu- Sergei Mechtcheriakov, Claudia Rupp Research at the lab focusses on the mech- rope (OPTiMiSE) were the first large-scale A 27 bed alcohol rehabilitation inpatient anisms of reward and the mode of action of independent comparative first episode unit as well as a large outpatient clinic for psychoactive drugs. In addition, the lab of- studies worldwide, evaluating treatment patients suffering from substance-relat- fers clinical service for psychiatric patients, outcomes in 14 European countries and ed and addictive disorders from the illegal i.e. Therapeutic Drug Monitoring (TDM). In Israel. Currently, the European Long-acting spectrum are the base for research in this this context, blood levels of over 30 anti- Antipsychotics in Schizophrenia Trial (EU- clinical field. Much emphasis is devoted to depressant or antipsychotic drugs are de- LAST) pursues related research questions neuropsychological deficits in patients suf- termined daily for the University Hospital with advanced methodology fering from alcohol use disorder and their Innsbruck and for additional hospitals and impact on the development and mainte- physicians in Austria and Northern Italy, The group is also involved in global efforts to nance of this chronic, relapsing disease as by use of liquid chromatography-tandem improve clinical trial design in order to ease well as their relevance with respect to treat- mass spectrometry. TDM results are also the translation from rigorous randomized ment outcomes. Individually tailored neu- exploited for addressing various research controlled clinical trial standards into every ropsychological interventions complement questions, and the lab is the core laboratory day clinical practice. In this context, the structured treatment programs. for drug monitoring in two large European issues of treatment attitudes, compliance ­multicentre studies (OPTiMiSE and EU- and drug safety have been given particular The effects of chronic alcohol intake on im- LAST). emphasis, a prospective therapeutic drug mune system, kynurenine metabolism and monitoring program in schizophrenia pa- bone metabolism are other areas of inter- The Experimental Psychiatry Unit is also tients treated with new generation antipsy- est in this research group. With respect to

Research Report 2016 Medical University of Innsbruck 135 Center of Psychiatry, Psychotherapy and Psychosomatic Medicine

illegal drugs, patients in opioid maintenance Selected Publications treatment programs constitute a large Thiazine Red(+) platelet inclusions in Cerebral Blood Vessels group of interest. Currently, preferences for are first signs in an Alzheimer's Disease mouse model Kniewallner, Kathrin M., Wenzel, Daniela, Humpel, Christian, the different drugs available in substitution SCIENTIFIC REPORTS: 2016; 6: S. 28447 programs and the relevance of subjective attitude are studied. The use of EORTC measures in daily clinical practiced-A synopsis of a newly developed manual Wintner, Lisa M., Sztankay, Monika, Aaronson, Neil, Bottomley, Andrew, Giesinger, Johannes M., Groenvold, Mogens, Petersen, Suicide and Affective Disorders Morten Aa, van de Poll-Franse, Lonneke, Velikova, Galina, Armand Hausmann, Eberhard Deisenhammer Verdonck-de Leeuw, Irma, Holzner, Bernhard, EORTC Quality Life Grp, A continuing focus of the research activities EUROPEAN JOURNAL OF CANCER: 2016; 68: S. 73-81 of this group in 2016 was suicide, in particu- lar in association with hospitalization. The Impulsivity and Alcohol Dependence Treatment Completion: Is There a Neurocognitive Risk Factor at Treatment Entry? final stage of a major project on in-patient Rupp, Claudia I., Beck, J. Katharina, Heinz, Andreas, Kemmler, Georg, Manz, Sarah, Tempel, Katharina, Fleischhacker, W. and post-discharge suicides started with Wolfgang, the first publication. Another paper on the ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH: 2016; stability in the choice of method during the 40: S. 152-160 period preceding a suicide attempt was also Dyadic social interaction of C57BL/6 mice versus interaction published. We finalized a project on deci- with a toy mouse: conditioned place preference/aversion, substrain differences, and no development of a hierarchy sion making behavior in suicide attempters, Pinheiro, Barbara S., Seidl, Simon S., Habazettl, Eva, Gruber, Bernadette E., Bregolin, Tanja, Zernig, Gerald, the manuscript of which is currently under BEHAVIOURAL PHARMACOLOGY: 2016; 27: S. 279-288 review. Further research activities included the association between resilience and sui- Dyadic social interaction inhibits cocaine-conditioned place preference and the associated activation of the accumbens cidal behaviour/ideation and colour identi- corridor Zernig, Gerald, Pinheiro, Barbara S., fication in depression. BEHAVIOURAL PHARMACOLOGY: 2015; 26: S. 580-594

Three book chapters for the Austrian 2017 Changes in psychopathology in schizophrenia patients starting treatment with new-generation antipsychotics: depression report were prepared. Topics therapeutic drug monitoring in a naturalistic treatment setting were gender-specific differences in depres- Kaufmann, Alexandra, Wartelsteiner, Fabienne, Yalcin-Siedentopf, sion, differential efficacy between pharma- Nursen, Baumgartner, Susanne, Biedermann, Falko, Edlinger, Monika, Kemmler, Georg, Rettenbacher, Maria A., Rissanen, Tanja cological and psycho-therapeutical inter- T., Widschwendter, Christian G., Zernig, Gerald, Fleischhacker, W. ventions in depression as well as a chapter Wolfgang, Hofer, Alex, EUROPEAN NEUROPSYCHOPHARMACOLOGY: 2016; 26: S. 717- on patient centred care in depression. One 728 of the reviews rules out differences ­between early- and late-onset bipolar disorder. The The Two Faces of Social Interaction Reward in Animal Models of Drug Dependence second depicts renal side effects of ­lithium El Rawas, Rana, Saria, Alois, in old age. NEUROCHEMICAL RESEARCH: 2016; 41: S. 492-499 Social interaction reward decreases p38 activation in the nucleus accumbens shell of rats Salti, Ahmad, Kummer, Kai K., Sadangi, Chinmaya, Dechant, Georg, Saria, Alois, El Rawas, Rana, NEUROPHARMACOLOGY: 2015; 99: S. 510-516

Selected Funding

Experimental Psychiatry Unit • Austrian Science Fund W1206 – Graduate School: Signal Processing in Neurons (PI: Gerald Zernig) • Austrian Science Fund P26248: Social interaction as an alternative to cocaine (PI: Gerald Zernig) • Austrian Science Fund P 27852-B21: Does social interaction have an anti-stress effect? (PI: Rana El Rawas) • Austrian Science Fund T758-BBL : Drug reward and natural reward are mediated by different intracellular pathways • European Commission FP7-ICT-2013-FET-F: Human Brain Project (PI: Alois Saria)

Group Humpel: • BrainMatTrain project is funded by the European Union Horizon 2020 Programme (H2020-MSCA-ITN-2015) under the Marie Skłodowska-Curie Initial Training Network and Grant Agreement No. 676408 • Austrian Nationalbank Jubiläumsfonds (Nr. 15887) • Austrian Science Funds P24541-B24

Collaborations

• Andreas Frick, Universite de Bordeaux, France • Scott J Russo, Mount Sinai School of Medicine, NY, NY, USA • Charles Gerfen, NIMH, NIH, Bethesda, MD, USA • Michael T Bardo, University of Kentucky, Lexington, KY, USA

136 Research Report 2016 Medical University of Innsbruck Psychiatry I

Research Report 2016 Medical University of Innsbruck 137 Center of Psychiatry, Psychotherapy and Psychosomatic Medicine Psychiatry II

Research Branch (ÖSTAT Classification) well as in psychosomatic research. Most of our research projects directly or indirectly 301408, 301905, 302046, involve the subjective judgement of the indi- 302065, 302067 vidual patient regarding his/her own mental and physical well-being. Keywords Research Psychophysiology, stress, depression, eating disorders, patient-reported outcomes, Research in Stress Related Disorders Psychoimmunology as a discipline studies Research Focus the interaction of psychological process- es, the nervous system, and the immune • Interdisciplinary psycho-somatic research: system. Stress is thought to be a major using the field of „psychophysiology“ to mediator in this circle leading to psycho-so- study psycho-somatic and somato-psychic matic and somato-psychic comorbidities. comorbidities: We investigated changes in neurotrans- • Research of stress related disorders mitter precursor amino acids (kynurenine, • Research of eating disorders ­phenylalanine, tyrosine, tryptophan) in pa- Director: • Research of patient reported outcomes tients with depression and/or breast cancer Univ.-Prof.in Dr.in Barbara and healthy controls and we were able to Sperner-Unterweger General Facts show that levels of neurotransmitter pre- cursor amino acids correlate with mental Contact: Research in the field of psychosomatic health scores; this was much more evident Anichstraße 35 medicine is interested in the complex in patients with breast cancer than in those 6020 Innsbruck interaction of the following: without (Fig. 1). • physical, mental, and social conditions barbara.sperner-unterweger@i-med. contributing to health and disease Platelets are sometimes used as a model ac.at • somatic and mental health problems in this context because they contain many Phone: +43 512 504 23691 resulting in psycho-somatic and somato- receptors and transmitters that are also Fax: +43 512 504 24778 psychic comorbidities found in the brain. Furthermore, they con- https://psychiatrie.tirol-kliniken.at/ tain immunologically active compounds. page.cfm?vpath=psychiatrie-ii1 This Research is characterized by We showed that platelet bioactivity is influ- interdisciplinary approaches enced by chronic stress in healthy individ- • in cooperation with the Psychiatric/ uals and is also altered in depressed sub- Psychotherapeutic Consultation-Liaison jects. We are currently investigating healthy Service individuals as well as patients with depres- • in cooperation with other clinical units sion and depressive adjustment disorders outside the Department of Psychiatry, and are evaluating their platelet function in Psychotherapy and Psychosomatic. chronic and acute mental stress conditions. We consider the “patient´s perspective” of These projects are supported by an ongoing major importance in the clinical setting as ÖNB grant (Platelet function as biomarker

Fig. 1: Graphical depiction of the amino acid derived neurotransmitter biosynthesis pathways analyzed in our current studies. Changes induced by inflammation are indicated with an arrow.

138 Research Report 2016 Medical University of Innsbruck Psychiatry II

Fig. 2: Results of the interaction of breast cancer with depression on PHE/TYR ratio (A) and of breast cancer and state anxiety on KYN/TRP (B). The interactions demonstrate an effect of psychological distress on neurotransmitter precursor amino acids in patients with breast cancer, which is less evident in physical healthy subjects. of depression - Can acute mental stress in- ­somatic settings, which is widely accepted Selected Publications crease the diagnostic value?; 01.01.2013 by patients and staff alike; and, that graph- Cost-utility analyses of drug therapies in breast cancer: a – ongoing). ical questionnaire outputs are mostly well systematic review. Nerich V, Saing S, Gamper EM, Kemmler G, Daval F, Pivot X, understood by patients and their attending Holzner B. Research in Eating Disorders physicians. Furthermore, we extended our BREAST CANCER RESEARCH AND TREATMENT: 2016; 159:407- Present research is focused on various PRO research activities beyond oncology 24. ­aspects of clinical eating disorders; current- and orthopaedics and are currently con- The use of EORTC measures in daily clinical practice. A synopsis of a newly developed manual. ly we are researching the following topics: ducting studies in psychosomatic medi- Wintner LM, Sztankay M, Aaronson N, Bottomley A, Giesinger a) addictive symptoms in anorexic and cine dealing with in- and outpatients of the JM, Groenvold M, Petersen MA, van de Poll-Franse L, Velikova G, Verdonck-de Leeuw I, Holzner B; EORTC Quality of Life Group.:. bulimic patients, ­Division of Psychiatry II. At the moment we EUROPEAN JOURNAL OF CANCER:2016; 68: S. 73-81 b) gender specific differences in bariatric are scientifically monitoring the integration patients of PRO research into routine psychosomatic Thresholds for clinical importance for four key domains of the EORTC QLQ-C30: physical functioning, emotional c) eating pathology in middle aged and older patient care and are planning on assessing functioning, fatigue and pain. Giesinger JM, Kuijpers W, Young T, Tomaszewski KA, Friend E, men the impact of PRO monitoring on medical Zabernigg A, HEALTH AND QUALITY OF LIFE OUTCOMES: 2016; In a study of 470 men in and around interventions. 14: S. 87 ­Innsbruck, 32 (6.8%) reported having symp- Evaluation of electronic patient-reported outcome toms of an eating disorder. The 32 men with Beyond clinical studies the research group assessment with cancer patients in the hospital and at home. eating disorder symptoms, compared to the is also engaged in conducting methodo- Wintner LM, Giesinger JM, Zabernigg A, Rumpold G, Sztankay M, 438 men presenting normal eating, showed logical projects, for example, by developing Oberguggenberger AS, Gamper EM, Holzner B. BMC MEDICAL INFORMATICS AND DECISION MAKING: a significantly greater pathology on scales computer-adaptive instruments for more 2015;15:S. 110. which are used to assess eating behaviours, accurate and efficient evaluations of PRO exercise habits, addiction, satisfaction with constructs, as well as by validating the use Selected Funding one´s body shape, and body weight. of the international cancer specific utility Development of an EORTC questionnaire for individuals at risk for instrument called EORTC QLU-10D in cost a Hereditary Cancer Predisposition Syndrome: the EORTC QLQ- HCPSxx, Agency: EORTC:,Grantee: Medical University Innsbruck Patient-reported Outcome and Health effectiveness trials in the future. (Principal Investigator: Mag. Dr. Anne Oberguggenberger), Technology Assessment Platelet function as biomarker of depression - Can acute One of the major research focuses of our mental stress increase the diagnostic value? Österreichische group in 2015 and 2016 was the evalua- Nationalbank, 01.01.2013 -extended till 31.12.2017 tion of medical treatments and the impact of chronic diseases from the patient’s per- Collaborations spective. We have conducted a number of • Harrison G. Pope, MD; Biological Psychiatry Laboratory, McLean Hospital/Harvard Medical School, Boston, USA patient-reported outcome (PRO) studies • Hans W. Hoek, MD; Parnassia Psychiatric Institute, The in cancer and orthopaedic patients inves- Hague/Department of Psychiatry, Groningen University, The Netherlands / Department of Epidemiology, Columbia tigating clinical, as well as methodological University, New York, USA research questions with a focus on qual- • Dr. K.M. Giesinger; Kantonsspital St. Gallen (Dept. of Orthopedia), St. Gallen, Schweiz ity of life parameters. Our most important • Univ.-Prof. Dr. Henning Flechtner; Magdeburg University contributions in the field of PRO and health Hospital • Univ.-Prof. Dr. Susanne Singer; Leipzig University Hospital technology assessments were to show (Stepped care project) that PRO monitoring is feasible in different • Prof. Dr. Fabio Efficace, GIMEMA Group, Roma, Italy

Research Report 2016 Medical University of Innsbruck 139 Center of Psychiatry, Psychotherapy and Psychosomatic Medicine Medical Psychology

Research Branch (ÖSTAT Classification) Prof. Dr. Dietmar Fuchs).

301402, 301905, 302045, The Center for Advanced Psychology in 302046, 302065 Plastic and Transplant Surgery (CAPPTS) represents a psychological center of excel- Keywords lence that is dedicated to the psychosocial evaluation of different transplant candi- Bio-psycho-social aspects of diseases, dates, particularly of living kidney donors doctor-patient-relationship, psychotherapy and recipients as well as other candidates undergoing vascularized composite al- Research Focus lotransplantation (VCA) or solid organ trans- plantation. • Psychoneuroimmunology: investigation of psychosomatic/psychoneuroimmunologi- The research group ICONE – Innsbruck cal complexity Cognitive Neuroscience cooperates lo- • Patient reported outcomes cally and internationally. The facility “Lab • Quality of life, health psychology, well- for Cognitive Neurosciences Innsbruck” is being, psychometric assessment, fully equipped with electroencephalography Director: questionnaire development, positive (EEG), functional near-infrared spectros- o. Univ.-Prof. Dr. Gerhard Schüßler psychology copy (fNIRS), and behavioural measuring • Transplant psychology: psychosocial eval- methods suitable for studies in infants, chil- Contact: uation, treatment protocols dren, adults, and patients. Schöpfstraße 23a • Cognitive Neuroscience: neuronal pro- 6020 Innsbruck cessing for cognitive processes e.g. The working group “Psychotraumatology ­language and Trauma Therapy” examines the ef- [email protected] • Psychotraumatology and Trauma Therapy fects of specific trauma-therapeutic treat- Phone: +43 512 504 27707 • Psychotherapy research concerning ment in patients with complex post-trau- Fax: +43 512 504 6727708 emotions, diagnosis, efficacy and delivery matic stress disorders (cPTSD) and in https://psychiatrie.tirol-kliniken.at/ patients with dissociative disorders. In this page.cfm?vpath=medizinische-p General Facts project the group works together with Euro- pean research groups. The Psychoneuroimmunology Laborato- ry run by a.o. Prof. DDr. Christian Schubert A broad training of medical students in was founded in 1995. Currently, there is doctor-patient-relationship and commu- strong collaboration activity with Division of nication is one major task. A psychothera- Biological Chemistry, Biocentre, Innsbruck peutic inpatient and mainly outpatient clinic Medical University, Innsbruck, Austria (a.o. gives the opportunity for research in this

Fig. 1: Simultaneous assessment of electrophysiological and vascular signals by means of the electroencephalography and the functional near-infrared spectroscopy.

140 Research Report 2016 Medical University of Innsbruck Medical Psychology

Selected Publications

Cause-effect relations between 55 kD soluble TNF receptor concentrations and specific and unspecific symptoms in a patient with mild SLE disease activity: an exploratory time series analysis study. Schubert, Christian, Haberkorn, Julia, Ocaña-Peinado, Francisco M., König, Paul, Sepp, Norbert, Schnapka-Köpf, Mirjam, Fuchs, Dietmar, BMC RESEARCH NOTES: 2015; 8: S. 465

Standardizing psychosocial assessment for vascularized composite allotransplantation Jowsey-Gregoire, Sheila, Kumnig, Martin, CURRENT OPINION IN ORGAN TRANSPLANTATION: 2016; 21: S. 530-535

Functional and Psychosocial Outcomes of Hand Transplantation Compared with Prosthetic Fitting in Below- Fig. 2: Negative Incidents with Cortisol. Fig. 3: Positive Incidents with Neopterin. Elbow Amputees: A Multicenter Cohort Study Salminger, Stefan, Sturma, Agnes, Roche, Aidan D., Hruby, Laura A., Paternostro-Sluga, Tatjana, Kumnig, Martin, Ninkovic, Marina, clinical field. In 2014 a highly competitive the near-infrared spectroscopy (fNIRS), Pierer, Gerhard, Schneeberger, Stefan, Gabl, Markus, Chelmonski, Adam, Jablecki, Jerzy, Aszmann, Oskar C., grant from the Austrian Science Foundation both applicable also simultaneously. PLOS ONE: 2016; 11: S. e0162507 (P 27228-G22) was received to focus on the Key psychosocial challenges in vascularized composite health and well-being of medical students Health Psychology allotransplantation and practitioners. In particular health pro- Kumnig, Martin, Jowsey-Gregoire, Sheila G., Stefan Höfer WORLD JOURNAL OF TRANSPLANTATION: 2016; 6: S. 91-102 fessionals in the medical field are prone to Research focuses on three key areas: the burnout. This research project focuses on first key area is the development of interna- The Chauvet 2014 Meeting Report: Psychiatric and Psychosocial Evaluation and Outcomes of Upper Extremity identifying key factors to promote health tional patient reported outcome measures Grafted Patients and well-bing throughout the medical cur- in different areas (i.e. heart disease) and Jowsey-Gregoire, Sheila G., Kumnig, Martin, Morelon, Emmanuel, Moreno, Elisa, Petruzzo, Palmina, Seulin, Christian, ricula. The unique approach is to investigate different languages worldwide (i.e. Malay, TRANSPLANTATION: 2016; 100: S. 1453-1459 environmental (work- and organisational Tagalog, Korean). The application of health International SF-36 reference values in patients with psychology) as well as personal factors psychological theories to enhance the qual- ischemic heart disease (health psychology, positive psychology) to- ity of life and well-being of patients is the Huber, Alexandra, Oldridge, Neil, Hoefer, Stefan, QUALITY OF LIFE RESEARCH: 2016; 25: S. 2787-2798 gether to determine pathways to health and second key area. The third is the health and well-being throughout the professional life. well-being of medical students and resident The dimensional structure of the MacNew Health Related Quality of Life questionnaire: A Mokken Scale Analysis physicians. Prof. Höfer is the current con- Friedrich, O., Sipoetz, J., Benzer, W., Kunschitz, E., Hoefer, S., Research ference president of the 15th annual meet- JOURNAL OF PSYCHOSOMATIC RESEARCH: 2015; 79: S. 43-48 ing of the International Society for Quali- Supporting cardiac patient physical activity: a brief health ty-of-Life Studies, to be held on September psychological intervention Psychoneuroimmunology Platter, Marion, Hofer, Markus, Hoelzl, Cornelia, Huber, Alexandra, Christian Schubert 28-30, 2017. Renn, Daniela, Webb, Dave, Hofer, Stefan, Stress system dynamics during “life as it WIENER KLINISCHE WOCHENSCHRIFT: 2016; 128: S. 175-181 is lived”: integrative single-case studies on Psychotraumatology and Psychosocial aspects in cardiac rehabilitation: From theory healthy women and women with LE, breast to practice. A position paper from the Cardiac Rehabilitation Trauma ­Therapy Section of the European Association of Cardiovascular cancer, depression et al. Astrid Lampe Prevention and Rehabilitation of the European Society of In addition to the main task of trauma Cardiology Pogosova, Nana, Saner, Hugo, Pedersen, Susanne S., Cupples, Transplantation Psychology therapy, the effects of training measures Margaret E., Mcgee, Hannah, Hoefer, Stefan, Doyle, Frank, to sensitize medical professionals for Schmid, Jean-Paul, von Kaenel, Roland, Cardiovasc Prevention & Martin Kumnig Rehabil Eu, Psychological assessments are crucial domestic violence are reviewed and possible EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY: 2015; 22: for the evaluation and optimization of the negative consequences of traumatic events S. 1290-1306 suitability of transplant patients, consider- are surveyed regarding the prevalence for Health-related long-term effects of adverse childhood ing solid organ or vascularized composite illnesses. Within the project "The experience experiences - an update Egle, Ulrich T., Franz, Matthias, Joraschky, Peter, Lampe, Astrid, allotransplantation (VCA). Psychological and the stress processing of executives in Seiffge-Krenke, Inge, Cierpka, Manfred, assessment is mandatory for living kidney emergency organisations" two measure BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG- GESUNDHEITSSCHUTZ: 2016; 59: S. 1247-1254 donation. packages have been developed; on one hand a self-management tool for executives Psychosocial factors in reproductive medicine Lampe, Astrid, Schuessler, Gerhard, Lab for Cognitive Neurosciences which helps the affected executives to ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND Sonja Rossi efficiently adjust their stress load, on the PSYCHOTHERAPIE: 2015; 61: S. 309-326 The research group "ICONE – Innsbruck other hand a guide for psychosocial experts Selected Funding Cognitive Neuroscience" focuses primarily for the professional support of stress- on neuronal processing mechanisms dur- loaded executives. The annual meeting Austrian Science Foundation 2014-2017, Stefan Höfer ing first and second language acquisition of the Society for Psychotraumatology Collaborations in infancy and adulthood. Furthermore, the (DeGPT) 2015 took place in Innsbruck. The interaction between language and cognitive focus was on the health consequences of Multiple international cooperations, s.a. processes such as cognitive control, atten- severe stress in childhood, epigenetics, and tion or memory is put under investigation. brain development after traumatic stress in Neuronal markers are assessed by means childhood. of the electroencephalography (EEG) and

Research Report 2016 Medical University of Innsbruck 141 Center of Psychiatry, Psychotherapy and Psychosomatic Medicine Child and Adolescent Psychiatry

Research Branch (ÖSTAT Classification) how they contribute to the development of this complex and painful condition. The 302036, 501005, 501009, 501010 aim of our research is to assess attachment representations in adolescent patients with Keywords Anorexia Nervosa or Bulimia Nervosa. We will analyse attachment themes con­cerning Child and adolescent psychiatry, child and parent-child relationships and experiences adolescent psychology, clinical psychiatry, of separation, abuse and loss in the attach- psychopathology, psychotherapy, personality ment narratives of our adolescent ED pa- disorders, eating disorders, attachment tients. Additionally, we are interested in the research, internet addiction, cyber-mobbing links between attachment representations, symptom severity, comorbid disorders and Research Focus personality pathology. One of the most challenging directions taken by attachment Assessment and Course of Personality researchers focuses on the influence of Disorders in Adolescence: The diagnosis attachment representations on the course of personality disorders (PD) in adolescence and outcome of mental disorders. To date, has long been controversially discussed there is no study investigating that influ- Director: in the research literature. Major concerns ence in adolescent patients with ED. Thus, Univ.-Prof.in Dr.in Kathrin Sevecke include the validity and stability of diag- we want to examine the influence of attach- nosing PD, the heterogeneity of the psy- ment representations on the outcome and Contact: chopathological profile and stigmatisation also analyse the extent to which attach- Anichstraße 35 in that age group. Even though studies on ment can change after treatment for the 6020 Innsbruck temperament and personality evidence that first time. the main ingredients of adult PD are pres- [email protected] ent during puberty, only very little is known General Facts Phone: +43 512 504 23670 about the course of these disorders in ado­ Fax: +43 512 504 23650 lescents. Therefore, the purpose of this This is a new research unit with a special https://psychiatrie.tirol-kliniken.at/ study to examine underlying dimensions focus on personality pathology and attach- page.cfm?vpath=kinder--und-jugendpsychiatrie (e.g. attachment patterns, emotion regula- ment research in child and adolescent psy- tion, integration level of mental structure) chiatry. mediating the course and outcome of PD in adolescents. Furthermore, we are inter- Collaborations inside the MUI: ested in examining possible links between • Neuropsychoimmunology in adoles- attachment representations, symptom se­ cent patients with eating disorders verity, comorbid disorders, course and out- (Univ.- Prof. Dr. Dietmar Fuchs, ­Section come in adolescent patients with PD. for biological chemistry, Biocenter Innsbruck) Attachment and Eating Disorders in • Neural correlates and personality pa- Adolescence: The emerging body of at- thology in adolescents with eating dis- tachment research in patients with eating orders (Univ.-Prof. Dr. Elke Gizewski, disorders (ED) provides us with a promising Department of Radiology, Medical insight into the interplay between environ- ­University of Innsbruck) mental, social and individual factors and

Dr. Astrid Bock, Dr. Manuela Gander, Dr. Martin Fuchs, Senior Scientist (Postdoc) Senior Scientist (Postdoc) Specialist for Child and ­Adolescent Psychiatry

142 Research Report 2016 Medical University of Innsbruck Child and Adolescent Psychiatry

Research Assessing Trauma in Children and Adolescents Assessment and Course of Personality Univ.-Prof. Dr. Barbara Juen, Disorders in Adolescence Prof. Dr. Kathrin Sevecke Prof. Dr. Kathrin Sevecke, This study aims to improve the assessment Dr. Manuela Gander, Dr. Astrid Bock of trauma and analyse consequences of The purpose of this study is to examine traumatic experiences in children and ado- underlying dimensions (e.g. attachment lescents. patterns, emotion regulation, integration level of mental structure) mediating the Self-Injurious Behaviours in Adolescent course and outcome of PD in adolescents. Psychiatric In- and Outpatients Furthermore, we are interested in examin- Univ.- Prof. Dr. Kathrin Sevecke, ing possible links between attachment rep- Dr. Martin Fuchs resentations, symptom severity, comorbid This research topic focuses on the preva- disorders, course and outcome in adoles- lence of self-injurious behaviours (SIB) in cent patients with PD. our adolescent patients and analyses the most common forms, the frequency, dura- Attachment and Eating Disorders in tion and severity of these behaviours within Adolescence the different psychiatric disorders. Prof. Dr. Kathrin Sevecke, Dr. Manuela Gander, Prof. Dr. Anna Buchheim The aim of our research is to assess at- Selected Publications tachment representations in adolescent Emotional dysregulation and trauma predicting psychopathy patients with Anorexia Nervosa and Bulimia dimensions in female and male juvenile offenders, Child and Adolescent Psychiatry and Mental Health Nervosa and analyse their influence on the Sevecke Kathrin, Franke, Sebastian, Kossen, David, Krischer, outcome. Maya, CHILD AND ADOLESCENT PSYCHIATRY AND MENTAL HEALTH: 2016; 10: S. 43 Neuropsychoimmunology in Adolescent Child and adolescent psychiatry patients coming of age: a Patients with Eating Disorders retrospective longitudinal study of inpatient treatment in Prof. Dr. Dietmar Fuchs, Tyrol Fuchs, Martin, Kemmler, Georg, Steiner, Hans, Marksteiner, Josef, Prof. Dr. Kathrin Sevecke Haring, Christian, Miller, Carl, Hausmann, Armand, Sevecke To examine relevant neurotransmitters in Kathrin plasma samples of patients with Anorexia BMC PSYCHIATRY: 2016; 16: S. 225 Nervosa. Nutzungsmuster von Internet und Computerspielen: Ergebnisse einer Beobachtungsstudie an Tiroler Jugendlichen Neural Correlates and Personality Riedl, David, Stöckl, Andrea.; Nußbaumer, Charlotte, Rumpold, Gerhard, Sevecke, Kathrin, Fuchs, Martin Pathology in Adolescents with Eating NEUROPSYCHIATRIE: 2016; 30: S. 181-190 Disorders Prof. Dr. Elke Gizewski, Eating disorders in adolescence: Attachment issues from a developmental perspective Prof. Dr. Kathrin Sevecke Gander, Manuela, Sevecke, Kathrin, Buchheim, Anna To investigate neural correlates of adoles- FRONTIERS IN PSYCHOLOGY: 2015; 6: S. 1136 cents with eating disorders while watching Collaborations visual food cues in an fMRI environment. • Univ.-Prof. Dr. Anna Buchheim, Institute of Psychology at the University of Innsbruck, Austria Emotional and Structural Indicators • Univ.-Prof. Dr. Barbara Juen, Institute of Psychology at the University of Innsbruck, Austria of Psychopathological Development in • Univ.-Prof. Dr. Svenja Taubner, Institute for Psychosocial Adolescence Prevention at the Universitätsklinikum Heidelberg, Germany • Dr. Florian Juen, KBO Child Center Munich, Germany Dr. Astrid Bock • Prof. Dr. med. Dipl. Psych. Klaus Schmeck, KJPK Basel, The aim of this study is to examine factors Switzerland • PD Dr.Maya Krischer, Department of Child and Adolescent like affect regulation and emotion recogni- Psychiatry, Psychosomatics and Psychotherapy, Cologne, tion that might contribute to the early onset Germany of psychopathology in adolescence.

Digital Media Prof. Dr. Kathrin Sevecke, Dr. Martin Fuchs This research study investigates the use, the potential misuse and comorbidities of excessive use of digital media in children and adolescents.

Research Report 2016 Medical University of Innsbruck 143 Center of Neurology and Neurosurgery Neurology

as MS and neuroimmunology and cognitive 3. Peter Willeit: Förderungspreis des neurology. The Division of Neurobiology is Landes Tirol für Wissenschaft 2016 focused on animal modelling of neurode- 4. Philipp Mahlknecht: Preis der generation with an emphasis on multiple Ärztekammer für Tirol 2015 system atrophy. A recently-established pro- 5. Gregor Wenning: Dr. Johannes Tuba fessorship for computational neuroscience Preis 2015 der Ärztekammer für Tirol is concerned with establishing novel image analysis algorithms for MRI datasets. Research

General Facts Research Group Stroke Leaders: ao. Univ.-Prof. Johann Willeit, The Department of Neurology at Innsbruck ao. Univ.-Prof. Stefan Kiechl, Medical University has a total of 114 in-pa- Assoz. Prof. PD Michael Knoflach tient beds including a stroke unit (8 beds), Research priorities of the neurovascular a neurocritical care unit (10 fully-ventilat- research group are acute and post-acute ed beds, 6 post-immediate care beds), an stroke care, atherosclerosis and vascular epilepsy monitoring unit (4 beds) and a biology, as well as cardiovascular ageing. dedicated sleep laboratory (6 beds). The High-quality epidemiological research is Director: department acts as a referral centre for the based on the internationally-respected o. Univ.-Prof. Dr. Werner Poewe entire spectrum of neurological diseases Bruneck Study and the large international encompassing the entire area of the state Proof-ATHERO consortium (PI Peter Willeit). Contact: of Tyrol and neighbouring areas. Further- Johann Willeit and Stefan Kiechl head the Anichstraße 35 more, the department receives referrals on ‘Research Center of Excellence in Vascular 6020 Innsbruck an Austria-wide scale when second opinions Ageing – Tyrol’ which has its headquarters and specialised diagnostic and therapeutic in Innsbruck (4.3 Mio €), the Tyrol Stroke [email protected] procedures are required. The large number Pathway and the largest RCT on post-stroke Phone: +43 512 504 23850 of patients received by the department each disease management (Stroke Card). Risk Fax: +43 512 504 23852 year (more than 6,000 in-patient admis- predictors for stroke recurrence in patients www.i-med.ac.at/neurologie sions per year, close to 40,000 out-patient with cervical artery dissections are current- contacts per year) results in a significant ly evaluated in a project funded by the Anni- clinical routine workload. Key collaborations versary Fund of the Austrian National Bank. Research Branch (ÖSTAT Classification) in the field of clinical routine include joint (PI: Michael Knoflach). programs with the Department of Neuro- 301402, 302052, 301401, surgery, in particular vascular surgery, neu- Research Group Multiple Sclerosis and 302073, 302043 rooncology, epilepsy surgery and deep brain Neuroimmunology stimulation for movement disorders. Equally Leaders: ao. Univ.-Prof. Thomas Berger, Keywords close collaborations exist with the Depart- ao. Univ.-Prof. Florian Deisenhammer, ments of Neuroradiology and Vascular Sur- ao. Univ.-Prof. Markus Reindl Multiple sclerosis, neuroimmunology, gery and Cardiology in the field of stroke Embedded in long-lasting and excellent neurointensive care medicine, stroke, medicine. Research collaborations in the research collaborations the main research neurovascular research, movement field of neuroimaging are centred upon the topics are related to pathomechanisms, disorders, Parkinson’s Disease, Department of Neuroradiology and Nuclear clinical and therapeutic aspects of auto- chorea, multiple system atrophy, sleep, Medicine. Dedicated research infrastruc- immune CNS and PNS disorders: multiple polysomnography, daytime sleepiness, tures within the clinical department include sclerosis (MS), antibody-associated neuro- narcolepsy, restless legs syndrome, the Division of Neurobiology (animal model- logical disease (neuromyelitis optica [NMO], neurobiology, computational neuroscience ling of neurodegeneration), the neurological acute disseminated encephalomyelitis or research laboratory (focus on biomarker NMDAR-encephalitis) and immune neu- Research Focus research and neuroimmunology), as well as ropathies. Thus, scientific foci are the role the recently established computational neu- of human autoantibodies directed against The clinical Department of Neurology at the roscience unit for the development of novel different CNS tissue antigens (mainly MOG, Medical University of Innsbruck has an in- image analysis algorithms. AQP4 and NMDA-R) and neutralising an- ternationally-established research focus in tibodies in the monitoring of various MS the fields of epidemiology and pathophysi- Prizes treatments. These research activities are ology of ischemic stroke, neurocritical care committed to complement and translate to (including infectious diseases of the nerv- 1. Werner Poewe: Wissenschaftspreis our neurological laboratory diagnostics. In ous system), Parkinson’s Disease, MSA and Verband der Professorinnen und addition, extensive databases for MS and degenerative movement disorders. In addi- Professoren der Innsbrucker NMO have been established, which are of tion, the department is the only academic Universitäten (UPVI) 2015 paramount importance for past and current institution in Austria with an internationally 2. Stefan Kiechl: Tiroler Landespreis research activities, both national and inter- recognised and certified sleep laboratory für Wissenschaft 2016, Research national. with a focus on research into the field of Excellence Award of the European sleep-related movement disorders, as well Stroke Organisation 2016

144 Research Report 2016 Medical University of Innsbruck Neurology

Research Group Neurocritical Care and well as on clinical trials in PD and related Division of Neurobiology Infectious Diseases of the Nervous movement disorders. Current aims are to Leaders: Univ.-Prof. Gregor K. Wenning, ­System validate biomarkers on early diagnosis and Assoz. Prof. PD Nadia Stefanova Leaders: Univ.-Prof. Erich Schmutzhard, progression of PD, MSA and other move- The research programme at the Division of PD Bettina Pfausler, Assoz. Prof. PD Ronny ment disorders including HD and ataxias as Neurobiology focuses on multiple system Beer, PD Raimund Helbok well as to introduce clinical trials of novel at­­rophy (MSA), a neurodegenerative disor- This study group focuses both in clinical and therapies for these disorders, including der associated with autonomic failure, atax- translational research. Invasive multimodal an EU-funded conservative iron chelation ia and parkinsonism. Over the last decade neuromonitoring, covering structural (imag- therapy as a disease-modifying strategy in our research group has made important ing), metabolic (microdialysis, PBti02, CBF), PD and a deep brain stimulation (globus contributions regarding clinical presenta- functional monitoring (electrocorticogra- ­pallidus) therapy as a symptomatic treat- tion, diagnostic tools and pathogenesis phy – COSBID) and the clinical aspects of ment strategy in HD. of MSA. We are especially interested in neurocritical care (blood pressure and glu- α-­ synu­clein mediated oligodendroglial pa- cose management, nosocomial infections, Major achievements: Completion of an im- thology that includes protein misfolding and ventilator associated pneumonia, moni- munisation trial against alpha-synuclein, aggregation as well as cell-to-cell propaga- toring and management of post-intensive identification of risk factors and prodromal tion. We identified fundamental interactions care dysphagia, etc.) are major foci in the markers for the development of PD, natural between MSA pathology and mitochondrial department’s research. Furthermore, the history study of different ataxias. or proteolytic stress. The latter contribute influence of enteral and/or parenteral nu- Future goals: better characterisation of to the specific neuronal vulnerability in MSA trition towards brain metabolism is another premotor PD, clinical trials on novel thera- and represent powerful interventional tar- research focus. The research group partici- peutics for PD, MSA and other movement gets. We were the first to demonstrate that pates in a number of international multicen- disorders. the toll-like receptor 4 (TLR4) promotes tre trials, in particular traumatic brain inju- α-synuclein clearance by microglia. ry, nutrition of neurocritical care patients, Research Group Sleep Medicine More recently our work also involved pre- aneurysmatic spontaneous subarachnoid Leader: ao. Univ.-Prof. Birgit Högl clinical screening of candidate neuroprotec- haemorrhage, intracerebral haemorrhage, The Sleep Laboratory and Sleep Disorders tive and neuroregenerative strategies that refractory convulsive status epilepticus, Research Group at the Department of Neur­ are currently being evaluated for safety and etc. Major achievements result from this ology serves a dual purpose of research and efficacy in controlled clinical trials tight collaboration with regional, European clinics. From a research perspective, the and international neurocritical care. main focus is on restless legs syndrome Computational Neuroscience and REM sleep behaviour disorder, and Leader: Univ.-Prof. Christoph Scherfler Research Group Movement Disorders other motor disorders of sleep. The Sleep The research unit for Computational Neuro- Leaders: o. Univ.-Prof. Werner Poewe, Research Group publishes more than 20 science was established within the Depart- ao. Univ.-Prof. Klaus Seppi, Univ.-Prof. papers per year and has funding from FWF, ment of Neurology in October 2014 to ac- Christoph Scherfler, PD Sylvia Bösch, ÖNB, Michael J. Fox Foundation and the commodate and support existing research Univ.-Prof. Gregor K. Wenning pharmacological industry. groups in the field of MRI and PET image Movement disorders groups at the Depart- Clinically, the sleep lab is a high-tech mod- analysis. The unit is tightly intertwined with ment of Neurology and their partners at ern facility with an advanced sleep lab, a the Department of Neuroradiology and MUI have established an internationally re­c­ large outpatient clinic and the possibility to has broad access to the MRI core facility, ognised clinical research focus on degener- perform state of the art video polysomnog- equipped with a dedicated 3 Tesla research ative movement disorders including Parkin- raphy and several additional relevant inves- tomograph. Members of the laboratory are son’s disease (PD) and related syndromes. tigations, including ambulatory cardiorespi- developing and exploring mathematical Major contributions have been in the field ratory polygraphy, pupillography, different models of structural and functional image of clinical trials in PD, rating scale develop- types of actigraphy and measurements of analysis for its value to be translated into ment for PD and multiple system atrophy circadian functions. the routine neurological and radiological (MSA), natural history and imaging studies The group has high international recogni- work-up of patients with CNS disorders. in parkinsonian syndromes and other move- tion and cooperation with various research Due to long-lasting expertise in the field of ment disorders, with key papers in major groups at Harvard University, Stanford Uni- movement disorders, the main focus was journals like the Annals of Neurology, JAMA versity, Tokyo University, Barcelona Univer- set to neurodegenerative parkinsonian dis- Neurology, Neurology, Brain, Lancet Neuro­ sity and Technical University of Munich, to orders and was recently extended to neu- logy, NEJM or Nature communications. It is name but a few. rodegenerative dementias, sleep disorders involved in multiple international research The sleep disorders unit (sleep lab and Sleep and intracranial haemorrhages. consortia and networks and between 2015 Research Group) at Innsbruck Medical Uni- (contact: Prof. Christoph Scherfler Research and 2016 authored and co-authored a to- versity, Department of Neurology is headed Unit for Computational Neuroscience,­ tal of 82 papers in peer-reviewed journals. by Birgit Högl, with Elisabeth Brandauer and ­Department of Neurology, email: christoph. Recent clinical research projects have fo- Melanie Bergmann in her team. [email protected]). cussed on the epidemiology, genetics and Current Research Group members are natural history of PD and other movement Ambra Stefani (PhD student) and Evi Research Group Cognitive Neurology disorders including dystonia, MSA, Hunting- Holzknecht (PhD student), the Head and Neuropsychology ton’s disease (HD) and ataxias, on the vali- Technician is Heinz Hackner. Leaders: ao. Univ.-Prof. Thomas Benke, dation of imaging and biomarker studies for ao. Univ.-Prof. Margarete Delazer PD, MSA, ataxias and related disorders as The research group focuses on the neu-

Research Report 2016 Medical University of Innsbruck 145 Center of Neurology and Neurosurgery

ropsychological consequences of neurolog- A clinical approach to diagnosis of autoimmune encephalitis Klaus, SINBAR Sleep Innsbruck Barcelona, Graus, Francesc, Titulaer, Maarten J., Balu, Ramani, Benseler, NEUROLOGY: 2015; 84: S. 654-658 ical diseases as well as on the elucidation of Susanne, Bien, Christian G., Cellucci, Tania, Cortese, Irene, Dale, neurological mechanisms supporting cogni- Russell C., Gelfand, Jeffrey M., Geschwind, Michael, Glaser, Carol Biological and clinical characteristics of the European A., Honnorat, Jerome, Hoeftberger, Romana, Iizuka, Takahiro, Irani, Friedreich's Ataxia Consortium for Translational Studies tion. Main topics of the group include deci- Sarosh R., Lancaster, Eric, Leypoldt, Frank, Pruess, Harald, Rae- (EFACTS) cohort: a cross-sectional analysis of baseline data sion processes in neurological disease and Grant, Alexander, Reindl, Markus, Rosenfeld, Myrna R., Rostasy, Reetz, Kathrin, Dogan, Imis, Costa, Ana S., Dafotakis, Manuel, Kevin, Saiz, Albert, Venkatesan, Arun, Vincent, Angela, Wandinger, Fedosov, Kathrin, Giunti, Paola, Parkinson, Michael H., Sweeney, healthy ageing, the neurological implemen- Klaus-Peter, Waters, Patrick, Dalmau, Josep, Mary G., Mariotti, Caterina, Panzeri, Marta, Nanetti, Lorenzo, tation of numerical processing, rehabilita- LANCET NEUROLOGY: 2016; 15: S. 391-404 Arpa, Javier, Sanz-Gallego, Irene, Durr, Alexandra, Charles, Perrine, Boesch, Sylvia, Nachbauer, Wolfgang, Klopstock, Thomas, Karin, tion and learning. An extensive database for Multicentre comparison of a diagnostic assay: aquaporin-4 Ivan, Depondt, Chantal, Hagen, Jennifer Muller Vom, Schols, Alzheimer’s disease has been established in antibodies in neuromyelitis optica Ludger, Giordano, Ilaria A., Klockgether, Thomas, Burk, Katrin, Waters, Patrick, Reindl, Markus, Saiz, Albert, Schanda, Kathrin, Pandolfo, Massimo, Schulz, Joeg B., collaboration with other national centres, Tuller, Friederike, Kral, Vlastimil, Nytrova, Petra, Sobek, Ondrej, LANCET NEUROLOGY: 2015; 14: S. 174-182 which is of major importance in current and Nielsen, Helle Hvilsted, Barington, Torben, Lillevang, Soren T., Illes, Zsolt, Rentzsch, Kristin, Berthele, Achim, Berki, Timea, Granieri, Efficacy of rasagiline in patients with the parkinsonian future research. Research methods include Letizia, Bertolotto, Antonio, Giometto, Bruno, Zuliani, Luigi, variant of multiple system atrophy: a randomised, placebo- neuro-psychological experimental methods, Hamann, Dorte, van Pelt, E. Danielle, Hintzen, Rogier, Hoeftberger, controlled trial Romana, Costa, Carme, Comabella, Manuel, Montalban, Xavier, Poewe, Werner, Seppi, Klaus, Fitzer-Attas, Cheryl J., Wenning, eye-tracking analysis and various methods Tintore, Mar, Siva, Aksel, Altintas, Ayse, Deniz, Gunnur, Woodhall, Gregor K., Gilman, Sid, Low, Phillip A., Giladi, Nir, Barone, Paolo, of brain imaging together with the research Mark, Palace, Jacqueline, Paul, Friedemann, Hartung, Hans-Peter, Sampaio, Cristina, Eyal, Eli, Rascol, Olivier, Rasagiline-for-MSA Aktas, Orhan, Jarius, Sven, Wildemann, Brigitte, Vedeler, Christian, Investigators, group computational neuroscience. Further Ruiz, Anne, Leite, M. Isabel, Trillenberg, Peter, Probst, Monika, LANCET NEUROLOGY: 2015; 14: S. 145-152 issues are related to the early diagnosis of Saschenbrecker, Sandra, Vincent, Angela, Marignier, Romain, JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY: Substantia nigra hyperechogenicity and Parkinson's disease Alzheimer’s disease, and the frontotempo- 2016; 87: S. 1005-1015 risk in patients with essential tremor ral and vascular dementia complex. Sprenger, Fabienne S., Wurster, Isabel, Seppi, Klaus, Stockner, Research Group Neurocritical Care and Infectious Diseases of the Heike, Scherfler, Christoph, Sojer, Martin, Schmidauer, Christof, Nervous System Berg, Daniela, Poewe, Werner, MOVEMENT DISORDERS: 2016; 31: S. 579-583 Results of the ICTuS 2 Trial (Intravascular Cooling in the Selected Publications Treatment of Stroke 2) Research Group Sleep Medicine Lyden, P., Hemmen, T., Grotta, J., Rapp, K., Ernstrom, K., Rzesiewicz, Research Group Stroke T., Parker, S., Concha, M., Hussain, S., Agarwal, S., Meyer, B., Jurf, IgLON5 autoimmunity and abnormal behaviours during J., Altafullah, I., Raman, R., Hess, MJ., Mullin, A., Jane Hess, M., sleep Thrombolysis and clinical outcome in patients with stroke Muranevici, G., Piantadosi, B., Jimenez-Maggiora, G., So, JS., Jain, Hoegl, Birgit, Heidbreder, Anna, Santamaria, Joan, Graus, after implementation of the Tyrol Stroke Pathway: a S., Diringer, M., Derdeyn, C., Stern, B., Hamilton, S., Dietrich, D., Francesc, Poewe, Werner, retrospective observational study Becker, K., Yenari, M., Dirnagl, U., Wijman, C., Chamorro, Á., Janis, LANCET: 2015; 385: S. 1590-1590 Willeit, Johann, Geley, Theresa, Schoech, Johannes, Rinner, S., Moy, C., Lin, F., Song, S., Schlick, K., Khanolkar, P., Edwards, NJ., Heinrich, Tuer, Andreas, Kreuzer, Hans, Thiemann, Norbert, Roldan, A., Wilson, J., Little, A., Lewis, P., Neil, W., Bruce, N., Guzik, Natural course of restless legs syndrome/Willis-Ekbom Knoflach, Michael, Toell, Thomas, Pechlaner, Raimund, Willeit, A., Sohdi, A., Herial, N., Ovbiagele, B., Meyer, D., Modir, R., Chavez, disease: long-term observation of a large clinical cohort Karin, Klingler, Natalie, Praxmarer, Silvia, Baubin, Michael, R., Velazquez, A., Mayer, S., Claassen, J., Falo, C., Tafreshi, G., Neil, Mitterling, Thomas, Heidbreder, Anna, Stefani, Ambra, Fritz, Josef, Beck, Gertrud, Berek, Klaus, Dengg, Christian, Engelhardt, W., Bruce, N., Guzik, A., Modir, R., Kelly, N., Chavez, R., Ovbiagele, Ulmer, Hanno, Poewe, Werner, Hoegl, Birgit, Klaus, Erlacher, Thomas, Fluckinger, Thomas, Grander, Wilhelm, B., Shell, E., Dugan, G., Kim, E., Tanner, A., Michel, P., Eskandari, SLEEP MEDICINE: 2015; 16: S. 1252-1258 Grossmann, Josef, Kathrein, Hermann, Kaiser, Norbert, Matosevic, A., Oddo, M., Suys, T., Remillard, S., Cordier, M., Brown, R., Jasak, Benjamin, Matzak, Heinrich, Mayr, Markus, Perfler, Robert, Poewe, S., McCullough, L., Brautigam, R., Alexandrov, A., Sisson, A., Risk Factors for Neurodegeneration in Idiopathic Rapid Eye Werner, Rauter, Alexandra, Schoenherr, Gudrun, Schoenherr, Albright, K., Broessner, G., Schmutzhard, E., Escioglou, E., Jones, Movement Sleep Behavior Disorder: A Multicenter Study Hans-Robert, Schinnerl, Adolf, Spiss, Heinrich, Thurner, Theresa, W., Poisson, S., Simpson, J., Shah, Q., Jonczak, K., Bussinger, P., Postuma, Ronald B., Iranzo, Alex, Hogl, Birgit, Arnulf, Isabelle, Vergeiner, Gernot, Werner, Philipp, Woell, Ewald, Willeit, Peter, Lewandowski, C., Berry, S., Lundell, A., Miller, JB., Cruz-Flores, Ferini-Strambi, Luigi, Manni, Raffaele, Miyamoto, Tomoyuki, Kiechl, Stefan, S., Holzer, E., Torretta, S., Brown, D., Heim, L., Smith, C., Kelley, Oertel, Wolfgang, Dauvilliers, Yves, Ju, Yo-El, Puligheddu, Monica, LANCET NEUROLOGY: 2015; 14: S. 48-56 C., Greer, D., Marcolini, EG., Gilmore, EJ., Rutledge, N., McBee, Sonka, Karel, Pelletier, Amelie, Santamaria, Juan, Frauscher, D., Khanna, A., Warren, S., Wilsom, C., Shushrutha Hedna, V., Birgit, Leu-Semenescu, Smaranda, Zucconi, Marco, Terzaghi, Predictive value of ABCD2 and ABCD3-I scores in TIA and Rosado, C., Kizza, R., O'Phelan, K., Escobar, A., Merenda, A., Perez Michele, Miyamoto, Masayuki, Unger, Marcus M., Carlander, minor stroke in the stroke unit setting Barcena, J., Malik, A., Bertrand, Fantini, Maria-Livia, Montplaisir, Jacques Y., Knoflach, Michael, Lang, Wilfried, Seyfang, Leonhard, Fertl, STROKE: 2016; 47: S. 2888-2895 ANNALS OF NEUROLOGY: 2015; 77: S. 830-839 Elisabeth, Oberndorfer, Stefan, Daniel, Gerhard, Seifert-Held, Thomas, Brainin, Michael, Krebs, Stefan, Matosevic, Benjamin, Clinical findings and management of patients with Dreaming furiously? A sleep laboratory study on the dream Toll, Thomas, Kiechl, Stefan, Willeit, Johann, Ferrari, Julia, Austrian meningitis with an emphasis on Haemophilus influenzae content of people with Parkinson's disease and with or Stroke Unit Collaborators, meningitis in rural Tanzania without rapid eye movement sleep behavior disorder NEUROLOGY: 2016; 87: S. 861-869 Storz, Corinna, Schutz, Cornelia, Tluway, Anthony, Matuja, William, Valli, Katja, Frauscher, Birgit, Peltomaa, Taina, Gschliesser, Viola, Schmutzhard, Erich, Winlder, Andrea S., Revonsuo, Antti, Hoegl, Birgit, Cardioprotection and lifespan extension by the natural JOURNAL OF THE NEUROLOGICAL SCIENCES: 2016; 366: S. 52- SLEEP MEDICINE: 2015; 16: S. 419-427 polyamine spermidine 58 Eisenberg, Tobias, Abdellatif, Mahmoud, Schroeder, Sabrina, Division of Neurobiology Primessnig, Uwe, Stekovic, Slaven, Pendl, Tobias, Harger, Prognostic Significance of Hyponatremia in Acute Alexandra, Schipke, Julia, Zimmermann, Andreas, Schmidt, Intracerebral Hemorrhage: Pooled Analysis of the Intensive Multiple-System Atrophy Albrecht, Tong, Mingming, Ruckenstuhl, Christoph, Dammbrueck, Blood Pressure Reduction in Acute Cerebral Hemorrhage Fanciulli, Alessandra, Wenning, Gregor K., Christopher, Gross, Angelina S., Herbst, Viktoria, Magnes, Trial Studies NEW ENGLAND JOURNAL OF MEDICINE: 2015; 372: S. 249-263 Christoph, Trausinger, Gert, Narath, Sophie, Meinitzer, Andreas, Carcel C., Sato S., Zheng D., Heeley E., Arima H., Yang J., Wu G., Hu, Zehan, Kirsch, Alexander, Eller, Kathrin, Carmona-Gutierrez, Chen G., Zhang S., Delcourt C., Lavados P., Robinson T., Lindley Computational Neuroscience Didac, Buettner, Sabrina, Pietrocola, Federico, Knittelfelder, Oskar, RI., Wang X., Chalmers J., Anderson CS.; Intensive Blood Pressure Schrepfer, Emilie, Rockenfeller, Patrick, Simonini, Corinna, Rahn, Reduction in Acute Cerebral Hemorrhage Trial 2 Investigators., Diagnostic potential of automated subcortical volume Alexandros, Horsch, Marion, Moreth, Kristin, Beckers, Johannes, CRITICAL CARE MEDICINE: 2016; 44: S. 1388-1394 segmentation in atypical parkinsonism Fuchs, Helmut, Gailus-Durner, Valerie, Neff, Frauke, Janik, Dirk, Scherfler, Christoph, Goebel, Georg, Mueller, Christoph, Nocker, Rathkolb, Birgit, Rozman, Jan, de Angelis, Martin Hrabe, Moustafa, Research Group Movement Disorders Michael, Wenning, Gregor K., Schocke, Michael, Poewe, Werner, Tarek, Haemmerle, Guenter, Mayr, Manuel, Willeit, Peter, von Seppi, Klaus, Frieling-Salewsky, Marion, Pieske, Burkert, Scorrano, Luca, Pieber, Loss of Dorsolateral Nigral Hyperintensity on 3.0 Tesla NEUROLOGY: 2016; 86: S. 1242-1249 Thomas, Pechlaner, Raimund, Willeit, Johann, Sigrist, Stephan J., Susceptibility-Weighted Imaging in Idiopathic Rapid Eye Linke, Wolfgang A., Muehlfeld, Christian, Sadoshima, Junichi, Movement Sleep Behavior Disorder Longitudinal profile of iron accumulation in good-grade Dengjel, Joern, Kiechl, Stefan, Kroemer, Guido, Sedej, Simon, De Marzi, Roberto, Seppi, Klaus, Hoegl, Birgit, Mueller, Christoph, subarachnoid hemorrhage Madeo, Frank, Scherfler, Christoph, Stefani, Ambra, Iranzo, Alex, Tolosa, Scherfler, Christoph, Schiefecker, Alois Josef, Delazer, Margarete, NATURE MEDICINE: 2016; 22: S. 1428-+ Eduardo, Santamaria, Joan, Gizewski, Elke, Schocke, Michael, Beer, Ronny, Bodner, Thomas, Spinka, Georg, Kofler, Mario, Skalla, Elisabeth, Kremser, Christian, Poewe, Werner, Pfausler, Bettina, Kremser, Christian, Schocke, Michael, Benke, Research Group Multiple Sclerosis and Neuroimmunology ANNALS OF NEUROLOGY: 2016; 79: S. 1026-1030 Thomas, Gizewski, Elke R., Schmutzhard, Erich, Helbok, Raimund, ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY: 2016; Long Term Clinical Prognostic Factors in Relapsing- Olfactory dysfunction predicts early transition to a Lewy 3: S. 781-790 Remitting Multiple Sclerosis: Insights from a 10-Year body disease in idiopathic RBD Observational Study Mahlknecht, Philipp, Iranzo, Alex, Hoegl, Birgit, Frauscher, Birgit, 1.5 Versus 3 Tesla Magnetic Resonance Planimetry in Bsteh, Gabriel, Ehling, Rainer, Lutterotti, Andreas, Hegen, Harald, Mueller, Christoph, Santamaria, Joan, Tolosa, Eduardo, Serradell, Neurodegenerative Parkinsonism Di Pauli, Franziska, Auer, Michael, Deisenhammer, Florian, Reindl, Monica, Mitterling, Thomas, Gschliesser, Viola, Goebel, Georg, Mangesius, Stephanie, Krismer, Florian, Gizewski, Elke R., Mueller, Markus, Berger, Thomas, Brugger, Florian, Scherfler, Christoph, Poewe, Werner, Seppi, Christoph, Hussl, Anna, Schocke, Michael, Scherfler, Christoph, PLOS ONE: 2016; 11: S. e0158978

146 Research Report 2016 Medical University of Innsbruck Neurology

Poewe, Werner, Seppi, Klaus, • ParkinsonFonds Österreich – Opthalmological disordes in United States MOVEMENT DISORDERS: 2016; 31: S. 1925-1927 Parkinson’s disease: prevalence and clinical impact 166.650 € -2016- Research Group Neurocritical Care and Infectious Diseases Research Group Cognitive Neurology and Neuropsychology of the Nervous System Research Group Sleep Medicine • Craig Anderson, The George Institute for Global Health, Oxygen desaturation during night sleep affects decision- • I 21 20 B 27 01/2015-01/2018: Safer Screening for RBD, Sydney, Australia making in patients with obstructive sleep apnea funding from FWF Bilateral Austria/Argentina. Project Leader: • John Stover, Zürich, Switzerland: NOSTRA trialists Delazer, Margarete, Zamarian, Laura, Frauscher, Birgit, Mitterling, Birgit Högl • Peter Kremsner: Tübingen, Germany and Lambarene, Gabun: Thomas, Stefani, Ambra, Heidbreder, Anna, Hoegl, Birgit, • 11/2012-10/2016: RLS-Iron: Investigation of iron SMAC trialists JOURNAL OF SLEEP RESEARCH: 2016; 25: S. 395-403 metabolism in patients with idiopathic RLS, funding from • Peter Le Roux: Wynnewood, PA, USA, International the Government of Tyrol, translational research fund. Global Multidisciplinary Consensus Conference on Multimodality Impaired Information Sampling in Mild Dementia of project Leader Birgit Högl Neuro-Monitoring. Alzheimer's Type but Not in Healthy Aging • KLI 236 (former KLI 112) 2012-2016: Motor activity during • JH Zhang: Loma Linda, CA, USA Zamarian, Laura, Benke, Thomas, Brand, Matthias, Djamshidian, sleep in health and disease Funded by FWF, Project Leader • Sarah Gabriel, Cystinet-project, Antwerp, Belgium Atbin, Delazer, Margarete, Birgit Frauscher. formally transferred to Gregor Wenning in • Nino Stocchetti, Milano, Italy: SyNAPSE trialists NEUROPSYCHOLOGY: 2015; 29: S. 353-367 2012 Research Group Sleep Medicine Quantifying synchrony patterns in the EEG of Alzheimer's Division of Neurobiology • Oscar Gershanik, University of Buenos AIres, Argenitina patients with linear and non-linear connectivity markers • Stefanova N & Wenning GK. Alpha-synuclein: a pathogenic • SINBAR, Sleep Innsbruck Barcelona Waser, Markus, Garn, Heinrich, Schmidt, Reinhold, Benke, trigger and interventional target Pathogenic role of alpha- • Joan Santamaria and Alex Iranzo, Hospital Clinic of Barcelona, Thomas, Dal-Bianco, Peter, Ransmayr, Gerhard, Schmidt, Helena, synuclein in MSA. FWF SPIN DK W1206-08, 180.000 € (PI: Barcelona, Spain Seiler, Stephan, Sanin, Guenter, Mayer, Florian, Caravias, Georg, Nadia Stefanova) • Claudia Trenkwalder, Paracelsus-Elena Clinic, Kassel, and Grossegger, Dieter, Fruehwirt, Wolfgang, Deistler, Manfred, • ARTEMIS: Targeting alpha-synuclein for treating MSA, E-RARE, University of Goettingen Germany JOURNAL OF NEURAL TRANSMISSION: 2016; 123: S. 297-316 FWF I2102, 308.500€ (PI: Gregor K. Wenning) • University of Barcelona, Harvard University, Stanford • Inside the gait – a new era on the horizon for atypical University, Johns Hopkins University, the Rush Medical Center, parkinsonian disorders, MSA Coalition, 50.000 USD (PI: and other universities in Japan, Latin America etc. Selected Funding Gregor K. Wenning) • Global MSA Registry & Natural History Study, MSA Coalition, Research Group Multiple Sclerosis and Neuroimmunology Research Group Stroke 50.000USD, (PI: Gregor K. Wenning) • Hans Lassmann, Monika Bradl, Romana Höftberger, Fritz In 2015 and 2016 funding was derived from the FWF (J 3679 • Targeting alpha-synuclein pathology with the molecular Leutmezer and Alexander Zimprich, Medical University of Schrödinger-Program: Role of miR-122 in Cardiometabolic tweezer CLR01 in MSA, MSA Coalition, 100.000 USD (PI: Vienna, Vienna, Austria Disease), Standortagentur Tyrol (Translational Research Project Nadia Stefanova) • Michael Khalil, Christian Enzinger and Franz Fazekas,Medical Tyrol Score, 340 K€), the Reformpool (Tyrol Stroke Pathway, • Alpha-synuclein: a pathogenic trigger and interventional target University of Graz, Graz, Austria 200 K€) and the FFG (VASCage, 4300 K€). FFG recommended in MSA. FWF SFB F4414, 479.955 € (deputy speaker and PI: • Kevin Rostasy: Childrens Hospital Datteln, Datteln, Germany to submit a revised K1 Application VASCage-C in 2017 (19 Mio Nadia Stefanova, co-PI: Gregor K. Wenning) • Edgar Meinl, LMU Munich, Munich, Germany €). Funding of 800 K€ was obtained to conduct the post-Stroke • Progression of microglial activation in a mouse model of MSA. • Bernhard Hemmer, TU Munich, Munich, Germany Disease Management Project Stroke Card. The neurovascular FWF SPIN DK W1206-08, 150.000 € (PI: Nadia Stefanova) • Sven Jarius and Brigitte Wildemann, University of Heidelberg, research group participates in in large international research and • MultiSyn: Multimodal Imaging of rare Synucleinopathies, Heidelberg, Germany meta-analysis consortia (steering/writing committee: FSC, ERFC, HEALTH-F5-2013-602646, 537.410 €, (PI: Gregor K. Wenning) • Orban Aktas and Hanspeter Hartung, University of Düsseldorf, LSC, NPSC, IMT-PROG, GBD, various GWA studies) and heads its • Wenning GK. Cardiac Magnetic Resonance Spectroscopic Düsseldorf, Germany own consortium Proof-ATHERO. Correlates of Cardiac Sympathetic Denervation in Parkinson’s • Christine Stadelmann and Wolfgang Brück, University of disease: A Comparison with MSA-P and Healthy Controls, Göttingen, Göttingen, Germany Research Group Multiple Sclerosis and Neuroimmunology KLI380 109.620 € • Andreas Lutterotti, Mireia Sospreda, Jan Lünemann and Roland • 2016: Österreichische Forschungsförderungsgesellschaft • Stefanova N. Alpha-Synuclein and Oligodendroglia in MSA Martin, University of Zürich, Zürich, Switzerland (FFG) Bridge 1 Projekt 853209 “ENTWICKLUNG EINES Pathogenesis, FWF P25161 302.773 € • L. Kappos, University of Basel, Basel, Switzerland DIAGNOSTISCHEN TESTKITS FÜR NEUROLOGISCHE • Wenning GK & Stefanova N. Functional read-outs and novel • Romain Marignier, University of Lyon, Lyon, France AUTOIMMUNERKRANKUNGEN (EDNA)” interventional targets in a transgenic MSA model, FWF SFB • Albert Saiz, Frances Graus, Josep Dalmau and M. Comabella, • 2016: Österreichische Multiple Sklerose F4404 364.790 € University of Barcelona, Barcelona, Spain Forschungsgesellschaft: “Clinical, morphologic and • Paddy Waters, Jackie Palace, Isabel Leite and Angela Vincent, biochemical markers at different stages of multiple sclerosis Computational Neuroscience University of Oxford, Oxford, UK (MS) and their dynamics over time” • Hochschulraumstrukturmittel - Projekt: Neuroimage Wien • Anne Fogdell-Hahn, Karolinska Institute, Stockholm, Sweden Innsbruck Graz (WING) • Eva Havrdova, University of Prague, Prague, Czech Republic Research group Neurocritical Care and Infectious Diseases • Austrian Wirtschaftsservice P1504563-WZP01 • Jeffrey Bennett, University of Denver, Denver, Colorado of the Nervous System • Douglas Sato, Tatsuro Misu and Kazuo Fujihara, Tokohu Clinical Neurocritical Care Medicine Research Group Cognitive Neurology and Neuropsychology University, Sendai, Japan • NOSTRA 2 NO Synthase Inhibitor in TBI – a microdialysis trial, Project leader: Laura Zamarian phase 2 study COSBID in TBI and ICH Tau in aSAH MUI-Start Projekt (2014-05-001) „Decision making abilities in Division of Neurobiology • Center TBI patients with multiple sclerosis – Assessment and training” • Gal Bitan, UCLA, Los Angeles, USA • Neuropsychological longterm outcome and neuro-imaging in • Angela Cenci, Lund University, Lund, Sweden aSAH patients • Marina Romero-Ramos, Aarhus University, Aarhus, Denmark • The role of Remote Ischemic Preconditioning in the prevention Collaborations • Leonidas Stefanis, University of Athens Medical School, Athens, of ischemic brain damage during intracranial Aneurysm Greece Research Group Movement Disorders Treatment (RIPAT) • Wassilios Meisner, University of Bordeaux, Bordeaux, France • Prof. Christopher Goetz, Department of Neurological Sciences, • SWITCH : decompressive craniectomy in ICH • Armin Giese, Ludwig-Maximillian-University, Munich, Germany Rush University Medical Center, Chicago, Ilinois, USA • NEWTON: intraventricular Nimodipine in aneurysmatic SAH • Christian Griesinger, Max Plank Insitute for Biophysical • Prof. Cristina Sampaio, CHDI Management/CHDI Foundation, • NOSTRA 3: NO Synthase Inhibitor in TBI –prospective Chemistry, Göttingen, Germany Princeton, New Jersey, USA randomized phase 3 study • Thomas Gasser, University of Tübingen, Tübingen, Germany • Prof. Eduardo Tolosa, 4Parkinson's Disease and Movement • Influence of nutrition - in neurocritical care patients – • Bernd Pichler, University of Tübingen, Tübingen, Germany Disorders Unit, Neurology Service, Hospital Clinic de on glucose homeostatsis, a cerebral and subcutaneous • Deniz Kirik, University of Lund, Lund, Sweden Barcelona, Universitat de Barcelona, microdialysis study • Horacio Kaufmann, NYU, New York, USA • Phast Trac Studie • Prof. Alex Iranzo, Neurology Service, Hospital Clínic de Barcelona, IDIBAPS, CIBERNED, C/Villarroel 170, Barcelona Translational Neurocritical Care Medicine Computational Neuroscience 08036, Spain • Cerebral microdialysis in murine sepsis syndrome • HRSM Wien Innsbruck Graz • Prof. Juliane Winkelmann, Klinik und Poliklinik für Neurologie, • Sepsis-Otopathy: hearing impairment in murine (CLP) sepsis • Neuroimage Wien Innsbruck Graz (WING) Klinikum rechts der lsar, Technische Universität München, • Experimental SAH – neuroprotective effects of nimodipine in • EU Horizon 2020, FAIRPARK II Munich, Germany murine SAH • PRODEM AUSTRIA (Pospektives Demenzregister der • Prof. Susan Fox, Movement Disorder Clinic, Dept. of Medicine, Österreichischen Alzheimer Gesellschaft) Tropical and Infectious Disease Neurology University of Toronto, Canada • ENIGMA: Enhancing Neuro Imaging Genetics through Meta • PET in arboviral encephalitides (TBE and Japanese Encephalitis • Prof. Tilo van Eimeren, Department of Nuclear Medicine & Analysis; University of Southern California viruses) – a trinational (Austria, Thailand, Malaysia) study Department of Neurology, University of Cologne, Germany • Hearing loss in murine cerebral malaria • Prof. Thomas Warner, UCL Institute of Neurology, London, • Nodding Syndrome: validation of WHO-Definition United Kingdom Devices and Services • Nodding Syndrome: prevalence in Mahenge, Tanzania – a door • Dr Pedro Barbosa, UCL Institute of Neurology, London, United to door survey Kingdom Neurological Research Laboratory (head: ao. Univ.-Prof. Markus • Nodding Syndrome, long-term course (10 years evaluation) in • Dr Ana Rosso, Federal University of Rio de Janeiro (UFRJ), Rio Reindl) Tanzania de Janeiro, Brazil • Longterm hearing impairment in Gabunese children with • Dr Flavio de Renze Costa, Federal University of Rio de Janeiro severe P.f. malaria (UFRJ), Rio de Janeiro, Brazil • Dr Sean O'Sullivan,Department of Neurology, Cork University Research Group Movement Disorders Hospital, Cork, Ireland • EU (HORIZON2020 EC project Grant 633190 – FAIR-PARK II) • Dr. Eimer Maloney,Department of Neurology, Cork University – Conservative iron chelation as a disease modifying strategy Hospital, Cork, Ireland in PD (FAIR-PARK II) (226.735 € projected) -2015- • Dr Bruno Averbeck, National Institutes of Health, Bethesda,

Research Report 2016 Medical University of Innsbruck 147 Center of Neurology and Neurosurgery Neurosurgery

Research Branch (ÖSTAT Classification) and precise biopsies are taken from these regions to demonstrate that infiltrative be- 301405, 301904, 302051, haviour in brain tumours (metastasis and 304007, 302048 gliomas) can be found by state-of-the-art MR-imaging. The borders and surround- Keywords ings of resected metastases are examined immunohistochemically. Operative tech- Neuro-oncology, cerebrovascular, neuro­ niques are currently under investigation, intensive care, neuromonitoring, neuro- as in cases­ of gliomas, fluorescence guided trauma, spine surgery, spinal implants, disc resections and intra-operative imaging with ­degeneration, regenerative medicine CT is evaluated through posthoc image ren- dering with prototypic algorithms. The aim Research Focus of this collaborative project with industrial partners is to predict the extent of tumour • Tumour: enhance resectable tumour resection through intraoperative CT-imag- volume with aid of intraoperative imaging ing. and fluorescence in combination with electrophysiological stimulation and Selected Trials: Director: neuropsychology. • Elastic Fusion: intraoperative CT is ren- Univ.-Prof. Dr. Claudius Thomé • Vascular: prevention and treatment dered by prototypic algorithms to gener- of clinical and experimental cerebral ate a “virtual” MRI. The extent of resection Contact: vasospasm after aneurysmal subarachnoid is evaluated by neuroradiology (proof of Anichstraße 35 haemorrhage. principle) 6020 Innsbruck • Spine: deploy regenerative strategies for • 31P-MR-Spectroscopy: several tumour discal degeneration and implementation entities are assessed by 31 P-MR-Spec- [email protected] to clinical trials. troscopy to determine “hot-spots” of en- Phone: +43 512 504 27452 hanced metabolic activity Fax: +43 512 504 27453 General Facts • Biopsy: regions of high phosphorus levels http://neurochirurgie.tirol-kliniken.at (high ATP-levels) are precisely targeted by The Department of Neurosurgery actively a navigated biopsy to correlate P-concen- hosts investigator-driven academic studies tration with histologic patterns. and is recruiting patients in multinational • METIS: a multinational, multi-centric trials in different fields of our daily practice. trial to assess efficacy of Tumour-Treat- Clinical research is paralleled with exper- ing-Fields for treatment of brain metasta- imental work in our laboratory. We pursue sis after radiosurgical intervention. the idea of leading innovative concepts from • ReSURGE: a multi-centre trial designed to “bench to bedside”, exemplarily­ shown in evaluate the beneficial effect of surgery the case of chondrocyte cell transplantation for recurrent high-grade gliomas. after surgical treatment of lumbar disc her- • Ischemic preconditioning of patients un- niations. Besides ongoing research focusing dergoing surgical resection for at least on tumour cell infiltration into healthy brain one brain tumour. It aims at the reduction tissue, we implemented different pre- and of perilesional ischemic zones. postoperative routines to determine the • Influence of Methadon in combination “functional status” of patients after treat- with Temozolomide on glioblastoma cell ment of intracranial pathologies. Our main lines — a laboratory investigation in coope­ clinical research focuses are divided into ration with the University of Regensburg, three (interacting) groups. Prof. A. Brawanski.

Research Research Focus: Vascular/ Neurotrauma/Intensive Care Research Focus: Tumour In addition to prospective analysis of treat- The neuro-oncology program of our de- ment results of vascular pathologies (an- partment is focusing on two main fields of eurysms, arteriovenous malformations and interest, “infiltration” and “optimisation of stroke) and the ongoing improvements in functional outcomes” of patients after brain technical standards and operative tech- tumour surgery. Infiltration is always pres- niques, the use of hypoxic preconditioning ent in gliomas, whereas metastatic disease and serum biomarkers are investigated to of solid cancers was believed to be circum- beneficially influence patient treatment. script lesions in the brain. The surrounding The Department of Neurosurgery is partic- tissues of metastatic disease and primary ipating in several international registries gliomas are currently under investigation and is in close collaboration with the De- with 31-Phosphorus-MR-Spectroscopy partment of Neurology. Invasive multimodal

148 Research Report 2016 Medical University of Innsbruck Neurosurgery

the use of closure devices to reduce recur- rences (Barricaid) and have conducted ex- perimental studies to elucidate the benefits of regenerative approaches. Clinical stud- ies on corpectomies and instrumentation procedures are supplemented with biome- chanical studies to determine the stability and durability of spinal implants needed for surgical stabilisation of the human spine in close collaboration with the Department of Trauma Surgery. Recently established coope­rations including the Härtl-lab at Weill-Cornell University, New York, USA.

Selected Trials: • N-DISC: autologous chondrocyte cells to be reinjected in the patient’s interverte- bral disc several weeks after surgery to prevent ongoing degeneration. • Barricaid: a composite material annulus closure device is implanted during stand- ard surgery for lumbar disc herniation. • DynorFuse: a multinational trial to investi- gate the effectiveness of rigid vs. dynamic fusion techniques in patients with spinal stenosis and mild signs of instability. Fig. 1: Multimodal treatment plan for the resection of a solid brain tumour. • ForaC: a multi-center randomised trial on anterior versus posterior approaches for cervical foraminal stenosis with radiculop- monitoring of brain oxygenation, metabo- • MISA: prospective cohort trial of athy. lism and blood flow, in combination with in- 31P-MR-spectroscopy in patients under- • Implantation of tissue-engineered in- tracranial pressure is performed to evaluate going treatment for incidental and rup- tervertebral discs in a porcine animal mod- the use of these invasive techniques on pa- tured aneurysms. It includes plasma and el – laboratory investigation in coopera­tion tient outcome after severe head trauma and CSF biomarker analysis to determine with the Weill-Cornell University, Prof. R. subarachnoid haemorrhage. Researchers factors associated with delayed cerebral Härtl, New York, USA from the Department are currently working ischemia. • Biomechanical and clinical evaluations of in close collaboration with the Mayo Clinic • German Cranioplasty Register – active alternative screw placement in cervical in Rochester, Minnesota and the Zhang re- participation in this bilateral register for and lumbar spine. search lab in Loma Linda, California. patients undergoing cranioplasty after de- Severe head injury is a common medical compressive surgery. The experimental focus of the spine group condition at our department. In addition to • Cerebellar hematomas – several surveys is biological treatment approaches for in- multimodal monitoring and pathophysio- and prospective multinational cohort stud- tervertebral disc degeneration (IVD). IVD, logical investigations, a mono-centric study ies. often accompanied by inflammatory and was launched in close collaboration with patho-immunological processes, has been the Departments of Neuroradiology and Research Focus: Spine described as structural failures of disc tis- Neurology to determine the use and inter- In accordance with our experimental re- sues. Current treatment approaches are pretation of early MRI data and their corre- search of spinal pathologies, our spine restricted to symptomatic therapies and do lation to serum biomarkers of brain injury. group is leading ongoing regenerative stud- not address the option of biological repair Furthermore, treatment of chronic subdural ies such as the N-DISC trial. Human (autol- of the discs. Intervertebral disc cells play hematomas, a widely underestimated dis- ogous) chondrocytes are cultivated from a central role in the maintenance of discs ease predominantly arising in the elderly, herniated disc material and reinjected three by coordinating the expression of anabolic, was analysed based on a mono-centric ran- months after standard surgery. This is the catabolic, anti-catabolic and inflammatory domised protocol. first clinical trial also investigating prophy- cytokines affecting the extracellular matrix. lactic treatment of degenerated discs. An- Our electronic database search has identi- Selected Trials: other main (clinical) research interest is fied several target genes that could have a • NICAPLANT: Phase IIa trial of Nicardipine based on minimally invasive surgery using significant impact on disc matrix anabolism prolonged release pellets in aneurysmatic state-of-the-art neuro-navigation systems and catabolism. By combinatorial relative subarachnoid haemorrhage. and imaging technology. Recurrent pathol- mass value evaluations of the identified • TIBI: multimodal invasive neuromonitor- ogies (i.e., re-herniation of lumbar discs) target proteins in degenerative lumbar and ing in patients with severe head trauma might be reduced by closure of substance cervical discs, we have ascertained imbal- in combination with early MRI data and defects in the annulus fibrosus. We collab- anced protein expression patterns of cer- ­serum biomarkers of neuronal injury. orate with industrial partners to approve tain anabolic, catabolic, anti-catabolic and

Research Report 2016 Medical University of Innsbruck 149 Center of Neurology and Neurosurgery

Fig. 2: Intraoperative fluorescence of a clipped aneurysm (to confirm complete repair) and a malignant brain tumour (to delineate the lesion from healthy brain tissue). inflammatory cytokines. Our progressive characterisation of the target genes give us the opportunity to develop new therapeutic approaches. Currently, we are establishing an ad- eno-associated virus (AAV) based gene therapeutic system as a new biological treatment approach for degenerative disc diseases. So far, AAV serotypes with human IVD tissue tro- pism have not been identified and characterised. The use of AAV-mediated­ gene therapy for human intervertebral disc research has not yet been investigated.

150 Research Report 2016 Medical University of Innsbruck Neurosurgery

Selected Publications ANTICANCER RESEARCH: 2015; 35: S. 4955-4960

The value of quantitative sensory testing in spine research Biomechanical testing of circumferential instrumentation Tschugg, Anja, Löscher, Wolfgang N., Lener, Sara, Hartmann, after cervical multilevel corpectomy Sebastian, Wildauer, Matthias, Neururer, Sabrina, Thomé, Hartmann, Sebastian, Thome, Claudius, Keiler, Alexander, Fritsch, Claudius, Helga, Hegewald, Aldemar Andres, Schmoelz, Werner, NEUROSURGICAL REVIEW: 2016; [Epub ahead of print]: S. EUROPEAN SPINE JOURNAL: 2015; 24: S. 2788-2798

Improvement of sensory function after sequestrectomy for Safety and efficacy of microsurgical treatment of previously lumbar disc herniation: a prospective clinical study using coiled aneurysms: a systematic review and meta-analysis quantitative sensory testing Petr, Ondra, Brinjikji, Waleed, Thome, Claudius, Lanzino, Giuseppe, Tschugg, Anja, Lener, Sara, Hartmann, Sebastian, Neururer, ACTA NEUROCHIRURGICA: 2015; 157: S. 1623-1632 Sabrina, Wildauer, Matthias, Thome, Claudius, Loescher, Wolfgang N., Gender Influences Radicular Pain Perception in Patients EUROPEAN SPINE JOURNAL: 2016; 25: S. 3543-3549 with Lumbar Disc Herniation Tschugg, Anja, Loescher, Wolfgang N., Hartmann, Sebastian, A prospective multicenter phase I/II clinical trial to Neururer, Sabrina, Wildauer, Matthias, Thome, Claudius, evaluate safety and efficacy of NOVOCART Disc plus JOURNAL OF WOMENS HEALTH: 2015; 24: S. 771-776 autologous disc chondrocyte transplantation in the treatment of nucleotomized and degenerative lumbar disc A Sandwich Technique for Prevention of Cerebrospinal Fluid to avoid secondary disease: study protocol for a randomized Rhinorrhea and Reconstruction of the Sellar Floor after controlled trial Microsurgical Transsphenoidal Pituitary Surgery Tschugg, Anja, Michnacs, Felix, Strowitzki, Martin, Meisel, Hans Freyschlag, Christian F., Goerke, Stephanie Alice, Obernauer, Joerg, Thome, Claudius, Jochen, Kerschbaumer, Johannes, Thome, Claudius, Seiz, Marcel, TRIALS: 2016; 17: S. 108 JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY: 2016; 77: S. 229-232 Cervical corpectomies: results of a survey and review of the literature on diagnosis, indications, and surgical technique Calcium-binding proteins in focal cortical dysplasia Hartmann, Sebastian, Tschugg, Anja, Obernauer, Jochen, Kuchukhidze, Giorgi, Wieselthaler-Hoelzl, Anna, Drexel, Meinrad, Neururer, Sabrina, Petr, Ondra, Thome, Claudius, Unterberger, Iris, Luef, Gerhard, Ortler, Martin, Becker, Albert J., ACTA NEUROCHIRURGICA: 2016; 158: S. 1859-1867 Trinka, Eugen, Sperk, Guenther, EPILEPSIA: 2015; 56: S. 1207-1216 Retinal Vessel Analysis (RVA) in the Context of Subarachnoid Hemorrhage - A Proof of Concept Study Long-Term Follow-Up of Motor Cortex Stimulation for Albanna, Walid, Conzen, Catharina, Weiss, Miriam, Clusmann, Neuropathic Pain in 23 Patients Hans, Fuest, Matthias, Mueller, Marguerite, Brockmann, Marc Slotty, Philipp J., Eisner, Wilhelm, Honey, Christopher R., Wille, Alexander, Vilser, Walthard, Schmidt-Trucksass, Arno, Hoellig, Christian, Vesper, Jan, Anke, Seiz, Marcel, Thome, Claudius, Kotliar, Konstantin, STEREOTACTIC AND FUNCTIONAL NEUROSURGERY: 2015; 93: Schubert, Gerrit Alexander, S. 199-205 PLOS ONE: 2016; 11: S. e0158781 Neuroprotective Strategies after Neonatal Hypoxic Ischemic Intradural synovial cyst of the atlantoaxial joint: a case Encephalopathy report Dixon, Brandon J., Reis, Cesar, Ho, Wing Mann, Tang, Jiping, Zhang, Hartmann, Sebastian, Tschugg, Anja, Kavakebi, Pujan, Thome, John H., Claudius, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES: 2015; 16: ACTA NEUROCHIRURGICA: 2016; 158: S. 1583-1586 S. 22368-22401

Spreading depolarizations in patients with spontaneous What's New in Traumatic Brain Injury: Update on Tracking, intracerebral hemorrhage: Association with perihematomal Monitoring and Treatment edema progression. Reis, Cesar, Wang, Yuechun, Akyol, Onat, Ho, Wing Mann, Helbok, R., Schiefecker, AJ., Friberg, C., Beer, R., Kofler, M., Applegate, Richard, II, Stier, Gary, Martin, Robert, Zhang, John H., Rhomberg, P., Unterberger, I., Gizewski, E., Hauerberg, J., Möller, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES: 2015; 16: K., Lackner, P., Broessner, G., Pfausler, B., Ortler, M., Thome, C., S. 11903-11965 Schmutzhard, E., Fabricius, M., JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM: 2016; Safety and efficacy of treatment strategies for posterior [Epub ahead of print]: S. 271678X16651269 inferior cerebellar artery aneurysms: a systematic review and meta-analysis Opening the Internal Hematoma Membrane Does Not Alter Petr, Ondra, Sejkorova, Alena, Bradac, Ondrej, Brinjikji, Waleed, the Recurrence Rate of Chronic Subdural Hematomas: A Lanzino, Giuseppe, Prospective Randomized Trial ACTA NEUROCHIRURGICA: 2016; 158: S. 2415-2428 Unterhofer, Claudia, Freyschlag, Christian F., Thome, Claudius, Ortler, Martin, Safety and efficacy of endovascular treatment for WORLD NEUROSURGERY: 2016; 92: S. 31-36 intracranial infectious aneurysms: A systematic review and meta-analysis Cervical arthroplasty with ROTAIO((R)) cervical disc Petr, Ondra, Brinjikji, Waleed, Burrows, Anthony M., Cloft, Harry, prosthesis: first clinical and radiographic outcome analysis Kallmes, David F., Lanzino, Giuseppe, in a multicenter prospective trial JOURNAL OF NEURORADIOLOGY: 2016; 43: S. 309-316 Obernauer, J., Landscheidt, J., Hartmann, S., Schubert, G. A., Thome, C., Lumenta, C., Current Trends and Results of Endovascular Treatment of BMC MUSCULOSKELETAL DISORDERS: 2016; 17: S. 11 Unruptured Intracranial Aneurysms at a Single Institution in the Flow-Diverter Era Analysis of a performance-based functional test in Petr, O., Brinjikji, W., Cloft, H., Kalimes, D. F., Lanzino, G., comparison with the visual analog scale for postoperative AMERICAN JOURNAL OF NEURORADIOLOGY: 2016; 37: S. 1106- outcome assessment after lumbar spondylodesis 1113 Hartmann, Sebastian, Hegewald, Aldemar Andres, Tschugg, Anja, Neururer, Sabrina, Abenhardt, Michael, Thome, Claudius, Selected Funding EUROPEAN SPINE JOURNAL: 2016; 25: S. 1620-1626 Diverse Industry sponsored and academic clinical trials Identification and characterization of human nucleus pulposus cell specific serotypes of adeno-associated virus for gene therapeutic approaches of intervertebral disc Collaborations disorders Mern, Demissew S., Thome, Claudius, Numerous research collaborations with institutions in Austria and BMC MUSCULOSKELETAL DISORDERS: 2015; 16: S. 341 neighboring countries in the fields of neurooncology (i.e. Vienna,­ Regensburg, Heidelberg), cerebrovascular neurosurgery (i.e. Dual Anti-angiogenic Chemotherapy with Temozolomide and Aachen, Düsseldorf, Berlin) and regenerative medicine (i.e. ­Berlin, Celecoxib in Selected Patients with Malignant Glioma Not Mannheim). The multicenter clinical trials involve numerous Eligible for Standard Treatment partners throughout Europe. Researchers are currently staying at Kerschbaumer, Johannes, Schmidt, Franziska Anna, Grams, the Mayo Clinic, Rochester, MS/USA and in Loma Linda, CA/USA Astrid Ellen, Nowosielski, Martha, Pinggera, Daniel, Brawanski, within the scope of ongoing cooperations. Konstantin Robert, Petr, Ondra, Thome, Claudius, Tuettenberg, Jochen, Seiz, Marcel, Freyschlag, Christian Franz,

Research Report 2016 Medical University of Innsbruck 151 Center of Obstetrics and Gynecology Obstetrics and Gynecology

Research Branch (ÖSTAT Classification) Research

302022, 302017, 302055, 301306 Clinical Trials: Gynaecologic Oncology Leader: Christian Marth Keywords A number of gynaecological cancer trials (surgical and therapeutic trials) are being Clinical studies, Gynaecologic Oncology, conducted in our department to ­assess Senology, Biobanking, Translational ­efficacy and safety of different types Research, Biomarker-identification of thera­pies e.g. VEGF, Anti-angiogenic, Hsp90, MEK and PARP-Inhibitors. These tri- Research Focus als are conducted in ovarian, endometrial and cervical cancer, as well as other gynae- • Clinical and pre-clinical studies in women cologic diseases such as vulvar intraepithe- specific cancer in regard to prevention, lial neoplasia. diagnostics, therapy and follow-up care Selected trials are described below: • Translational research • Our department was participating in the • Collection of biosamples (tissues, serum, phase 3 randomized double-blind AGO 40 ascites, …) NOVA trial which evaluated the efficacy Director: • Biomarker identification in breast and of the PARP inhibitor Niraparib compared Univ.-Prof. Dr. Christian Marth gynaecological malignancies to placebo as maintenance therapy in pa- • Specialist interest in increasing tients with platinum-sensitive ovarian can- Contact: understanding of the development of cer. The duration of progression-free sur- Anichstraße 35 women specific cancer vival (PFS) was significantly longer in the 6020 Innsbruck • Pregnancy Research Niraparib group than in the placebo group, regardless of the presence or absence of [email protected] General Facts germline BRCA mutations or homologous Phone: +43 512 504 23051 recombination deficiency status. Due to Fax: +43 512 504 23055 The clinical trials conducted at the Depart- this trial Niraparib has been approved for https://frauenheilkunde-innsbruck.tirol- ment in collaboration with other task forc- the maintenance treatment for patients kliniken.at es and research groups within the clinic with recurrent ovarian cancer in the US but also internationally are coordinated by and the approval in Europe is expected AGO Studienzentrale as trial office of the shortly. non-profit organization AGO Austria (Asso- • The AGO 47 PAOLA-1 trial is a randomized, ciation of gynaecologic oncology in Austria). double-blind, phase III trial assessing the The aim is to promote and advance gynae- efficacy of the PARP inhibitor Olaparib vs. cologic (especially ovarian and breast) can- placebo in the maintenance treatment of cer research regarding prevention, diagnos- patients with advanced FIGO stage IIIb-IV tics, therapy and follow-up care. Current high-grade serous or endometrioid ovar­ trials involve targeted therapies e.g. PARP ian, fallopian tube or peritoneal cancer. or PI3K inhibitors, as well as novel cytotoxic All patients will need to have been treat- substances and antibody-drug conjugates. ed with standard first-line treatment, Chemotherapy based and surgical trials for combining platinum-taxane chemothera­ other gynaecologic malignancies are also py with Bevacizumab concurrent with being assessed. chemothera­py and in maintenance.

The pre-clinical studies are conducted main- Clinical Trials: Breast Cancer ly in the Laboratory of Clinical Biochemistry Leader: Christian Marth (Head: Heidi Fiegl) and in the Morphological The Breast Cancer Care unit was able to Laboratory (Head: Christian Marth; respon- successfully participate in several clinical sible pathologist: Afschin Soleiman). Both trials in 2015 and 2016, especially also in laboratories are certified according to ISO trials using substances that interact with the 9001:2008 and house the biobank of this cyclin-dependent kinase (CDK) 4 or CDK6 Department which contains FFPE tissue pathway. In the recent years it became evi- samples from nearly 6.500 patients, fresh dent that among the most important and in- frozen tissue samples from over 1.000 pa- novative treatment for patients with breast tients, ascites samples from over 1.500 pa- cancer are these CDK4/6 Inhibitors. tients and serum samples (pre-therapeutic­ In the following as short selection of the samples and samples drawn during the most important clinical trials is shown: follow-up period from over 3.000 patients). • An adjuvant trial with the CDK Inhibi- Biobanking is performed there since the tor Palbociclib with adjuvant endocrine 1980s and has been optimized over the thera­py versus endocrine therapy alone years. for hormone receptor positive (HR+)/

152 Research Report 2016 Medical University of Innsbruck Obstetrics and Gynecology

presence and relevance in ovarian cancer.

Gamma-glutamyltransferase (GGT) in breast cancer Leader: Nicole Concin GGT is a known marker for apoptotic bal- ance and cell detoxification. Elevated GGT serum levels are associated with increased risk of overall cancer incidence and several site-specific malignancies. • In a prospective study in two patient co- horts with over 100,000 participants, GGT was identified as an independent risk factor for breast cancer beyond the con-

© Oncotarget, 2016 sumption of alcohol and other life style risk factors. • In a multicentre study the association of Fig. 1: Kaplan Meier survival analysis and L1CAM mRNA expression. A. Progression-free pre-therapeutic GGT levels, clinical-patho- and B. Overall survival in 138 ovarian cancer patients according to the median L1CAM logical parameters and survival in 114 mRNA expression as cut-off value. patients with primary metastatic breast cancer were assessed. Pre-therapeutic human epidermal growth receptor 2 dominance of aggressive type II tumours, GGT serum level might serve as a novel (HER2)-­negative early breast cancer, and which are characterized by a high frequency prognostic factor for OS in these patients. a randomized double-blinded, placebo of p53 mutations, and primary or acquired controlled study of Ribociclib in combina- resistance to platinum-based chemothera­ Impact of aluminium on breast cancer tion with Fulvestrant for the treatment of py profoundly contribute to the high mor- Leader: Nicole Concin postmenopausal woman with hormone re- tality rate. Addressing this need for more To clarifying recently raised issues relating ceptor positive, HER2-negative, advanced effective treatment strategies to improve underarm antiperspirants containing alu- breast cancer who have received no or the dismal survival in these patients, the minium salts with breast cancer, history only one line of prior endocrine treatment GANNET53 trial (Ganetespib in meta­static, of underarm cosmetic products use and are also investigated at our department in p53 mutant, platinum-resistant ovarian aluminium concentration was assessed in the hopes to advance the research of new cancer) was conducted. GANNET53 is a breast cancer patients and age-matched treatment options to patients with breast Europe-wide, multi-centre Phase I and ran- healthy women. cancer. domized Phase II clinical trial, targeting mu- • The ABCSG-18 trial, a prospective, ran­ tant p53, via an innovative new Hsp90 (heat L1CAM Expression domized, placebo-controlled, double-blind shock protein 90) inhibitor in platinum-re- Leader: Alain Zeimet phase 3 study, investigated the effects sistant EOC patients. The consortium con- • Recently, L1CAM immunohistochemical of adjuvant anti-RANK ligand antibody sists of clinical trial groups in gynaecologi­ (IHC) evaluation showed a unique value ­Denosumab on fractures and other bone cal oncology, university centres as well as to predict the outcome of early endome- health parameters, and on safety out- noted p53 scientists and three innovative trial cancer. However IHC results are of- comes, in postmenopausal patients with enterprises. We aim to substantially im- ten conflicting for lack of inter-laboratory early-stage HR+ BC receiving treatment prove overall survival (OS) in EOC patients standardisation. Therefore, as a proof of with aromatase inhibitors (AI). It was with metastatic type II platinum-resistant concept, quantitative real-time PCR (qRT- shown that that adjuvant Denosumab sig- tumours. On the molecular level we aim to PCR) was used to analyse L1CAM mRNA nificantly reduces AI-induced fractures in identify the tumours mutational status in all expression and showed a high overall con- these patients. GANNET53 study patients. cordance with IHC staining. • A Phase 2 Neoadjuvant Trial in Postmeno­ • In a retrospective study L1CAM mRNA pausal Woman with Hormone Receptor A sub-project is dealing with prion-like ag- expression was examined in fresh frozen Positive, HER2 Negative Breast Cancer gregation of p53 protein in ovarian cancer. tissue samples from 138 patients with was the NeoMONARCH trial. It compared There is a growing number of evidence in- FIGO I-IV stage ovarian cancer to define its the biological effects of Abemaciclib dicating cancer as one of a protein aggre- relevance in ovarian cancer biology. High (LY2835219) in Combination with Anas- gation disease. Recently, p53 protein has L1CAM mRNA expression was associat- trozole to those of Abemaciclib Monother- been shown as amyloid forming protein. ed with PFS and OS (Figure 1). A signifi- apy and Anastrozole Monotherapy and Furthermore, it has been suggested that cant positive correlation between L1CAM evaluated the clinical activity and safety of dominant-negative and gain-of-function mRNA expression and tumour grade, FIGO a subsequent therapy with Abemaciclib in effects of p53 mutant result from its in- stage as well as the histological subtype combination with Anastrozole. creased aggregation propensity. There- was found. L1CAM mRNA expression fore, prion-like behaviour of p53 may play appears to play a substantial role in the GANNET53 (EU project) a crucial role in initiation and progression pathophysiology of ovarian cancer. Leader: Nicole Concin of cancer. The aims of this study are to es- Epithelial ovarian cancer (EOC) is the most tablish reliable methodology to detect p53 lethal gynaecological malignancy. The pre- prion-like aggregates and to analyse their

Research Report 2016 Medical University of Innsbruck 153 Center of Obstetrics and Gynecology

­carboplatin-treated patients.

The Copenhagen Index (CPH-I) – a diagnostic index combining HE4, CA125 and age index to optimize referral of women with suspected ovarian cancer. Leader: Irene Mutz-Dehbalaie In collaboration with the University of ­Copenhagen an international multicentre study, comprising 2665 patients, was per- formed to develop and validate a biomark- er-based index to optimize referral and di- agnosis of patients with suspected ovarian cancer. CPH-I was highly significant in dis- criminating benign from malignant ovarian disease independently of ultrasound and menopausal status. Therefore it may pro- vide a simple index to optimize referral of women with suspected ovarian cancer.

Human papillomaviruses (HPV) research

© BMC Cancer, 2016 © BMC Cancer, Leader: Andreas Widschwendter In collaboration with the University Clinic Fig. 2: Kaplan Meier survival analysis and NFE2L2 mRNA expression 176 breast cancer pa- of Craniomaxillofacial Surgery it was shown tients. A. Relapse-free survival and B. overall survival in 176 breast cancer patients ­according that the prevalence of oral HPV infection the 65th percentile as cut-off value as identified by Youden’s index. (c) Relapse-free survival was higher in young, sexual active adults and (d) overall survival in 176 breast cancer patients according the median as cut-off value compared to other population groups. ­Tobacco and alcohol may facilitate an oral HPV infection. Also a significant association DNA methylation and mRNA expression sion data from the Molecular Taxonomy of was found between high-risk oral HPV infec- analyses in ovarian cancer Breast Cancer International Consortium tion and the presence of oral premalignant Leader: Alain Zeimet, Daniel Reimer (METABRIC; n=1942) and from 176 breast lesions. • The clinical relevance of FOLR1 mRNA ex- cancer tissues from the biobank of the pression and DNA methylation (DNAme) Department, a reduced NFE2L2 mRNA ex- Pregnancy research was assessed in 254 type I and type II pression was identified as an independent Leader: Angela Ramoni, Sebastian ovarian cancers, and 60 normal fallopian predictor of shortened survival in breast Schröcksnadel, Hans-Peter Krause or ovarian epithelial tissues. No correla- cancer patients (Figure 2). Preeclampsia is a disorder of pregnancy tions were found between FOLR1 expres- • The potassium channel gene KCNJ3 (en- characterized by the onset of high blood sion and its DNAme. In type I cancers, coding for GIRK1 proteins) has been pressure and often a significant amount of strong FOLR1 expression has been found reported to be upregulated in tumours protein in the urine. In 10–20% of patients to be a reliable indicator of improved plati- of breast cancer patients and to corre- with severe preeclampsia the HELLP syn- num responsiveness. late with positive lymph node status. In drome (Hemolysis, Elevated Liver enzymes, • In another study the clinical relevance collaboration with the Medical Universi- and Low Platelet count) is diagnosed. of mir34a was analysed in 133 ovarian ty Graz KCNJ3 mRNA expression levels • In collaboration with other gynaecological cancers. The expression of miR-34a was were analysed in different breast cancer centres in Austria a HELLP-biobank was found to be lower in type II ovarian can- subtypes from more than 1000 patients. conducted where blood, urine, plasma, cers, in TP53 mutated tumours and in high High KCNJ3 mRNA expression levels were serum, cord blood and placenta tissues grade cancers. In multivariate survival shown to be associated with poor survival are collected. analysis low expressing miR-34a cancers in Oestrogen receptor-positive breast can- • Increased levels of the anti-angiogenic sol- exhibited a reduced PFS and OS. cer patients. uble fms-like tyrosine kinase 1 (sFlt-1) and • In collaboration with the University reduced levels of pro-angiogenic placental Biomarker identification in cancer ­College London the expression of the growth factor (PlGF) were described in the Leader: Heidi Fiegl long non-coding RNA HOTAIR (HOX tran- maternal circulation. In collaboration with A selection of the most important projects script antisense intergenic RNA), which several German gynaecological centres, a is shown: is involved in mesenchymal stem cell positive influence of the sFlt-1/PlGF ratio • The transcription factor nuclear factor fate and cancer biology, and associated determination on clinical decision-making erythroid 2-related factor 2 (NFE2L2) DNAme was analysed and validated in in women with suspected preeclampsia is a crucial regulator of the intracellular 1080 ­ovarian cancer cases. HOTAIR ex- was shown. antioxidant response. In a retrospective pression or its surrogate DNAme signa- study comprising NFE2L2 mRNA expres- ture were predictors for poor survival in

154 Research Report 2016 Medical University of Innsbruck Obstetrics and Gynecology

Selected Publications Selected Funding

Clinical impact of L1CAM expression measured on the GANNET53 European Union Seventh Framework Program transcriptome level in ovarian cancer (FP7) is planned for 5.5 years with a funding of 6 million Euros Abdel-Azim, Samira, Duggan-Peer, Michaela, Sprung, Susanne, (Prof. Dr. Nicole Concin). Reimer, Daniel, Fiegl, Heidi, Soleiman, Afschin, Marth, Christian, Zeimet, Alain G., ONCOTARGET: 2016; 7: S. 37205-37214 Collaborations

Niraparib Maintenance Therapy in Platinum-Sensitive, • Prof. Dr. Robert Zeillinger, Medical University Vienna, Vienna, Recurrent Ovarian Cancer Austria Mirza, M. R., Monk, B. J., Herrstedt, J., Oza, A. M., Mahner, S., • Prof. Dr. Ignace Vergote, Katholieke Universiteit Leuven, Redondo, A., Fabbro, M., Ledermann, J. A., Lorusso, D., Vergote, Leuven, Belgien I., Ben-Baruch, N. E., Marth, C., Madry, R., Christensen, R. D., • Dr. Neda Slade, Ruđer Bošković Institute, Zagreb, Croatia Berek, J. S., Dorum, A., Tinker, A. V., du Bois, A., Gonzalez-Martin, • Priv.-Doz. Dr. Roland Reitsamer, Paracelsus Medical University, A., Follana, P., Benigno, B., Rosenberg, P., Gilbert, L., Rimel, B. J., Salzburg, Austria Buscema, J., Balser, J. P., Agarwal, S., Matulonis, U. A., ENGOT- • Primar Dr. Arthur Scherer, Medical Services Hospital, OV16 NOVA Investigators, Bressanone, Italy NEW ENGLAND JOURNAL OF MEDICINE: 2016; 375: S. 2154- • Primar Dr. Herbert Heidegger, Medical Services Hospital, 2164 Meran, Italy • Prof. Dr. Andreas Obermair, University of Queensland, Brisbane, Evaluating L1CAM expression in human endometrial cancer Australia using qRT-PCR • Prof. Dr. Martin Oehler, University of Adelaide, Adelaide, Notaro, Sara, Reimer, Daniel, Duggan-Peer, Michaela, Fiegl, Heidi, Australia Wiedermair, Annamarie, Roessler, Julia, Altevogt, Peter, Marth, • Prof. Dr. Martin Widschwendter, University College London, Christian, Zeimet, Alain Gustave, London, United Kingdom ONCOTARGET: 2016; 7: S. 40221-40232 • Dr. Heinrich Roehder, Biodesix, Colorado, USA

Long-term significance of urinary neopterin in ovarian Collaborations in Clinical Trials with (inter)national research cancer: a study by the Austrian Association for Gynecologic groups: Oncology (AGO) • AGO Austria – Arbeitsgemeinschaft Gynäkologische Onkologie Volgger, B. M., Windbichler, G. H., Zeimet, A. G., Graf, A. H., • ENGOT – European Network for Gynecological Oncological Trial Bogner, G., Angleitner-Boubenizek, L., Rohde, M., Denison, U., groups (Cooperation with 19 trial groups) Sliutz, G., Fuith, L. C., Fuchs, D., Marth, C., • GCIG – Gynecologic Cancer InterGroup (Cooperation with 25 ANNALS OF ONCOLOGY: 2016; 27: S. 1740-1746 international trial groups) • ABCSG – Austrian Breast & Colorectal Cancer Study Group Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled International collaboration with trial groups outside of trial ENGOT, GCIG or ABCSG trials: Gnant, Michael, Pfeiler, Georg, Dubsky, Peter C., Hubalek, • Prof. Dr. Jalid Sehouli, Charité Berlin, Germany Michael, Greil, Richard, Jakesz, Raimund, Wette, Viktor, Balic, • Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie Marija, Haslbauer, Ferdinand, Melbinger, Elisabeth, Bjelic-Radisic, (NOGGO e.V.) Vesna, Artner-Matuschek, Silvia, Fitzal, Florian, Marth, Christian, • EORTC – European Organization for Research and Treatment of Sevelda, Paul, Mlineritsch, Brigitte, Steger, Guenther G., Manfreda, Cancer Diether, Exner, Ruth, Egle, Daniel, Bergh, Jonas, Kainberger, Franz, Talbot, Susan, Warner, Douglas, Fesl, Christian, Singer, Christian F., Austrian Breast Colorectal Canc St, LANCET: 2015; 386: S. 433-443

Research Report 2016 Medical University of Innsbruck 155 Center of Obstetrics and Gynecology Gynecological ­Endocrinology and ­Reproductive Medicine

Research Branch (ÖSTAT Classification) Previous work from our group presented novel theories regarding disease pathogen- 302089, 302022 esis, centred on the concept of tissue injury and repair (TIAR). This concept views endo- Keywords metriosis as well as the closely related ade- nomyosis as the consequence of repetitive Reproductive medicine, fertility preservation, autotraumatization of the uterus caused by endometriosis, PCOS, recurrent miscarriage, exaggerated uterine contractions followed gynaecological, endocrinology, early preg- by local injury, induction of prostaglandin nancy, gender identity disorders synthesis and a further oestrogen-induced increase in the strength of uterine contrac- Research Focus tions.

Our research focuses on the physiology and Along a similar line, the induction of growth pathology of ovarian and uterine function, of pain nerve fibres in endometriotic le- fertility preservation, early and recurrent sions by neurotrophins and their receptors pregnancy loss, endometriosis, gynaecolog- is a topic of interest for our group. We per- ical endocrine disorders, contraception and formed immunohistochemistry on superfi- Director: disturbances of gender identity. cial and deep infiltrating lesions and,using ­ Univ.-Prof.in Dr.in Bettina Toth quantitative computer-driven analyses, General Facts showed differences in neurotrophins and Contact: their receptors between the two sub-types Anichstraße 35 The research unit is structured around the of endometriosis lesions. Our results sug- 6020 Innsbruck clinical unit of Gynaecological Endocrinol­ gest differences in pain signal conduction ogy and Reproductive Medicine. We provide and in the potential for deep infiltration, [email protected] clinical out-patient services with more than shedding further light on the molecular bi- Phone: +43 512 504 23276 10,000 annual patient contacts for both ology of this disease. Fax: +43 512 504 23277 endocrine- and fertility-related disorders. www.kinderwunsch-zentrum.at We perform approximately 300 stimulated Altered pain perception in patients with IVF/ICSI and more than 100 frozen em- primary and secondary dysmenorrhea has bryo cycles annually. In addition, we offer been examined by our group in cooperation oocyte, sperm, embryo and ovarian tissue with Prof. Gizewski, Department of Neuro- cryopreservation for patients facing loss of radiology: In other chronic pain conditions fertility due to autoimmune and malignant like irritable bowel disease, a different cer- dis­eases. The IVF laboratory, whose prin- ebral processing of pain following a visceral cipal clinical workload consists of sperm pain stimulus had been shown. Therefore, and oocyte preparation, fertilization and we aimed to apply this pain model to pa- culture, and cryopreservation, works hand tients with dysmenorrhea compared to in hand with our research unit. We collabo­ healthy controls using functional magnetic rate closely with a number of clinical and resonance imaging. First data are available scientific units of the Medical University of but have not been published yet. Another Innsbruck as well as international research focus of research in this patient cohort is on partners. known co-morbidities such as quality of life, anxiety, and depression. Research Polycystic Ovary Syndrome (PCOS) This research report primarily focuses Beata Seeber, Bettina Böttcher on scientific work which was performed Polycystic ovarian syndrome is the most under the supervision of Prof. Dr. Ludwig­ frequent endocrine disorder in women of Wildt, former head of the Department. Prof. reproductive age, and is associated with Dr. Bettina Toth took over the position in clinical hyperandrogenemia (hirsutism, October 2016. acne) and biochemical elevation of serum testosterone as well as oligo-amenorrhea Endometriosis due to anovulation. Consequently, nearly all Beata Seeber, Bettina Böttcher women with PCOS suffer from subfertility. Endometriosis affects up to 10 % of the fe- In recent years, more attention has been male population and can be a debilitating directed to the metabolic disturbances as- disease marked by pelvic pain and infer- sociated with this syndrome, which include tility. The aetiology is not completely clear insulin resistance, hypercholesterolemia, but likely due to a combination of factors hypertriglyceridemia and hypertension. including genetic predisposition, retrograde Previous publications from our group pre- menstruation, and immunologic deficits. sented the prevalence of these metabolic

156 Research Report 2016 Medical University of Innsbruck Gynecological ­Endocrinology and Reproductive Medicine

evaluating their role in other conditions as- sociated with anovulation, especially oocyte aging. Opiate signalling during the oocyte maturation process is also being studied further.

Recurrent Miscarriage Bettina Toth, Beata Seeber, Susanne Hofer-Tollinger Recurrent miscarriage affects 2-5% of women during childbearing years. Although several risk factors including anatomical, endocrine, genetic and other risk factors are established, the aetiology in nearly 50% of cases remains unknown. Therefore the identification of new risk factors as well as potential new treatment strategies is part of our ongoing research.

Medical Management of Early Pregnancy Failure Bettina Toth, Beata Seeber Early pregnancy failure (EPF) (e.g. missed abortion) has traditionally been managed by surgical curettage and evacuation of the uterus. This is an operative procedure that is associated with potential surgical risks and with adverse effects on the function of the endometrium with respect to future preg- nancies. In cooperation with the Depart- ment of Obstetrics and Gynaecology, we have optimized the medical management of EPF and offer it as a first-line management option to women. We have ­undertaken sev- eral projects to look critically at the out- comes and success rates. We have achieved an over 90% success rate with this method © Dewanto et al. Reprod Biol Endocrinol 2016 with a high safety and tolerability, with very Fig. 1: Histological sections from peritoneal (PE) and deep infiltrating endometriosis (DIE). few women needing additional medical or Immunohistochemistry was performed to stain for nerve growth factor (NGF) and the TrkA operative interventions. In addition, through neurotrophin receptor. The percentage of NGF positive immune staining cells in stroma as a survey of patients, we have received very well as glandular tissue showed significant differences between PE and DIE. In contrast, no positive feedback about the acceptability of differences were seen in TrkA-positive immunostaining. the treatment, which the women strongly prefer to surgery. In cooperation with Prof. ­Courtney Schreiber of the University of disturbances in our central European popu­ emotional role function. Pennsylvania, we are focusing on predictive lations and studied potential predictive Opiate Signalling in the Ovary markers in cases of treatment failure, to markers. In recent years, we have focused Beata Seeber better be able to counsel our patients. our efforts on the study of follicular gran- Prompted by our clinical work on the cen- ulosa cells from women with PCOS. Using tral nervous system effects of opiate antag- Tolerance, Early Implantation Failure in vitro stimulation experiments, we report- onists on ovulatory disorders, we focused Susanne Hofer-Tollinger, Bettina Toth ed that these cells differ at fundamental on studying the effects of opiates in the Tolerance is the accepted hypothesis for level from granulosa cells of controls and periphery. Specifically, we were able to the immunological paradox of maintaining may explain the high prevalence of certain demonstrate for the first time the presence a pregnancy. Despite the antigenic dissimi­ IVF-related complications, such as ovarian of opiate receptors on human granulosa larity between mother and embryo, the em- hyperstimulation syndrome, in women with cells. Further, we have reported results bryo is not rejected. Previous studies have PCOS. from stimulation­ experiments using opiate proposed that a break-down of tolerance agonists and antagonists in vitro on the may induce pathological conditions asso- Using a questionnaire battery we analysed functioning of human granulosa cell lines ciated with miscarriage or preeclampsia. life quality, anxiety, and depression in this as well as primary granulosa cells. Future Since immune dysfunction may contribute patient cohort and found a significantly re- experiments are focusing on specific sub- to implantation failure through negative duced quality of life especially in regard to types of opiate receptors in the ovary and in ­effects on the foeto-maternal interphase, we

Research Report 2016 Medical University of Innsbruck 157 Center of Obstetrics and Gynecology

sess the quality of ovarian tissue prior to transplantation as well as to investigate the mechanisms of follicular development after transplantation.

The fertility preservation unit of our clinic is interested in studying follicular growth and functionality. Hereby we are focused on the molecular mechanisms involved in the initiation of follicular growth and folli- cular loss. For this purpose, we conducted © REPROD BIOMED ONLINE 2016 © REPROD a xenotransplantation study to analyse the effects of transplantation on human ovarian Fig. 2: First report of the detection of opiate receptors OPRM1 by Western Blot in a human tissue. By means of immunohistochemistry, granulosa cell line (COV434) and in whole cell lysates of primary granulosa cells (PGC). TUNEL staining and qPCR we could show HepG2 cells served as a positive control. In the presence of the immunizing peptide, the that following xenotransplantation, follicles detected signal is absent. initiated growth while Phosphatase and Ten- sin Homolog Deleted on Chromosome 10 (PTEN) gene expression was down-regulat- aimed to study in vitro the role of dendritic­ ­Gynaecological Endocrinology and Repro- ed. Thus, the higher proportion of growing cells (DCs) in human reproduction, focus- ductive Medicine was the first centre to follicles compared to resting follicles ob- ing on their function and gene expression. perform ovarian tissue cryopreservation in served after xenotransplantation is most DCs not only initiate the immune response Austria. Oncologic patients from all over likely due to down-regulation of PTEN gene but also induce tolerance. We have already Austria, South Tyrol and Southern Germany expression followed by acceleration of folli- identified promising candidates which are have been referred to Innsbruck. In order cular recruitment. now being studied in more detail. We aim to to improve the success rates of cryopres- further elucidate the immunological events ervation and transplantation, we have used surrounding implantation, especially to xenotransplantation as an approach to as- clarify the role of DC. The potential clinical ­applications might be the establishment of a test for embryo selection. With this work we hope to make a valuable contribution to the understanding of foetal tolerance and in the long run help to establish immune sup- pressive strategies and treatment options especially for patients with implantation failure. This research project is conducted in close collaboration with the Dept. of Der- matology (Ch. Heufler).

Fertility Preservation Katharina Winkler-Crepaz, Susanne Hofer- Tollinger, Bettina Böttcher Cancer affects many women of reproduc- tive age who wish to preserve their fertility. An undesirable consequence of many of the commonly used chemotherapies as well as pelvic irradiation is their deleterious effect on the gonads. This can lead to premature ovarian failure, symptoms of menopause, infertility and childlessness. Other disease processes such as ovarian tumours, chro- mosomal disorders such as Turner Mosaic or fragile X Premutation can likewise lead to a premature loss of ovarian function and fertility. © J ASSIST REPROD GENET 2016 One possible strategy to preserve female Fig. 3: Immunohistochemical visualization of PTEN. A) PTEN IHC positive control staining fertility is the cryopreservation of ovarian of human colon tissue. PTEN positive cells are indicated by brown staining; B) PTEN IHC tissue prior to the gonadotoxic treatment. negative control of human colon tissue; C) PTEN positive primary follicle (arrow) was in- Once the patient is cured, ovarian func- dicated by brown staining of granulosa cells as well as staining of nuclei and cytoplasm tion can be restored by autotransplan- of an oocyte; a primordial follicle shown in the picture is PTEN negative D) PTEN positive tation of the tissue. The Department of secondary follicle.

158 Research Report 2016 Medical University of Innsbruck Gynecological ­Endocrinology and Reproductive Medicine

Transgender and Gender- Selected Publications

Nonconforming Individuals Follicular growth after xenotransplantation of Katharina Winkler-Crepaz, Bettina Böttcher cryopreserved/thawed human ovarian tissue in SCID mice: dynamics and molecular aspects Transgender individuals experience ­discord Ayuandari, Sarrah, Winkler-Crepaz, Katharina, Paulitsch, Monika, between their biological sex and their Wagner, Cora, Zavadil, Claudia, Manzl, Claudia, Ziehr, Stephanie C., Wildt, Ludwig, Hofer-Tollinger, Susanne, self-identified gender and seek to develop JOURNAL OF ASSISTED REPRODUCTION AND GENETICS: 2016; the physical characteristics of the desired 33: S. 1585-1593 gender. The Department provides cross-sex Localization of TrkB and p75 receptors in peritoneal and hormone therapy for adolescents as well deep infiltrating endometriosis: an immunohistochemical study as adults, both in cases of female to male Dewanto, Agung, Dudas, Jozsef, Glueckert, Rudolf, Mechsner, (FtM) and male to female (MtF) treatment. Sylvia, Schrott-Fischer, Anneliese, Wildt, Ludwig, Seeber, Beata, REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY: 2016; 14: S. We are currently investigating the effect 43 of visual erotic stimuli on the activity of ­specific brain regions in FtM transgender Opiate receptor blockade on human granulosa cells inhibits VEGF release patients via functional MRT in collaboration Lunger, Fabian, Vehmas, Anni P., Fuernrohr, Barbara G., Sopper, Sieghart, Wildt, Ludwig, Seeber, Beata, with the Department of Neuroradiology. REPRODUCTIVE BIOMEDICINE ONLINE: 2016; 32: S. 316-322

The TRUFFLE study; fetal monitoring indications for delivery Industry-Sponsored Studies in 310 IUGR infants with 2 year's outcome delivered before Verena Porto 32 weeks of gestation. Visser, GH., Bilardo, CM., Derks, JB., Ferrazzi, E., Fratelli, N., ESPARIOS - the aim of the study was to Frusca, T., Ganzevoort, W., Lees, C., Napolitano, R., Todros, T., evaluate the safety and efficacy of different Wolf, H., Hecher, K., Marlow, N., Arabin, B., Brezinka, C., Diemert, A., Duvekot, JJ., Martinelli, P., Ostermayer, E., Papageorghiou, AT., dose combinations of an aromatase inhibi- Schlembach, D., Schneider, K., Thilaganathan, B., Valcamonico, A., tor and a progestin intravaginal ring versus ULTRASOUND IN OBSTETRICS & GYNECOLOGY: 2016; [Epub placebo and leuprorelin/leuprolide acetate ahead of print]: S. in women with symptomatic endometriosis. Impact of endometriosis on quality of life, anxiety, and depression: an Austrian perspective Secondary objectives were the sustainabil- Friedl, F., Riedl, D., Fessler, S., Wildt, L., Walter, M., Richter, R., ity of treatment effect and recurrence of Schuessler, G., Boettcher, B., ARCHIVES OF GYNECOLOGY AND OBSTETRICS: 2015; 292: S. symptoms. 1393-1399

ASTEROID 2 - the aim of this study was to Selected Funding assess the efficacy and safety of vilaprisan Diverse industry-sponsored and academic projects (a novel progesterone receptor modulator -PRM-) in patients with uterine fibroids a Collaborations randomized, placebo- and active compara- • Prof. Dr. Udo Markert, Plazentalabor Jena, Germany tor-controlled study to assess the efficacy­ • Dr. Rienk Nieuwland, AMC Amsterdam, the Netherlands and safety of vilaprisan in patients with • Prof. Courtney Schreiber, University of Pennsylvania, USA uterine fibroids. The primary measure of Devices & Services efficacy was the amenorrhoea rate; second- • Ovarian tissue cryobank ary measures included time to normalized • CL-863 Freeze Control, Cryologic (automated freezer) menstrual bleeding and percentage change • Tecan Reader, Genius Pro, Fluorescence/Luminescence/Ab- sorbance Reader in UF volume.

MK8342B-062 - the aim of this study was to compare the contraceptive efficacy and safety of the MK-8342B (Etonogestrel + 17β-Estradiol) Vaginal Ring in compari- son to the Levonorgestrel-Ethinyl Estra- diol (LNG-EE) 150/30 μg Combined Oral Contraceptive (COC) in Healthy Women 18 Years of Age and Older, at Risk for Preg- nancy. This was a Phase 3, Randomized, ­Active-Comparator Controlled Clinical Trial

Research Report 2016 Medical University of Innsbruck 159 Center of Otorhinolaryngology and Hearing, Speech and Voice Disorders Otorhinolaryngology

Research Branch (ÖSTAT Classification) Further clinical research focuses on clinical oncology, rhonchopathy and clinical as- 302023, 302027, 302029, 302055 pects of hearing implants.

Keywords Research

Head and neck neoplasm, HPV, inner ear Molecular Biology and morphology, accuracy of computer aided ­Oncology Laboratory surgery PD Dr. Joszef Dudas Tumor-associated fibroblast-conditioned Research Focus medium induces CDDP resistance in HNSCC cells • Error analyses for computer assisted surgery Objective: the epithelial-mesenchymal • Targeted therapy for head and neck transition (EMT) contributes to tumour squamous cell carcinoma progression and metastasis. We aimed to • Ion channel and nerve regeneration inner investigate the effects of EMT on Cisplatin ear resistance in HNSCC (head and neck squa- Director: mous cell carcinoma)-cells. Univ.-Prof. Dr. Herbert Riechelmann General Facts Methods: EMT was induced in HNSCC cells using conditioned medium from a tumour Contact: The major aim of the Department of Otorhi- cell/fibroblast co culture and confirmed Anichstraße 35 nolaryngology is to provide independent with vimentin and E cadherin expression 6020 Innsbruck basic and clinical research in the field of analysis at RNA and protein level. The tu- Otorhinolaryngology to optimize patient mour cells were alternatively treated with [email protected] treatment. The basic research is provided 1 ng/ml TGFβ1. The response to Cisplatin Phone: +43 512 504 23141 by three independent laboratories: 1) the was evaluated with viability and clonogenic Fax: +43 512 504 23144 Molecular Biology and Oncology Laboratory assays. http://hno.tirol-kliniken.at by PD Dr. Joszef Dudas; 2) the 4D Visualiza- Results: Treatment with conditioned medi- tion Laboratory by Univ.-Prof. Dr. Wolfgang um induced a mesenchymal phenotype and Freysinger; 3) the Inner ear Laboratory by increased the viability of the tumour cells. Univ.-Prof. Dr. Annelies Schrott-Fischer. Moreover, it doubled the IC50 of Cisplatin These three major research units are in of SCC-25 cells from 6.2 μM to 13.1 μM close cooperation with the clinician scien- (p<0.001). The IC50 of Cisplatin of Detroit tists enabling translational research pro- 562 cells was increased following treat- jects with clinical impact in three major fo- ment with conditioned medium from 13.1 cuses of Otorhinolaryngology. Furthermore μM to 26.8 μM (p<0.01). Treatment with the Department is in close cooperation with TGF1 induced similar phenotypic changes local industry, developing for instance a la- as co-culture conditioned medium, but de- ryngeal pacemaker or a vestibular implant. creased tumor cell viability and did not alter

© Oncotarget, 2016

Fig. 1: Cell viability of SCC-25 cells (A) or Detroit 562 cells (B) exposed to increasing doses of CDDP (0- 50 µM) following treatment with albumin-containing medium (control; dotted line with spheres), co-culture conditioned medium (solid line with black squares), medium supplemented with TGFβ1 1 ng/ml (dotted line with triangles) and co-culture conditioned medium plus anti TGFβ antibody (1.5 µg/ml) (solid line with white squares). Four parameter nonlinear logistic regression model, whiskers indicate standard error of the mean (SEM).

160 Research Report 2016 Medical University of Innsbruck Otorhinolaryngology

Our study provides first-hand insight into the foetal development of the vestibular end organs as well as their pattern of innerva- tion by means of immunohistochemical and EM techniques, with the aim of contributing towards our understanding of balance de- velopment.

4D Visualization Laboratory Univ.-Prof. Dr. Wolfgang Freysinger Estimating FLEimage distributions of manual fiducial localization in CT images

Purpose: The fiducial localization error distribution (FLE) and fiducial configura- tion govern the application accuracy of point-based registration and drive target registration error (TRE) prediction models. The error of physically localizing patient fiducials (FLEpatient) is negligible when a registration probe matches the implanted screws with mechanical precision. Reliable trackers provide an unbiased estimate of the positional error (FLEtracker) with cheap repetitions. FLE further contains the locali- zation error in the imaging data (FLEimage), © Biology Open 2017 sampling of which in general is expensive Fig. 2: Sepsis mice with a high hearing loss showed positive CC-3 cells mainly in the lat- and possibly biased. Finding the best tech- eral wall and in the organ of Corti (a,c). In the lateral wall, positive immunostaining was niques for estimating FLEimage is crucial observed in type I and type V fibrocytes (a). In the organ of Cortithe Deiters`cells and inner for the applicability of the TRE prediction hair cells were strongly stained, while no reactivity was found in the cell body of the outer methods. hair cells (c). In sepsis mice with a low hearing loss altogether fewer cells were stained and Methods: We built a ground-truth (gt)-based immunoreactivity intensity was lower. (b,d) In the sham mice only a faint staining of some unbiased estimator (FLEgt) of FLEimage fibrocytes of the spiral ligament was found (e-g). from the samples collected in a virtual CT dataset in which the true locations of image Cisplatin resistance (Figure). the human foetal inner ear have been limit- fiducials are known by definition. Replacing Conclusion: Cell free medium from an ep- ed. We present an investigation of the cells true locations in FLEgt by the sample mean ithelial tumour cell/fibroblast co-culture of the vestibular end organs with specific creates a practical difference-to-mean (dt- was able to induce EMT in HNSCC cells. focus on the hair cell differentiation and m)-based estimator (FLEdtm) that is appli- Co-culture treated HNSCC cells revealed innervation pattern using an uninterrupted cable to any dataset. To check the practical increased viability and were less sensitive series of unique specimens from gestation- validity of the dtm estimator, ten persons to Cisplatin treatment. TGFβ1 also induced al weeks 8 to 12. manually localized nine fiducials ten times a mesenchymal phenotype, but decreased in the virtual CT and the resulting FLEdtm tumour cell viability and did not alter resist- Nerve fibres positive for peripherin inner- and FLEgt distributions were tested for ance to CDDP in HNSCC cells. vate the entire foetal crista and utricle, statistical equality with a kernel-based whereas in rodents only the peripheral re- two-sample test using the maximum mean Inner Ear Biology gions of the cristae and the extra-striolar discrepancy (MMD) (Gretton in J Mach Univ.-Prof. Dr. Annelies Schrott-Fischer region of the statolithic organs are stained. Learn Res 13:723–773, 2012) statistics at Neurosensory differentiation and At week nine, transcription factors PAX2 α = 0.05. innervation patterning in the human and PAX8 were observed in the hair cells Results: FLEdtm and FLEgt were found (for foetal vestibular end organs between the whereas PAX6 was observed for the first most of the cases) not to be statistically gestational weeks 8-12 time among the supporting cells of the significantly different; conditioning them on cristae and the satellite glial cells of the persons and/or screws however yielded sta- Balance orientation depends on the precise vestibular ganglia. Glutamine synthetase, tistically significant differences much more operation of the vestibular end organs and a regulator of the neurotransmitter gluta- often. the vestibular ganglion neurons. Previous mate, is strongly expressed among satellite Conclusions: We conclude thatFLEdtm is research on the assemblage of the neu- glia cells, transitional zones of the utricle the best candidate (within our model) for ronal network in the developing foetal ves- and supporting cells in the sensory epi- estimating FLEimage in homogeneous TRE tibular organ has been limited to data from thelium. At gestational week 11, electron prediction models. The presented approach animal models. Insights into the molecular microscopic examination reveals bouton also allows ground-truth-based numeri- expression profiles and signalling moieties contacts at hair cells and first signs of the cal validation of FLEimage estimators and involved in embryological development of formation of a protocalyx at type I hair cells. (manual/automatic) image fiducial localiza-

Research Report 2016 Medical University of Innsbruck 161 Center of Otorhinolaryngology and Hearing, Speech and Voice Disorders

nolaryngology of the Medical University of Innsbruck. A relational database model in Microsoft Access was used for several reasons. As a first step all existing tables were included into the database. Further- more queries for data from external data- bases were established, so that they can be included in periodic intervals. Multi-step procedures have been developed to convert this data to valid and complete variables. Incomplete data are automatically marked for manual editing. By this strategy it was possible to include the results of the weekly tumour board sessions into the database. This is very important, because essential changes in the history of a patient are usu- ally stated in these board meetings. A user friendly surface was generated, so that even staff members unexperienced with Access could easily be trained to use this database. In the start-up period the database was fre- quently re-evaluated by several staff mem- bers. So far more than 900 patients are success- fully administered by the database. Data for retrospective analysis and studies could be easily exported to other file formats and statistically analysed. Number of cases for prospective studies could easily be estimat- ed upon the available information. The implemented clinical cancer register at our department is very effective to get in- formation about cancer patients for clinic,

© Tumor Biology 2017 © Tumor research and quality control.

Sensitivity of Tumour Surface Brushings Fig. 3: Proliferation, viability and migration of conditioned medium treated or co-cultured to detect Human Papilloma Virus DNA SCC-25 cells. After three days of treatment SCC-25 cells were counted and cell migration in Head and Neck Cancer was investigated using a scratch assay. (a) The treatment of SCC-25 cells with fibroblasts Dr. Barbara Kofler (FIB) and mix culture conditioned medium (CM) (p<0.001) and co-culture (p<0.01) lead to significantly higher cell numbers compared to control (albumin-medium treated cells, Objective: Human papilloma virus (HPV) which was set to 100%). (b) FIB CM and mix culture CM significantly (p<0.001) increased induced head and neck squamous cell the lateral migration of SCC-25 cells even in the first 24 hours. SCC-25 cells treated with carcinoma (HNSCC) represents a distinct SCC-25 CM or co-cultured with FIBs exhibited a significant higher cell coverage than al- tumour subset. We questioned how accu- bumin-medium-treated (control) cells (SCC-25 CM: p<0.001, co-culture: p<0.01). (c) These rately a brushing from the tumour surface effects could also be observed in the images taken every 24 hours, where SCC-25 cells detects HPV in patients with HNSCC. migrated towards empty space when treated with FIB CM or mix culture CM. CM, condi- Materials and methods: Brushings from the tioned medium; FIB, Human gingival fibroblasts; P<0.01: **; P<0.001: ***. Cells treated tumour surface were compared with HPV with FIB CM, or mix culture CM, or co-cultured SCC-25 cells showed elongated, mesenchy- DNA isolation from formalin-fixed and par- mal-like morphology, especially in the scratched area. Bars: 100 µm. affin-embedded (FFPE) tumour biopsies, which served as the reference standard. tion methods in phantoms with parameters istrated by simple tables. So, cancer reg- In both matrices, HPV DNA was detected similar to clinical datasets. istries need extensive concepts to provide using a commercially available test kit. In high levels of validity, completeness, com- addition, p16 was assessed in tumour bi- Clinical Research parability and timeliness. They need a data opsies by immunohistochemistry (IHC). The Dr. Volker Schartinger structure which allows simultaneous mul- tumors were considered p16 positive if 70% Implementation of a clinical cancer register ti-user access and high quality data analy- or more of cancer cells expressed p16. at the department of otorhinolaryngology sis. Standardized data input should lead to Results: 93 patients with HNSCC were in- comparable results over the years and ex- cluded. Sensitivity and specificity of the A clinical cancer register is an important ternal data should be integrated easily. brush test were 83% (95% CI: 67–92%) and tool for research and quality control. In- In 2015 a clinical cancer register was im- 85% (95%CI: 72–93%). Results of p16 IHC creasing numbers of data cannot be admin- plemented at the Department of Otorhi- were concordant with FFPE samples DNA

162 Research Report 2016 Medical University of Innsbruck Otorhinolaryngology

determinations in 73/93 patients. In 53 pa- Selected Publications Collaborations tients (57%) the tumour was located in the Tumor-associated fibroblast-conditioned medium induces • TU München mit Informatik, Prof. Nassir NABAB oropharynx and in 40 patients (43%) the tu- CDDP resistance in HNSCC cells • Universität Bern, HNO, Prof. Marco Caversaccio Steinbichler, Teresa Bernadette, Metzler, Veronika, Pritz, Christian, • Brigahm & Womens Hospital, Harvard, Boston, MA, USA, Prof. mour was located in the non-oropharynx re- Riechelmann, Herbert, Dudas, Jozsef, Ron KIKINIS gion. Sensitivity and specificity of the brush ONCOTARGET: 2016; 7: S. 2508-2518 • Mechatronik, MCI, Innsbruck, DI Dr. Andres MEHRLE Brainlab, test in patients with oropharyngeal cancer München Neurosensory Differentiation and Innervation Patterning • iSYS, Kitzbühel, CEO Dr. Michael VOGELE was higher with 86% (95%CI: 70–95%) and in the Human Fetal Vestibular End Organs between the • ACMIT, Wr. Neustadt, CEO Dr. Gernot Kronreif Gestational Weeks 8-12 • LSTMH, Liverpool, UK 89% (95%CI: 65–99%). Johnson Chacko, Lejo, Pechriggl, Elisabeth J., Fritsch, Helga, Rask- • Semmelweis University Budapest, Inst. Pathology and Conclusion: Superficial brushes from the Andersen, Helge, Blumer, Michael J. F., Schrott-Fischer, Anneliese, Experimental Cancer Research Budapest, Hungary Glueckert, Rudolf, • Department of Surgical and Molecular Pathology, National tumour surface may be used to identify HPV FRONTIERS IN NEUROANATOMY: 2016; 10: S. 111 Institute of Oncology, Budapest, Hungary positive HNSCC. • Department of Otorhinolaryngology, University Lübeck, Laryngeal pacing via an implantable stimulator for the Germany rehabilitation of subjects suffering from bilateral vocal fold • Cochlear Signaling and Tissue Engineering Laboratory, paralysis: A prospective first-in-human study Laboratory Director, USA Josef M. Miller, Ph.D., Mueller, Andreas H., Hagen, Rudolf, Foerster, Gerhard, Grossmann, www.khri.med.umich.edu/research/miller_lab/index.php Wilma, Baumbusch, Katrin, Pototschnig, Claus, • Auditory Anatomy Laboratory, Laboratory Director, USA Richard LARYNGOSCOPE: 2016; 126: S. 1810-1816 Altschuler, Ph.D. www.khri.med.umich.edu/research/altschuler_lab/index.php Severe malaria in children leads to a significant impairment • Universität Uppsala, Schweden, Helge Rask-Andersen of transitory otoacoustic emissions - a prospective www.medfarm.uu.se multicenter cohort study (vol 13, pg 125, 2015) • Department für Anatomie, Histologie und Embryologie, Sektion Schmutzhard, Joachim, Lackner, Peter, Helbok, Raimund, Hurth, für Neuroanatomie, MUI, Lars Klimaschewski, Barbara Hausott Helene Verena, Aregger, Fabian Cedric, Muigg, Veronika, Kegele, • Department für Anatomie, Histologie und Embryologie Sektion Josua, Bunk, Sebastian, Oberhammer, Lukas, Fischer, Natalie, für Klinisch-Funktionelle Anatomie, Brenner Erich, Elisabeth Pinggera, Leyla, Otieno, Allan, Ogutu, Bernards, Agbenyega, Tsiri, Pechriggl Ansong, Daniel, Adegnika, Ayola A., Issifou, Saadou, Zorowka, • Department für Anatomie, Histologie und Embryologie, Sektion Patrick, Krishna, Sanjeev, Mordmuller, Benjamin, Schmutzhard, für Histologie und Embryologie, Kristian Pfaller Erich, Kremsner, Peter, • Veterinärmedizinische Universität, VetCore Facility for Research BMC MEDICINE: 2016; 14: S. 70 Imaging Unit, Stephan Handschuh • UMIT Hall Institut für Biomedizinische Informatik, Division für Microdebrider-Assisted Intracapsular Tonsillectomy in Biomedizinische Bildanalyse, Karl Fritscher, Rainer Schubert Adults With Chronic or Recurrent Tonsillitis • UMIT Hall, Institut für Elektrotechnik und Biomedizinische Bender, Birte, Blassnigg, Elisabeth Constanze, Bechthold, Technik,Christian Baumgartner Jana, Kral, Florian, Riccabona, Ursula, Steinbichler, Teresa, • MedEl Innsbruck ,Ingeborg Hochmair, Carolyn Garnham, Claude Riechelmann, Herbert, Jolly LARYNGOSCOPE: 2015; 125: S. 2284-2290 • Frank Rattay, Computational Neuroscience and Biomedical Engineering, Institute for Analysis and Scientific Computing, Vienna University of Technology, Austria Selected Funding • University of Tampere, Finland, Ilmari Pyykko • University of Angers, France, Saulnier Patrick, Guillaume Bastiat • Univ.-Prof. Mag. Dr. Wolfgang Freysinger, Project: navABI FFG • University of Southampton, UK, Tracey Newman 350.000 EUR • The Bionics Institute, East Melbourne, Australia, Andrew K. Wise • PD Mag. Dr. Rudolf Glueckert, Project: Gapless • Inserm U 254 Neurobiologie de l’Audition, Montpellier, France, Mensch:Maschine Interface für das Innenohr FWF 280.000 EUR Eybalin Michel • Georgi Diakov, BSc, MSc, PhD, Project: Trifokale Rekonstruktion durch Gesichtsmerkmale zur automatisierten Navigation der HNO-Chirurgie. OeNB 100.000 EUR Devices and Services • TissueFaxs from TissueGnostics

Research Report 2016 Medical University of Innsbruck 163 Center of Otorhinolaryngology and Hearing, Speech and Voice Disorders Hearing, Speech ­and ­Voice Disorders

General Facts high-standard audio processor fitting in pa- tients with hearing implants. The Department HSV was founded in 1974, after a "Chair in Audiology and Phoniatrics" Research was established at Innsbruck Medical Facul- ty in 1968. This was the first chair in these Stapedius Reflex in Cochlear Implant specialties in the German speaking coun- (CI) Patients tries. Today, the HSV is Austria's largest in- Kurt Stephan stitution in the fields of Audiology, Pediatric The postoperative measurement of the Audiology and Phoniatrics. It offers a full Stapedius reflex elicited via CI is a well- range of clinical services for diagnosis and established objective method for fitting treatment of disorders of hearing, speech, cochlear implants in children. Thereby, language, swallowing and of childhood the electrical reflex threshold (ESRT) is learning problems. determined through impedance audiometry, Research facilities of the HSV include the and the results are used for setting the level Lab for Psycho-Acoustics and the Lab for of maximum stimulation intensity in the Cognitive Neuroscience. In the latter neu- fitting of the CI speech processor. Efficient ronal processing mechanisms underlying application of this method requires a normal Director: language acquisition in children are inves- functioning middle ear – a condition not o. Univ.-Prof. Dr. Patrick Zorowka tigated by electroencephalography (EEG), always present in young children. A further functional near-infrared spectroscopy limiting factor for its routine application Contact: (fNIRS) and magnetic resonance imaging is the lack of easy to use and optimized Anichstraße 35 (MRI). In the Lab for Psycho-Acoustics, instrumentation. 6020 Innsbruck which is equipped with an anechoic cham- In order to overcome these restraints ber for high-precision acoustic measure- of ESRT testing, a computerized testing [email protected] ments, human hearing functions are tested system was developed at the HSV. The Phone: +43 512 504 23218 under very specific conditions, including the system provides simultaneous impedance Fax: +43 512 504 23217 use of hearing implants. monitoring of the Stapedius reflex in real www.hss-innsbruck.at Since the 1990s, the Department has time during electrical stimulation via CI with www.hoerimplantate-innsbruck.at been significantly involved in implement- minimum effort for the investigator. The ing Universal Newborn Hearing Screening clinical usability of the testing procedure in Austria. In addition, the Department en- (which may be extended to CI fitting in Research Branch (ÖSTAT Classification) joys an excellent reputation as a centre for elderly and multiple handicapped patients)

103002, 301401, 302023, 302027, 302029

Keywords

Aural effects of noise, hearing disorders, hearing rehabilitation, sound localisation, sound localisation with hearing implants, speech understanding with hearing implants, tinnitus, voice disorders

Research Focus

• Assessing auditory performance (e.g. speech understanding, sound source localisation) of patients with hearing im- plants or hearing aids. • Assessing neurocognitive processes as- sociated with first and second language acquisition. • Developing objective methods for hearing implant fitting in children. • Analysing the effects of noise on hearing health through epidemiological studies of tinnitus and hearing complaints in adoles- cents. Fig. 1: A baby is being prepared for participation in a study revealing her brain activities related to specific language cues.

164 Research Report 2016 Medical University of Innsbruck Hearing, ­Speech and Voice Disorders

was evaluated. It was found that ESRT hearing implantation can be still improved. at a behavioral level. Children aged 6-7 and testing can be successfully applied in 66% of 8-9 years as well as adults as a control the children. This percentage can be raised Identifying Early Neuronal Markers in group listen to morphosyntactically to about 85% if the children with middle ear Infants with a Familiar Risk for Dyslexia correct or incorrect sentences while the problems are administered detumescent Sonja Rossi electroencephalography (EEG) is recorded. nose drops. In addition to these findings, Developmental dyslexia is a disorder Different amplitudes are expected with the evaluation of the long-term stability of affecting reading and writing abilities in respect to the P600 component (i.e., an ESRT is an ongoing research question of school-aged children. The present project event-related brain potential component this project. aims at identifying early neuronal markers reflecting the difficulty of syntactic in infants below 2 years of age, thus prior integration). Sound Localization in Single-Sided to a possible manifestation of dyslexia. By Deaf Cochlear Implant Patients applying simultaneously two neuroscientific Josef Seebacher methods, the electroencephalography Sound source localization (SSL) was studied (EEG) and the functional near-infrared in patients with single-sided deafness spectroscopy (fNIRS) we investigate the supplied with cochlear implants (CI). differentiation of linguistic rules of the Selected Publications A New Transcutaneous Bone Conduction Hearing Implant: Short-term Localization tests performed in an anechoic native language compared to rules of a Safety and Efficacy in Children chamber showed that the strategies of foreign language in order to identify early Baumgartner, Wolf-Dieter, Hamzavi, Jafar-Sasan, Boeheim, Klaus, Wolf-Magele, Astrid, Schloegel, Max, Riechelmann, Herbert, Zorowka, Patrick, Koci, Viktor, SSL in these patients differ considerably neuronal abnormalities. Familial risk for Keck, Tilman, Potzinger, Peter, Sprinzl, Georg, from those of normal hearing individuals. dyslexia is classified by either a parent or OTOLOGY & NEUROTOLOGY: 2016; 37: S. 713-720 Age of onset of Recurrent Respiratory Papillomatosis: a distribution They make use rather of interaural older siblings suffering from developmental analysis San Giorgi, M., van den Heuvel, ER., Tjon Pian Gi, RE., Brunings, JW., Chirila, level differences than of interaural time dyslexia. Neuronal markers in the focus M., Friedrich, G., Golusinski, W., Graupp, M., Horcasitas Pous, RA., Ilmarinen, differences to localize where the sound of investigation are an atypical brain T., Jackowska, J., Koelmel, JC., Ferran Vilà, F., Weichbold, V., Wierzbicka, M., Dikkers, FG., comes from. Interaural level differences lateralization and an absent or delayed CLINICAL OTOLARYNGOLOGY: 2016; 41: S. 448-453 occur due to the head shadow effect, discrimination ability. Bilateral use of active middle ear implants: speech discrimination results in noise which is effective at frequencies above Wolf-Magele, Astrid, Koci, Viktor, Schnabl, Johannes, Zorowka, Patrick, Riechelmann, Herbert, Sprinzl, Georg Mathias, 1.5 kHz. Exactly in this frequency range Electrophysiological and Optical EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY: 2016; 273: S. 2065- the cochlea implant transmits its signal Correlates of Inner Speech 2072 faster to the hearing nerve than does a in Children and Adults Improvement of sound source localization abilities in patients bilaterally supplied with active middle ear implants normal functioning inner ear. In a second Sonja Rossi, Franziska Stephan Koci, Viktor, Seebacher, Josef, Weichbold, Viktor, Zorowka, Patrick, Wolf- Magele, Astrid, Sprinzl, Georg, Stephan, Kurt, experiment an attempt was made to Adults are able to use inner speech when ACTA OTO-LARYNGOLOGICA: 2016; 136: S. 692-698 compensate this time lag by delaying the they think. This is a complex executive Universal and language-specific sublexical cues in speech perception: a signal of the cochlear implant. Results function involving several aspects such novel electroencephalography-lesion approach Obrig, Hellmuth, Mentzel, Julia, Rossi, Sonja, confirmed the hypothesis that a delay on as cognitive control, inhibition, and BRAIN: 2016; 139: S. 1800-1816 the cochlear implant side has an impact attention. If the task gets more difficult Impact of associative word learning on phonotactic processing in 6-month-old infants: A combined EEG and fNIRS study. on the patients’ SSL abilities. The SSL using overt speech increases. Children Obrig, Hellmuth, Mock, Julia, Stephan, Franziska, Richter, Maria, Vignotto, Micol, Rossi, Sonja, performance was best when the delay was have to develop this ability. However, it DEVELOPMENTAL COGNITIVE NEUROSCIENCE: 2016; [Epub ahead of print]: S. in the range of 1–2 ms, which corresponds is not clear at which age children start Electrically evoked compound action potentials are different depending to electrophysiologically measured latency using inner speech like adults. Thus, we on the site of cochlear stimulation. van de Heyning, P., Arauz, SL., Atlas, M., Baumgartner, WD., Caversaccio, M., differences in patients with CI. These results study the impact of executive functions Chester-Browne, R., Estienne, P., Gavilan, J., Godey, B., Gstöttner, W., Han, D., Hagen, R., Kompis, M., Kuzovkov, V., Lassaletta, L., Lefevre, F., Li, Y., Müller, J., motivate further investigations in patients on speech by simultaneously assessing Parnes, L., Kleine Punte, A., Raine, C., Rajan, G., Rivas, A., Rivas, JA., Royle, N., Sprinzl, G., Stephan, K., Walkowiak, A., Yanov, Y., Zimmermann, K., Zorowka, with bimodal supply (i.e. with a CI on one the electroencephalography (EEG) and P., Skarzynski, H., side and a hearing aid on the other) where the functional near-infrared spectroscopy COCHLEAR IMPLANTS INTERNATIONAL: 2016; 17: S. 251-262 even larger time differences are observed. (fNIRS). 6-7-year-olds, 8-9-year-olds, and Collaborations adults will be assessed while they see Factors influencing Quality pictures of real objects they have to name • Charité University Medicine, Berlin, Germany • Clinic for Cognitive Neurology, University Hospital, Leipzig, of Life in CI Patients either overtly or covertly. Stronger inhibitory Germany Viktor Weichbold effects associated with elevated prefrontal • Saxonian Cochlear Implant Center, Technical University of Dresden, Germany This project is part of an extensive project activity as well as increased amplitudes of • Department of Linguistics, University of Leipzig, Germany investigating the factors influencing the event-related brain potentials (ERPs) are • Department of Subject Education, Leopold-Franzens University Innsbruck, Austria outcome after cochlear or middle ear expected when planning inner speech in • Faculty of Education, University of Leipzig, Germany implantation in hearing impaired persons. contrast to overt speech. • Institute of Sport Science, Leopold Franzens University Innsbruck, Austria Previous studies showed that cochlear • Max Planck Institute for Human Cognitive and Brain Sciences, implantation improves the quality of Syntactic Processing in Leipzig, Germany • MED-EL, Innsbruck, Austria life in these patients, but the degree of Children and Adults • Scott Sports SA, Givisiez, Switzerland improvement varies considerably between Sonja Rossi patients. In consequence, attention has Processing irregular verbs is a quite difficult Devices and Services been directed to identifying the factors task, especially for children. With the • Medical outpatient unit • Audiology unit that account for the variation. It is hoped present project we aim at investigating • Pediatric Audiology unit that, by considering these factors in patient whether electrophysiological correlates can • Logopedic unit • Psychology unit selection, patient counselling and provision provide differential processing mechanisms • Lab for Psycho-Acoustics of clinical services, the outcome after at a neuronal level, possibly not yet present • Lab for Cognitive Neuroscience

Research Report 2016 Medical University of Innsbruck 165 Center of Diagnostic Radiology Diagnostic and Interventional Radiology

• Real time dose monitoring of patients used for the high resolution imaging of small • Diagnosis and treatment of HCC animals (ranging from mice to rabbits). The • Percutaneous stereotactic RFA XtremeCTII is also used for high resolution • Digital imaging/PACS/post processing of scanning of extremities of patients, mostly imaging data for the evaluation of bone density (Osteo- • Clinical trials in oncology porosis). Our research projects are mostly clinically orientated. We focus on the rap- General Facts id translation of research results into clin- ical practice. Also, most research projects For clinical research, the Department is are interdisciplinary. The Department of equipped with state of the art imaging ­Radiology and the Department of Neurora- equipment including 7 CT scanners (1 Dual diology have a close cooperation regard-ing source/three 64 row/one 32 row/two 16 training, patient care and research. row), 3 MRI scanners (3T and 1.5T), 1 PET- CT (in cooperation with the Department of Research Nuclear Medicine), 3 angio suites (1 biplane) and 15 high end ultrasound systems. One Atherosclerotic Burden and its CT with a sliding gantry operating in an ­Relevance in Case of Different ­Diseases Director: OR and an imaging suite is dedicated to and Treatment Strategies. o. Univ.-Prof. Dr. Werner Jaschke stereotaxy and CT guided procedures. The Bernhard Glodny, Johannes Petersen Department operates completely digitally Cardiovascular and cerebrovascular se­ Contact: using a comprehensive imaging archive that quelae of atherosclerotic disease are one of Anichstraße 35 was installed in the year 1999. the leading causes of morbidity and mortal- 6020 Innsbruck There are 66 staff members including 30 ity in humans, and concerns many different residents (radiologists in training). fields of medicine. Atherosclerosis can be [email protected] detected using different modalities of diag- Phone: +43 512 504 22761 The Section of Experimental Radiology nostic imaging. Moreover, treatments are Fax: +43 512 504 22758 is staffed with 6 phycisists with different planned using clinical imaging, and cardio­ http://radiologie.tirol-kliniken.at areas of interest such as MRI, MRS, image vascular risk profiles can be compiled in- data processing,radiation protection and dividually. Computed tomography can be computer applications. used to quantify the “atherosclerotic bur- den” of all vascular territories in an objec- Research Branch (ÖSTAT Classification) The Department houses research facilities tive and reproducible manner. Relationships for animals (Small Animals Research Lab). between oral health and health in general 302010, 302043, 302070, High resolution RF coils for MR imaging have been suspected since many years. 302071, 302075 of animals are available as well as access One of the first observations to be made in to PET imaging. Large animals can be im- this area of study was that oral and general Keywords aged on 1 of the clinical CT scanners (32 health is impacted similarly by certain be- rows/Siemens). The Core Facility MicroCT havioural, social and environmental factors. Radiology, interventional radiology, MRI, CT, is equipped with 2 MicroCT scanners In the late eighties, and the nineties of the angiography, contrast media, ultrasound, (­vivaCT40/Scanco Medical and XtremeCT last century, a causal relationship between PET-CT, robotics, interventional oncology, II/Scanco Medical) which are operated in marginal periodontitis, and atherosclerosis radiation protection, digital imaging, PACS, cooperation with the Department of Trauma­ was established. microCT Surgery. Both microCT scanners can be

Research Focus

• Ultrasound (elastography, musculoskelettal ultrasound, ultrasound of peripheral nerves, ultrasound guided interventions) • Multiparametric imaging of prostate cancer • MRI (quantification of fat/iron; cardiac MRI; spectrosopy of muscle/myocardium; musculo skeletal MRI including stress MRI of the hip and knee, MR mammography) • Cardiac CT • Dual Energy CT Fig. 1: A typical CAP lesion of a tooth (14) in a semi-coronal reconstruction of a CT. The tooth • Emergency Radiology, especially trauma shows an endodontic filling (a), a CAP lesion of a tooth (46) in a semi-sagittal reconstruction • Sports injury of a CT (b), and a semicoronal reconstruction in the region 46 (c), showing the methods of • Interventional Radiology (endovascular/ measurement of the distance between the crown and the alveolar ridge (double arrow) and oncology) of measurement of the height of the bone (white line).

166 Research Report 2016 Medical University of Innsbruck Diagnostic and Interventional Radiology

breast ultrasound studies are performed (fat, iron or combined diease); influence of each year making our unit the biggest in iron on the evaluation of liver fat (see Fig. 4). Austria. b) Diffusionweighted MRI of peripherial Non-Invasive Cardiac/Cardiovascular nerves (with M. Reinhold, Orth. Surgery) Imaging Value of diffusion-weighted magnetic Gudrun Feuchtner resonance imaging for the diagnosis and Fig. 2: 65-year-old woman with an invasive CT: 10 Multicenter trials treatment of patients with lumbar nerve ductal carcinoma showing inhomogeneous MRI: Pulse wave velocity (PWV) is the root entrapment syndromes. breast tissue at 9 o’clock as demonstrated­ by proposed gold-standard for the assessment conventional mammography (a, b). Low-en- of aortic elastic properties. It is the aim of c) Diffusion tensor imaging of the median ergy CESM images (c) are equivalent to this research project to use MR based pulse nerve in carpal tunnel syndrome. conventional mammography, while spectral wave velocity imaging to assess aortic PI: A. Klauser imaging shows a contrast enhancing mass. stiffness as a biomarker of myocardial wall stress. d) Assessment of tumour microcirculation This fitted perfectly with the concept of by dynamic magnetic resonance imaging atherosclerosis as an inflammatory disease. Experimental Radiology (DMRI): Tumour microcirculation is an The aim of the present studies is to adopt the Wolfgang Recheis important biomarker for diagnosis, therapy theory of atherosclerosis as inflammatory Image processing and analysis including outcome prediction and therapy monitoring. disease in order to ascertain whether caries Rapid Prototyping based on radiological In our study group DMRI is applied for these may be causative for atherosclerosis as well, data represent core interests and tasks of purposes to prostate carcinoma, rectal especially in cases in which the disease has the work group “Experimental Radiology”. carcinoma, glioblastomas, etc. crossed the enamel. Consequent infections These projects include multidimensional of the dental pulp and apical periodontitis visualization, quantification of disease e) MR Molecular Imaging using ­Nanoparti­ may represent additional causes for patterns based on texture analysis, shape cles. Recent developments in nanotechnolo­ atherosclerosis. Dental caries (Fig. 1) turned analysis and others (see Fig. 3). Moreover, gy provide a wide spectrum of nano sized out to be an independent risk factor for a our new core facility micro-CT allows for material for various applications, including higher atherosclerotic burden of the aorta. the depiction of structures in µm scale in all tumour targeting and molecular imaging. Moreover, dental fillings showed an inverse three spatial dimensions. The main task of our work in this field is to effect, and were found to be an independent implement MR measurement techniques protective factor for aortic atherosclerotic Morphological and MR-Imaging to facilitate the preclinical characterization burden (Fig. 2). Chronic apical periodontitis Benjamin Henninger, Christian Kremser and testing of such materials from varying also emerged as a risk factor for higher Morphological and functional MR-imaging research groups. Main contact: C. Kremser atherosclerotic burden. in all organ systems deveolopment of novel MR-imaging applications and MR Imaging of Prostate Cancer Imaging of Breast Cancer sequences Image Fusion and Image Guided Biopsy Martin Daniaux, Tobias De Zordo Examples of research projects: of the Prostate Example: Dual-energy contrast-enhanced a) MRI for the Evaluation of Diffuse Liver Multimodal Imaging of the GU-Tract mammography Disease: Evaluation of different MRI-meth- Friedrich Aigner, Daniel Junker Dual-energy contrast-enhanced mammog- ods (relaxometry, chemical-shift imaging, PSA is commonly used in screening for raphy is one of the latest developments in multi-echo approach, screening dixon) for prostatic cancer. Patients with high PSA breast care. Imaging with contrast agents in the determination of diffuse liver disease levels frequently undergo systematic breast cancer has already been described in previous magnetic resonance imaging and computed tomography studies. How- ever, high costs, limited availability—or high radiation dose—led to the development of contrast-enhanced spectral mammography (CESM). Our most recent research evaluat- ed this novel technique and was supported by GE Health Care (literature below). The research team focussing on the diagno- sis of breast cancer has a vast experience with all of the imaging modalities currently used for evaluating the breast. In case of a suspicious imaging finding we perform Fig. 3: Left: Application of micro-computed tomography to microstructure studies of the me- fine needle aspiration and/or percutane- dicinal fungus Hericium coralloides. Pallua JD, Kuhn V, Pallua AF, Pfaller K, Pallua AK, ous biopsies using stereotaxy or ultrasound Recheis W, Pöder R., Mycologia. 2015 Jan-Feb;107(1):227–38. arrow) and of measurement of guidance. Our unit serves as the largest the height of the bone (white line) screening and assessment centre of the na- Right: 3D Visualization of the round window (pink), the scala tympani (light yellow) and the tional breast-screening programme in Tirol. length (measuring points= yellowish brown) of a sheep cochlea from micro CT datasets, Approximately 10 000 mammograms and which were used for round window area, cochlea length and scala tympani measurement.

Research Report 2016 Medical University of Innsbruck 167 Center of Diagnostic Radiology

prostatic biopsies. However, PSA is not leader in the development of ultrasound a reliable indicator for prostate cancer techniques for evaluation of peripheral and systematic prostate biopsies are nerves and ultrasound guided nerve root invasive and suffer from a rather high infiltration and pain therapy. One of the false negative rate. Thus, there exists the most recent publications illustrates our need for improving non invasive methods work: for detecting prostate cancer in its early The axillary nerve (AN) is frequently injured stages. Our group has dealt with imaging during shoulder trauma and imaging is of the prostate using ultrasound and required to define the site and extent of multiparametric MRI for nearly 2 decades. nerve injury. However, the AN has a rather Also, we used ultrasound since the early complex course through several soft tissue 90s for performing ultrasound guided compartments of the shoulder and axilla. biopsies. Recently, image fusion became Therefore, imaging of the nerve with MRI available. We use ultrasound/MRI-fusion and sonography is troublesome. Thus for guiding biopsies and avoiding “blind” detection and sonographic assessment systematic biospies of the prostate. This requires a thorough knowledge of local approach improves the detection of cancer topography. in large prostates, in the anterior portion of the prostate and in the inner gland. Also, Our investigation is aimed at defining reli- reporting imaging results using the PI-RADS able anatomical landmarks for AN-sonog- Fig. 4: Above: 43year old patient with classification helps to avoid unnecessary raphy in 5 volunteers and later validating suspected diffuse liver disease. The biopsies. A low PI-RADS classification is a the proposed sonographic examination screening dixon sequence (work in pro- very reliable indicator for the absence of protocol in 10 unselected patients. With gress package 718B, Siemens Healthcare) prostate cancer. Our results indicate, that strict adherence to the proposed exam- can provide a fast diagnosis of the predo- patients with a high PI-RADS classification ination ­algorithm, sonography of the AN minant pathologic liver deposition – in this should undergo an image guided biopsy was feasible in all volunteers and patients. case it shows a fatty liver. Below: Automated which has a much higher true positive rate ­Furthermore, sonographic findings correlat- two-point dixon screening for the evaluati- than “blind” biopsies (see Fig. 5). ed nicely with the gold standard “surgical on of hepatic steatosis and siderosis: com- exploration” concerning the severity and parison with R2*-relaxometry and chemical Musculosklettal Imaging topography of neural impairment. shift-based sequences. Andrea S. Klauser et al. • Sonography of Carpaltunnel: definition of Based on our study results we propose our cut off values algorithm for AN-sonography as the first- • Sonoelastography of epicondylitis: accu- line imaging tool for the assessment of racy compared to histology axillary nerve trauma. (PIC) • Sonoelastography of plantar fasciitis: ac- curacy compared to histology Interventional Oncology • Sonoelastography of achilles tendon: ac- Reto Bale curacy compared to histology • Image guided tumor ablation • US guided injections in CTS: Sonoelasto- • Stereotaxy graphic appearance • Robotics • MR-Tractography (DTI, ADI) in median • Targeting nerves in healty voluntees and CTS pa- • Interventional Oncology Fig. 5: A 67-year old patient with an anterior tients: comparison to so-nography located Gleason score 7b prostate cancer in • US guided injection in Sacroiliac joints of Stereotactic Ablation of Liver Tumors: the transitional zone (PSA 5.69 ng/ml), encir- children: to prove feasability Radiofrequency ablation (RFA) allows for cled on the whole-mount step-section slide • DECT in gout: comparsion to US, findings local curative tumour treatment by inducing (a): The carcinoma (arrows) shows low sig- in extraarticular regions coagulation necrosis with a high-frequency nal on T2-weighted images with ill-defined • Hip Traction MRI (FIG) alternating current. The major limiting factor margins (b), diffusion restriction on diffu- of percutaneous ablation methods is the sion-weighted imaging (c, d), and hyperper- Ultrasound tumour size, requiring multiple overlapping fusion on dynamic contrast-enhanced MRI Hannes Gruber; Alexander Loizides ablation zones. 3D-planning allowing (e: red circle on perfusion map) with a focal Research Focus of the Research Unit: for the simultaneous display of multiple plateau curve (f: red curve). An area with hy- • Peripheral nerve sonography trajectories and increased accuracy is perplastic nodules appears unsuspicious in • Sonographic evaluation of soft tissue required. In addition, the virtual 3D plan has T2-weighted images (b), diffusion-weighted massesv to be precisely transferred into the patient. imaging (c, d), but shows hyperperfusion on • Ultrasound guided injections in the spine Our team has developed frameless dynamic contrast-enhanced MRI (e: green • Sonography of the musculoskeletal sys- stereotactic aiming devices and circle on perfusion map) with a focal wash- tem immobilization devices for precise out curve (f: green curve), which is even • Contrast enhanced sonography punctures in different body regions. more pathological (PI-RADS 5) than the per- Stereotaxy enables highly accurate ablation fusion of the carcinoma. The Section of surgical ultrasound is a probe positioning in liver tumors. In 2001 the

168 Research Report 2016 Medical University of Innsbruck Diagnostic and Interventional Radiology

worldwide first stereotactic radiofrequency Excellent post-transplant survival in patients with intermediate stage hepatocellular carcinoma responding to ablation (SRFA) of a liver tumor was neoadjuvant therapy. performed in Innsbruck. In the meantime Finkenstedt, A., Vikoler, A., Portenkirchner, M., Mülleder, K., Maglione, M., Margreiter, C., Moser, P., Vogel, W., Bale, R., Freund, more than 600 patients were successfully M., Luger, A., Tilg, H., Petersen, J., Schneeberger, S., Graziadei, I., treated at our department. Recently a Zoller, H., Glodny, B., LIVER INTERNATIONAL: 2016; 36: S. 688-695 database was established and connected Fig. 6: Carpal tunnel syndrome: diagnosis by to the hospital information system (HIS). All Gender influence on clinical presentation and high- resolution ultrasound findings in primary carpal tunnel means of median nerve elasticity—improved the relevant information about every patient, syndrome: do women only differ in incidence? diagnostic accuracy of US with sonoelasto- treatment and follow-up examinations is Gruber, Leonhard, Gruber, Hannes, Djurdjevic, Tanja, Schullian, Peter, Loizides, Alexander, graphy (Miyamoto et al., 2014). continuously collected. Local recurrence JOURNAL OF MEDICAL ULTRASONICS: 2016; 43: S. 413-420 rate, complications, long-term survival etc. Meralgia paraesthetica: Ultrasound-guided injection at can now easily be calculated. Currently the multiple levels with 12-month follow-up efficacy and long-term survival after SRFA Klauser, Andrea S., Abd Ellah, Mohamed M. H., Halpern, Ethan J., Sporer, Isabella, Martinoli, Carlo, Tagliafico, Alberto, Sojer, Martin, is evaluated for different tumor entities. Taljanovic, Mihra S., Jaschke, Werner R., In addition, a major topic of research is EUROPEAN RADIOLOGY: 2016; 26: S. 764-770 the implementation of robotic devices for Sonoelastography of the Common Flexor Tendon of the interventional procedures. Elbow with Histologic Agreement: A Cadaveric Study. Klauser, Andrea S., Pamminger, Mathias J., Halpern, Ethan J., Abd Ellah, Mohamed M H., Moriggl, Bernhard, Taljanovic, Mihra Theragnostics/Image Guided Tumor S., Deml, Christian, Sztankay, Judith, Klima, Guenter, Gruber, Leonhard, Jaschke, Werner R., Therapy (Mitigate Project) RADIOLOGY: 2016; [Epub ahead of print]: S. 160139 MITIGATE stands for Closed-loop Molecular Evaluation of myocardial involvement in patients Environment for Minimally Invasive Treat- with connective tissue disorders: a multi-parametric ment of Patients with Metastatic Gastroin- cardiovascular magnetic resonance study Mayr, Agnes, Kitterer, Daniel, Latus, Joerg, Steubing, Hannah, testinal Stromal Tumours. Henes, Joerg, Vecchio, Francesco, Kaesemann, Philipp, Patrascu, Alexandru, Greiser, Andreas, Groeninger, Stefan, Braun, Niko, Alscher, M. Dominik, Sechtem, Udo, Mahrholdt, Heiko, Greulich, Fig. 7: The 2 US scans a (longitudinal and Gastrointestinal stromal tumour (GIST) Simon, axial) show the sonographic situation at the is a rare disease and frequently affects JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE: 2016; 18: S. 67 “leaving” of the AN from the plexus. The 2 young patients and often results in a US scans b (longitudinal and axial) show short life expectancy of less than 3 years. MR arthrography of the hip with and without leg traction: Assessing the diagnostic performance in detection of the sonographic situation at the “middle Currently there is only one class of effective ligamentum teres lesions with arthroscopic correlation segment” and the 2 US scans c (longitudinal medications for systemic GIST therapy and Schmaranzer, Florian, Klauser, Andrea, Kogler, Michael, Henninger, Benjamin, Forstner, Thomas, Reichkendler, Markus, Schmaranzer, and axial) show the sonographic situation at often the tumours develop drug resistance Ehrenfried, the “distal segment”. The white arrowheads after a few years. The MITIGATE consortium EUROPEAN JOURNAL OF RADIOLOGY: 2016; 85: S. 489-497 indicate the AN, the white arrow indicates representing three European universities, Ultralow dose dentomaxillofacial CT imaging and iterative the posterior fascicle of the plexus, (*) in- three research organisations and four SMEs reconstruction techniques: variability of Hounsfield units and contrast-to-noise ratio dicates the axillary artery, (^) indicate the will pursue the ultimate goal of developing Widmann, Gerlig, Bischel, Alexander, Stratis, Andreas, Kakar, cortex of the humeral head, (Δ) indicate the new protocols and guidelines to effectively Apoorv, Bosmans, Hilde, Jacobs, Reinhilde, Gassner, Eva-Maria, Puelacher, Wolfgang, Pauwels, Ruben, subscapular muscle, the rings (0) indicate diagnose and treat patients with metastatic BRITISH JOURNAL OF RADIOLOGY: 2016; 89: S. 20151055 the teres minor muscle, (~) indicates the GIST resistant to current treatment. Pathogenesis, Diagnosis and Treatment of Hemochromatosis long head of the triceps muscle and the 3 Zoller, Heinz, Henninger, Benjamin, bowed, white arrows indicate the 3 termi- MITIGATE is co-funded by the European DIGESTIVE DISEASES: 2016; 34: S. 364-373 nal branches of the AN forming within the Community’s Seventh Framework Pro- Selected Fundings ­axillary gap. gramme (FP7/2007–2013) under grant • K-REGIO Projekt Cardiospect, Land Tirol, Wirtschaftsförderung, agreement no 602306 and will run from ao. Univ.-Prof. Dr. Michael Schocke ­October 2013–2017 (Fig. 9). • MITIGATE #602306, EU FP7, o. Univ.-Prof. Dr. Werner Jaschke • RLS-Iron, Land Tirol, Translationales Research Programm, ao. Univ.-Prof. Dr. Michael Schocke • DISCHARGE #603266; EU FP7; ao. Univ.-Prof. Dr. Gudrun Feuchtner • Einsatz genetischer Algorithmen zur Erstellung realer, farbkodierter 3D-Modelle zur gleichzeitigen Darstellung von Hämodynamik und Morphologie in zerebralen arterio-venösen Selected Publications Malformationen; Autonome Provinz Bozen, PD Dr. Wolfgang Recheis Stereotactic Radiofrequency Ablation for Metastatic • Oralkarzinom WIF ‑273-01-00015/014-0034, Land Tirol, Melanoma to the Liver Translationales Research Programm, PD Dr. Wolfgang Recheis Bale, Reto, Schullian, Peter, Schmuth, Matthias, Widmann, Gerlig, Jaschke, Werner, Weinlich, Georg, CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY: 2016; Collaborations 39: S. 1128-1135 • iSYS Medizintechnik GmbH The high-risk criteria low-attenuation plaque <60 HU and • Siemens Healthcare Österreich the napkin-ring sign are the most powerful predictors of • Ergospect GmbH MACE: a long-term follow-up study. Feuchtner, Gudrun, Kerber, Johannes, Burghard, Philipp, Dichtl, Core Facilites Wolfgang, Friedrich, Guy, Bonaros, Nikolaos, Plank, Fabian, EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING: 2016; • Micro CT [Epub ahead of print]: S. • Neuroimaging Research

Fig. 8: Stereotactic Ablation of Liver Tumors.

Research Report 2016 Medical University of Innsbruck 169 Center of Diagnostic Radiology Neuroradiology

Research Branch (ÖSTAT Classification) experimental projects, Neuroradiology also carries out clinical studies addressing neu- 301111, 301401, 302010, rovascular disease (Fig. 1), brain tumors 302043, 302044 and brain development. The ­Department of Neuroradiology administrates and leads Keywords the Core Facility Neuroimaging ­Research (CF -NIR). High-field MRI, MR-spectroscopy, fMRI, DTI, VBM, multimodal imaging, dual-energy-CT, General Facts interventional neuroradiology Structure of the Research Unit, Aims Research Focus and Clinical Routine The Department of Neuroradiology was es- Neuroradiological research is to a large tablished in 2012 and is therefore still under extent connected to and driven by its clin- development. Together with the Department ical partners (Neuro-Focus at the MUI, e.g. of General Radiology, the Neuroradiology is neuro­degenerative and neuroimmunolog- involved in the radiographer and physician ical disorders, epilepsy, sleep medicine, educational programs, but also in research Director: degenerative spine diseases, brain tum- and clinical routine activities. Furthermore, Univ.-Prof.in Dr.in ors, neurovascular diseases, psychiatric the two departments have a long-standing Elke R. Gizewski MHBA diseases…). Besides those main partners, PhD program, and they also started a clini- ­Neuroradiology is also involved in the pro- cal PhD program in 2013. Contact: jects of many other departments (clinical Anichstraße 35 and theoretical) at the MUI, MCI and LFU. Neuroradiology is a department with a 6020 Innsbruck large clinical workload, which includes di- Projects generated within the Department of agnostic and interventional neuroradiology [email protected] Neuroradiology itself mostly focus on tech- for all neuro-cases both of pediatric and Phone: +43 512 504 27095 nical developments (dose reduction/dual of adult patients. One focus of research is Fax: +43 512 504 27096 energy CT, MRI-sequence developments, clinically related imaging and intervention http://radiologie.tirol-kliniken.at fMRI/VBM, 1H and 31P MR-­Spectroscopy); studies (including multicentre studies, e.g. some projects arise in cooperation with SITS open, ACTS II). The senior physicians the Department of Radiology, and yet oth- lead the younger colleagues with interest ers arise from research experiences in the in neuroradiology and the PhD students of cerebral processing of pain with emphasis the Department­ in all aspects of clinical on gender differences. Beside these more studies, and cooperate with clinical part-

Fig. 1: Endovascular therapy of cerebral aneurysms is more and more important in clinical routine. The first row shows a recent development in stents which is here evaluated in ­clinical studies. The second row shows an example of endovascular stroke therapy with thrombektomy ­using one of the recently developed stent retrievers (arrows). Here, the Neuroradiology (in cooperation with Neurology) is part of a big mulicentre study.

170 Research Report 2016 Medical University of Innsbruck Neuroradiology

ners within the MUI (mainly Neurology, Neurosurgery, Psychiatry, Child and Youth Psychiatry, ­Neuropediatrics, Radiology, but also Gynecology, ENT, Nuclear Medicine, Cardiology, Neonatology, Radiation Therapy, Orthodontics and others).

The more experimental research is still de- veloping. Up to now, Neuroradiology has 2 “Laufbahnstellen” (Tenure Track posi- tions) with Ass. Profs. who lead their own research groups: “Diffusion Tensor Imaging (DTI) of spine and nerves” and “Multimodal imaging with focus on MR-Spectroscopy”. Within the latter group, one PhD student be- gan studies in 2015 (ÖNB grant) with focus on 31P MR-Spectroscopy (MRS) in cerebral diseases; MRS and multimodal imaging rep- resent a significant focus of the Department (Fig. 2).

One research focus of the Head of the de- partment is the cerebral processing of pain. She was co-PI of two DFG-funded research projects dealing with visceral pain imaging: “Extinction learning” and “Placebo modula- Fig. 2: Multimodal imaging in tumor patients. Multicystic WHO grade IV glioma on the right tion of visceral pain processing”, and is now hemisphere with edema in T2 weighted images (A, arrow), contrast-enhancement (B, ar- translating that experience to local research row), restricted diffusion (C, arrow) and increased perfusion (D, arrow) of the solid parts. (Fig. 3, and project listed below). The exten- 31P MRS spectrum, displaying the high energy metabolites phosphocreatine (PCr, arrow) sive experience with high field MRI (3 T and and ATP (E), the arrow is pointing at the relevant voxel. 7 T (now in cooperation with the Erwin L Hahn Institute in Essen, with the Excellence and an assistant radiographer. The Team Centre of High Field MRI at the Medical Uni- ­“Neuro­radiology” provides support to all Research versity Vienna, and with the Imag­ing Unit associated scientists in technical and post-­ of the DKFZ in Heidelberg)), both structur- processing questions. Furthermore, the This section lists only those research pro- al and fMRI (multimodal) also represent a core facility develops and introduces new jects which are mainly led by Neuroradi- further focus on brain processing related MR sequences and technical equipment, ology (NR). Further collaborations, mainly to cognitive and emotional processes, par- such as improved coils. Above all, the those involving the CF ‑NIR, have undertak- ticularly with respect to possible gender Neuro­imaging platform offers opportunities en many additional projects, and yet other differences. The fMRI group has a second to bring different groups together and to projects work with many further radiologi- focus on psychiatric research (re­silience, transfer knowledge, and it provides a set- cal techniques. affective disorders, eating disorders), and ting for communication and cooperation. also on critical emotional situations arising Attachment and Cerebral Processing in cardiology. One important recent development with the led by Prof. Dr. Buchheim and CF ‑NIR is the Neuroimage WING, which Prof. Dr. Gizewski, in cooperation with The Department of Neuroradiology has also is a grant (­Hochschulraumstrukturmittel) Dr. Labisch and Prof. Viviani a considerable number of collaborations sup­porting an imaging platform at the Attachment is a core function in healthy outside the MUI. Medical Universities Innsbruck, Graz and human life, but it is vulnerable in patients Vienna. Neuroimage WING (WienINns- with psychiatric diseases. Well known tools Core Facility Neuroimaging Research bruckGraz) is led by MUI (Department such as the “Adult Attachment Projective (CF ‑NIR) of Neurology, Univ.-Prof. Dr. Christoph Picture System” are available; however, this The main modality of this CF is the ­Scherfler: ­“Com­putational Neuroimaging”, imaging system is not optimal for use in BMWF ‑funded 3 Tesla-MRI-system, which in cooperation with the Department of fMRI experiments. The goal of this study is establishes a core facility for MR-based ­Neuroradiology) and was set up to collect to evaluate a new imaging suite we creat- neuroimaging research at the MUI. The and analyse data from ­different sites and ed, which is especially adapted for fMRI in 3T MRI was installed in 2011 and started from pooled patient populations­ . This will healthy volunteers in a 3T MRI setting. work exclusively for research use in 2012. lead to higher ­efficiency and synergies in The CF ‑NIR is centrally administered by research projects and also to a know-how Cerebral Processes of Enteroceptive the Head of the Department of Neuro­ transfer. Multiple sclerosis, movement dis- Pain in Patients with Dysmenorrhoea radiology, who leads an interdisciplinary orders and dementias were defined as the led by Prof. Gizewski; NR: Dr. ­Siedentopf, Steering Board. The technical equipment starting projects. Dr. Steiger in cooperation with Prof. Wildt, is supported by one physicist (since 2014) Dr. Böttcher, and Prof. Elsenbruch (Essen)

Research Report 2016 Medical University of Innsbruck 171 Center of Diagnostic Radiology

Pelvic pain is an important symptom hav- ters (Fig. 3) with psycho-social data. hypotheses and to develop a study address- ing high impact in clinical care and thera- Resilience: Neuroimaging of Gender ing not only structure but also metabolism py. There are several relevant pelvic pain ­Differences in Healthy Subjects in preterm children, using MRS. Additional- types, including primary and secondary dys- led by Prof. Hofer and Prof. Gizewski in ly, fMRI and psychological tests will be ap- menorrhea. To date, there is no study that cooperation with NR: Dr. Siedentopf plied to obtain data from grown-up former addresses interoceptive pain thresholds, Resilience represents the capacity of some preterm children. subjective perception of pain, and cerebral individuals to remain healthy or recover processing of such stimuli in patients with easily from adverse events, despite marked 31P MRS in Cerebral Gliomas and dysmenorrhea. The rectal barostat disten- negative circumstances and risk factors, ­Metastases sion model, which is well established in the whereas others under comparable condi- led by Ass.-Prof. Grams; NR: Dr. Walchhofer Essen laboratory and has now been trans- tions are particularly vulnerable to disor- and Dr. Steiger in coop. with Prof. Thomé, ferred to Innsbruck, is a clinically relevant, ders and illness. Few studies have examined Dr. ­Kerschbaumer, Dr. Freyschlag, valid and reliable interoceptive pain model. the structural correlates of resilience, and Prof. Stockhammer and Dr. Nowosielski, This paradigm is now being used in a pilot they involved mostly subjects under risk Prof. Nevinny-Stickel study on dysmenorrhea patients, with the circumstances or suffering post-traumatic By using MR spectroscopy of phosphorus first results showing typical activation in stress disorder (PTSD). The Neuroradiology compounds (31P MRS) it is possible to “pain matrix” areas. is involved in this study firstly by analyzing detect various metabolites of energy me- a cross-sectional survey to investigate resil- tabolism and of membrane turnover. 31P Cerebral Processing of Food Stimuli in ience in healthy volunteers, with a primary MRS is being applied in patients with cer- Young Anorectic Patients in Respect to focus on potential gender differences, and ebral ­gliomas and metastases in order to Personality Disorders and Gender secondly by addressing the cerebral rep- investigate tumour heterogeneity and the led by Prof. Gizewski, Prof. Sevecke, in resentation of resilience in the same individ- effects of therapy not only on the tumorous cooperation with NR: Dr. Steiger, Child and uals, with emphasis on gender specificities. area but on the healthy brain hemisphere Youth Psychiatry: Dr. Fuchs as well. The resulting data will be correlat- Some earlier studies have revealed alter­ MRI and MRS Parameters in Cerebral ed with results obtained from established ations in cerebral processing in adult Development of Preterm Infants methods such as 1H MR spectroscopy, MR anorec­tic patients. However, since they led by Dr. Djurdjevic in cooperation with perfusion- and MR diffusion-weighted imag- were based on longstanding disease, their Prof. Kiechl-Kohlendorf, Prof. Gizewski and ing, as well as with clinical, histological and results could not give clear answers on how Prof. Buchheim PET parameters. those functional and structural differences Up to now, some studies have revealed developed in contrast to healthy volunteers. structural parameters in preterm children 31P MRS in Stroke Patients We have therefore established the applica- that indicate an unfavourable clinical out- led by Ass.-Prof. Grams; NR: Dr. Walchhofer tion of these stimuli to young patients and come (e.g. the Innsbruck NEOBRAIN study). and Dr. Steiger in cooperation with will correlate the measured brain parame- These first results led to formulate further Prof. Willeit and Dr. Knoflach 31P MRS is being applied in patients with acute, subacute and chronic ischemic stroke to gain further insights into the en- ergy metabolism and reorganization mecha- nisms of infarcted brain and surrounding ar- eas during the acute stage, and to monitor subacute and chronic changes. The results will be correlated with those obtained from established imaging methods (see above) and with clinical data that are routinely col- lected in the Department of Neurology.

31P MRS in Healthy Volunteers and Brain Trauma Patients 8 led by Ass.-Prof. Grams; NR: Dr. Walchhofer, Dr. Steiger in cooperation Prof. Thomé, Dr.

6 Petr, and Dr. Pinggera 31P MRS is being performed in patients

4 with severe traumatic brain injury during the acute, sub-acute and chronic stages.

2 Trauma influence on energy metabolism and on reorganization processes will be

0 investigated and the results correlated with established imaging parameters (see Fig. 3: Activation of orbitofrontal, prefrontal and medial temporal gyrus in contrast of above) and with clinical parameters. high-calorie food and low-calorie food in the group of anorectic patient in contrast to the control group. These areas are involved in altered perception and rating strategies of food but also in body perception (medial temporal gyrus).

172 Research Report 2016 Medical University of Innsbruck Neuroradiology

Selected Publications

Neural Correlates of the Appraisal of Attachment Scenes in Healthy Controls and Social Cognition - An fMRI Study Labek, Karin, Viviani, Roberto, Gizewski, Elke R., Verius, Michael, Buchheim, Anna, FRONTIERS IN HUMAN NEUROSCIENCE: 2016; 10: S. 345

Loss of Dorsolateral Nigral Hyperintensity on 3.0 Tesla Susceptibility- Weighted Imaging in Idiopathic Rapid Eye Movement Sleep Behavior Disorder De Marzi, Roberto, Seppi, Klaus, Hoegl, Birgit, Mueller, Christoph, Scherfler, Christoph, Stefani, Ambra, Iranzo, Alex, Tolosa, Eduardo, Santamaria, Joan, Gizewski, Elke, Schocke, Michael, Skalla, Elisabeth, Kremser, Christian, Poewe, Werner, ANNALS OF NEUROLOGY: 2016; 79: S. 1026-1030

1.5 Versus 3 Tesla Magnetic Resonance Planimetry in Neurodegenerative Parkinsonism Mangesius, Stephanie, Krismer, Florian, Gizewski, Elke R., Mueller, Christoph, Hussl, Anna, Schocke, Michael, Scherfler, Christoph, Poewe, Werner, Seppi, Klaus, MOVEMENT DISORDERS: 2016; 31: S. 1925-1927

Endovascular stroke therapy in Austria: a nationwide 1-year experience Serles, W., Gattringer, T., Mutzenbach, S., Seyfang, L., Trenkler, J., Killer- Oberpfalzer, M., Deutschmann, H., Niederkorn, K., Wolf, F., Gruber, A., Hausegger, K., Weber, J., Thurnher, S., Gizewski, E., Willeit, J., Karaic, R., Fertl, E., Nasel, C., Brainin, M., Erian, J., Oberndorfer, S., Karnel, F., Grisold, W., Auff, E., Fazekas, F., Haring, H. -P., Lang, W., Austrian Stroke Unit Registry Coll, EUROPEAN JOURNAL OF NEUROLOGY: 2016; 23: S. 906-911

Longitudinal profile of iron accumulation in good-grade subarachnoid hemorrhage Scherfler, Christoph, Schiefecker, Alois Josef, Delazer, Margarete, Beer, Ronny, Bodner, Thomas, Spinka, Georg, Kofler, Mario, Pfausler, Bettina, Kremser, Christian, Schocke, Michael, Benke, Thomas, Gizewski, Elke R., Schmutzhard, Erich, Helbok, Raimund, ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY: 2016; 3: S. 781- 790 Fig. 4: A shows an optimized DTI sequence from a healthy volunteer. The anisotropy can be Placebo analgesia in patients with functional and organic abdominal pain: a fMRI study in IBS, UC and healthy volunteers. calculated without significant artefacts and the tracts can be visualized in both sagittal and Schmid, J., Langhorst, J., Gaß, F., Theysohn, N., Benson, S., Engler, H., Gizewski, ER., Forsting, M., Elsenbruch, S., transverse orientation with high resolution. 4B shows two patients with degenerative spine GUT: 2015; 64: S. 418-427 disease and visualizes tract disturbances. Between- and Within-Site Variability of fMRI Localizations Rath, Jakob, Wurnig, Moritz, Fischmeister, Florian, Klinger, Nicolaus, Hoellinger, Ilse, Geissler, Alexander, Aichhorn, Markus, Foki, Thomas, Kronbichler, Martin, Nickel, Janpeter, Siedentopf, Christian, Staffen, Wolfgang, Verius, Michael, Golaszewski, Stefan, Koppelstaetter, Florian, Auff, Eduard, Felber, Stephan, Seitz, Ruediger J., Beisteiner, Roland, HUMAN BRAIN MAPPING: 2016; 37: S. 2151-2160 DTI of Spinal Cord Dual Energy CT for Artefact Reduction Residual Thrombembolic Material in Cerebral Arteries after led by Ass.-Prof. Dr. Cartes-Zumelzu; in Patients with Cranial and Spinal Endovascular Stroke Therapy Can Be Identified by Dual-Energy CT A.E. Grams, M. Knoflach, R. Rehwald, J. Willeit, M. Sojer, E.R. Gizewski and B. Radiology: Dr. Kremser in c­­ooperation with ­Implants Glodny, Prof. Thomé, Prof. Feuchner, Prof. ­Granata, led by Ass.-Prof. Grams; NR: Prof. Gizewski, AMERICAN JOURNAL OF NEURORADIOLOGY: 2015; 36: S.1413-1418 PD Dr. Broessner and ­ Dr. Kurz, in cooperation with Ass.-Prof. Selected Funding Siemens Medical Imaging Glodny, Prof. Ortler, Prof. Crismani • Characterization of brain metabolism in ischemic stroke with DTI is well established for analysis of white DECT also offers the opportunity to reduce MR spectroscopy of phosphorous compounds, ÖNB, Dr. Grams matter and brain structure. However, this beam-hardening artefacts from metal im- • As Co-investigator: Myocardial MRS correlates of cardiac sym- pathetic Denervation in PD, FWF, Prof. Wenning and: Clinical method might also be helpful in spinal im- plants by extrapolation of monochromatic Neuroimaging / Neuroimage WING, BMWFS, Prof. Scherfler aging, especially in degenerative diseases. (MC) series. This method is being applied in • „Emotionserkennung und soziale Kognition bei JME Patienten“, However, it offers many challenges. The se- patients with cerebral clips, dentogenic and FWF, PI Prof. Trinka quence used is influenced by many anatom- spinal implants. The aim of these studies is Collaborations ical structures which cause artefacts, and to evaluate the presence of artefacts and to • Austria: NEUROIMAGE WING (BMWFW grand: pooled MRI data it also has limited resolution. This project assess the surrounding tissue, in compari- collection and analysis Med. Universities Innsbruck, Graz, Wien successfully optimized the sequence and son to conventional computed tomography. (Neurology and Neuroradiology, 7T MRI), MCI Innsbruck • Germany: University Hospital Essen (Medical Psychology & then started the study of the first patients Behavioural Immunobiology, Forensic Psychiatry, Neurology, showing degenerative cervical changes with Methods of Quantifying Supra-Aortal Neurosurgery, Radiology), Erwin L. Hahn Institut Essen, DKFZ Heidelberg/MR-Imaging, Justus-Liebig University narrowing of the spinal canal (Fig. 4). and Intracranial Artery Calcifications Giessen (Neurology, Neuroradiology, Neuropediatrics), led by Ass.-Prof. Grams; NR: Dr. Steinkohl, University Marburg (Neurology), LMU Munich and Technical University Dresden (Neuroradiology), University Hamburg Dual Energy CT in Stroke Patients in cooperation Ass.-Prof.­ PD Glodny, PD Dr. (Neuroradiology), Goethe University Frankfurt (Neuroradiology), led by Ass.-Prof. Grams; NR: Dr. Kurz in Beer, PD Dr. Helbok, Prof. Ortler and Dr. Julia University Tübingen (Psychosomatic Medicine) cooperation Prof. Poewe, Ass.-Prof. ­Glodny, Kerschbaum • Switzerland: Hirslanden Clinic Zürich, Neuroradiology Prof. Willeit, Dr. Knoflach, and Prof. Ortler A method developed in our department to Core Facilities Dual energy computed tomography (DECT) quantify aortal calcification is being applied Neuroimaging Research Core Facility (3T MRI) can distinguish up to three different materi- to examine the supra-aortal and intracranial als or tissues. Various projects are investigat- arteries. The amount of calcification will be ing the differentiation of blood-brain-barrier correlated with the incidence of intracranial disruption, haemorrhage, thromboembolic aneurysms or cerebral vasospasm after a material, and infarcted and healthy brain, subarachnoid haemorrhage. and are correlating them with conventional CT.

Research Report 2016 Medical University of Innsbruck 173 Center of Dentistry and CMF-Surgery Prosthodontics, Restorative Dentistry and Periodontology

comprises theoretical lectures and practical while allowing substance-preserving tooth training on phantom models, as well as su- preparations. Both ceramic and composite pervised patient treatment. The Innsbruck materials are bonded to the tooth struc- dental education uses the “integrative ther- tures using adhesive techniques. While apeutical concept”, which teaches the stu- composite materials are bonded directly dents how to perform a full dental treatment, onto dentin or enamel, dental all-ceramic including oral hygiene instruction, restora- restorations are fixed by using resin ce- tive treatment and, when necessary, prost- ments. Many of the currently available resin hodontic rehabilitation on each patient. cements are dual-curing. This means that Our main goal is to teach evidence-based they consist of a light curing and a self-cur- dentistry in a close supervisory relationship. ing component. Insufficiently cured cement causes clinical failure due to disintegration Besides educating dental students, the over time. Our studies have found that that University Hospital for Dental Prosthetics the self-curing component of dual-curing and Restorative Dentistry has also devel- resin cements is not able to fully cure the oped, and currently provides, the Austrian cement on its own. As a consequence, we admissions test for dental medicine (MED- have investigated the influence of light AT-Z test), which is used as access limita- absorption caused by ceramic thickness Director: tion to all Austrian public dental schools. and opacity on the cement curing degree. Univ.-Prof.in DDr.in Ingrid Grunert For degree thesis and research, the de- Further pursuing this approach, we have partment also owns research laboratories also investigated the influence of differ- Contact: well-equipped for in-vitro testing of dental ent light-curing protocols on the bonding Anichstraße 35 materials. Particularly our research and strength of different composite resins to 6020 Innsbruck clinical expertise on dental ceramics are of human dentin using push-out tests in a international standing, and our publications universal testing machine, during which [email protected] on this topic have a high citation index. a steadily increasing load is applied onto Phone: +43 512 504 27159 the bonded composite (figure 1C).The test Fax: +43 512 504 27157 Research results showed that the bonding strength www.zmk-innsbruck.at between composite resin and dentin is sub- Dental Ceramics, Composite Filling stantially influenced by the intensity of the Materials and Adhesive Systems curing light, whereas the use of different ad- René Steiner, Mathias Keller, hesive systems does not have a significant Research Branch (ÖSTAT Classification) Herbert Dumfahrt influence. The same experimental setting Dental ceramic and composite restora- was used to evaluate the bonding strengths 302088, 302029 tions have become an indispensable part of different composite types to dentin. A of modern dentistry, as they satisfy the pa- particular focus was set on so-called bulk- Keywords tient’s demand for aesthetic restorations fill composites, which allow the treatment

Dental ceramics, composite materials, adhesive technique, CAD/CAM dentistry, dental implants, removable complete dentures, periodontitis, rare diseases

Research Focus

• Dental ceramics • Composite filling materials and adhesive systems • CAD/CAM dentistry • Rare diseases with oral phenotypes

General Facts

The University Hospital for Dental Prosthet- ics and Restorative Dentistry is part of the Department of Dental and Oral Medicine and Cranio-Maxillofacial and Oral Surgery. Fig. 1: (A) Indentation deepness of a diamond tip on dual-curing resin cements as criterion for hardness, tested by a Micro-Vickers-Hardness tester. (Incident light microscopic Our main focus is the education and training image; ×400 magnification); (B) Scanning electron micrographs of dental ceramic, of pre-doctoral students. Currently, about comparing roughened and polished ceramic surfaces (Representative micrographs; ×1000 80% of the dental curriculum is covered magnification); (C) Push-out procedure applying a steadily increasing load until detachment by our department. The student education of the composite core, tested in a universal testing machine.

174 Research Report 2016 Medical University of Innsbruck Prosthodontics, Restorative Dentistry and Periodontology

of up to 4 mm deep cavities in one clinical group has developed a protocol enabling ter-Tönz syndrome. Clinical and histological step. Contrary to the expectations, the bulk- the automatized, objective evaluation of evaluation of teeth identified distinct differ- fill composites did not achieve satisfacto- practical performances, which replaces the ences between Kohlschütter-Tönz syndrome ry bonding strength values, while flowable less reproducible subjective evaluations. caused by different mutations. In Jeune as- composite resins, surprisingly, performed Three master thesis supervised by members phyxiating syndrome, molar-incisor-malfor- best. The frequently used universal compos- of the CAD/CAM research group have been mation was linked to ciliary dysfunction due ites achieved satisfactory bonding strength awarded with the “VTZ-Preis“, one gradu- to mutations in TCTEX1D2 for the first time. values. Our results indicate that flowable ate’s presentation on the topic of removable composite may be the most favourable ma- CAD/CAM dentures has won the Austrian terial for restorations submitted to no or Dental Award for the best oral presentation Selected Publications only minimal occlusal stress. Bulk-fill com- 2016, and in 2015 the project on the evalua- Periodontal Ehlers-Danlos Syndrome Is Caused by Mutations posites, on the other hand, should only be tion of material-specific properties of CAD/ in C1R and C1S, which Encode Subcomponents C1r and C1s of Complement used with some reservations, as sufficient CAM fabricated dentures has been award- Kapferer-Seebacher, Ines, Pepin, Melanie, Werner, Roland, Aitman, long-term durability may not be guaranteed. ed the with the “ODV Wissenschaftspreis”. Timothy J., Nordgren, Ann, Stoiber, Heribert, Thielens, Nicole, Gaboriaud, Christine, Amberger, Albert, Schossig, Anna, Gruber, Robert, Giunta, Cecilia, Bamshad, Michael, Bjorck, Erik, Chen, CAD/CAM Dentistry Future Goals: Christina, Chitayat, David, Dorschner, Michael, Schmitt-Egenolf, Marcus, Hale, Christopher J., Hanna, David, Hennies, Hans PI: Patricia-Anca Steinmassl; Besides further pursuing ongoing projects, Christian, Heiss-Kisielewsky, Irene, Lindstrand, Anna, Lundberg, Researchers: Raphael Antretter, David the CAD/CAM research group works on in- Pernilla, Mitchell, Anna L., Nickerson, Deborah A., Reinstein, Eyal, Rohrbach, Marianne, Romani, Nikolaus, Schmuth, Matthias, Juranek, Florian Klaunzer, Lukas Ruech; tegrating digital dentistry into student edu- Silver, Rachel, Taylan, Fulya, Vandersteen, Anthony, Vandrovcova, Senior Investigators: Herbert Dumfahrt, cation. A step-by-step plan for familiarising Jana, Weerakkody, Ruwan, Yang, Margaret, Pope, F. Michael, Byers, Peter H., Zschocke, Johannes, Mol Basis Periodontal EDS Ingrid Grunert; the students with the new, computer-based Consorti, Aleck, K., Banki, Z., Dudas, J., Dumfahrt, H., Haririan, Computer aided design and computer aid- processes is currently being developed. H., Hartsfield, JK., Kagen, CN., Lindert, U., Meitinger, T., Posch, W., Pritz, C., Ross, D., Schroer, RJ., Wick, G., Wildin, R., Wilflingseder, ed manufacturing (CAD/CAM) gains in- D., creasing importance in dentistry. Digital Hereditary Diseases with Oral AMERICAN JOURNAL OF HUMAN GENETICS: 2016; 99: S. 1005- impression taking can reduce treatment Phenotypes 1014 expenditure and increase patient comfort. Ines Kapferer-Seebacher, Irene Heiss- Shortcomings of prosthodontic rehabilitation of patients living in long-term care facilities Digitally designed and manufactured fixed Kisielewsky, Dagmar Schnabl Steinmassl, P. -A., Steinmassl, O., Kraus, G., Dumfahrt, H., and removable prosthodontic restorations Molecular investigations of rare Mendelian Grunert, I. ., have a high degree of precision, as well as forms of diseases contribute to our under- JOURNAL OF ORAL REHABILITATION: 2016; 43: S. 286-290 production-specific material advantages. standing of gene functions and may ex- Is Cognitive Status Related to Oral Hygiene Level and Besides revolutionising patient treatment pose critical new pathways involved in the Appropriate for Determining Need for Oral Hygiene Assistance? procedures, digital dentistry also provides molecular pathogenesis of common health Steinmassl P.-A., Steinmassl O., Kraus G., Dumfahrt H., Grunert I. new option of automatizing the evalua- problems. In periodontal Ehlers-Danlos JOURNAL OF PERIODONTOLOGY: 2016; 1: S. 41-47. tion of students’ practical performance. syndrome (EDS) we have found a novel and Adjusting dental ceramics: An in vitro evaluation of the surprising link between the inflammatory ability of various ceramic polishing kits to mimic glazed dental ceramic surface The Innsbruck CAD/CAM research group classical complement pathway and con- Steiner, Rene, Beier, Ulrike S., Heiss-Kisielewsky, Irene, Engelmeier, Robert, Dumfahrt, Herbert, Dhima, Matilda, has three main focuses of high topicality: nective tissue homeostasis. Periodontal JOURNAL OF PROSTHETIC DENTISTRY: 2015; 113: S. 616-622 • CAD/CAM fabricated removable com- EDS is a specific subtype of EDS, a group plete dentures of rare connective tissue diseases. As part Selected Fundings

• CAD/CAM fabricated fixed prosthodon- of an international collaboration, we delin- • Functional implications of C1r and C1s proteases alterations tics eated the spectrum of clinical features of identified in patients with Ehlers-Danlos syndrome periodontal- type • Digital evaluation of students’ practical periodontal EDS in 19 independent families • Fonds zur Förderung der wissenschaftlichen Forschung, FWF performance comprising 107 affected individuals. We • I.Kapferer-Seebacher together with Johannes Zschocke (Division of Human Genetics, MUI) and Heribert Stiober further determined that periodontal EDS is (Division of Virology); Major Achievements: caused by gain of function mutations of the The Innsbruck CAD/CAM research group has complement 1 subunits C1r and C1s and Collaborations provided first evidences on material-prop- provided data on the possible pathomech- • Poliklinik für Zahnärztliche Prothetik, Ludwig-Maximlilians- Universität München, Munich, Germany erties of CAD/CAM fabricated denture anism. To further elucidate this new link • Institute of Analytical Chemistry and Radiochemistry, University bases. The clinically highly relevant results between the inflammatory classical com- of Innsbruck, CCB, Innsbruck, Austria • Swarovski Research and Development Department, Wattens, show that CAD/CAM dentures have more plement pathway and connective tissue ho- Austria favourable surface properties and a higher meostasis, a FWF grant has been awarded. • Dr. Christine Gaboriaud and Dr. Nicole Thielens, Groupe IRPAS (Immune response to pathogens and altered self), Institut de precision of fit than conventionally fabricat- In 2016, a joint consultation for hereditary Biologie Structurale, Grenoble, France ed dentures, but do not release less MMA diseases with dental and /or dermatological • Prof. Dr. Adrian Lussi und Prof.Dr. Dieter Bosshard, monomer. Clinical evaluations will follow. phenotypes has been established in collab- Zahnmedizinische Kliniken der Universität Bern, Bern, Schweiz Our studies involving intraoral scanning of oration with the Division of Human Genetics tooth preparations for fixed prosthodontic and the Department of Dermatology, Venere- restorations have shown that CAD/CAM ology and Allergology. As a consequence, fabricated restorations are very precise, clinical phenotypes and the molecular basis but are currently limited to shoulder prepa- of several rare diseases with dental pheno- rations. Chamfered preparations cannot be types have been described by our group. replicated in sufficient quality yet. In addi- For example, SLC13A5 has been described tion, the Innsbruck CAD/CAM research as second gene associated with Kohlschüt-

Research Report 2016 Medical University of Innsbruck 175 Center of Dentistry and CMF-Surgery Orthodontics

tra lab-staff exists. The research topics are mainly derived from questions of clinical relevance: impression material accuracy for palatal orthodontic mini screws, skeletal and dentoalveolar changes due to a class II correction with a non-compliance-appliance, transfer ac- curacy of two indirect bonding techniques, and Enamel surface quality after adhesive remnant removal are examples of such an approach. Many collaborations were initiat- Fig. 1: Mini Screws inserted in the palate of ed inside the campus in Innsbruck: Institute a cadaver before impression with different of Anatomy, University Clinic of Cranio-, materials ­Maxillofacial and Oral Surgery, University Clinic of Radiology etc. For outside collabo- clinicians, a biphasic PVS impression with rations and core facilities see below. intraoral light body and heavy body appli- cation in tray should be used (putty-wash), Research due to the combination of setting times. The Director: most cost-effective version, alginate, can be Univ.-Prof. Dr. Adriano Crismani Impression Material Accuracy for used if consequences of stronger deviations Palatal Orthodontic Mini Screws can be handled. If sterilisation is necessary, Contact: Adriano Crismani as in highly infectious patients, alginate Anichstraße 35, MZA With current model scanners, dental casts should not be used. Caution is advised with 6020 Innsbruck and similar objects can be easily compared polyether if undercuts are present. in 3D reference programs. Orthodontic mini [email protected] screws have become an important tool in Skeletal and Dentoalveolar Changes Phone: +43 512 504 27194 orthodontic practice. This study investi- due to a Class II Correction with the Fax: +43 512 504 27199 gates the accuracy of abutment transfer BioBiteCorrector®: a Retrospective www.zmk-innsbruck.at/ with current impression materials and tries Radiological Study Kieferorthopaedie.9.0.html to give a compact overview with other fac- Johanna Schmid tors relevant to permit an informed decision Orthodontics deals with diagnosis, pre- for the optimal impression for this treat- vention and treatment of malpositions of Research Branch (ÖSTAT Classification) ment method. 96 impressions of a cadav- teeth or jaw in the stomatognathic system. er head with two orthodontic mini screws Class-II-malocclusion, also called distal oc- 302033, 302034, 302044, in place were taken with four impression clusion, represents the largest amount of 302073, 211904 materials: Alginate (Palgat™ Plus), a mono- dysgnathia. The BioBiteCorrector® (BBC®) phasic polyvinylsiloxane (Imprint™4 Pre- is an intermaxillary non-compliance-class- Keywords liminary), a biphasic polyvinylsiloxane (Im- II-device, screwed onto a multi-bracket ap- print™4 Penta™ Putty and Imprint™ 4 light) pliance and causing a direct advancement Skeletal anchorage, bio-functionalisation, and a polyether (Impregum™ Penta) by two of the mandible into the neutral occlusion. adhesives and debonding, dental agenesis, observers (experienced, inexperienced) and Developed according to the functional prin- 3D-printers, non-compliance class-II- in two methods of application (application ciple of the classic Herbst Appliance, it is appliances, indirect bonding in a perforated metal tray with or without made up of two triple telescopes and can local application near transfer caps). Af- be individually adjusted by using distance Research Focus ter pouring with a standard type IV stone spacers. The aim of this retrospective study (silky rock yellow) and abutment transfer, all was to identify the skeletal and dentoalve- The investigation of different removal pa- models and the upper jaw (which had been olar effects of a class-II-malocclusion-treat- rameters by a confocal microscope with re- separated from the head) were scanned ment, using the BBC® and investigate its gard to surface homogeneity, e.g. abrasive in a standard model scanner (Zirkonzahn effectiveness, compared to the non-compli- polisher and rotational speed. S600 ARTI) and evaluated in a CAD-pro- ance class-II-device of Herbst. In each case, The investigation of transfer accuracy of dif- gram (GOM-Inspect). The deviations meas- two lateral cephalometric radiographs of ferent indirect bonding methods by means ured in 6 points per screw and statistically 36 patients were analysed by two different of scans and 3D-inspection software. evaluated with SPSS®. Optimal values were clinicians. The first x-ray represents the ini- The investigation of abutment transfer with obtained with the biphasic PVS. Observer tial situation, before starting treatment with impression materials when using palatal an- experience showed no effect, the method BBC®. The second one was taken after re- chorage by means of scans and 3D-inspec- of application showed a minor effect on ac- moval of the whole multi-bracket-appliance. tion software. curacy. Within the limitations of this study, The patients had a mean age of 14.5 years it seems all impression materials are suited when the first x-ray was taken, they wore General Facts for mini screw abutment transfer, if means the BBC® 6.1 months on average. The ra- of intraoral adaptation of the orthodontic tio of male to female patients was 17:19. The University Clinic of Orthodontics con- appliance can be performed. If higher ac- A total of sixteen parameters were used for sists of the head and two residents. No ex- curacy is needed and for inexperienced cephalometric analysis, inter alia ANB, Wits,

176 Research Report 2016 Medical University of Innsbruck Orthodontics

fixed on working models. Transfer trays are tive statistics were used for data analysis. then built on these models. After that, the Data significance was determined with the brackets can be transferred to the patient’s Mann-Whitney U test. The black 3M Sof-Lex­ mouth. There are several different meth- disc showed the lowest variance of Sa. De- ods and materials for the manufacturing creasing the speed of the Komet H22ALGK of these trays. The aim of this in vitro study bur from 120,000 to 40,000 rpm increased was the measurement and comparison of the variance of Sa. The distribution of the the transfer accuracy of two different indi- root mean square of profile deviation Sq rect bonding methods. A total of 60 plas- was similar to the Sa values for all abrasive ter models (15 different models, each was instruments. The mean drag line depth Sz grouted four times) were built and then sep- showed the widest variance for untreated arated into two groups of 30 models each teeth. The black 3M Sof-Lex discs produced (15 working models, 15 patient models). On the most homogeneous, the Reliance Re- these models, a total of 30 indirect bonding new 218 the roughest enamel surfaces. Fig. 2: Example of a bracket with discrepan- trays were built, thereof 15 silicone trays Of two identical burs with different shanks cies at the 12 measuring points Bisico® S1 A+B (putty), S4 (light body) (Komet H22ALKG), the one with the higher and 15 double-vacuum forms (Bioplast® 1 speed generated smoother surfaces. mm, Duran® 0.75 mm on top). With these trays, the brackets were transferred from the working models to the patients’ models. The bracket positions were scanned by us- Selected Publications ing an intraoral scanner (TRIOS®, 3Shape Behavior of osteoblasts on TI surface with two different Dental Systems, Copenhagen, Denmark) coating designed for orthodontic devices Fleischmann, Leonardo, Crismani, Adriano, Falkensammer, Frank, before and after the indirect bonding pro- Bantleon, Hans-Peter, Rausch-Fan, Xiaohui, Andrukhov, Oleh, cedure. The linear and angular discrep- JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE: ancies were then digitally determined by 2015; 26: S. 10 measuring six different dimensions: vertical Stellungnahme der Österreichischen Gesellschaft für Kief- erorthopädie zum Thema Allergien in der Kieferorthopädie (occlusogingival), horizontal (mesiodistal), Wendl, B.; Crismani, A.; Bantleon, H.-P.; Kränke, B Statement of the Austrian Orthodontic Society on the Issue of transversal (faciolingual), tip, rotation and Allergies torque. The silicone trays show lower trans- INF ORTHOD KIEFERORTHOP: 2015; 47: S. 117-121 fer discrepancy on average in all measured Betrachtung der Zahnoberfläche nach Adhäsiventfernung Fig. 3: Enamel surface quality after adhesive mit einem Konfokalmikroskop dimensions. There were obvious discrepan- Paal, B.; Unterberger, S. H.; Nahler, M.; Neururer, S.; Crismani, A.: remnant removal: a comparative confocal cy tendencies for certain directions in both Tooth Surface Appearance After Adhesive Removal Evaluation by microscopy study a Confocal Microscope methods: vertical: to the occlusal direction; INF ORTHOD KIEFERORTHOP: 2016; 48: S. 89-94 transversal: to the facial direction; torque: Gibt es dann noch Zahnbewegung? APDI and the distance of different measur- to the lingual/palatinal direction. Silicone Lauterbach D. Antiphlogistika in der Kieferorthopädie ing points to the perpendicular line to the trays have a higher precision than dou- STOMATOLOGIE 2016; 03: S. 6-9 occlusal plane drawn through sella, called ble-vacuum forms and should therefore be Schlafbezogene Atmungsstörungen aus zahnärztlicher Sicht Olp: Olp-A, Olp-Pog, Olp-Pog+Cond, Olp- preferred for indirect bonding. Schustereder B. OK1, Olp-UK1. A significant change was ob- STOMATOLOGIE 2016; 03: S. 10-12 served both in the position of Pogonion and Enamel Surface Quality after Adhesive Selected Funding point A referring to Olp. ANB, Wits and APDI Remnant Removal: a Comparative • 45.000€ for Projects at the University Clinic of Orthodontics altered significantly as well as the mandible Confocal Microscopy Study sponsored by the Austrian Society of Orthodontics length. Referring to all observed parame- Barbara Paal Collaborations ters the effect of the BBC® is in the same To assess the effects of different removal • Andrukhov O, Competence Center Periodontal Research, Medi- cal University of Vienna, Vienna, Austria range as the effect of the Herbst Appliance variables, i.e. type of abrasive polisher, ro- • Bantleon HP, Department of Orthodontics, Medical University of and thus the BBC® is classified as an ef- tational speed and cooling conditions, on Vienna, Vienna, Austria • Brenner M, Department of Orthodontics, Goethe University, fective and recommended method to treat surface homogeneity. 120 human incisors Frankfurt am Main, Germany a Class-II-malocclusion in growing patients. were polished with different carbide burs • Proff P, Department of Orthodontics, University of Regensburg, Regensburg Germany (Komet Torpedo H284, Komet H22ALGK • Wendl B, Department of Orthodontics, Medical University of Transfer Accuracy of two Indirect and Reliance Renew 218) and the black 3M Graz, Graz, Austria • Werbein H, Department of Orthodontics, University of Mainz, Bonding Techniques – an In Vitro Study Sof-Lex disc attached to the pop-on mandrel Mainz, Germany with 3D Scanned Models to remove adhesive compomer remnants. • Förster S, Forestadent Company, Pforzheim, Germany • Unterberger SH, Department of Material Technology, University Johanna Schmid Another four teeth were left untreated and of Innsbruck, Innsbruck, Austria Brackets are a main component in fixed served as controls. After polishing the sur- orthodontic appliances as they transmit faces were scanned with a confocal micro- Devices and Services • Micro-CT (University Clinic of Radiology, Innsbruck) the forces on the teeth. Their correct ini- scope. The resultant surface quality was • Extra oral scanner Zirkonzahn S600 ARTI (University Clinic of tial placement is essential for a quick and evaluated by computing the arithmetic area Orthodontics, Innsbruck) • Intraoral scanner TRIOS® (Department of Orthodontics, Go- permanent treatment success. Indirect roughness Sa, the root mean square of pro- ethe University, Frankfurt am Main) bonding is proved to be an effective meth- file deviation Sq, the average surface rough- • confocal microscope (Department of Material Technology, Uni- versity of Innsbruck) od to establish appropriate bracket posi- ness Sz, the average smoothing depth Sp • CAD-program, GOM-Inspect (University Clinic of Radiology, tions in patients. The brackets are initially and the mean drag line depth Sv. Descrip- Innsbruck)

Research Report 2016 Medical University of Innsbruck 177 Center of Dentistry and CMF-Surgery Cranio-Maxillo-Facial and Oral Surgery­

Research Branch (ÖSTAT Classification) osteosynthetic material • Smart Implants - Monitoring of osseous 302010, 302029, 302033, healing and bone remodelling in vivo. 301904, 304007 • VascuBone – Development of a tool box for tailor-made angio-inductive or Keywords Vascularized Bone implants • Dose reduction (Ultra low dose CT) in Cranio-Maxillofacial and Oral Surgery, CMF-Radiology (interdisciplinary clinical Implants, Ultra low dose CT, Biological cooperation) Surfaces, Osseointegration, Wound Healing, Tissue Engineering, Reconstructive General Facts Medicine, Nano Technology, Trauma Surgery. The consequences of Radiation Therapy in Research Focus Head and Neck Tumour Patients is a major focus of the Department of Cranio-Maxillo- • Reversing impaired healing of irradiated Facial and Oral Surgery since all aspects of bone through the use of immobilized wound healing including cellular behaviour, growth factors on nanostructured blood flow and stem cell activation are influ- Director (till 31st of May 2017): Univ.-Prof. DDr. Michael Rasse Contact: Anichstraße 35 6020 Innsbruck

[email protected] Phone: +43 512 504 24373 Fax: +43 512 504 24371

Director (interim): ao. Univ.-Prof. DDr. Wolfgang Puelacher Contact: Anichstraße 35 6020 Innsbruck Fig. 1: Histological evaluation of the bone implant contact ratio (BICR) at the osteosynthesis screws. (A) Histological overview of the locking screw in bone subjected to toluidin blue [email protected] O staining. (B) Detailed view of the osteosynthesis screw highlighting the bone contact Phone: +43 512 504 24373 areas (arrows). (C) BICR after 1, 2, 4, and 8 weeks of the 3 groups. BMP-2 immobilized Fax: +43 512 504 24371 on nano-crystalline­ diamond (green) resulted in an initial increase of BICR in the irradi- www.zmk-innsbruck.at ated bone. Despite this initial increase the BICR after 8 weeks was lower compared with ­unir­radiated bone (p ¼ .08) (blue).

178 Research Report 2016 Medical University of Innsbruck Cranio-Maxillo-Facial and Oral ­Surgery

enced by radiation. cro-CT as well as histology, demonstrated Using smart implants as a new sensing incomplete yet ongoing osseous healing as technology allows us to gain an insight into the defect was filled with both connective bone healing based on serial analysis of tissue as well as with newly formed bone. impedance spectroscopic examinations be- Furthermore, no obvious signs of inflamma- fore radiographic or histologic changes are tion were observed indicating that the im- detectable. planted biosensor is biocompatible. Our re- sults on dielectric spectroscopy may serve Reconstructive Medicine as a potential method for close continuous Reconstructive facial surgery is one focus monitoring of bone wound healing in crani- of the Department of Cranio-Maxillofacial omaxillofacial and oral surgery in the future and Oral Surgery. After ablative tumour (Fig. 2). surgery or resection of osteonecrotic and infected bone, free tissue transplants are 3) VascuBone microvascularly anastomosed for facial re- The FP7 Project Vascubone deals with the habilitation. Research is focused on the de- development of an artificial vascularized velopment of minimally invasive or artificial bone transplant for the reconstruction transplants. of large facial defects. This is achieved To achieve this goal the Department is part through the use of a construct consisting of of the FP-7 framework project “VascuBone” Fig. 2: Implantation of the biosensor and ra- a vascular bed, modified bone replacement together with a further 14 partners. The de- diological control. (A, B) Creation of a full material and mesenchymal progenitor partment is a leader in the field of preclini- thickness calvarial defect; (C) Fixed bio- cells. The vascular bed is engineered by cal trials, provides the technology for hard sensor; (D) Postoperative impedance meas- decellularicing a porcine gut segment with tissue histology and immohistochemistry urement; (E) Radiological control of sensor its supplying vascular bed and reseeding and plans and conducts animal trials. position in two planes. the vessels with endothelial progenitor cells from the future recipient. Research 2) Smart Implants: Sensors as Several animal experiments were performed Technology Asset in order to improve the common bone re- 1) Bioactive Surfaces in Cranio-Maxillo- Radiology remains the gold standard to placement material beta-tricalcium-phos- Facial and Oral Surgery show bone wound healing and osseointe- phate. The functionality of the beta TCP Implants have revolutionized patient care in gration of implants despite the fact that it surface with nanocrystalline diamonds was all fields of medicine and dentistry. Titani- provides only a snap shot of the dynamic tested in animal models. The diamond parti- um has evolved as the leading raw material bone growth and regeneration process. cles by themselves modified the wettability when treatment of bone and cartilage dis- Even histology provides only a glimpse of and cell adhesion properties of the surface eases/degeneration as well as tooth loss the activity or inactivity of osteoblasts, os- and were further shown to bind covalently necessitates osseointegration of individual- teoclasts and osteocytes in bone. or via physisorption different growth factors ized tissue replacement options. The goal of this research was to test a novel such as BMP-2 and Angiopoietin-1. The new This is mainly due to its bioinert properties. sensing technology that is based on bioim- knowledge thus acquired on functionalized Titanium implants in particular provide pedance and which in due course may al- biomaterials and cell behaviour led to the excellent results in healthy young and low the monitoring of the osseous healing application of such an artificial transplant adult patients. But the success rate of any processes in an uninterrupted manner. A for reconstructing a mandibular continuity implant is hampered if the implant site sub-critical size defect with full thickness defect in sheep. The Horizon2020 Propos- suffers from poor bone wound healing. Due was created in a rabbit calvaria that was suf- al “VascuReGenTis” has been submitted in to conditions affecting bone turnover and ficiently large to accomodate the biosensor order to test this technique in clinical trials homeostasis such as osteoporosis, age, which was mounted on a titanium mesh and (Fig. 3). radiation therapy, bisphosphonate intake, inserted into the defect. infection, severe trauma or other pathology- The mesh was then fixed to the adjacent 4) Ultralow Dose Dentomaxillofacial CT related bone changes, osseous healing at bone with micro-screws. Measurements Imaging and Iterative Reconstruction the implant site is frequently limited. To were performed every 3 or 4 days during a Techniques overcome shortcomings of bone healing period of 6 weeks and spectroscopic anal- Cone Beam Computed Tomography vs Mul- and osseointegration­ we used bioactive ysis of the sensor signals were archived tislice Computed Tomography in Comput- BMP‑2 on nano-crystalline DIAMOND (NCD) for later analyses. After 6 weeks the bone er-Aided Design/Computer-Assisted Man- coated implants based on nanotechnology defects together with the biosensor was ex- ufacture Guided Implant Surgery Based on and physisorption which is an approach planted and examined by means of micro-CT Three Dimensional Optical Scanning and that has been patented (­Steinmueller- and histology. Serial analysis of the imped- Stereolithographic Guides. Nethl D, Inventors: Steinmueller-Nethl­ D, ance spectroscopic examinations was per- Steinmueller D; Bonn G, Huck C, Najam- formed by firstly fitting the data gathered 5) Bone Regenerating Effect of Ul-Haq M, Rainer M, Stecher G; Kloss F, during defect healing to a Cole-Cole equa- ­Strontium Functionalized Implant Gassner R. Biological Surfaces. Patent tion. Thereafter the results were compiled, Surfaces Number: EP1824528 (Fig. 1). and the spectra thus obtained revealed The functionalization of implant surfaces gross changes in material densities during has gained increased attention in the last healing. Terminal analyses, by means of mi- decade due to research into implant den-

Research Report 2016 Medical University of Innsbruck 179 Center of Dentistry and CMF-Surgery

Fig. 4: Schematic illustration and histology (toluidine blue staining) of merged slides with representatives of each group. The 1500 x 1000 μm box marked scheme (a, left) indicates Fig. 3: Picture shows the mandibular con- the standard area used to evaluate new bone formation. The area of new bone formation tinuity defect bridged with reconstruction inside this box was measured for all samples and used to calculate the percentage of de plates and the microvascular anastomo- novo bone synthesis with respect to the total reference area. The side of the reference box sed artificial transplant. The magnification facing the implant surface was used to evaluate the percentage of direct bone-to-implant shows the circulation of the transplant after contact with respect to the total length of the reference. Minimal bone formation observed anastomosis (DDr. Stigler). in the Grade 4 Ti (a, right). 6.7 at.% Ti-Sr-O with a 60 minute pre-wash (b, left) and no pre- wash (b right) showed increased bone formation. A higher amount of bone apposition could be observed for the 8.9 at.% Ti-Sr-O with a 60 minute pre-wash (c, left) and a 20 minute pre- tistry. A lot of different approaches directed wash (c, right). The implant bodies are not shown to scale as these had a diameter of 1100 towards enhanced bone healing have been μm. Scale bar is 1000 μm. Data and references cited in Offermanns et al. 2014. investigated over the past couple of years and they always attempt to achieve rap- id osseointegration of titanium implants. Selected Publications How meta-analytic evidence impacts clinical decision Since strontium (Sr) is known for its ana- making in oral implantology: a Delphi opinion poll Pommer B, Becker K, Arnhart C, Fabian F, Rathe F, Stigler RG. A domestic porcine model for studying the effects of bolic and anti-catabolic effects on bone, CLINICAL ORAL IMPLANTS RESEARCH: 2016; 27: S. 282-287 radiation on head and neck cancers research has been focused on this alkaline Arnold CR, Kloss F, Singh S, Vasiljevic D, Stigler R, Auberger T, Wenzel V, Klima G, Lukas P, Lepperdinger G, Gassner R. Palatal Osseous Choristoma Sasaki R, Yamamoto T, Ando T. earth metal and its potential impact on os- ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL JOURNAL OF CRANIOFACIAL SURGERY: 2016; 27: S. E2-E4 seointegration. RADIOLOGY: 2016; Epub ahead of print: S. The objective of our studies was to investi- Biofunctionalization of scaffold material with nano-scaled Ridge augmentation in an organ transplant patient gate the performance of Ti implants with a Dalla Torre D, Burtscher D. diamond particles physisorbed with angiogenic factors INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL enhances vessel growth after implantation Schimke MM, Stigler R, Wu X, Waag T, Buschmann P, Kern Sr functionalized titanium coating (Ti-Sr-O), SURGERY: 2016; 45: S. 658-661 which exhibits a continuous release of J, Untergasser G, Rasse M, Steinmüller-Nethl D, Krueger A, Lepperdinger G. The impact of sexual behavior on oral HPV infections in strontium, with respect to osseointegration. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE: young unvaccinated adults 2016; 12: S. 823-833 The examined Ti-Sr-O coatings, prepared Dalla Torre D, Burtscher D, Soelder E, Widschwendter A, Rasse M, Puelacher W. from a magnetron co-sputtering process, CLINICAL ORAL INVESTIGATIONS: 2016; 20: S. 1551-1557 Accuracy of a flapless protocol for computer-guided differed from each other in coating thick- zygomatic implant placement in human cadavers: expectations and reality Osteoneogenesis due to periosteal elevation with ness, Sr content and Sr release charac- Schiroli G, Angiero F, Zangerl A, Benedicenti S, Ferrante F, degradable and nondegradable devices in Gottingen Widmann G. teristics and the observed increase in new Minipigs INTERNATIONAL JOURNAL OF MEDICAL ROBOTICS AND Dziewiecki D, van de Loo S, Gremse F, Kloss-Brandstätter A, Kloss COMPUTER ASSISTED SURGERY: 2016; 12: S. 102-108 bone formation was found to correlate with F, Offermanns V, Yamauchi K, Kessler P, Lethaus B. the amount of Sr released in vitro (Fig. 4). JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY: 2016; 44: S. 318-324 Kooperation von Kieferorthopädie, Kieferchirurgie The results indicate that sputtered Ti-Sr-O und Prothetik bei der umfassenden Rehabilitation von DysgnathiepatientInnen. Teil 1: Fallbeispiel Klasse-III- coatings, showing sustained release of Sr, Condylar Erosion in Patients With Chronic Malokklusion, Unterkiefer-Schaltlücken Temporomandibular Joint Arthralgia: A Cone-Beam accelerate osseointegration in healthy and Schnabl D, Brock M, Puelacher W. Computed Tomography Study SWISS DENTAL JOURNAL: 2016; 126: S. 1031-1046 osteoporotic bone plus in comparison to Emshoff R, Bertram F, Schnabl D, Stigler R, Steinmaßl O, Rudisch A. established surfaces and may thus have an JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY: 2016; 74: Kooperation von Kieferorthopädie, Kieferchirurgie impact on practical applications for medical S. 1343 und Prothetik bei der umfassenden Rehabilitation von DysgnathiepatientInnen. Teil 2: Fallbeispiel Klasse-II- implants. Malokklusion, Tiefbiss, Hypodontie Success Rate of Two-Piece Zirconia Implants: A Schnabl D, Brock M, Puelacher W. Retrospective Statistical Analysis SWISS DENTAL JOURNAL: 2016; 126: S. 1036-1052 Jank S, Hochgatterer G. Major achievements include: The produc- IMPLANT DENTISTRY: 2016; 25: S. 193-198 tion of implant surfaces with predictable Sr Shortcomings of prosthodontic rehabilitation of patients living in long-term care facilities Pain perception during debridement of hypersensitive teeth release properties; Verification of beneficial Steinmassl PA, Steinmassl O, Kraus G, Dumfahrt H, Grunert I. elicited by two ultrasonic scalers JOURNAL OF ORAL REHABILITATION: 2016; 43: S. 286-290 effects of Sr functionalized surfaces in vivo. Müller S, Huber H, Goebel G, Wimmer G, Kapferer-Seebacher I. CLINICAL ORAL INVESTIGATIONS: 2016; Epub ahead of print: S. Is Cognitive Status Related to Oral Hygiene Level and Appropriate for Determining Need for Oral Hygiene Future Goals: The evaluation of mechanical Bone regenerating effect of surface-functionalized titanium Assistance? implants with sustained-release characteristics of anchorage via push-out tests; Implementa- Steinmassl PA, Steinmassl O, Kraus G, Dumfahrt H, Grunert I. strontium in ovariectomized rats JOURNAL OF PERIODONTOLOGY: 2016; 87: S. 41-47 tion of Sr functionalized implant surfaces in Offermanns V, Andersen OZ, Riede G, Andersen IH, Almtoft KP, Sørensen S, Sillassen M, Jeppesen CS, Rasse M, Foss M, Kloss F. orthopedic and dental implantology. INTERNATIONAL JOURNAL OF NANOMEDICINE: 2016; 11: S. Do CAD/CAM dentures really release less monomer than 2431-2442 conventional dentures? Steinmassl PA, Wiedemair V, Huck C, Klaunzer F, Steinmassl O,

180 Research Report 2016 Medical University of Innsbruck Cranio-Maxillo-­Facial and Oral ­Surgery

Grunert I, Dumfahrt H. The current state of facial prosthetics - A multicenter CLINICAL ORAL INVESTIGATIONS: 2016; [Epub ahead of print]: S. analysis Thiele OC, Brom J, Dunsche A, Ehrenfeld M, Federspil P, Frerich Moving the mandible in orthognathic surgery - A multicenter B, Hölzle F, Klein M, Kreppel M, Kübler AC, Kübler NR, Kunkel M, analysis Kuttenberger J, Lauer G, Mayer B, Mohr C, Neff A, Rasse M, Reich Thiele OC, Kreppel M, Bittermann G, Bonitz L, Desmedt M, Dittes RH, Reinert S, Rothamel D, Sader R, Schliephake H, Schmelzeisen C, Dörre A, Dunsche A, Eckert AW, Ehrenfeld M, Fleiner B, Frerich R, Schramm A, Sieg P, Terheyden H, Wiltfang J, Ziegler CM, B, Gaggl A, Gerressen M, Gmelin L, Hammacher A, Haßfeld S, Mischkowski RA, Zöller JE. Heiland M, Hemprich A, Hidding J, Hölzle F, Howaldt HP, Iizuka T, JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY: 2015; 43: S. Kater W, Klein C, Klein M, Köhnke RH, Kolk A, Kübler AC, Kübler 1038-1041 NR, Kunkel M, Kuttenberger JJ, Kreusch T, Landes C, Lehner B, Mischkowski RA, Mokros S, Neff A, Nkenke E, Palm F, Paulus Comparison of the prevalence of human papilloma virus GW, Piesold JU, Rasse M, Rodemer H, Rothamel D, Rustemeyer infection in histopathologically confirmed premalignant oral J, Sader R, Scheer M, Scheffler B, Schippers C, Schliephake H, lesions and healthy oral mucosa by brush smear detection Schmelzeisen R, Schramm A, Spitzer WJ, Stoll C, Terheyden H, Dalla Torre D, Burtscher D, Edlinger M, Sölder E, Widschwendter Weingart D, Wiltfang J, Wolff KD, Ziegler CM, Zöller JE. A, Rasse M, Puelacher W. JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY: 2016; 44: S. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL 579-583 RADIOLOGY: 2015; 119: S. 333-339

Ultralow dose dentomaxillofacial CT imaging and iterative Ultralow-dose computed tomography imaging for surgery of reconstruction techniques: variability of Hounsfield units midfacial and orbital fractures using ASIR and MBIR and contrast-to-noise ratio Widmann G, Dalla Torre D, Hoermann R, Schullian P, Gassner EM, Widmann G, Bischel A, Stratis A, Kakar A, Bosmans H, Jacobs R, Bale R, Puelacher W. Gassner EM, Puelacher W, Pauwels R. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL BRITISH JOURNAL OF RADIOLOGY: 2016; 89: S. 20151055 SURGERY: 2015; 44: S. 441-446

Cone Beam Computed Tomography vs Multislice Computed Accuracy of Image-Fusion Stereolithographic Guides: Tomography in Computer-Aided Design/Computer-Assisted Mapping CT Data with Three-Dimensional Optical Surface Manufacture Guided Implant Surgery Based on Three- Scanning Dimensional Optical Scanning and Stereolithographic Widmann G, Berggren JP, Fischer B, Pichler-Dennhardt AR, Guides: Does Image Modality Matter? Schullian P, Bale R, Puelacher W. Widmann G, Fischer B, Berggren JP, Dennhardt A, Schullian P, Reto CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH: 2015; B, Puelacher W. 17: S. E736-E744 INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS: 2016; 31: S. 527-533 Ultralow-Dose CT of the Craniofacial Bone for Navigated Surgery Using Adaptive Statistical Iterative Reconstruction A prospective multicenter study to compare the precision of and Model-Based Iterative Reconstruction: 2D and 3D Image posttraumatic internal orbital reconstruction with standard Quality preformed and individualized orbital implants Widmann G, Schullian P, Gassner EM, Hoermann R, Bale R, Zimmerer R, Ellis E, Aniceto G, Schramm A, Wagner M, Grant M, Puelacher W. Cornelius C, Strong E, Rana M, Chye L, Calle A, Wilde Fm Perez AMERICAN JOURNAL OF ROENTGENOLOGY: 2015; 204: S. 563- D, Tavassol F, Bittermann G Mahoney N, Alamillos M, Basic J, 569 Dittmann J, Rasse M, Gellrich N. JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY: 2016; 44: S. Selected Funding 1485-1497 • “Strontium functionalized titanium implants”, Danish National A 7-year prospective radiographic evaluation of marginal Advanced Technology Foundation, Frank Kloss/Vincent bone level around two different implant systems: a Offermanns randomized clinical trial • EU project FP7-HEALTH project: VascuBone – Development of Burtscher D, Norer B, Torre DD, Beier U, Schubert K, Grunert I. a tool box for tailor-made angio-inductive or Vascularized Bone CLINICAL ORAL IMPLANTS RESEARCH: 2015; 26: S. 1244-1249 implants Medical University of Innsbruck/Robert Stigler (Frank Kloss), Robert Gassner, Michael Rasse Surgical treatment of mandibular condyle fractures using Consortium with 15 participating institutions/universities the retromandibular anterior transparotid approach and a triangular-positioned double miniplate osteosynthesis technique: A clinical and radiological evaluation of 124 Collaborations fractures • Interdisciplinary Nanoscience Center (iNANO), Aarhus Torre DD, Burtscher D, Widmann G, Pichler A, Rasse M, Puelacher University, Denmark W. • Danish Technological Institute (DTI), Aarhus, Denmark JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY: 2015; 43: S. • Danish National Advanced Technology Foundation, Copenhagen, 944-949 Denmark • Elos Medtech Pinol A/S, Gørløse, Denmark Validation of Next-Generation Sequencing of Entire • Department of Engineering Sciences, Applied Materials Mitochondrial Genomes and the Diversity of Mitochondrial Science, University of Uppsala, Sweden DNA Mutations in Oral Squamous Cell Carcinoma • Fraunhofer-Gesellschaft zur Förderung der angewandten Kloss-Brandstaetter A, Weissensteiner H, Erhart G, Schaefer G, Forschung e.V. Würzburg, Germany, Heike Walles Forer L, Schoenherr S, Pacher D, Seifarth C, Stoeckl A, Fendt L, • Division of Cell Biology, Salzburg, Austria, Günter Lepperdinger Sottsas I, Klocker H, Huck CW, Rasse M, Kronenberg F, Kloss FR. • DiaCoating GmbH c/o Werkstätte Wattens, 6112 Wattens, PLOS ONE: 2015; 10: S. e0135643 Austria, Doris Steinmüller-Nethl Enhanced osseointegration of endosseous implants by predictable sustained release properties of strontium Offermanns V, Andersen OZ, Falkensammer G, Andersen IH, Almtoft KP, Sorensen S, Sillassen M, Jeppesen CS, Rasse M, Foss M, Kloss F. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS: 2015; 103: S. 1099-1106

Systemic impact molds mesenchymal stromal/stem cell aging Reitinger S, Schimke M, Klepsch S, de Sneeuw S, Yani SL, Gaßner R, Ertl P, Lepperdinger G. TRANSFUSION AND APHERESIS SCIENCE: 2015; 52: S. 285-289

Release and bioactivity of bone morphogenetic protein-2 are affected by scaffold binding techniques in vitro and in vivo Suliman S, Xing Z, Wu X, Xue Y, Pedersen TO, Sun Y, Døskeland AP, Nickel J, Waag T, Lygre H, Finne-Wistrand A, Steinmüller-Nethl D, Krueger A, Mustafa K. JOURNAL OF CONTROLLED RELEASE: 2015; 197: S. 148-157

Research Report 2016 Medical University of Innsbruck 181 Center of Pediatrics Pediatrics I

Research Branch (ÖSTAT Classification) toinflammatory diseases. The complement system might be a potential biomarker for 301114, 301301, 302078, monitoring autoimmune diseases and may 202012, 202016 herald subclinical inflammation.

Keywords Inherited Metabolic Diseases/ Rare Diseases molecular genetics of rare diseases, cell The main research focus of our group is the biology, cancer biology, drug discovery, bio- biochemical characterization of known and markers, inherited metabolic disorders, me- unknown inherited metabolic diseases, in- tabolomics, breath gas analysis, hemostasi- cluding identification of new diseases. Addi- ology, diabetes in childhood (epidemiology, tionally, we have implemented methods for national diabetes registry and international investigating pathophysiology and for eval- registry comparison) uation of treatment in diagnosed patients. Inherited metabolic disorders are also part Research Focus of the project for characterization of Rare and Undiagnosed Diseases. Pediatric Gastroenterology and Head of Research Unit Hepatology Neuropediatric Diseases (until March 2017) The identification of gene defects causing The main research focus is the identifica- Univ.-Prof. Dr. Gerhard Gaedicke (†) rare gastrointestinal diseases is one of the tion of new genetic causes for neurological leading and most successful research areas diseases including epilepsy, rare channelo- of our Department. In close collaboration pathies and neuromuscular diseases. Fur- with the Section of Cell Biology we study thermore, we focus on acquired demyelinat- the functional consequences of identified ing syndromes in children, especially those gene defects in genome edited cell cultures associated with autoantibodies to myelin and intestinal organoids derived from hu- oligodendrocyte glycoprotein. man biopsies. Pediatric Diabetes Cancer Biology Epidemiology: data collection on national Our research team investigates how cell registry basis, benchmarking and quality death and metabolism in childhood malig- control between small, median and large nancies is controlled by FOXO transcription diabetes centres in Austria and Germany. factors and by Inhibitor of Apoptosis pro- International and trans-Atlantic comparison teins (XIAP and Survivin). In a translational of diabetes management in children and ad- approach we develop strategies to target olescents these death regulators with small com- Treatment: research focus on insulin pump pounds discovered by drug repositioning. treatment and continous glucose monitor- By magnetic bioprinting and 3D additive bi- ing, improvement of closed loop systems. oprinting we develop novel cell culture mod- Diabetes complications: research focus on els which resemble the 3D architecture of cardiovascular outcome parameters and normal and malignant tissue. early signs of cardiovascular complica- tions, establishing screening methods for Pediatric Hematology-Oncology early detection using IMT (intima media Our main research is focussed on optimiz- thickness) aortic stiffness and distensibility ing therapy in treatment in childhood can- measurements. cer. We focus on characteristics of cancer Genetic forms of diabetes: neonatal diabe- cells and on the underlying pathology mech- tes, hyperinsulinism in the neonate anisms in cancer biology; the knowledge Director: gained leads to the development of new Pediatric Critical Care Medicine Univ.-Prof. Dr. Thomas Müller clinical interventions. Our research focusses mainly on extracor- poreal therapies in ciritically ill children; Contact: Pediatric Rheumatology/Rare Diseases these include extracorporeal membrane Anichstraße 35 The main research focus in pediatric rheu- oxygenation (ECMO), continuous renal re- 6020 Innsbruck matology is development of biomarkers for placement therapy (CRRT) and therapeutic autoimmune diseases in infancy and ado- plasma exchange (TPE). [email protected] lescence. The complement system, part of Phone: +43 512 504 23500 innate immunity, is rather under estimated General Facts Fax: +43 512 504 25450 in the pathogenesis of autoimmune diseas- https://kinderzentrum.tirol-kliniken.at/ es. The first results of our work suggest an The molecular biology laboratory hosts the page.cfm?vpath=paediatrie-i extremely high turnover of complement in research teams of Assoc. Prof. Dr. Michael some pediatric autoimmunopathies and au- J. Ausserlechner (Cancer Biology) and As-

182 Research Report 2016 Medical University of Innsbruck Pediatrics I

soc. Prof. Dr. Andreas Janecke (Molecular the Department of Pediatrics (e.g. ped. car- detoxification and longevity in childhood Genetics) and associate groups (Priv.Doz. diology - both, for clinical collaboration as malignancies. In cooperation with partners Dr. Jürgen Brunner (Pediatric Rheumatolo- well as in scientific projects - complications from Innsbruck, Padua, Prague, Frankfurt gy) and Assoc. Prof. Dr. Roman Crazzolara screening), within the Medical University of and Canada we investigate prognostic rel- (Pediatric Hematology-Oncology) and is Innbruck (Center of blood transfusion and evance, molecular function of these master equipped with a Apotome live-cell imaging immunology, Institute of Medical Statistics, regulators of cell homeostasis and identify fluorescence microscope, luminescence Informatics, and Health Economics). Strong novel drugs by pharmacophore-based virtu- and fluorescence imaging, a flow cytome- collaborations are performed with the uni- al screening. ter, FPLC, quantitative realtime PCR, a 3D versity based diabetes centres in Austria The second focus lies on the Inhibitor of Bioprinter, a pipetting robot for drug screen- (Graz and Vienna - physical activity study, Apoptosis Proteins XIAP and Survivin that ing and a level 2 cell culture laboratory. The parietal antibody study, diabetes registry,…) are frequently overexpressed in childhood teams closely cooperate with national and and furthermore very strong collaborations cancer. These proteins inhibit cell death international partners in Europe and Cana- are established with the German diabetes either by directly binding caspases or by da. registry (DPV) and the US based diabetes reprogramming cellular metabolism (coop- registry (T1D Exchange). eration with Exp. Neonatology, Priv.Doz.Dr. The metabolic laboratory of the Department Hagenbuchner at the Department of Pedi- of Pediatrics I is sustained by Assoc. Profs. Research atrics II). We defined how Survivin regulates Drs. Sabine Scholl-Bürgi and Daniela Karall. mitochondrial structure and activity and There is a close collaboration with other Molecular genetics of congenital diarrheas: promotes glycolysis in cancer cells (War- research groups within the campus, espe- In 2015 and 2016, our Research Group burg effect). Via fluorescence polarization cially with the Department of Human Ge- (Assoc. Prof. Dr. Andreas Janecke, Assoc. screening of drug libraries we identified netics, the Breath Gas Research Group and Prof. Dr. Thomas Müller, Assoc. Prof. Dr. Pe- several repositioned drugs that efficiently Division of Biological Chemistry; as well as ter Heinz-Erian) identified mutations in the interfere with the function of IAP proteins international cooperation with mainly Euro- NHE3 and GUCY2C genes as causes of con- (XIAP) and sensitize cancer cells to chemo- pean Research Groups. genital sodium diarrhea. therapy-induced apoptosis in vitro and in vivo. A team of physicians (specialized in pedi- Cancer Biology atric endocrinology and diabetes) and spe- The main research interests of the group of Inherited Metabolic Disorders/Rare cialized nurses (diabetes educators) are Assoc.Prof.Dr. M.J. Ausserlechner are the diseases running the outpatient clinical routine ser- molecular function and regulation of FOXO The main research interests of the group vice. Collaborations are established within transcription factors that control cell death, of A.Univ-Prof.Dr. D. Karall and PD Dr. S.

Research Report 2016 Medical University of Innsbruck 183 Center of Pediatrics

Scholl-Bürgi are the inherited metabolic dis- orders propionic/methylmalonic acidemia, long-chain fatty acid oxidation disorders, and disorders of energy metabolism on the clinical, epidemiological, biochemical and molecular level. In the last years the research focussed on identification of new disorders (e.g. CoQ4, mitochondrial fission and fusion, SPENCD, PIGQ) and characteri- zation of known disorders (e.g. LCHAD de- ficiency, GLUT1-deficiency syndrome, PIGA, FBXL4, ALG8-CDG). Inherited metabolic disorders are embed- ded in the activities around the Center of Rare Diseases Innsbruck (“Zentrum für Sel- Diabetes Registries Georg F., Prokisch, Holger, Staufner, Christian, AMERICAN JOURNAL OF HUMAN GENETICS: 2016;99: S.414-422 tene Krankheiten Innsbruck”), that has co- Assoz. Prof. PD Dr. Sabine Hofer, member ordinated networking between colleagues of the scientific committee of the Austri- Reduced sodium/proton exchanger NHE3 activity causes congenital sodium diarrhea involved in clinical and research on the an/German Diabetes registry (DPV), is co- Janecke, Andreas R., Heinz-Erian, Peter, Yin, Jianyi, Petersen, Britt- campus since 2015. ordinating scientific research hypotheses Sabina, Franke, Andre, Lechner, Silvia, Fuchs, Irene, Melancon, Serge, Uhlig, Holmh H., Travis, Simon, Marinier, Evelyne, Perisic, based on data obtained from registries. Our Vojislav, Ristic, Nina, Gerner, Patrick, Booth, Ian W., Wedenoja, Pediatric Hematology-Oncology main focus since 2013 is the international Satu, Baumgartner, Nadja, Vodopiutz, Julia, Frechette-Duval, Marie-Christine, De Lafollie, Jan, Persad, Rabindranath, Warner, Studies on deletion in the 11p15.5 imprint- comparison of diabetes management and Neil, Tse, C. Ming, Sud, Karan, Zachos, Nicholas C., Sarker, ing center region in Beckwith-Wiedemann outcome parameters in children and ado- Rafiquel, Zhu, Xinjun, Muise, Aleixo M., Zimmer, Klaus-Peter, Witt, Heiko, Zoller, Heinz, Donowitz, Mark, Mueller, Thomas, patients and deletions of the KINDLIN-3 lescents of diabetes with various European HUMAN MOLECULAR GENETICS: 2015; 24: S. 6614-6623 region in patients with osteopetrosis have countries and world wide. Early Clinical Diagnosis of PC1/3 Deficiency in a Patient contributed to knowledge about the respec- With a Novel Homozygous PCSK1 Splice-Site Mutation tive diseases, pointing to possible strate- Diabetes Complications Screening Haerter, Bettina, Fuchs, Irene, Mueller, Thomas, Akbulut, Ulas Emre, Cakir, Murat, Janecke, Andreas R., gies for future Ass. Prof. PD Dr. Sabine Hofer and Univ. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION: treatment management. In ß-thalassem- Prof. Dr. Daniela Baumgartner focussed on 2016; 62: S. 577-580 ia patients progress on monitoring mixed screening for complications in children with Congenital secretory diarrhoea caused by activating chimerism after hematopoietic stem cell diabetes, testing and establishing an early germline mutations in GUCY2C Mueller, Thomas, Rasool, Insha, Heinz-Erian, Peter, Mildenberger, transplant has been proposed as a rationale non invasive method measuring aortic dis- Eva, Huelstrunk, Christian, Mueller, Andreas, Michaud, Laurent, for therapy modification, improving the lev- tensibility and stiffness - this work is ongo- Koot, Bart G. P., Ballauff, Antje, Vodopiutz, Julia, Rosipal, Stefan, Petersen, Britt-Sabina, Franke, Andre, Fuchs, Irene, Witt, Heiko, el of donor erythroid precursors. Finally, the ing. Zoller, Heinz, Janecke, Andreas R., Visweswariah, Sandhya S., report of successful hematopoietic stem GUT: 2016; 65: S. 1306-1313 cell transplants in infants with Blackfan Di- Genetic Diabetes Cargo-selective apical exocytosis in epithelial cells is amond anemia will extend the therapeutic Univ. Prof. Dr. Elisabeth Steichen and Ass. conducted by Myo5B, Slp4a, Vamp7, and Syntaxin 3 options for patients that are otherwise com- Prof. PD Dr. Sabine Hofer focussed on rare Vogel, Georg F., Klee, Katharina M. C., Janecke, Andreas R., Mueller, Thomas, Hess, Michael W., Huber, Lukas A., promised by life-threatening conditions and neonatal forms and manifestations of dia- JOURNAL OF CELL BIOLOGY: 2015; 211: S. 587-604 improve their clinical outcome. betes and hyperinsulinism. Cancer Biology

Pediatric Rheumatology/Rare Diseases Pediatric Criticial Care Medicine Nuclear FOXO3 predicts adverse clinical outcome and promotes tumor angiogenesis in neuroblastoma We focussed on the role of the complement Dr. Gerard Cortina focussed on identifi- Hagenbuchner, Judith, Rupp, Martina, Salvador, Christina, Meister, system in autoinflammatory diseases and cation of criteria influencing outcome of Bernhard, Kiechl-Kohlendorfer, Ursula, Müller, Thomas, Geiger, Kathrin, Sergi, Consolato, Obexer, Petra, Ausserlechner, Michael provide patient data to the following inter- critically ill chilrden who received extracor- J., national registries: poreal therapies such as ECMO, CRRT and ONCOTARGET: 2016; 7: S. 77591-77606 BIKER( the biological registry of the Ge- TPE, both alone or in combination. These BIRC5/Survivin as a target for glycolysis inhibition in high- sellschaft für Kinder und Jugendrheumatol- retrospective analyses were performed in stage neuroblastoma Hagenbuchner, J., Kiechl-Kohlendorfer, U., Obexer, P., ogie), EUROFEVER (registry of PRINTO for collaboration with the Department of criti- Ausserlechner, M. J., autoinflammatory disorders) cal care of the Royal Children`s Hospital in ONCOGENE: 2016; 35: S. 2052-2061

Melbourne, Australia. Targeting transcription factors by small compounds-Current Neuropediatric Diseases strategies and future implications Hagenbuchner, Judith, Ausserlechner, Michael J., Our research focusses on cooperations to Selected Publications BIOCHEMICAL PHARMACOLOGY: 2016; 107: S. 1-13 describe rare channelopathies of neurolog- Molecular Genetics/Congenital Diarrheas Mitochondrial survivin - an Achilles' heel in cancer ical diseases (Ehlers Danlos, KCNQ2-, GA- chemoresistance BRG2-, GRIN2A-mutations and Ring Chro- Biallelic IARS Mutations Cause Growth Retardation with Ausserlechner, Michael J., Hagenbuchner, Judith, mosome 18). Prenatal Onset, Intellectual Disability, Muscular Hypotonia, MOLECULAR & CELLULAR ONCOLOGY: 2016; 3: S. e1076589 and Infantile Hepatopathy Dr. Matthias Baumann focusses on cooper- Kopajtich, Robert, Murayama, Kei, Janecke, Andreas R., Haack, Pediatric Hematology-Oncology Tobias B., Breuer, Maximilian, Knisely, A. S., Harting, Inga, Ohashi, ations to describe especially Ehlers Danlos Toya, Okazaki, Yasushi, Watanabe, Daisaku, Tokuzawa, Yoshimi, Successful management of mixed chimerism after bone syndrome and acquired demyelinating syn- Kotzaeridou, Urania, Koelker, Stefan, Sauer, Sven, Carl, Matthias, marrow transplant in beta-thalassemia major Straub, Simon, Entenmann, Andreas, Gizewski, Elke, Feichtinger, Kropshofer, Gabriele, Sopper, Sieghart, Steurer, Michael, dromes in children (e.g. MOG-Ab associated Rene G., Mayr, Johannes A., Lackner, Karoline, Strom, Tim M., Schwinger, Wolfgang, Crazzolara, Roman, diseases). Meitinger, Thomas, Mueller, Thomas, Ohtake, Akira, Hoffmann, AMERICAN JOURNAL OF HEMATOLOGY: 2016; 91: S. E357-E358

184 Research Report 2016 Medical University of Innsbruck Pediatrics I

A new mutation in the KINDLIN-3 gene ablates integrin- Pediatric and Adolescent Diabetes Collaborations dependent leukocyte, platelet, and osteoclast function in a patient with leukocyte adhesion deficiency-III Obesity in Youth with Type 1 Diabetes in Germany, Austria, • Prof. Dr. Tomas Obsil, Biophysical Chemistry, Charles Crazzolara, Roman, Maurer, Kathrin, Schulze, Harald, Zieger, and the United States University, Prague, Czech Republic Barbara, Zustin, Jozef, Schulz, Ansgar S., DuBose, Stephanie N., Hermann, Julia M., Tamborlane, William • Dr. Veronica Obsilova, Institute of Physiology, Academy of PEDIATRIC BLOOD & CANCER: 2015; 62: S. 1677-1679 V., Beck, Roy W., Dost, Axel, DiMeglio, Linda A., Schwab, Karl Sciences, Prague, Czech Rep. Otfried, Holl, Reinhard W., Hofer, Sabine E., Maahs, David M., Type • Prof. Dr. Jan Vesely, Organic Chemistry, Charles University Pediatric Hemostasiology 1 Diabet Exchange Clinic, Prague, Czech Republic JOURNAL OF PEDIATRICS: 2015; 167: S. 627-+ • Prof. Dr. Consolato Sergi, Institute of Pathology, University of Ex vivo reversal of effects of rivaroxaban evaluated using Alberta, Edmonton, Canada thromboelastometry and thrombin generation assay Structural Analysis of Treatment Cycles Representing • Dr. Giampietro Viola, Department of Woman’s and Child’s Schenk, B., Wuertinger, P., Streif, W., Sturm, W., Fries, D., Bachler, Transitions between Nursing Organizational Units Inferred Health, Oncohematology laboratory, University of Padova, Italy M., from Diabetes • Prof.Dr. Franz Rödel, Department of Radiotherapy and BRITISH JOURNAL OF ANAESTHESIA: 2016; 117: S. 583-591 Dehmer, Matthias, Kurt, Zeyneb, Emmert-Streib, Frank, Them, Oncology, Goethe-University, Frankfurt am Main, Germany Christa, Schulc, Eva, Hofer, Sabine, • Prof. Dr. Ralf Rieker, Institut of Pathology, University of Predicting Transfusion Requirements During Extracorporeal PLOS ONE: 2015; 10: S. e0127152 Membrane Oxygenation Erlangen, Germany • Prof. Dr. Allan Kaasik, Department of Pharmacology, University Tauber, Helmuth, Streif, Werner, Fritz, Josef, Ott, Helmut, Weigel, Increased DNA methylation variability in type 1 diabetes of Tartu, Estonia Guenter, Loacker, Lorin, Heinz, Anneliese, Velik-Salchner, Corinna, across three immune effector cell types • Prof. Dr. Gerhard Wolber, Institute of Pharmaceutical JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA: Paul, Dirk S., Teschendorff, Andrew E., Dang, Mary A. N., Lowe, Chemistry, FU-Berlin, Germany 2016; 30: S. 692-701 Robert, Hawa, Mohammed I., Ecker, Simone, Beyan, Huriya, Cunningham, Stephanie, Fouts, Alexandra R., Ramelius, • Prof. Dr. Judith Rollinger, Pharmakognosie/Pharmazeutische Biopsychronology: A Method Using Live Tissue Staining to Anita, Burden, Frances, Farrow, Samantha, Rowlston, Sophia, Biologie, Universität Wien Image Cell Function in the Kidney Rehnstrom, Karola, Frontini, Mattia, Downes, Kate, Busche, • Dr. Suse Benseler, Childhood Arthritis and Rheumatology Ashraf, Muhammad Imtiaz, Fries, Dietmar, Streif, Werner, Aigner, Stephan, Cheung, Warren A., Ge, Bing, Simon, Marie-Michelle, Research Alliance (CARRA), Pediatric Rheumatology European Felix, Hengster, Paul, Troppmair, Jakob, Hermann, Martin, Bujold, David, Kwan, Tony, Bourque, Guillaume, Datta, Avik, Lowy, Society: BRAIN WORKS; Toronto, Canada METHODS IN MOLECULAR BIOLOGY: 2016; 1397: S. 81-90 Ernesto, Clarke, Laura, Flicek, Paul, Libertini, Emanuele, Heath, • Prof. Dr. Hans Clevers, Hubrecht Institute, Utrecht, The Simon, Gut, Marta, Gut, Ivo G., Ouwehand, Willem H., Pastinen, Netherlands Pediatric Rheumatology Tomi, Soranzo, Nicole, Hofer, Sabine E., Karges, Beate, Meissner, • Prof.Marco Gattorno, Isttituo Gaslini, University of Genova, Thomas, Boehm, Bernhard O., Cilio, Corrado, Larsson, Helena Italy. Tick-borne encephalitis in a child with previous history of Elding, Lernmark, Ake, Steck, Andrea K., Rakyan, Vardhman K., • Prof. Zoltan Prohaska of Immunology, Semmelweis University, completed primary vaccination Beck, Stephan, Leslie, R. David, 3rd Department of Medicine, Research Laboratory.Budapest Zlamy, Manuela, Haberlandt, Edda, Brunner, Juergen, Dozcy, NATURE COMMUNICATIONS: 2016; 7: S. 13555 Ungarn Ludwig, Rostasy, Kevin, • Prof. Dr. Dirk Foell, Münster:, Klinik für Pädiatrische PEDIATRICS INTERNATIONAL: 2016; 58: S. 56-58 International Comparison of Smoking and Metabolic Control Rheumatologie und Immunologie, Münster, Germany in Patients With Type 1 Diabetes • Prof. Peter Haas, Deutsches Zentrum für Kinder- und A novel therapeutic approach for LPIN1 mutation-associated Hofer, Sabine E., Miller, Kellee, Hermann, Julia M., DeSalvo, Daniel Jugendrheumatologie, Garmisch-Partenkirchen, Germany rhabdomyolysisThe Austrian experience J., Riedl, Michaela, Hirsch, Irl B., Karges, Wolfram, Beck, Royw., • Prof. Dr. Wolfgang Sperl, Assoc. Prof. Dr. Johannes A. Mayr, Pichler, Karin, Scholl-Buergi, Sabine, Birnbacher, Robert, Holl, ReinhardW., Maahs, David M., DPV Initiative, T1D Exchange Mitocenter, University Children´s Hospital Salzburg Freilinger, Michael, Straub, Simon, Brunner, Juergen, Zschocke, Clinic Network, • Prof. Dr. Holger Prokisch, mitoNET (Network for diagnosis Johannes, Bittner, Reginald E., Karall, Daniela, DIABETES CARE: 2016; 39: S. E177-E178 and therapy in mitochondrial diseases), Helmholtz Institute, MUSCLE & NERVE: 2015; 52: S. 437-439 München, Germany Pediatric Critical Care Medicine • Prof. Dr. Stefan Kölker, EIMD (European Network for Feasibility of Ultrasound-Guided Sacroiliac Joint Injections Intoxication Type Metabolic Disorders), Medical University of in Children Presenting with Sacroiliitis De novo tacrolimus-induced thrombotic microangiopathy Heidelberg, Germany Klauser, A. S., Sailer-Hoeck, M., Abdellah, M. M. H., Taljanovic, M. in the early stage after renal transplantation successfully • Assoc. Prof. Dr. Martina Huemer, EHOD (European Network S., Siedentopf, C., Auer, T., Brunner, J., Jaschke, W. R., treated with conversion to everolimus for Homocystinurias and Remethylation Defects), University ULTRASCHALL IN DER MEDIZIN: 2016; 37: S. 389-394 Cortina, Gerard, Trojer, Raphaela, Waldegger, Siegfried, Children´s Hospital Zürich, Switzerland Schneeberger, Stefan, Gut, Nadezda, Hofer, Johannes, • Prof. Dr. Thomas Obladen, iNTD (International Neurotransmitter Inherited Metabolic Disorders PEDIATRIC NEPHROLOGY: 2015; 30: S. 693-697 Disease Network), Medical University of Heidelberg, Germany • Prof. Dr. Matthias R. Baumgartner, MMA-PA (methlymalonic Clinical outcome, biochemical and therapeutic follow-up in Clonidine as a First-Line Sedative Agent After Neonatal and propionic acidemias) guideline group, University 14 Austrian patients with Long-Chain 3-Hydroxy Acyl CoA Cardiac Surgery: Retrospective Cohort Study Children´s Hospital Zürich, Switzerland Dehydrogenase Deficiency (LCHADD) Kleiber, Niina, de Wildt, Saskia N., Cortina, Gerard, Clifford, • Prof. Dr. Johnnes Häberle, UCD (urea cycle disorders) guideline Karall, Daniela, Brunner-Krainz, Michaela, Kogelnig, Katharina, Michael, Ducruet, Thierry, Tibboel, Dick, Millar, Johnny, group, University Children´s Hospital Zürich, Switzerland Konstantopoulou, Vassiliki, Maier, Esther M., Moeslinger, PEDIATRIC CRITICAL CARE MEDICINE: 2016; 17: S. 332-341 • Prof. Dr. Ron Wevers, Dr. Dirk J. Lefeber, University Children´s Dorothea, Plecko, Barbara, Sperl, Wolfgang, Volkmar, Barbara, Hospital Nijmegen, The Netherlands Scholl-Buergi, Sabine, Pediatric Neurology • Assoc. Prof. Dr. Dorothea Möslinger, for the Austrian Metabolic ORPHANET JOURNAL OF RARE DISEASES: 2015; 10: S. 21 Group, University Children´s Hospital Vienna Clinical and neuroradiological differences of paediatric • Prof. Dr. M. Feucht, Universitiy Children´s Hospital Vienna, COQ4 Mutations Cause a Broad Spectrum of Mitochondrial acute disseminating encephalomyelitis with and without Austria. Disorders Associated with CoQ(10) Deficiency antibodies to the myelin oligodendrocyte glycoprotein • PD. Dr. T. Bast, Epilepsiezentrum Kork, Kehl-Kork Germany. Brea-Calvo, Gloria, Haack, Tobias B., Karall, Daniela, Ohtake, Baumann, M., Sahin, K., Lechner, C., Hennes, E. M., Schanda, K., • PD Dr. G. Kluger, University Hospital Salzburg, Austria. Akira, Invernizzi, Federica, Carrozzo, Rosalba, Kremer, Laura, Dusi, Mader, S., Karenfort, M., Selch, C., Haeusler, M., Eisenkoelbl, A., • Prof. Dr. J. Hardwick, John Hopkins Medicine, University Sabrina, Fauth, Christine, Scholl-Buergi, Sabine, Graf, Elisabeth, Salandin, M., Gruber-Sedlmayr, U., Blaschek, A., Kraus, V., Leiz, S., Baltimore, USA, Pharmacology and Molecular Sciences. Ahting, Uwe, Resta, Nicoletta, Laforgia, Nicola, Verrigni, Daniela, Finsterwalder, J., Gotwald, T., Kuchukhidze, G., Berger, T., Reindl, • PD Dr. Peter Borusiak, Pädiatrie Wuppertal, Universitätsklinik Okazaki, Yasushi, Kohda, Masakazu, Martinelli, Diego, Freisinger, M., Rostasy, K., Köln Peter, Strom, Tim M., Meitinger, Thomas, Lamperti, Costanza, JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY: • Univ. Prof. Birgit Rami, Department of Pediatrics, Medical Lacson, Atilano, Navas, Placido, Mayr, Johannes A., Bertini, Enrico, 2015; 86: S. 265-272 Murayama, Kei, Zeviani, Massimo, Prokisch, Holger, Ghezzi, University of Vienna, Austria Daniele, • PD Dr. Elke Fröhlich-Reiterer, Department of Pediatrics, Children with multiphasic disseminated encephalomyelitis AMERICAN JOURNAL OF HUMAN GENETICS: 2015; 96: S. 309- Medical University of Graz, Austria and antibodies to the myelin oligodendrocyte glycoprotein 317 • Prof. Reinhard Holl, Institute of Epidemiology and medical (MOG): Extending the spectrum of MOG antibody positive Biometry, University of Ulm, Germany diseases Ketogenic diets in patients with inherited metabolic • PD Dr. Klemens Raile, Department of Pediatrics, Virchow Baumann, Matthias, Hennes, Eva-Maria, Schanda, Kathrin, Clinic, Charite Berlin, Germany disorders Karenfort, Michael, Kornek, Barbara, Seidl, Rainer, Diepold, Scholl-Buergi, S., Hoeller, A., Pichler, K., Michel, M., Haberlandt, • Prof. Dr. Sian Ellard, Division of Human Genetics, University of Katharina, Lauffer, Heinz, Marquardt, Iris, Strautmanis, Jurgis, Southampton, U.K. E., Karall, D., Syrbe, Steffen, Vieker, Silvia, Hoeftberger, Romana, Reindl, • Prof. Dr. Justin T Warner, Children’s Hospital for Wales, Cardiff, JOURNAL OF INHERITED METABOLIC DISEASE: 2015; 38: S. 765- Markus, Rostasy, Kevin, U.K. on behalf of the National Diabetes audit and the Royal 773 MULTIPLE SCLEROSIS JOURNAL: 2016; 22: S. 1821-1829 College of Paediatrics and Child Health Clinical phenotype, biochemical profile, and treatment in 19 • Prof. Dr. Kim Donaghue and Prof. Maria Craig, Department patients with arginase 1 deficiency Selected Funding of Pediatrics, Childrens Hospital at Westmead, University of Huemer, Martina, Carvalho, Daniel R., Brum, Jaime M., Unal, Sydney, Australia Ozlem, Coskun, Turgay, Weisfeld-Adams, James D., Schrager, Nina • “Mutations in primary intestinal lymphangiectasia”, ÖNB Nr. • Prof. Dr. Gerd Horneff, Asklepios Kliniken St. Augustin.BIKE: L., Scholl-Buergi, Sabine, Schlune, Andrea, Donner, Markus G., 16678 Thomas Müller, 2016 (total: 150 000 €) Biological registry, Germany Hersberger, Martin, Gemperle, Claudio, Riesner, Brunhilde, Ulmer, • „Hemmung der FOXO3-DNA Interaktion durch kleinmolekulare • Prof. Dr Warwick Butt. Department of critical care medicine. Hanno, Haeberle, Johannes, Karall, Daniela, Inhibitoren“, FWF Joint International Project (Austria – Czech The Royal Children´s Hospital, Melbourne, Australia JOURNAL OF INHERITED METABOLIC DISEASE: 2016; 39: S. 331- Republic), M.J. Ausserlechner (total: 586.955 €) • PD Dr.Marianne Rohrbach, University Children´s Hospital 340 • Horizon 2020 call for Project (KidsAP) for the next 4 years Zürich, Switzerland (2017-2020) (total: 400.000 €) • Dr. Cecilia Giunta, University Children´s Hospital Zürich, Switzerland

Research Report 2016 Medical University of Innsbruck 185 Center of Pediatrics Pediatrics II

General Facts Research

The Department of Neonatology at the Neonatal Neuroscience - Clinical and Medical University of Innsbruck is a per- Experimental Research Groups inatal centre with the highest level of Elke Griesmaier, Vera Neubauer, care. It offers care for all very preterm Anna Posod, Karina Wegleiter, Karina and critically ill neonates in Tyrol and of- Wechselberger, Marlene Biermayr, Ulrike fers a standardized follow-up programme Pupp Peglow, Ursula Kiechl-Kohlendorfer until these children reach school-age. Neonatal brain injury is a major cause of Researchers in the Department of Neona- infant mortality and morbidity and thus a tology focus on both clinical and basic sci- problem of great global and national con- ence (www.neonatal-research.at) with the cern. In industrialized Western countries, aim of improving the survival and long-term the most common cause of neonatal brain outcome of neonates. Clinical research in- injury is prematurity. During the last years, cludes the characterization of neurodevel- improvements in neonatal intensive care opmental and cardiovascular outcome of medicine have decreased preterm infant very preterm infants until school-age and mortality. However, infants born prema- the definition of risk predictors for adverse turely remain at high risk of neurodevelop- Director: outcome. mental delay and lifelong handicap. To date, Univ.-Prof.in Dr.in Ursula This encompasses multimodal monitoring causal therapeutic strategies for neonatal Kiechl-Kohlendorfer of the neonatal brain (aEEG, MRI), the eval- brain injury are not available. Clinical man- uation of the role of nutrition/growth and agement is based on an optimization of per- Contact: research on the optimization of perinatal inatal care and supportive measurements Anichstraße 35 resuscitation. The department also focuses and on identifying infants at high risk for 6020 Innsbruck on risk factors for and prevention of sudden adverse neonatal outcome. infant death syndrome (SIDS). [email protected] Clinical Research Projects Phone: +43 512 504 27307 The basic research programme is dedicat- Evaluation of Preterm Brain Fax: +43 512 504 27308 ed to identifying mechanisms of neuropro- Development and Outcome Prediction https://kinderzentrum.tirol-kliniken.at/ tection in perinatal brain injury models and For the preterm infant, the provision of diag- page.cfm?vpath=paediatrie-ii aims at assessing new therapeutic strat- nostic measurements of brain compromise egies. In addition, the department partici- is of high priority in order to minimize the pates in a world-wide quality improvement risk of developmental impairment. Reliable Research Branch (ÖSTAT Classification) collaboration - the Vermont Oxford network tools for early prediction of outcome are - with the aim of following key neonatal out- needed in order to provide the best care 302049, 301401, 302060 comes and thereby continuously improving and support available. Amplitude integrated patient care. There are close national and electroencephalography (aEEG) is used to Keywords international collaborations with other per- monitor the functional status of the brain inatal centres and with the local neurosci- and to observe maturational changes during preterm infants, neonatal neuroscience, ence and cardiovascular science group. extrauterine development. developmental outcome, cardiovascular risk, sudden infant death syndrome, neuro- Magnetic resonance imaging (MRI) gives protection, sigma-1 receptor ligands, mito- detailed information about brain develop- chondrial metabolism, FOXO3, apoptosis ment, cortical folding and myelination (Fig. 1). General movements (GM) are part of the Research Focus spontaneous movement repertoire of new- born infants. The presence of GM, quality • Characterization of risk predictors for ad- and intensity are a marker of central nerv- verse outcome of preterm infants ous system integrity. Our group investigates • Monitoring of the preterm brain (aEEG, the value of these three methods (aEEG, GM MRI) and MRI) to predict neurological outcome in • Investigation of effects of prematurity, ne- preterm infants. onatal growth and feeding practices (fo- cus on human milk) on cardiovascular risk Neurodevelopmental Follow-Up of Very factors and neurodevelopmental outcome Preterm Infants • Development of substances for neuropro- Children born preterm are at risk for neu- tection and treatment of perinatal brain rodevelopmental delay or disorder. There- injury fore, regular follow-up visits are important • Role of anti-apoptotic substances in mito- not only to provide support for these chil- chondrial metabolism dren and their parents but also for research • Impact of FOXO3 on cell death and stress Fig. 1: Diffusion tension imaging of a pre- purposes and quality control of neonatal resistance in neuronal cells term-born infant at 40 weeks of gestation intensive care.

186 Research Report 2016 Medical University of Innsbruck Pediatrics II

Experimental Research Projects dia thickness measurements, echocardi- and characterization of FOXO3-interacting Biomarkers of Perinatal Brain Injury ography) as well as fasting blood sampling drugs that inhibit the function of FOXO3 in Perinatal asphyxia is one of the leading (glucose metabolism, lipid status, adipocy- neuronal cells. causes of neonatal deaths worldwide. Up tokines, amino acid analyses and derived to one third of asphyxiated newborns suf- indices, hormone status). fer from neonatal encephalopathy with substantial long-term morbidity. In order to Early Vascular Ageing (EVA) improve prognosis, early identification of Anna Schmid, Anna Katharina Stock, children at risk for neurodevelopmental im- Nina Gande, Ursula Kiechl-Kohlendorfer pairment and timely initiation of supportive EVA aims at improving vascular health of treatments are crucial. Our research group 15/16-year-old Tyrolean pupils and appren- is dedicated to the assessment of both diag- tices, and at elucidating mechanisms of nostic and prognostic biomarkers of neona- early vascular ageing. Specifically, poten- tal encephalopathy, with a particular focus tial effects of dietary habits and sedentary on parameters which can be easily meas- behaviors as well as prematurity, neonatal ured in umbilical cord or patient blood and growth characteristics and feeding prac- where determination requires only small tices on early vascular abnormalities, body Fig. 2: Histological lesion in an animal sample volumes. Promising biomarkers cur- mass index and risk factor levels are tested. model of neonatal excitotoxic brain injury rently being investigated are the neuropep- (5x magnification, light microscopy, cresyl tide secretoneurin as well as short non-cod- Further Experimental Research Groups violet staining) ing ribonucleic acids, so-called microRNAs. Neuronal Metabolism A main aim is to link basic research with Judith Hagenbuchner Selected Publications clinical routine and decision making and to Mitochondria are at the centre of cellular Aortic Elastic Properties in Preschool Children Born Preterm provide tools which help caretakers tailor pathways such as oxidative phosphoryla- Komazec, Irena Odri, Posod, Anna, Schwienbacher, Martin, Resch, Maria, Peglow, Ulrike Pupp, Kiechl, Stefan, Baumgartner, Daniela, therapeutic approaches. tion (ATP generation), the TCA cycle, glu- Kiechl-Kohlendorfer, Ursula, cose metabolism and oxidation of fatty ac- ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY: 2016; 36: S. 2268-+ Neuroprotective Agents ids. Therefore alterations of mitochondrial Our research group is also dedicated to metabolism, as for example by oxidative Former Very Preterm Infants Show an Unfavorable Cardio- vascular Risk Profile at a Preschool Age the evaluation of readily available, cost-ef- stress, can contribute to cell death as well Posod, Anna, Komazec, Irena Odri, Kager, Katrin, Peglow, Ulri- fective agents with neuroprotective poten- as to prevention of cell death. We recently ke Pupp, Griesmaier, Elke, Schermer, Elisabeth, Wuertinger, Phil- ipp, Baumgartner, Daniela, Kiechl-Kohlendorfer, Ursula, tial. We use both in vitro (neuronal and glial identified the protein BIRC5/survivin as an PLOS ONE: 2016; 11: S. e0168162 cell lines, primary cell cultures) and in vivo essential regulator of neuronal metabolism Secretoneurin Serum Levels in Healthy Term Neonates and model systems (rodent pups) and apply that affects mitochondrial fusion/fission Neonates with Hypoxic-Ischaemic Encephalopathy well-established injury models of neonatal dynamics, which protects neuronal cells as Wechselberger, Karina, Schmid, Anna, Posod, Anna, Hoeck, Mi- chaela, Neubauer, Vera, Fischer-Colbrie, Reiner, Kiechl-Kohlendor- brain injury (oxygen-glucose deprivation/ well as neuronal tumor cells from cell death fer, Ursula, Griesmaier, Elke, hypoxia-ischemia, excitotoxicity (Fig.2), by shifting cells into aerobic glycolysis. NEONATOLOGY: 2016; 110: S. 14-20 hyperoxia). Our main research foci are he- Based on these findings we are currently Bronchopulmonary Dysplasia Is Associated with Delayed matopoetic growth factors, neuropeptides, screening/developing small-compounds Structural Brain Maturation in Preterm Infants exogenous and endogenous sigma-1 recep- which modulate mitochondrial metabolism Neubauer, Vera, Junker, Daniel, Griesmaier, Elke, Schocke, Micha- el, Kiechl-Kohlendorfer, Ursula, tor agonists as well as substances already and the metabolom of neuronal cells to NEONATOLOGY: 2015; 107: S. 179-184 being used in neonatal/pediatric intensive mimic the effect of survivin. BIRC5/Survivin as a target for glycolysis inhibition in care units with different indications (e.g. high-stage neuroblastoma sedative agents, anticonvulsants). Impact of FOXO3 on Cell Death and Hagenbuchner, J., Kiechl-Kohlendorfer, U., Obexer, P., Ausserlech- ner, M. J., Stress Resistance in Neuronal Cells ONCOGENE: 2016; 35: S. 2052-2061 Cardiovascular Science Petra Obexer Cardiovascular Follow-Up of Very The pathophysiology of preterm brain dam- Selected Funding Preterm Infants age is multifactorial and phases of hypoxia Early vascular ageing (EVA), part of the excellence initiative (Competence Centers for Excellent Technologies - COMET) of the Anna Posod, Irena Odri Komazec, and ischemia are known to play an impor- Austrian Research Promotion Agency FFG: “Research Center of Ursula Kiechl-Kohlendorfer tant role. Since FOXO transcription factors Excellence in Vascular Ageing – Tyrol, VASCage” (K-Project Nr. An increasing body of evidence suggests are activated by different cellular stresses 843536) funded by the BMVIT, BMWFW, the Wirtschaftsagentur Wien and the Standortagentur Tirol; 1,1 Mio. Euro that prematurity is associated with an ad- and are important regulators of apopto- verse cardiovascular risk profile in adoles- sis as well as longevity, the research team Collaborations cent and adult life. As early detection of investigates the impact of FOXO3 on cell • Lena Hellström-Westas, Department of Women`s and Children`s Health, University of Uppsala, Sweden cardiovascular risk indicators is crucial in death regulation, autophagy induction and • Christiane Richter-Landsberg, Carl von Ossietzky University, order to implement effective prevention stress resistance in neuronal cells. Our Oldenburg, Germany programs, our research group assesses group identified C10orf10/DEPP as a di- • Jan Lewerenz, Department of Neurology, University Hospital Ulm, Germany both traditional and novel cardiovascular rect transcriptional target of FOXO3 which • Martin Lee, Proalcta Bioscience, Monrovia, CA risk factors already at a preschool age. localizes to peroxisomes and mitochon- • Moon R, Goldberg Center for Community Pediatric Health, Chil- dren´s National Medical Center, Washington, US, and Blair PS, Methods used include anthropometry (e.g. dria, impairs cellular reactive oxygen spe- University of Britstol, UK (International Society for the Preven- body mass index, waist-to-hip ratio), de- cies detoxification and thereby mediates tion of Infant Death) • Consolato Sergi, Institute of Pathology, University of Alberta, vice-based non-invasive measurements autophagy in neuronal cells. The research Edmonton, Canada (blood pressure readings, aortic intima-me- team focusses further on the identification • NCD Risk Factor Collaboration – Imperial College London

Research Report 2016 Medical University of Innsbruck 187 Department of Nuclear Medicine Nuclear Medicine

plications towards imaging of biomarkers therapy (PLRT) of prostate cancer ­patients used for cancer treatment (70% of clinical are our most important therapy tools. routine), treatment of neurological impair- ment (20% of clinical routine) or cardiac dis- Research ease (10% of clinical routine). The structure of the Department of Nuclear Medicine is Preclinical Research Activities – ­Research based on a very creative, high quality pro- & Development Unit ductive, well-funded and internationally The research activities are focussed on respected preclinical Research & Develop- preclinical research dedicated to the opti- ment Unit. This group consists of several misation and improvement of radiolabelling radiochemists/pharmacists, medical physi­ procedures for established radiopharma- cists and PhD students. Their work results ceuticals, the in-house preparation of new in the construction of radiotracers using dif- radiopharmaceuticals for clinical studies, ferent modal systems, including a variety of as well as the preclinical development of radiolabelled peptide analogues such as for new radioligands for molecular imaging and somatostatin, vasoactive intestinal peptide therapeutic purposes. Different research (VIP), CCK-2/gastrin, or prostate-specific­ projects illustrate the activities in this field. membrane antigen (PSMA) ligand for spe- The FWF project P25899-B23 “Novel­ Director: cific tumour targeting. Other important de- 68Ga/89Zr-chelators for targeted bio­ Univ.-Prof.in Dr.in Irene J. Virgolini velopments are based on Arg-Gly-Asp (RGD) molecules in PET (project leader: Prof. Clem- peptides for imaging of angiogenesis in tu- ens Decristoforo, PhD Dominik ­Summer) Contact: mour lesions, or on hepatic binding protein explores a novel scaffold to prepare high- Anichstraße 35 imaging with galactosylated albumin for ly-specific radiolabelled biomolecules for 6020 Innsbruck functional liver reserve estimation. Radio­ PET for radiolabelling with Ga-68 and Zr-89. pharmaceuticals are produced at clinical Based on Fusarinine C (FSC), strategies [email protected] grade in our dedicated laboratories for use were developed to prepare multimeric and Phone: +43 512 504 22651 in SPECT/CT or PET/CT studies. About 20 multifunctional ligands for targeted molec- Fax: +43 512 504 22659 whole body PET/CT studies are performed ular imaging especially for oncological ap- www.nuklearmedizin-innsbruck.com daily in our PET Center. Patients previously plications. Different FSC conjugates with evaluated by dosimetry following SPECT/CT RGD peptide, minigastrin and affibodies studies are treated at our Nuclear Medicine were prepared showing excellent tumour Research Branch (ÖSTAT Classification) Therapy ward with high dose theranostics. targeting properties in tumour models and Radioiodine ablation therapy of thyroid can- have already been published in high-rank- 302054, 301904, 301206 cer remnants, peptide receptor radionuclide ing journals. Combining radiolabelling with therapy (PRRT) of neuroendocrine tumour optical signalling allows combination of Keywords patients and peptide ligand radionuclide imaging techniques for a variety of applica-

Peptide receptor radionuclide therapy, peptide ligand radionuclide therapy, radioiodine refractory thyroid cancer, hormone refractory prostate cancer, neuroendocrine tumours

Research Focus

The Department of Nuclear Medicine is best known for its work with radiolabelled pep- tides, both for diagnostic and therapeutic purposes, a theme that we have systemat- ically explored over the last two decades. We develop a variety of radiopharmaceuti- cals for different targets in clinical use. Our goal is to engineer more effective ligands/ peptides/antibodies - "theranostics" - for individualised treatment.

General Facts

The Department of Nuclear Medicine accel- erates translation of preclinical radiophar- Fig. 1: Imaging of tumour bearing mice after injection of a multimodality probe allowing maceutical research development (focus both optical imaging (left) and nuclear imaging by PET (right). In both imaging specific on radiolabelled peptides) into clinical ap- ­accumulation only the tumour expressing the targeted receptor (left flank).

188 Research Report 2016 Medical University of Innsbruck Nuclear Medicine

tions. In cooperations with the University of ­Uppsala, Olomouc and Nijmegen imaging properties of these promising compounds were established (see Fig. 1). The FWF project 27844-BBL “Optimizing CCK2R targeting for theranostic nuclear medicine” (project leader: Priv.-Doz.Dr. Elis- abeth von Guggenberg, PhD ­Maximilian Klin- gler) deals with the development of novel radiolabelled minigastrin analogues target- ing cholecystokinin-2 receptors for possible application in the diagnosis and therapy of medullary thyroid cancer and small cell lung cancer, as well as other CCK2R expressing malignancies. We have designed a pool of new stabilised MG analogues conjugated to the bifunctional chelator DOTA for radi- olabelling with trivalent radiometals, such as 111In for SPECT and 68Ga for PET, and the therapeutic radiometals 90Y and 177Lu. With one of our most promising radioligands 111­ In-DOTA-MGS4, we could ­successfully improve the tumour uptake (10% ID/g) Fig. 2: Comparative biodistribution of 111In-DOTA-MGS4 in A431-CCK2R and A431-mock and uptake in receptor-expressing organs xenografted mice at 4 h p.i. (stomach, pancreas) while maintaining the kidney uptake low (4% ID/g). The promising ment of Ga-68-labelled galactosyl serum suitable chelator for Ga. These studies pro- properties become clear from the compar- albumin derivatives for imaging function- vided two potential tracers for non-invasive ison with our lead structure 111In-DOTA- al liver reserve. In an initial study, it was determination of the asialoglycoprotein re- MG11 as well as 111In-CP04 a gastrin ana- demonstrated that Ga-68-DTPA-GSA strong- ceptor and will be studied in humans during logue under current clinical investigation ly accumulates in the healthy liver of rats, the next stage. (see Fig. 2). These results give high promise which indicates the potential to be used for for a future clinical translation of this new functional liver imaging. In a subsequent Clinical Research Activities radioligand. study, the in vivo stability was improved by Another topic is focused on the develop- replacement of DTPA with NOTA, a more ERA-NET The ERA-NET project “Phase I clini- cal trial using a novel CCK-2/gastrin ­receptor-localizing radiolabelled peptide probe for personalized diagnosis and ther- apy of patients with progressive or meta- static medullary thyroid carcinoma” (FWF project I1224-B19, project leader: Prof. Clemens Decristoforo) aims to translate a new promising cholecystokinin-2-receptor targeting peptide CP04 (DOTA-DGlu-DGlu- DGlu-DGlu-DGlu-DGlu-Ala-Tyr-Gly-Trp-Met- Asp-Phe-NH2) for the diagnosis of medul- lary thyroid carcinoma (MTC) from bench to bedside. In the final part of this project, a multicentric clinical trial has been initiated and the first patients to be studied includ- ing the Nuclear Medicine Department at the Medical University Innsbruck. So far, results show a promising accumulation of this tar- geted radiolabelled peptide in metastases of medullary thyroid carcinoma, opening © EJNMMI, 2016 new ways for diagnosis and treatment of this rare disease. Fig. 3: 68Ga-PSMA-HBED-CC PET/CT before 177Lu-PSMA617 therapy (left), after two (12.1 GBq; middle) and three therapy cycles (18.1 GBq; right). The SUVmax value decreased from Prostate Cancer Theranostics 27.7 to 20.4 in skeletal metastases, from 37.9 to 23.9 in LN metastases and from 32.3 to New radiotracers binding to PSMA signif- 40.5 in liver metastases, whereas SUVmax also decreased from 17.8 to 10.4 in the parotid icantly increased expression on prostate glands and from 23.2 to 14.2 in the sub-mandibular glands. cancer (PC) cells and have been proposed

Research Report 2016 Medical University of Innsbruck 189 Department of Nuclear Medicine

Fig. 5: Imaging of Liver metastasis of a therapy resistant GIST. Specific binding of 68Ga-NeoBOMB1 to Gastrin Releasing Peptide Receptors leads to delineation of the tumour only one hour after injection.

Phase I clinical trial with a novel radiophar- maceutical (68Ga-NeBOMB1) was started (EUDRACT No 2016 002053-38). This kit- based radiopharmaceutical is radiolabelled­ with Gallium-68 targeting the gastrin re- leasing peptide receptor that is over-ex- pressed in GIST. This opens new ways for non-invasive molecular characterisation of this rare tumour type and could lead to novel strategies for targeted treatment. The first patients have been enrolled in this trial Fig. 4: Vasculariszation modes and typical patterns and the first images are promising to identi- fy GIST lesions that are resistant to conven- for PET imaging. The 68Ga-PSMA ligand Transcan project as well as by the FWF pro- tional therapies. (see Fig. 5) HBED-CC proved its feasibility in detect- ject 27844-BBL (see above). ing PC relapses and metastases with high Further research in the field of thyroid dis- Angiogenesis Imaging sensitivity. Our extensive clinical stud- ease is being carried out on the basis of With Ga-68-NODAGA-RGD, we developed a ies demonstrated the great potential of ultrasound imaging. We are currently inves- tracer for the non-invasive determination 68Ga-PSMA ligand PET/CT in patients with tigating the utility of 3-dimensional imaging of the integrin avb3 expression. This com- biochemical relapse. Recently 68Ga-PSMA together with detailed depiction of the vas- pound was studied in a phase I/II clinical ligand PET/CT also indicated potential for cular system. trial and has shown rapid predominant- staging of primary prostate cancer. Further- Ultrasounds were performed using two ly renal­ elimination with low background more, based on the high level expression of probes: linear 8-18 MHz transducer for ­activity in most of the body (see Fig. 6). The PSMA on PC cells, we have started to treat routine imaging at 12 MHz together with calculated effective dose was comparable patients with metastasised disease with specialised perfusion modes, i.e. mSMI to routinely-used radiopharmaceuticals and high dose 177Lu-PSMA ligand. Initial results and cSMI. mSMI stands for monochrome the compound was well tolerated (Haubner demonstrate high tumour control ability of Superb Micro-Vascular Imaging and cSMI et al. EJNMMI 2016). In further studies, up- this radiopharmaceutical with significant for color Superb Micro-Vascular Imaging. take in different tumour lesions will be con- implication on future PC therapy protocols. The advanced dynamic flow mode (ADF) sidered. (see Fig. 3) was used routinely for depicting perfusion. In a second examination step, a 3D image Quality of Life Thyroid Research Activities was obtained using the 7.2-14 MHz 3D/4D Patients treated with radiopharmaceuticals Our recent thyroid research activities con- probe. ADF was also used to demonstrate are usually already at an advanced stage of centrated on the therapy options of radio­ perfusion. (see Fig. 4) disease and due to regulations of radiation iodine-refractory thyroid cancer. Several safety they have to stay isolated for the pe- potential kinase inhibitors were clinically MITIGATE riod of radioactive treatment. This causes implemented, however they come with a In this EU-FP7 project (grant agreement no an additional level of anxiety for patients. rather broad range of side effects. Radio- 602306), new ways for diagnosis and treat- To support the wellbeing and well feeling of labelled somatostatin analogues were clin- ment of therapy resistant Gastrointestinal the patients we have initiated translational ically implemented for treatment by our Stromal Tumours (GIST) are being investi- projects integrating not only psychooncol- group. The diagnosis and therapy of the gated and developed. At the Nuclear Medi- ogists but also theologists, psychologists MTC-subtype is addressed by the ERA-NET cine department of the Medical University a and nutritionists for the patients' supportive

190 Research Report 2016 Medical University of Innsbruck Nuclear Medicine

Comparison of Ga-68-Labeled Fusarinine C-Based Multivalent RGD Conjugates and [Ga-68]NODAGA-RGD-In Vivo Imaging Studies in Human Xenograft Tumors Zhai, Chuangyan, Franssen, Gerben M., Petrik, Milos, Laverman, Peter, Summer, Dominik, Rangger, Christine, Haubner, Roland, Haas, Hubertus, Decristoforo, Clemens, MOLECULAR IMAGING AND BIOLOGY: 2016; 18: S. 758-767

Targeting Gastrointestinal Stromal Tumor with Ga-68- Labeled Peptides: An In Vitro Study on Gastrointestinal Stromal Tumor-Cell Lines Paulmichl, Achim, Summer, Dominik, Manzl, Claudia, Rangger, Christine, Orlandi, Francesca, Niedermoser, Sabrina, Taguchi, Takahiro, Waengler, Bjoern, Decristoforo, Clemens, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS: 2016; 31: S. 302-310 © EJNMMI, 2016 Selected Funding Fig. 6: Maximum intensity projections from static [68Ga]NODAGA-RGD PET scans of a male patient (no. 3) with HCC starting at 13 min (A), 40 min (B), and 76 min (C) after “Enhanced CCK2R targeting for theragnostic use in nuclear medicine”, FWF: Projekt Nr. P 27844, Priv-Doz.Dr. Elisabeth von tracer injection. The tracer shows rapid predominant renal elimination with the highest Guggenberg / 339.378,39 Euro radioactivity in the bladder, kidneys, liver, spleen, and intestine. Low background radioactivity is found in the brain, thorax, and extremities. For all three images, greyscale Collaborations is set to the same values. • Prof. Dr. Richard Baum, Zentralklinik Bad Berka, Bad Berka, Germany • Prof. Dr. John Buscombe, Cambridge University Hospitals, Cambridge, UK • Prof. Pietro Muto, Ospedali dei Colli, Monaldi, Italia care. Selected Publications • Prof. Annibale Versari, Az. Osp. Arcispedale S.Maria Nuova, The strong correlation of gastrointestinal Reggio Emilia, Italia Current knowledge on the sensitivity of the Ga-68- • Prof. Stefano Fanti, Policlinico S.Orsola-Malpighi, Bologna, Italia symptoms and psychosocial issues with somatostatin receptor positron emission tomography and • Dr. Chiara Maria Grana, IEO Istituto Europeo di Oncologia, quality of life warrant more detailed analy- the SUVmax reference range for management of pancreatic Milano, Italia neuroendocrine tumours • Prof. Helmut Maecke, University Hospital Freiburg, Freiburg, ses of our data in order to identify predic- Virgolini, Irene, Gabriel, Michael, Kroiss, Alexander, von Germany tors for quality of life in the specific patient Guggenberg, Elisabeth, Prommegger, Rupert, Warwitz, Boris, • Prof. Georgios S Limouris, Athens University Medical Faculty, Nilica, Bernhard, Roig, Ilanos Geraldo, Rodrigues, Margarida, Athens, Greece group with neuroendocrine tumours con- Uprimny, Christian, • Prof. Dr. Thomas Beyer, Medical University Vienna, Vienna, sidering physical as well as emotional and EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR Austria IMAGING: 2016; 43: S. 2072-2083 • Prof. Dr. Marcus Hacker, Medical University Vienna, Vienna, social domains and their relationship. Austria [Ga-68]NODAGA-RGD - Metabolic stability, biodistribution, • Prof. Dr. Bernd Pichler, Eberhard Karls University Tübingen, and dosimetry data from patients with hepatocellular Tübingen, Germany carcinoma and liver cirrhosis • Prof. Dr. Olaf Prante, Friedrich Alexander University, Erlangen, Haubner, Roland, Finkenstedt, Armin, Stegmayr, Armin, Rangger, Germany Christine, Decristoforo, Clemens, Zoller, Heinz, Virgolini, Irene J., • Dr. Milos Petrik, Palacky University Olomouc, Czech Republic EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR • Prof.Renata Mikolajczak, Radioisotope Centre POLATOM, IMAGING: 2016; 43: S. 2005-2013 Otwock, Poland • Research Report MUI 2016: Input Form 10/10 Targeting Gastrointestinal Stromal Tumor with Ga-68- • Prof.Björn Wängler, Prof.Stefan Schönberg, Medical Faculty Labeled Peptides: An In Vitro Study on Gastrointestinal Mannheim of , Mannheim, Germany Stromal Tumor-Cell Lines • Prof. Paola Erba, Azienda Ospedaliero-Universitaria Pisana, Paulmichl, Achim, Summer, Dominik, Manzl, Claudia, Rangger, Pisa, Italy Christine, Orlandi, Francesca, Niedermoser, Sabrina, Taguchi, • Prof. Alicja Hubalewska-Dydejczyk, Jagiellonian University Takahiro, Waengler, Bjoern, Decristoforo, Clemens, Medical College, Krakow, Poland CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS: 2016; • Dr. Petra Kolenc-Peitl, University Medical Centre Ljubljana, 31: S. 302-310 Solvenia • Dr. Peter Laverman, Radboud University Medical Center, Systematic review reveals lack of quality in reporting health- Nijmegen, Netherlands related quality of life in patients with gastroenteropancreatic • Prof.Jane K. Sosabowski, Queen Mary University of London, neuroendocrine tumours London, UK Martini, Caroline, Gamper, Eva-Maria, Wintner, Lisa, Nilica, • Prof.Vladimir Tolmachev, University Uppsala, Sweden Bernhard, Sperner-Unterweger, Barbara, Holzner, Bernhard, • Prof. Jean-Noël Talbot, AP-HP & Université P&M Curie, Paris, Virgolini, Irene, France HEALTH AND QUALITY OF LIFE OUTCOMES: 2016; 14: S. 127 • Prof. David R. Vera, University of California, San Diego, United States From preclinical development to clinical application: Kit • Prof. Stanley J. Goldsmith, Weill Cornell Medical College, New formulation for radiolabelling the minigastrin analogue York, United States CP04 with In-111 for a first-in-human clinical trial • Prof. Ajit Shinto, Kovai Medical Centre and Hospital, Pawlak, Dariusz, Rangger, Christine, Peitl, Petra Kolenc, Coimbatore, India Garnuszek, Piotr, Maurin, Michal, Ihli, Laura, Kroselj, Marko, • Prof. Anthony Goh, Singapore General Hospital, Singapore Maina, Theodosia, Maecke, Helmut, Erba, Paola, Kremser, • Prof. Emerita Andres-Barrenechea, St. Luke’s Medical Center, Leopold, Hubalewska-Dydejczyk, Alicja, Mikolajczak, Renata, Quezon City, Philippines Decristoforo, Clemens, • Prof. Harvey Turner, University of Western Australia, Murdoch, EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES: 2016; Australia 85: S. 1-9 • Prof. Mike Sathekge, University of Pretoria, Pretoria, South Africa Pelvic Lymph Node Staging by Combined (18)F-FDG-PET/ • Prof. N. Ozlem Küçük, Ankara University, Ankara, Turkey CT Imaging in Bladder Cancer Prior to Radical Cystectomy. • Prof. Levent Kabasakal, Istanbul University, Istanbul, Turkey Pichler, Renate, De Zordo, Tobias, Fritz, Josef, Kroiss, Alexander, Aigner, Friedrich, Heidegger, Isabel, Virgolini, Irene, Horninger, Wolfgang, Uprimny, Christian, CLINICAL GENITOURINARY CANCER: 2016; [Epub ahead of print]: S.

Research Report 2016 Medical University of Innsbruck 191 Department of Therapeutic Radiology and Oncology Therapeutic Radiology & Oncology

tution is worldwide famous for the devel- opment of Patient Fixation Devices for high Research precision radiotherapy. Peter Lukas Radiobiology: Impact of low doses for the Main international involvement of the insti- induction of secundary malignoma; cell cul- tution is concerning the quality of radiation ture modelling, nano-particle applications treatment in Hodgkin’s Lymphoma (see in vitro, modelling of micro-fluidics, elec- publication 2). Peter Lukas is member of the tro-spinning of nano-fibrous cell culture Quality Panel on Radiation Treatment (Ra- substrates, developing cell-to-electrode in- diotherapy Panel) of the German ­Hodgkin terfaces at micron-scales. Study Group (GHSG). Main institutional Projects in 2015/16 be- General Facts sides concluding the pre-described SEMPER­ project have been concerning radiotherapy Peter Lukas has headed the Department of of breast cancer. Therapeutic Radiology and Oncology (ROI) The Institution, represented by Dr. Danjela at the Medical University of Innsbruck (MUI) Vasiljevic, planned, conducted and finished since 1993. He has introduced several im- a prospective trial on the incidence and rea- Director: proved treatment techniques in radiothera- sons for radiotherapy related pneumonitis, o. Univ.-Prof. DI Dr. Peter Lukas peutic routine, nowadays globally accepted including 400 patients. Analysis is on-going, as standard treatment protocols (see pub- publication is in preparation. Contact: lication 1). Beside his clinical experience, In addition we prepared the participation Anichstraße 35 Peter Lukas has strongly promoted basic in a German trial on hypofractionation and 6020 Innsbruck and translational research in the field of ra- integrated boost (HYPOSIB), patient acqui- diobiology at his department. sition will start April 2017. Responsible for [email protected] The Dept. of Therapeutic Radiology and mentoring: Dr. Danjela Vasiljevic. Phone: +43 512 504 22801 Oncology (MUI) comprises eight units to The group of Arnold et al. prepared a paper Fax: +43 512 504 22869 perform therapeutic as well as experimen- on the evaluation of a domestic porcine http://www3.i-med.ac.at/strahlentherapie tal irradiation (five linear accelerators to model for studying the effects of radiation generate photon beams of energies up to in head and neck cancer (see publication 3). 20 MeV; two Brachytherapy units, and a conventional x-ray-device up to 200 keV. Ira-Ida Skvortsova Research Branch (ÖSTAT Classification) Further Information under: (EXTRO-Lab, Dept. of Therapeutic http://www3.i-med.ac.at/strahlentherapie. Radiology and Oncology, Innsbruck 302080, 302055, 301904, Medical University, Innrain 66A, Floor 302058, 302044, The first associated Laboratory of Radio­ 3, Room 15, 6020 Innsbruck) biology (headed by Thomas Seppi) dispos- The main aim of the EXTRO-Lab is to de- Keywords es of experienced staff personnel (four VPs) velop novel biomarkers predicting radia- skilled in a broad spectrum of cell biology tion response of malignant tumors and/ Radiotherapy, oncology, radiosurgery, as well as in nano-technological methodol- or therapeutic targets that could be used radiation biology, radiation protection, ogies. for improvement of the radiotherapy out- medical physics, medical biotechnology, Equipment is available to perform flow come in cancer patients (see publication 4). medical molecular biology, cell biology, ­cytometry analyses, long-term live-cell ­EXTRO-Lab has four permanent members nanobiotechnology imaging (by light and fluorescence tech- and three cooperative members. niques), proteomics, metabolomics, in- Our research group recently reported that Research Focus tracellular ROS-quantification, advanced radioresistant prostate and breast carcino- cell and tissue culturing (in-house fabri- ma cell lines with high CSC content over­ Major research topics are: cation of nano-fiber scaffolds, 2D- and express Ape1/Ref1 protein, which has a ­3D-perfusion culture models), impedance dual function as a ROS scavenger and as a Radio-Sensitizing in Radiation ­Oncology: and TEER-methods to assess tissue integ- DNA repair enzyme. Attenuation of Ape1/ Many of the new systemic substances used rity, cell-migration tracking, as well as up- Ref1 expression was accompanied by the in Oncology have a radiosensitizing (RSP) take studies and subcellular localization of restoration of radiation sensitivity in pros- or radioprotective(RPP) potential. Often lit- nano-particles by scanning and transmis- tate carcinoma cells. Ape1/Ref1 is a pro- tle is known about these properties before sion electron microscopy. tein consisting of two domains: the N-ter- going into clinical use because investigation minal domain which is responsible for the in this concern is not part of the EU guide- The second associated labatory is the redox activity, and the C-terminal domain lines for marketing authorisation. For Radio­ Laboratory for Experimental and Trans- which is essential for DNA repair. oncologists the knowledge of RSP or RPP is lational Research­ on Radiation Oncology As already mentioned above, CSCs have essential for the planning of any form of (­EXTRO-Lab), headed by Ira Skvortsova. unique capacities to reduce intracellular combined treatments. This laboratory was established in 2006 ROS levels and thus to protect themselves (http://www3.i-med.ac.at/strahlentherapie/ against ROS-caused DNA damage and cell High Precision Radiotherapy: Our Insti- de/05_labor1.php). death. Their constitutive up-regulation of

192 Research Report 2016 Medical University of Innsbruck Therapeutic Radiology and Oncology

Selected Publications

1.) Long-term surveillance of locally advanced rectal cancer patients with neoadjuvant chemoradiation and aggressive surgical treatment of recurrent disease: a consecutive single-centre experience Zitt, Matthias, DeVries, Alexander, Thaler, Josef, Kafka-Ritsch, Reinhold, Eisterer, Wolfgang, Lukas, Peter, Oefner, Dietmar, INTERNATIONAL JOURNAL OF COLORECTAL DISEASE: 2015; 30: S. 1705-1714

2.) Relapse Analysis of Irradiated Patients Within the HD15 Trial of the German Hodgkin Study Group Kriz, Jan, Reinartz, Gabriele, Dietlein, Markus, Kobe, Carsten, Kuhnert, Georg, Haverkamp, Heinz, Haverkamp, Uwe, Engenhart- Cabillic, Rita, Herfarth, Klaus, Lukas, Peter, Schmidberger, Heinz, Staar, Susanne, Hegerfeld, Kira, Baues, Christian, Engert, Andreas, Eich, Hans Theodor, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS: 2015; 92: S. 46-53

© Semin Cancer Biol. 2015 3.) Proteomic approach to understand metastatic spread Skvortsov, Sergej, Arnold, Christoph R., Debbage, Paul, Lukas, Fig. 1: Intracellular ROS and formation of radiation-resistant CSCs. It is assumed that CSCs Peter, Skvortsova, Ira, may be generated from normal stem cells. An increased concentration of intracellular ROS PROTEOMICS CLINICAL APPLICATIONS: 2015; 9: S. 1069-1077 enhances processes involved in cell differentiation/de-differentiation, in dysregulated cell 4.) Sex Differences in Renal Proximal Tubular Cell cycle progression, in activation of pro-survival signallings, in accumulation of gene mu- Homeostasis Seppi, Thomas, Prajczer, Sinikka, Doerler, Maria-Magdalena, Eiter, tations, and in genome instability. Acting together, all these ROS-mediated intracellular Oliver, Hekl, Daniel, Nevinny-Stickel, Meinhard, Skvortsova, Iraida, processes generate the most aggressive treatment-resistant carcinoma cells, which have Gstraunthaler, Gerhard, Lukas, Peter, Lechner, Judith, JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY: 2016; stem-ness characteristics. In order to protect themselves from ROS-induced damage, these 27: S. 3051-3062 CSCs overexpress ROS scavengers. Finally, malignant tumours become enriched for the radiation-resistant CSC subpopulation having up-regulated ROS scavengers and lower ROS Selected Funding concentrations. • i-Scaff – Intelligent scaffolds of electro-spun nano-fibres in advanced cell culture models, TZS-Translational Research Program, Seppi T, Schmiedinger T (294.000 €) ROS scavengers, including Ape1/Ref1, affect cell growth and the cell cycle. It is • FWF Project P29457 (Priv.-Doz. Dr. Ira-Ida Skvortsova) may be induced by factors belonging to currently not fully understood how ROS and the microenvironmental CSC niche, such ROS scavengers regulate CSC survival and Collaborations as hypoxia, or release of pro-inflammatory cell cycle progression, but it is plausible to • Fachhochschule Vorarlberg, Feldkirch, Austria • Unit of Hydraulic Engineering, University of Innsbruck; cytokines, or dysregulation of mitochondri- hypothesize that ROS scavenging can lead Innsbruck al functions. The formation of CSCs, with to generation of the most aggressive slowly • Institute of Physics, Academy of Sciences Prague, Prague, Czech Republic their constitutive up-regulation of enzymes proliferating radioresistant CSCs. • Università del Sacro Cuore, Rome, Italy directed to ROS scavenging and DNA repair, • Department of Engineering, University of Trento, Trento, Italy • Anna Dubrovska, OncoRay - National Center for Radiation may explain primary radiation resistance, Thomas Seppi Research in Oncology whereas an enhancement of their expres- The associated Laboratory of Radiobiology • Medical Faculty Dresden Carl Gustav Carus, TU Dresden Fetscherstr. 74 / PF41 01307 Dresden, Germany sion accompanying radiotherapy may un- conducted several projects in the field of • Connie R. Jimenez, OncoProteomics Laboratory, Dept. Medical derlie acquired radiation resistance. Note nano-technology and tissue engineering Oncology, VUmc-Cancer Center Amsterdam, Room CCA 1-60, De Boelelaan 1117, 1081HV Amsterdam, The Netherlands that an imbalance between ROS formation funded by the Austrian Nano-Initiative (FFG) • Emilie Varin, Translational Research Officer, EORTC, Avenue E. and the expression of ROS scavengers, fa- or by other peer reviewed governmental Mounier 83/11, Brussels, Belgium • Takashi Imai, Advanced Radiation Biology Research Program, vouring increased intracellular ROS levels, grants. The team, headed by Thomas ­Seppi, Research Center for Charged Particle Therapy, National can activate CSC differentiation. In con- is experienced in radiobiology, analytical Institute of Radiological Sciences, 4-9-1 Anagawa, Inage, Chiba 263-8555 Japan trast, downregulation of ROS formation chemistry, nano-coatings in biomedical ap- • Silvia Pastorekova, Institute of Virology, Slovak Academy of leads to enhanced CSC self-renewal, with plications, laser-optical cell analyses, elec- Sciences, Dubravska cesta 9, 84505 Bratislava, Slovakia • MedAustron, Wiener Neustadt, Austria more pronounced cancer cell aggressive- tron-microscopy protocols, designing and • University for Health Sciences, Medical Informatics and ness. Inhibition of the redox function of prototyping of advanced cell culture mod- Technology (UMIT), Hall i.T./Department of Biomedical Computer Science and Mechatronics Ape1/Ref-1 initiates cell differentiation fol- els, as well as in molecular biology and toxi- • Zentrum für Biomedizin; EURAC, Bozen, Italy lowed by cell death in H2O2-treated cardiac cology of cancer cells. stem cells. Similar processes might also A main objective of ongoing projects - per- be observed in CSCs. Furthermore, Ape1/ formed in collaboration with several local Ref1 regulates the redox status of a variety and international partners - is to synthesize of signaling molecules, including p53 pro- advanced nanoparticles (NPs) composed tein: its reduction of oxidized p53 enhanc- by a coated super-paramagnetic iron oxide es p53 and DNA binding, and modulates core (SPIOs), to accommodate chemothera- DNA repair. Alterations in p53 functions peutics on the surface of NPs, and to inves- can ­result in inaccurate and defective DNA tigate the potential of inducing drug release repair, in formation of additional DNA muta- by gamma-ray/proton dilation as a trigger tions, in genome instability and finally in the modality. NPs made of heavy metals, such enhancement of CSC survival and CSC ag- as gold, may enhance the efficacy of cancer gressiveness. In carcinoma cells, ROS scav- radiotherapy by increasing the local absorp- enging by proteins such as Ape1/Ref1 can tion of photon as well as proton radiation. reduce radiation sensitivity, and can also

Research Report 2016 Medical University of Innsbruck 193 Department of Dermatology and Venereology Dermatology, Venereology and Allergology & Experimental Dermatology Research Unit

Research Branch (ÖSTAT Classification) closely related molecules of the lipocalin family can be either allergenic or non-aller- 302011, 301902, 301904, genic. We worked on identifying the molec- 302002, 302087 ular basis for these differential responses in human dendritic cells exposed to non-al- Keywords lergenic and allergenic lipocalins, the most frequent group of animal derived respiratory dendritic cells, Langerhans cells, genoder- allergens. matoses, histiocytoses, HIV, lupus, melano- ma, parasitoses, psoriasis, epidermal barrier Differential T cell responses and broad gene expression analyses of dendritic cells were Research Focus performed by microarray. Candidate mole- cules were identified, and their intracellular The dermatology research programs can be trafficking and processing by dendritic cells subdivided into the following major research­ are now being studied in detail. Furthermore, topics: molecular alterations of allergens were in- • Dendritic cells/Langerhans cells/Immu- vestigated with the aim of rendering aller- nobiology of the skin genic molecules non-allergenic. The expect- Director: • Epidermal biology ed results will add to our knowledge of the Univ.-Prof. Dr. Matthias Schmuth • Genodermatoses fundamental biology of dendritic cells and • Cutaneous autoimmunity may help to better understand the develop- Contact: • Infectious diseases of the skin, HIV/AIDS ment of allergies to respiratory antigens. Anichstraße 35 • Dermatohistopathology 6020 Innsbruck • Photomedicine Immunological Studies on Dendritic • Clinical trials Cells of the Skin: Immunosurveillance [email protected] against Cancer and potential Clinical Phone: +43 512 504 24801 General Facts Application for Immunotherapy Fax: +43 512 504 23002 Patrizia Stoitzner, Daniela Ortner-Tobider, http://dermatologie.tirol-kliniken.at In the dermatology department, basic re- Christoph Tripp search and patient care are intimately in- The main topic of our research in the Labora- terconnected with each other. This will ulti- tory for Langerhans Cell Research, headed by mately be of advantage to our patients, who Assoc.-Prof. Stoitzner, is the immunobiology will be able to benefit from new diagnostic of the different types of skin dendritic cells, and therapeutic approaches early in develop- with emphasis on epidermal Langerhans ment. For instance, dendritic cell-based vac- cells (Figure 1). The immunogenic function cination strategies against melanoma were of Langerhans cells has been investigated in developed and applied. Innsbruck dermatol- the context of skin cancer (melanoma and ogy's researchers have played a leading role squamous cell / basal cell carcinoma). Here- in the development of methods for the iso- by, different mouse tumor models, including lation, propagation and clinical application spontaneously arising melanoma, have been of these cells over the past three decades. used to determine the phenotype of tumor Another prominent example is the investi- infiltrating dendritic cells and effector cells, gation of the skin barrier function in healthy such as T cells and natural killer T cells. The and diseased skin. Additional, equally inter- occurrence and function of myeloid suppres- connected research programs focus on the sor cells and their influence on the growth of cutaneous immune system, autoimmunity, tumors was studied. infectious diseases of the skin, HIV infection, and dermatohistopathology. Importantly, mouse models, in which de- fined subsets of skin dendritic cells can be Research depleted, have helped to identify the critical Head of Experimental Dermatology: role of Langerhans cells for the prevention Univ.-Prof. Dr. Nikolaus Romani Differential Effects of Allergens and of chemically induced squamous cell carci- Non-Allergenic Antigens on Human noma (Figure 2). Crosstalk between Langer- Contact: Dendritic Cells hans cells and Natural Killer Cells was found Anichstraße 35 Christine Heufler Tiefenthaler, to be essential for the control of this type of 6020 Innsbruck Norbert Reider skin cancer. Based on these findings we cur- Patients suffering from type I, IgE-mediated rently attempt to develop novel alternative [email protected] allergies constitute an important clientele of immunotherapies which can be tested for Phone: +43 512 504 28559 our department. Dendritic cells initiate and their efficacy in mouse tumor models and Fax: +43 512 504 23002 regulate virtually all immune reactions in the eventually translated into human medicine. body, including the undesired allergic hyper- As a first step we have investigated the direct sensitivities. It is still unclear why chemically­ targeting of dendritic cells in the skin with

194 Research Report 2016 Medical University of Innsbruck Dermatology, Venereology and Allergology & Experimental Dermatology Research Unit

inflammation. Alterations in T-cell subsets, both disease mechanisms and therapeutic lipid metabolites and in cellular metabolism strategies. Recent work has demonstrated involving mitochondriae are the focus of serologic markers of malignancy in patients ongoing research. Gene mutations relevant with autoimmune disease. for epidermal function are tested in 3D skin cultures and compared with biopsies from Infectious Diseases of the Skin patients carrying these mutations. In vitro 3D Robert Zangerle, Mario Sarcletti, culture models allow for mechanistic stud- Martin Gisinger, Maria Kitchen-Hosp, ies, forming the basis for new therapeutic Reinhard Höpfl Fig. 1: Network of Langerhans cells in an concepts, which in turn can be tested in the This research program addresses questions epidermal sheet specimen. Approximately models. Discovery of disease-causing muta- of HIV epidemiology and response to thera- 700 Langerhans cells reside in one square tions in patients with hereditary skin disease py using the large national OEHIVKOS cohort millimetre. These cells are directly targeted (i.e. disorders of cornification and atopic that was initiated, and is led by researchers in situ by antibody-coupled vaccines. dermatitis), carried out in collaboration with from the Innsbruck Department of Dermatol- the Human Genetics Division, feeds into this ogy. The cohort is increasingly linked to Euro- antibody-antigen conjugates (anti-DEC-205, approach. Various microscopic techniques pean and international collaborative efforts, anti-langerin), by intradermal application in a including confocal imaging and electron mi- e.g. the Antiretroviral Therapy Cohort Collab- human skin explant model. Different dendrit- croscopy (Figure 3) are used to decipher the oration (ART-CC), the Collaboration of Obser- ic cell subsets, such as Langerhans cells and consequences of mutations on epidermal vational HIV Epidemiological Research Eu- dermal dendritic cells were targeted differ- structure and function. rope (COHERE) in EuroCoord, the CASCADE ently. Subsequently, T cell stimulatory func- The collaboration with Human Genetics also Collaboration in EuroCoord, and EuroSIDA in tions of targeted skin dendritic cells were extends to studying connective tissue dis- EuroCoord. Additional research addressed studied in this model, using an EBV-based ease. Another line of research explores the sexually transmitted infections (STI) and skin T cell read-out that will eventually lead to a role of nuclear hormone receptors (PPAR, disorders caused by viruses (HPV), as well as model with melanoma tumor antigens (NY- LXR) in regulating inflammation and epider- by various parasites and fungi. ESO-1). We are testing the hypothesis that mal differentiation. Recently, we discovered such antibody-conjugated antigens elicit Pregnane X receptor (PXR), a transcription Photomedicine massively augmented T cell responses. First factor mainly known to be expressed in liver Gudrun Ratzinger observations within this reporting period and intestine to be activated by xenobiotic This research program addresses the effects suggest that this is indeed the case. Such chemicals in skin, to protect from DNA dam- of UV-irradiation as a causative factor of pho- immunizations, for instance against neoan- age and to modulate the cutaneous immune todermatoses, as well as the therapeutic ef- tigens in cancer, could prove highly useful system. fects of UV-irradiation on common inflamma- in tandem with modern immune checkpoint tory skin diseases and skin cancer. Ongoing therapies. Cutaneous Autoimmunity trials investigate the effects of phototherapy Barbara Böckle, Gudrun Ratzinger on the autoimmune skin disorder scleroder- Epidermal Biology This group has established registries of auto- ma and on cutaneous T-cell lymphoma. Addi- Sandrine Dubrac, Robert Gruber, immune skin disorders. Thoroughly recorded tionally, the group participates in the Austri- Verena Moosbrugger-Martinz clinical and immune parameters were inte- an Psoriasis Registry (PsoRA) to gain clinical This research group focuses on the biolog- grated with information about response to and epidemiologic data. ical processes that regulate the interplay therapy and thus provided a rich scientific between skin barrier function and cutaneous resource with which to address questions of

Fig. 2: Mouse skin treated with a cancerogenic substance and immunolabeled for visualization DNA damage (red fluorescence). Epidermis from mice, where Langerhans cells had been removed experimentally by means of the diphtheria toxin receptor approach („no LC“) have markedly more damaged cell nuclei. This illustrates a novel protective role of Langerhans cells (in collaboration with natural killer cells) in skin cancer. Ortner et al., Oncoimmunology.

Research Report 2016 Medical University of Innsbruck 195 Department of Dermatology and Venereology

Dermatohistopathology Bernhard Zelger Dermatohistopathology research in Inns- bruck is renowned for innovative concepts describing a variety of morphologic discov- eries in many skin disorders (Figure 4), with special emphasis on soft tissue tumors and cutaneous vasculitis. Collaborative research projects included studies characterizing ­inflammation and rejection in limb transplan- tation.

Clinical Trials Fig. 4: Malignant cells in the blood of a patient with a plasmacytoid dendritic cell lymphoma, a Norbert Reider, Gudrun Ratzinger, very rare entity. This illustrates clinical research, bridging methodology from basic research, Robert Zangerle, Van Anh Nguyen, Georg such as flow cytometry (left), immunofluorescence (middle) and electronmicroscopy (right) Weinlich, Matthias Schmuth and diagnostic dermatohistopathology. The Department’s clinical trial unit carried out numerous phase I-III clinical trials on The Late Endosomal Adaptor Molecule p14 (LAMTOR2) A Single Quantifiable Viral Load Is Predictive of Virological chronic inflammatory skin disease (psoria- Regulates TGFβ1-Mediated Homeostasis of Langerhans Failure in Human Immunodeficiency Virus (HIV)-Infected Cells Patients on Combination Antiretroviral Therapy: The sis), allergies, skin cancer (foremost melano- Sparber, Florian, Tripp, Christoph H., Komenda, Kerstin, Scheffler, Austrian HIV Cohort Study Julia M., Clausen, Bjoern E., Huber, Lukas A., Romani, Nikolaus, Leierer, Gisela, Grabmeier-Pfistershammer, Katharina, Steuer, ma), HIV and genetic skin diseases. Although Stoitzner, Patrizia, Andrea, Sarcletti, Mario, Geit, Maria, Haas, Bernhard, Taylor, most of our current trials are pharma-initiat- JOURNAL OF INVESTIGATIVE DERMATOLOGY: 2015; 135: S. 119- Ninon, Kanatschnig, Manfred, Rappold, Michaela, Ledergerber, 129 Bruno, Zangerle, Robert, Austrian HIV Cohort Study Grp, ed, the Department also encouraged and OPEN FORUM INFECTIOUS DISEASES: 2016; 3: S. supported the planning and implementation Still Alive and Kicking: In-Vitro-Generated GM-CSF Dendritic of investigator-initiated trials. The unit works Cells! Impact of low-level viremia on clinical and virological Lutz, Manfred B., Inaba, Kayo, Schuler, Gerold, Romani, Nikolaus, outcomes in treated HIV-1-infected patients in close collaboration with the ­Coordination IMMUNITY: 2016; 44: S. 1-2 Vandenhende, Marie-Anne, Ingle, Suzanne, May, Margaret, Chene, Center for Clinical Trials (KKS) and the Genevieve, Zangerle, Robert, et al. and Antiretroviral Therapy Atopic dermatitis induces the expansion of thymus-derived Cohort, ­Comprehensive Cancer Center. regulatory T cells exhibiting a Th2-like phenotype in mice AIDS: 2015; 29: S. 373-383 Moosbrugger-Martinz, Verena, Tripp, Christoph H., Clausen, Bjoern E., Schmuth, Matthias, Dubrac, Sandrine, Mortality According to CD4 Count at Start of Combination JOURNAL OF CELLULAR AND MOLECULAR MEDICINE: 2016; 20: Antiretroviral Therapy Among HIV-infected Patients S. 930-938 Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study Skin response to a carcinogen involves the xenobiotic May, Margaret T., Vehreschild, Jorg-Janne, Trickey, Adam, Obel, receptor pregnane X receptor Niels, Reiss, Peter, Bonnet, Fabrice, Mary-Krause, Murielle, Samji, Elentner, Andreas, Ortner, Daniela, Clausen, Bjoern E., Gonzalez, Hasina, Cavassini, Matthias, Gill, Michael John, Shepherd, Leah C., Frank J., Fernandez-Salguero, Pedro M., Schmuth, Matthias, Crane, Heidi M., Monforte, Antonella d'Arminio, Burkholder, Greer Dubrac, Sandrine, A., Johnson, Margaret M., Sobrino-Vegas, Paz, Domingo, Pere, EXPERIMENTAL DERMATOLOGY: 2015; 24: S. 835-840 Zangerle, Robert, Justice, Amy C., Sterling, Timothy R., Miro, Jose M., Sterne, Jonathan A. C., Antiretroviral Therapy Cohort, Epidermal barrier abnormalities in exfoliative ichthyosis CLINICAL INFECTIOUS DISEASES: 2016; 62: S. 1571-1577 with a novel homozygous loss-of-function mutation in CSTA Moosbrugger-Martinz, V., Jalili, A., Schossig, A. S., Jahn-Bassler, K., Zschocke, J., Schmuth, M., Stingl, G., Eckl, K. M., Hennies, H. Selected Funding C., Gruber, R., • Control of epidermal eicosanoid metabolism and barrier BRITISH JOURNAL OF DERMATOLOGY: 2015; 172: S. 1628-1632 function by PPARs. Sandrine Dubrac, FWF P28039, 2015-2018, € 268.000. Smoking is highly associated with discoid lupus • Effects of allergenic lipocalins on dendritic cells. erythematosus and lupus erythematosus tumidus: analysis Christine Heufler, FWF P27543, 2015- 2018, € 348.000. of 405 patients • Langerhans cells and Natural Killer cells in the immune Boeckle, B. C., Sepp, N. T., surveillance of cancer. Fig. 3: Electron microscopic visualisation of LUPUS: 2015; 24: S. 669-674 Daniela Ortner-Tobider, FWF T737 Hertha-Firnberg, 2015- lamellar bodies and secreted lipid contents 2018, € 224.000. Evidence Of In Vivo Existence Of Borrelia Biofilm In Borrelial • EU Training Network for the Immunotherapy of Cancer: in the intercellular space at the stratum Lymphocytomas Dendritic cell-based immunotherapy: antibody-mediated Sapi, E., Balasubramanian, K., Poruri, A., Maghsoudlou, J. S., targeting of dendritic cells in vivo through the skin. granulosum - stratum corneum junction in Socarras, K. M., Timmaraju, A. V., Filush, K. R., Gupta, K., Shaikh, Patrizia Stoitzner, EU IMMUTRAIN, 2016-2019, € 256.000. the outer epidermis. S., Theophilus, P. A. S., Luecke, D. F., MacDonald, A., Zelger, B., EUROPEAN JOURNAL OF MICROBIOLOGY & IMMUNOLOGY: Collaborations 2016; 6: S. 9-24 • Universitäts Hautklinik, Wien (Profs. Georg Stingl, Adelheid Selected Publications Elbe-Bürger, Erwin Tschachler) Survival and Effectiveness of Tumour Necrosis Factor-alpha • Universitäts Hautklinik, Erlangen (Prof. Gerold Schuler) Allergenic Can f 1 and its human homologue Lcn-1 direct Inhibitors in the Treatment of Plaque Psoriasis under Daily • Laboratory of Cellular Physiology & Immunology, The dendritic cells to induce divergent immune responses Life Conditions: Report from the Psoriasis Registry Austria Rockefeller University, NY (Prof. Michel Nussenzweig) Posch, Beate, Irsara, Christian, Gamper, Fabian S., Hermann, Inzinger, Martin, Wippel-Slupetzky, Katharina, Weger, Wolfgang, • Stanford University (Assoc. Prof.Juliana Idoyaga) Martin, Bindreither, Daniel, Fuchs, Dietmar, Reider, Norbert, Redl, Richter, Leo, Mlynek, Alexander, Fleischanderl, Barbara, • The Malaghan Institute for Medical Research, Wellington, NZ Bernhard, Heufler, Christine, Scheurecker, Christine, Sandor, Nicolaus, Mairhofer, Daniela, (Prof.Franca Ronchese) JOURNAL OF CELLULAR AND MOLECULAR MEDICINE: 2015; 19: Sator, Paul G., Moser-Oberthaler, Sabine, Haering, Nina, • Johannes Gutenberg Universität Mainz (Prof.Björn Clausen) S. 2375-2384 Viznerova, Petra, Painsi, Clemens, Tanew, Adrian, Ponholzer, Peter, • University of California at San Francisco (Profs.Peter Elias, Ken Tatarski, Rafaella, Brenner, Wilhelm, Stingl, Georg, Salmhofer, Feingold) Impaired gp100-Specific CD8(+) T-Cell Responses in Wolfgang, Rappersberger, Klemens, Klein, Georg, Saxinger, • Université de Strasbourg, Frankreich (Dr.Vincent Flacher) the Presence of Myeloid-Derived Suppressor Cells in a Werner, Auboeck, Josef, Koelli, Claudia, Trautinger, Franz, Steiner, • Universität Zürich, Schweiz (Prof.Christian Münz) Spontaneous Mouse Melanoma Model Andreas, Ratzinger, Gudrun, Strohal, Robert, Riedl, Elisabeth, • Max Planck Institute of Colloids and Interfaces, Potsdam (Dr. Mairhofer, David G., Ortner, Daniela, Tripp, Christoph H., Lange-Asschenfeldt, Bernhard, Pehamberger, Hubert, Volc- Christoph Rademacher) Schaffenrath, Sandra, Fleming, Viktor, Heger, Lukas, Komenda, Platzer, Beatrix, Selhofer, Sylvia, Legat, Franz J., Muellegger, Kerstin, Reider, Daniela, Dudziak, Diana, Chen, Suzie, Becker, Robert, Reider, Norbert, Schmuth, Matthias, Hintner, Helmut, Juergen C., Flacher, Vincent, Stoitzner, Patrizia, Hofer, Angelika, Gruber-wackernagel, Alexandra, Aberer, Werner, JOURNAL OF INVESTIGATIVE DERMATOLOGY: 2015; 135: S. Quehenberger, Franz, Wolf, Peter, 2785-2793 ACTA DERMATO-VENEREOLOGICA: 2016; 96: S. 207-212

196 Research Report 2016 Medical University of Innsbruck Dermatology, Venereology and Allergology & Experimental Dermatology Research Unit

Research Report 2016 Medical University of Innsbruck 197 Department of Ophthalmology and Optometry Ophthalmology and Optometry

Research Branch (ÖSTAT Classification) liferation assays for certain cells. We work with different cell-lines: (1) cryo-preserved 301101, 301103, 301107, retinal pigment epithelial cells to study the 302055, 302080 significance of the pathogenesis of prolifer- ative vitreoretinopathy using migration and Keywords proliferation assays; (2) choroidal endothe- lial cells have been isolated and cultured Ophthalmic oncology, vitreoretinal surgery,­ from pig eyes,migration and proliferation retinal diseases, cornea, conjunctiva, assays serve to obtain a better understand- ­neovascularization, age-related macular ing of the pathogenesis of wet age-related degeneration, glaucoma macular degeneration; (3) retinal endothe- lial cells are cultured, the performance of Research Focus these assays is important for understanding the pathogenesis of proliferative diabetic Major research topics include diagnosis retinopathy. For the in vivo experiments, a and management of tumors of the eye, PhD student has been employed by means development of novel vitreoretinal surgical of an accepted grant proposal from the techniques as well as vitrectomy fluidics “Fonds zur Förderung der wissenschaftli- Director: research, basic angiogenesis research and chen Forschung” (FWF) (principle investi- Univ.-Prof. Dr. Dr.h.c. Nikolaos its suppression in an animal model, clinical gator: Prof. NE Bechrakis; title: VEGF and Bechrakis research of retinal, corneal and eye surface neuropeptides in experimental choroidal pathology as well as glaucoma research. neovascularization; P 26356-B23). The aim Contact: Special emphasis is given to development of the Head of this research unit is to always Anichstraße 35 of new diagnostic methods in various as- create an additional position for the labo- 6020 Innsbruck pects of epi- and intraocular diseases. ratory of this research institution, either a PhD student or a PostDoc. There are both [email protected] General Facts international as well as national scientific Phone: +43 512 504 23720 cooperations present to improve the quality Fax: +43 512 504 23722 Both basic as well as clinically-oriented of this research unit. Collaborations exist https://augenklinik.tirol-kliniken.at research is performed at the Department with Prof. Peng Loh (Bethesda, USA), Prof. of Ophthalmology/Medical University of D. Weber (PSI, Villigen, CH), Prof. S. Kaye Innsbruck. There are several clinically-ori- (Liverpool, UK), Dr. O. Gramlich (Dept. of ented research projects described below, Ophthalmology and Visual Sciences, Iowa for basic research a laboratory is available City, USA), Prof. Christian Humpel, Prof. which is appropriately equipped to perform Reiner Fischer-Colbrie and Prof. Rudolf science of high quality. Two medical techni- Kirchmair (from the Medical University of cians are employed, one responsible for the Innsbruck). cornea bank, and the other for performance of the methods of the research groups. Research Both in vitro as well as in vivo methods are established in the laboratory; the in vitro Quality Assurance in Ophthalmology methods include special migration and pro- The Department of Ophthalmology at the

Fig. 1: In vivo fluorescein angiography of the posterior pole of the mouse retina after laser induction of choroidal neovascularization. Early phase (left) and late phase leakage (right). The leakage areas are measured and quantified. Cumulative leakage is documented in the late fluorescein stages.

198 Research Report 2016 Medical University of Innsbruck Ophthalmology and Optometry

Medical University of Innsbruck is commit- ted to quality management programs based explicitly on continuous quality improve- ment and continuous quality control. Since 2013 a risk management system has been implemented in the Department. Two have recently been added additionally:

• Macular Pucker Registry Kralinger, Bechrakis Austrian Multi Centre quality manage- ment project in the surgical management of Macular pucker where more than 300 cases were analyzed. Fig. 2: In vivo examination of laser induced choroidal neovascularization in the mouse mod- el. The left figure shows an infrared en face image of the posterior pole of the mouse retina • Retinal Detachment Registry and the right image shows the in vivo optical coherence tomography (OCT) of one choroidal Zehetner, Bechrakis neovascularization spot. Implementation of a Retina detachment Register Innsbruck to analyze and eval- eration (AMD) and diabetic retinopathy next generation of drugs for more effective uate outcomes in retinal detachment (DR) are the leading causes of visual loss treatment of ocular vasculopathies. surgery. This project is integrated in the in ageing western populations. The current PD Dr. Zehetner was awarded two prizes for implementation of electronic patient files standard of care involves intravitreal ad- his excellent scientific work. both for out- (established in 2015) as well ministration of monoclonal antibody-based as for inpatient records (established in therapies directed against VEGF (Vascular Diagnostics in Ophthalmology 2016). Endothelial Growth Factor). VEGF is a mul- Blatsios, Bechrakis tifunctional cytokine that regulates antia- There are four projects in progress on this Vitrectomy Fluidics poptotic pathways of endothelial cells in topic. Firstly, a descriptive evaluation of the Zehetner, Bechrakis adult vasculature. Systemic VEGF acts as characteristics of choroidal melanomas pre- The goal of all vitreous surgery is to perform a vascular protective factor and is essen- and post-irradiation therapy using the laser the desired intraoperative intervention with tial for maintaining the integrity and the imaging system OPTOMAP® is performed. minimum collateral damage in the most effi- anti-thrombogenic as well as anti-inflam- Secondly, we aim to explore the clinical cient way possible. An understanding of the matory properties of the endothelium. Our assessment and ultrasound biomicroscop- principles of fluidics is of pivotal scientific study group could demonstrate that in- ic evaluation of sclera fixated intraocular importance. Fluidic stability is a main prin- traocular application of VEGF inhibitors can lenses. Next, a clinical assessment and ciple of vitrectomy within a closed system. induce a significant reduction of systemic ultrasound biomicroscopic evaluation of The flow rate of a Newtonian fluid through VEGF. Our study results are of translational sclera fixated toric intraocular lens will also a vitrectomy probe can be described by Po- relevance in regards to clinical safety. Sus- be performed, and finally, there is a joint iseuille’s law, but the flow of the aspirated tained reduction of systemic VEGF in gen- project with the Department of Physics and material during vitrectomy is more complex eral circulation is an inadvertent off-target Institute of Theoretical and Computational to characterize. Viscous material increases effect that might increase the incidence of Physics at the University of Crete, where the resistance of flow through the vitrecto- cardiovascular anti-VEGF class effects. The the fundamental principle of using quantum my probe and due to the constantly chang- selective therapeutic interference with fac- biometrics in retinal perception for subject ing outflow the inflow of balanced salt solu- tors of the proangiogenic signalling circuit identification should be described. tion (BSS) must be continuously adjusted. for the treatment of pathologic neovascu- The objectives of our study group are in-vit- larization is likely to result in compensatory N-Chlorotaurin Treatment and XEN 45 ro analyses of physical parameters related increases of other factors involved in this Gel Stent Implantation to vitreous surgery utilizing high-speed cut- process. This could induce converse regu- Teuchner ting 23-, 25- and 27-gauge (G) vitrectomy latory effects that might weaken the thera- PD Dr. Teuchner works on two topics: On probes. These results provide information peutic efficacy of antiangiogenic drugs. Our the one hand, the efficacy of N-Chlorotau- to surgeons about how small gauge probe study group found a significant systemic rin against candida albicans was investi- size and new double-cutting vitrectome de- upregulation of the proangiogenic cytokine gated in an ex vivo corneal infection model signs may affect the efficiency of bulk core PlGF (Placental Growth Factor) after intra- which provided evidence of a strong mi- vitreous removal as well as safety during vitreal administration of VEGF inhibitors. crobicidal effect; this could enable clinical shaving of the vitreous base. These labo- Secondary alterations of proangiogenic fac- use of this agent in infectious keratitis. On ratory parameters influence the choice of tors could potentially promote an escape the other hand, explorations on XEN 45 vitrectomy instrumentation and the intra- from angiogenesis inhibition and may be Gel Stent implantations were performed. operative safety of the respective surgical responsible for the decreased therapeutic The XEN 45 Gel Stent is an FDA approved techniques. efficacy or persistence of the neovascular device which is implanted through an ab tissue in patients undergoing intravitreal interno approach and reduces the intraoc- Anti -VEGF Therapy in AMD and DR antiangiogenic therapy. Identification of ular pressure (IOP) by creating a drainage Zehetner, Bechrakis factors that confer antiangiogenic drug re- channel between the anterior chamber and Neovascular age-related macular degen- sistance would enable development of the the subconjunctival space. It is considered

Research Report 2016 Medical University of Innsbruck 199 Department of Ophthalmology and Optometry

Ophthalmic Pathology Lab of the Depart- ment of Ophthalmology). Finally, treatment outcomes of various therapeutic modal- ities of intraocular tumors are analysed, especially in uveal melanoma. In coopera- tion with the Department of Ophthalmolo- gy (Medical University of Graz), treatment with photodynamic therapy or intravitreal anti-VEGF therapy are compared in cho- roidal naevi with secondary choroidal ne- ovascularization. Treatment outcomes are analysed as well in choroidal hemangiomas both by proton beam radiotherapy or by photodynamic therapy.

Neuropeptide Research Nowosielski, Troger, Bechrakis Fig. 3: Confocal image of a sclerochoroidal flatmount (ex vivo) with four choroidal neovascu- There is evidence that certain neuropep- larization spots visible (left line corresponds to 200 µm). The right Figure shows an enlarged tides act in a proangiogenic manner and image of one of the four choroidal neovascular membranes with capillaries depicted in red thus may contribute to abnormal neovas- (left line corresponds to 50 µm). cularizations in the eye. This might be the case for choroidal neovascularisations in wet age-related macular degeneration and a minimal invasive glaucoma surgery proce- a clinical study to describe vascular and also for retinal neovascularisations in prolif- dure as the collagen stent is placed with an in-vivo confocal microscopic changes in erative diabetic retinopathy. As a first step, injector through a 2mm small clear cornea ocular surface neoplastic lesions (OSN) in- the involvement of the neuropeptides sub- incision into the angle of the anterior cham- cluding squamous cell carcinoma, conjunc- stance P, neuropeptide Y and secretoneurin ber. As a result, the Stent showed an up to tival naevi, and malignant melanoma, with are currently investigated in laser-induced 50% drop of IOP in the early post-operative the aim to identify characteristics with high choroidal neovascularization (funded by the phase and no severe intra or post-operative diagnostic sensitivity and specificity to im- FWF). The induction of choroidal neovas- complications; the long term results are un- prove non-invasive diagnostic assessment cularizations due to laser treatment repre- der investigation. of OSN. sents a well-established animal model and the formation of neovascular membranes is Ocular Surface Imaging Group Diagnosis and Treatment of Intraocular analysed by different methods. The involve- Steger, Palme, Seifarth Tumors ment of these peptides is explored by the The “Ocular Surface Imaging Group” is fo- Haas, Blatsios, Zehetner, Bechrakis performance of experiments not only in cer- cusing on innovative diagnostic methods We are the only Department of tain knock out mice but also by intravitreal to quantitatively and qualitatively assess ­Ophthalmology in Austria which has es- injections of receptor antagonists in mice. the corneal and conjunctival inflammatory tablished proton beam irradiation for in- The results of these experiments will hope- response. Several articles were published traocular tumors. This treatment modal- fully provide novel treatment strategies in in 2016 including a) the use of anterior ity is performed in collaboration with the wet age-related macular degeneration. In segment optical coherence tomography Paul-Scherer Institute (PSI) in Villigen/CH. the future, the involvement of these pep- (­AS-OCT) to describe anterior stromal scar- tides should be explored also in a mouse ring associated with pterygium; b) the use The treatment is prospectively monitored model of proliferative diabetic retinopathy. of ocular surface fluorescence angiogra- for metastatic incidence, eye and visual Another aim of this research group is to phy to quantify corneal neovascularization acuity preservation, as well as radiation investigate the presence and distribution (CoNV), to describe the architecture and induced side-effects. Typical features of of granin-derived peptides in the rat eye, origin of CoNV, to guide the selective arteri- choroidal melanomas after proton therapy in particular of the serpinins, ­vasostatins olar fine needle diathermy of CoNV, and to using the OPTOMAP® imaging system are and of secretolytin and pancreastatin. assess conjunctival inflammation in atopic evaluated (see also above). Secondly, tu- Furthermore, the source of these pep- keratoconjunctivitis; c) the use of in vivo mour specimens are processed for analysis tide-containing nerves must be explored, confocal microscopy to describe a novel with various stains of melanocytic markers namely by determination of their sympa- inherited corneal dystrophy and to assess (HMB-45, Melan-A) to identify the type, thetic, parasympathetic or sensory origin. corneal stromal postoperative tissue re- histological tumour location and biological modelling after femtosecond laser anteri- characteristics. Furthermore, cytogenet- or lamellar keratectomy for the treatment ic aberrations are analysed in cooperation of corneal stromal dystrophies; d) the use with the Department of Human Genetics of optical coherence tomography to aid in (Medical University of Innsbruck) including lamellar keratoplasty. immunohistochemical BAP-1 (tumour sup- pressor gene) mutation detection, which While finishing these projects, the described should allow conclusions on prognosis and imaging techniques are currently applied in estimation of survival (established in the

200 Research Report 2016 Medical University of Innsbruck Ophthalmology and Optometry ©American Journal of Ophthalmology, 2016 ©American Journal of Ophthalmology,

Fig. 4: Kaplan-Meier survival curves displaying overall survival after diagnosis of metastatic uveal melanoma in 249 patients in the entire validation dataset (Top left); according to the Helsinki University Hospital Working Formulation for all patients (Top right); and for patients managed without surgery (Bottom left) and with surgery (Bottom right). Numbers below graphs are patients at risk and shaded ranges are 95% confidence intervals. Note that the intervals completely overlap when surgery was part of the treatment of metastases.

Selected Publications Selected Funding

Neoadjuvant proton beam irradiation followed by VEGF and neuropeptides in experimental choroidal transscleral resection of uveal melanoma in 106 cases neovascularization; P 26356-B23, FWF-Grant, Prof. Dr. Dr.h.c. NE Willerding, Gregor D., Cordini, Dino, Moser, Lutz, Krause, Lothar, Bechrakis Foerster, Michael H., Bechrakis, Nikolaos E., BRITISH JOURNAL OF OPHTHALMOLOGY: 2016; 100: S. 463-467 Collaborations Validation of a Prognostic Staging for Metastatic Uveal Melanoma: A Collaborative Study of the European Ophthalmic Oncology Group • Section of Cellular Neurobiology, Bethesda, USA Kivela, Tero T., Piperno-Neumann, Sophie, Desjardins, Laurence, Schmittel, • Dept. of Ophthalmology and Visual Sciences, Iowa City, USA Alexander, Bechrakis, Nikolaos, Midena, Edoardo, Leyvraz, Serge, Zografos, • Paul Scherer Institute (PSI) Villigen, CH Leonidas, Grange, Jean-Daniel, Ract-Madoux, Guillaume, Marshall, Ernest, • Department of Ophthalmology, Medical University Graz, A Damato, Bertil, Eskelin, Sebastian, AMERICAN JOURNAL OF OPHTHALMOLOGY: 2016; 168: S. 217-226 • St. Pauls Eye Unit, Liverpool, UK

Detection of tumour cells in the bloodstream of patients with uveal melanoma: influence of surgical manipulation on the dissemination of tumour cells in the bloodstream Charitoudis, Georgios, Schuster, Ronny, Joussen, Antonia M., Keilholz, Ulrich, Bechrakis, Nikolaos E., BRITISH JOURNAL OF OPHTHALMOLOGY: 2016; 100: S. 468-472

Sequential Bilateral Corneal Transplantation and Graft Survival Steger, Bernhard, Curnow, Elinor, Cheeseman, Robert, Romano, Vito, Kaye, Abigail, Jones, Mark, Kaye, Stephen, Natl Hlth Serv Blood, Transplant Ocular Tissue Advisory, Contributing Ophthalmologists OTAG, AMERICAN JOURNAL OF OPHTHALMOLOGY: 2016; 170: S. 50-57

Systemic Counterregulatory Response of Placental Growth Factor Levels to Intravitreal Aflibercept Therapy Zehetner, Claus, Bechrakis, Nikolaos E., Stattin, Martin, Kirchmair, Rudolf, Ulmer, Hanno, Kralinger, Martina T., Kieselbach, Gerhard F., INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE: 2015; 56: S. 3279- 3286

Systemic levels of vascular endothelial growth factor before and after intravitreal injection of aflibercept or ranibizumab in patients with age- related macular degeneration: a randomised, prospective trial Zehetner, Claus, Kralinger, Martina T., Modi, Yasha S., Waltl, Inga, Ulmer, Hanno, Kirchmair, Rudolf, Bechrakis, Nikolaos E., Kieselbach, Gerhard F., ACTA OPHTHALMOLOGICA: 2015; 93: S. E154-E159

Research Report 2016 Medical University of Innsbruck 201 Women’s Health Center Women’s Health Center

Research Branch (ÖSTAT Classification) Beside the Women’s Health Outpatient Clinic there is a research institute. This research in- 305902, 504013, 504014 stitute focuses on research on Gender Medi- cine and related topics. One main topic is the Keywords implementation of Gender Medicine into the curricula of all health professions. Gender medicine, women’s health, lifelong learning, prevention, affirmative action for At the Medical University of Innsbruck we women, work-life-balance provide courses on Gender Medicine in hu- man medicine, dental medicine and molec- Research Focus ular medicine, and in addition we also teach at the Fachhochschule Gesundheit (for mid- • How to get Gender Medicine into the wives and all technical-medical professions) Medical Curricula? and the school of nurses (AZW). • How to get Gender Medicine into the Clin- ic? Our research work focuses also on migra- • Gender Medicine and Prevention, Cardi- tion. We carry out numerous surveys with ology our migrant medical students, mainly the Director: • Women’s Empowerment, Women’s Ca- Turkish ones, and also with our Turkish pa- Univ.-Prof.in Dr.in reers, Work-Life-Balance tients. Recently we also conducted studies Margarethe Hochleitner • Diversity, Migration on German medical students studying at • How to deal with Sex and Violence in a the Medical University of Innsbruck. Contact: Medical Setting? Innrain 66/1st floor Another focus is on sex and violence. We 6020 Innsbruck General Facts developed a history-taking questionnaire including aspects of sex and violence, ap- [email protected] The Gender Medicine Unit includes a Wom- proved by the Ethical Commission for our Phone: +43 512 504 25710 en’s Health Outpatient Clinic focussing on all patients at the Women’s Health Clinic and Fax: +43 512 504 25719 Women’s Health issues. It is a routing station the midwives. The aim is to implement our http://fgz.i-med.ac.at/ within the University Hospitals. There is a paper into everyday clinical practice. special focus on migrant women. The Wom- en’s Health Clinic consists of an outpatient We work on numerous Women’s issues and clinic, but there is also a lot of activity out- are very pleased to have implemented Gen- side the hospital, like awareness campaigns der aspects in research topics, from basic and talks for women’s organisations. to clinical science.

Ring Lecture Series Gender Medicine

202 Research Report 2016 Medical University of Innsbruck Women’s Health Center

Ring Lecture Series Gender Medicine

Research

Implementation of Gender Medicine Sex and Violence Selected Publications We developed a questionnaire for patients into the Curricula Support for Female Physicians at a University Hospital: After completion of the EuGiM project on on sex and violence and started working What Do Differences Between Female and Male Physicians Tell Us? Lifelong Learning which developed Gen- with it at our Women’s Health Outpatient Siller, Heidi, Bader, Angelika, Hochleitner, Margarethe der Medicine curricula for implementation Clinic. Now we work with the midwives and In Roxane L. Gervais & M. Prudence M. Millear (Eds.), Exploring into master studies and summer schools their patients. Additionally we initiated a Resources, Life-Balance and Well-Being of Women Who Work in a Global Context Cham: Springer International Publishing. 2016, there is now a follow-up project EuGenMed project including questions to men about S. 109-123. “Roadmap for a gender-sensitive approach sexuality and violence, aiming to include Drafting intersections in the career of female medical doc- to health care research and practice in Eu- their experiences and needs in this topic. tors. rope”. The “Innsbruck Model” of integration Our aim is to develop a questionnaire for Siller, Heidi, Hochleitner, Margarethe In: Tsouroufli Maria, editor. Gender, Careers and Inequalities in of sex and gender in the different curricula all patients at all clinics that is accepted Medicine and Medical Education: International perspectives. UK: was cited as example of best practice. Addi- not only by patients but also by the pro- Emerald Group Publishing Limited; 2015: S. 99-125 tionally, various talks were held, e.g. at the viders, i.e. doctors. Furthermore, projects Turkish Migrant Women with Recurrent Depression: Results Claudiana, Bozen/South Tyrol, to inform with midwifery students (Master level) are from Community-based Self-help Groups Siller, Heidi, Renner, Walter, Juen, Barbara. about possibilities of implementing Gender planned to facilitate inclusion and imple- BEHAVIORAL MEDICINE, 0., 2015; doi: Medicine in the curricula. mentation of this topic in everyday practice. 10.1080/08964289.2015.1111858 Additionally we started to investigate expe- Dichotomien in der interpersonellen Gewalt unter Berück- Migration riences of discrimination, mistreatment and sichtigung einer Genderperspektive Siller, Heidi, Hochleitner, Margarethe We launched numerous questionnaires violence among employees and students. JURIDIKUM, 4, 2015: S. 505-515. with Austrian, German and Turkish medical Two medical students also included this students. The questionnaire asks for their topic in their diploma theses. Collaborations study situation, problems and barriers, but • Univ.-Prof.in Dr.in Vera Regitz-Zagrosek, Charité, GiM, Berlin/ also for their perception of sex and gender. There is also a PhD-student and a post-doc Germany • Univ.-Prof.in Dr.in Karin Schenck-Gustafsson, Karolinska, Additionally, focus groups with Austrian and working on the topic of sexuality and vio- Stockholm/Sweden Turkish medical students were conducted lence. • Univ.-Prof. in Dr. in Bettina Pfleiderer, Universität Münster • Assoc.-Prof.in Dr.in Petra Verdonk, Amsterdam Medical Cen- to get in-depth knowledge on specific bar- tre, Amsterdam/Netherlands riers and resources of medical students. • Univ.-Prof.in Dr.in Ineke Klinge, Maastricht University, Maas- tricht/Netherlands We also analyse sex and gender differences • Univ.-Prof.in Dr.in Alexandra Kautzky-Willer, MUW, Internal within these groups. A PhD-student and a Medicine, Vienna/Austria • Univ.-Ass.in Dr.in Caroline Voithofer, Leopold Franzens Univer- post-doc are working on this topic. sität, Zivilrecht, Innsbruck/Austria • Priv.-Doz.in Dr.in Susanne Perkhofer, FH gesundheit, Inns- bruck/Austria • Dr.in Waltraud Buchberger MSc, AZW, Innsbruck/Austria • ao. Univ.-Prof.in Dr.in Barbara Juen, Leopold Franzens Universi- ty, Institute for Psychology, Innsbruck/Austria • Prof.in Dr.in Patricia Davidson, Johns Hopkins University, Dean of the School of Nursing, Baltimore/USA • FH Gesundheit – Zentrum für Gesundheitsberufe Tirol GmBh • AZW-Ausbildungszentrum West Gesundheitsberufe der Tirol Kliniken GmbH

Research Report 2016 Medical University of Innsbruck 203 Institute for Neuroscience Neuroscience

General Facts neurotransmission, which occurs in differ- entiated postganglionic sympathetic neu- The Institute for Neuroscience is located on rons under the influence of target-derived the third floor of the building at Innrain 66 in signals. We identified the genome organiser close vicinity to laboratories of Psychiatry, Special AT-rich sequence binding protein 2 Neurology and Neurosurgery. Members of (Satb2) as an acutely up-regulated target the Institute participate in the FWF-funded gene of neurokine/p38 MAPK signalling in networks SFB-F44 and DK 106 SPIN. The sympathetic neurons undergoing trans-dif- Institute offers modern infrastructure and ferentiation. Our gain-and loss-of-function state-of-the-art research equipment. Lab- studies revealed that Satb2 is both neces- oratories include a stem cell laboratory li- sary and sufficient to trigger the sympathet- censed for biosafety level 2 work dedicated ic neurotransmitter switch. We reasoned to generation and differentiation of human that modulation of Satb2 and consequent- iPSCs. Procedures have been implemented ly chromatin architecture by neurotrophic to generate, stably maintain and differenti- factors might serve as a novel pathway in- ate human iPSC-derived cell lines. Separate volved in the long-term adaptive processes laboratory rooms are dedicated to work with underlying higher brain functions. nucleic acids and proteins. In addition, the Director: Institute supports a primary cell culture and In support of this hypothesis, recent re- Univ.-Prof. Dr. Georg Dechant animal transplantation laboratory. Rooms sults in our laboratory showed that Satb2 are fully-equipped with stereomicroscopes, is induced by plasticity-mediating extra- Contact: epifluorescence and confocal microscopes cellular signals such as BDNF or Ca2+-in- Innrain 66/G3 and a specialised room is dedicated to his- flux through L-type voltage-gated calcium 6020 Innsbruck tology, sectioning and immunostaining. channels in CNS neurons. The analysis of a conditional mutant lacking Satb2 in the [email protected] Research adult forebrain (generated by our group), Phone: +43 512 504 27297 demonstrated that Satb2 is required for Fax: +43 512 504 27390 Neuronal Plasticity Group synaptic plasticity and long-term memory www.i-med.ac.at/neuroscience Dr. Galina Apostolova formation. In addition, we found that Satb2 interacts with genome organising proteins Modulation of Higher-Order Chromatin of the inner nuclear membrane and regu- Architecture – Implications for ­Neuronal lates the geometry of neuronal nuclei in the Research Branch (ÖSTAT Classification) Plasticity hippocampus in vivo. Our findings give us 301402, 301114, 304003, 304007 Complex behaviours such as learning and grounds to hypothesise that a Satb2-con- memory depend on changes in gene ex- taining DNA-protein complex determines Keywords pression and subsequent long-lasting adap- both the nuclear shape and chromosomal tations in synaptic strength and structure. conformations in neurons downstream of Neuronal plasticity, neurotrophic factors, Our current research interests are focused L-VGCC and BDNF signalling, thereby inte- cell signalling, transgenic animal models, on the mechanisms of neuronal plasticity, grating plasticity-mediating extracellular induced pluripotent stem cells, neuronal with a special emphasis on the role of chro- signals into changes in the transcriptome. differentiation, human models of matin conformation regulation in adaptive Our future goals are to provide evidence neurological diseases gene transcription. that Satb2-dependent rearrangements of A classic example of neuronal plasticity is the nuclear architecture and/or changes Research Focus the switch from noradrenergic to cholinergic­ in the epigenetic profiles are necessary for

Our laboratory studies how nerve cells can be programmed and re-programmed de- pending on neural activity and neurotrophic growth factors. In transgenic mouse models we investigate activity-dependent mecha- nisms of learning and memory that depend on plastic chromatin reorganisation in the cell nucleus. Another focus is to generate neurons from stem cells. We are develop- ing protocols to differentiate human stem cells obtained with the "induced pluripotent stem cell" (iPSC) technology into specific neuronal populations. Based on these pro- tocols we have established cellular models of human neurological diseases. Fig. 1: Immunostaining for Satb2 in sagittal mouse brain sections reveals strong Satb2 ­expression in the cortex and CA1 area of the hippocamus.

204 Research Report 2016 Medical University of Innsbruck Neuroscience

Fig. 2: (A) Neurons from Spinocerebellar Ataxia type 6 (SCA6) patients are generated via differentiation of induced pluripotent stem cells (iPSCs) and neural progenitors cells (NPCs) (phase-contrast microscopy, scale bars: 75 μm). (B) human neuron express CaV2.1 channel protein (red) and MAP2 (green). Immunocytochemistry after 5 weeks of neuronal culture (confocal microscopy, scale bar: 10 μm). higher cognitive functions and that dysfunc- Friedreich Ataxia remain elusive, and no therapy is known. We tion of these mechanisms leads to learning Friedreich Ataxia (FRDA) is an autosomal re- generated iPSC lines from SCA6 patients and memory deficits. We also aim to study cessive neurodegenerative disease caused and differentiated them in neurons. We whether cognitive deficits inherent to nor- by an elongated intronic GAA repeat in are currently investigating the subcellular mal ageing and neuropsychiatric diseases the gene encoding the mitochondrial pro- localisation of CaV2.1 channel protein and are caused by alterations in Satb2 expres- tein frataxin. Peripheral sensory neurons neuronal excitability, calcium currents and sion or function. are the most susceptible cells for FRDA synaptic transmission in SCA6 neurons. pathophysio­logy. Animal models of FRDA Stem Cells and Neural Differentiation reproduced GAA repeat expansion, fratax- Group in deficiency, mitochondrial alterations and PD Dr. Roxana Nat neurodegeneration observed for the human disease, but the central questions con- Selected Publications The availability of human-induced pluripo- cerning FRDA pathophysiology remained Satb2 determines miRNA expression and long-term memory tent stem cells (iPSCs) and human embry- elusive: why are specific neuronal popula- in the adult central nervous system onic stem cells (hESCs) provides a unique tions particularly susceptible to FRDA and Jaitner, Clemens, Reddy, Chethan, Abentung, Andreas, Whittle, Nigel, Rieder, Dietmar, Delekate, Andrea, Korte, Martin, Jain, opportunity to investigate the mechanisms when during ontogeny does the pathology Gaurav, Fischer, Andre, Sananbenesi, Farahnaz, Cera, Isabella, of human nervous system development and manifest in susceptible neurons? To ad- Singewald, Nicolas, Dechant, Georg, Apostolova, Galina, its disorders. There are currently two major dress these questions, we have generated ELIFE: 2016; 5: S. e17361 areas of interest: patient iPSC lines and differentiated them Reduced Anxiety-Like Behavior and Altered Hippocampal Morphology in Female p75NTR(exon) IV-/- Mice to peripheral sensory neurons (Eigentler et Puschban, Zoe, Sah, Anupam, Grutsch, Isabella, Singewald, 1) To explore the molecular mechanisms al 2013). Mitochondrial functions and cell Nicolas, Dechant, Georg, that regulate PSC conversion into specific death are compared during in vitro matu- FRONTIERS IN BEHAVIORAL NEUROSCIENCE: 2016; 10: S. 103 neural progenitor populations, their neu- ration of control and FRDA iPSC-derived Alternative Generation of CNS Neural Stem Cells and PNS Derivatives from Neural Crest-Derived Peripheral Stem Cells ronal subtype specification and function- sensory neurons. Furthermore, we analyse Weber, Marlen, Apostolova, Galina, Widera, Darius, Mittelbronn, al maturation. To this end, develop and whether the frataxin deficit affects the pe- Michel, Dechant, Georg, Kaltschmidt, Barbara, Rohrer, Hermann, apply protocols for neural induction, pat- ripheral sensory neurons after their trans- STEM CELLS: 2015; 33: S. 574-588 terning and specification to human PSCs plantation in chicken embryos. Selected Funding based on knowledge of nervous system • 2013-2016 FWF DK W1206 “Signal Processing in Neurons" development. Spinocerebellar Ataxia Type 6 Dechant 2) To model human neurological disorders Spinocerebellar Ataxia type 6 (SCA6) is • 2013-2016 FWF Stand-alone project P25014-B24 "Role of genome organizer Satb2 in adult brain function" Apostolova with iPSC derivatives in order to under- an autosomal dominant neurodegenera- • 2015-2019 FWF SFB-F44 "Cell Signaling in Chronic CNS stand the molecular pathomechanisms. tive disease associated with the CACNA1A Disorders" Apostolova, Dechant • 2014-2016 FWF Standalone Project Nr P 26886-B19, "Modeling We reprogram patient-derived somatic gene, coding for the alpha 1 A subunit of Friedreich Ataxia with patient iPSC-derived neurons", Nat cells into iPSC lines, which are than differ- P/Q type voltage-gated calcium channel entiated into disease-relevant neurons. CaV2.1. SCA6 mutation consists of CAG Collaborations

Currently, our efforts are focussed on two repeats leading to a short expansion of a • Roland Foisner, Medical University Vienna; Vienna, Austria monogenic neurological diseases. polyglutamine stretch located in the cyto- • Marin Korte; TU Braunschweig, Braunschweig; Germany • Nicolas Singewald; Innsbruck University, Innsbruck; Austria plasmic C-terminal tail of the channel pro- • Andre Fischer, German Center for Neurodegenerative Diseases, tein. Currently, the pathogenic mechanisms Göttingen Germany

Research Report 2016 Medical University of Innsbruck 205 206 Research Report 2016 Medical University of Innsbruck FWF–funded ­Programmes

Doctoral Programmes (DK): DK Molecular Cell ­Biology and Oncology – MCBO DK Host Response in ­Opportunistic Infections – HOROS DK Signal Processing in Neurons – SPIN

Special Research Programmes (SFB): SFB-F44: Cell signaling in chronic CNS disorders

Research Report 2016 Medical University of Innsbruck 207 FWF ‑funded Programmes Molecular Cell ­Biology and Oncology

Research Branch (ÖSTAT Classification) participation from the University of Inns- bruck. The goal of the MCBO doctoral pro- 301110, 301114, 301206, gram is to equip young researchers with the 301902, 301904 knowledge, skills and attitudes necessary to excel in an independent scientific career Keywords in basic and applied bio-medical sciences.

Doctoral research training, molecular Training cell biology, Austrian Science Fund (FWF) Research training within MCBO is designed W1101 to prepare students for solving basic re- search questions and to teach in-depth Research Focus knowledge of cell biology with the ultimate goal of creating the basis for the develop- Research Training ment of novel treatments to fight preva- • State-of-the-art PhD training in molecular lent human diseases. To achieve this goal, cell biology and oncology MCBO is dedicated to providing its students • Benchmark training standards: compet- with a multitude of state-of-the-art method- Speaker: itive recruitment, training opportunities, ological skills, important basic knowledge ao. Univ.-Prof. Dr. international exchange in the field of cancer cell biology and tumor immunology, as well as with a set of com- Bernhard E. Flucher FWF DK Program plementary and transferrable skills required The DK-Program by the Austrian Science to perform front-line research. It is the main Contact: Fund supports structured PhD programs at goal of MCBO to teach its students strate- Biocenter, Innrain 80–82 centers of excellence at Austrian universi- gies that allow them to efficiently and suc- 6020 Innsbruck ties. Programs are initiated by consortia of cessfully study features of a particular mol- leading scientists and selected through a ecule or a specific signalling process at the [email protected] stringent international evaluation process. subcellular or single-cell level, as well as in Phone: +43 512 9003 70818 Programs are regularly reviewed and can be the context of an entire organism. Fax: +43 512 9003 73836 extended up to a total of 12 years. MCBO offers a comprehensive system of lectures and laboratory courses. Peer-re- www.mcbo.at General Facts viewed research projects, dedicated super- vision by three-member thesis committees Molecular Cell Biology and Oncology and a lively seminar program create a stim- (MCBO) is an excellence PhD program at ulating research environment, conducive to the Medical University of Innsbruck funded the successful completion of the PhD. by the FWF (Austrian Science Fund), with

Research Training

208 Research Report 2016 Medical University of Innsbruck MCBO Team at mid-term retreat

Research Funding

• Established in 2005 Austrian Science Fund (FWF): • 34 students enrolled € 10.037.000 • 56 students graduated Medical University Innsbruck: • Students from 21 nations and 3 continents € 3.365.000 • More than 180 publications University Innsbruck (LFU): • Competitive recruitment € 250.000 • Courses and lectures in English Total: • Three to four years thesis research € 13.652.000 • International symposia and meetings • Six-month stays abroad at prestigious universities like the University of California (San Francisco), John Hopkins University (Baltimore), Karolinska-Institut (Stockholm) and many more.

MCBO Students

Research Report 2016 Medical University of Innsbruck 209 FWF ‑funded Programmes HOROS - doctoral programme of excellence

versity of Innsbruck (MUI), one is heading bacteria and fungi, but also of complement the Institute of Biomedical Aging Research related kidney diseases. He is the coor- (IBA), now part of University of Innsbruck / dinating speaker of all MUI doctoral pro- Leopold Franzens University (LFU). It is en- grammes and also head the related doctor- visaged to strengthen the cooperation be- al programme "Infectious Diseases". tween both local universities in the coming periods. Four members of the consortium The Role of the human Bone marrow in are medical doctors - one works at bedside the regulation of immune responses in and 3 mainly preclinically - two are natural old age scientists. All 6 contribute to various as- Univ.-Prof.Dr.med.Beatrix Grubeck-Loeben- pects of host-pathogen interaction, com- stein (Deputy- Speaker, LFU) prising inherited and acquired immunity. On Beatrix Grubeck-Loebenstein direct the In- the infection side fungal, bacteriological or stitute for Biomedical Aging Research (IBA) virological models are in use. which is now part of LFU. She is a leading scientist in biogerontology and in particular General Facts in the immunology of old age and has in- augurated the related doctoral programme From Basic Research to Clinical immen- “Aging”. Her contribution to HOROS will Speaker: tation bridge the medical and science faculties of ao. Univ.-Prof. DDr. HOROS is carried out by scientists and both universities. Reinhard Würzner physicians working in clinical departments or “pre-clinical” research institutes of both Siderophore- mediated diagnosis of fun- Contact: universities, thus providing an important gal infections translational link between basic research Ao.Univ.-Prof.Mag.Dr.rer.nat.Hubertus Haas Schöpfstrasse 41 and clinical application. MUI is very inter- (MUI) 6020 Innsbruck ested to have a broad and excellent DK on Hubertus Haas is working at the Biocenter. “Infection, Immunity & Transplantation”, He is a basic scientist involved in fungal dis- [email protected] one of its major officially stated research eases and in particular is interested in the Phone: +43 512 9003 70707 topics. A strong liaison with industrial part- iron homeostasis of the fungus and the role Fax: +43 512 9003 73700 ners has been established for supplementa- of iron as a virulence factor. One of his tar- www.horos.at ry funding. HOROS fosters even closer col- gets is siderophores which allow the fungus laborations between research groups, the to acquire iron in hostile environments. strategic added values lie in an attractive Research Branch (ÖSTAT Classification) educational curriculum, more coherent and practical than previously. HOROS provides 106023, 106024, 301902, a perfect means to finance research stays 302020, 303020 of PhD students in collaborators’ laborato- ries and a “HOROS annual retreat”. Thus, Keywords HOROS strengthens the scientific environ- ment of the research campus Innsbruck Host response, opportunistic infections, im- that attracts not only the best students, but munity, transplantation, biogerontology also distinguished scientists to the campus.

Research Focus Research

Scientists and physicians of the Innsbruck At present, 16 PhD students study in campus working in the related fields of in- connection with HOROS. HOROS has or- fection, immunity, transplantation and/or ganised a scientific retreat together with biogerontology decided to join forces and PhD students from Univ. of Copenhagen created a structured and multidisciplinary and has participated in the MUI Life Sci- research and training programme of excel- ence Day, both in spring 2016. In 2017 lence (DK). Their intention is to investigate HOROS is applying for a second and thus genetic and environmental parameters, final four-year-period, which would start in which destroy immune homeostasis during March 2018.The projects of the HOROS host-pathogen interaction, thus leading to faculty members are: opportunistic infections. Such infections seldomly develop in healthy individuals but Identification of factor H binding com- quite often in immuno-compromised sub- plement evasion molecules in fungi jects. The consortium originally consisted Ao.Univ.-Prof.DDr.Reinhard Würzner HOROS retreat in Obergurgl with PhD of 7 members (Prof. Kotsch has taken up a (HOROS-Speaker, MUI) students from Univ. of Copenhagen and professorship in Berlin). Five of the remain- Reinhard Würzner is an expert in comple- lecturers from Copenhagen, Erlangen, ing 6 members work at the Medical Uni- ment evasion strategies, in particular of Helsinki, Oslo and Oxford, March 2016

210 Research Report 2016 Medical University of Innsbruck HOROS work group

Establishment of a human lung tissue Role of NRAMP-1 (Natural resistance-as- Selected Publications model to study fungal infections sociated macrophage protein 1) in the • https://www.i-med.ac.at/mypoint/news/678834.html • https://www.i-med.ac.at/mypoint/news/685914.html Univ.-Prof.Dr.med.Cornelia Lass-Flörl (MUI) control of host resistance against infec- • https://www.i-med.ac.at/mypoint/thema/689516.html Cornelia Lass-Flörl direct the Division of tion with intracellular bacteria • https://www.i-med.ac.at/mypoint/news/698948.html Hygiene and Medical Microbiology. Her re- Univ.-Prof.Dr.med. Günter Weiss (MUI) search focuses on fungal infections with a Günter Weiss is professor of clinical immu- Selected Funding special emphasis on the diagnosis, preven- nology and infectious diseases at the Dept. • HOROS - doctoral programme of excellence, FWF DK tion and therapy of invasive infections and of Internal Medicine. His research interest W1253-B24, € 2.380.000 antifungal drug resistance. focuses on disorders of iron homeostasis Collaborations and host-pathogen interaction with a spe- • Peter Zipfel, Univ. Jena, Germany Influence of donor and recipient age on cial emphasis on regulatory interactions be- • Peter Garred, Univ. Copenhagen, Denmark • David Denning, Univ. Manchester, Great Britain the outcome in SOT (Solid Organ Trans- tween iron homeostasis, natural resistance • Beate Kehrel, Univ. Münster, Germany plantation) genes and immune function in various infec- • Jürgen Löffler, Univ. Würzburg, Germany • Axel Brakhage, Univ. Jena, Germany Univ.-Prof.Dr.rer.nat. Katja Kotsch tions. He is the coordinator of CIIT at MUI. • Ioav Cabantchik, Univ. Jerusalem, Israel Katja Kotsch was working at the Dept. of • Ferric Fang, Univ. Washington/Seattle; USA • Andreas Radbruch, DRFZ Berlin, Germany Visceral-, Transplantation- and Thoracic • Guiseppe del Giudice, Novartis, Siena Surgery and has recently taken up a profes- • Stefan G. Tullius, Univ. Boston, USA • Ondrej Viklicky, Univ. Prague, Czech Replublic sorship in Berlin. Her PhD student moved • Thomas Pietschmann, Univ. Hannover, Germany with her and will soon finish her PhD in Ber- • Alexandra Trkola, Univ. Zurich, Switzerland lin, as the university has recognized all her achievements under the wings of HOROS.

Mechanisms for the specific acquisition of complement regulatory proteins by HCV (Hepatitis C Viruses) Ao.Univ.-Prof.Dr.rer.nat. Heribert Stoiber (MUI): Heribert Stoiber is specialized in medical microbiology and virology; he is deputy head of the Division for Virology. His re- search focuses on the interplay of viruses with the complement system, in particular with evasion mechanisms that viruses apply Horos or Horus, Egyptian god of in order to circumvent the lytic action of the protection from disease, patron for doc- human complement system. toral programme of excellence HOROS

Research Report 2016 Medical University of Innsbruck 211 FWF ‑funded Programmes Signal Processing in Neurons – DK SPIN

What is SPIN? der to reach a new level of understanding of the fundamental integrative processes that SPIN is a joint doctoral program at the Med- govern the signalling within and between ical University of Innsbruck (MUI) and the nerve cells under normal and pathological University of Innsbruck (LFUI). It was estab- conditions. To that end, the network has in- lished in September 2007 with the support itiated a variety of integrated PhD projects. of the Austrian Science Fund (FWF) and offers interdisciplinary postgraduate train- The SPIN program has identified three ing in translational Neuroscience for excel- broader areas of research: lent Austrian and international students. It • molecular/cellular neuroscience combines the expertise in Neurosciences • neuronal physiology and pathophysiology across departments, making it currently the • behavioural neuroscience only FWF-funded doctoral college in Austria with an exclusive focus on Neuroscience. Training in SPIN

Research The field of Neuroscience has changed con- siderably in the past few years, increasing Speaker: SPIN focuses on inter- and intraneuronal the demand for highly-trained Neuroscien- signalling mechanisms in both health and tists. The main goal of SPIN is to equip its Univ.-Prof. Dr. disease and concentrates on the role that students with the practical and theoretical Francesco Ferraguti fundamental molecules involved in neural knowledge they need in order to contribute signalling may have in neurodegenerative substantially to future scientific advances Contact: diseases, neuroinflammation and plasticity. in Neuroscience. In order to obtain a PhD Department of Pharmacology The network thus strongly focuses on the at our institution, students must carry out Peter Mayr Str. 1a development and characterisation of novel an experimental study and complete the 6020 Innsbruck cellular and animal models. In order to in- courses in the PhD curriculum. SPIN stu- vestigate the neural mechanisms by which dents work under the tutelage of a super- [email protected] the brain produces adaptive and maladap- vising professor and a board of advisors, tive behaviours, the SPIN network uses the “Thesis Steering Committee” (TSC). In Phone: +43 512/9003-71204 an integrative, crossover approach. SPIN addition to the supervisor, the TSC consists www.neurospin.at steers towards stronger interactions be- of two experienced researchers that guide tween students and faculty members in or- the student. Throughout the process of

212 Research Report 2016 Medical University of Innsbruck preparing the thesis, the steering commit- tee evaluates and supervises the progress of the PhD work in regular and structured meetings with the student.

Spin Activities

The SPIN network meets on a bi-weekly ba- sis for the progress reports. At the progress reports, two students present the progress of their research to other students and fac- ulty members and the members have the opportunity to discuss various matters. SPIN students also benefit from the many extra activities that the network offers. These include a lecture series, to which stu- dents get to invite senior scientists of their choice, as well as career development activ- ities and annual retreats.

SPIN in numbers

PIs: 9 Departments: 8 Current students: 18 ( 10 female, 8 male) Alumni: 29 (17 female, 12 male) Nationalities: 15 Student Publications: 97

Funding SPIN Faculty Members and students

FWF: 6.904619,50 € (until the end of 2019) ao. Univ.-Prof. Dr. Nadia Stefanova MUI: 2.613743,50 € (until the end of 2016) Department of Neurology, Division of Neurobiology SPIN Faculty ao. Univ.-Prof. Dr. med. Gerald Zernig Univ.-Prof. Dr. Christine Bandtlow Experimental Psychiatry Unit Division of Neurobiochemisty Associated Members Univ.-Prof. Dr. Georg Dechant Institute for Neuroscience Univ. Prof. Dr. med. Lars Klimaschewski Department of Anatomy, Histology and Univ.-Prof. Dr. Francesco Ferraguti Embryology Department of Pharmacology Univ. Prof. Dr. Hans-Günther Knaus Univ.-Prof. Dr. Frank Edenhofer Department of Molecular Pharmacology Department of Genomics, Stem Cell Biology & Regenerative Medicine (LFUI) Assoz. Prof. Dr. Alexandra Koschak Department of Pharmacology and Univ.-Prof. Dr. med. Michaela Kress Toxicology (LFUI) Department of Physiology and Biomedical Physics Ao. Univ-Prof. Dr. Markus Reindl Department of Neurology ao. Univ.-Prof. Dr. Christoph Schwarzer Department of Pharmacology Univ.-Prof. Dr. Alois Saria Experimental Psychiatry Unit ao. Univ.-Prof. Dr. Nicolas Singewald Department of Pharmacology and Univ.-Prof. Dr. Gregor Wenning Toxicology (LFUI) Department of Neurology, Division of Neurobiology

Research Report 2016 Medical University of Innsbruck 213 FWF ‑funded Programmes SFB-F44 – Cell Signaling in Chronic CNS Disorders

linked. Strong local expertise is bundled ised by oligodendroglial cytoplasmic inclu- to study calcium-mediated, epigenetic and sions of fibrillaryα -synuclein (α-syn) and non-coding RNA (ncRNA)-mediated regu- associated with progressive multisystem latory mechanisms to disclose the role of neurodegeneration. Our group will provide these pathways for the pathophysiology of detailed characterisation of the functional Parkinsonian disorders (Parkinson’s dis- phenotype of a transgenic mouse model ease, Multiple System Atrophy), Alzheimer’s with targeted overexpression of α-syn in disease and abnormal fear and anxiety and oligodendrocytes as an important readout more recently autism spectrum disorders. for preclinical drug screening for MSA. To identify underlying pathogenic mechanisms Members and Projects MUI and candidate targets for future therapies, Gerald Obermair, Bernhard E. Flucher, we will focus on the putative bilateral in- Division of Physiology teractions between epigenetic factors and Importance of Intra- and Extracellular Cav1.3 α-syn aggregation and propagation in MSA Modulators for Synapse Stability in Normal models. The outcomes are likely to critically and Diseased Striatal Medium Spiny Neurons enhance our insights into the pathogenesis In brain dendritic spines are small postsyn- and progression of MSA. The results will Coordinator : aptic membrane protrusions on neuronal have immediate relevance for interventional Univ.-Prof. Dr. Jörg Striessnig (LFU) dendrites involved in excitatory synaptic target discovery which in turn will promote transmission and synaptic plasticity. Neu- future clinical trial activities in MSA patients. Contact: ronal L-type calcium channels are located Alexander Hüttenhofer, Division for Department of Pharmacology and in dendritic spines and contribute to the Genomics and RNomics Toxicology - Institute of Pharmacy, local concentration of the ubiquitous sec- Identification of Regulatory ncRNAs in Innrain 80-82, Innsbruck ond messenger calcium. Thereby, calcium Chronic CNS Disorders University of Innsbruck (LFU) channels integrate synaptic signals, ef- This project aims to identify regulatory fect changes in spine morphology and the ncRNAs involved in neuronal development [email protected] synaptic structure and contribute to basic and chronic CNS disorders. Using special Phone: +43 512 507 58801 neuronal functions including learning and probes and techniques recently developed Fax: +43 512 507 58899 memory formation. Neurological diseases in this lab, ncRNAs that are regulated in www.uibk.ac.at/pharmazie/pharma- are often accompanied by synaptic adap- disease and may therefore contribute to kologie/sfb-f44/ tations including altered form and function signalling pathways involved in neurodegen- of dendritic spines. For example, a specific eration will be identified and characterised. loss of dendritic spines of striatal neurons Existing expertise will also be used to probe General Facts has previously been shown to be involved in for regulatory ncRNAs participating in L-type the pathology of Parkinson’s disease (PD). calcium channel-mediated plasticity and nu- As outlined in previous reports, the major Interestingly, a loss of dendritic spines in the clear signalling in various neurons. research goal of the SFB-F44 is to improve striatum may also underlie the development Georg Dechant, Galina Apostolova, our understanding of molecular mecha- of L-DOPA-induced dyskinesia, the major Institute for Neuroscience nisms relevant for normal brain function and debilitating side effect of the common treat- Function of Special AT-rich Sequence- their dysfunction in human central nervous ment for PD. In publications during the first Binding Protein 2 (SatB2) in Aging and system (CNS) disorders. A better under- SFB funding period, we identified a specific Neuronal Pathophysiology standing of disease-relevant processes is role of a specific L-type calcium channel and Complex behaviours such as learning and particularly important in neuropsychiatric its interaction with postsynaptic proteins in memory depend on changes in gene ex- and neurodegenerative disorders, which regulating the stability of dendritic spines. pression and subsequent long-lasting adap- would ultimately lead to improvement of Building on this important result, we now tations in synaptic strength and structure. currently drug therapies, which are often un- test in the ongoing project whether and Current research interests of this group satisfactory. The development of novel and how this proposed mechanism contributes are focused on the mechanisms of neuro- improved therapeutic strategies requires to the aetiology of PD and other neuronal nal plasticity, with special emphasis on the the identification of innovative targets for diseases, such as autism. We are employing role of chromatin conformation regulation therapeutic intervention. Therefore, com- high- and super-resolution fluorescence mi- in adaptive gene transcription. A classic petent laboratories at the two Innsbruck croscopy and state-of-the-art electrophysi- example of neuronal plasticity is the switch universities joined their complementary ex- ology. Our results will contribute to the un- from noradrenergic to cholinergic neuro- pertise to comprehensively study signalling derstanding of synaptic during transmission, which occurs in differentiated pathways that bear such potential. The ma- neurological disorders and probe the ther- postganglionic sympathetic neurons under jor research focus is on L-type calcium chan- apeutic potential of targeting the identified the influence of target-derived signals. We nels (LTCCs) and epigenetic modulators, in- synaptic mechanisms. identified the genome organiser Special AT- cluding histone deacetylases (HDACs) and Nadia Stefanova, Gregor Wenning, rich sequence binding protein 2 (Satb2) as non-coding RNAs. These pathways partici- Department of Neurology an acutely up-regulated target gene of neu- pate in the aetiology of several neurological Alpha-synuclein – a Pathogenic Trigger and In- rokine/p38 MAPK signalling in sympathetic and neuropsychiatric disorders. Moreover, terventional Target in Multiple System Atrophy neurons undergoing trans-differentiation. recent findings from our consortium show Multiple system atrophy (MSA) is a distinc- Gain-and loss-of-function studies of this that they can be (patho-) physiologically tive neurodegenerative disorder character- group revealed that Satb2 is both necessary

214 Research Report 2016 Medical University of Innsbruck and sufficient to trigger the sympathetic neu- tally addressed by means of a multidisci- Jörg Striessnig, Department of rotransmitter switch. Therefore, modulation plinary approach combining optogenetics, Pharmacology and Toxicology of Satb2 and consequently chromatin archi- viral monotransynaptic tracing and novel Role of Cav1.2 and Cav1.3 Calcium- tecture by neurotrophic factors might serve ultra- structural techniques. A mouse model Channels for Parkinson’s Disease and as a novel pathway involved in the long-term for non-motor symptoms of early PD, lacking Neuropsychiatric Disorders adaptive processes underlying higher brain motor impairments, will also be established L-type calcium channels (LTCCs) have re- functions. In support of this hypothesis, a and characterised. Therefore, this project cently emerged as novel drug targets for the recent publication in our laboratory showed will complement other investigations within treatment of Parkinson’s disease (PD) with that Satb2 is induced by plasticity-mediat- this SFB on aberrant signalling mechanisms already licensed or new channel blockers. The ing extracellular signals such as BDNF or leading to selective neurodegeneration (e.g. concentrations of available drugs required for calcium-influx through L-type voltage-gated PD), altered neural plasticity and abnormal effective block, the LTCC channel isoforms in- calcium channels in CNS neurons. The anal- fear memory processing. volved in PD pathophysiology and the mecha- ysis of a conditional mutant lacking Satb2 in nisms of neuroprotection are still not known. the adult forebrain (generated by our group), Members University of Innsbruck (LFU) This group recently also published evidence demonstrated that Satb2 is required for syn- Nicolas Singewald, Department of that human mutations causing an increase aptic plasticity and long-term memory for- Pharmacology and Toxicology in the activity of brain LTTCs, in particular the mation. In addition, we found that Satb2 in- Epigenetic Mechanisms in Aberrant Memory so-called Cav1.3 subtype, because neuropsy- teracts with genome organising proteins of Regulation chiatric diseases such as autism spectrum the inner nuclear membrane and regulates Effective long-term treatment for fear and disorders (ASD). This suggests a pathogenic the geometry of neuronal nuclei in the hip- anxiety-related disorders is a continuing and thus also potentially therapeutic role of pocampus in vivo. Therefore Satb2-contain- challenge. One emerging treatment strate- brain LTCCs beyond PD. New tools and assays ing DNA-protein complex may determine gy is to combine exposure-based cognitive developed to determine if LTCCs in the brain both the nuclear shape and chromosomal behavioural therapy (CBT) with cognitive are blocked as effectively as Cav1.2 channels conformations in neurons downstream of enhancers. Key results from the first SFB in the cardiovascular system. This allows pre- L-VGCC and BDNF signalling, thereby inte- funding period (FP) support the utility of this dictions if already licensed drugs can be used grating plasticity-mediating extracellular approach for long-term fear inhibition. Spe- for neuroprotection in PD or the therapy of signals into changes in the transcriptome. cifically, we provide evidence that histone selected ASD patients with Cav1.3 mutations. Future goals are to provide evidence that deacetylase (HDAC) inhibitors and facilitat- Meanwhile, suitable mouse models were es- Satb2-dependent rearrangements of the ing dopaminergic signalling act as cognitive tablished that will allow studying the function- nuclear architecture and/or changes in the enhancing strategies to rescue aberrant al consequences of human ASD mutations in epigenetic profiles are necessary for higher fear extinction consolidation in S1 (129S1/ different tissues, in particular the brain. Final- cognitive functions and that dysfunction of SvImJ) mice. Recently published evidence ly, we ask the question if knockout of Cav1.3 these mechanisms leads to learning and does indeed show that non-coding RNAs, channels or chronic inhibition of these chan- memory deficits. Another aim is to study including microRNAs (miRNAs), additional nels leads to compensatory upregulation of whether cognitive deficits inherent to nor- promising targets to exploit novel pro-cogni- other ion channels that could counteract their mal ageing and neuropsychiatric diseases tive properties supporting extinction mem- pharmacological action. These highly transla- are caused by alterations in Satb2 expres- ory formation. Building on results obtained tional questions will be addressed in collabo- sion or function. in the 1st FP, we now aim to elucidate the ration with other members of the consortium. Francesco Ferraguti, Institute or how and where in the brain HDAC inhibi- Our work has immediate relevance for the bet- Pharmacology: Dopamine Regulation of tion, enhancement of dopaminergic signal- ter understanding of calcium-dependent hu- Amygdala Inhibitory Circuits: Relevance for ling, interference with non-coding RNAs- or man disease mechanisms and ongoing drug Pathological Fear Structures Cav1.3 mediated-signalling can augment discovery in industry. Parkinson’s disease (PD) is classically con- fear extinction to form a persistent and con- sidered as a movement disorder resulting text-independent fear inhibitory memory. In Members from other Universities­ from the loss of dopaminergic (DAergic) addition, we aim to improve the tolerability Birgit Liss, University of Ulm neurons. However, a number of non-motor of exposure-based therapy by combining Ludwig Aigner, Paracelsus Medical symptoms, including pathological fear and the therapeutic actions of non-sedative ­University Salzburg anxiety, predate the emergence of motor anxiolytic drugs which do not impair ex- impairment. PD could then be seen as a tinction learning and appropriate cognitive Associated Members multi-dimensional disease. Dopamine ex- enhancers. Finally, this project started to Alexandra Koschak, Department of Pharma- erts a pivotal role in the regulation of fear re- identify potential epigenetic biomarkers in cology and Toxicology, University of Innsbruck sponses most likely by affecting GABAergic blood cells that can be associated with the Klaus Liedl, Institute of General, Inorgan- trans- mission within the amygdaloid com- sensitivity to and the extent of the therapeu- ic and Theoretical Chemistry, University of plex. We postulate that pathological fear in tic effect of exposure therapy in anxiety dis- Innsbruck; early PD results from altered associative order patients. Revealing mechanisms via Alexandra Lusser, Division of Molecular plasticity in the basolateral amygdala (BLA) which the rescue of impaired fear extinction Biology, Medical University Innsbruck; mostly dependent on the reduced function can be achieved in a better tolerated, per- Eduard Stefan, Institute of Biochemistry, of DA on specific local interneurons. In addi- sistent and context-independent manner is University of Innsbruck; tion, enhanced phasic DAergic transmission expected to foster the rational development during fear extinction training may facilitate of novel cognitive enhancers which may be Publications extinction learning and the concurrent plas- used as augmenting CBT adjuncts to treat See: https://www.uibk.ac.at/pharmazie/ ticity. These hypotheses will be experimen- anxiety disorders more effectively. pharmakologie/sfb-f44/publications/

Research Report 2016 Medical University of Innsbruck 215 © S. Schwarz

216 Research Report 2016 Medical University of Innsbruck Core Facilities

Research Report 2016 Medical University of Innsbruck 217 © S. Schwarz

© S. Schwarz

218 Research Report 2016 Medical University of Innsbruck Core Facilities

Protein Micro Analysis Biooptics/Light microscopy tion of 3D model prints of the objects and The protein facility established at Innsbruck The Biooptics/microscopy facility of MUI, substances examined under high resolution Medical University is dedicated to provide located at the new CCB (room 01.370), down to μm scale. Where applicable infor- investigators with equipment, expertise and aims at providing university wide access to mation is passed on to competent partners. custom services for the detection, char- advanced equipment, such as automated Contact: acterization and quantification of proteins widefield fluorescence microscopes, con- PD Dr. Wolfgang Recheis and peptides on a recharge basis. The fa- focal microscopes (LSM and spinining disk) [email protected] cility maintains a suite of state of the art and a gSTED superresolution microscope Phone: +43 512 504 24216 instrumentation including different mass (Nobelprize 2014 to Hell and colleagues) spectrometers (e.g. QExactive HF and LTQ which is offered in cooperation with the High Resolution Ultrasound Orbitrap XL from ThermoScientific) coupled LFU Innsbruck, training, education and ex- With the beginning of 2016 a high-resolution to nano-LC gradient systems and capillary pertise in light microscopy. The facility cur- ultrasound device (VisualSonics Vevo1100) electrophoresis. Also trace element anal- rently offers assisted access to research will be on hand at the Cardiac Surgery Re- ysis is provided using a Solaar M6 Dual microscopes and image processing soft- search Laboratory. The new ultrasound de- Zeeman spectrometer (ThermoScientific). ware. Moreover a number of courses are vice facilitates non-invasive, functional, and Services include comprehensive protein offered within the different PhD training image-based analyses of different organ identification of simple and complex pro- programmes at MUI. systems in mouse, rat, and (with limitations) tein digests, quantitative proteomics using Contact: rabbit. The technology allows for a time-re- isotope labeling strategies (e.g., SILAC, PD Dr. Martin Offterdinger solved analysis in individual animals, which iTRAQ, TMT), localization and quantification [email protected] results in increased data quality with a si- of post-translational modifications (phos- Phone: +43 512 9003 70284 multaneous reduction in the number of ex- phorylation, acetylation, methylation, etc.). perimental animals. The system facilitates Contact: FACS Sort Core Facility high resolution, time-resolved, and func- ao. Univ.-Prof. Dr. Herbert Lindner The Innsbruck Flow Cytometry Unit pro- tional in vivo imaging of moving structures [email protected] vides access to state of the art analytical e.g. heart. Phone: +43 512 9003 70310 and sorting flow cytometry instrumentation Contact: and technology and offers professional cell PD Dr. Johannes Holfeld Metabolomics sorting service to the research communi- [email protected] The mission of the Core Facility Metabo- ty in Innsbruck. The facility also provides Phone: +43 512 504 80800 lomics is to serve as an enabling resource training in flow cytometer use and data for research and development programs. analysis for students, researchers and staff, Neuroimaging Research We aim to provide expertise and state-of- and supports investigators in experimental The main modality of this CF is the the-art technologies for the qualitative and design of flow cytometric applications. In ­BMWFW­-funded 3 Tesla-MRI-system, which quantitative analysis of small bioorganic addition, educational courses on recent ad- establishes a core facility for MR-based molecules. Common targets are drugs, vancements in flow cytometry are regularly neuroimaging research at the MUI. The 3T pharmaceuticals, endogenous compounds, organized. MRI started work exclusively for research and metabolites thereof included in all kinds Contact: use in 2012. The CF-NIR is centrally admin- of biological samples (e.g. biofluids, cells, PD Mag. Dr. Sieghart Sopper istered by the Head of the Department of tissues). The analytical method of choice [email protected] Neuroradiology, who leads an interdiscipli- is mass spectrometry (MS). Usually MS is Phone: +43 512 504 26332 nary Steering Board. The technical equip- hyphenated to chromatographic Methods ment is supported by one physicist and an (liquid chromatography or gas chromatog- Deep Sequencing assistant radiographer. The Team “Neurora- raphy). The Genome-Seq Core is an integral part of diology” provides support to all associated Contact: the Innsbruck Medical University Biocenter, scientists in technical and post-processing o. Univ.-Prof. Dr. Richard Scheithauer providing large-scale sequencing to the lo- questions. Furthermore, the core facility [email protected] cal and international research community. develops and introduces new MR sequenc- Phone: +43 512 9003 70601 We aim to provide the highest level of ser- es and technical equipment. Above all, the Assoz. Prof. Dr. Herbert Oberacher vice, confidentiality, and support, working Neuroimaging platform offers opportunities [email protected] with the researchers to reach their goals. to bring different groups together and to Phone: +43 512 9003 70639 Contact: transfer knowledge, and it provides a set- Univ.-Prof. Dr. Alexander Hüttenhofer ting for communication and cooperation in Sequencing and Genotyping [email protected] neuroimaging. A recently acquired BMWFW The Sequencing & Genotyping Core Facil- Phone: +43 512 9003 70250 grand (Neuroimage WING) is an excellent ity was founded in 2004 and focuses on Anne-Margrethe Krogsdam Christensen, example of this interdisciplinary and in- high throughput DNA sample processing, MSc PhD ter-universityorientation. SNP genotyping, real-time PCR, Sanger [email protected] Contact: sequencing and analysis of mitochondrial Univ.-Prof.in Dr.in Elke Ruth Gizewski MHBA DNA using both Sanger and next-generation Micro CT [email protected] sequencing. High-resolution cross-sectional imaging Phone: +43 512 504 24202 Contact: examinations and non-destructive 2D and Univ.-Prof. Dr. Florian Kronenberg 3D structural analyses in μm scale based [email protected] on x-rays. Support and implementation of Phone: +43 512 9003 70560 advanced image analysis and image pro- Dr. Stefan Coassin cessing and visualization methods with [email protected] high-performance programmes, as well as Phone: +43 512 9003 70576 Finite Element (FE) analyses. Implementa-

Research Report 2016 Medical University of Innsbruck 219 Imprint Research Report 2016 of the Medical University of Innsbruck

A publication of the Medical University of Innsbruck; editors and layout: Pamela Schech, Johannes Ghetta, BSc, Damla Celikel; Servicecenter Forschung, Schöpfstraße 45, A-6020 Innsbruck Language editors: a. Univ-Prof. Dr. Paul Debbage, Mag. Gudrun Thurner, PhD, Mary Creighton, Dr. Agnes Balog Images: Medical University of Innsbruck, Florian Lechner, Christof Lackner; ao. Univ.‑Prof. Dr. Siegfried Schwarz Pictures of buildings: MUI/Christof Lackner, MUI/Franz Oss, Siegfried Schwarz, MUI/Kinderklinik, MUI/Romed Hörmann Cover layout: Servicecenter Forschung; cover photos: MUI/Lechner, MUI/Dr. Martin Hermann & ao.Univ.-Prof. Dr. Cornelia Speth, MUI/Lackner Printed by: Onlineprinters GmbH, certificated by FSC and PEFC; produced climate neutrally; electronic version: KULTIG Werbeagentur The head of the research unit is responsible for the content and pictures of the relevant­ contribution. Typing and printing errors reserved.

220 Research Report 2016 Medical University of Innsbruck 221 Research Report 2016 Medical University of Innsbruck 222www.i-med.ac.at Research Report 2016 Medical University of Innsbruck